<SEC-DOCUMENT>0000049071-23-000025.txt : 20230426
<SEC-HEADER>0000049071-23-000025.hdr.sgml : 20230426
<ACCEPTANCE-DATETIME>20230426150720
ACCESSION NUMBER:		0000049071-23-000025
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230426
DATE AS OF CHANGE:		20230426

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HUMANA INC
		CENTRAL INDEX KEY:			0000049071
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				610647538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05975
		FILM NUMBER:		23849172

	BUSINESS ADDRESS:	
		STREET 1:		500 W MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202
		BUSINESS PHONE:		5025801000

	MAIL ADDRESS:	
		STREET 1:		500 W. MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXTENDICARE INC
		DATE OF NAME CHANGE:	19740404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HERITAGE HOUSE OF AMERICA INC
		DATE OF NAME CHANGE:	19671129
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>hum-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:a7548c89-cbcc-4020-9549-0b2a193c2a02,g:7564a905-24e2-4ab4-9ab3-db550d1e5638,d:91c607a8fabc48adb102d5eefcab1efa--><html xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:hum="http://www.humana.com/20230331" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hum-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80L2ZyYWc6ZWFhNjNkMDg0MjJhNGQ3ZDg4NzYyOWNmZGJhOTE2OTgvdGFibGU6YzdkNWJkNDQxZGMzNDE2ZmI2OGJhNzI3YmE3NzU5ZTQvdGFibGVyYW5nZTpjN2Q1YmQ0NDFkYzM0MTZmYjY4YmE3MjdiYTc3NTllNF8yLTEtMS0xLTE3ODkyNQ_82a4fd8b-20a7-4395-9c04-a1f8c98c1a20">0000049071</ix:nonNumeric><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80L2ZyYWc6ZWFhNjNkMDg0MjJhNGQ3ZDg4NzYyOWNmZGJhOTE2OTgvdGFibGU6YzdkNWJkNDQxZGMzNDE2ZmI2OGJhNzI3YmE3NzU5ZTQvdGFibGVyYW5nZTpjN2Q1YmQ0NDFkYzM0MTZmYjY4YmE3MjdiYTc3NTllNF8zLTEtMS0xLTE3ODkyNQ_5dd11146-a110-41f0-8e22-d56173591ce8">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80L2ZyYWc6ZWFhNjNkMDg0MjJhNGQ3ZDg4NzYyOWNmZGJhOTE2OTgvdGFibGU6YzdkNWJkNDQxZGMzNDE2ZmI2OGJhNzI3YmE3NzU5ZTQvdGFibGVyYW5nZTpjN2Q1YmQ0NDFkYzM0MTZmYjY4YmE3MjdiYTc3NTllNF80LTEtMS0xLTE3ODkyNQ_e7bdfbf0-188e-4d08-b73e-6753a6abea2f">2023</ix:nonNumeric><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80L2ZyYWc6ZWFhNjNkMDg0MjJhNGQ3ZDg4NzYyOWNmZGJhOTE2OTgvdGFibGU6YzdkNWJkNDQxZGMzNDE2ZmI2OGJhNzI3YmE3NzU5ZTQvdGFibGVyYW5nZTpjN2Q1YmQ0NDFkYzM0MTZmYjY4YmE3MjdiYTc3NTllNF81LTEtMS0xLTE3ODkyNQ_247d0609-2408-4b85-8d5b-f890d6f89ac8">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80L2ZyYWc6ZWFhNjNkMDg0MjJhNGQ3ZDg4NzYyOWNmZGJhOTE2OTgvdGFibGU6YzdkNWJkNDQxZGMzNDE2ZmI2OGJhNzI3YmE3NzU5ZTQvdGFibGVyYW5nZTpjN2Q1YmQ0NDFkYzM0MTZmYjY4YmE3MjdiYTc3NTllNF82LTEtMS0xLTE3ODkyNQ_759c20de-77ea-4d65-80cc-a351eef95d49">false</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMy9mcmFnOmNlZDMzMmVmNmU1MTQ3NzA4MzYwYmZjM2M1NTk3ODgyL3RhYmxlOjhmZmFmZjRhYjU5NjQxM2ViYTY2MTQzMzdiNmFiOTQ3L3RhYmxlcmFuZ2U6OGZmYWZmNGFiNTk2NDEzZWJhNjYxNDMzN2I2YWI5NDdfMy0xLTEtMS0xNzg5MjU_8872b42b-6f36-4675-a1a3-a9798c2ff68c">0.1667</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMy9mcmFnOmNlZDMzMmVmNmU1MTQ3NzA4MzYwYmZjM2M1NTk3ODgyL3RhYmxlOjhmZmFmZjRhYjU5NjQxM2ViYTY2MTQzMzdiNmFiOTQ3L3RhYmxlcmFuZ2U6OGZmYWZmNGFiNTk2NDEzZWJhNjYxNDMzN2I2YWI5NDdfMy0yLTEtMS0xNzg5MjU_a87f0a3e-d9d4-455b-8f20-9e992376e001">0.1667</ix:nonFraction><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNS0wLTEtMS0xNzg5MjU_c2bb13b4-0c36-4c9b-9e4c-42a20ef7d4d9">http://fasb.org/us-gaap/2022#HealthCareMember</ix:nonNumeric><ix:nonNumeric contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNS0wLTEtMS0xNzg5MjU_fb53923e-7f4e-463e-930a-0bbb5507b029">http://fasb.org/us-gaap/2022#HealthCareMember</ix:nonNumeric><ix:nonNumeric contextRef="ie7875175150c464986253f694017f369_D20221201-20221231" name="hum:TRICAREManagedCareSupportContractBaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTA5OTUxMTY1MjExMw_2669b125-bc7d-4903-8a53-f6a32cfce9ee">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hum-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0b3e6cb82b043229c6de3f534953330_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i192cbe1b72e34457bc41adff9b0e5179_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67be62ec4a604c6baeeae7c8acfa32da_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie80b91c2c2c84ebb871c1ba1a0f82413_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f0bb767b8b44c9bb4b925e7d6846b4c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib43b2bdef5554a95a305773800d5f4f6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c80fc54c1ed425abb2f454166ba8b76_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieef509857c8e4467a2fc109e0bf10f4b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie764c2fbaa0e46349d4f04c484a4ae01_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaee9f0e494b544da926fe616f385aac5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b281d1bbb96464f86dd82da174e2334_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0d2f28ca1ea4a64ae9ed5eee0ba5068_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8a695ef6e9d487ab733b856a3f72501_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff79ee49692740f8b35cbc8e80b347a0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4750367ee1e4a689f97fa9022bdf5e4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33bde0043da6450e8ef28277a10de49e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id38d4d0509824793b1c7ea2b970a5957_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie443272811ed49d6a8d422744f898488_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00969cc0983a4871891aca903e70709b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb4314807c944d55b84b257f3f3dc4cc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i608d6a1b874146d8b2906b872c802885_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id52b99f262dd4f5fbc64485fdc490c62_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i070b3a983b8d4c1c9d6d883ff6c49107_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fb1c5dba70e4995a50495bdf4c7e1d3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd32fea20e5e4fba97023cd2a12758d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a2924212fff4b95a06c6336134700a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide04b81f591a460480759551ea2d4c60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1f1a85fe48643ddad4b2657effc5ddc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if66f7e3bde694a2fa6f2b9ad88e258ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69b771e99aeb411385b87bc78aba0005_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefba7d8c1a25422f8083be1c96fbf1fd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id26120571436434494bfb975fa78d99e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice488527531041f1bea3aaf535bacb76_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0da5c588273f46f9b2f1a42b9dd81da4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i342c27c8ea80488ba306fb99128b5cf4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f2a8ed54eca45fba1b5a8a2a7875edb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i623ed6554dfa4892b099de29261154be_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d833c58d6684d1fbe8a6b639c1c2914_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9be79b2b55e54535aff3cbec252b67f5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1bd06ce061245718d7a679efdb9836b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55a5772c9e08479ba75577876ccf8013_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2449d3dd94054171a333473a8b30e8d9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffa2d44aeefe49eb901d869a778d954f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86b101ff14884b76ba0a3e3909ff5915_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hum:ValueCreationInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba36eec577cb4c97b3c20a998f977679_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hum:ValueCreationInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa05aa9eea8340d1a4b6993427e169a6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dfc221ac14a4241a352cd2c7e2133be_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="iec2ff4cf5f8a4840a5cfda8104745276_I20220811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:GentivaHospiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f3a5a6a5bd240fd8dc9dddaaf415109_D20220811-20220811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:TermLoanDueOctober2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:GentivaHospiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-11</xbrli:startDate><xbrli:endDate>2022-08-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i774b70cfc8b949b4b88dc4f2aefa89c5_D20220811-20220811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:GentivaHospiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-11</xbrli:startDate><xbrli:endDate>2022-08-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7411361d05ab46818cbd5d7ff1e21d74_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:GentivaHospiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47c85cc668754e14a243b50fa57763f4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0051509dd034287a67b025711d2b730_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15abec1371de4cf7bf934abdac554c41_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2aab95a3fa1453f9e1ad63604416346_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib51726213f4349ada57bbe678b9ecbe9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54bb3ec275a04853bd67cc69eda788a6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81fc15fb6f8747a3b130af075be61c68_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i390f059dfaec48feb01a156d8783fc91_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i890ddd7992a2436fb3eeb7c9589676f4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87f38b14697145628ecc307a28156bc7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39a81466c1f7403098573c8663478092_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i996180d89c8e4507a623f2af94aa1a1b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29186f806c58412193bb9d3fb6965e02_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if809f4ba53f94156aaf6671a93356b6a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:GentivaHospiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8260b100247b44eea92f3356e1b28db7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsAARatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>hum:position</xbrli:measure></xbrli:unit><xbrli:context id="i96e6af2307314f46be9d1d0b03502013_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc24f5c05d5441b6ac8827d88f991c2e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1a5f1cccae8416f9bc599fff3f8e1d4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b13e4a05827464d8b24ae1ead744fbd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if65bf87d9361462aaf0a0ac5f9556c38_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a47acf1908a40b2af4d3cd0d68e3910_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d921a49fc8e435386aef2bf71f59872_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6bbb7d6ca004e8a908a13b5eed703ec_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id68f6d863b0042c2b99dadf26d204628_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if14d9ee3acf541a8a80edb1dae2c5c51_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i450207aa5894438f9c2c646c0ce9982d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i857c0bd469ed4f57a4d62245b9c850ad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82a7da6de90f4292a75b4ff142ac0839_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i904a6646c1c74766ad237ced5460d3b7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81015bdf666841988a8d3083b77b955b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb95cb15ca9b431f83fabb95130459cb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8862232402c4d6eaf52edf65048202e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72d189fde50f4d818a6f390bc4fc11a1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b4080af65ca47cfb1edb387d17a5d36_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic00c16389c034f59895277e520697c6f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie692d3daf2da432f84a4d2bba4f54421_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37b5903d02c84da3b134cc8b5828e4e6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2d2e19b91464e48b9c851e183850d14_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1ff90bae9d54e1e973a6a3fee17c018_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72ea4b788a8f48c185d7fda9b12db75c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d6e7427cc38408f801653d6fe0309ba_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib81031dfb7aa4eef857cf826a330605d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbc4c8c594954395822ec239de2a59f9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc8d3332e21f4115ad4811a1901d881a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i340393b9ebe54ab2b5864af5e584548c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10a5e9db863849bcad9826c573d3ad01_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fbc3e66d57845169e1aff68c77b3197_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92ee919d2f184cf7949d0916d4f1ccb1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f44fd8b7d7943429ac546aea13d21f6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f045e713b3f4183a844967854a098d2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0a9a1917c8f47a5836ac770133b8421_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70628c781dab4482bf2a82089e58407c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60e56a4abb3148b3a47ea17e821ce331_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb9d324ecf5045808b96815c38a7eaaf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a9a3430ebaf429886fbd03e394bb465_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa02a4a665234d36b7de271c9e9e73b4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b2bd12e6e20458f8f4892b3040ac67e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dddf02ed2304674986163307e834a6c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3c66b776082466ea556dce65306d942_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ec9bf427d0d47a3b08bf8a294f9efd9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a211d5ff9bb4a4589e60af4080172f9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i060d5600c50d4d6093631349614ca333_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic732fa8df9034ee0a649c2601e5b6cff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9037b2b16c75430caac0e82c3c767c2e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc036307c91f4c9593abeaff015430b2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic82ffec88c8042de8e8a1dbf644279a5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73062b9f6c3946998028a6772ce9264f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37d0240334144c13b97f059cadb7034b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd5d6eb79ea5478c9f1ec177266b62cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6858edb4103a4d41ae1249f6acf86c38_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i779b10a8a0554fe5a72d0d42c1badb15_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd635cbfddf44141945808c29cbc55eb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia39754b4e45940db8cb97fe1ff3d7880_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c84525d35214f6c9815e8351adfd02a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39fc8e1461704c80aef7a77108d678a7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e057100f4124140bac2dcc36e38be91_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03be5b990dcd41ed91f338937639131a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i581027d290ae46cfa11f5ee26717a967_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib330972c763d4fdfab8db010a1908b51_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2516335975c48cf807e97640b5043bf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">hum:FairValueRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba4807ab291b411ba709086ff2b0ca6b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4b60d2223724b5b852a7861a92b748d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64b0b2cce9c4429eb7e08589df09657a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2298c1aedcf4c389d4500f8dfca5cd7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7dfa681e84e4a328abd29adc43edeb8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">hum:TermLoanAndCommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffacfea7d72c41969e8c61520fc3f3fe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">hum:TermLoanAndCommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aecae41941c4949a148814d02c27b4c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c4cd7500ddd4042987e2f54456204e8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9241eb7b1705466a9f42cbc6c027a7e3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9c5e672fb5646a5b6ef97e6cd7e5fe2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib841b2af88bc479392f83bdf0da74d8a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86e34249f19741d8bfc9dfb0d72a9a0a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i213d04e139894278bd43204227e8da44_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52c5649fd533485aa955d121bd05719e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57134d84c2ac447a84c8200c372a35f8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a0d174b8c8d4fe0ba5550e6b43544fa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idee655553fa24a6bbe52a7b3d4ca04ad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20d1e957c4434a06af24cf6ac0397e7f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f0f9995f95947629017ed8fed503fa1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61634fa707254b90a8db03c0fa13102a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic46ba81be64948dfb5b93511ef5de0cb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i580fb323c37c4b618f287b4d6dfa7f5a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i000d5227848d42249813688992aac2b1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i377cc2a8446b4761b2676862a02afc19_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93acdee7a8de48d2ad5e50b6216e5223_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6060040f6de2440d9e22ed16c9c48f07_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32ddf5d36d5045038d50eaf21c6818b2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f173f5f0d7a4516ad1a0ff666bedec2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17047b60198b4741bd5ebeea3412295e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">hum:RiskCorridorSettlementsMedicarePartDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62763ccb5eac4f28974a0b1010e8a360_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">hum:CmsSubsidiesOrDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22ea645d881244feb48020446f2c6961_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">hum:RiskCorridorSettlementsMedicarePartDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1755902072d64e9cb2f6181073517a64_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">hum:CmsSubsidiesOrDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2ccf77cbd704aa9a50f730c09b643b5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93e22a22917143fb9f847c7288ff5d00_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic69f76c986f34f1b9ba9eb7a9c317d65_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83bf3dc5af6c4f2eb6caaad2ac9f84b8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i602a0549ee5e4de58fd4f6d95c040179_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54bd717275cd4a1ba7a908f4c92495ab_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd572f2390164976be20fe3a140197cd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">hum:CertificateOfNeedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d23511b94f84defb1f54af0330dc9e3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">hum:CertificateOfNeedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3178f9117bab4d4788c41331f0e1dc09_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0802607a67b4c848b58734b6b762529_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i150ea53c09e74fcb851b6053b9e40298_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8054b45e04e441f6b73aeb7346969a3c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f7aaf3b0b0d4b86bbe081d04e1b0c0e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d0ef9aa2df04dada2b6de53639369a3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48b4610f5eff4676ae8a83d142ee62a3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58b795c8e2a749b195affd66d768c0f8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i209ef83489cc4686aca29a75e66a999e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i355b7a91cbe642259e6c7b0a6b9415a5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i586b2df071664278b33320a690171b5a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7208e156cf594c919494eb2550d73a05_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:NoncompetesAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1186c96f23294e26be46ab0face47239_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:NoncompetesAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88f55df1f8fe486285179afd07008365_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:NoncompetesAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a2c0126f2424bb8ab0ee87fe08cb666_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e434f71448049a284869f73abeb0b98_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i930b18f4afe34fec9820ff5a19092628_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7542e08ec319422a9b4c757d3a9accd0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b9ac383e9ea4b719311556136d97415_D20230127-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-27</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i855926020dce4bea9a6964c5647f3657_D20230201-20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22b1e29a3e1c4bc98acae1e9ce50b759_D20230401-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab7b66d9b316428980dce49fe22290b3_I20230215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:A2021ShareRepurchaseAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c95ac6806e14b6bbfa8a1f730d7bb0b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:A2023ShareRepurchaseAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b88da85e02742d1b115a353bcae6004_I20230425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5378147acd6413d98ab4a87badd98a5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66bc861b6d684110a1c01760cf75a9d9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia745190caecb4ad18029594fbd44dad9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A065PercentSeniorNotesDueAugust2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia91bce3ad2614069b112478f13ea4bbd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A065PercentSeniorNotesDueAugust2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0baef8994ca946c49745a0878f83ccea_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86bac7559acf4a0a8e9e4af23f7cc8ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a64f9f747cc4b969bd58c5a210d96b8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.85PercentSeniorNotesDueOctober2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8ee81e69e7d4f708f12b170210cf50e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.85PercentSeniorNotesDueOctober2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2dbfa0791a746e891144da65c98163c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A450PercentSeniorNotesDueApril2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i601f7293934844dd8581d285010fe8a3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A450PercentSeniorNotesDueApril2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f93bb52470a423f83007bbe6311ef88_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A570PercentSeniorNotesDueMarch2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i769a17d71bce4bc9ad29794468e1d407_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A570PercentSeniorNotesDueMarch2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f1e6a5d467542119ee41abdb08e8bfe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A135PercentSeniorNotesDueFebruary2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice043f0edb0b45ebb9871681a935057d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A135PercentSeniorNotesDueFebruary2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if56c1215e57f42b58ee613738b0f54df_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.95PercentSeniorNotesDueMarch2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9826367b47364f6383b302d5941fb1b3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.95PercentSeniorNotesDueMarch2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc6dc428ebc14290b36d57fb1719bf13_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A5750PercentSeniorNotesDueMarch2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i352c829a0e07400faa05ac2176bc9839_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A5750PercentSeniorNotesDueMarch2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26e5ceadc3fd4816b11932771a952db5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3700PercentSeniorNotesDueMarch2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia978a4df05104b8d9e0c86ae761b25a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3700PercentSeniorNotesDueMarch2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf8ec40657e04aa2b23060d00732bdef_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3125PercentSeniorNotesDueAugust2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib78aa39252ea44aea1a09bb8f388149d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3125PercentSeniorNotesDueAugust2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14cc50d065954e1287d2acb52e3f4d75_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4875PercentSeniorNotesDueApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbbf8eeed67d47678e97ce557e665c35_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4875PercentSeniorNotesDueApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf517366f109416a81eaf87157f208a6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A215PercentSeniorNotesDueFebruary2032Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i091bf184716543a691cccbef4e0a6911_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A215PercentSeniorNotesDueFebruary2032Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1987ecea13f144a6b016db1433b4edad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A588PercentSeniorNotesDueMarch2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4828bda4e27e4c81a26419b5e9fcf71d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A588PercentSeniorNotesDueMarch2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c2bb3882bf541f0b41f0a999f57989e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A8.15PercentSeniorNotesDueJune2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecb222c03b6b4488b13789f1508b415c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A8.15PercentSeniorNotesDueJune2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9d6ead9d85d451e8b8a7651924f9bc1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.625PercentSeniorNotesDueDecember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11064c69b1ae4ba6a3588922076a07a4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.625PercentSeniorNotesDueDecember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7717d896545c4a218cf32e09098785e2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.95PercentSeniorNotesDueOctober2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7032ea7ab0740d38bc437206fc5d938_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.95PercentSeniorNotesDueOctober2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd3cf22ac75d404380d62b35ce279abb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.80PercentSeniorNotesDueMarch2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i287c4ed0af71453dbafbd6c72bda52cd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.80PercentSeniorNotesDueMarch2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15cd5b523c8b45408ca5a4cfbcaadc77_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A395PercentSeniorNotesDueAugust2049Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie58ccd3ad9cf4484869350e55c97daa9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A395PercentSeniorNotesDueAugust2049Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81618d62a5464513a79e9149e2a960be_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A550PercentSeniorNotesDueMarch2053Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44f39416bf6d42a18eb86f26dba70f57_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A550PercentSeniorNotesDueMarch2053Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14a912e506d74aabb1927dc325a1b647_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d06da66baf1438495bd1819635d56fc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia699014a8a7c45b4877ccab91d786647_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80317ae1ece041a3be5e392acc5b7f32_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c6800fd78e7409d9fc9e4e3e89146b1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A570PercentSeniorNotesDueMarch2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e6bb461948f467880d14a15c5c56cc4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A550PercentSeniorNotesDueMarch2053Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6722660df9ae426fba8939630f33aba2_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4600a55e099c4531bc7d43ae4f7b2b61_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6ef86f63d5c4341b776612f407688ab_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if954b4dd458243c192b80a70934aab3b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i277382cd831d44e68146d96819af483f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfe7731c31ef4c5d8ace727574933dbc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16a8b22589364b0cabcaeebe88c025fd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac8c9ca5d8d047529559c7212dd98d0a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cfe16f46375489ab53b2a64c31248d4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic709c99d9e6e4394aec61e0022ddc186_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id20841ace72748718a4437b57f98c65a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb617ce6644248ea8db1728a74bbbf53_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4480f878da3046eca330bf17a448e268_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hum:TRICAREContractAxis">hum:TRICARE2017EastRegionContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ff845a818d94f94ab5d91f1b9bd6c7e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hum:TRICAREContractAxis">hum:TRICARE2017EastRegionContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>hum:state</xbrli:measure></xbrli:unit><xbrli:context id="i0bc5a60bb99048cbad4400d49e4dcfe7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hum:TRICAREContractAxis">hum:TRICARE2017EastRegionContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="beneficiary"><xbrli:measure>hum:beneficiary</xbrli:measure></xbrli:unit><xbrli:context id="ie7875175150c464986253f694017f369_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hum:TRICAREContractAxis">hum:TRICAREManagedCareSupportContractEffective2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78f2374ea9724509bf4c2fb579684e3f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hum:TRICAREContractAxis">hum:TRICAREManagedCareSupportContractEffective2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="option_period"><xbrli:measure>hum:option_period</xbrli:measure></xbrli:unit><xbrli:context id="i05af7d59e35843539a7b53e907c4cb75_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>hum:segment</xbrli:measure></xbrli:unit><xbrli:context id="i7aa8e3070afb4b448db7275ed5cf09ca_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4319d9cb6494f90a71ae9662c3e17d5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i470b8c2f91574be1a05a696adddc73d9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i941da18a02fd4a139b8237908e1baf76_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30d50dfae3c94d26a91ba9941b08ff7f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81af849246674d489655377c62775fed_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66882a36b65243afb23812e2ec2c1d48_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41ce6672cc904de4a0fa8074bf62a0c4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia631787e98fd47d59231450f5a5d6e0c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i993a679845f947fab947d46e0ae0bc4a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c8a4218c34d47a989b327c872bb0ba7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05c27701e7bf4a9eb3938c2a39eb4494_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85424f2642a04af48e0d21aa6e0a0e12_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialFullyInsuredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06996810dd5b475591115e20ef9e8d24_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialFullyInsuredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1aed85758234038bfaf99ea4aaa00a2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialFullyInsuredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfaab4185db447efbc4d239013c8fa8a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a0dbdb752344a29bf7a8dc0c0719182_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib49f1498622e4c778b5d7aa7fc4c3199_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9ac0ab1a1dc41678e04eee0f1f1ad54_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4b77a33b1934d86a91aee24b2970f4d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9c99fa97fdd46efa402ed8333894c1f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96917ef2e24c4974a71ff8d5a0ea7000_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22a98e5c970f455fa835963d955ebff1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30b27af532384e309d0f76b56db9d08a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i902976e0e687455ea7079d0816405649_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6382c523c2c14c259a92f891ff8641e2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bb29b1e903c42e8b12951e278dbb473_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i047ea355a1614e12b9cde7bc63efd653_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6268a711de84001a5c09e366d9a3963_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic03ae8d1abd346bfa0535b979b06277d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b40b350a7fb4e1d870155ce20f7d278_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43a33ad615e44970a83fb6e045c08ff2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dcae53256ef467fa83afa413e3c23fc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialASOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bd5912c45d1492f813493782cbdbc80_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialASOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4acc50637daf4886ae4c4f6c103cb12c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialASOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7da82ae3b48451ab567fe66a54b3194_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94f607e57a414dbd88161908a6184c14_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36acb1a7c1d345b3943ed7a3681da4d7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cc60e9c797f4763ae37557308571d2b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e3ed6555fe4401e81ef3b5e8e4a7609_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfea55c447bc431e88f5dd8ccd9676b6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i809bb5ba4494400f9c6448d500364985_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e8cff38f04f46889b1ef765ac327305_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f7364cde4984551936b23d0ec98a423_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83c34f3a227048a392485f67a2c322db_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i305512b6bb2e4e2e9206830a3cba8e75_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2682fa4c07b74a9c8032dd2cfde6c7b5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i924faf8bcd494d4faa31ef8543a91f5d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e2db9b6b2644ba4bfd40bfe1aec493e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i918c5fb606154cbba2f8731c331034bd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aa3a9ceced248e495a3ebf2f980dced_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2b6b9a177e640c9b1223decda0a16fb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e2b6793244a439ca56ce9a5219dc82d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib02c4523f3fe4bc4867f91bdf4482fc4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b8563afa71d4ffebd8b2d1bf8f9abc9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf26032dd8144e439cadbdd99e543c72_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i665f623ad1564c0f801b7a6398439b3f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e6586aa7b7c4bfeb6055f8260cb2050_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaeba68a15074c20a7a47147aa79fb77_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0c10c27bb084521b8749197d596563b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78789613dafe4a62a86c3ef058061f4c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05630ac13ae84efdb04206d248841934_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc8d8e3c20604d8987b4b3655c1d1355_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialFullyInsuredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3d1b9e97d684afc9b309b5a8dc2e4d6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialFullyInsuredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if043a642b7914944bf349068b08d7044_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialFullyInsuredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a01bf5c57d243ffb4876ff5019fcd4e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6079fbef93f6490d97c24453e1658164_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie50e4586d40f4d86b9ebbc2912804444_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i065f8703eb4643deb20037003c705c1b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00a4268e2aca40b19aab2ba00cb0f314_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0f2b22146644209b8afa3fee32230c6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb2fc93318814cb9b70dd7040ef479f3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cd9580b0c9c484ea82d73c64b502501_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e3541bbcdc747cbbd38489ad83936dc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dcfae0532054fd79308e5a557cced34_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb9f8bafe49f47b49a45569e1bcb1998_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d60c49195f64463b8e21dd65e9c6e65_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd6bb8d1d674435d811376f081f0a3dd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc893a7474a44474861813dd6d84ae6e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i949a7d5c28cd498e91c058a16f06bbe6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i851a87a7f05942cdbf990ae5cd30af78_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic07c1d16537a42429449e7882849141c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialASOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66f6101ae0774289b5b8751a4634d40e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialASOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b2d48e3ac324ec08b2ca88ab3f53e55_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialASOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i335400f88d18407a92f768050cebbf44_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7edb8e82518e4dc5b3fb898234ab15cb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf6ff2b013bb4cff8f0653d9c2b0488d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7fbf5c1d49c42e5bed343c27eeb8965_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd793a27f90f404091d71353a03a9ae4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2e0f4edd2b64c2e85362a841a3aa4c4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91de43b8e733413cacc845a70df17963_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i717dfb30995240bb96ad4c44b5acfbad_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i027d84a6dd0d47719c06eedaeaa90374_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2020e045c5147f5a45fe1de02a9f902_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i746462efde464666b16b26676cbe2082_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf76fe4fdae4409e884a7ac6c029af9b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97353868e33140a2b65bce298de17656_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i536c52251be647d6987d688d1febcad5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b05f4d2446843fa8e4a6429ac7a6e41_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id04b5505b5b949b4b46f6df5221ff61b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3ccf78d11e54281b041b1ad37820d52_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i91c607a8fabc48adb102d5eefcab1efa_1"></div><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDEy_1019ebb1-ae6a-4dc2-ad9d-b39363ef0350">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"></td><td style="width:5.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.490%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6YWM1NTllZGU5YTE2NGEyYTg4Nzk5ODk5ZDhmMTJiODQvdGFibGVyYW5nZTphYzU1OWVkZTlhMTY0YTJhODg3OTk4OTlkOGYxMmI4NF8wLTAtMS0xLTE3ODkyNQ_a005e5ed-d416-48c3-9d16-e636f96f0b54">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d)&#160;OF THE <br/>&#160;&#160;&#160;&#160;SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8xMjA_6b59d3f3-4eea-4446-9fc0-3ae975be7be6">March&#160;31, 2023</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"></td><td style="width:5.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.490%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6Y2FiMjQ4YTgzM2M5NDcwMGJjYzdlNjE4YjJiODkyYjcvdGFibGVyYW5nZTpjYWIyNDhhODMzYzk0NzAwYmNjN2U2MThiMmI4OTJiN18wLTAtMS0xLTE3ODkyNQ_f8631d37-d870-4b8f-915a-16ce16ec0323">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)&#160;OF THE <br/>&#160;&#160;&#160;&#160;SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDE2_db261277-57e7-4187-9ad1-99291f922427">1-5975</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.555%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDE5_ad7f65ed-4d19-46c8-a941-ecca8ada3943">HUMANA INC</ix:nonNumeric>.</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.555%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Exact name of registrant as specified in its charter)</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6MDI5YmFmODE2OGRjNGRlMzkyOTk0NmU2YzVmY2Y3ZjMvdGFibGVyYW5nZTowMjliYWY4MTY4ZGM0ZGUzOTI5OTQ2ZTZjNWZjZjdmM18wLTAtMS0xLTE3ODkyNQ_f5e73ec9-d0be-4d0f-8b62-33a291fe9bb4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6MDI5YmFmODE2OGRjNGRlMzkyOTk0NmU2YzVmY2Y3ZjMvdGFibGVyYW5nZTowMjliYWY4MTY4ZGM0ZGUzOTI5OTQ2ZTZjNWZjZjdmM18wLTItMS0xLTE3ODkyNQ_5d48d8b0-d751-4ffe-b7cb-ca6b3caa4239">61-0647538</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDE3_4835b3bf-b108-4bbe-a040-b010f2574e27">500 West Main Street</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDE4_0d5eac2c-7b28-45be-8a03-8f99c42827cf">Louisville</ix:nonNumeric>, <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDIw_febe48b4-4cb0-4e01-b4ec-63327eae3aa1">Kentucky</ix:nonNumeric> <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDEw_16a48804-60b3-44be-81c2-2faa299bc4a1">40202</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDIx_8abac877-08b4-471e-8453-174537b77239">502</ix:nonNumeric>) <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDEz_54788b5c-fd38-46ae-934c-914b542d28aa">580-1000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.638%"><tr><td style="width:1.0%"></td><td style="width:38.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6Y2VmNDBjZDM4MDc4NDRhYmFiY2E1ZTlkYTc0YmQ5MjYvdGFibGVyYW5nZTpjZWY0MGNkMzgwNzg0NGFiYWJjYTVlOWRhNzRiZDkyNl8xLTAtMS0xLTE3ODkyNQ_68d975ca-5f32-40a6-89f4-47837f22ebcb">Common stock, $0.16 2/3 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6Y2VmNDBjZDM4MDc4NDRhYmFiY2E1ZTlkYTc0YmQ5MjYvdGFibGVyYW5nZTpjZWY0MGNkMzgwNzg0NGFiYWJjYTVlOWRhNzRiZDkyNl8xLTEtMS0xLTE3ODkyNQ_7353389e-7d40-4bcc-b9bb-347734deea86">HUM</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6Y2VmNDBjZDM4MDc4NDRhYmFiY2E1ZTlkYTc0YmQ5MjYvdGFibGVyYW5nZTpjZWY0MGNkMzgwNzg0NGFiYWJjYTVlOWRhNzRiZDkyNl8xLTItMS0xLTE3ODkyNQ_ca334b17-bfb3-4d6c-a0ec-1ddd37bca68a">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDIy_770826ac-5d40-4c0c-8bdc-0c91a0be7e52">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDE0_66ecee93-daea-4974-8e8d-ef1d0f880fbd">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.638%"><tr><td style="width:1.0%"></td><td style="width:35.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6NDZiODNmMjA5MzQxNDlkOThjZDAwYTdjNjFlYmQ5MGEvdGFibGVyYW5nZTo0NmI4M2YyMDkzNDE0OWQ5OGNkMDBhN2M2MWViZDkwYV8wLTAtMS0xLTE3ODkyNQ_1c43286a-5ed6-44a0-aa10-d8742a7da03c">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6NDZiODNmMjA5MzQxNDlkOThjZDAwYTdjNjFlYmQ5MGEvdGFibGVyYW5nZTo0NmI4M2YyMDkzNDE0OWQ5OGNkMDBhN2M2MWViZDkwYV8yLTQtMS0xLTE3ODkyNQ_85095901-6b93-48e1-a422-c73b9c491829">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6NDZiODNmMjA5MzQxNDlkOThjZDAwYTdjNjFlYmQ5MGEvdGFibGVyYW5nZTo0NmI4M2YyMDkzNDE0OWQ5OGNkMDBhN2M2MWViZDkwYV80LTEtMS0xLTE3ODkyNQ_a0af1fbe-11ff-4d25-a708-fae1e0e7f0c4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDIz_3b790461-988b-45c8-b854-d12b658ab075">&#9746;</ix:nonNumeric></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock as of the latest practicable date.</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.222%"><tr><td style="width:1.0%"></td><td style="width:59.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class of Common Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding at March&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.16 2/3 par value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6NzBkMWMyYzE5MjlhNGQ2MTlmOGVmOWJkNmZjMDY1NGIvdGFibGVyYW5nZTo3MGQxYzJjMTkyOWE0ZDYxOWY4ZWY5YmQ2ZmMwNjU0Yl8xLTEtMS0xLTE3ODkyNQ_217d8409-dfe3-446c-aec0-f0dafae06439">124,944,994</ix:nonFraction> shares</span></td></tr></table></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_7"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM 10-Q</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MARCH&#160;31, 2023 </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.958%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Part I: Financial Information</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_10">Condensed Consolidated Balance Sheets (Unaudited) </a></span></div><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_10">at </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_10">March 31, 2023</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_10"> and December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_10">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_10">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_16">Condensed Consolidated Statements of Income (Unaudited) </a></span></div><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_16">for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_16">months ended</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_16"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_16">March 31, </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_16">2023</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_16"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_16">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_16">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_19">Condensed Consolidated Statements of Comprehensive Income (Unaudited) </a></span></div><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_19">for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_19">months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_19">March 31, 2023</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_19"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_19">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_19">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_22">Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</a></span></div><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_22">for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_22">months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_22">March 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_22">1, 2023 and</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_22"> 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_22">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_25">Condensed Consolidated Statements of Cash Flows (Unaudited) </a></span></div><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_25">for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_25">three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_25"> months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_25">M</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_25">arch </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_25">31, 2023</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_25"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_25">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_25">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_28">Notes to Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_28">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_79">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_79">33</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_106">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_106">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_109">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_109">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_112">Part II: Other Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_115">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_115">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_118">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_118">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_121">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_121">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_124">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_124">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_127">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_127">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_130">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_130">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_133">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_133">51</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_139">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_139">52</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:69.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions,&#160;except&#160;share&#160;amounts)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNC0xLTEtMS0xNzg5MjU_16798679-e0de-42cc-a8f2-ef9e58ef5a54">13,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNC0zLTEtMS0xNzg5MjU_c94e0f0e-f1d8-4050-b942-28b24b60a725">5,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNS0xLTEtMS0xNzg5MjU_b86e4c53-dfc6-4fbb-8d23-78697a997c84">14,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNS0zLTEtMS0xNzg5MjU_e47efcaf-035a-4070-b373-41434142276e">13,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNi0wLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjo5ZjFiOTBjYzU0ZTM0ZGNkYWJiMGIxODdmZDliODQ3OV8zOA_bfc6350e-d51a-4dc0-acc6-ec0e2de3e512">69</ix:nonFraction> in 2023</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;and $<ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNi0wLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjo5ZjFiOTBjYzU0ZTM0ZGNkYWJiMGIxODdmZDliODQ3OV81NQ_5591a656-2b1e-4409-bcdf-0da3f1551bc2">70</ix:nonFraction> in 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNi0xLTEtMS0xNzg5MjU_e4fae022-aff4-45bc-85c4-4f3d35d16a72">3,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNi0zLTEtMS0xNzg5MjU_545eee4b-1fb1-46bf-9423-d9656f4bb23e">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNy0xLTEtMS0xNzg5MjU_6b321d0f-befb-4a3b-b1cb-82dc4011c3df">5,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNy0zLTEtMS0xNzg5MjU_987e3f1e-3118-4e12-a5ed-07dc8867927c">5,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfOS0xLTEtMS0xNzg5MjU_d434a69e-91f6-4934-9b1e-0894041698cf">37,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfOS0zLTEtMS0xNzg5MjU_e1ac4d9c-89b6-44b4-b68b-d027667a0557">26,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTAtMS0xLTEtMTc4OTI1_b5332739-0e9b-487c-a2b5-0e09af0479fc">3,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTAtMy0xLTEtMTc4OTI1_71136944-c900-47bb-aa3e-dbd75e167d1c">3,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTEtMS0xLTEtMTc4OTI1_5524913e-34be-4c73-ba0f-46be9d544f66">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTEtMy0xLTEtMTc4OTI1_317514ae-99d6-49b3-bf3e-d4cf67d5e57d">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTItMS0xLTEtMTc4OTI1_b71d9072-7d9b-4639-b000-f475294a83ae">739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTItMy0xLTEtMTc4OTI1_ed31e41a-7931-4c13-8597-5dc816ecda2b">749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTMtMS0xLTEtMTc4OTI1_0ff51e68-7d24-4eec-b99c-e38b77fb10f9">9,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTMtMy0xLTEtMTc4OTI1_539157a7-8190-4759-b83d-c1fbd47430a7">9,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTQtMS0xLTEtMTc4OTI1_d4a9320b-0cf0-4e57-a0ec-7bb76c93aa48">3,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTQtMy0xLTEtMTc4OTI1_6e89c20e-3287-4929-9a24-5c8979bf866c">3,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTYtMS0xLTEtMTc4OTI1_369dde0c-e640-415d-b28f-ea2f163b81c4">54,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTYtMy0xLTEtMTc4OTI1_abee0d4b-546e-44d2-ba88-3b12cefef5d8">43,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTktMS0xLTEtMTc4OTI1_1f8537fa-76f2-406d-963b-af2ba437c725">10,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTktMy0xLTEtMTc4OTI1_c0f3dda7-a060-4c1a-9d2c-9261229641b3">9,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjAtMS0xLTEtMTc4OTI1_5c71001b-4ed6-432d-a4f2-49905f69a742">7,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjAtMy0xLTEtMTc4OTI1_331e36d5-affe-4829-8ce0-94dffa28d376">5,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book overdraft</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="hum:BookOverdraftLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjEtMS0xLTEtMTc4OTI1_3001c210-a22a-411b-9189-308c3d56f0e0">406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="hum:BookOverdraftLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjEtMy0xLTEtMTc4OTI1_9d9c8377-d179-4136-a07e-589a3e8fc0a2">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjItMS0xLTEtMTc4OTI1_c64e8c0b-63f0-42bc-bd12-3bd61ed6a669">7,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjItMy0xLTEtMTc4OTI1_ee8cfd68-2b11-47e4-825d-e6943b294b0d">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjMtMS0xLTEtMTc4OTI1_be3e4309-db60-46c4-a409-bf5184b87327">1,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjMtMy0xLTEtMTc4OTI1_40784010-eb59-4c93-a784-c798a32bf4f2">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjUtMS0xLTEtMTc4OTI1_b24e3438-b96e-45e3-b2bd-2189e99049a9">26,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjUtMy0xLTEtMTc4OTI1_72f9d41d-f507-4306-a01c-dbd6a65dbd95">17,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjYtMS0xLTEtMTc4OTI1_e2031806-7efb-4cd4-85f1-d88a743daf12">9,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjYtMy0xLTEtMTc4OTI1_9b0afdf2-5419-4ea0-b9d7-f5e0786ac336">9,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjctMS0xLTEtMTc4OTI1_4d90328d-3c8f-435a-a9f8-482f150b8a69">1,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjctMy0xLTEtMTc4OTI1_c3dc9e2c-4b19-4037-aa0e-f612046765fc">1,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjktMS0xLTEtMTc4OTI1_68db1701-c3fa-4cfe-8ff5-3f392693b797">38,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjktMy0xLTEtMTc4OTI1_25b05b05-35e7-4949-b9be-8c052ee24528">27,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGI0ZDIxNjVhZDJhNGNhNmI0MjU1ZjZjNDJhNDc0NmNfMjE_3d04a88e-c135-43e6-97c3-73cdb092d183"><ix:nonFraction unitRef="usdPerShare" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGI0ZDIxNjVhZDJhNGNhNmI0MjU1ZjZjNDJhNDc0NmNfMjE_523a6862-db74-4bcb-8c81-df598a96d0e3">1</ix:nonFraction></ix:nonFraction> par; <ix:nonFraction unitRef="shares" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGI0ZDIxNjVhZDJhNGNhNmI0MjU1ZjZjNDJhNDc0NmNfMjk_6054283e-0b6e-4b7b-8360-0512748fa6e1"><ix:nonFraction unitRef="shares" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGI0ZDIxNjVhZDJhNGNhNmI0MjU1ZjZjNDJhNDc0NmNfMjk_a530f4d0-b85d-4026-9793-75e9d77130c4">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGI0ZDIxNjVhZDJhNGNhNmI0MjU1ZjZjNDJhNDc0NmNfNTE_3e4bb2ab-f099-4fb5-85cc-1ea60bfc11a5"><ix:nonFraction unitRef="shares" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGI0ZDIxNjVhZDJhNGNhNmI0MjU1ZjZjNDJhNDc0NmNfNTE_d16a5b04-afdc-4541-9b15-51dc8ede5d3f">none</ix:nonFraction></ix:nonFraction> issued</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMS0xLTEtMTc4OTI1_d183b2c8-8e47-434f-9247-bf8dcbafbc9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMy0xLTEtMTc4OTI1_53627f08-3c94-4aa1-8830-0f73eee42474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.16 2/3 par; <ix:nonFraction unitRef="shares" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzMtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MmU0ZTExZDA4NGE3NDc2NThhNDA5ZDk5OWE2MjE0NjVfMzM_5f97e28a-70b0-4361-8eb9-5bd621e2b58c"><ix:nonFraction unitRef="shares" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzMtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MmU0ZTExZDA4NGE3NDc2NThhNDA5ZDk5OWE2MjE0NjVfMzM_c430e72f-becc-4362-a559-f5042259797f">300,000,000</ix:nonFraction></ix:nonFraction> shares authorized; </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;<ix:nonFraction unitRef="shares" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzMtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MmU0ZTExZDA4NGE3NDc2NThhNDA5ZDk5OWE2MjE0NjVfNTg_8ae43282-43ba-4c11-bfdf-ec71736ee788"><ix:nonFraction unitRef="shares" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzMtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MmU0ZTExZDA4NGE3NDc2NThhNDA5ZDk5OWE2MjE0NjVfNTg_faa060da-f0e5-4def-8d9e-fe1cf6ed0959">198,666,598</ix:nonFraction></ix:nonFraction> shares issued at March&#160;31, 2023 and December 31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzMtMS0xLTEtMTc4OTI1_5bf28321-80b7-4563-ab63-cbcba9f804cf">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzMtMy0xLTEtMTc4OTI1_9fc48ae8-41f4-4d9f-87f7-6e23a4b3f94d">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in excess of par value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzQtMS0xLTEtMTc4OTI1_7f4fd255-7567-419c-aff9-8a405bc76f6c">3,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzQtMy0xLTEtMTc4OTI1_dedd4423-abaf-44c9-acb4-e642549c6d86">3,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzUtMS0xLTEtMTc4OTI1_d299fb5b-e3ca-403e-ad48-db5930c9bbb4">26,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzUtMy0xLTEtMTc4OTI1_6a10e169-71bf-46d7-8a9b-bbb19f486670">25,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzYtMS0xLTEtMTc4OTI1_343e8a9f-3e71-406b-9b8f-88514d1fb3ee">1,113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzYtMy0xLTEtMTc4OTI1_65145e55-3a50-4498-a162-2d9940626d8b">1,304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzctMC0xLTEtMTc4OTI1L3RleHRyZWdpb246Y2U5NzA0Nzk0NmYzNGFhZDk5OGQ4MDM2NGFiYmRiMWRfMjk_4b04636c-6f63-49ae-992c-ac37ebe562e7">73,721,604</ix:nonFraction> shares at March&#160;31, 2023 and </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;<ix:nonFraction unitRef="shares" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzctMC0xLTEtMTc4OTI1L3RleHRyZWdpb246Y2U5NzA0Nzk0NmYzNGFhZDk5OGQ4MDM2NGFiYmRiMWRfNTQ_5a8bc70f-2145-400d-ad4d-d026734c2a4c">73,691,955</ix:nonFraction> shares at December 31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzctMS0xLTEtMTc4OTI1_48ceea04-6490-496a-b5f0-86c503b45745">12,224</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzctMy0xLTEtMTc4OTI1_83395e7f-1557-403b-b12d-5ff2caf1c400">12,156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzgtMS0xLTEtMTg2Mjc5_954a4ddd-460c-4847-bb2c-1e4bbce0be9c">16,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzgtMy0xLTEtMTg2Mjc5_64062288-c9fd-48bf-91d9-2399a26ed6db">15,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzgtMS0xLTEtMTc4OTI1_ce45fbf5-8e24-4b47-8cfd-ee31b9dd316d">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzgtMy0xLTEtMTc4OTI1_3d068c75-a6bc-4a5a-be88-49690e1e97ed">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzktMS0xLTEtMTc4OTI1_0b8e69ab-0642-4d28-8b9e-355b1fb94ec7">16,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzktMy0xLTEtMTc4OTI1_4c54df6b-6bc5-4911-bac0-246ba4061913">15,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNDAtMS0xLTEtMTc4OTI1_37ae9014-8d3a-4481-9a54-acc295714799">54,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNDAtMy0xLTEtMTc4OTI1_0795a78a-ab25-45da-864b-f8851191b7f6">43,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_16"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:70.764%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.565%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share results)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNC0xLTEtMS0xNzg5MjU_3f9cc226-7804-438e-9d78-8d67ea47e597">25,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNC0zLTEtMS0xNzg5MjU_bc8244f4-a3a9-4c1b-9683-bc849d12bf1b">22,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNS0wLTEtMS0xNzg5MjU_c2bb13b4-0c36-4c9b-9e4c-42a20ef7d4d9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNS0wLTEtMS0xNzg5MjU_fb53923e-7f4e-463e-930a-0bbb5507b029">Services</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNS0xLTEtMS0xNzg5MjU_972ab94b-79bc-4523-9dcd-6031a9a39647">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNS0zLTEtMS0xNzg5MjU_9817aed6-ffff-4b99-8ba4-1eb6d28e5f2e">1,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNi0xLTEtMS0xNzg5MjU_426868a4-2cad-4079-b6a5-0402965c75a5">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNi0zLTEtMS0xNzg5MjU_fc487084-c047-476d-959b-6587b3ff5e0f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNy0xLTEtMS0xNzg5MjU_63b7c29e-0bbf-40dd-b51e-b66000129493">26,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNy0zLTEtMS0xNzg5MjU_8de75cef-7dca-4ad3-b08b-43ec043c45f8">23,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfOS0xLTEtMS0xNzg5MjU_8fc36318-acdc-4fda-b76a-23ed5afd3300">21,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfOS0zLTEtMS0xNzg5MjU_2a0485a2-892b-4711-b527-5d529407beea">19,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTAtMS0xLTEtMTc4OTI1_63c00138-f8d7-4e5e-9d0c-c99bcd41ed70">2,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTAtMy0xLTEtMTc4OTI1_96b8ffd7-dd1f-4271-8376-baf6461d7c90">2,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTEtMS0xLTEtMTc4OTI1_7f23182a-e572-4f82-a3c1-7723ee05ff67">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTEtMy0xLTEtMTc4OTI1_6bd5d56e-52c2-4aa0-af88-95e91115a151">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTItMS0xLTEtMTc4OTI1_1de3c3dc-9665-4e69-b92c-c87677c72409">25,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTItMy0xLTEtMTc4OTI1_b7109df5-3b15-40fc-8b05-657c65a6777d">22,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTMtMS0xLTEtMTc4OTI1_86ea24ec-49a3-4757-ac22-25c6ca8a5150">1,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTMtMy0xLTEtMTc4OTI1_cefde9ff-3942-46af-8298-aa155869cce5">1,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTUtMS0xLTEtMTc4OTI1_9babe27d-d8ae-46bf-84fd-9f6c7d2a1030">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTUtMy0xLTEtMTc4OTI1_985079bf-0232-499d-8ac9-93fa290e412b">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTYtMS0xLTEtMTc4OTI1_a1db8944-2142-45fa-a03d-a7d08b6328e0">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTYtMy0xLTEtMTc4OTI1_f0e13254-759d-4a31-9b1d-1c15a1ad1bae">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net losses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTctMS0xLTEtMTc4OTI1_1dd105c6-b4da-43ab-b57d-9b1fcb930e9c">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTctMy0xLTEtMTc4OTI1_933b83a1-d5e5-492a-91f4-95ca51128793">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTgtMS0xLTEtMTc4OTI1_5d8cbca1-1ccc-45da-8c20-bd58eadd6c25">359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTgtMy0xLTEtMTc4OTI1_f6936ca2-dc26-4236-953b-2f260f2423e3">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTktMS0xLTEtMTc4OTI1_ba6873e4-320f-48e9-860e-a65294607cfc">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTktMy0xLTEtMTc4OTI1_18814769-3d46-410a-af69-120117c4934c">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjAtMS0xLTEtMTc4OTI1_e71e2270-6de1-4c38-905c-e5d264eb1105">1,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjAtMy0xLTEtMTc4OTI1_3b2cf6b7-7aa3-4491-884f-60ac618afbec">930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjEtMS0xLTEtMTc4OTI1_2f75bcc7-8e49-4401-bb26-cc9991e5d04f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjEtMy0xLTEtMTc4OTI1_7e1269e7-e589-4a81-86f9-d945f0953260">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Humana</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjItMS0xLTEtMTc4OTI1_06511023-bef2-44de-8b03-35077e669047">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjItMy0xLTEtMTc4OTI1_04329df4-987f-4cb1-a2ba-43b2d1cd7af2">930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjMtMS0xLTEtMTc4OTI1_77bcccd5-0fa2-456e-b2da-793e6f79ff45">9.91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjMtMy0xLTEtMTc4OTI1_7c188305-f913-41e5-86e9-dd61f1b53652">7.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjQtMS0xLTEtMTc4OTI1_6e910401-6413-4288-9fbb-616e45c8da9a">9.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjQtMy0xLTEtMTc4OTI1_8546aeea-ba4d-42fa-b404-d0414adb5328">7.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.596%"><tr><td style="width:1.0%"></td><td style="width:70.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.858%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Humana</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMy0xLTEtMS0xNzg5MjU_ee0a543a-58f8-49e9-9982-ad60444070c2">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMy0zLTEtMS0xNzg5MjU_b05451a2-80f9-448c-bc29-19960b55064b">930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in gross unrealized investment gains (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfNS0xLTEtMS0xNzg5MjU_5c83055b-1585-4e16-9370-2ca23a368fb9">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfNS0zLTEtMS0xNzg5MjU_2a615a93-cbc1-4bf5-873b-94be2ade3c6c">769</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfNi0xLTEtMS0xNzg5MjU_d8d11d75-c5a3-4afd-98c2-95da3e9fa540">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfNi0zLTEtMS0xNzg5MjU_e3e28a5b-0efe-4c2a-90ff-144c67f7d171">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total change in unrealized investment gains (losses), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfNy0xLTEtMS0xNzg5MjU_58d88beb-8c38-47f4-bd1c-e3a2d3d5e246">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfNy0zLTEtMS0xNzg5MjU_dcc983f3-4842-4c3e-a357-7847d2f9b63c">593</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification adjustment for net realized losses (gains)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfOC0xLTEtMS0xNzg5MjU_c88d3b60-6b8d-4716-b4b6-62f1df44ad49">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfOC0zLTEtMS0xNzg5MjU_9c490bd7-cd32-4e25-9112-b4e7bddcab27">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfOS0xLTEtMS0xNzg5MjU_6a57ea4e-ab8f-411a-af64-73921574d51c">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfOS0zLTEtMS0xNzg5MjU_ff94badd-5add-4fcc-b6f1-89983a8048a1">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassification adjustment, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMTAtMS0xLTEtMTc4OTI1_0008702c-24e1-43a7-9bf8-9e87030192a4">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMTAtMy0xLTEtMTc4OTI1_12075780-17d6-45c9-b0ca-661155fc93c5">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMTEtMS0xLTEtMTc4OTI1_09f30390-a7f0-4243-b158-c2fd1bee0051">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMTEtMy0xLTEtMTc4OTI1_590e3591-15fd-4ddc-9c54-bd8953378f1b">614</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to Humana</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMTQtMS0xLTEtMTc4OTI1_f90de7bb-9b5f-4995-bc5f-a89707325ed0">1,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMTQtMy0xLTEtMTc4OTI1_944e6709-8481-45b9-bd70-4b6ba8d5de9b">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_22"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.836%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.836%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.836%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.140%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital&#160;In<br/>Excess&#160;of<br/>Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Issued<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions, share amounts in thousands)</span></td></tr><tr><td colspan="54" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances, December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67be62ec4a604c6baeeae7c8acfa32da_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC0xLTEtMS0xNzg5MjU_fb166dec-9adb-4cc1-bee6-c5e42d04f9bb">198,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67be62ec4a604c6baeeae7c8acfa32da_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC0zLTEtMS0xNzg5MjU_22c88b32-fa5a-49b8-9921-4d10e908c7c2">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie80b91c2c2c84ebb871c1ba1a0f82413_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC01LTEtMS0xNzg5MjU_9b202b92-7a37-465c-af12-c4877ae646ef">3,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f0bb767b8b44c9bb4b925e7d6846b4c_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC03LTEtMS0xNzg5MjU_630fd096-ecf9-472f-aa92-03959a328497">25,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib43b2bdef5554a95a305773800d5f4f6_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC05LTEtMS0xNzg5MjU_ea7a49cf-f56e-43a4-a0be-4f65e1a94a7e">1,304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c80fc54c1ed425abb2f454166ba8b76_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC0xMS0xLTEtMTc4OTI1_f9920cb6-f47d-4865-85f7-e233ded0c73a">12,156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef509857c8e4467a2fc109e0bf10f4b_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC0xMy0xLTEtMTg2Mjk1_6fec7763-ca08-4fb9-a931-569ac4711e9b">15,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie764c2fbaa0e46349d4f04c484a4ae01_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC0xMy0xLTEtMTc4OTI1_ae056b33-d54d-462f-94d0-9d465ec8a64b">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC0xNS0xLTEtMTc4OTI1_77c0fe2e-321a-4ecf-b585-0aa596cbb38e">15,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee9f0e494b544da926fe616f385aac5_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNS03LTEtMS0xNzg5MjU_4b12c783-9bb4-4061-a8d6-33fc268b2c8b">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNS0xMy0xLTEtMTg2Mjk1_ccc9b949-87c2-41dc-b8c3-46cbf14921dd">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b281d1bbb96464f86dd82da174e2334_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNS0xMy0xLTEtMTc4OTI1_51022664-a363-4fed-8448-bb583c179cba">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNS0xNS0xLTEtMTc4OTI1_d1e9d8f8-1e19-4d11-8c40-6fd5c24fae4d">1,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distribution from noncontrolling interest holders, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b281d1bbb96464f86dd82da174e2334_D20230101-20230331" decimals="-6" name="hum:NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNi0xMy0xLTEtMTc4OTI1_a672421f-7fa1-4ada-b100-d714a9099a4e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="hum:NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNi0xNS0xLTEtMTc4OTI1_192d6b39-8c1b-4034-aa1c-911b3988e292">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b281d1bbb96464f86dd82da174e2334_D20230101-20230331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfOC0xMy0xLTEtMTc4OTI1_136943f8-d1e8-4c5a-8cdc-2bd5ea649256">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfOC0xNS0xLTEtMTc4OTI1_f104b668-b4d9-49a4-a640-ca8b46d0ab18">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0d2f28ca1ea4a64ae9ed5eee0ba5068_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfOS05LTEtMS0xNzg5MjU_e544f264-e6c6-4bac-9693-ffa5b332ac06">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfOS0xMy0xLTEtMTg2Mjk1_5559f7f9-027a-4054-803a-599f04bb9d17">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfOS0xNS0xLTEtMTc4OTI1_eb719981-7dc0-45dc-b813-148bf0fdf709">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8a695ef6e9d487ab733b856a3f72501_D20230101-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTAtMTEtMS0xLTE3ODkyNQ_d7ee167a-a097-4bb5-a33f-17d0b7f83578">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTAtMTMtMS0xLTE4NjI5NQ_b14b06f2-7311-4b40-9758-2c863384b64b">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTAtMTUtMS0xLTE3ODkyNQ_53363b62-c88e-4e52-aad8-c78d6d764b6d">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends and dividend <br/>&#160;&#160;&#160;equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaee9f0e494b544da926fe616f385aac5_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTEtNy0xLTEtMTc4OTI1_0706cbe0-4ce8-43ae-8347-bef2f9cccef2">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTEtMTMtMS0xLTE4NjI5NQ_4f0d18f3-41e9-4d3a-a9ba-87abaf325e03">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTEtMTUtMS0xLTE3ODkyNQ_e4dcc34f-0b26-419b-b12c-c1b0548f51ee">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff79ee49692740f8b35cbc8e80b347a0_D20230101-20230331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTItNS0xLTEtMTc4OTI1_526873b4-15a4-44d3-9ecf-515f70f5af7c">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTItMTMtMS0xLTE4NjI5NQ_dae10172-7d53-4737-9b64-ab5f2cedb6c5">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTItMTUtMS0xLTE3ODkyNQ_ed78a2a1-3c6b-4a6c-86ac-6d76f71cebc7">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted stock unit vesting</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff79ee49692740f8b35cbc8e80b347a0_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTMtNS0xLTEtMTc4OTI1_6dad67d8-8f35-4ac6-a6b8-3b8989609548">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8a695ef6e9d487ab733b856a3f72501_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTMtMTEtMS0xLTE3ODkyNQ_5920ab31-9895-4078-a70d-cc2db00b4450">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTMtMTUtMS0xLTE3ODkyNQ_704cc1f7-e297-46fc-bbbe-8758f49a8513">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option exercises</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff79ee49692740f8b35cbc8e80b347a0_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTQtNS0xLTEtMTc4OTI1_d1441a7a-b604-46e2-a5ab-9990e618e55d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8a695ef6e9d487ab733b856a3f72501_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTQtMTEtMS0xLTE3ODkyNQ_76ef982f-2c48-4c21-affb-2863a2f1634d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTQtMTMtMS0xLTE4NjI5NQ_984d9e01-124b-4625-b0c0-448a8094b06c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTQtMTUtMS0xLTE3ODkyNQ_7c4d04a3-f8af-453c-84df-f97f8e760da1">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances, March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4750367ee1e4a689f97fa9022bdf5e4_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtMS0xLTEtMTc4OTI1_3e90813f-1e3f-4d2b-a7c5-deade9666d09">198,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4750367ee1e4a689f97fa9022bdf5e4_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtMy0xLTEtMTc4OTI1_0faa06c9-219c-4d2c-baeb-41e61cf62c9c">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33bde0043da6450e8ef28277a10de49e_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtNS0xLTEtMTc4OTI1_c2f1d36e-7bfc-4e84-b73b-f636e5194eb4">3,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38d4d0509824793b1c7ea2b970a5957_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtNy0xLTEtMTc4OTI1_0df807ea-ac62-4ca4-8e16-b84284d3874d">26,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie443272811ed49d6a8d422744f898488_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtOS0xLTEtMTc4OTI1_d723bfaf-506c-440b-987a-69c4b5a2671c">1,113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00969cc0983a4871891aca903e70709b_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtMTEtMS0xLTE3ODkyNQ_9a10fd61-895e-4583-a501-af79fedc69de">12,224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4314807c944d55b84b257f3f3dc4cc_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtMTMtMS0xLTE4NjI5NQ_e835844a-580c-40d9-8a28-f0a86bd9f7ec">16,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i608d6a1b874146d8b2906b872c802885_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtMTMtMS0xLTE3ODkyNQ_692b34f9-7ac6-4cd9-9cb6-2c737f36acdd">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtMTUtMS0xLTE3ODkyNQ_adedbe69-6b35-4d81-b48c-4d339d9b9f4c">16,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="54" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id52b99f262dd4f5fbc64485fdc490c62_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtMS0xLTEtMTc4OTI1_8754fe06-a23f-423c-b34d-d8c9167bea3c">198,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52b99f262dd4f5fbc64485fdc490c62_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtMy0xLTEtMTc4OTI1_c08ccf53-1e77-4501-89ca-94e9c251daa5">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070b3a983b8d4c1c9d6d883ff6c49107_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtNS0xLTEtMTc4OTI1_0aa64152-02ba-4340-b99a-56ba25e1d344">3,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb1c5dba70e4995a50495bdf4c7e1d3_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtNy0xLTEtMTc4OTI1_815e0599-3ed7-4dbd-8d94-00541e123c62">23,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd32fea20e5e4fba97023cd2a12758d7_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtOS0xLTEtMTc4OTI1_fdd15f9f-10be-49f7-ba87-f74cad0dda6b">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a2924212fff4b95a06c6336134700a1_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtMTEtMS0xLTE3ODkyNQ_6f4618b0-8daf-4ad4-86c6-17806e6ed198">10,163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide04b81f591a460480759551ea2d4c60_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtMTMtMS0xLTE4NjI5NQ_4be9cc59-fff4-420f-a3c0-ec5fd1f8859e">16,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f1a85fe48643ddad4b2657effc5ddc_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtMTMtMS0xLTE3ODkyNQ_7f5a299d-4e6e-4c70-a397-be972bdf8e3c">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if66f7e3bde694a2fa6f2b9ad88e258ff_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtMTUtMS0xLTE3ODkyNQ_a265a478-202d-4a2f-9e49-6757eb16c70a">16,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69b771e99aeb411385b87bc78aba0005_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTktNy0xLTEtMTc4OTI1_9c879693-e5ef-4a1e-a4ad-f4f3c6d9b992">930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTktMTMtMS0xLTE4NjI5NQ_5fc32321-3d1f-426a-8b2c-32c08f17e978">930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTktMTUtMS0xLTE3ODkyNQ_3cf260c0-e217-4028-8502-841c73795be4">930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefba7d8c1a25422f8083be1c96fbf1fd_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjMtOS0xLTEtMTc4OTI1_0c50aaa0-6143-4459-8356-94585d51764c">614</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjMtMTMtMS0xLTE4NjI5NQ_5e6864b3-b23d-4ffb-95b7-d22028ee9f9c">614</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjMtMTUtMS0xLTE3ODkyNQ_16717fa2-6c38-43a5-b071-39e3eb59e520">614</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id26120571436434494bfb975fa78d99e_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjQtMTEtMS0xLTE3ODkyNQ_5547a838-2aea-485b-93f5-abe5b5f20d72">1,024</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjQtMTMtMS0xLTE4NjI5NQ_ce6b28c8-c685-401b-95f2-370507dc22b6">1,024</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjQtMTUtMS0xLTE3ODkyNQ_d671ccbb-3db2-40ff-997f-a5da8b375ce8">1,024</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends and dividend <br/>&#160;&#160;&#160;equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69b771e99aeb411385b87bc78aba0005_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjUtNy0xLTEtMTc4OTI1_9167b219-17a9-4a0c-a1b0-86b382cdc7e2">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjUtMTMtMS0xLTE4NjI5NQ_ba372ce4-3d9b-4a1e-b63e-8d04172a3a66">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjUtMTUtMS0xLTE3ODkyNQ_d9c0b091-331e-4a28-8e10-47f83a4e5750">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice488527531041f1bea3aaf535bacb76_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjYtNS0xLTEtMTc4OTI1_85e3cfc2-8530-45bc-8fbd-8b9a2f9dff7f">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjYtMTMtMS0xLTE4NjI5NQ_f123e2fc-153e-4b6e-ba88-04f1d85581d7">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjYtMTUtMS0xLTE3ODkyNQ_0c2ff7b1-f6b2-4149-93ca-7aa514ac2990">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted stock unit vesting</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice488527531041f1bea3aaf535bacb76_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjctNS0xLTEtMTc4OTI1_6f33a1e3-a465-45ca-9d3b-e3dada86455d">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id26120571436434494bfb975fa78d99e_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjctMTEtMS0xLTE3ODkyNQ_6ca74efd-1b6b-40b8-bc10-f662b917a638">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjctMTUtMS0xLTE3ODkyNQ_bde38881-c092-4fde-a47b-fc0199d62673">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option exercises</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice488527531041f1bea3aaf535bacb76_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjgtNS0xLTEtMTc4OTI1_888b488f-74ee-4c82-bb0c-a2c75be06eb9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id26120571436434494bfb975fa78d99e_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjgtMTEtMS0xLTE3ODkyNQ_b9645116-8bbd-41fe-8e64-e5e51803dd4a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjgtMTMtMS0xLTE4NjI5NQ_8713a04a-f31f-499c-be5a-b1a4f6b49e6e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjgtMTUtMS0xLTE3ODkyNQ_43ac74ce-ae38-402b-8b51-461c4f47ad02">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0da5c588273f46f9b2f1a42b9dd81da4_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktMS0xLTEtMTc4OTI1_2da34cf9-0d76-4674-8998-c36bd0865711">198,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0da5c588273f46f9b2f1a42b9dd81da4_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktMy0xLTEtMTc4OTI1_38f67a98-1431-46a7-8335-a6bc5b9ceb73">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342c27c8ea80488ba306fb99128b5cf4_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktNS0xLTEtMTc4OTI1_3d44d613-0b93-4e2a-be0b-5f771b1bfc36">3,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f2a8ed54eca45fba1b5a8a2a7875edb_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktNy0xLTEtMTc4OTI1_157dec4e-8d3f-4d63-a272-066ef398525f">23,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i623ed6554dfa4892b099de29261154be_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktOS0xLTEtMTc4OTI1_c96b8bfd-7258-4f61-ad5e-4b23b944ae35">572</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d833c58d6684d1fbe8a6b639c1c2914_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktMTEtMS0xLTE3ODkyNQ_c08bc48a-2f73-4c07-ab6f-f551f83526a7">11,160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be79b2b55e54535aff3cbec252b67f5_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktMTMtMS0xLTE4NjI5NQ_533202a8-08e9-49b6-8225-ab0668ddb2fc">15,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bd06ce061245718d7a679efdb9836b_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktMTMtMS0xLTE3ODkyNQ_4ab020cc-312b-49f9-809a-0afe49ce4ad5">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55a5772c9e08479ba75577876ccf8013_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktMTUtMS0xLTE3ODkyNQ_426da686-ec3f-449a-b474-7e801cfc761e">15,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:20.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.480%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.512%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.770%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.770%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.770%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.230%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:7pt;text-align:center"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNC0xLTEtMS0xNzg5MjU_a954ccdd-c59d-4f6b-a369-009f323e6782">1,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNC0zLTEtMS0xNzg5MjU_e5be6ce1-445c-4aae-bea4-1008026545fc">930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by<br/>&#160;&#160;&#160;&#160;operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on investment securities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNy0xLTEtMS0xNzg5MjU_e5e74747-15b6-41d6-8882-2d2524fb5e92">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNy0zLTEtMS0xNzg5MjU_3a4f5eda-d2d9-4407-86c1-1f1aed21ac85">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfOS0xLTEtMS0xNzg5MjU_a991b60e-e36d-474e-89bd-a4c127136bc6">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfOS0zLTEtMS0xNzg5MjU_98f4e2e3-50d7-4ad1-bc65-2dc858b26738">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTAtMS0xLTEtMTc4OTI1_85bc8852-9404-408f-9d01-bd0c4f5004d8">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTAtMy0xLTEtMTc4OTI1_f8f4e987-2bf3-4fc2-9183-e6d7527bf790">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTEtMS0xLTEtMTc4OTI1_de3c9c0d-de63-4afc-aa49-3e95610f2394">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTEtMy0xLTEtMTc4OTI1_334e29a5-484d-46fb-a641-9395fe228b5f">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTItMS0xLTEtMTc4OTI1_7733d596-090f-428f-8d63-134b96b69030">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTItMy0xLTEtMTc4OTI1_45b093bf-7a27-4585-8822-d0e13de3cb80">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of effect of <br/>&#160;&#160;&#160;&#160;businesses acquired and disposed:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTYtMS0xLTEtMTc4OTI1_999fb216-2337-4e89-a874-290bdfa3b523">1,433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTYtMy0xLTEtMTc4OTI1_d7508930-9595-42b1-bb86-cc43465d9328">1,360</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTctMS0xLTEtMTc4OTI1_05d2d60a-0eac-4d82-b73c-d68af7c71daa">907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTctMy0xLTEtMTc4OTI1_46b46a1d-8243-4ac4-a1eb-7ecdc17bf07c">628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTgtMS0xLTEtMTc4OTI1_c9640c6a-8d28-448f-a279-ce1faa1a999a">754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTgtMy0xLTEtMTc4OTI1_17129f74-353b-4909-870e-13204527b2a9">1,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTktMS0xLTEtMTc4OTI1_fd9abc82-e760-476c-8d0f-3e21f0dbd263">238</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTktMy0xLTEtMTc4OTI1_8ed862e9-54f4-468b-81fd-65c49072777d">103</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjAtMS0xLTEtMTc4OTI1_ad337cd1-6ea7-4a26-b033-e00de51a45fc">6,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjAtMy0xLTEtMTc4OTI1_1b5928b6-7bd2-449b-9ec7-3e8edc9b5290">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjEtMS0xLTEtMTc4OTI1_84132bc2-ab5a-4c1b-81d8-3a9e65a642e1">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjEtMy0xLTEtMTc4OTI1_db3a35f6-619b-4ccd-a208-8b40590c0a92">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjItMS0xLTEtMTc4OTI1_0aea6c06-cb5c-4014-9d9a-9b407312a93d">6,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjItMy0xLTEtMTc4OTI1_88cfa6a1-8f5f-4abb-91b4-83ac633074d1">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash and cash equivalents acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjUtMS0xLTEtMTc4OTI1_515c9287-8fbc-4326-a1aa-1f4ed084cc68">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjUtMy0xLTEtMTc4OTI1_981a5d95-a70e-44ff-b868-6797b4f9c2fc">74</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjYtMS0xLTEtMTc4OTI1_307e20a0-31e8-4c76-9c23-278fc8d27284">223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjYtMy0xLTEtMTc4OTI1_2df741ca-53ef-4740-a9aa-1e54873c8029">295</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjctMS0xLTEtMTc4OTI1_028479d1-dd72-4b67-a2c0-616287deddb4">1,313</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjctMy0xLTEtMTc4OTI1_983603da-38c1-40b5-9720-0645cbf2f0f2">2,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from maturities of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjgtMS0xLTEtMTc4OTI1_34e4516e-ae2b-4f50-a6f3-c7fed21b6c45">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjgtMy0xLTEtMTc4OTI1_eabd4c86-386d-480c-9b03-d58ed986d63e">588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjktMS0xLTEtMTc4OTI1_1516af18-a69e-4340-af4f-61ba240e18da">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjktMy0xLTEtMTc4OTI1_e04eb62a-7be9-47f9-8341-dcdf2984d73e">1,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzAtMS0xLTEtMTc4OTI1_1af4f15c-ff94-4e6f-a19c-51d06eacc0c1">1,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzAtMy0xLTEtMTc4OTI1_05664a7e-6218-4547-ad0d-6382a356b9a4">648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipts from contract deposits, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="hum:PaymentsForProceedsFromContractDeposits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzItMS0xLTEtMTc4OTI1_e2140e90-47c8-4b69-9250-187202e1c3d7">2,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="hum:PaymentsForProceedsFromContractDeposits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzItMy0xLTEtMTc4OTI1_879524e1-4eca-4426-8252-8225a571803c">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzMtMS0xLTEtMTc4OTI1_1cc58827-ff12-4737-a72a-e661d58f3620">1,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzMtMy0xLTEtMTc4OTI1_41fcedb2-52b1-47bc-aeb4-a87524602403">744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzQtMS0xLTEtMTkyNDk1_4e7d6914-72ac-47d6-8643-d47393c4f712">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzQtMy0xLTEtMTkyNDk1_44618226-1287-4640-81e1-b52e2e313906">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments from issuance of commercial paper, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzQtMS0xLTEtMTc4OTI1_fb0ee8c8-803f-45ad-8857-b947dfee876f">177</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzQtMy0xLTEtMTc4OTI1_d318de8e-0a72-466d-822e-707e5fcda570">265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:RepaymentsOfNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzYtMS0xLTEtMTc4OTI1_e1957073-1ded-4639-94d2-6afc64d5300d">500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzYtMy0xLTEtMTc4OTI1_73a2459d-89d6-4d61-a446-8666e8704eca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issue costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzctMS0xLTEtMTc4OTI1_593e6cee-78b0-4bf8-a168-3786eaf37cc1">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzctMy0xLTEtMTc4OTI1_ce1e31fa-2e37-4d30-9eb6-b47c02ed35b2">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in book overdraft</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInBookOverdrafts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzgtMS0xLTEtMTc4OTI1_e50767c9-507d-4761-8b32-bab0dbb8a365">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInBookOverdrafts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzgtMy0xLTEtMTc4OTI1_2c284f7a-d528-4f9f-b1dc-3f4852f3d8ea">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzktMS0xLTEtMTc4OTI1_c87708cd-94ce-4214-8dd1-833391d47d0d">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzktMy0xLTEtMTc4OTI1_77f38ff4-3f80-4fd5-9c78-d3139dc001a9">1,024</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDAtMS0xLTEtMTc4OTI1_01a351a3-f4cd-4ce6-a10c-4c19c11d978c">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDAtMy0xLTEtMTc4OTI1_b0f967c3-5586-470b-ad45-d56def4a375b">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDEtMS0xLTEtMTc4OTI1_5eaa3162-e0c5-43b4-98ae-0f527d939bed">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDEtMy0xLTEtMTc4OTI1_61568bb7-0feb-45fe-8790-717c82ba12d1">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDItMS0xLTEtMTc4OTI1_e9449eab-c4c5-4067-b471-73ac30d57de8">3,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDItMy0xLTEtMTc4OTI1_3b235110-1ff6-499a-88c4-90ed755011ff">1,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDMtMS0xLTEtMTc4OTI1_d1a285c9-a669-42d6-9d4d-8768d1ab9919">8,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDMtMy0xLTEtMTc4OTI1_bd341f0a-ad31-4982-bff2-7992f58448ec">1,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDQtMS0xLTEtMTc4OTI1_4a4209ef-ee1d-4c7c-83c6-4ceba55ad1a2">5,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if66f7e3bde694a2fa6f2b9ad88e258ff_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDQtMy0xLTEtMTc4OTI1_0b950996-c8ca-4a42-9642-f698346ca384">3,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDUtMS0xLTEtMTc4OTI1_d5e6caf5-825c-40b1-a17e-0b05d1fe9ecb">13,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55a5772c9e08479ba75577876ccf8013_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDUtMy0xLTEtMTc4OTI1_b625c142-50b7-4dfb-972d-9f739af46a94">4,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span><br/></span></div><div style="margin-top:7pt;text-align:center"><span><br/></span></div><div style="margin-top:7pt;text-align:center"><span><br/></span></div><div style="margin-top:7pt;text-align:center"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:7pt;text-align:center"><span><br/></span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:72.319%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.865%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfNC0xLTEtMS0xNzg5MjU_8b48dd5d-980a-428a-a2ca-c76f7b3bd84f">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfNC0zLTEtMS0xNzg5MjU_9d555765-b103-4032-842c-722adfc92d77">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payments (refund), net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfNS0xLTEtMS0xNzg5MjU_79ac2128-ada8-4a52-bf39-8ba385e3ffb7">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfNS0zLTEtMS0xNzg5MjU_8351eca2-6eb4-4077-b311-0a1c62675601">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Details of businesses acquired in purchase transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired, net of cash and cash equivalents acquired</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfNy0xLTEtMS0xNzg5MjU_e3df6645-158f-4230-9d87-75f90b7fc1e1">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfNy0zLTEtMS0xNzg5MjU_47066311-a219-4d44-9c64-36d0e978ad0f">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Fair value of liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfOC0xLTEtMS0xNzg5MjU_07a8e047-41cf-445f-8cc2-435f574f0d37">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfOC0zLTEtMS0xNzg5MjU_ed457ff8-4f13-4ffb-a169-fd0f6d2ea5bb">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncontrolling interests acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfOS0xLTEtMS0xNzg5MjU_d403ddcf-1ca8-4b13-b239-2622dbefbd18">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfOS0zLTEtMS0xNzg5MjU_a6e3a0b9-22b5-4527-93ed-b4cda40e2250">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquired businesses, net of cash and cash equivalents acquired</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfMTEtMS0xLTEtMTc4OTI1_6dee3666-63bf-4cfd-9134-556982bedaef">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfMTEtMy0xLTEtMTc4OTI1_e08aaf97-994b-4c38-a1da-8cfbea85a162">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_28"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_34"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfNjczMQ_7e5506f1-dcb1-4d0d-b7d9-0bf8aac0719e" continuedAt="idbc7fd0fb0c14e9ea46e2ef8d05a3aea" escape="true">BASIS OF PRESENTATION AND SIGNIFICANT EVENTS</ix:nonNumeric></span></div><ix:continuation id="idbc7fd0fb0c14e9ea46e2ef8d05a3aea" continuedAt="i3f354d0c0c10426f948f250b5dd6f1a5"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfNjc0OQ_fc79885f-b7bc-4a74-bfc3-d185763caed2" continuedAt="i1ae4f248f31b4d338a6ad8cb1fe6a391" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements are presented in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the disclosures normally required by accounting principles generally accepted in the United States of America, or GAAP, or those normally made in an Annual Report on Form 10-K. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. For further information, the reader of this Form 10-Q should refer to our Form 10-K for the year ended December 31, 2022, that was filed with the Securities and Exchange Commission, or the SEC, on February&#160;16, 2023. We refer to this Form 10-K as the &#8220;2022 Form 10-K&#8221; in this document. References throughout this document to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Company,&#8221; and &#8220;Humana&#8221; mean Humana Inc. and its subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our condensed consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The areas involving the most significant use of estimates are the estimation of benefits payable, the impact of risk adjustment provisions related to our Medicare contracts, the valuation and related impairment recognition of investment securities, and the valuation and related impairment recognition of long-lived assets, including goodwill and indefinite-lived intangible assets. These estimates are based on knowledge of current events and anticipated future events, and accordingly, actual results may ultimately differ materially from those estimates. For additional information regarding accounting policies considered in preparing our consolidated financial statements, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial information has been prepared in accordance with our customary accounting practices and has not been audited. In our opinion, the information presented reflects all adjustments necessary for a fair statement of interim results. All such adjustments are of a normal and recurring nature.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Employer Group Commercial Medical Products Business Exit</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, we announced our planned exit from the Employer Group Commercial Medical Products business, which includes all fully insured, self-funded and Federal Employee Health Benefit medical plans, as well as associated wellness and rewards programs. No other Humana health plan offerings are materially affected. Following a strategic review, we determined the Employer Group Commercial Medical Products business was no longer positioned to sustainably meet the needs of commercial members over the long term or support our long-term strategic plans. The exit from this line of business will be phased over the next <ix:nonNumeric contextRef="i2449d3dd94054171a333473a8b30e8d9_D20230101-20230331" name="hum:DiscontinuedOperationsSegmentPhaseOutPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfMTY0OTI2NzQ2MDQ1Nw_12ddb789-2b93-4cd0-958d-aef59c33f8c1">18</ix:nonNumeric> to <ix:nonNumeric contextRef="iffa2d44aeefe49eb901d869a778d954f_D20230101-20230331" name="hum:DiscontinuedOperationsSegmentPhaseOutPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfMTY0OTI2NzQ2MDQ2MQ_92704fc5-c4f2-4285-8474-57e807c71ada">24</ix:nonNumeric> months.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Creation Initiatives </span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1ae4f248f31b4d338a6ad8cb1fe6a391">During 2022, in order to create capacity to fund growth and investment in our Medicare Advantage business and further expansion of our healthcare services capabilities in 2023, we committed to drive additional value for the enterprise through cost saving, productivity initiatives, and value acceleration from previous investments. As a result of these initiatives, we recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i86b101ff14884b76ba0a3e3909ff5915_D20220101-20221231" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfMjkzMg_b6bd5dc7-ca50-4bd2-bccc-0ea987259ebc">473</ix:nonFraction> million for the year-ended December 31, 2022. These charges primarily relate to $<ix:nonFraction unitRef="usd" contextRef="i86b101ff14884b76ba0a3e3909ff5915_D20220101-20221231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfMTA5OTUxMTYzNzI4OQ_f4ba852d-d180-4d67-b436-9a28007a8e6f">248</ix:nonFraction>&#160;million in asset impairments, including software and abandonment, and $<ix:nonFraction unitRef="usd" contextRef="i86b101ff14884b76ba0a3e3909ff5915_D20220101-20221231" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfMTA5OTUxMTYzNzI3NQ_db154284-5a9f-4a77-abc3-47984f6b12fa">116</ix:nonFraction>&#160;million of severance charges in connection with workforce optimization. The remainder of the charges primarily relate to external consulting fees. These charges were recorded at the corporate level and not allocated to the segments. We did <ix:nonFraction unitRef="usd" contextRef="iba36eec577cb4c97b3c20a998f977679_D20220101-20220331" decimals="INF" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfMTY0OTI2NzQ2MDQ2OA_374fdfc0-dff6-4545-b905-d3c088cd2524">not</ix:nonFraction> record any charges in the first quarter of 2022, with no recurring charges in 2023.</ix:continuation>  </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i3f354d0c0c10426f948f250b5dd6f1a5"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The emergence and spread of the novel coronavirus, or COVID-19, beginning in the first quarter of 2020 has impacted our business. During periods of increased incidences of COVID-19, a reduction in non-COVID-19 hospital admissions for non-emergent and elective medical care have resulted in lower overall healthcare system utilization. At the same time, COVID-19 treatment and testing costs increased utilization. During 2022, we experienced lower overall utilization of the healthcare system than anticipated, as the reduction in COVID-19 utilization following the increased incidence associated with the Omicron variant outpaced the increase in non-COVID-19 utilization. The significant disruption in utilization during 2020 also impacted our ability to implement clinical initiatives to manage health care costs and chronic conditions of our members, and appropriately document their risk profiles, and, as such, significantly affected our 2021 revenue under the risk adjustment payment model for Medicare Advantage plans. Finally, changes in utilization patterns and actions taken in 2021 as a result of the COVID-19 pandemic, including the suspension of certain financial recovery programs for a period of time and shifting the timing of claim payments and provider capitation surplus payments, impacted our claim reserve development and operating cash flows for 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 National Emergency declared in 2020 was terminated on April 10, 2023 and the Public Health Emergency is set to expire on May 11, 2023.</span></div><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfNjcyOQ_88b23527-c21d-468d-ba82-d7c61f37f4d6" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues include premiums and services revenue. Services revenue includes administrative service fees that are recorded based upon established per member per month rates and the number of members for the month and are recognized as services are provided for the month. Additionally, services revenue includes net patient services revenue that are recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For additional information regarding our revenues, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. For additional information regarding disaggregation of revenue by segment and type, refer to Note 14 to the unaudited Condensed Consolidated Financial Statements included in Part I, Item 1, "Financial Statements" of this Form 10-Q.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, accounts receivable related to services were $<ix:nonFraction unitRef="usd" contextRef="ifa05aa9eea8340d1a4b6993427e169a6_I20230331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfNjIyNQ_f0c965b3-0275-4b4f-be72-91e966578a91">246</ix:nonFraction>&#160;million. For the three months ended March 31, 2023, we had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the condensed consolidated balance sheet at March&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, services revenue recognized from performance obligations related to prior periods, such as due to changes in transaction price, was not material. Further, services revenue expected to be recognized in any future year related to remaining performance obligations was not material.</span></div></ix:continuation><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_37"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNy9mcmFnOjFkMzgzNmVjNDJhYjQ3MzU5NWY2NDNkMzVlYmRhZWE1L3RleHRyZWdpb246MWQzODM2ZWM0MmFiNDczNTk1ZjY0M2QzNWViZGFlYTVfMTc5Mg_3a6816de-d0ae-4f46-8f43-3a6d20de9ef5" continuedAt="iaced027b6db54f4b9feff77ae609ba94" escape="true">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaced027b6db54f4b9feff77ae609ba94" continuedAt="i5d18c4cac0454ab39235399522a7eed1"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNy9mcmFnOjFkMzgzNmVjNDJhYjQ3MzU5NWY2NDNkMzVlYmRhZWE1L3RleHRyZWdpb246MWQzODM2ZWM0MmFiNDczNTk1ZjY0M2QzNWViZGFlYTVfMTc5MQ_a1ffb293-54b3-4541-b156-7ad29455340c" continuedAt="ib9a19e46caf346bd8a785331362c774c" escape="true">In November 2020, the FASB issued Accounting Standards Update No. 2020-11, Financial Services&#8212;Insurance (Topic 944): Effective Date and Early Application (&#8220;ASU 2020-11&#8221;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12, Financial Services&#8212;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (&#8220;ASU 2018-12&#8221;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The new guidance relates to accounting for long-duration contracts of insurers which revises key elements of the measurement models and disclosure requirements for long-duration contracts issued by insurers, including the amortization of deferred contract acquisition costs and the measurement of liabilities for future policy benefits using current, rather than locked-in, assumptions. The new guidance, limited to our Medicare Supplement product which represent less than <ix:nonFraction unitRef="number" contextRef="i6dfc221ac14a4241a352cd2c7e2133be_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNy9mcmFnOjFkMzgzNmVjNDJhYjQ3MzU5NWY2NDNkMzVlYmRhZWE1L3RleHRyZWdpb246MWQzODM2ZWM0MmFiNDczNTk1ZjY0M2QzNWViZGFlYTVfMTA5OTUxMTY0MDcwNw_8ac9ae79-4764-4c54-8bc1-75a76bec6540">1</ix:nonFraction>% of consolidated premiums and services revenue, became effective for us beginning January 1, 2023 and is to be applied to contracts in force on the basis of their existing carrying value amounts at the beginning of the earliest period presented. The adoption of the new standard in 2023 did not have a material impact on our consolidated results of operations, financial position or cash flows.</ix:nonNumeric></ix:continuation></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5d18c4cac0454ab39235399522a7eed1"><ix:continuation id="ib9a19e46caf346bd8a785331362c774c">There are no other recently issued accounting standards that apply to us or that are expected to have a material impact on our results of operations, financial condition, or cash flows.</ix:continuation></ix:continuation></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_40"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfMjcwMA_92682e4c-cb8e-4eb8-9a2f-fcc58bf53033" continuedAt="i0242e0a8d19048f4b7bb1d96c52cef8a" escape="true">ACQUISITIONS AND DIVESTITURES </ix:nonNumeric></span></div><ix:continuation id="i0242e0a8d19048f4b7bb1d96c52cef8a"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 11, 2022, we completed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the sale of a <ix:nonFraction unitRef="number" contextRef="iec2ff4cf5f8a4840a5cfda8104745276_I20220811" decimals="2" name="hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfODY_09951cdc-70a0-49ed-b1f2-d4aec94d638b">60</ix:nonFraction>% i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterest in Gentiva, formerly Kindred, Hospice to Clayton, Dubilier &amp; Rice, or CD&amp;R, for cash proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="iec2ff4cf5f8a4840a5cfda8104745276_I20220811" decimals="-8" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfMjM1_495cf04f-0bca-412b-ad92-10a1b5f64ba3">2.7</ix:nonFraction>&#160;billion, net of cash disposed, including debt repayments from Gentiva Hospice to Humana of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i1f3a5a6a5bd240fd8dc9dddaaf415109_D20220811-20220811" decimals="-8" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfMzE3_ed1d59bf-95f2-4810-a54d-d4f3e6c72894">1.9</ix:nonFraction>&#160;billion. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale we recognized a pre-tax gain, net of transaction costs, of $<ix:nonFraction unitRef="usd" contextRef="i774b70cfc8b949b4b88dc4f2aefa89c5_D20220811-20220811" decimals="-6" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfNDA4_b70cc4af-ab7b-4a41-bea9-084b8ba30960">237</ix:nonFraction>&#160;million. For the three months ended March 31, 2022, the accompanying condensed consolidated statement of income includes revenues related to Gentiva Hospice of $<ix:nonFraction unitRef="usd" contextRef="i7411361d05ab46818cbd5d7ff1e21d74_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfMzI5ODUzNDg4NzY4OQ_052a3d24-367b-43f4-87b4-63fcefb26201">382</ix:nonFraction>&#160;million and pretax earnings of $<ix:nonFraction unitRef="usd" contextRef="i7411361d05ab46818cbd5d7ff1e21d74_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfMzI5ODUzNDg4NzcwMQ_295a3cd9-217c-4614-b4ae-f14fa35da991">62</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023 and 2022, we acquired various health and wellness related businesses which, individually or in the aggregate, have not had a material impact on our results of operations, financial condition, or cash flows. The results of operations and financial condition of these businesses acquired in 2023 and 2022 have been included in our condensed consolidated statements of income and condensed consolidated balance sheets from the respective acquisition dates. Acquisition-related costs recognized in 2023 and 2022 were not material to our results of operations. For asset acquisitions, the goodwill acquired is partially amortizable as deductible expenses for tax purposes. The pro forma financial information assuming the acquisitions had occurred as of the beginning of the calendar year prior to the year of acquisition, as well as the revenues and earnings generated during the year of acquisition, were not material for disclosure purposes.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_43"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMzE0MQ_62dd0037-0e82-429e-ae6c-050960fe783d" continuedAt="i2ad36e2191ac4505a964cfada7225ddc" escape="true">INVESTMENT SECURITIES</ix:nonNumeric></span></div><ix:continuation id="i2ad36e2191ac4505a964cfada7225ddc" continuedAt="i657e3f4c66434766ba7c18eb175ce117"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMzExNQ_8dbf6202-d17d-4a46-8b1d-0a76fd601dc9" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities classified as current and long-term were as follows at March&#160;31, 2023 and December 31, 2022, respectively:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.551%"><tr><td style="width:1.0%"></td><td style="width:43.476%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.120%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.120%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.120%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government<br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNC0xLTEtMS0xNzg5MjU_80af0a3e-9dcf-4549-ad7d-832078e18b9a">1,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNC0zLTEtMS0xNzg5MjU_562a89ab-dc8d-4940-9a58-618640221599">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNC01LTEtMS0xNzg5MjU_d97c78d2-b0d5-4621-88f7-e191b8d605fe">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNC03LTEtMS0xNzg5MjU_4785c071-356d-4e7a-9686-66ebc5198dac">1,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0051509dd034287a67b025711d2b730_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNS0xLTEtMS0xNzg5MjU_13a9aedc-fb27-4d0c-87f0-56b7b441fce4">3,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0051509dd034287a67b025711d2b730_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNS0zLTEtMS0xNzg5MjU_7ec7abb1-e26f-45f7-a508-65c042357831">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0051509dd034287a67b025711d2b730_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNS01LTEtMS0xNzg5MjU_0dae6436-9b25-4e0d-8f75-d078c5476331">423</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0051509dd034287a67b025711d2b730_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNS03LTEtMS0xNzg5MjU_8a589018-e393-4742-b07b-bced07f9fa82">3,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNi0xLTEtMS0xNzg5MjU_92379b3c-2af4-4dbd-b3db-87ee7934d9fe">762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNi0zLTEtMS0xNzg5MjU_d1b267e1-457a-4e84-a139-566fafb4c1f5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNi01LTEtMS0xNzg5MjU_6699dd06-c268-45e4-91de-a7b74def076c">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNi03LTEtMS0xNzg5MjU_73c8ddbf-c9b5-4b38-8841-ee5463a9d6e5">736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOC0xLTEtMS0xNzg5MjU_57a65baf-421a-4888-adba-e810f89b27c8">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOC0zLTEtMS0xNzg5MjU_8a0e8a31-baf1-4489-bbc9-296a4308e1ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOC01LTEtMS0xNzg5MjU_d636d7d4-793d-4239-ad4a-0719fd6ffa96">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOC03LTEtMS0xNzg5MjU_1efd561f-4cba-46be-abd8-cacdb45a9a71">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOS0xLTEtMS0xNzg5MjU_09b6dc73-c778-4b96-876a-255d73cc582c">1,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOS0zLTEtMS0xNzg5MjU_96adeebd-4f46-4aa7-9e99-ac58a22c7c0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOS01LTEtMS0xNzg5MjU_798dee22-986f-41fc-ac73-a939555657a4">149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOS03LTEtMS0xNzg5MjU_44aecebb-f9b9-4518-a8e6-882a43e258a4">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTAtMS0xLTEtMTc4OTI1_9947a836-2de6-47e3-9fe4-c9b4ee0dc347">1,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTAtMy0xLTEtMTc4OTI1_d238cfa5-6049-458c-8c29-98948f571b84">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTAtNS0xLTEtMTc4OTI1_150fed47-1045-4574-929f-159ffac288a7">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTAtNy0xLTEtMTc4OTI1_8ded9a7e-d6c9-4c20-b4be-2032ce876168">1,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTEtMS0xLTEtMTc4OTI1_98e3de38-039d-47dd-9d34-f190c45ac0c7">6,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTEtMy0xLTEtMTc4OTI1_771a27dd-cce2-494a-addb-60c4872453bb">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTEtNS0xLTEtMTc4OTI1_7935b312-e385-46fe-907b-1081c0a31831">696</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTEtNy0xLTEtMTc4OTI1_eaa57657-a888-4f3a-b667-4827159a7ff2">6,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTItMS0xLTEtMTc4OTI1_0367892f-30c1-403b-9736-90f6e743cc88">16,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTItMy0xLTEtMTc4OTI1_db70bb5f-1784-4059-aa87-081316202214">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTItNS0xLTEtMTc4OTI1_b165d356-108f-4764-a2f7-806492d09656">1,479</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTItNy0xLTEtMTc4OTI1_da9beba0-3e68-4efa-a9c3-fb2113306ee6">15,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTMtNy0xLTEtMTc4OTI1_9b048ce6-401d-4052-8b77-2952c7da1825">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTQtNy0xLTEtMTc4OTI1_f4845e8b-7c24-458b-ae80-6093abfcfc25">15,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTgtMS0xLTEtMTc4OTI1_7d25ca7e-e305-4a4b-95f0-4d45820ae5f5">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTgtMy0xLTEtMTc4OTI1_15bc583e-5d40-4d05-a86f-4b9c04dae5c4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTgtNS0xLTEtMTc4OTI1_21835a86-e037-43ab-aa8c-bbb8c13d8a25">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTgtNy0xLTEtMTc4OTI1_7e1dbc60-4112-4889-a5f2-63bc5519ccff">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTktMS0xLTEtMTc4OTI1_48827ad4-e2a4-495a-892f-4926d63a40c6">3,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTktMy0xLTEtMTc4OTI1_252fcf01-3c2b-4041-ae39-47b5df317f4d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTktNS0xLTEtMTc4OTI1_9a0ce769-be4a-44ab-ab65-376513634f08">471</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTktNy0xLTEtMTc4OTI1_f0e57b64-5f29-45a6-9a77-f74538df59a7">3,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjAtMS0xLTEtMTc4OTI1_8f0482b0-89e1-41ba-ae36-69e7affde170">765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjAtMy0xLTEtMTc4OTI1_366f2938-2a69-4b01-a7f2-94de6da4b1ce">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjAtNS0xLTEtMTc4OTI1_d9cb6baf-c017-4333-b7e5-fb01f2dad6c9">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjAtNy0xLTEtMTc4OTI1_ced31fcd-177b-4472-9095-47657b3162e9">728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f38b14697145628ecc307a28156bc7_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjItMS0xLTEtMTc4OTI1_bb24a943-53c1-4bbf-a1c7-6c2cd02c09af">477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f38b14697145628ecc307a28156bc7_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjItMy0xLTEtMTc4OTI1_df7e855e-9a86-4e2f-90e7-f851daadec57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87f38b14697145628ecc307a28156bc7_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjItNS0xLTEtMTc4OTI1_6d9f7a08-6aca-478f-bb19-185754791e89">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f38b14697145628ecc307a28156bc7_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjItNy0xLTEtMTc4OTI1_7be8648a-ccb9-4580-a3a5-dda2f0fd5275">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a81466c1f7403098573c8663478092_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjMtMS0xLTEtMTc4OTI1_2223454f-a311-4dfb-bbcb-e43b3b661590">1,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a81466c1f7403098573c8663478092_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjMtMy0xLTEtMTc4OTI1_a4583a8f-56ce-4258-a636-b5b26e1e5cf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39a81466c1f7403098573c8663478092_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjMtNS0xLTEtMTc4OTI1_45d70c2e-6084-47f8-84cb-6b59622b36c8">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a81466c1f7403098573c8663478092_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjMtNy0xLTEtMTc4OTI1_1fe72646-8e77-45d5-a3ca-f57f8d2933dc">1,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjQtMS0xLTEtMTc4OTI1_935a0b5c-a23f-4933-a3f3-f61230146861">1,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjQtMy0xLTEtMTc4OTI1_9ffe378c-e0a6-4e37-ab63-232b61e91303">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjQtNS0xLTEtMTc4OTI1_a0b922c3-2b59-4fcd-a2d0-1eb441e722ba">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjQtNy0xLTEtMTc4OTI1_53874ce9-0731-4122-9a01-c4cfa58b4adf">1,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjUtMS0xLTEtMTc4OTI1_1e8c6a16-2602-4d27-8db1-801dfba8fddc">6,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjUtMy0xLTEtMTc4OTI1_1f3624ec-8c16-40bf-aad1-bc8247aeafd5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjUtNS0xLTEtMTc4OTI1_115387c0-3efe-4535-abde-d3484e9d51cc">828</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjUtNy0xLTEtMTc4OTI1_51ed7baa-0711-4709-9d10-ca12f9748ed9">5,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjYtMS0xLTEtMTc4OTI1_6ea3ad3e-36ed-449a-aab9-f7e0fe2bbfca">15,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjYtMy0xLTEtMTc4OTI1_22e45c32-0f9b-4b76-8660-36d1dfc799a9">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjYtNS0xLTEtMTc4OTI1_843800c9-9938-4521-9bd2-ebc929eea08c">1,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjYtNy0xLTEtMTc4OTI1_90d367ad-5207-42d4-a48d-393d472aa48e">14,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjctNy0xLTEtMTc4OTI1_b99f5e47-f55e-4265-9016-e072c35c2777">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjgtNy0xLTEtMTc4OTI1_d53339a3-0a89-4067-b9ff-16ac5a115490">14,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i657e3f4c66434766ba7c18eb175ce117" continuedAt="i90682082089441fb990c48a8fdbfa18f"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We held certain corporate debt securities of Gentiva Hospice at March&#160;31, 2023 with amortized cost and fair value of approximately $<ix:nonFraction unitRef="usd" contextRef="if809f4ba53f94156aaf6671a93356b6a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMjcw_eeaf2af6-4efe-4f5f-9c6b-d44944215f66">281</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if809f4ba53f94156aaf6671a93356b6a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMjc3_45fe6da2-858b-4198-a869-c79229ab887a">286</ix:nonFraction>&#160;million, respectively.</span></div><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMzE1Mg_89d7e77a-0f9f-41fa-946c-d9899a1830ee" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross unrealized losses and fair values aggregated by investment category and length of time of individual debt securities that have been in a continuous unrealized loss position for which no allowances for credit loss has been recorded were as follows at March&#160;31, 2023 and December 31, 2022, respectively:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or more</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNS0xLTEtMS0xNzg5MjU_d5e8739d-bd47-428e-832c-e07e78f08bcd">290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNS0zLTEtMS0xNzg5MjU_991da004-8e51-4332-813a-9e6f9617ca9b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNS01LTEtMS0xNzg5MjU_7095d1c7-0897-448b-b389-04898f7a2c7d">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNS03LTEtMS0xNzg5MjU_75000a7f-afe3-4d8a-b4ed-727f83900382">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNS05LTEtMS0xNzg5MjU_325fa703-671f-46b6-ba11-39e59dd63278">686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNS0xMS0xLTEtMTc4OTI1_31ee96a5-bf69-4f48-98b5-5c37c720e410">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0051509dd034287a67b025711d2b730_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNi0xLTEtMS0xNzg5MjU_4e941270-a72c-4365-be3f-e45c78bddaf5">867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0051509dd034287a67b025711d2b730_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNi0zLTEtMS0xNzg5MjU_c70487a7-238f-41a0-8b85-3193bb37ad2d">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0051509dd034287a67b025711d2b730_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNi01LTEtMS0xNzg5MjU_8db3f8fc-ee00-4550-ab90-ad1e81186cc6">2,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0051509dd034287a67b025711d2b730_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNi03LTEtMS0xNzg5MjU_b1f6c6b4-4a62-4c7f-8c5a-2d483e88c229">406</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0051509dd034287a67b025711d2b730_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNi05LTEtMS0xNzg5MjU_cde104ce-74f5-4daf-a2d9-bd105aa3cfa4">2,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0051509dd034287a67b025711d2b730_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNi0xMS0xLTEtMTc4OTI1_7f1777ea-506e-4924-8d58-ed881159a601">423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNy0xLTEtMS0xNzg5MjU_acf5a7dc-ae1f-4169-b069-8cae00f337a4">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNy0zLTEtMS0xNzg5MjU_c8a2d65a-66e5-4c22-b9dc-cead27d55555">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNy01LTEtMS0xNzg5MjU_fefc5acc-2301-4c0a-8f5f-a91f3e5ea450">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNy03LTEtMS0xNzg5MjU_125a60dc-e4e8-47f0-b849-e9cdf3bce12a">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNy05LTEtMS0xNzg5MjU_0070a5aa-1875-481e-b839-c62b506e06d7">657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNy0xMS0xLTEtMTc4OTI1_bcd5ba70-5ee7-4866-a905-37978f9f91da">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfOS0xLTEtMS0xNzg5MjU_eee821f6-cb71-4d1d-adb8-acb4b9beb02d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfOS0zLTEtMS0xNzg5MjU_88646536-b9b4-4e7e-b6ed-71b1c0339234">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfOS01LTEtMS0xNzg5MjU_81fdeaf3-fbd2-43d9-8988-48218331f242">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfOS03LTEtMS0xNzg5MjU_f9ea9fc5-e213-4ee6-922f-0ca4eba99a38">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfOS05LTEtMS0xNzg5MjU_eaef8ae2-ef2b-4d40-87a2-c3244d822086">394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfOS0xMS0xLTEtMTc4OTI1_c0fca5ef-9b0c-40ec-af4f-db13885a5d16">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTAtMS0xLTEtMTc4OTI1_4c5136d5-227d-4b4a-8c39-824bdca4de25">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTAtMy0xLTEtMTc4OTI1_e542fab2-96c3-4868-af30-5b0aaf8c8b92">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTAtNS0xLTEtMTc4OTI1_3415e0a4-dfee-4151-92f1-dcded6422232">1,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTAtNy0xLTEtMTc4OTI1_0d6363dd-c5e4-4aad-aae1-ce873e9be6ea">145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTAtOS0xLTEtMTc4OTI1_08ce3c5b-e2a9-4964-9b69-7289179d70cb">1,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTAtMTEtMS0xLTE3ODkyNQ_3b99398b-9192-4ca7-bfd9-3c2ccc2028f8">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTEtMS0xLTEtMTc4OTI1_2729d4c5-76d6-43cd-a58d-59b4c69fab3f">583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTEtMy0xLTEtMTc4OTI1_e5b1c9e5-1144-4f70-a172-1e112a332525">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTEtNS0xLTEtMTc4OTI1_ce40408c-36a2-430f-97ae-2dad65c92ff4">971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTEtNy0xLTEtMTc4OTI1_aff6a244-2077-4f15-aff8-720a23f7a789">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTEtOS0xLTEtMTc4OTI1_337f8fea-b6fc-4609-b442-94ec1e249068">1,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTEtMTEtMS0xLTE3ODkyNQ_ca4f594f-c787-4c6c-ad05-127e91c86236">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTItMS0xLTEtMTc4OTI1_e1a91212-277e-4d6e-8442-01a2ce8ec8ff">1,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTItMy0xLTEtMTc4OTI1_6903d6dc-82e4-4c0b-a96c-d7ae5a6d35ba">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTItNS0xLTEtMTc4OTI1_d48e440e-99b5-4285-b181-055521399e33">3,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTItNy0xLTEtMTc4OTI1_2270a9ec-a194-460a-b893-30044cc21f31">649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTItOS0xLTEtMTc4OTI1_5ca67d2d-447e-47ce-8f34-0b01d2ca157d">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTItMTEtMS0xLTE3ODkyNQ_11bc0b9c-9e84-4fcb-a17e-c7c5ed48098b">696</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTMtMS0xLTEtMTc4OTI1_1b8bccb7-844c-46b3-9e0e-72631cbbba46">3,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTMtMy0xLTEtMTc4OTI1_481cfd96-1e36-4b09-bc76-a814356d538d">98</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTMtNS0xLTEtMTc4OTI1_6c535b01-f4d3-46bf-8a9d-079671dfa3ee">9,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTMtNy0xLTEtMTc4OTI1_69dbd014-c4f1-44cf-99c1-f742aa67bf07">1,381</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTMtOS0xLTEtMTc4OTI1_6dc9e71e-a619-419f-8e1f-d06107bf6586">12,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTMtMTEtMS0xLTE3ODkyNQ_6bb3ed0b-6dc0-4df1-b99f-e431d01433a2">1,479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTctMS0xLTEtMTc4OTI1_a1626378-d0b5-4cd2-b240-d3dcb5e20d9d">512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTctMy0xLTEtMTc4OTI1_b140fe58-c803-486c-9f75-dfcbcae374e9">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTctNS0xLTEtMTc4OTI1_7fd74452-1614-4b8f-b65b-64b4e63316ac">397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTctNy0xLTEtMTc4OTI1_36be3061-a7cd-4e4a-bb8d-a81ed379e71d">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTctOS0xLTEtMTc4OTI1_847c92fc-46be-4649-9f4a-b180b3eaee57">909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTctMTEtMS0xLTE3ODkyNQ_012acf58-1e8c-4d1a-94b3-ac4b2231e613">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTgtMS0xLTEtMTc4OTI1_14ec9b66-a4e1-43a0-9820-468eb83f1aed">1,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTgtMy0xLTEtMTc4OTI1_2cbd5fbc-359c-435b-81c9-c5672cb947ea">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTgtNS0xLTEtMTc4OTI1_ea81c2a3-6342-4192-9783-1a44f2653821">1,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTgtNy0xLTEtMTc4OTI1_9075f495-e480-4130-b5d5-2faf798201fa">367</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTgtOS0xLTEtMTc4OTI1_ce53d365-704f-4b48-ad41-1f20eee7133e">2,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTgtMTEtMS0xLTE3ODkyNQ_d981ea3f-5e11-417b-8785-ed02d6870527">471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTktMS0xLTEtMTc4OTI1_65fbddec-8dcd-4ab2-abbc-03db77f1be9f">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTktMy0xLTEtMTc4OTI1_df593d3b-3e23-4fdb-9fad-253810bcd0cc">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTktNS0xLTEtMTc4OTI1_330f0123-d222-4437-902b-b50d733cc8b9">615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTktNy0xLTEtMTc4OTI1_342f7c01-0056-4abb-8960-cd72da6c9dba">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTktOS0xLTEtMTc4OTI1_471306d4-bb82-4f1c-8072-4c5777048872">679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTktMTEtMS0xLTE3ODkyNQ_5a769524-7713-4632-8df8-75889b480c38">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f38b14697145628ecc307a28156bc7_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjEtMS0xLTEtMTc4OTI1_192bf3f6-f452-41b6-b05a-2c3772161820">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87f38b14697145628ecc307a28156bc7_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjEtMy0xLTEtMTc4OTI1_5d425c3d-45eb-4778-9742-61183d096de7">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f38b14697145628ecc307a28156bc7_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjEtNS0xLTEtMTc4OTI1_1a503267-7a94-4b64-8d04-81df2903ee4d">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87f38b14697145628ecc307a28156bc7_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjEtNy0xLTEtMTc4OTI1_f7c658da-6e5c-4011-918b-27dcb3f0a773">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f38b14697145628ecc307a28156bc7_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjEtOS0xLTEtMTc4OTI1_38bf3719-81c7-4b09-b157-832993718d99">398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87f38b14697145628ecc307a28156bc7_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjEtMTEtMS0xLTE3ODkyNQ_2e17d0e8-22eb-4dcd-8d27-a2f270c78039">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a81466c1f7403098573c8663478092_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjItMS0xLTEtMTc4OTI1_44939845-7aa0-4b2d-9935-797293f33068">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39a81466c1f7403098573c8663478092_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjItMy0xLTEtMTc4OTI1_2a16fbcc-cd60-448d-88d4-645fbc1ff5d5">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a81466c1f7403098573c8663478092_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjItNS0xLTEtMTc4OTI1_3150726f-5d7b-4d28-ae7d-bda7ecee1ac9">1,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39a81466c1f7403098573c8663478092_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjItNy0xLTEtMTc4OTI1_f3fba807-d17d-49bb-8e6f-ff66bed01f8d">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a81466c1f7403098573c8663478092_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjItOS0xLTEtMTc4OTI1_912bdb1e-4dcb-4018-a1d1-d5fb19cf9b68">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39a81466c1f7403098573c8663478092_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjItMTEtMS0xLTE3ODkyNQ_51afc760-d086-4c82-979d-fd3faa6d7b9d">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjMtMS0xLTEtMTc4OTI1_2fa4ee2a-723f-4d89-9a21-300337100e4d">620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjMtMy0xLTEtMTc4OTI1_bda2ebf7-7c93-49dc-8964-fc6dcd639b5f">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjMtNS0xLTEtMTc4OTI1_0f631a34-0ffb-4fba-a502-db7ef8ad23af">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjMtNy0xLTEtMTc4OTI1_f6d43aee-2133-4e86-960f-d3bdfa014971">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjMtOS0xLTEtMTc4OTI1_2dbc8f07-7d5c-4913-bbc6-00a07f7d8f6d">1,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjMtMTEtMS0xLTE3ODkyNQ_666b394e-31a1-4272-887c-e022e89e5eab">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjQtMS0xLTEtMTc4OTI1_3d49c7d7-cce9-4526-92da-79c20387b306">1,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjQtMy0xLTEtMTc4OTI1_4884427e-dae1-44ea-9c3d-5ebfc3f53b63">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjQtNS0xLTEtMTc4OTI1_9eb01e6c-a1e2-43cd-ac58-4c4fb1bfd786">3,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjQtNy0xLTEtMTc4OTI1_093ed19e-ce1d-4d88-93fb-13f96566b3bd">730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjQtOS0xLTEtMTc4OTI1_380ec331-684c-4392-96bb-34dae2d4520f">5,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjQtMTEtMS0xLTE3ODkyNQ_9b9f2649-aaa9-403d-bc2e-88a5d2eb7e4b">828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjUtMS0xLTEtMTc4OTI1_a7d2e01c-b9f2-407e-86f9-5090711f0ff5">4,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjUtMy0xLTEtMTc4OTI1_6ff7624b-b10e-4252-be58-0063b3a1fe32">270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjUtNS0xLTEtMTc4OTI1_140a67c3-8d54-4775-8a61-7843a2876ef7">8,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjUtNy0xLTEtMTc4OTI1_d7ae2bf1-efbd-460a-9319-3227d2f6f070">1,431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjUtOS0xLTEtMTc4OTI1_0af37d1f-3fe5-4e06-a464-682f2ddbff4b">13,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjUtMTEtMS0xLTE3ODkyNQ_42ce05b3-745c-43e6-97f7-2bbe16c8a779">1,701</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately <ix:nonFraction unitRef="number" contextRef="i8260b100247b44eea92f3356e1b28db7_I20230331" decimals="2" name="hum:PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfNjAw_16974207-359d-47a5-8895-74d930bc2ddc">98</ix:nonFraction>% of our debt securities were investment-grade quality, with a weighted average credit rating of AA by Standard &amp; Poor's Rating Service, or S&amp;P, at March&#160;31, 2023. Most of the debt securities that were below investment-grade were rated BB-, the higher end of the below investment-grade rating scale. Tax-exempt municipal securities were diversified among general obligation bonds of states and local municipalities in the United States as well as special revenue bonds issued by municipalities to finance specific public works projects such as utilities, water and sewer, transportation, or education.&#160;Our general obligation bonds are diversified across the United States with no individual state exceeding <ix:nonFraction unitRef="number" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="2" name="hum:MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMTI5NQ_d179e405-eb70-492a-9f75-bca436348ffb">1</ix:nonFraction>% of our total debt securities. Our investment policy limits investments in a single issuer and requires diversification among various asset types.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our unrealized losses from all debt securities were generated from approximately <ix:nonFraction unitRef="position" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMTUyNQ_2b214225-f152-4fae-b6da-c2c4708ef132">1,550</ix:nonFraction> positions out of a total of approximately <ix:nonFraction unitRef="position" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="0" name="hum:DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMTU3MA_6103f2a3-aa09-4b5b-81f4-cf2dc313fd09">1,950</ix:nonFraction> positions at March&#160;31, 2023. All issuers of debt securities we own that were trading at an unrealized loss at March&#160;31, 2023 remain current on all contractual payments. After taking into account these and </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i90682082089441fb990c48a8fdbfa18f" continuedAt="id7222742570b428e8467b8850df53b30"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other factors previously described, we believe these unrealized losses primarily were caused by an increase in market interest rates in the current markets since the time these debt securities were purchased. At March&#160;31, 2023, we did not intend to sell any debt securities with an unrealized loss position in accumulated other comprehensive income, and it is not likely that we will be required to sell these debt securities before recovery of their amortized cost basis. Additionally, we did not record any material credit allowances for debt securities that were in an unrealized loss position for the three months ended March 31, 2023 or 2022.</span></div><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:ScheduleOfRealizedGainLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMzE1Mw_6827aa48-76ef-461e-8b8f-fe22a8e16396" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The detail of (losses) gains related to investment securities and included within investment income was as follows for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:4pt;margin-top:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"></td><td style="width:70.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.484%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.485%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains on investment securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="hum:DebtSecuritiesRealizedGainGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfMy0xLTEtMS0xNzg5MjU_e454f7b4-0eb4-4f5e-9ecf-3305b6bb9e24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="hum:DebtSecuritiesRealizedGainGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfMy0zLTEtMS0xNzg5MjU_08fb2f50-1854-4073-836a-c9e5aa51a616">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses on investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="hum:DebtSecuritiesRealizedLossGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNC0xLTEtMS0xNzg5MjU_1caa1d33-65c8-4dd0-90d5-f5449f54fd5a">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="hum:DebtSecuritiesRealizedLossGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNC0zLTEtMS0xNzg5MjU_7592aaa3-7d78-4d94-9da5-c5fe73ae08f5">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains on equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNS0xLTEtMS0xNzg5MjU_531c95da-f0e0-4054-bc74-0b05e15c990d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGain" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNS0zLTEtMS0xNzg5MjU_11835be6-7356-4c89-95f3-cb338c1d6628">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNi0xLTEtMS0xNzg5MjU_052fff34-3a47-4d91-8006-1f167f3d99ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNi0zLTEtMS0xNzg5MjU_7731f791-45c0-4613-85ba-2a2fcab6330d">108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net recognized losses on investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNy0xLTEtMS0xNzg5MjU_f6541d7b-8632-4eef-b9db-0c528e3fb8b2">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNy0zLTEtMS0xNzg5MjU_2de92cc4-2426-414b-a676-abf99cc5d9b0">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:GainLossOnInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMzExNA_ae7f8a5c-53db-41c3-b429-4f54ef41b845" escape="true"><div style="margin-bottom:9pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses related to equity securities for the three months ended March 31, 2023 and 2022 was as follows:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:71.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.330%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.332%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains (losses) recognized on equity securities during the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjQwODYxZmIxNmM1MDRjMjI5YjA0MTI2OTg5ZmY2MmI0L3RhYmxlcmFuZ2U6NDA4NjFmYjE2YzUwNGMyMjliMDQxMjY5ODlmZjYyYjRfMy0xLTEtMS0xNzg5MjU_a3e7f299-3dd3-407e-a4f7-6b4101b7ad5e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjQwODYxZmIxNmM1MDRjMjI5YjA0MTI2OTg5ZmY2MmI0L3RhYmxlcmFuZ2U6NDA4NjFmYjE2YzUwNGMyMjliMDQxMjY5ODlmZjYyYjRfMy0zLTEtMS0xNzg5MjU_24099c4d-d5c8-465e-b4ab-25cacefeec6e">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net gains (losses) recognized on equity securities sold during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjQwODYxZmIxNmM1MDRjMjI5YjA0MTI2OTg5ZmY2MmI0L3RhYmxlcmFuZ2U6NDA4NjFmYjE2YzUwNGMyMjliMDQxMjY5ODlmZjYyYjRfNC0xLTEtMS0xNzg5MjU_271ba7d7-1185-4a6f-b228-82ca4361553a">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjQwODYxZmIxNmM1MDRjMjI5YjA0MTI2OTg5ZmY2MmI0L3RhYmxlcmFuZ2U6NDA4NjFmYjE2YzUwNGMyMjliMDQxMjY5ODlmZjYyYjRfNC0zLTEtMS0xNzg5MjU_f955614b-819f-430e-bc6b-a65d590098ef">59</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses recognized on equity securities still held at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjQwODYxZmIxNmM1MDRjMjI5YjA0MTI2OTg5ZmY2MmI0L3RhYmxlcmFuZ2U6NDA4NjFmYjE2YzUwNGMyMjliMDQxMjY5ODlmZjYyYjRfNS0xLTEtMS0xNzg5MjU_a26fac62-e5a0-4a55-a4f3-4acb69eb3c56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjQwODYxZmIxNmM1MDRjMjI5YjA0MTI2OTg5ZmY2MmI0L3RhYmxlcmFuZ2U6NDA4NjFmYjE2YzUwNGMyMjliMDQxMjY5ODlmZjYyYjRfNS0zLTEtMS0xNzg5MjU_170c8a86-d341-4935-9b5d-a847aa3d3d66">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMzEzMA_dc10daa7-86bc-4d9d-adb6-ef6dcc9186b3" escape="true"><div style="margin-bottom:9pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of debt securities available for sale at March&#160;31, 2023, regardless of their balance sheet classification, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:70.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.704%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfMi0xLTEtMS0xNzg5MjU_3295d3a5-e0ab-40b6-ba4f-fbc4ff7b8c8a">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfMi0zLTEtMS0xNzg5MjU_f22ca371-b85d-4c34-b603-0431b9f20044">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfMy0xLTEtMS0xNzg5MjU_3671c4da-3dde-46a2-8ed4-ade485e5ca90">4,116</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfMy0zLTEtMS0xNzg5MjU_03a3d042-09be-4bde-a667-239b2c3c7550">3,941</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNC0xLTEtMS0xNzg5MjU_0b125cd8-c1a7-4ff3-835b-c6fda3055ef0">3,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNC0zLTEtMS0xNzg5MjU_977ccc11-083a-4754-bb3b-359bd3926933">2,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNS0xLTEtMS0xNzg5MjU_85aaab39-2849-4ce1-8002-c223a6d8d172">1,251</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNS0zLTEtMS0xNzg5MjU_78543c63-66ec-4765-a398-fd13c9f0386b">1,051</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage and asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNi0xLTEtMS0xNzg5MjU_ba38d7ab-8202-45eb-9b76-839d93f9e787">7,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNi0zLTEtMS0xNzg5MjU_c3aa4830-1efb-42b6-bdbb-4db3b25292c8">7,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNy0xLTEtMS0xNzg5MjU_3d1a619f-9f48-42a2-8bba-946930e5e02c">16,747</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNy0zLTEtMS0xNzg5MjU_bad7abc0-ff28-42e6-a6b7-4d1716e25173">15,303</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id7222742570b428e8467b8850df53b30">For additional information regarding our investment securities, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</ix:continuation> </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_46"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNDQ0NQ_eecfba80-d560-41d2-8c71-a560a76695de" continuedAt="i586be527839d4bbaa97392e6bf575c0b" escape="true">FAIR VALUE</ix:nonNumeric></span></div><ix:continuation id="i586be527839d4bbaa97392e6bf575c0b" continuedAt="if8d2356e3eb44ce09b651662bef432b3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Assets</span></div><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNDQ0Mg_40fc29a5-51fc-4ee6-9f63-9ac9fd9d2584" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our fair value measurements at March&#160;31, 2023 and December 31, 2022, respectively, for financial assets measured at fair value on a recurring basis:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:49.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.617%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.617%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.617%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96e6af2307314f46be9d1d0b03502013_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNC0xLTEtMS0xNzg5MjU_8e978c3d-725b-4ad3-9a8b-b11c31bf685e">13,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc24f5c05d5441b6ac8827d88f991c2e_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNC0zLTEtMS0xNzg5MjU_e4e8e011-f889-4afc-8ac7-ffbff8b846f0">13,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1a5f1cccae8416f9bc599fff3f8e1d4_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNC01LTEtMS0xNzg5MjU_bf364042-6912-48f1-b4c9-610a139b6302">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b13e4a05827464d8b24ae1ead744fbd_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNC03LTEtMS0xNzg5MjU_526c3ee9-e757-4378-87e0-2bddddd206f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government<br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65bf87d9361462aaf0a0ac5f9556c38_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNy0xLTEtMS0xNzg5MjU_a82a9feb-fc6c-41ec-9e41-8091f11ad796">1,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a47acf1908a40b2af4d3cd0d68e3910_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNy0zLTEtMS0xNzg5MjU_d41a785f-03a1-4a6e-aef1-d74632e18492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d921a49fc8e435386aef2bf71f59872_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNy01LTEtMS0xNzg5MjU_a26a0007-a5b2-4664-a03b-dd5e41b23467">1,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6bbb7d6ca004e8a908a13b5eed703ec_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNy03LTEtMS0xNzg5MjU_0e4f137a-6471-4376-9f36-4817ced82f66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id68f6d863b0042c2b99dadf26d204628_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOC0xLTEtMS0xNzg5MjU_ff2c98e4-1407-4fac-8958-e4db92a77f6d">3,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if14d9ee3acf541a8a80edb1dae2c5c51_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOC0zLTEtMS0xNzg5MjU_85f5db23-cd6f-4128-b68f-40aaa055eeb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450207aa5894438f9c2c646c0ce9982d_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOC01LTEtMS0xNzg5MjU_1ceb18c7-394a-4787-8dfb-0fa887cf9a52">3,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i857c0bd469ed4f57a4d62245b9c850ad_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOC03LTEtMS0xNzg5MjU_f4ff7737-0f04-4767-8530-9f5f7181ce19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82a7da6de90f4292a75b4ff142ac0839_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOS0xLTEtMS0xNzg5MjU_737e1c70-9523-4fd2-a312-ec177f5f2189">736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904a6646c1c74766ad237ced5460d3b7_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOS0zLTEtMS0xNzg5MjU_820daced-13f3-413c-ab58-91c8bbf0b0fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81015bdf666841988a8d3083b77b955b_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOS01LTEtMS0xNzg5MjU_ada967f4-05cd-4308-8612-7d370902761c">736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb95cb15ca9b431f83fabb95130459cb_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOS03LTEtMS0xNzg5MjU_ad02948c-fc18-4c59-87e6-a111bb54cd59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8862232402c4d6eaf52edf65048202e_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTEtMS0xLTEtMTc4OTI1_143ea0a0-139d-432c-9ade-6015d2e92b55">397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72d189fde50f4d818a6f390bc4fc11a1_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTEtMy0xLTEtMTc4OTI1_dd737b74-0509-4c9d-b4ff-26cb83db5cf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b4080af65ca47cfb1edb387d17a5d36_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTEtNS0xLTEtMTc4OTI1_cc30ecf3-3db8-4a58-8c3e-c46681e520e0">397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00c16389c034f59895277e520697c6f_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTEtNy0xLTEtMTc4OTI1_03935553-8303-49ac-8154-6c154836bf17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie692d3daf2da432f84a4d2bba4f54421_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTItMS0xLTEtMTc4OTI1_e72aa9eb-c1e9-41db-8c23-d9125e8804d3">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37b5903d02c84da3b134cc8b5828e4e6_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTItMy0xLTEtMTc4OTI1_fd662a94-0129-4c28-9870-35f57102749d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2d2e19b91464e48b9c851e183850d14_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTItNS0xLTEtMTc4OTI1_78dd25b8-cb57-4a06-80b1-97a5a4513c8a">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1ff90bae9d54e1e973a6a3fee17c018_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTItNy0xLTEtMTc4OTI1_b40f0cda-a899-43d7-91fa-6a78bedfa3f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ea4b788a8f48c185d7fda9b12db75c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTMtMS0xLTEtMTc4OTI1_8c9f4cd7-45bf-4bce-818d-861956f738d3">1,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d6e7427cc38408f801653d6fe0309ba_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTMtMy0xLTEtMTc4OTI1_3a2a3896-0480-4b78-a0b1-981a7992dda8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib81031dfb7aa4eef857cf826a330605d_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTMtNS0xLTEtMTc4OTI1_ce91de59-41e2-4a9d-9728-cf1ec8188532">1,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbc4c8c594954395822ec239de2a59f9_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTMtNy0xLTEtMTc4OTI1_2794e1ad-b4ca-400c-a5b4-05134a55343b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc8d3332e21f4115ad4811a1901d881a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTQtMS0xLTEtMTc4OTI1_d853d578-52d8-4328-84a8-0e03299c9f5d">6,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340393b9ebe54ab2b5864af5e584548c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTQtMy0xLTEtMTc4OTI1_27bc83c5-155e-4f2b-8dee-1f143e7098c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a5e9db863849bcad9826c573d3ad01_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTQtNS0xLTEtMTc4OTI1_a40832c8-82a8-49b6-bb28-381c56551a44">5,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fbc3e66d57845169e1aff68c77b3197_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTQtNy0xLTEtMTc4OTI1_edd8bcfe-4937-4bdd-ab61-fb0f74817533">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96e6af2307314f46be9d1d0b03502013_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTUtMS0xLTEtMTc4OTI1_1fdcc404-28c7-47c8-b2c2-b2940335aaf1">15,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc24f5c05d5441b6ac8827d88f991c2e_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTUtMy0xLTEtMTc4OTI1_739b8027-f82f-46c6-ab55-fae354cb5969">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1a5f1cccae8416f9bc599fff3f8e1d4_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTUtNS0xLTEtMTc4OTI1_edaa7190-8a06-4785-97ee-0f08d63db376">15,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b13e4a05827464d8b24ae1ead744fbd_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTUtNy0xLTEtMTc4OTI1_fc5c2247-a869-4070-b058-05bd7f57ae3a">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96e6af2307314f46be9d1d0b03502013_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTYtMS0xLTEtMTc4OTI1_71ffee1f-dafd-47e7-a8fd-826faed480c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc24f5c05d5441b6ac8827d88f991c2e_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTYtMy0xLTEtMTc4OTI1_d256aeb2-0c7f-4e57-8f40-a8c1f087a997">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1a5f1cccae8416f9bc599fff3f8e1d4_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTYtNS0xLTEtMTc4OTI1_552874e3-93ce-46f9-8238-4242c6e229c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b13e4a05827464d8b24ae1ead744fbd_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTYtNy0xLTEtMTc4OTI1_8938d7a4-f0bd-493d-963e-332133539640">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 66.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total invested assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96e6af2307314f46be9d1d0b03502013_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTctMS0xLTEtMTc4OTI1_7024777d-8226-42c0-ae5d-510d512d9f18">28,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc24f5c05d5441b6ac8827d88f991c2e_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTctMy0xLTEtMTc4OTI1_3db9f882-1c0d-4f03-9ebf-1fa310366acf">13,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1a5f1cccae8416f9bc599fff3f8e1d4_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTctNS0xLTEtMTc4OTI1_45fcec4a-656d-490f-801a-45e8f76c1124">15,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b13e4a05827464d8b24ae1ead744fbd_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTctNy0xLTEtMTc4OTI1_c1c59519-6205-486c-a855-3523f6161d1b">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ee919d2f184cf7949d0916d4f1ccb1_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjAtMS0xLTEtMTc4OTI1_d861c14e-62c5-47fd-a224-79499a323a2d">4,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f44fd8b7d7943429ac546aea13d21f6_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjAtMy0xLTEtMTc4OTI1_088c1ace-3d72-4651-899f-c7e830dc37ef">4,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f045e713b3f4183a844967854a098d2_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjAtNS0xLTEtMTc4OTI1_50dbebee-ecc5-4077-90ca-5acb1500ea08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0a9a1917c8f47a5836ac770133b8421_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjAtNy0xLTEtMTc4OTI1_99911d38-aacf-4528-84ac-9a5db248da34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government<br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70628c781dab4482bf2a82089e58407c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjMtMS0xLTEtMTc4OTI1_c5fb5ebc-c028-4143-8843-e5acf468f749">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60e56a4abb3148b3a47ea17e821ce331_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjMtMy0xLTEtMTc4OTI1_38c91b29-3f6d-4ce4-9cb3-7c1cb869fbcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9d324ecf5045808b96815c38a7eaaf_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjMtNS0xLTEtMTc4OTI1_89513cf7-f922-4bb5-abf5-beb9e331aa9b">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a9a3430ebaf429886fbd03e394bb465_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjMtNy0xLTEtMTc4OTI1_08db4d8a-84c0-474f-9d03-45f0c3b2f6f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa02a4a665234d36b7de271c9e9e73b4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjQtMS0xLTEtMTc4OTI1_9d97c4ef-17c8-45fd-89cf-39677d90f1e7">3,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b2bd12e6e20458f8f4892b3040ac67e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjQtMy0xLTEtMTc4OTI1_7489ac7c-8712-4f5a-8273-6fd5fd437995">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dddf02ed2304674986163307e834a6c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjQtNS0xLTEtMTc4OTI1_eef8ca9c-0226-415a-88db-197d247cc558">3,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c66b776082466ea556dce65306d942_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjQtNy0xLTEtMTc4OTI1_13e08495-0223-4cb8-900e-616b49ec1513">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9bf427d0d47a3b08bf8a294f9efd9_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjUtMS0xLTEtMTc4OTI1_0dfde96e-6267-44f0-912e-162df37280be">728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a211d5ff9bb4a4589e60af4080172f9_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjUtMy0xLTEtMTc4OTI1_92fc0c89-37c0-4a91-98a3-d2a92c8872fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i060d5600c50d4d6093631349614ca333_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjUtNS0xLTEtMTc4OTI1_5472f5ae-beac-422e-a8f0-ff85c513dba6">728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic732fa8df9034ee0a649c2601e5b6cff_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjUtNy0xLTEtMTc4OTI1_689b199c-96a3-4ca1-a5d2-6b437cb112ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9037b2b16c75430caac0e82c3c767c2e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjctMS0xLTEtMTc4OTI1_b56a238c-bea0-49e0-ae68-f3bbb04d7574">401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc036307c91f4c9593abeaff015430b2_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjctMy0xLTEtMTc4OTI1_3fd00e21-d5be-4b16-ac9c-f0b5735cab57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic82ffec88c8042de8e8a1dbf644279a5_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjctNS0xLTEtMTc4OTI1_495723a4-9faf-4789-ab53-0f2ce90d8a55">401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73062b9f6c3946998028a6772ce9264f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjctNy0xLTEtMTc4OTI1_ea34bcfd-ed40-4e42-8731-6da9ed602fb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37d0240334144c13b97f059cadb7034b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjgtMS0xLTEtMTc4OTI1_99b1e6c4-ea10-45e0-9882-29ae7d730540">1,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd5d6eb79ea5478c9f1ec177266b62cc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjgtMy0xLTEtMTc4OTI1_879805ce-f868-46c4-bd57-2621eeebcf83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6858edb4103a4d41ae1249f6acf86c38_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjgtNS0xLTEtMTc4OTI1_9b2be9f1-de94-438a-8103-db5adfee7e22">1,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i779b10a8a0554fe5a72d0d42c1badb15_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjgtNy0xLTEtMTc4OTI1_178ac3bf-2a37-4dcb-ada5-939c797eda05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd635cbfddf44141945808c29cbc55eb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjktMS0xLTEtMTc4OTI1_a65a30a1-c49b-41cb-9787-c704903774bd">1,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia39754b4e45940db8cb97fe1ff3d7880_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjktMy0xLTEtMTc4OTI1_32ecb90a-1de2-432a-adef-c4aca3aa8a6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c84525d35214f6c9815e8351adfd02a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjktNS0xLTEtMTc4OTI1_30305395-19c8-48cc-a876-15ff62f2bd4e">1,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39fc8e1461704c80aef7a77108d678a7_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjktNy0xLTEtMTc4OTI1_b3a99e25-7be9-432a-a7b7-c84c40e1aa46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e057100f4124140bac2dcc36e38be91_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzAtMS0xLTEtMTc4OTI1_6621bac4-d01e-4db1-a84a-6ecfcbc30bfe">5,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03be5b990dcd41ed91f338937639131a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzAtMy0xLTEtMTc4OTI1_ed9bd383-37fa-44ec-9869-825be893d1b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i581027d290ae46cfa11f5ee26717a967_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzAtNS0xLTEtMTc4OTI1_868b446b-ea95-4fbd-8058-aad64ed1d99c">5,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib330972c763d4fdfab8db010a1908b51_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzAtNy0xLTEtMTc4OTI1_7db57e3b-82e4-428f-b8cd-ec076c1c1be5">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ee919d2f184cf7949d0916d4f1ccb1_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzEtMS0xLTEtMTc4OTI1_69601b13-d3d2-4b95-b8c9-32a49df69407">14,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f44fd8b7d7943429ac546aea13d21f6_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzEtMy0xLTEtMTc4OTI1_af3652e4-5be7-4eb2-a309-7d0ea1f1a8d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f045e713b3f4183a844967854a098d2_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzEtNS0xLTEtMTc4OTI1_fe56ce0a-bd5f-410e-866e-7f44af0473fd">14,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0a9a1917c8f47a5836ac770133b8421_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzEtNy0xLTEtMTc4OTI1_ed27505b-730f-489c-bff1-dc0e5f4ddf16">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ee919d2f184cf7949d0916d4f1ccb1_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzItMS0xLTEtMTc4OTI1_da0e17c3-d74d-43fc-8ed1-94f090f897ef">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f44fd8b7d7943429ac546aea13d21f6_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzItMy0xLTEtMTc4OTI1_8be8c170-822b-40cc-b2a7-2fd66292d9f9">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f045e713b3f4183a844967854a098d2_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzItNS0xLTEtMTc4OTI1_f94a5996-360b-4b78-a035-b1230bff448a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0a9a1917c8f47a5836ac770133b8421_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzItNy0xLTEtMTc4OTI1_621e4a71-3b90-4201-b555-3ed80df64038">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 66.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total invested assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ee919d2f184cf7949d0916d4f1ccb1_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzMtMS0xLTEtMTc4OTI1_b4a2e38d-1124-4c8c-86e2-9724cd303840">19,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f44fd8b7d7943429ac546aea13d21f6_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzMtMy0xLTEtMTc4OTI1_7e7d054c-f14c-4774-b939-bb8362141d42">4,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f045e713b3f4183a844967854a098d2_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzMtNS0xLTEtMTc4OTI1_62804cd8-61d8-4167-be5d-c89d760ae466">14,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0a9a1917c8f47a5836ac770133b8421_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzMtNy0xLTEtMTc4OTI1_61950ba9-91b3-4bfa-aa52-e6f118395f9e">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="if8d2356e3eb44ce09b651662bef432b3" continuedAt="i1e042bddb4704d48bd1d1507c78e13c1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Level 3 assets had a fair value of $<ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMjMw_0f530f52-95ca-4180-a8f6-fb1419cdf9f0">99</ix:nonFraction> million at March&#160;31, 2023, or <ix:nonFraction unitRef="number" contextRef="ib2516335975c48cf807e97640b5043bf_D20230101-20230331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMjQ0_f0a56f6f-580b-49e3-84f6-902d1fb69f7e">0.3</ix:nonFraction>% of our total invested assets. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNDQ1Mw_2d9211a4-be47-4b43-ba37-7ed2a706fde5" continuedAt="i1878e182d3084ddd854b8e3e50f81250" escape="true">During the year ended March&#160;31, 2023, the changes in the fair value of the assets measured using significant unobservable inputs (Level 3) were comprised of the following:</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><ix:continuation id="i1878e182d3084ddd854b8e3e50f81250"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.946%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Private Placements</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance at January&#160;1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfMy0xLTEtMS0xNzg5MjU_98cb34ba-6a24-4ae4-aff9-fbed67402cf9">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if66f7e3bde694a2fa6f2b9ad88e258ff_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfMy0yLTEtMS0xODMzNDI_6862aa05-5166-4913-8dfd-b6f4662a4447">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gains or losses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized in other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfNi0xLTEtMS0xNzg5MjU_1852ca3e-6356-46a3-9c5a-3ece6c4a5f20">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfNi0yLTEtMS0xODMzNDI_dee33ec9-1336-457d-bb30-36bf2e38cdb0">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfNy0xLTEtMS0xNzg5MjU_ddc030d9-a586-4240-89ca-b3aebadd2a47">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfNy0yLTEtMS0xODMzNDI_d456f44d-cabd-433a-84a1-b6cd996a1c97">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfOC0xLTEtMS0xNzg5MjU_ccb94ea6-ade5-4881-b561-bea018ab4800">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfOC0yLTEtMS0xODMzNDI_da11d237-6e55-4579-a3c2-eab92a466830">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer out</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfMTAtMS0xLTEtMTkwMzk4_ecb35cf7-b7c6-4eda-8cff-2845b49f4226">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfMTAtMi0xLTEtMTkwNTYy_8831a792-f437-4a1b-b888-0e73b3a1b257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfMTAtMS0xLTEtMTc4OTI1_ad9ec439-9630-4eb2-87e3-39e1f51dbfe5">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55a5772c9e08479ba75577876ccf8013_I20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfMTAtMi0xLTEtMTgzMzQy_b1f1ab49-db96-4094-bb5b-9c7410268d4f">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Liabilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt is recorded at carrying value in our consolidated balance sheets. The carrying value of our senior notes debt outstanding, net of unamortized debt issuance costs, was $<ix:nonFraction unitRef="usd" contextRef="iba4807ab291b411ba709086ff2b0ca6b_I20230331" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNjc4_0158e45f-7d3d-4a20-bfa7-cba6458ee0ed">11.2</ix:nonFraction> billion at March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="ic4b60d2223724b5b852a7861a92b748d_I20221231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNjkx_6e2dbd05-56e7-4ee5-8182-3a0e32d0bca2">10.0</ix:nonFraction> billion at December 31, 2022. The fair value of our senior notes debt was $<ix:nonFraction unitRef="usd" contextRef="i64b0b2cce9c4429eb7e08589df09657a_I20230331" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNzQ1_f70f2478-6be4-470c-9951-7cf97f144c29">10.9</ix:nonFraction> billion at March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="ib2298c1aedcf4c389d4500f8dfca5cd7_I20221231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNzU4_5c4c6040-94e6-4721-8f8a-6978f70876da">9.4</ix:nonFraction> billion at December 31, 2022. The fair value of our senior notes debt is determined based on Level 2 inputs, including quoted market prices for the same or similar debt, or if no quoted market prices are available, on the current prices estimated to be available to us for debt with similar terms and remaining maturities. Carrying value approximates fair value for our term loans and commercial paper borrowings. The commercial paper borrowings were $<ix:nonFraction unitRef="usd" contextRef="id7dfa681e84e4a328abd29adc43edeb8_I20230331" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMTIwNA_862ec798-6e95-4f4e-ab62-bac07addca10">426</ix:nonFraction> million at March&#160;31, 2023. The term loans and commercial paper borrowings were $<ix:nonFraction unitRef="usd" contextRef="iffacfea7d72c41969e8c61520fc3f3fe_I20221231" decimals="-8" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMTIxNw_e6259af5-d183-4835-ba04-fd14b7e3badd">1.1</ix:nonFraction> billion at December 31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Put and Call Options Measured at Fair Value</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our put and call options associated with our equity method investments are measured at fair value each period using a Monte Carlo simulation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The put and call options fair values associated with our Primary Care Organization strategic partnership with  Welsh, Carson, Anderson &amp; Stowe, or WCAS, which are exercisable at a fixed revenue exit multiple and provide a minimum return on WCAS' investment if exercised, are measured at fair value each reporting period using a Monte Carlo simulation. The put and call options fair values, derived from the Monte Carlo simulation, were $<ix:nonFraction unitRef="usd" contextRef="i8aecae41941c4949a148814d02c27b4c_I20230331" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMTc0MQ_e5f734ab-a29c-4d53-8345-35768aa891af">318</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6c4cd7500ddd4042987e2f54456204e8_I20230331" decimals="-6" name="hum:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMTc0OA_ea6822df-9add-4ce0-bf71-290aa4421a24">8</ix:nonFraction> million, respectively, at March&#160;31, 2023. The put and call options fair values, derived from the Monte Carlo simulation, were $<ix:nonFraction unitRef="usd" contextRef="i9241eb7b1705466a9f42cbc6c027a7e3_I20221231" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMTg1Nw_769e9980-8247-4d32-9513-6ee26eabdd13">267</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia9c5e672fb5646a5b6ef97e6cd7e5fe2_I20221231" decimals="-6" name="hum:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMTg2NA_0fc2ffca-4525-4cfd-83b5-67fff74a3169">10</ix:nonFraction> million, respectively, at December 31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant unobservable inputs utilized in these Level 3 fair value measurements (and selected values) include the enterprise value, annualized volatility and credit spread. Enterprise value was derived from a discounted cash flow model, which utilized significant unobservable inputs for long-term revenue, to measure underlying cash flows, weighted average cost of capital and long term growth rate. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNDQ2MQ_2b3021f1-f2bc-4d08-9cef-6d94af9bd601" continuedAt="i37d511f4ebd344c4a4bd676b86b1a33e" escape="true">The table below presents the assumptions used for each reporting period.</ix:nonNumeric></span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i1e042bddb4704d48bd1d1507c78e13c1"><div style="margin-bottom:9pt;text-align:right;text-indent:18pt"><ix:continuation id="i37d511f4ebd344c4a4bd676b86b1a33e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:59.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.805%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib841b2af88bc479392f83bdf0da74d8a_I20230331" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMS0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjpiMGYwOGJkNjAyYTM0MjY5YWVhNjIzZDYxMTQ5MWYyZl80_ee11cd21-d78f-47f3-ab1f-eca7065591c4">16.7</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i86e34249f19741d8bfc9dfb0d72a9a0a_I20230331" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMS0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjpiMGYwOGJkNjAyYTM0MjY5YWVhNjIzZDYxMTQ5MWYyZl85_dd9b00c3-90a4-400d-89b6-1399fdce1c8b">19.3</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i213d04e139894278bd43204227e8da44_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMS0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjplNjZmZDBhMjQ2MjA0MTQxYjMyOTg2YTA2OWYxYjA4ZF8xMDk5NTExNjI3Nzg4_1c77754a-f2bc-4a47-8d8c-3c2ab49a3448">16.7</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i52c5649fd533485aa955d121bd05719e_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMS0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjplNjZmZDBhMjQ2MjA0MTQxYjMyOTg2YTA2OWYxYjA4ZF8xMDk5NTExNjI3Nzky_e05f58c7-52f5-465d-b41c-e5c5665a179e">20.8</ix:nonFraction>%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit spread</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i57134d84c2ac447a84c8200c372a35f8_I20230331" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMi0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjoxYWU5YzRlMWRiZTk0ZTRlOTk5NzJlZjAxYzM3N2Q3Ml80_156f2ec4-e900-466c-81fa-9c2ac4a84a39">1.2</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i8a0d174b8c8d4fe0ba5550e6b43544fa_I20230331" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMi0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjoxYWU5YzRlMWRiZTk0ZTRlOTk5NzJlZjAxYzM3N2Q3Ml85_1d261057-b9f5-4ffe-8fcd-22a011fb90c0">1.4</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idee655553fa24a6bbe52a7b3d4ca04ad_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMi0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjo3M2UxZThhZjczZDE0N2IwYjhhY2Q3ZGU0YWM5ZWIwOF8xMDk5NTExNjI3Nzg4_3dec0312-52d4-498c-ac95-ec1755edca2f">1.3</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i20d1e957c4434a06af24cf6ac0397e7f_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMi0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjo3M2UxZThhZjczZDE0N2IwYjhhY2Q3ZGU0YWM5ZWIwOF8xMDk5NTExNjI3Nzky_c375c258-0ab4-41a4-960a-277073d092a2">1.5</ix:nonFraction>%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue exit multiple</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f0f9995f95947629017ed8fed503fa1_I20230331" decimals="1" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMy0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjpmZjI5NzdmNDJjZGQ0ZTlhYmYyMDk5NTlmMmFkNzg2MV80_2339571e-6526-4a9a-b40f-e196005bcc73">1.5</ix:nonFraction>x - <ix:nonFraction unitRef="number" contextRef="i61634fa707254b90a8db03c0fa13102a_I20230331" decimals="1" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMy0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjpmZjI5NzdmNDJjZGQ0ZTlhYmYyMDk5NTlmMmFkNzg2MV8xMA_dd212299-5f2a-4cd4-b420-2a9c5ff2a587">2.5</ix:nonFraction>x</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic46ba81be64948dfb5b93511ef5de0cb_I20221231" decimals="1" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMy0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjphZDIxMzlmNmY2ZWY0OGYxYjA0NTkxNzRjYmQ2ZDY1MF80_9fdffc94-65c6-4d6c-96cd-1a311f756f93">1.5</ix:nonFraction>x - <ix:nonFraction unitRef="number" contextRef="i580fb323c37c4b618f287b4d6dfa7f5a_I20221231" decimals="1" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMy0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjphZDIxMzlmNmY2ZWY0OGYxYjA0NTkxNzRjYmQ2ZDY1MF8xMA_78497b69-a96e-4211-aee5-617af3a9a8ef">2.5</ix:nonFraction>x</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average cost of capital</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i000d5227848d42249813688992aac2b1_I20230331" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfNC0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjoyNjZkMDViMzYzMDI0MmRmYTM0YjQxYTI5MjU0NmZkMF83MTQ2ODI1NTgwNTUy_36bdabd1-fa8a-4392-beb0-3fcc37a350a8">12.0</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i377cc2a8446b4761b2676862a02afc19_I20230331" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfNC0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjoyNjZkMDViMzYzMDI0MmRmYTM0YjQxYTI5MjU0NmZkMF83MTQ2ODI1NTgwNTU4_378cca39-3d15-4397-9122-58c949f1b53c">13.0</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93acdee7a8de48d2ad5e50b6216e5223_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfNC0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjplNDI5ODk4ZmFiNTk0MWVlYjczYzQxMTdjYjliYjkyYl8xMDk5NTExNjI3ODE2_0cd29704-c7ef-4adf-b9d8-f382ed30e53d">11.5</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i6060040f6de2440d9e22ed16c9c48f07_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfNC0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjplNDI5ODk4ZmFiNTk0MWVlYjczYzQxMTdjYjliYjkyYl8xMDk5NTExNjI3ODA4_21eefee7-048c-4bef-b6d6-701f53b8ad3a">12.5</ix:nonFraction>%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term growth rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32ddf5d36d5045038d50eaf21c6818b2_I20230331" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfNS0xLTEtMS0xNzg5MjU_9091130c-898a-4bce-8b08-9982b8a7883f">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8f173f5f0d7a4516ad1a0ff666bedec2_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfNS0yLTEtMS0xNzg5MjU_3705d7d2-9297-41d1-8be0-16e0eccfebdb">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used for annualized volatility, credit spread and weighted average cost of capital reflect the lowest and highest values where they differ significantly across the series of put and call options due to their expected exercise dates.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Assets and Liabilities Measured at Fair Value</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities are measured at fair value on a non-recurring basis subject to fair value adjustment only in certain circumstances. As disclosed in Note 3, we acquired various health and wellness related businesses during 2023. The net assets acquired and resulting goodwill and other intangible assets were recorded at fair value primarily using Level 3 inputs. The net tangible assets including receivables and accrued liabilities were recorded at their carrying value which approximated their fair value due to their short term nature. The fair value of goodwill and other intangible assets were internally estimated based primarily on the income approach. The income approach estimates fair value based on the present value of cash flow that the assets could be expected to generate in the future. We developed internal estimates for expected cash flows in the present value calculation using inputs and significant assumptions that include historical revenues and earnings, revenue growth rates, the amount and timing of future cash flows, discount rates, contributory asset charges and future tax rates, among others. The excess purchase price over the fair value of assets and liabilities acquired is recorded as goodwill.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed in Note 3, we completed the sale of Gentiva Hospice on August 11, 2022. The carrying value of the assets and liabilities of Gentiva Hospice disposed approximates fair value. The amount of goodwill included in the carrying value is based on the relative fair value of the Home Solutions reporting unit included within the CenterWell segment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the assets and liabilities acquired during 2023, there were no other material assets or liabilities measured at fair value on a recurring or nonrecurring basis during 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our fair value measurements, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_49"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="hum:MedicarePartDDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RleHRyZWdpb246ZjZmYWVhZmU4NzQ1NDU2NDllZjYyNTNjZDlhZGQ3MzlfODgz_95822979-a032-4f15-b6e6-0419fbb224f4" continuedAt="icc6ae1acc7da4d47a3ea87418e6a8372" escape="true">MEDICARE PART D</ix:nonNumeric></span></div><ix:continuation id="icc6ae1acc7da4d47a3ea87418e6a8372"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with the Centers for Medicare and Medicaid Services, or CMS. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="hum:BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RleHRyZWdpb246ZjZmYWVhZmU4NzQ1NDU2NDllZjYyNTNjZDlhZGQ3MzlfODc5_85a35a81-9810-42ff-a676-f34094d1a7e0" continuedAt="ic30710dc2bec4b5c8c72c9ce12b75fb2" escape="true">The accompanying condensed consolidated balance sheets include the following amounts associated with Medicare Part D at March&#160;31, 2023 and December 31, 2022. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers. For additional information regarding our prescription drug benefits coverage in accordance with Medicare Part D, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:1pt;text-align:center"><ix:continuation id="ic30710dc2bec4b5c8c72c9ce12b75fb2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:41.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.565%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.565%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.565%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.570%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk<br/>Corridor<br/>Settlement</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CMS<br/>Subsidies/<br/>Discounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk<br/>Corridor<br/>Settlement</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CMS<br/>Subsidies/<br/>Discounts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfMy0xLTEtMS0xNzg5MjU_b7cc221c-dfe5-4a5b-b1b8-a18651a811f8">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfMy0zLTEtMS0xNzg5MjU_faae4a48-4bce-40a1-984d-5214a435a2f0">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ea645d881244feb48020446f2c6961_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfMy01LTEtMS0xNzg5MjU_16698487-7088-4684-b9af-b3c1eb5f5db5">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1755902072d64e9cb2f6181073517a64_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfMy03LTEtMS0xNzg5MjU_5d57a408-d0dc-46f6-b6ae-86cc3226964c">696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable and accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNC0xLTEtMS0xNzg5MjU_229dc0c8-4b57-4b10-87e4-69eea712b0c4">147</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNC0zLTEtMS0xNzg5MjU_98777acf-4f80-4554-a134-52c7daa747eb">3,805</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22ea645d881244feb48020446f2c6961_I20221231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNC01LTEtMS0xNzg5MjU_2ebb7e73-cffc-47ac-b319-5d6d40257bf9">166</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1755902072d64e9cb2f6181073517a64_I20221231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNC03LTEtMS0xNzg5MjU_b8eda7bb-e0c2-4309-bcb0-af5e5177b7be">1,236</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current (liability) asset</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331" decimals="-6" sign="-" name="hum:NetCurrentLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNS0xLTEtMS0xNzg5MjU_07bd10c3-b30a-44a4-b70a-c1fd30277fe0">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331" decimals="-6" sign="-" name="hum:NetCurrentLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNS0zLTEtMS0xNzg5MjU_5b7823b6-3828-4611-a287-656216c36b69">3,566</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ea645d881244feb48020446f2c6961_I20221231" decimals="-6" name="hum:NetCurrentLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNS01LTEtMS0xNzg5MjU_6217c1a5-f53d-4839-8501-dfbef2ea0363">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1755902072d64e9cb2f6181073517a64_I20221231" decimals="-6" sign="-" name="hum:NetCurrentLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNS03LTEtMS0xNzg5MjU_ec31a05e-23d2-4bdf-baab-17865e52c43f">540</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNi0xLTEtMS0xNzg5MjU_702839ce-2e50-444f-a3a8-b036fea1f49a">307</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNi0zLTEtMS0xNzg5MjU_b37454ac-cc5c-42db-8ad7-599ad3038aaf">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ea645d881244feb48020446f2c6961_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNi01LTEtMS0xNzg5MjU_ac18b658-6ac2-4fb9-a3a8-7133373cd8ad">19</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1755902072d64e9cb2f6181073517a64_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNi03LTEtMS0xNzg5MjU_51d39d8f-0bb3-41fb-b4c9-578cc672b1a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNy0xLTEtMS0xNzg5MjU_e703dc66-ed9d-4ba6-ab87-f07df34f987c">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNy0zLTEtMS0xNzg5MjU_433d2a6a-aef1-4f18-86d3-81d345bef028">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22ea645d881244feb48020446f2c6961_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNy01LTEtMS0xNzg5MjU_3751817e-9ac5-4018-9841-ad1c53da5bd7">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1755902072d64e9cb2f6181073517a64_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNy03LTEtMS0xNzg5MjU_cee6fd02-93b1-4348-8f7e-f1f5eda31505">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net long-term asset (liability)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331" decimals="-6" name="hum:NetNoncurrentAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOC0xLTEtMS0xNzg5MjU_7991ea8e-d758-4877-97bc-13dff1038a55">214</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331" decimals="-6" name="hum:NetNoncurrentAssetLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOC0zLTEtMS0xNzg5MjU_61dc73bb-6837-4281-8af2-a87d312e50fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22ea645d881244feb48020446f2c6961_I20221231" decimals="-6" sign="-" name="hum:NetNoncurrentAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOC01LTEtMS0xNzg5MjU_58b567b3-ba2d-49c7-ab59-0368ca5bf99d">59</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1755902072d64e9cb2f6181073517a64_I20221231" decimals="-6" name="hum:NetNoncurrentAssetLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOC03LTEtMS0xNzg5MjU_cf930033-01b1-473b-8bc6-7ed4f651c61e">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net asset (liability)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331" decimals="-6" name="hum:NetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOS0xLTEtMS0xNzg5MjU_d5f82f68-a2b5-4ad5-8d77-26426b290b80">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331" decimals="-6" sign="-" name="hum:NetAssetLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOS0zLTEtMS0xNzg5MjU_e2ea6727-7eb8-4e7d-8c7e-af78b3aefbe3">3,566</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ea645d881244feb48020446f2c6961_I20221231" decimals="-6" name="hum:NetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOS01LTEtMS0xNzg5MjU_aa251e10-a046-46d0-af8e-2d41876074e0">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1755902072d64e9cb2f6181073517a64_I20221231" decimals="-6" sign="-" name="hum:NetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOS03LTEtMS0xNzg5MjU_32d2297e-278c-4973-9df7-0e5a049d1170">540</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-bottom:9pt"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_52"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfOTI2_99086baf-905c-465b-b006-09ee7180cc06" continuedAt="i4b0f94adb68b4ca183a9563dfbcd655e" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i4b0f94adb68b4ca183a9563dfbcd655e" continuedAt="i4fe35174e69540fabb5dde5afde14fde"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfOTE5_f0ac9160-1406-437e-a9de-f1cac3cbc78f" escape="true"><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill for our reportable segments for the three months ended March 31, 2023 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.557%"><tr><td style="width:1.0%"></td><td style="width:55.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.613%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2ccf77cbd704aa9a50f730c09b643b5_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfMi0xLTEtMS0xNzg5MjU_ceb36e4d-1b48-4b89-94c1-d248966f421c">2,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93e22a22917143fb9f847c7288ff5d00_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfMi0zLTEtMS0xNzg5MjU_fe7c58a7-3180-4833-b0bd-e98d89336fbc">6,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfMi05LTEtMS0xNzg5MjU_7da308d3-36dd-4782-8371-e3b3d8bbc9a9">9,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69f76c986f34f1b9ba9eb7a9c317d65_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfMy0xLTEtMS0xNzg5MjU_37ef68d2-dfa1-492d-b25a-e2ee53178379">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83bf3dc5af6c4f2eb6caaad2ac9f84b8_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfMy0zLTEtMS0xNzg5MjU_d6b24d9d-aa8a-47ec-829d-1b786224a3da">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfMy05LTEtMS0xNzg5MjU_dd38d2fa-d8e7-4cab-a75f-b74d85966fbd">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i602a0549ee5e4de58fd4f6d95c040179_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfNi0xLTEtMS0xNzg5MjU_ad72cd14-c40f-483a-a5e1-873259c56e8c">2,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54bd717275cd4a1ba7a908f4c92495ab_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfNi0zLTEtMS0xNzg5MjU_3d0c2aa4-b91b-49e3-8666-400612dcc957">6,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfNi05LTEtMS0xNzg5MjU_2da94643-8d55-4ce0-8069-933f9f3e2b61">9,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i4fe35174e69540fabb5dde5afde14fde"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfOTIx_6f8a0bb3-f8eb-4875-8ecb-f5f76b739dad" escape="true"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfOTIx_d1f1ef04-f4ce-4d39-80f8-befbcf2be0e5" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents details of our other intangible assets included in other long-term assets in the accompanying condensed consolidated balance sheets at March&#160;31, 2023 and December 31, 2022:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.681%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of need</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd572f2390164976be20fe3a140197cd_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNC0zLTEtMS0xNzg5MjU_7f8a6bfc-13e5-4c79-9370-9b57bf89269d">1,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd572f2390164976be20fe3a140197cd_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNC03LTEtMS0xNzg5MjU_9b757b61-592a-4abf-9d5b-6e65123093fa">1,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d23511b94f84defb1f54af0330dc9e3_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNC05LTEtMS0xNzg5MjU_37b3565a-a7ce-4209-9581-6aecc09afc9e">1,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d23511b94f84defb1f54af0330dc9e3_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNC0xMy0xLTEtMTc4OTI1_6efa29d2-de57-4887-80b5-3fb24d598ee8">1,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3178f9117bab4d4788c41331f0e1dc09_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNS0zLTEtMS0xNzg5MjU_0a64ac50-5a79-48a2-9ba2-f9fe5f2ab5d8">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3178f9117bab4d4788c41331f0e1dc09_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNS03LTEtMS0xNzg5MjU_13033999-7370-4813-83c1-1e5b890532ca">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0802607a67b4c848b58734b6b762529_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNS05LTEtMS0xNzg5MjU_0f24d851-3efd-4fd5-a051-90a89140cdbb">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0802607a67b4c848b58734b6b762529_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNS0xMy0xLTEtMTc4OTI1_bee00cb0-012a-49e2-a2bc-04fc5e9b06a9">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/<br/>&#160;&#160;&#160;&#160;relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i150ea53c09e74fcb851b6053b9e40298_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi0xLTEtMS0xNzg5MjU_5307137c-4e41-4801-b57c-4b37be7660d6">9.3</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8054b45e04e441f6b73aeb7346969a3c_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi0zLTEtMS0xNzg5MjU_842b4165-d045-4b98-99b3-09ceb288e061">932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8054b45e04e441f6b73aeb7346969a3c_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi01LTEtMS0xNzg5MjU_21d7221d-b677-4006-82b7-8aa102b57287">685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8054b45e04e441f6b73aeb7346969a3c_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi03LTEtMS0xNzg5MjU_931427ad-4781-48e6-bcee-1b296a59df03">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7aaf3b0b0d4b86bbe081d04e1b0c0e_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi05LTEtMS0xNzg5MjU_2735b87a-107a-42a6-8038-da3e180b8c21">929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7aaf3b0b0d4b86bbe081d04e1b0c0e_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi0xMS0xLTEtMTc4OTI1_88cc70d4-9b28-4a86-8d33-038da43b44c4">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7aaf3b0b0d4b86bbe081d04e1b0c0e_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi0xMy0xLTEtMTc4OTI1_e381f428-7b82-417f-a669-85503cd82a87">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names and <br/>&#160;&#160;&#160;&#160;technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2d0ef9aa2df04dada2b6de53639369a3_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy0xLTEtMS0xNzg5MjU_d7279e1d-773d-4b66-bc16-92df2a5ef116">6.8</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48b4610f5eff4676ae8a83d142ee62a3_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy0zLTEtMS0xNzg5MjU_a98b9957-201c-4408-a743-c3745ff96c84">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48b4610f5eff4676ae8a83d142ee62a3_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy01LTEtMS0xNzg5MjU_0ddcf569-b24c-4b91-9154-5d1ecdedde78">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48b4610f5eff4676ae8a83d142ee62a3_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy03LTEtMS0xNzg5MjU_27ee7e3c-4f7d-480b-b63f-596b9a9a0268">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b795c8e2a749b195affd66d768c0f8_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy05LTEtMS0xNzg5MjU_4970590e-8962-46f9-bec9-4db967a11c31">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b795c8e2a749b195affd66d768c0f8_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy0xMS0xLTEtMTc4OTI1_e4258b7c-37ed-4d96-a8d0-4e774c2e1341">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b795c8e2a749b195affd66d768c0f8_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy0xMy0xLTEtMTc4OTI1_2f6a893a-2ff2-4c14-9055-f91e00450914">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i209ef83489cc4686aca29a75e66a999e_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC0xLTEtMS0xNzg5MjU_803b976c-e8a9-4637-9aca-db587b040c04">11.6</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i355b7a91cbe642259e6c7b0a6b9415a5_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC0zLTEtMS0xNzg5MjU_fea6ef29-a4f9-460c-a7fa-5b76f01c4a87">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i355b7a91cbe642259e6c7b0a6b9415a5_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC01LTEtMS0xNzg5MjU_c659c33f-ac8a-4c4f-8ebc-e1b3145dada7">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i355b7a91cbe642259e6c7b0a6b9415a5_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC03LTEtMS0xNzg5MjU_c34dc1b9-6db3-4b40-9813-668d02d08836">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i586b2df071664278b33320a690171b5a_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC05LTEtMS0xNzg5MjU_cfa351f3-f3bd-47d9-a4c7-4604948bc098">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i586b2df071664278b33320a690171b5a_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC0xMS0xLTEtMTc4OTI1_c7e07e7d-7260-473c-aa3a-ead61feeaded">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i586b2df071664278b33320a690171b5a_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC0xMy0xLTEtMTc4OTI1_e7b55965-acea-4e75-846a-8162aa4daa92">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetes and <br/>&#160;&#160;&#160;&#160;other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7208e156cf594c919494eb2550d73a05_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS0xLTEtMS0xNzg5MjU_882576a2-6dd2-4a4e-8856-490676681560">8.4</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1186c96f23294e26be46ab0face47239_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS0zLTEtMS0xNzg5MjU_3110fda5-f197-479e-be13-04806ceb73fe">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1186c96f23294e26be46ab0face47239_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS01LTEtMS0xNzg5MjU_5d408caf-f8cc-4f74-abca-b2342e7a78e6">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1186c96f23294e26be46ab0face47239_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS03LTEtMS0xNzg5MjU_4b3130e8-2b35-4cc4-9eca-9245f4c278d4">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88f55df1f8fe486285179afd07008365_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS05LTEtMS0xNzg5MjU_51c8eb99-0e86-46ad-a753-dfda7962d004">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88f55df1f8fe486285179afd07008365_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS0xMS0xLTEtMTc4OTI1_f7475324-d40e-4061-b1d5-f08ea12145d1">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88f55df1f8fe486285179afd07008365_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS0xMy0xLTEtMTc4OTI1_6e48a372-e444-46cb-944e-085667dde2e5">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible <br/>&#160;&#160;&#160;&#160;assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtMS0xLTEtMTc4OTI1_ef2e0dc0-fb02-4f61-9586-a7a17ec358c8">9.1</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtMy0xLTEtMTc4OTI1_787c07ab-4855-434a-b2d7-4c1914f1a914">2,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtNS0xLTEtMTc4OTI1_721bc218-109c-4cb5-9a0f-ab351ee39791">887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtNy0xLTEtMTc4OTI1_493c68c2-cdb3-4364-987f-bcc10b0ac52d">1,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtOS0xLTEtMTc4OTI1_0d6778a9-f48e-45f4-a913-263b2ee42dae">2,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtMTEtMS0xLTE3ODkyNQ_51694fad-471c-46be-b1a1-74cbc566f18b">883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtMTMtMS0xLTE3ODkyNQ_6bed6596-08aa-433c-aec8-dd126f11fac0">1,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March 31, 2023 and 2022, amortization expense for other intangible assets was approximately $<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfNDEw_430bd533-e64d-480e-8702-6225add3c7cd"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfNDEw_d199871d-b1fe-4493-a566-e4874346973c">18</ix:nonFraction></ix:nonFraction> million. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfOTI0_fb636403-b0f0-437a-8b6c-30274326113b" continuedAt="ia64d9f42ab644a71a568778cda5d1aeb" escape="true">The following table presents our estimate of amortization expense remaining for 2023 and each of the five next succeeding years at March&#160;31, 2023:</ix:nonNumeric></span></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify"><ix:continuation id="ia64d9f42ab644a71a568778cda5d1aeb"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:88.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.351%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the years ending December 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOjdlNmNmMGI1ODhkZTRlNjZiZjhjOWU3OWEzMzgyNjgxL3RhYmxlcmFuZ2U6N2U2Y2YwYjU4OGRlNGU2NmJmOGM5ZTc5YTMzODI2ODFfMi0xLTEtMS0xNzg5MjU_98460619-296e-422b-8d59-b638a8121c0f">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOjdlNmNmMGI1ODhkZTRlNjZiZjhjOWU3OWEzMzgyNjgxL3RhYmxlcmFuZ2U6N2U2Y2YwYjU4OGRlNGU2NmJmOGM5ZTc5YTMzODI2ODFfMy0xLTEtMS0xNzg5MjU_bdaa37a8-b56f-4005-ab17-20c081bc1339">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOjdlNmNmMGI1ODhkZTRlNjZiZjhjOWU3OWEzMzgyNjgxL3RhYmxlcmFuZ2U6N2U2Y2YwYjU4OGRlNGU2NmJmOGM5ZTc5YTMzODI2ODFfNC0xLTEtMS0xNzg5MjU_2a4620b7-46d3-4b2e-8b64-dae6fe1fc1dc">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOjdlNmNmMGI1ODhkZTRlNjZiZjhjOWU3OWEzMzgyNjgxL3RhYmxlcmFuZ2U6N2U2Y2YwYjU4OGRlNGU2NmJmOGM5ZTc5YTMzODI2ODFfNS0xLTEtMS0xNzg5MjU_ff49ea73-8e80-43e2-8dcb-2d0217feb413">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOjdlNmNmMGI1ODhkZTRlNjZiZjhjOWU3OWEzMzgyNjgxL3RhYmxlcmFuZ2U6N2U2Y2YwYjU4OGRlNGU2NmJmOGM5ZTc5YTMzODI2ODFfNi0xLTEtMS0xNzg5MjU_70de86de-186d-4f3c-8d85-657fd51c1d52">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOjdlNmNmMGI1ODhkZTRlNjZiZjhjOWU3OWEzMzgyNjgxL3RhYmxlcmFuZ2U6N2U2Y2YwYjU4OGRlNGU2NmJmOGM5ZTc5YTMzODI2ODFfNy0xLTEtMS0xNzg5MjU_bf10ca51-bfc3-4155-b1a6-20f5a4e8fb9d">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our goodwill and intangible assets, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_55"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:InsuranceDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RleHRyZWdpb246MDhjNzViNWU4ZjBjNDQ3YmExOTM2ZWFiNDBlMzJiZjhfMTQxMA_78ec0a91-5779-4fcf-a7d5-f5590d735905" continuedAt="i3a87b3907d4d410db98d39f1fa178b1e" escape="true">BENEFITS PAYABLE</ix:nonNumeric></span></div><ix:continuation id="i3a87b3907d4d410db98d39f1fa178b1e"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RleHRyZWdpb246MDhjNzViNWU4ZjBjNDQ3YmExOTM2ZWFiNDBlMzJiZjhfMTQxNg_7db9a0c4-e151-4020-9aac-3c1511ca9e13" escape="true"><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a consolidated basis, which represents our Insurance segment net of eliminations, activity in benefits payable was as follows for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:6pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.435%"><tr><td style="width:1.0%"></td><td style="width:52.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.103%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.106%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMy0yLTEtMS0xNzg5MjU_6f3f05e6-434e-4f28-a678-543ddf9c0343">9,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if66f7e3bde694a2fa6f2b9ad88e258ff_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMy00LTEtMS0xNzg5MjU_db3276d5-bd45-4948-af77-697bd374dc50">8,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfNi0yLTEtMS0xNzg5MjU_6155686b-cf0c-4aae-93e7-b1b9b5c52860">22,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfNi00LTEtMS0xNzg5MjU_56654eaa-76d5-48e4-876e-9fcc463065b9">19,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfNy0yLTEtMS0xNzg5MjU_f64284d7-afb2-48fb-b616-da973eb23e4c">522</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfNy00LTEtMS0xNzg5MjU_4199f4ac-fe2e-4bd0-9103-6ec6cb21ee1c">360</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfOC0yLTEtMS0xNzg5MjU_79db838a-ee3e-4011-8865-884c690030f6">21,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfOC00LTEtMS0xNzg5MjU_9f52d2c2-7c20-4671-8585-64dde9b9630a">19,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTAtMi0xLTEtMTc4OTI1_922fc5c9-52a5-4b4d-8687-3cbeff2492f7">14,203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTAtNC0xLTEtMTc4OTI1_428efc52-4877-4df7-a064-191835438f10">12,284</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTEtMi0xLTEtMTc4OTI1_da7f58a8-c8b8-470a-b2fb-534d13fbcc6b">6,901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTEtNC0xLTEtMTc4OTI1_335e3d09-9b96-4547-8b84-0a0c2654e252">6,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTItMi0xLTEtMTc4OTI1_16d521c2-85b2-4be1-95d8-b47f9c11e117">21,104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTItNC0xLTEtMTc4OTI1_cb79eede-a160-4bda-8160-b36d60678e4c">18,536</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTMtMi0xLTEtMTc4OTI1_b8b96d3c-e26d-49cf-bb60-ab72df9ba9ed">10,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55a5772c9e08479ba75577876ccf8013_I20220331" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTMtNC0xLTEtMTc4OTI1_7376ef24-1cf6-49b5-96c8-79c5771248e5">9,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total estimate of benefits payable for claims incurred but not reported, or IBNR, is included within the net incurred claims amounts. At March&#160;31, 2023, benefits payable included IBNR of approximately $<ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-8" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RleHRyZWdpb246MDhjNzViNWU4ZjBjNDQ3YmExOTM2ZWFiNDBlMzJiZjhfMzQ1_11e618db-9b80-441f-84e0-2aaede14b4d0">6.3</ix:nonFraction> billion, primarily associated with claims incurred in 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts incurred related to prior periods vary from previously estimated liabilities as the claims ultimately are settled. Negative amounts reported for incurred related to prior years result from claims being ultimately settled for amounts less than originally estimated (favorable development). </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reserving practice is to consistently recognize the actuarial best estimate of our ultimate liability for claims. Actuarial standards require the use of assumptions based on moderately adverse experience, which generally results in favorable reserve development, or reserves that are considered redundant. For additional information regarding our benefits payable and benefits expense recognition, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div></ix:continuation><div style="margin-bottom:1pt;text-align:center"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_58"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 9. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RleHRyZWdpb246M2YzMTUyNTUyZjFkNDU2YjhmZmJlNTIyMWZjOTc1YjRfMzk3_24ea59ba-cd62-4c9e-88d6-f0a5ec68f47a" continuedAt="i891e0326fcf54e1b9f43ede4d7ee0876" escape="true">EARNINGS PER COMMON SHARE COMPUTATION</ix:nonNumeric></span></div><ix:continuation id="i891e0326fcf54e1b9f43ede4d7ee0876" continuedAt="i1c4b7016fd6e4c00b8a3563c39b549ed"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RleHRyZWdpb246M2YzMTUyNTUyZjFkNDU2YjhmZmJlNTIyMWZjOTc1YjRfNDAw_5419c6a1-e2d0-4f1c-8b62-2bc3cf06f34a" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Detail supporting the computation of basic and diluted earnings per common share was as follows for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.955%"><tr><td style="width:1.0%"></td><td style="width:57.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.395%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.626%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.398%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions, except per common share results; number of shares in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income available for common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfMy0xLTEtMS0xNzg5MjU_06511023-bef2-44de-8b03-35077e669047">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfMy0zLTEtMS0xNzg5MjU_04329df4-987f-4cb1-a2ba-43b2d1cd7af2">930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average outstanding shares of common stock <br/>&#160;&#160;&#160;&#160;used to compute basic earnings per common share</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfNC0xLTEtMS0xNzg5MjU_69a3864a-6651-445c-8d06-51d4ee190a4a">125,005</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfNC0zLTEtMS0xNzg5MjU_bcda7a69-fd3d-4b86-a4cd-bf4ce8e99292">126,938</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a2c0126f2424bb8ab0ee87fe08cb666_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfNi0xLTEtMS0xNzg5MjU_d5d76f90-0ff7-4cc2-a988-2d4e403d52af">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e434f71448049a284869f73abeb0b98_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfNi0zLTEtMS0xNzg5MjU_98714e5c-b77f-4bea-b8cd-043e39f280ab">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i930b18f4afe34fec9820ff5a19092628_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfNy0xLTEtMS0xNzg5MjU_32fe3d73-a7e9-42b2-a74b-f626189ddbd4">525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7542e08ec319422a9b4c757d3a9accd0_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfNy0zLTEtMS0xNzg5MjU_5305de7d-c829-471a-abe6-f149300bdcde">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute diluted earnings per common share</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfOC0xLTEtMS0xNzg5MjU_60fc7ff8-946d-47aa-a8d5-e86965a1c586">125,564</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfOC0zLTEtMS0xNzg5MjU_a8aae853-fe9f-4d3f-8db1-f154d54d00a1">127,474</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfOS0xLTEtMS0xNzg5MjU_77bcccd5-0fa2-456e-b2da-793e6f79ff45">9.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfOS0zLTEtMS0xNzg5MjU_7c188305-f913-41e5-86e9-dd61f1b53652">7.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfMTAtMS0xLTEtMTc4OTI1_6e910401-6413-4288-9fbb-616e45c8da9a">9.87</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfMTAtMy0xLTEtMTc4OTI1_8546aeea-ba4d-42fa-b404-d0414adb5328">7.29</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of antidilutive stock options and restricted stock <br/>&#160;&#160;&#160;&#160;excluded from computation</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfMTEtMS0xLTEtMTc4OTI1_a564dd1e-d8d3-481f-924e-785bb374af95">538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfMTEtMy0xLTEtMTc4OTI1_eb9a8e21-04c0-416e-9dbe-7c1069eb4f92">626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1c4b7016fd6e4c00b8a3563c39b549ed">For additional information regarding earnings per common share, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</ix:continuation> </span></div><div style="margin-bottom:1pt;text-align:center"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_61"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMzEwMQ_389e6b2b-77cd-4ee4-8a09-5a2c06914457" continuedAt="i85d5e9213c6e463dbd8520092273b297" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="i85d5e9213c6e463dbd8520092273b297" continuedAt="ica0d90ff13b54b5e90bcf19db449808e"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:DividendsDeclaredTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMzEyNA_10620f4e-c971-4116-bf21-97f0eaa8ac6a" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of dividend payments, excluding dividend equivalent rights for unvested stock awards, during 2023 under our Board approved quarterly cash dividend policy:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:23.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record<br/>Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment<br/>Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/30/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/27/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0b9ac383e9ea4b719311556136d97415_D20230127-20230127" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RhYmxlOjAyOTFkMDJkNmIwNDRmYmJiYWY0ODIxM2FlYjY3ZjViL3RhYmxlcmFuZ2U6MDI5MWQwMmQ2YjA0NGZiYmJhZjQ4MjEzYWViNjdmNWJfOC00LTEtMS0xNzg5MjU_ef889a05-4d41-4c65-9d6d-d906152c9344">0.7900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b9ac383e9ea4b719311556136d97415_D20230127-20230127" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RhYmxlOjAyOTFkMDJkNmIwNDRmYmJiYWY0ODIxM2FlYjY3ZjViL3RhYmxlcmFuZ2U6MDI5MWQwMmQ2YjA0NGZiYmJhZjQ4MjEzYWViNjdmNWJfOC02LTEtMS0xNzg5MjU_d4e95af8-819d-4802-ae33-4e80f5e19325">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Board declared a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i855926020dce4bea9a6964c5647f3657_D20230201-20230228" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMTA5OTUxMTYzMjY4Mw_5f5c11f7-0bc8-470c-9416-0555cb8a1284">0.885</ix:nonFraction> per share payable on April 28, 2023 to stockholders of record on March 31, 2023. In April 2023, the Board declared a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i22b1e29a3e1c4bc98acae1e9ce50b759_D20230401-20230430" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMjc3_614f76b1-5cd1-4b96-a799-22db2dd5a651">0.885</ix:nonFraction> per share payable on July 28, 2023 to stockholders of record as of the close of business on June&#160;30, 2023. Declaration and payment of future quarterly dividends are at the discretion of our Board and may be adjusted as business needs or market conditions change.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our Board of Directors may authorize the purchase of our common stock shares. Under the share repurchase authorization, shares may be purchased from time to time at prevailing prices in the open market, by block purchases, through plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, or in privately-negotiated transactions, including pursuant to accelerated share repurchase agreements with investment banks, subject to certain regulatory restrictions on volume, pricing, and timing.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ica0d90ff13b54b5e90bcf19db449808e"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 15, 2023, the Board of Directors replaced the previous share repurchase authorization of up to $<ix:nonFraction unitRef="usd" contextRef="iab7b66d9b316428980dce49fe22290b3_I20230215" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMzg0ODI5MDcwNjQ0Ng_f910c654-e32b-4988-9270-02f4c7818d8f">3</ix:nonFraction>&#160;billion (of which approximately $<ix:nonFraction unitRef="usd" contextRef="iab7b66d9b316428980dce49fe22290b3_I20230215" decimals="-9" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMzg0ODI5MDcwNjQ1OA_394da80e-3b38-472f-ac8a-771c84ac10b8">1</ix:nonFraction>&#160;billion remained unused) with a new authorization for repurchases of up to $<ix:nonFraction unitRef="usd" contextRef="iab7b66d9b316428980dce49fe22290b3_I20230215" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMzg0ODI5MDcwNjQ3MA_4283ef96-ea95-4da2-b9fe-0f5ce6eda51e">3</ix:nonFraction>&#160;billion of our common shares exclusive of shares repurchased in connection with employee stock plans, expiring as of February 15, 2026. During the three months ended March 31, 2023, we repurchased <ix:nonFraction unitRef="shares" contextRef="i1c95ac6806e14b6bbfa8a1f730d7bb0b_D20230101-20230331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMTA5OTUxMTYzNjUxNA_77e4107b-b9e8-4b9e-9b06-16b4d1c71b17">0.1</ix:nonFraction>&#160;million shares in open market transactions for $<ix:nonFraction unitRef="usd" contextRef="i1c95ac6806e14b6bbfa8a1f730d7bb0b_D20230101-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMTA5OTUxMTYzNjUzMA_f2993a50-f0ef-4a31-8ddc-1c0404433d67">67</ix:nonFraction>&#160;million at an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1c95ac6806e14b6bbfa8a1f730d7bb0b_D20230101-20230331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMTA5OTUxMTYzNjU0OQ_bb198356-50af-468d-b709-774363fa52f0">495.68</ix:nonFraction> under the current share repurchase authorization. During the three months ended March 31, 2022 we did <ix:nonFraction unitRef="shares" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMzI5ODUzNDg5MjU5Mw_84b8b6ec-868e-4132-9ac3-d9ae2dbd513e">not</ix:nonFraction> repurchase shares in open market transactions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our remaining repurchase authorization was $<ix:nonFraction unitRef="usd" contextRef="i2b88da85e02742d1b115a353bcae6004_I20230425" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMjcxNw_98b34ea3-3f9a-4fce-b512-9056b985c9a0">2.8</ix:nonFraction>&#160;billion as of April&#160;25, 2023.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with employee stock plans, we acquired <ix:nonFraction unitRef="shares" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-4" name="hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMjc4Mw_3c251d50-73f7-457c-a327-e5a55ea76aaf">0.05</ix:nonFraction> million common shares for $<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMjgwNA_3f27e753-f9c4-4529-af73-4efa03e50050">27</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-4" name="hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMjgxMQ_8209086e-6a8d-4578-8cdd-3f33a4807b5e">0.06</ix:nonFraction>&#160;million common shares for $<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMjgzMg_2d7e7465-ddcd-4700-957f-9a3663bcb917">24</ix:nonFraction> million during the three months ended March 31, 2023 and 2022, respectively.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our stockholders' equity, refer to Note 16 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_64"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82NC9mcmFnOmZiOGNjOTQ0ZGVkODRkN2M4YjM0MzM1NDFjZTVjNzRlL3RleHRyZWdpb246ZmI4Y2M5NDRkZWQ4NGQ3YzhiMzQzMzU0MWNlNWM3NGVfMTM5Nw_808f34b3-879c-40ea-8978-c42f3c873b75" continuedAt="i32f7fea4c8a94d79bc10ee5ffcaf0d64" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i32f7fea4c8a94d79bc10ee5ffcaf0d64"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate was&#160;<ix:nonFraction unitRef="number" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82NC9mcmFnOmZiOGNjOTQ0ZGVkODRkN2M4YjM0MzM1NDFjZTVjNzRlL3RleHRyZWdpb246ZmI4Y2M5NDRkZWQ4NGQ3YzhiMzQzMzU0MWNlNWM3NGVfMTA5OTUxMTYzMDAxNg_c57ce828-d6a3-4ffb-be11-8fea6cd4578b">22.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82NC9mcmFnOmZiOGNjOTQ0ZGVkODRkN2M4YjM0MzM1NDFjZTVjNzRlL3RleHRyZWdpb246ZmI4Y2M5NDRkZWQ4NGQ3YzhiMzQzMzU0MWNlNWM3NGVfMTA5OTUxMTYzMDAyMA_f50f9ee4-245b-4273-9338-30e3476e9b27">23.5</ix:nonFraction>% for the three months ended March 31, 2023 and 2022, respectively. The year-over-year decrease in the effective income tax rate is primarily due to the recognition of a non-taxable gain in the 2023 quarter. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For additional information regarding income taxes, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_67"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;<ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfNDA4OQ_4fd66e90-0c95-4295-8200-7e6d6d53d054" continuedAt="i30fb35b6acdd4d878cfc5eade0572bde" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="i30fb35b6acdd4d878cfc5eade0572bde" continuedAt="i75eb14290904439191dc45a24fe1e9b8"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfNDA4Mg_bfac2291-7056-4ee6-8f76-b7c3cc49cb9c" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of debt outstanding, net of unamortized debt issuance costs, was as follows at March&#160;31, 2023 and December 31, 2022:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:62.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5378147acd6413d98ab4a87badd98a5_I20230331" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMy0xLTEtMS0xNzg5MjU_c4fd078d-4560-4611-af9a-54e5215a78e8">426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bc861b6d684110a1c01760cf75a9d9_I20221231" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMy0zLTEtMS0xNzg5MjU_04d38dca-5c97-40d3-b391-69409943e3da">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia745190caecb4ad18029594fbd44dad9_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfNi0wLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjpkODYxZTI5YzZhMzg0MDgwODllYTI4NzBiNTg4YTA2Zl80_ff5bcca1-a018-4d5b-8379-782e92bb951c">1.5</ix:nonFraction>&#160;billion, <ix:nonFraction unitRef="number" contextRef="ia745190caecb4ad18029594fbd44dad9_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfNi0wLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjpkODYxZTI5YzZhMzg0MDgwODllYTI4NzBiNTg4YTA2Zl84_5623ba52-ac5d-40c0-973c-b84cc2224d68">0.650</ix:nonFraction>% due August 3, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia745190caecb4ad18029594fbd44dad9_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfNi0xLTEtMS0xNzg5MjU_69471366-1921-470c-98f7-a52bb2424e9b">1,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia91bce3ad2614069b112478f13ea4bbd_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfNi0zLTEtMS0xNzg5MjU_a25bb1bf-7d99-4e2d-b005-82812437c925">1,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0baef8994ca946c49745a0878f83ccea_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfOS0xLTEtMS0xNzg5MjU_1a56b987-9c51-45e5-8d3e-d0b3ba7e5fd6">1,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86bac7559acf4a0a8e9e4af23f7cc8ec_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfOS0zLTEtMS0xNzg5MjU_a0a29e90-239d-481e-b132-16175a984190">1,497</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTAtMS0xLTEtMTc4OTI1_2a772b74-26db-40ed-b6ef-ec729ca4f686">1,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTAtMy0xLTEtMTc4OTI1_ac55a55f-5525-4665-8bb7-4cb7c166f904">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior notes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i3a64f9f747cc4b969bd58c5a210d96b8_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTQtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246ZTU3MWVhZjdiNjFlNGVmMTk3OTIxNTIwOGMwMzg5NWVfNA_37bae04e-4051-4fc0-896b-648b02f7dfea">600</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i3a64f9f747cc4b969bd58c5a210d96b8_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTQtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246ZTU3MWVhZjdiNjFlNGVmMTk3OTIxNTIwOGMwMzg5NWVfOA_4c316798-d986-4da2-8900-2c2127d8bcb3">3.850</ix:nonFraction>% due October 1, 2024</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a64f9f747cc4b969bd58c5a210d96b8_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTQtMS0xLTEtMTc4OTI1_c71fbc36-6834-4dbb-80a6-85c75ca9e521">595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8ee81e69e7d4f708f12b170210cf50e_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTQtMy0xLTEtMTc4OTI1_743b475a-4dca-4601-a003-60d9396d49a6">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia2dbfa0791a746e891144da65c98163c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MzE5NmRkMjcwYTY2NDRlYmJkNzRhYTY2ZGJmMDQxODBfNA_025d1709-f208-4e17-88d4-b4476ea495d2">600</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ia2dbfa0791a746e891144da65c98163c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MzE5NmRkMjcwYTY2NDRlYmJkNzRhYTY2ZGJmMDQxODBfOA_2594439f-f1b5-4298-9860-50558a3fe000">4.500</ix:nonFraction>% due April 1, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2dbfa0791a746e891144da65c98163c_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMS0xLTEtMTc4OTI1_8e516d6b-326c-4c73-ad6d-dfd1b60a4fb5">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i601f7293934844dd8581d285010fe8a3_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMy0xLTEtMTc4OTI1_7ea97d6e-9ae3-482d-9d24-4d52eec9e335">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i2f93bb52470a423f83007bbe6311ef88_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMC0xLTEtMTg1NjkzL3RleHRyZWdpb246OGUwNzJmZTM4YTU0NDAyZjllZGNiYmJiMmFkNThhYjVfMTA5OTUxMTYyNzgwNQ_1f5854d7-ef11-4415-939a-b690eadc0467">500</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="i2f93bb52470a423f83007bbe6311ef88_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMC0xLTEtMTg1NjkzL3RleHRyZWdpb246OGUwNzJmZTM4YTU0NDAyZjllZGNiYmJiMmFkNThhYjVfMTA5OTUxMTYyNzgwOQ_7e71455d-a822-436e-b8a8-b934290a10b6">5.700</ix:nonFraction>% due March 13, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f93bb52470a423f83007bbe6311ef88_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMS0xLTEtMTg1Njg2_3960ef32-746a-4406-848c-a922d664fb80">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i769a17d71bce4bc9ad29794468e1d407_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMy0xLTEtMTg1Njg2_ab5a60d7-516a-4c1c-a445-807f9f54555d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6f1e6a5d467542119ee41abdb08e8bfe_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MGU5Yjc2NmNjOGExNGMwYjhiNmJmZTE3ZmMyMjBjZTlfNA_040e5d74-d202-48f2-8d5e-3916b3387fc6">750</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i6f1e6a5d467542119ee41abdb08e8bfe_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MGU5Yjc2NmNjOGExNGMwYjhiNmJmZTE3ZmMyMjBjZTlfOA_3386a8a9-d8bb-4983-9f7b-e4d0f54b078b">1.350</ix:nonFraction>% due February 3, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1e6a5d467542119ee41abdb08e8bfe_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMS0xLTEtMTc4OTI1_d5322749-feb6-42a5-ace3-6ee018b5cef7">745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice043f0edb0b45ebb9871681a935057d_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMy0xLTEtMTc4OTI1_67b13b3a-6c8e-4c9f-961b-5de4006713df">745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if56c1215e57f42b58ee613738b0f54df_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTctMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NDE4YzRjYTBkMDVlNDNjYTgwYTViMzBkNDRiOWU5YWNfNA_04fe4688-4fba-419a-bb00-c813c6f516d5">600</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="if56c1215e57f42b58ee613738b0f54df_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTctMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NDE4YzRjYTBkMDVlNDNjYTgwYTViMzBkNDRiOWU5YWNfOA_3cc7a6fb-7572-41d8-a848-38b65907009f">3.950</ix:nonFraction>% due March 15, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if56c1215e57f42b58ee613738b0f54df_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTctMS0xLTEtMTc4OTI1_6369f3f2-7e10-4e4f-8425-b1357954b09e">597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9826367b47364f6383b302d5941fb1b3_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTctMy0xLTEtMTc4OTI1_e4762851-d221-49e6-ac68-212f37643834">597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="idc6dc428ebc14290b36d57fb1719bf13_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMC0xLTEtMTkwMDY2L3RleHRyZWdpb246NTQwYjA2OTA2YTAzNDk1ZjgzNTk2NzA2OTVkNzJjMzRfODI0NjMzNzIwODM1MA_4d98a008-b77e-4e1e-96d1-4d31508feb33">500</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="idc6dc428ebc14290b36d57fb1719bf13_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMC0xLTEtMTkwMDY2L3RleHRyZWdpb246NTQwYjA2OTA2YTAzNDk1ZjgzNTk2NzA2OTVkNzJjMzRfODI0NjMzNzIwODM1Ng_f27690e6-44d6-48ef-a933-b85822a03bdb">5.750</ix:nonFraction>% due March 1, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc6dc428ebc14290b36d57fb1719bf13_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMS0xLTEtMTkwMDg4_e7b516c1-d564-49b7-b438-7817e88280e6">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i352c829a0e07400faa05ac2176bc9839_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMy0xLTEtMTkwMDg4_f3fee808-4350-47b1-b82b-a76771b0f697">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i26e5ceadc3fd4816b11932771a952db5_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTgtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246ODBlYzkxYWJiZDBkNDY2OWJjMDEzNjAyZTBiNDcwYmVfNA_bc91fbee-0291-483a-8f5d-8a5cfa0fc1a1">750</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="i26e5ceadc3fd4816b11932771a952db5_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTgtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246ODBlYzkxYWJiZDBkNDY2OWJjMDEzNjAyZTBiNDcwYmVfOA_2b049883-55e8-4be2-ad0e-22e3f6e18908">3.700</ix:nonFraction>% due March 23, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26e5ceadc3fd4816b11932771a952db5_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTgtMS0xLTEtMTc4OTI1_e9faa59f-0f58-4a26-86b5-1a88fb118e36">743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia978a4df05104b8d9e0c86ae761b25a0_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTgtMy0xLTEtMTc4OTI1_06d61a0f-c9f7-4eb3-9b6c-3fed93d09f98">743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="icf8ec40657e04aa2b23060d00732bdef_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTktMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MjFjYzZmYzRiY2FhNDQ1YTg5MmQ5MjViMmE5ZjI4Y2JfNA_39ee0f25-23c9-4066-98c2-b122ca99ea54">500</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="icf8ec40657e04aa2b23060d00732bdef_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTktMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MjFjYzZmYzRiY2FhNDQ1YTg5MmQ5MjViMmE5ZjI4Y2JfOA_d1e0343a-7570-4788-86a9-db0921a20e1a">3.125</ix:nonFraction>% due August 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8ec40657e04aa2b23060d00732bdef_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTktMS0xLTEtMTc4OTI1_3f9b5053-4044-4a23-bd78-28ebed03d1d0">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib78aa39252ea44aea1a09bb8f388149d_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTktMy0xLTEtMTc4OTI1_b6b6d216-00e5-4958-af6d-fdf740131ca4">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i14cc50d065954e1287d2acb52e3f4d75_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGM5NmVjMWY3ZDliNDIxZGEzMDYzZTRhYzgyZThlMmFfNA_e202fe44-787b-40ff-a935-d4f18be8c34e">500</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i14cc50d065954e1287d2acb52e3f4d75_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGM5NmVjMWY3ZDliNDIxZGEzMDYzZTRhYzgyZThlMmFfOA_5cce96f3-dcb5-49fd-8a80-b1219bbd624d">4.875</ix:nonFraction>% due April 1, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cc50d065954e1287d2acb52e3f4d75_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMS0xLTEtMTc4OTI1_22db682f-28c9-4c99-9f49-e6e516b40efe">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbbf8eeed67d47678e97ce557e665c35_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMy0xLTEtMTc4OTI1_8f833a30-c728-4ea9-8ff4-07483e98408c">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iaf517366f109416a81eaf87157f208a6_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjEtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246ZGE4NDA1NGVkNzIzNGY0ZDhmNjRmYmZmODMwNGFlM2RfNA_51a4c307-64f7-4714-9d37-a9f59ec685f4">750</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="iaf517366f109416a81eaf87157f208a6_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjEtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246ZGE4NDA1NGVkNzIzNGY0ZDhmNjRmYmZmODMwNGFlM2RfOA_d8447835-0a48-42c9-8109-85fe62c82ee6">2.150</ix:nonFraction>% due February 3, 2032</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf517366f109416a81eaf87157f208a6_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjEtMS0xLTEtMTc4OTI1_a1167d7f-26b9-4e33-86e8-f0c662d699c6">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i091bf184716543a691cccbef4e0a6911_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjEtMy0xLTEtMTc4OTI1_6df4d842-c188-4893-9eb2-fea9e1e5c563">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i1987ecea13f144a6b016db1433b4edad_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMC0xLTEtMTg1Nzc4L3RleHRyZWdpb246MzExNGRlN2E4ODRkNDkzYjg1NDcxZTJiODZiYjY2OTdfMTA5OTUxMTYyNzgyNw_788511fd-4a7e-4803-a0d8-e4a511dffc91">750</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="i1987ecea13f144a6b016db1433b4edad_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMC0xLTEtMTg1Nzc4L3RleHRyZWdpb246MzExNGRlN2E4ODRkNDkzYjg1NDcxZTJiODZiYjY2OTdfMTA5OTUxMTYyNzgzMQ_f3e9ecbb-3685-4d65-98f6-48fc904234e3">5.880</ix:nonFraction>% due March 1, 2033</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1987ecea13f144a6b016db1433b4edad_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMS0xLTEtMTg1NzY5_3416529b-68c2-443e-8106-9323f383f608">740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4828bda4e27e4c81a26419b5e9fcf71d_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMy0xLTEtMTg1NzY5_508a4c1f-caf2-4934-a9b3-8dc8bb8525e9">739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i7c2bb3882bf541f0b41f0a999f57989e_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246YTNhZTVmNmJkOTgwNGEzY2EyZDAzNDI1MzQ2YmZhMDBfNA_f324a8f4-3db4-431c-abb6-9ced36d280f6">250</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i7c2bb3882bf541f0b41f0a999f57989e_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246YTNhZTVmNmJkOTgwNGEzY2EyZDAzNDI1MzQ2YmZhMDBfOA_eec145f9-f14f-4d4d-9d5f-0cd516f5991c">8.150</ix:nonFraction>% due June&#160;15, 2038</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c2bb3882bf541f0b41f0a999f57989e_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjItMS0xLTEtMTc4OTI1_d05529e0-c1e9-449f-90f9-86a14c167411">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb222c03b6b4488b13789f1508b415c_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjItMy0xLTEtMTc4OTI1_d60865b0-740f-4076-a5b7-8678055ab26e">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic9d6ead9d85d451e8b8a7651924f9bc1_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjMtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MmY5N2RiZDUyYjVkNDMwNjk0OTZlMmU0MTVlNTllZjdfNA_8ccd58cc-c568-4c8c-86ad-ba3011e8febd">400</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ic9d6ead9d85d451e8b8a7651924f9bc1_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjMtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MmY5N2RiZDUyYjVkNDMwNjk0OTZlMmU0MTVlNTllZjdfOA_96d0e5a2-5fd2-40cc-8198-2a2757fced28">4.625</ix:nonFraction>% due December&#160;1, 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9d6ead9d85d451e8b8a7651924f9bc1_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjMtMS0xLTEtMTc4OTI1_9521e5d8-31d3-44d1-b7c4-b61f85b36e78">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11064c69b1ae4ba6a3588922076a07a4_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjMtMy0xLTEtMTc4OTI1_96f7acaf-5d7a-4ab2-985d-3a2f4fda1fc9">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i7717d896545c4a218cf32e09098785e2_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjQtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NDVjNzgwNGJjOGFhNDI0Njk4ZThjM2ZlNDgwNzVhYWVfNA_8114f8ba-1e07-4536-a699-bd10478b0869">750</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i7717d896545c4a218cf32e09098785e2_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjQtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NDVjNzgwNGJjOGFhNDI0Njk4ZThjM2ZlNDgwNzVhYWVfOA_39824c11-cb89-4611-b02f-711199127c23">4.950</ix:nonFraction>% due October 1, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7717d896545c4a218cf32e09098785e2_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjQtMS0xLTEtMTc4OTI1_8d46b383-d548-4c72-ab3e-36ff4948b251">740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7032ea7ab0740d38bc437206fc5d938_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjQtMy0xLTEtMTc4OTI1_1a704bb7-88d4-4a57-8773-b5bd8601adee">740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ifd3cf22ac75d404380d62b35ce279abb_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjUtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NDUwNWEyM2E3MGI2NDVhMjljZmZkYmRmZWM5NTYxOTZfNA_e65014b7-dac0-4e0b-bd5f-1a0950b8f4e5">400</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ifd3cf22ac75d404380d62b35ce279abb_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjUtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NDUwNWEyM2E3MGI2NDVhMjljZmZkYmRmZWM5NTYxOTZfOA_21898189-da8f-447d-be6f-102e827cda43">4.800</ix:nonFraction>% due March 15, 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd3cf22ac75d404380d62b35ce279abb_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjUtMS0xLTEtMTc4OTI1_a5415041-b7d2-4748-b007-592791cdba5a">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i287c4ed0af71453dbafbd6c72bda52cd_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjUtMy0xLTEtMTc4OTI1_b599a70d-4a92-4d80-8e16-e1f38c10ab02">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i15cd5b523c8b45408ca5a4cfbcaadc77_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjYtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MzQwMTQyNzcxMzcwNGE5ZmE2NGY5ZmM1ZTQ2ODFkMWVfNA_b96dbee0-f862-406b-b591-0e73a580683b">500</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="i15cd5b523c8b45408ca5a4cfbcaadc77_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjYtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MzQwMTQyNzcxMzcwNGE5ZmE2NGY5ZmM1ZTQ2ODFkMWVfOA_2ae688c7-d774-4598-84f5-95c01802b046">3.950</ix:nonFraction>% due August 15, 2049</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15cd5b523c8b45408ca5a4cfbcaadc77_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjYtMS0xLTEtMTc4OTI1_94758e20-0ffc-4475-9a0a-b5d0a1f54a33">493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie58ccd3ad9cf4484869350e55c97daa9_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjYtMy0xLTEtMTc4OTI1_e97d20f6-7496-4a96-8997-9f9f927402ba">493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i81618d62a5464513a79e9149e2a960be_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjctMC0xLTEtMTg1NzI5L3RleHRyZWdpb246Njg2ZGMyZTU4MTk2NGFlOWE4NWQyMWM0MjIzY2ExNGRfMTA5OTUxMTYyNzgyOA_e666f93d-c6b5-4e4f-a8ee-788b7d879c81">750</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="i81618d62a5464513a79e9149e2a960be_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjctMC0xLTEtMTg1NzI5L3RleHRyZWdpb246Njg2ZGMyZTU4MTk2NGFlOWE4NWQyMWM0MjIzY2ExNGRfMTA5OTUxMTYyNzgzMg_24bb6fa5-0fad-4182-a1d0-44ee6ecc2a74">5.500</ix:nonFraction>% due March 15, 2053</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81618d62a5464513a79e9149e2a960be_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjctMS0xLTEtMTg1NzIw_3eba0079-4246-43a7-a484-69c3d231091f">714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44f39416bf6d42a18eb86f26dba70f57_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjctMy0xLTEtMTg1NzIw_044f9610-02e0-4683-b57e-e440ea25b193">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0baef8994ca946c49745a0878f83ccea_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjctMS0xLTEtMTc4OTI1_77cd897c-3d79-4e52-93d7-3b7f756970a0">9,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86bac7559acf4a0a8e9e4af23f7cc8ec_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjctMy0xLTEtMTc4OTI1_b5058c28-ddf9-4f2c-9545-51d884338fe7">8,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delayed draw term loan, due May 28, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14a912e506d74aabb1927dc325a1b647_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMzAtMS0xLTEtMTc4OTI1_7dac2080-831c-449b-8a4f-098080d578a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d06da66baf1438495bd1819635d56fc_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMzAtMy0xLTEtMTc4OTI1_214af7f2-6879-457b-993b-c9d12da373eb">500</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total term loans</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia699014a8a7c45b4877ccab91d786647_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMzEtMS0xLTEtMTc4OTI1_b9b2e031-9988-48e5-a974-4e8ecb0c95e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80317ae1ece041a3be5e392acc5b7f32_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMzEtMy0xLTEtMTc4OTI1_d1c0ac12-f78e-4ea7-8c3e-32850d926e73">500</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMzItMS0xLTEtMTc4OTI1_d857a7b9-b8e1-4695-a70d-08e818b3570d">9,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMzItMy0xLTEtMTc4OTI1_4c0af71e-2653-410d-9c92-d93f8604526c">9,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> In March 2023, we issued $<ix:nonFraction unitRef="usd" contextRef="i9c6800fd78e7409d9fc9e4e3e89146b1_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMTY2_b09c807b-9039-4202-aa3f-48573bc810eb">500</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i9c6800fd78e7409d9fc9e4e3e89146b1_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMTcy_a04b33f7-fb4d-407b-a7b7-5a6218c2691b">5.700</ix:nonFraction>% unsecured senior notes due March 13, 2026 and $<ix:nonFraction unitRef="usd" contextRef="i5e6bb461948f467880d14a15c5c56cc4_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMTY0OTI2NzQ1MzA0Nw_5bbd4ff3-52f4-46e3-838f-f19dfd8ca23e">750</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i5e6bb461948f467880d14a15c5c56cc4_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMTY0OTI2NzQ1MzA2MQ_d7fd6195-8ed6-4004-b8b4-46f509e3d067">5.500</ix:nonFraction>% unsecured senior notes due March 15, 2053. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $<ix:nonFraction unitRef="usd" contextRef="i6722660df9ae426fba8939630f33aba2_D20220301-20220331" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzAz_421a87ae-0755-4213-ac4f-0d9740ee5937">1.2</ix:nonFraction>&#160;billion. We used the net proceeds to repay outstanding amounts under our $<ix:nonFraction unitRef="usd" contextRef="i4600a55e099c4531bc7d43ae4f7b2b61_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5NDAyMA_01b90d9d-0adf-42fc-8fb4-eaa75f8acc0e">500</ix:nonFraction>&#160;million Delayed Draw Term Loan. The remaining net proceeds will be used for general corporate purposes, which include the repayment of existing indebtedness, including borrowings under our commercial paper program.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2023, we entered into a Rule 10b5-1 Repurchase Plan, or the Plan, to repurchase a portion of our $<ix:nonFraction unitRef="usd" contextRef="ia745190caecb4ad18029594fbd44dad9_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5MTI3OA_9ece2bf2-1f55-4de1-9620-407336ab79fd">1.5</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ia745190caecb4ad18029594fbd44dad9_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5MTI5Mg_df1fb878-231e-44a6-9cce-026c1eb4c0b2">0.650</ix:nonFraction>% senior notes maturing in August 2023 and our $<ix:nonFraction unitRef="usd" contextRef="i3a64f9f747cc4b969bd58c5a210d96b8_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5MTMwMA_96abe6bb-5c46-49aa-b080-284816a6b341">600</ix:nonFraction>&#160;million </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i75eb14290904439191dc45a24fe1e9b8" continuedAt="i4b63986e768448b28fcaf9cd102a5f80"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i3a64f9f747cc4b969bd58c5a210d96b8_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5MTMxNA_bc488a89-a609-4914-8547-a89f2b23b7d9">3.850</ix:nonFraction>% senior notes maturing in October 2024 during the Plan period beginning on March 13, 2023 and ending on June 15, 2023. During the three months ended March 31, 2023, we repurchased $<ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5MTMyMQ_4eb666b1-b7fc-43ed-b050-a35b9c11464a">61</ix:nonFraction>&#160;million aggregate principal amount, for cash totaling approximately $<ix:nonFraction unitRef="usd" contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5MTMyMg_9407bd54-9c0e-4b7b-b911-d5c2534aadbf">60</ix:nonFraction>&#160;million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For additional information regarding our Senior Notes, refer to Note 13 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revolving Credit Agreements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit agreements contain customary restrictive covenants and a financial covenant regarding maximum debt to capitalization of <ix:nonFraction unitRef="number" contextRef="if6ef86f63d5c4341b776612f407688ab_I20230331" decimals="INF" name="hum:DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjAwNA_e8f25886-7b97-4e34-bbc4-f9889475aa73">60</ix:nonFraction>%, as well as customary events of default. We are in compliance with this financial covenant, with actual debt to capitalization of <ix:nonFraction unitRef="number" contextRef="ia699014a8a7c45b4877ccab91d786647_I20230331" decimals="3" name="hum:DebtInstrumentCovenantDebtToCapitalizationPercentageActual" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjEzNw_8bbdae2a-230d-418c-9c84-0729fe055dd3">41.1</ix:nonFraction>% as measured in accordance with the revolving credit agreements as of March&#160;31, 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, we had <ix:nonFraction unitRef="usd" contextRef="if6ef86f63d5c4341b776612f407688ab_I20230331" decimals="INF" name="us-gaap:LinesOfCreditCurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjIyOQ_00a0e1bc-a1e1-457b-bd13-b50c751ba02e">no</ix:nonFraction> borrowings and approximately $<ix:nonFraction unitRef="usd" contextRef="if954b4dd458243c192b80a70934aab3b_I20230331" decimals="-6" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjI2MQ_bc2ff647-af8b-41cf-86bd-8a2082c302a7">39</ix:nonFraction> million of letters of credit outstanding under the revolving credit agreements, including those of KAH. Accordingly, as of March&#160;31, 2023, we had $<ix:nonFraction unitRef="usd" contextRef="i277382cd831d44e68146d96819af483f_I20230331" decimals="-8" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjM5MA_e7fd02d2-465d-4888-92ca-6558d587105c">2.4</ix:nonFraction> billion of remaining borrowing capacity under the <ix:nonNumeric contextRef="idfe7731c31ef4c5d8ace727574933dbc_D20230101-20230331" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjQzNQ_86fb45ec-0d08-450b-806b-1a8c3ab3e0ad">5</ix:nonNumeric>-year revolving credit agreement and $<ix:nonFraction unitRef="usd" contextRef="i16a8b22589364b0cabcaeebe88c025fd_I20230331" decimals="-8" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjQ3NA_8e8fdc05-11d7-46c7-90fc-f4bfa8df3a34">1.5</ix:nonFraction>&#160;billion of remaining borrowing capacity under the <ix:nonNumeric contextRef="iac8c9ca5d8d047529559c7212dd98d0a_D20230101-20230331" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjUxOQ_41b1cff3-7a17-4176-9a32-4603d0cbaa2d">364</ix:nonNumeric>-day revolving credit agreement (which excludes the uncommitted $<ix:nonFraction unitRef="usd" contextRef="if6ef86f63d5c4341b776612f407688ab_I20230331" decimals="INF" name="hum:LineOfCreditFacilityUncommittedIncrementalCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjU4NQ_dcdc819d-f26e-495a-b862-ac0c52e27513">750</ix:nonFraction> million of incremental loan facilities), none of which would be restricted by our financial covenant compliance requirement. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For additional information regarding our Revolving Credit Agreements, refer to Note 13 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Commercial Paper</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under our commercial paper program we may issue short-term, unsecured commercial paper notes privately placed on a discount basis through certain broker dealers at any time. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The net proceeds of issuances have been and are expected to be used for general corporate purposes. The maximum principal amount outstanding at any one time during the three months ended March 31, 2023 was $<ix:nonFraction unitRef="usd" contextRef="i1cfe16f46375489ab53b2a64c31248d4_D20230101-20230331" decimals="-6" name="us-gaap:ShorttermDebtMaximumAmountOutstandingDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzYyMw_71d186e3-faf5-4a91-bfb5-562f4f6fba3f">626</ix:nonFraction> million, with $<ix:nonFraction unitRef="usd" contextRef="ie5378147acd6413d98ab4a87badd98a5_I20230331" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzYzMg_c4fd078d-4560-4611-af9a-54e5215a78e8">426</ix:nonFraction> million outstanding at March&#160;31, 2023 compared to $<ix:nonFraction unitRef="usd" contextRef="i66bc861b6d684110a1c01760cf75a9d9_I20221231" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzY2NQ_04d38dca-5c97-40d3-b391-69409943e3da">595</ix:nonFraction> million outstanding at December 31, 2022. The outstanding commercial paper at March&#160;31, 2023 had a weighted average annual interest rate of <ix:nonFraction unitRef="number" contextRef="ie5378147acd6413d98ab4a87badd98a5_I20230331" decimals="4" name="us-gaap:ShortTermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzc3Mw_fca96c62-f4cf-4dd9-bc13-03070f857f61">5.45</ix:nonFraction>%.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For additional information regarding our Commercial Paper refer to Note 13 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Short-term Borrowings</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4b63986e768448b28fcaf9cd102a5f80">We are a member, through one subsidiary, of the Federal Home Loan Bank of Cincinnati, or FHLB. As a member we have the ability to obtain short-term cash advances, subject to certain minimum collateral requirements. At March&#160;31, 2023 we had <ix:nonFraction unitRef="usd" contextRef="ic709c99d9e6e4394aec61e0022ddc186_I20230331" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfNDAzMw_f6f82139-ccd7-4152-87ba-389fa718ea78">no</ix:nonFraction> outstanding short-term FHLB borrowings.</ix:continuation> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_70"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfOTExOQ_c9cfbcd0-39f1-418c-af91-82524c9926f5" continuedAt="i9e95a182329d4e95b2d3f9368070f230" escape="true">COMMITMENTS, GUARANTEES AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i9e95a182329d4e95b2d3f9368070f230" continuedAt="i9d3f9cc1bfda4dba982f86a3e77eea10"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Contracts</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicare products, which accounted for approximately <ix:nonFraction unitRef="number" contextRef="id20841ace72748718a4437b57f98c65a_D20230101-20230331" decimals="2" name="hum:PercentageOfTotalPremiumAndServicesRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTI5_8aafa4f5-0bbf-4194-932c-900b2baaa53e">84</ix:nonFraction>% of our total premiums and services revenue for the three months ended March 31, 2023, primarily consisted of products covered under the Medicare Advantage and Medicare Part D Prescription Drug Plan contracts with the federal government. These contracts are renewed generally for a calendar year term unless CMS notifies us of its decision not to renew by May 1 of the calendar year in which the contract would end, or we notify CMS of our decision not to renew by the first Monday in June of the calendar year in which the contract would end. All material contracts between Humana and CMS relating to our Medicare products have been renewed for 2023, and all of our product offerings filed with CMS for 2023 have been approved.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i9d3f9cc1bfda4dba982f86a3e77eea10" continuedAt="i8494235144c84a5d895cb04ddcda38b4"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS uses a risk-adjustment model which adjusts premiums paid to Medicare Advantage, or MA, plans according to health status of covered members. The risk-adjustment model, which CMS implemented pursuant to the Balanced Budget Act of 1997, or BBA, and the Benefits Improvement and Protection Act of 2000, or BIPA, generally pays more where a plan's membership has higher expected costs. Under this model, rates paid to MA plans are based on actuarially determined bids, which include a process whereby our prospective payments are based on our estimated cost of providing standard Medicare-covered benefits to an enrollee with a "national average risk profile." That baseline payment amount is adjusted to account for certain demographic characteristics and health status of our enrolled members. Under the risk-adjustment methodology, all MA plans must collect from providers and submit the necessary diagnosis code information to CMS within prescribed deadlines. The CMS risk-adjustment model uses the diagnosis data, collected from providers, to calculate the health status-related risk-adjusted premium payment to MA plans, which CMS further adjusts for coding pattern differences between the health plans and the government fee-for-service, or FFS, program. We generally rely on providers, including certain providers in our network who are our employees, to code their claim submissions with appropriate diagnoses, which we send to CMS as the basis for our health status-adjusted payment received from CMS under the actuarial risk-adjustment model. We also rely on these providers to document appropriately all medical data, including the diagnosis data submitted with claims. In addition, we conduct medical record reviews as part of our data and payment accuracy compliance efforts, to more accurately reflect diagnosis conditions under the risk adjustment model.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS and the Office of the Inspector General of Health and Human Services, or HHS-OIG, perform audits of various companies&#8217; risk adjustment diagnosis data submissions. We refer to these audits as Risk-Adjustment Data Validation Audits, or RADV audits. RADV audits review medical records in an attempt to validate provider medical record documentation and coding practices that influence the calculation of health status-related premium payments to MA plans. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS released an MA contract-level RADV methodology that would extrapolate the results of each CMS RADV audit sample to the audited MA contract&#8217;s entire health status-related risk adjusted premium amount for the year under audit.  In doing so, CMS recognized &#8220;that the documentation standard used in RADV audits to determine a contract&#8217;s payment error (medical records) is different from the documentation standard used to develop the Part C risk-adjustment model (FFS claims).&#8221; To correct for this difference, CMS stated that it would apply a &#8220;Fee-for-Service Adjuster (FFS Adjuster)&#8221; as &#8220;an offset to the preliminary recovery amount.&#8221; This adjuster would be &#8220;calculated by CMS based on a RADV-like review of records submitted to support FFS claims data.&#8221;  CMS stated that this methodology would apply to audits beginning with PY 2011. Humana relied on CMS&#8217;s 2012 guidance in submitting MA bids to CMS.  Humana also launched a &#8220;Self-Audits&#8221; program in 2013 that applied CMS&#8217;s 2012 RADV audit methodology and included an estimated FFS Adjuster.  Humana completed Self-Audits for PYs 2011-2016 and reported results to CMS. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, however, CMS issued a proposed rule announcing possible changes to the RADV audit methodology, including elimination of the FFS Adjuster.  CMS proposed applying its revised methodology, including extrapolated recoveries without application of a FFS Adjuster, to RADV audits dating back to PY 2011.  On January 30, 2023, CMS published a final rule related to the RADV audit methodology (Final RADV Rule).  The Final RADV Rule confirmed CMS&#8217;s decision to eliminate the FFS Adjuster. The Final RADV Rule states CMS&#8217;s intention to extrapolate results from CMS and HHS-OIG RADV audits beginning with PY 2018, rather than PY 2011 as proposed.  However, CMS&#8217;s Final RADV Rule does not adopt a specific sampling, extrapolation or audit methodology.  CMS instead stated its general plan to rely on &#8220;any statistically valid method . . . that is determined to be well-suited to a particular audit.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana is considering its legal options with respect to CMS&#8217;s changed position on the FFS Adjuster and seeking clarity regarding our compliance obligations in light of the Final RADV Rule. We believe that the Final RADV Rule fails to address adequately the statutory requirement of actuarial equivalence. Further, Humana&#8217;s actuarially certified bids through PY 2023 preserved Humana&#8217;s position that CMS should apply an FFS Adjuster in any RADV audit that CMS intends to extrapolate. We expect CMS to apply the Final RADV Rule, including the first application of extrapolated audit results to determine audit settlements without a FFS Adjuster, to CMS and HHS-OIG RADV audits conducted for PY 2018 and subsequent years.  The Final RADV Rule, including the lack of </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i8494235144c84a5d895cb04ddcda38b4" continuedAt="iaf98391d4fb44acea77822bb854ef6ab"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a FFS Adjuster, and any related regulatory, industry or company reactions, could have a material adverse effect on our results of operations, financial position, or cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as part of our internal compliance efforts, we routinely perform ordinary course reviews of our internal business processes related to, among other things, our risk coding and data submissions in connection with the risk adjustment model. These reviews may also result in the identification of errors and the submission of corrections to CMS that may, either individually or in the aggregate, be material. As such, the result of these reviews may have a material adverse effect on our results of operations, financial position, or cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we explore our legal options and compliance obligations, we remain committed to working alongside CMS to promote the integrity of the MA program as well as affordability and cost certainty for our members.  It is critical that MA plans are paid accurately and that payment model principles, including the application of a FFS Adjuster, are in accordance with the requirements of the Social Security Act, which, if not implemented correctly could have a material adverse effect on our results of operations, financial position, or cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our state-based Medicaid business, which accounted for approximately <ix:nonFraction unitRef="number" contextRef="icb617ce6644248ea8db1728a74bbbf53_D20230101-20230331" decimals="2" name="hum:PercentageOfTotalPremiumAndServicesRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfNzU4Nw_aa917ea5-06d6-4c77-8979-a166bce297ef">7</ix:nonFraction>% of our total premiums and services revenue for the three months ended March 31, 2023 primarily consisted of serving members enrolled in Medicaid, and in certain circumstances members who qualify for both Medicaid and Medicare, under contracts with various states. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At March&#160;31, 2023, our Military business, which accounted for approximately <ix:nonFraction unitRef="number" contextRef="i4480f878da3046eca330bf17a448e268_D20230101-20230331" decimals="2" name="hum:PercentageOfTotalPremiumAndServicesRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfNzg5OA_b51499c5-632b-4063-adee-6405e8c2351b">1</ix:nonFraction>% of our total premiums and services revenue for the three months ended March 31, 2023, primarily consisted of the TRICARE T2017 East Region contract. The T2017 East Region contract comprising <ix:nonFraction unitRef="state" contextRef="i2ff845a818d94f94ab5d91f1b9bd6c7e_I20230331" decimals="INF" name="hum:NumberOfStatesComprisingTRICAREBeneficiaries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfODA2MQ_c7cb7034-4c7a-4f20-a378-5a67032ec0fa">32</ix:nonFraction> states and approximately <ix:nonFraction unitRef="beneficiary" contextRef="i0bc5a60bb99048cbad4400d49e4dcfe7_D20230101-20230331" decimals="-6" name="hum:NumberOfTRICAREBeneficiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfODA4OQ_85de43c0-6568-4304-92c7-a341aa84f98d">6</ix:nonFraction> million TRICARE beneficiaries, under which delivery of health care services commenced on January 1, 2018. The T2017 East Region contract, which was originally set to expire on December 31, 2022, was subsequently extended by the DoD and is currently scheduled to expire on December 31, 2023, unless further extended. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, we were awarded the next generation of TRICARE Managed Care Support Contracts, or T-5, for the TRICARE East Region by the Defense Health Agency of the DoD. The contract is expected to go into effect in 2024. Until then the T2017 contract remains in place. Under the terms of the award, our service area covers approximately <ix:nonFraction unitRef="beneficiary" contextRef="ie7875175150c464986253f694017f369_D20221201-20221231" decimals="INF" name="hum:NumberOfTRICAREManagedCareSupportContractBeneficiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTA5OTUxMTY1MjA5Ng_6e1ffe2a-96c9-4f9e-a7ff-8c21d9b4508e">4.6</ix:nonFraction>&#160;million beneficiaries in a region consisting of <ix:nonFraction unitRef="state" contextRef="i78f2374ea9724509bf4c2fb579684e3f_I20221231" decimals="INF" name="hum:NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTA5OTUxMTY1MjEwOQ_46e58455-5dc0-4f3a-b57c-3436369ae2b8">24</ix:nonFraction> states and Washington, D.C. The length of the contract is <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTA5OTUxMTY1MjExMw_2669b125-bc7d-4903-8a53-f6a32cfce9ee">one</span> base year with <ix:nonFraction unitRef="option_period" contextRef="i78f2374ea9724509bf4c2fb579684e3f_I20221231" decimals="INF" name="hum:TRICAREManagedCareSupportContractNumberOfOptionPeriods" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTA5OTUxMTY1MjExNA_ee4f439f-7183-42f4-8164-570bd7481fa8">eight</ix:nonFraction> annual option periods, which, if all options are exercised, would result in a total contract length of <ix:nonNumeric contextRef="ie7875175150c464986253f694017f369_D20221201-20221231" name="hum:TRICAREManagedCareSupportContractTermWithOptionExercises" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTA5OTUxMTY1MjExMg_de4c1308-c81d-4cd1-8656-60c4057a6397">nine years</ix:nonNumeric>.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of any of the contracts above or significant changes in these programs as a result of legislative or regulatory action, including reductions in premium payments to us, regulatory restrictions on profitability, including reviews by regulatory bodies that may compare our Medicare Advantage profitability to our non-Medicare Advantage business profitability, or compare the profitability of various products within our Medicare Advantage business, and require that they remain within certain ranges of each other, or increases in member benefits or member eligibility criteria without corresponding increases in premium payments to us, may have a material adverse effect on our results of operations, financial position, and cash flows.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_73"></div><ix:continuation id="iaf98391d4fb44acea77822bb854ef6ab" continuedAt="i619da0bee88f42b9824432441886e523"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings and Certain Regulatory Matters</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, the Civil Division of the United States Department of Justice provided us with an information request in December 2014, concerning our Medicare Part C risk adjustment practices. The request relates to our oversight and submission of risk adjustment data generated by providers in our Medicare Advantage network, as well as to our business and compliance practices related to risk adjustment data generated by our providers and by us, including medical record reviews conducted as part of our data and payment accuracy compliance efforts, the use of health and well-being assessments, and our fraud detection efforts. We believe that this request for information is in connection with a wider review of Medicare Risk Adjustment generally that includes a number of Medicare Advantage plans, providers and vendors. We cooperated with the Department of Justice, and we have not heard from the Department of Justice on this matter since 2020. </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i619da0bee88f42b9824432441886e523" continuedAt="i2e58c2d29a2d4a3eaf555b2e9574b8ae"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, on January 19, 2016, an individual filed a qui tam suit captioned United States of America ex rel. Steven Scott v. Humana, Inc., in United States District Court, Central District of California, Western Division. The complaint alleges certain civil violations by us in connection with the actuarial equivalence of the plan benefits under Humana&#8217;s Basic PDP plan, a prescription drug plan offered by us under Medicare Part D. The action seeks damages and penalties on behalf of the United States under the False Claims Act. The court ordered the qui tam action unsealed on September 13, 2017, so that the relator could proceed, following notice from the U.S. Government that it was not intervening at that time. On January 29, 2018, the suit was transferred to the United States District Court, Western District of Kentucky, Louisville Division. We have substantially completed discovery with the relator who has pursued the matter on behalf of the United States following its unsealing. On March 31, 2022, the Court denied the parties' Motions for Summary Judgement. We take seriously our obligations to comply with applicable CMS requirements and actuarial standards of practice, and continue to vigorously defend against these allegations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Lawsuits and Regulatory Matters</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current and past business practices are subject to review or other investigations by various state insurance and health care regulatory authorities and other state and federal regulatory authorities. These authorities regularly scrutinize the business practices of health insurance, health care delivery and benefits companies. These reviews focus on numerous facets of our business, including claims payment practices, statutory capital requirements, provider contracting, risk adjustment, competitive practices, commission payments, privacy issues, utilization management practices, pharmacy benefits, access to care, sales practices, and provision of care by our healthcare services businesses, among others. Some of these reviews have historically resulted in fines imposed on us and some have required changes to some of our practices. We continue to be subject to these reviews, which could result in additional fines or other sanctions being imposed on us or additional changes in some of our practices.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also are involved in various other lawsuits that arise, for the most part, in the ordinary course of our business operations, certain of which may be styled as class-action lawsuits. Among other matters, this litigation may include employment matters, claims of medical malpractice, bad faith, nonacceptance or termination of providers, anticompetitive practices, improper rate setting, provider contract rate and payment disputes, including disputes over reimbursement rates required by statute, disputes arising from competitive procurement process, general contractual matters, intellectual property matters, and challenges to subrogation practices. Under state guaranty assessment laws, including those related to state cooperative failures in the industry, we may be assessed (up to prescribed limits) for certain obligations to the policyholders and claimants of insolvent insurance companies that write the same line or lines of business as we do.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a government contractor, we may also be subject to false claims litigation, such as qui tam lawsuits brought by individuals who seek to sue on behalf of the government, alleging that the government contractor submitted false claims to the government or related overpayments from the government, including, among other allegations, those resulting from coding and review practices under the Medicare risk adjustment model. Qui tam litigation is filed under seal to allow the government an opportunity to investigate and to decide if it wishes to intervene and assume control of the litigation. If the government does not intervene, the individual may continue to prosecute the action on his or her own, on behalf of the government. We also are subject to other allegations of nonperformance of contractual obligations to providers, members, and others, including failure to properly pay claims, improper policy terminations, challenges to our implementation of the Medicare Part D prescription drug program and other litigation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited number of the claims asserted against us are subject to insurance coverage. Personal injury claims, claims for extra contractual damages, care delivery malpractice, and claims arising from medical benefit denials are covered by insurance from our wholly owned captive insurance subsidiary and excess carriers, except to the extent that claimants seek punitive damages, which may not be covered by insurance in certain states in which insurance coverage for punitive damages is not permitted. In addition, insurance coverage for all or certain forms of liability has become increasingly costly and may become unavailable or prohibitively expensive in the future.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i2e58c2d29a2d4a3eaf555b2e9574b8ae"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record accruals for the contingencies discussed in the sections above to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described above because of the inherently unpredictable nature of legal proceedings, which also may be exacerbated by various factors, including: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties (including where it is uncertain how liability, if any, will be shared among multiple defendants); or (vii) there is a wide range of potential outcomes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outcome of any current or future litigation or governmental or internal investigations, including the matters described above, cannot be accurately predicted, nor can we predict any resulting judgments, penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities or as a result of actions by third parties. Nevertheless, it is reasonably possible that any such outcome of litigation, judgments, penalties, fines or other sanctions could be substantial, and the outcome of these matters may have a material adverse effect on our results of operations, financial position, and cash flows, and may also affect our reputation.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_76"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNjg0OA_f8412a44-2379-4643-a3cb-281b09d3f410" continuedAt="i361694f1bb0e4d9d975f209066b6a2d6" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i361694f1bb0e4d9d975f209066b6a2d6" continuedAt="i68bf979ab1bb4a52bf359c378d693838"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During December 2022, we realigned our businesses into <ix:nonFraction unitRef="segment" contextRef="i05af7d59e35843539a7b53e907c4cb75_D20221201-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNTQ5NzU1ODIwNzU3_edc5ec45-27db-41b8-8cce-e9e144e87d7a">two</ix:nonFraction> distinct segments: Insurance and CenterWell. The Insurance segment includes the businesses that were previously included in the Retail and Group and Specialty segments, as well as the Pharmacy Benefit Manager, or PBM, business which was previously included in the Healthcare Services segment. The CenterWell segment (formerly Healthcare Services) represents our payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. In addition to the new segment classifications being utilized to assess performance and allocate resources, we believe this simpler structure will create greater collaboration across the Insurance and CenterWell businesses and will accelerate work that is underway to centralize and integrate operations within the organization.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period segment financial information has been recast to conform to the 2023 presentation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our <ix:nonFraction unitRef="segment" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNTQ5NzU1ODIxNzM5_8a485072-83cb-4d31-be3e-af8642813c14">two</ix:nonFraction> reportable segments, Insurance and CenterWell, are based on a combination of the type of health plan customer and adjacent businesses centered on well-being solutions for our health plans and other customers, as described below. These segment groupings are consistent with information used by our Chief Executive Officer, the Chief Operating Decision Maker, to assess performance and allocate resources. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as our contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which we refer to collectively as our state-based contracts. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only, or ASO. In addition, our Insurance segment includes our Military business, primarily our T-2017 East Region contract, as well as the operations of our PBM business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CenterWell segment includes our pharmacy, provider services, and home solutions operations. The segment also includes our strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as our minority ownership interest in hospice operations. Services offered by this segment are designed to enhance the overall healthcare experience. These services may lead to lower utilization associated with improved member health and/or lower drug costs. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CenterWell intersegment revenues primarily relate to the operations of CenterWell Pharmacy (our mail- order pharmacy business), CenterWell Specialty Pharmacy, and retail pharmacies jointly located within CenterWell Senior Primary Care clinics. </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i68bf979ab1bb4a52bf359c378d693838" continuedAt="i54a96c0466d942e89450ba561591e635"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our CenterWell intersegment revenues include revenues earned by certain owned providers derived from certain value-based arrangements with our health plans. Under these value-based arrangements, our owned providers enter into agreements with our health plans to stand ready to deliver, integrate, direct and control the administration and management of certain health care services for our members. In exchange, the owned provider receives a premium that is typically paid on a per-member per-month basis. These value-based arrangements represent a single performance obligation where revenues are recognized in the period in which we are obligated to provide integrated health care services to our members. Fee-for-service revenue is recognized at agreed upon rates, net of contractual allowances, as the performance obligation is completed on the date of service.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We present our condensed consolidated results of operations from the perspective of the health plans. As a result, the cost of providing benefits to our members, whether provided via a third party provider or internally through a stand-alone subsidiary, is classified as benefits expense and excludes the portion of the cost for which the health plans do not bear responsibility, including member co-share amounts and government subsidies of $<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-8" name="hum:GovernmentAndHealthPlanMemberSubsidiesAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNDgyMQ_1443ae3e-41bd-469d-a825-ef1dd752f364">4.0</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-8" name="hum:GovernmentAndHealthPlanMemberSubsidiesAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNDgyOA_fbe55360-5ae9-49eb-971a-721cdf0b2187">4.0</ix:nonFraction> billion for the three months ended March 31, 2023 and 2022, respectively. In addition, depreciation and amortization expense associated with certain businesses delivering benefits to our members, primarily associated with our provider services and pharmacy operations, are included with benefits expense. The amount of this expense was $<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="hum:DepreciationAndAmortizationClassifiedAsBenefitExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNTIyMw_b9f6bb3f-7821-4f20-acb4-cf9192e7390c">33</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="hum:DepreciationAndAmortizationClassifiedAsBenefitExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNTIzMA_0afd1a99-33b9-494c-ad42-44bade9ef838">30</ix:nonFraction> million for the three months ended March 31, 2023 and 2022, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than those described previously, the accounting policies of each segment are the same. For additional information regarding our accounting policies refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. Transactions between reportable segments primarily consist of sales of services rendered by our CenterWell segment, primarily pharmacy, provider, and home services, to our Insurance segment customers. Intersegment sales and expenses are recorded at fair value and eliminated in consolidation. Members served by our segments often use the same provider networks, enabling us in some instances to obtain more favorable contract terms with providers. Our segments also share indirect costs and assets. As a result, the profitability of each segment is interdependent. We allocate most operating expenses to our segments. Assets and certain corporate income and expenses are not allocated to the segments, including the portion of investment income not supporting segment operations, interest expense on corporate debt, and certain other corporate expenses. These items are managed at a corporate level. These corporate amounts are reported separately from our reportable segments and are included with intersegment eliminations in the tables presenting segment results below. </span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i54a96c0466d942e89450ba561591e635" continuedAt="if0e7800d532641efaaff2c0e8674cd21"><ix:nonNumeric contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNjg0MQ_8fae371d-f4c2-42ee-a64c-1a8800795070" continuedAt="if7c3a0f915b240d58e12cbdae6ce8c0a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our segment results were as follows for the three months ended March 31, 2023 and 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:52.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.850%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.850%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.850%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.851%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.800%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:52.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.832%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.832%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.832%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External revenues </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aa8e3070afb4b448db7275ed5cf09ca_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNS0xLTEtMS0xNzg5MjU_f98ad0a0-edf0-49ba-a5e1-74a3af6a3296">19,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4319d9cb6494f90a71ae9662c3e17d5_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNS01LTEtMS0xNzg5MjU_060683a5-a2a0-4c22-8e10-e66828496ad4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i470b8c2f91574be1a05a696adddc73d9_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNS0xMy0xLTEtMTc4OTI1_e8202d4c-1008-4f50-b14c-f35cdafbc8b3">19,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i941da18a02fd4a139b8237908e1baf76_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNi0xLTEtMS0xNzg5MjU_01e9a983-e58b-4617-a32b-25a44e2d4a49">1,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d50dfae3c94d26a91ba9941b08ff7f_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNi01LTEtMS0xNzg5MjU_49d27866-8d5c-483d-a6d6-73d5ef7ae3c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81af849246674d489655377c62775fed_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNi0xMy0xLTEtMTc4OTI1_29e89448-9fba-470a-9ee7-7646c04f9df9">1,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66882a36b65243afb23812e2ec2c1d48_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNy0xLTEtMS0xNzg5MjU_27637d17-7670-4a3b-9211-c649104298d0">616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ce6672cc904de4a0fa8074bf62a0c4_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNy01LTEtMS0xNzg5MjU_3584a638-57a7-44a2-aeef-390f34a55ce5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia631787e98fd47d59231450f5a5d6e0c_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNy0xMy0xLTEtMTc4OTI1_e875c873-22de-4b71-8893-3c97c2031750">616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i993a679845f947fab947d46e0ae0bc4a_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfOC0xLTEtMS0xNzg5MjU_6cf1c649-bd6c-465e-84f6-857e9cfbfa48">22,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c8a4218c34d47a989b327c872bb0ba7_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfOC01LTEtMS0xNzg5MjU_7e9cbef7-956a-4857-b559-4451de89182c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05c27701e7bf4a9eb3938c2a39eb4494_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfOC0xMy0xLTEtMTc4OTI1_62915f48-587f-4552-8340-da8b6ac4c20c">22,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85424f2642a04af48e0d21aa6e0a0e12_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfOS0xLTEtMS0xNzg5MjU_235dff6d-2a6a-4337-8c58-cea76e64b6a2">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06996810dd5b475591115e20ef9e8d24_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfOS01LTEtMS0xNzg5MjU_fe342dcf-9ebc-428d-9f9b-e97f2369b1f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1aed85758234038bfaf99ea4aaa00a2_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfOS0xMy0xLTEtMTc4OTI1_018cf8e8-d42e-4ccc-b8e0-af1fa30dfdbe">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfaab4185db447efbc4d239013c8fa8a_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTAtMS0xLTEtMTc4OTI1_6aa1c4c1-7b9b-4efb-a7e4-38fd1b484f2b">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a0dbdb752344a29bf7a8dc0c0719182_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTAtNS0xLTEtMTc4OTI1_b6cd9818-83fe-41e3-a07c-f89a9576d510">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib49f1498622e4c778b5d7aa7fc4c3199_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTAtMTMtMS0xLTE3ODkyNQ_877c98dd-3722-4f16-b494-dfdb32aac451">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9ac0ab1a1dc41678e04eee0f1f1ad54_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTAtMS0xLTEtMTk0NTAy_cecbc917-b5f6-4e41-a20a-c4fe24b7be8c">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4b77a33b1934d86a91aee24b2970f4d_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTAtMy0xLTEtMTk1MTIz_f35c1a9a-b8ad-459e-9424-f3d5e8b5f47b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9c99fa97fdd46efa402ed8333894c1f_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTAtMTEtMS0xLTE5NDUxMg_009405b0-cf8e-4630-9fad-c838d14cdbf9">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96917ef2e24c4974a71ff8d5a0ea7000_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTEtMS0xLTEtMTc4OTI1_398d0399-b76e-4bf0-8e27-b605c18af110">1,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22a98e5c970f455fa835963d955ebff1_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTEtNS0xLTEtMTc4OTI1_eb67d6dd-40d0-481a-9454-3167c01a27a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30b27af532384e309d0f76b56db9d08a_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTEtMTMtMS0xLTE3ODkyNQ_74d37044-2ea7-40c8-b795-f66a110b0f1a">1,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTItMS0xLTEtMTc4OTI1_38ff8800-aec4-4b2b-aaa5-338da5fc5c2d">25,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTItNS0xLTEtMTc4OTI1_349c673a-6ee6-4d57-87ca-8b6a59256b55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6382c523c2c14c259a92f891ff8641e2_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTItMTMtMS0xLTE3ODkyNQ_d6e4768e-314a-45b5-87d4-3fbd3719079b">25,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb29b1e903c42e8b12951e278dbb473_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTYtMS0xLTEtMTc4OTI1_65d4f50b-de7e-4b3d-8ae4-946995e92c7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047ea355a1614e12b9cde7bc63efd653_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTYtNS0xLTEtMTc4OTI1_9d3fdcfc-300a-41e6-8a45-3dd3e2d868d7">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6268a711de84001a5c09e366d9a3963_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTYtMTMtMS0xLTE3ODkyNQ_2be66b71-42bd-440c-ad36-68d970c7dfa1">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03ae8d1abd346bfa0535b979b06277d_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTctMS0xLTEtMTc4OTI1_80d8f75b-0f68-4e61-b48a-2501d1b67615">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b40b350a7fb4e1d870155ce20f7d278_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTctNS0xLTEtMTc4OTI1_e7d42aec-7058-4a93-8d86-669599dd4ddd">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43a33ad615e44970a83fb6e045c08ff2_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTctMTMtMS0xLTE3ODkyNQ_d395d96f-514b-404c-a76c-5433af66c563">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dcae53256ef467fa83afa413e3c23fc_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTgtMS0xLTEtMTc4OTI1_9a215c3c-7b86-462c-865a-112ea67a07ee">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd5912c45d1492f813493782cbdbc80_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTgtNS0xLTEtMTc4OTI1_84be67a3-e374-4c9a-b030-8843de736a65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4acc50637daf4886ae4c4f6c103cb12c_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTgtMTMtMS0xLTE3ODkyNQ_20dda5c7-4252-4c72-9860-3dc549358033">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7da82ae3b48451ab567fe66a54b3194_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTgtMS0xLTEtMTkzODE4_05c99404-0b5b-4552-9042-645d60f4b349">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94f607e57a414dbd88161908a6184c14_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTktMy0xLTEtMTk1MTIz_89ffd539-14d0-4791-b0f1-1ee73df8d7e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36acb1a7c1d345b3943ed7a3681da4d7_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTgtMTEtMS0xLTE5Mzg2MQ_be8fdf58-904b-422a-b325-4e6cc2c768e3">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cc60e9c797f4763ae37557308571d2b_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTktMS0xLTEtMTc4OTI1_0e6fdf07-d783-4fdd-9baa-26c073a6491c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e3ed6555fe4401e81ef3b5e8e4a7609_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTktNS0xLTEtMTc4OTI1_bd14ea15-61ea-4812-8453-02f10cadd4a0">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfea55c447bc431e88f5dd8ccd9676b6_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTktMTMtMS0xLTE3ODkyNQ_b33623ee-f724-4cfe-b133-2b814bed3b74">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjAtMS0xLTEtMTc4OTI1_55a82d03-e0aa-4a8f-a1d3-8687748bb96b">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjAtNS0xLTEtMTc4OTI1_9e7cd5c8-7ee4-4c55-a753-5b29bc5b9a56">757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6382c523c2c14c259a92f891ff8641e2_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjAtMTMtMS0xLTE3ODkyNQ_dc402f36-139b-4724-81c0-ec8ece56ed00">999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjEtMS0xLTEtMTc4OTI1_fde42edc-5146-4301-97cb-95a6f0ea2a88">25,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjEtNS0xLTEtMTc4OTI1_3b8077a4-2f16-4646-94e0-a96851723a01">757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6382c523c2c14c259a92f891ff8641e2_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjEtMTMtMS0xLTE3ODkyNQ_ca4f6bbd-e415-43a2-b47a-0fd572a403ae">26,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809bb5ba4494400f9c6448d500364985_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjMtMS0xLTEtMTc4OTI1_4f10971f-9dd4-43fe-9015-2165f8275f68">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e8cff38f04f46889b1ef765ac327305_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjMtNS0xLTEtMTc4OTI1_ecce749e-e3ab-4ee3-8f8c-8cb0356934b4">1,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f7364cde4984551936b23d0ec98a423_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjMtMTEtMS0xLTE3ODkyNQ_f53c237f-ce14-4a10-ab23-d00736dda763">1,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83c34f3a227048a392485f67a2c322db_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjQtMS0xLTEtMTc4OTI1_655412ac-0970-4523-bab9-945440f2b28c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i305512b6bb2e4e2e9206830a3cba8e75_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjQtNS0xLTEtMTc4OTI1_0c02182f-f134-4f97-901a-db8646b197b7">2,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2682fa4c07b74a9c8032dd2cfde6c7b5_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjQtMTEtMS0xLTE3ODkyNQ_1b3d452e-714b-4277-9379-45400d723025">2,615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i924faf8bcd494d4faa31ef8543a91f5d_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjUtMS0xLTEtMTc4OTI1_63039c29-326e-47b6-8aed-0c5bdc9c04c0">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2db9b6b2644ba4bfd40bfe1aec493e_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjUtNS0xLTEtMTc4OTI1_bdf9e588-91b8-4cbe-bc21-1855e4d6387a">3,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i918c5fb606154cbba2f8731c331034bd_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjUtMTEtMS0xLTE3ODkyNQ_7125c86f-df8b-49ec-8acb-810c2e293b72">3,762</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69f76c986f34f1b9ba9eb7a9c317d65_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjYtMS0xLTEtMTc4OTI1_0605a9c5-94db-42cf-9641-3e95e9dc5245">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83bf3dc5af6c4f2eb6caaad2ac9f84b8_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjYtNS0xLTEtMTc4OTI1_aa01bc75-889b-4ec0-b1da-077197d2c8e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjYtMTEtMS0xLTE3ODkyNQ_c290ddd7-7e25-4420-ad03-da0b7d7c0c0f">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjYtMTMtMS0xLTE3ODkyNQ_1593abe3-4063-4491-8398-0e5737ff872d">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69f76c986f34f1b9ba9eb7a9c317d65_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjctMS0xLTEtMTc4OTI1_57056e9e-b644-4b43-be45-7b752ef37c9a">25,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83bf3dc5af6c4f2eb6caaad2ac9f84b8_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjctNS0xLTEtMTc4OTI1_7faabcfa-8482-406e-bcc6-46669e93e5d3">4,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjctMTEtMS0xLTE3ODkyNQ_b04b7fe3-1567-4f05-8b92-2686b299f948">3,666</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjctMTMtMS0xLTE3ODkyNQ_746b43be-f5c2-4962-a6aa-23981c7392c4">26,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjktMS0xLTEtMTc4OTI1_395d450d-adf6-4f98-8495-cc3b6a8f2126">21,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjktNS0xLTEtMTc4OTI1_1bf51108-2e73-42dc-82ba-f29c9f007b7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjktMTEtMS0xLTE3ODkyNQ_8a2b1a64-fe0f-4488-91a7-1125c15f05fa">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjktMTMtMS0xLTE3ODkyNQ_3b66656d-0581-4c39-a25b-1e9d87c28bcd">21,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzAtMS0xLTEtMTc4OTI1_37b700a2-4a66-4ee2-9af9-16a199ec360b">2,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzAtNS0xLTEtMTc4OTI1_ba37c6d0-5b9e-416e-aeb4-6fcf6e368399">4,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzAtMTEtMS0xLTE3ODkyNQ_075b52c8-243c-4f7f-89db-8685a73ff563">3,565</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzAtMTMtMS0xLTE3ODkyNQ_e5a00ec8-d832-4a38-9693-15e26641788c">2,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzItMS0xLTEtMTc4OTI1_801fd0ef-4ec0-4cc9-886a-3e81e3e0f084">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzItNS0xLTEtMTc4OTI1_c6184cf2-080b-4ecf-8666-b189ada04bbd">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" sign="-" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzItMTEtMS0xLTE3ODkyNQ_5f96eb38-9565-46dd-8aba-a0ce3930aae7">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzItMTMtMS0xLTE3ODkyNQ_98267643-295c-41b8-bb65-10dc09868be7">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69f76c986f34f1b9ba9eb7a9c317d65_D20230101-20230331" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzMtMS0xLTEtMTc4OTI1_afbca853-61bc-4962-986c-3628662e50cf">24,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83bf3dc5af6c4f2eb6caaad2ac9f84b8_D20230101-20230331" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzMtNS0xLTEtMTc4OTI1_66ff6657-3a82-42d2-957b-798c37bfbf14">4,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzMtMTEtMS0xLTE3ODkyNQ_9cf30cef-cd66-4eb8-a7d5-97a1a2e5a55d">3,728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzMtMTMtMS0xLTE3ODkyNQ_d614ea16-c8c8-4600-a37e-801397647761">25,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzQtMS0xLTEtMTc4OTI1_c08329bf-6189-43a0-8713-22ba64b6beba">1,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzQtNS0xLTEtMTc4OTI1_435fe939-b7e6-4ab2-b78d-fe80746927f5">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzQtMTEtMS0xLTE3ODkyNQ_06f29870-0fa9-4564-88b0-d143c03d779b">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzQtMTMtMS0xLTE3ODkyNQ_7b22056a-8ca7-4b0d-a3cd-a0e9510a2fea">1,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzYtMS0xLTEtMTc4OTI1_16063c97-2abc-4be7-8065-547a8a829336">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzYtNS0xLTEtMTc4OTI1_384000a2-678c-41fc-a32d-d5668c1c2996">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzYtMTEtMS0xLTE3ODkyNQ_8c68ca5c-bebf-4061-a340-0d949dce408e">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzYtMTMtMS0xLTE3ODkyNQ_bd29d03b-f659-46c0-824b-b812eb843be4">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzctMS0xLTEtMTc4OTI1_2c871f76-fa41-4547-bf5d-8a251f9897e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzctNS0xLTEtMTc4OTI1_59300b0f-733d-4290-a58a-02ba9501210b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzctMTEtMS0xLTE3ODkyNQ_b3eb41aa-e028-44f6-89d5-743e72652591">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzctMTMtMS0xLTE3ODkyNQ_812f48cb-e38b-4279-9664-873593ebb568">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity in net losses </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzgtMS0xLTEtMTc4OTI1_391fa453-9333-4389-bcd3-728a660308a4">1,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzgtNS0xLTEtMTc4OTI1_d2814356-16b1-4e82-aac2-c6eec7551a26">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzgtMTEtMS0xLTE3ODkyNQ_884a94ea-9253-454d-86d0-cec6058bbd04">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzgtMTMtMS0xLTE3ODkyNQ_e975d651-64dc-403d-9817-7f04ceee9bd7">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzktMS0xLTEtMTc4OTI1_7643f8f0-cea0-4a1e-980a-604fa0114c13">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzktNS0xLTEtMTc4OTI1_9cd6c099-f10e-48ea-9168-267a8c94fd13">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzktMTEtMS0xLTE3ODkyNQ_643b38a8-3b5e-4584-be79-c38baf4e349c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzktMTMtMS0xLTE3ODkyNQ_c217a36a-444b-434e-aecc-49e2aefd956f">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDAtMS0xLTEtMTc4OTI1_bab2f726-d56c-43d0-a985-3781bdc8ae20">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDAtNS0xLTEtMTc4OTI1_8cc5feee-4708-473f-ac4c-a02f45c357a3">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDAtMTEtMS0xLTE3ODkyNQ_7ec9900b-b7b6-4237-8aff-eb6eb1738e4c">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDAtMTMtMS0xLTE3ODkyNQ_53a3157f-c0c8-4d02-98c2-44198c79964e">1,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" sign="-" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDEtMS0xLTEtMTc4OTI1_96daad7c-7e54-4a20-8ce9-d5eba47b6d84">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDEtNS0xLTEtMTc4OTI1_ed4ac962-cf0b-44e5-aa25-8cdbd9a93196">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDEtMTEtMS0xLTE3ODkyNQ_e23cdf92-440b-48fc-97d5-96a883dbe858">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" sign="-" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDEtMTMtMS0xLTE3ODkyNQ_9c4ec1d8-733b-4f4d-8dd4-17c744ba8c0c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss) attributable to Humana</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDItMS0xLTEtMTc4OTI1_a98e7f45-f10f-40ea-b2e0-cd39f5ac10b8">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDItNS0xLTEtMTc4OTI1_f86dd8f2-49b9-47b1-a2ee-c0f0fa37cd15">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331" decimals="-6" sign="-" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDItMTEtMS0xLTE3ODkyNQ_a35ef26b-b2c8-4571-8ee4-9c6cf3c8317e">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDItMTMtMS0xLTE3ODkyNQ_334749c9-d18f-46b5-84e5-013c3b2c4cd3">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:4pt;text-align:center"><ix:continuation id="if0e7800d532641efaaff2c0e8674cd21"><ix:continuation id="if7c3a0f915b240d58e12cbdae6ce8c0a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:54.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.370%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.012%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.975%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="21" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External Revenues  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aa3a9ceced248e495a3ebf2f980dced_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNS0xLTEtMS0xNzg5MjU_68ff2d52-28a3-45bc-a9e2-7fc0b0996d46">17,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2b6b9a177e640c9b1223decda0a16fb_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNS01LTEtMS0xNzg5MjU_f5098c28-c5ad-4834-9c54-c628642187fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e2b6793244a439ca56ce9a5219dc82d_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNS05LTEtMS0xNzg5MjU_f02124bb-7c30-490d-8ba0-7994fd8f8044">17,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib02c4523f3fe4bc4867f91bdf4482fc4_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNi0xLTEtMS0xNzg5MjU_523b1fc6-3c1d-42f6-b9db-b81e29f8c4f8">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b8563afa71d4ffebd8b2d1bf8f9abc9_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNi01LTEtMS0xNzg5MjU_1eef2324-bf3f-457c-958d-e5ef1dd9e42f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf26032dd8144e439cadbdd99e543c72_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNi05LTEtMS0xNzg5MjU_1922a5d5-2da7-40a2-b892-bea9198606a5">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i665f623ad1564c0f801b7a6398439b3f_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNy0xLTEtMS0xNzg5MjU_c5f76661-7ed8-49a6-8780-d60f3a9d3051">639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e6586aa7b7c4bfeb6055f8260cb2050_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNy01LTEtMS0xNzg5MjU_74149e21-4960-403c-867b-6b0d23de1648">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaeba68a15074c20a7a47147aa79fb77_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNy05LTEtMS0xNzg5MjU_9d9ddfa0-ba3d-4159-bac0-0b1c7943c3f2">639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c10c27bb084521b8749197d596563b_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfOC0xLTEtMS0xNzg5MjU_42786033-2610-4feb-8396-2a51430a45d6">19,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78789613dafe4a62a86c3ef058061f4c_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfOC01LTEtMS0xNzg5MjU_31ed4e61-6023-4b81-8154-989e1dfce02f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05630ac13ae84efdb04206d248841934_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfOC05LTEtMS0xNzg5MjU_63e4523d-6380-4f62-a177-04b0c624c4ff">19,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc8d8e3c20604d8987b4b3655c1d1355_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfOS0xLTEtMS0xNzg5MjU_db8644d5-5fa1-4412-aedd-34e6dbdbf818">1,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3d1b9e97d684afc9b309b5a8dc2e4d6_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfOS01LTEtMS0xNzg5MjU_1a1f7c07-b968-4843-aa9b-4d16a2f0d96f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if043a642b7914944bf349068b08d7044_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfOS05LTEtMS0xNzg5MjU_330fc1db-fead-4226-b568-bb76a0a926a4">1,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a01bf5c57d243ffb4876ff5019fcd4e_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTAtMS0xLTEtMTc4OTI1_dd0bfd85-024e-44b2-9764-19e28de67024">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6079fbef93f6490d97c24453e1658164_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTAtNS0xLTEtMTc4OTI1_1c135835-2863-4c17-b29c-dc387ee4cad3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie50e4586d40f4d86b9ebbc2912804444_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTAtOS0xLTEtMTc4OTI1_5e14921e-3855-4091-b85c-55c6415bc68a">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i065f8703eb4643deb20037003c705c1b_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTAtMS0xLTEtMTk0NDc0_07b9f72e-1ac9-4dfd-8a7a-e723906749e2">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a4268e2aca40b19aab2ba00cb0f314_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTAtMy0xLTEtMTk1MTM3_6624bb2c-9d34-4006-8fdb-2da0cadf354a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0f2b22146644209b8afa3fee32230c6_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTAtNy0xLTEtMTk0NDg3_9719cd78-3288-452f-b82a-b9ae04242cba">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb2fc93318814cb9b70dd7040ef479f3_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTEtMS0xLTEtMTc4OTI1_0c634af0-cb28-4780-b33c-25df4e19cac8">1,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd9580b0c9c484ea82d73c64b502501_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTEtNS0xLTEtMTc4OTI1_030236b1-ce97-4e9f-8640-5a2caf15a8d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e3541bbcdc747cbbd38489ad83936dc_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTEtOS0xLTEtMTc4OTI1_5bba8506-cbe3-4f4e-a984-54ace3853fba">1,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTItMS0xLTEtMTc4OTI1_0486eecb-8c1f-4f74-865c-213a7b361c65">22,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTItNS0xLTEtMTc4OTI1_fe05b170-b373-4c4d-b6b7-083a9174bdff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dcfae0532054fd79308e5a557cced34_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTItOS0xLTEtMTc4OTI1_b27b6d52-0fe7-4f49-a72d-61bf7b967961">22,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9f8bafe49f47b49a45569e1bcb1998_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTYtMS0xLTEtMTc4OTI1_f85ed13c-9abd-4831-a488-c1b06b2c1c26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d60c49195f64463b8e21dd65e9c6e65_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTYtNS0xLTEtMTc4OTI1_2abf5f52-6a7f-43c4-aca3-feeb9a6a94c6">726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6bb8d1d674435d811376f081f0a3dd_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTYtOS0xLTEtMTc4OTI1_8adeac68-1eca-48ae-9d19-e104d59bd7b7">726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc893a7474a44474861813dd6d84ae6e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTctMS0xLTEtMTc4OTI1_edb751d1-a02d-429d-af93-3c564eb0dcc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949a7d5c28cd498e91c058a16f06bbe6_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTctNS0xLTEtMTc4OTI1_d6b6d853-f991-42f7-8649-34fe8ba66137">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i851a87a7f05942cdbf990ae5cd30af78_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTctOS0xLTEtMTc4OTI1_91d4dbb0-1efa-4296-b3ec-fb7098eb6146">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic07c1d16537a42429449e7882849141c_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTgtMS0xLTEtMTc4OTI1_e2f77128-13dd-441c-9735-85191e6a85eb">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66f6101ae0774289b5b8751a4634d40e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTgtNS0xLTEtMTc4OTI1_0d747dbe-394b-46ff-af6e-0b3fc0eaedcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b2d48e3ac324ec08b2ca88ab3f53e55_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTgtOS0xLTEtMTc4OTI1_ae922362-e79d-49c0-bcbe-455c4405c8f3">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i335400f88d18407a92f768050cebbf44_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTgtMS0xLTEtMTkzODcw_a1b8d919-aff2-4d42-8ef3-63117bc42dd9">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7edb8e82518e4dc5b3fb898234ab15cb_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTktMy0xLTEtMTk1MTM3_38c09ef5-bee9-4810-9397-a4d606d45ff0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6ff2b013bb4cff8f0653d9c2b0488d_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTgtNy0xLTEtMTkzODgw_1cac3d23-94a2-47b2-b553-2b52f7a1d529">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7fbf5c1d49c42e5bed343c27eeb8965_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTktMS0xLTEtMTc4OTI1_cdeefec7-eea0-47c5-b309-85e3df81f858">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd793a27f90f404091d71353a03a9ae4_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTktNS0xLTEtMTc4OTI1_8a811563-f849-4a8f-add9-68217e9ad4f8">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e0f4edd2b64c2e85362a841a3aa4c4_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTktOS0xLTEtMTc4OTI1_118ed69b-ca25-40e4-9419-a8d9e77d4d3f">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjAtMS0xLTEtMTc4OTI1_944120b7-2071-4703-a033-4181e4f967ad">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjAtNS0xLTEtMTc4OTI1_9a9a19c9-b3dd-4b1a-9c8a-ee7301089587">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dcfae0532054fd79308e5a557cced34_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjAtOS0xLTEtMTc4OTI1_6b2ac94d-7fa7-41ed-9e01-6e8128fb083e">1,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjEtMS0xLTEtMTc4OTI1_0add8b8d-3c73-419e-9683-59c4d6b945d5">22,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjEtNS0xLTEtMTc4OTI1_807c8f11-5888-4094-ab68-71df80efd6d7">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dcfae0532054fd79308e5a557cced34_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjEtOS0xLTEtMTc4OTI1_7789a5e1-5965-4e41-a648-4639e82ee4ca">23,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91de43b8e733413cacc845a70df17963_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjMtMS0xLTEtMTc4OTI1_ccd46083-9348-463f-935e-fb527f8b8f05">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i717dfb30995240bb96ad4c44b5acfbad_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjMtNS0xLTEtMTc4OTI1_a6bfd0ca-4f1d-4f52-9258-10e8f660b1fb">857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i027d84a6dd0d47719c06eedaeaa90374_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjMtNy0xLTEtMTc4OTI1_fd9cf5ea-af22-4635-8e69-fd741fa31bb3">871</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2020e045c5147f5a45fe1de02a9f902_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjQtMS0xLTEtMTc4OTI1_85cd1c83-a9ae-46e9-985f-615ba03a7bad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i746462efde464666b16b26676cbe2082_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjQtNS0xLTEtMTc4OTI1_db40aed5-d2e7-4bd4-bc32-f195bc14aa8b">2,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf76fe4fdae4409e884a7ac6c029af9b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjQtNy0xLTEtMTc4OTI1_c02eb3bf-f34a-4d29-92d7-3c58e539feb2">2,446</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97353868e33140a2b65bce298de17656_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjUtMS0xLTEtMTc4OTI1_ab3417a1-413a-4440-9e48-4c62124eeb70">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i536c52251be647d6987d688d1febcad5_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjUtNS0xLTEtMTc4OTI1_ea8c46e4-295b-48e3-a5e1-59603d91d519">3,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b05f4d2446843fa8e4a6429ac7a6e41_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjUtNy0xLTEtMTc4OTI1_6b0c9ea5-4be3-4833-b93b-becdebb901e4">3,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id04b5505b5b949b4b46f6df5221ff61b_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjYtMS0xLTEtMTc4OTI1_741dda71-7742-42ae-8253-bb71a3930817">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3ccf78d11e54281b041b1ad37820d52_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjYtNS0xLTEtMTc4OTI1_c1062616-9103-46dc-940c-a8ccb47545a3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjYtNy0xLTEtMTc4OTI1_8649f234-6b2e-4308-a3e4-ecdd83276809">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjYtOS0xLTEtMTc4OTI1_46fe60fe-61da-413e-96c6-3bfb040d45e8">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id04b5505b5b949b4b46f6df5221ff61b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjctMS0xLTEtMTc4OTI1_e1a1d778-2fe1-4ce2-a35f-30e1663159b5">22,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3ccf78d11e54281b041b1ad37820d52_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjctNS0xLTEtMTc4OTI1_e916acbd-8aee-4bc3-8963-434839a5f43f">4,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjctNy0xLTEtMTc4OTI1_2511af02-d934-40c3-93e1-d6282b06211c">3,362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjctOS0xLTEtMTc4OTI1_66d35efa-ee7f-4911-9197-f006dadbdcc6">23,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjktMS0xLTEtMTc4OTI1_4d881025-4b4f-4058-9b50-7a4b6950f8c7">19,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjktNS0xLTEtMTc4OTI1_f84ce179-2de6-4307-8cd2-6e0c92ff0687">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjktNy0xLTEtMTc4OTI1_8f0bf1c6-c517-4b8a-89e8-002e56744861">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjktOS0xLTEtMTc4OTI1_5917adb6-cc44-4253-87c7-e2f1c279dd58">19,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzAtMS0xLTEtMTc4OTI1_d3cf2370-234e-40a3-91f9-d615a2d6496f">2,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzAtNS0xLTEtMTc4OTI1_71241f5b-4359-497e-8478-1243dd346eff">3,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzAtNy0xLTEtMTc4OTI1_b263f39a-d5a8-4dfd-aed6-cbbbbd86a1fa">3,149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzAtOS0xLTEtMTc4OTI1_a225b9a5-c143-439e-83e6-bc51702d1eb3">2,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzItMS0xLTEtMTc4OTI1_a32bdb4d-540f-4260-9537-ecd846fee3d0">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzItNS0xLTEtMTc4OTI1_9e4ea4fc-c8e3-4ecc-8057-dd4e8385a487">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" sign="-" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzItNy0xLTEtMTc4OTI1_c084d4af-aa2d-43b0-9d3b-d32e83cbd9fc">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzItOS0xLTEtMTc4OTI1_d91632ae-d684-48d9-8460-efa546a4a3b9">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id04b5505b5b949b4b46f6df5221ff61b_D20220101-20220331" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzMtMS0xLTEtMTc4OTI1_8be7b1e9-36fc-4ab6-997d-24cf549ac853">21,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3ccf78d11e54281b041b1ad37820d52_D20220101-20220331" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzMtNS0xLTEtMTc4OTI1_2b0ee69f-7a49-4ef9-b806-709e760acbd5">3,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzMtNy0xLTEtMTc4OTI1_559d0a7d-d143-40b2-bce3-946b5c5ff89d">3,285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzMtOS0xLTEtMTc4OTI1_769661ce-15ac-4772-bde5-809c07866c6c">22,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzQtMS0xLTEtMTc4OTI1_33a218c2-a046-4f61-add9-55426e5da964">996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzQtNS0xLTEtMTc4OTI1_77f563b5-8484-4da5-bcfc-d292bf567247">370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzQtNy0xLTEtMTc4OTI1_ed0bd06c-6b4a-409a-b941-d8a4ff32d6fc">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzQtOS0xLTEtMTc4OTI1_5358aeba-bc0c-4bfd-8ecf-fdb0bdf4d574">1,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzYtMS0xLTEtMTc4OTI1_8b7d55ee-1d3a-4ce4-a9a8-ec0d84a81ac5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzYtNS0xLTEtMTc4OTI1_0a3f5e30-6b72-4085-a614-1727ed6c16c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzYtNy0xLTEtMTc4OTI1_49b7f93f-abba-4b2e-bd8a-5af649a3cb8d">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzYtOS0xLTEtMTc4OTI1_e2151b2e-8126-41fe-9cb5-4b8104846f2b">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzctMS0xLTEtMTc4OTI1_c782ab84-08cb-4ebc-94eb-447581f16374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzctNS0xLTEtMTc4OTI1_ec329be1-6e30-44e0-9ac9-4e62548bb9c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzctNy0xLTEtMTc4OTI1_7bb8ef9d-1f0a-412d-82ac-b4b10d5d5d40">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzctOS0xLTEtMTc4OTI1_68d24a72-2bf9-4ba8-a7ae-93123a0c8611">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity in net losses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzgtMS0xLTEtMTc4OTI1_854bb3b7-9c72-4c9e-9fbb-c0616ff7f021">996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzgtNS0xLTEtMTc4OTI1_2b3db9f3-6103-4a60-bf5b-72541a408e18">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzgtNy0xLTEtMTc4OTI1_86f5e2a2-e1f1-494d-a93f-8d4d92b19a84">146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzgtOS0xLTEtMTc4OTI1_d40a8fdc-b782-4997-a2ea-ba3a93f3a23c">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzktMS0xLTEtMTc4OTI1_1d733dab-225e-48b7-9a0b-205061e220d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzktNS0xLTEtMTc4OTI1_2df9ac03-fade-4b7f-9ec1-f18d8eaaaf25">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzktNy0xLTEtMTc4OTI1_f9b97f67-1ca6-4157-86ac-fdbf2ed50881">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzktOS0xLTEtMTc4OTI1_acddab66-dbfd-4677-8596-8f25bb8b7c92">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDAtMS0xLTEtMTc4OTI1_22c9b012-5348-4653-a4d4-51ef6858694b">996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDAtNS0xLTEtMTc4OTI1_2ac1b1e6-29ee-432c-9a8a-f1526c25e361">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDAtNy0xLTEtMTc4OTI1_4fe03da8-2bc4-4dd3-be94-222a27f49145">146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDAtOS0xLTEtMTc4OTI1_dd1c43dd-2d28-4e9c-a8c2-e73d4d726a61">1,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss (income) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDEtMS0xLTEtMTc4OTI1_89c8ca88-d71e-48ee-ad86-54f347f00b13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDEtNS0xLTEtMTc4OTI1_3b489b1f-0dc0-4021-81fe-9cb646cc13b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDEtNy0xLTEtMTc4OTI1_9e3cebb8-4b92-4181-b751-363bd42fbb72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDEtOS0xLTEtMTc4OTI1_f294bd09-e80f-4182-9ebf-eb8db22ba4b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss) attributable to Humana</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDItMS0xLTEtMTc4OTI1_6c556de8-a20a-43b2-8d44-ce73970bf1d7">996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDItNS0xLTEtMTc4OTI1_9c5efd4d-def6-47eb-bb9f-6b37af54396e">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331" decimals="-6" sign="-" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDItNy0xLTEtMTc4OTI1_19a11b15-b5af-4ab1-bc8d-0787a760fac0">146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDItOS0xLTEtMTc4OTI1_37ee25d3-e836-44b1-94ba-508a079aea54">1,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_79"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The condensed consolidated financial statements of Humana Inc. in this document present the Company&#8217;s financial position, results of operations and cash flows, and should be read in conjunction with the following discussion and analysis. References to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Company,&#8221; and &#8220;Humana&#8221; mean Humana Inc. and its subsidiaries. This discussion includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in filings with the Securities and Exchange Commission, or SEC, in our press releases, investor presentations, and in oral statements made by or with the approval of one of our executive officers, the words or phrases like &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;likely will result,&#8221; &#8220;estimates,&#8221; &#8220;projects&#8221; or variations of such words and similar expressions are intended to identify such forward&#8211;looking statements. These forward&#8211;looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions, including, among other things, information set forth in Item&#160;1A. &#8211; Risk Factors in our 2022 Form 10-K, as modified by any changes to those risk factors included in this document and in other reports we filed subsequent to February&#160;16, 2023, in each case incorporated by reference herein. In making these statements, we are not undertaking to address or update such forward-looking statements in future filings or communications regarding our business or results. In light of these risks, uncertainties and assumptions, the forward&#8211;looking events discussed in this document might not occur. There may also be other risks that we are unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward&#8211;looking statements.</span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_82"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Overview</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General    </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc., headquartered in Louisville, Kentucky, is a leading health and well-being company committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large. To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools, such as in home care, behavioral health, pharmacy services, data analytics and wellness solutions, combine to produce a simplified experience that makes health care easier to navigate and more effective.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our industry relies on two key statistics to measure performance. The benefit ratio, which is computed by taking</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">total benefits expense as a percentage of premiums revenue, represents a statistic used to measure underwriting profitability. The operating cost ratio, which is computed by taking total operating costs, excluding depreciation and amortization, as a percentage of total revenue less investment income, represents a statistic used to measure administrative spending efficiency.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Employer Group Commercial Medical Products Business Exit</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, we announced our planned exit from the Employer Group Commercial Medical Products business, which includes all fully insured, self-funded and Federal Employee Health Benefit medical plans, as well as associated wellness and rewards programs. No other Humana health plan offerings are materially affected. Following a strategic review, we determined the Employer Group Commercial Medical Products business was no longer positioned to sustainably meet the needs of commercial members over the long term or support our long-term strategic plans. The exit from this line of business will be phased over the next 18 to 24 months.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Sale of Hospice and Personal Care Divisions</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 11, 2022, we completed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the sale of a 60% i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterest in Gentiva, formerly Kindred, Hospice to Clayton, Dubilier &amp; Rice, or CD&amp;R, for cash proceeds of approximately $2.7&#160;billion, net of cash disposed, including debt repayments from Gentiva Hospice to Humana of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.9&#160;billion. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale we recognized a pre-tax gain, net of transaction costs, of $237&#160;million.</span></div><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The emergence and spread of the novel coronavirus, or COVID-19, beginning in the first quarter of 2020 has impacted our business. During periods of increased incidences of COVID-19, a reduction in non-COVID-19 hospital admissions for non-emergent and elective medical care have resulted in lower overall healthcare system utilization. At the same time, COVID-19 treatment and testing costs increased utilization. During 2022, we experienced lower overall utilization of the healthcare system than anticipated, as the reduction in COVID-19 utilization following the increased incidence associated with the Omicron variant outpaced the increase in non-COVID-19 utilization. The significant disruption in utilization during 2020 also impacted our ability to implement clinical initiatives to manage health care costs and chronic conditions of our members, and appropriately document their risk profiles, and, as such, significantly affected our 2021 revenue under the risk adjustment payment model for Medicare Advantage plans. Finally, changes in utilization patterns and actions taken in 2021 as a result of the COVID-19 pandemic, including the suspension of certain financial recovery programs for a period of time and shifting the timing of claim payments and provider capitation surplus payments, impacted our claim reserve development and operating cash flows for 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 National Emergency declared in 2020 was terminated on April 10, 2023 and the Public Health Emergency is set to expire on May 11, 2023.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Creation Initiatives </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, in order to create capacity to fund growth and investment in our Medicare Advantage business and further expansion of our healthcare services capabilities in 2023, we committed to drive additional value for the enterprise through cost saving, productivity initiatives, and value acceleration from previous investments. As a result of these initiatives, we recorded charges of $473 million for the year-ended December 31, 2022. These charges primarily relate to $248&#160;million in asset impairments, including software and abandonment, and $116&#160;million of severance charges in connection with workforce optimization. The remainder of the charges primarily relate to external consulting fees. These charges were recorded at the corporate level and not allocated to the segments. We did not record any charges in the first quarter of 2022, with no recurring charges in 2023.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During December 2022, we realigned our businesses into two distinct segments: Insurance and CenterWell. The Insurance segment includes the businesses that were previously included in the Retail and Group and Specialty segments, as well as the Pharmacy Benefit Manager, or PBM, business which was previously included in the Healthcare Services segment. The CenterWell segment (formerly Healthcare Services) represents our payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. In addition to the new segment classifications being utilized to assess performance and allocate resources, we believe this simpler structure will create greater collaboration across the Insurance and CenterWell businesses and will accelerate work that is underway to centralize and integrate operations within the organization.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period segment financial information has been recast to conform to the 2023 presentation. For a recast of prior period segment financial information, refer to Note 14 to the unaudited Consolidated Financial Statements included in Part I, Item 1, "Financial Statements" of this Form 10-Q.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our two reportable segments, Insurance and CenterWell, are based on a combination of the type of health plan customer and adjacent businesses centered on well-being solutions for our health plans and other customers, as described below. These segment groupings are consistent with information used by our Chief Executive Officer, the Chief Operating Decision Maker, to assess performance and allocate resources.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as our contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which we refer to collectively as our state-based contracts. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">health benefits, as well as administrative services only, or ASO. In addition, our Insurance segment includes our Military business, primarily our T-2017 East Region contract, as well as the operations of our PBM business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CenterWell segment includes our pharmacy, provider services, and home solutions operations. The segment also includes our strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as our minority ownership interest in hospice operations. Services offered by this segment are designed to enhance the overall healthcare experience. These services may lead to lower utilization associated with improved member health and/or lower drug costs. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of each segment are measured by income (loss) from operations. Transactions between reportable segments primarily consist of sales of services rendered by our CenterWell segment, primarily pharmacy, provider, and home services, to our Insurance segment customers. Intersegment sales and expenses are recorded at fair value and eliminated in consolidation. Members served by our segments often use the same provider networks, enabling us in some instances to obtain more favorable contract terms with providers. Our segments also share indirect costs and assets. As a result, the profitability of each segment is interdependent. We allocate most operating expenses to our segments. Assets and certain corporate income and expenses are not allocated to the segments, including the portion of investment income not supporting segment operations, interest expense on corporate debt, and certain other corporate expenses. These items are managed at a corporate level. These corporate amounts are reported separately from our reportable segments and are included with intersegment eliminations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 disrupted the pattern of our quarterly earnings and operating cash flows largely due to the temporary deferral of non-essential care which resulted in reductions in non-COVID-19 hospital admissions and lower overall healthcare system utilization during higher levels of COVID-19 hospital admissions. At the same time, during periods of increased incidences of COVID-19, COVID-19 treatment and testing costs increase. Similar impacts and seasonal disruptions from either higher or lower utilization are expected to persist as we respond to and recover from the COVID-19 global health crisis.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the product offerings of our Insurance segment is Medicare stand-alone prescription drug plans, or PDP, under the Medicare Part D program. Our quarterly Insurance segment earnings and operating cash flows are impacted by the Medicare Part D benefit design and changes in the composition of our membership. The Medicare Part D benefit design results in coverage that varies as a member&#8217;s cumulative out-of-pocket costs pass through successive stages of a member&#8217;s plan period, which begins annually on January 1 for renewals. These plan designs generally result in us sharing a greater portion of the responsibility for total prescription drug costs in the early stages and less in the latter stages. As a result, the PDP benefit ratio generally decreases as the year progresses. In addition, the number of low income senior members as well as year-over-year changes in the mix of membership in our standalone PDP products affects the quarterly benefit ratio pattern.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment also experiences seasonality in the commercial fully-insured product offering. The effect on the Insurance segment benefit ratio is opposite of the Medicare stand-alone PDP impact, with the benefit ratio increasing as fully-insured members progress through their annual deductible and maximum out-of-pocket expenses. The Employer Group Commercial Fully-Insured business decreased our Insurance segment benefit ratio by 30 basis points and 20 basis points for the three months ended March 31, 2023 and 2022, respectively. The Employer Group Commercial Fully-Insured business increased our Insurance segment operating cost ratio by 40 basis points and 50 basis points for the three months ended March 31, 2023 and 2022, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Insurance segment also experiences seasonality in the operating cost ratio as a result of costs incurred in the second half of the year associated with the Medicare marketing season.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2023 Highlights </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our strategy offers our members affordable health care combined with a positive consumer experience in growing markets. At the core of this strategy is our integrated care delivery model, which unites quality care, high member engagement, and sophisticated data analytics. Our approach to primary, physician-directed care for our members aims to provide quality care that is consistent, integrated, cost-effective, and member-focused, provided by both employed physicians and physicians with network contract arrangements. The model is designed to improve health outcomes and affordability for individuals and for the health system as a whole, while offering our members a simple, seamless healthcare experience. We believe this strategy is positioning us for long-term growth in both membership and earnings. We offer providers a continuum of opportunities to increase the integration of care and offer assistance to providers in transitioning from a fee-for-service to a value-based arrangement. These include performance bonuses, shared savings and shared risk relationships. At March&#160;31, 2023, approximately 3,505,100 members, or 68%, of our individual Medicare Advantage members were in value-based relationships under our integrated care delivery model, as compared to 3,053,600 members, or 67%, at March 31, 2022.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $1.2 billion, or $9.87 per diluted common share, and $930 million, or $7.29 per diluted common share, for the three months ended March&#160;31, 2023, and 2022, respectively. These comparisons were significantly impacted by put/call valuation adjustments associated with non-consolidating minority interest investments, transaction and integration costs, and the change in the fair value of publicly-traded equity securities. The impact of these adjustments to our consolidated income before income taxes and equity in net earnings and diluted earnings per common share was as follows for the 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 2022 quarter:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:74.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.940%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated income before income taxes and equity in net earnings: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Put/call valuation adjustments associated with our non consolidating minority interest investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction and integration costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of publicly-traded equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Put/call valuation adjustments associated with our non consolidating minority interest investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction and integration costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of publicly-traded equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact of all transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.64&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Health Care Reform</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are and will continue to be regularly subject to new laws and regulations, changes to existing laws and regulations, and judicial determinations that impact the interpretation and applicability of those laws and regulations. The Health Care Reform Law, the Families First Act, the CARES Act, and the Inflation Reduction Act, and related regulations, are examples of laws which have enacted significant reforms to various aspects of the U.S. health insurance industry, including, among others, mandated coverage requirements, mandated benefits and guarantee issuance associated with commercial medical insurance, rebates to policyholders based on minimum benefit ratios, adjustments to Medicare Advantage premiums, the establishment of federally facilitated or state-based exchanges coupled with programs designed to spread risk among insurers, and the introduction of plan designs based on set actuarial values, and changes to the Part D prescription drug benefit design.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that these laws and regulations, as well as other current or future legislative, judicial or regulatory changes (including further legislative or regulatory action taken in response to COVID-19) including restrictions on our ability to manage our provider network or otherwise operate our business, or restrictions on profitability, including reviews by regulatory bodies that may compare our Medicare Advantage profitability to our non-Medicare Advantage business profitability, or compare the profitability of various products within our Medicare Advantage business, and require that they remain within certain ranges of each other, increases in member benefits or changes to member eligibility criteria without corresponding increases in premium payments to us, or increases in regulation of our prescription drug benefit businesses, in the aggregate may have a material adverse effect on our results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting our ability to expand into new markets, increasing our medical and operating costs, further lowering our Medicare payment rates and increasing our expenses associated with assessments); our financial position (including our ability to maintain the value of our goodwill); and our cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend for the discussion of our financial condition and results of operations that follows to assist in the understanding of our financial statements and related changes in certain key items in those financial statements from year to year, including the primary factors that accounted for those changes. Transactions between reportable segments primarily consist of sales of services rendered by our CenterWell segment, primarily pharmacy, provider, and home services, to our Insurance segment customers and are described in Note 14 to the condensed consolidated financial statements included in this report.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_85"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comparison of Results of Operations for 2023 and 2022 </span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion primarily deals with our results of operations for the three months ended March 31, 2023, or the 2023 quarter and the three months ended March 31, 2022, or the 2022 quarter.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.920%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2023 vs 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($&#160;in&#160;millions,&#160;except&#160;per&#160;common&#160;share&#160;results)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,847&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CenterWell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,264&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,333.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,742&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,772&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,289&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.87&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.29&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.58&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit ratio (a)</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Represents benefits expense as a percentage of premiums revenue.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents operating costs as a percentage of total revenues less investment income.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated premiums revenue increased $2.8 billion, or 12.5%, from $22.7 billion in the 2022 quarter to $25.6 billion in the 2023 quarter primarily due to individual Medicare Advantage and state-based contracts membership growth and higher per member individual Medicare Advantage premiums. These factors were partially offset by the phase-out of COVID-19 sequestration relief in 2022, as well as the year-over-year decline in membership associated with group commercial medical, group Medicare Advantage and stand-alone PDP products. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated services revenue decreased $0.3 billion, or 21.0%, from $1.3 billion in the 2022 quarter to $1.0 billion in the 2023 quarter primarily due to the divestiture of the 60% ownership of Gentiva Hospice in August 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Income</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment income increased $190 million, or 6333.3%, from $3 million in the 2022 quarter to $193 million in the 2023 quarter primarily due to an increase in interest income on our debt securities combined with the 2022 quarter decrease in the fair value of our publicly traded equity securities investments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Benefit Expense&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated benefits expense increased $2.2 billion, or 11.4%, from $19.6 billion in the 2022 quarter to $21.9 billion in the 2023 quarter. The consolidated benefit ratio decreased 90 basis points from 86.4% for the 2022 quarter to 85.5% for the 2023 quarter primarily due to increased individual Medicare Advantage premium yield, lower COVID-19 inpatient utilization in the 2023 quarter, and the corresponding decrease in average unit cost given the additional 20% payment on these admissions during the Public Health Emergency, as well as higher favorable prior-period medical claims reserve development in the 2023 quarter. These factors were partially offset by investments in the benefit design of our products for 2023. Further, the 2023 quarter ratio continues to reflect a shift in line of business mix, with growth in individual Medicare Advantage and state-based contracts and other membership, which can carry a higher benefits expense ratio. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated benefits expense included $522 million of favorable prior-period medical claims reserve development in the 2023 quarter and $360 million of favorable prior-period medical claims development in the 2022 quarter. Prior-period medical claims reserve development decreased the consolidated benefit ratio by approximately 200 basis points in the 2023 quarter and decreased the consolidated benefit ratio by approximately 160 basis points in the 2022 quarter.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our segments incur both direct and shared indirect operating costs. We allocate the indirect costs shared by the segments primarily as a function of revenues. As a result, the profitability of each segment is interdependent.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated operating costs increased $0.1 billion, or 3.2%, from $2.9 billion in the 2022 quarter to $3.0 billion in the 2023 quarter. The consolidated operating cost ratio decreased 80 basis points from 12.0% for the 2022 quarter to 11.2% for the 2023 quarter</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to the divestiture of the 60% ownership of Gentiva Hospice in August 2022, which carried a significantly higher operating cost ratio compared to the historical consolidated operating cost ratio, scale efficiencies associated with growth in individual Medicare Advantage membership, as well as the impact of initiatives related to the previously-disclosed value creation plan. These factors were partially offset by an increase in commissions for brokers related to the individual Medicare Advantage membership growth during the 2023 Annual Election Period, or AEP, and the Open Enrollment Period, or OEP,  as well as the favorable impact to revenues in the 2022 quarter as a result of sequestration relief.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and Amortization</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization increased $16 million, or 9.4%, from $170 million in the 2022 quarter to $186 million in the 2023 quarter primarily due to capital expenditures.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased $23 million, or 25.6%, from $90 million in the 2022 quarter to $113 million in the 2023 quarter due to higher rates on the lower average debt balances.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate was&#160;22.5% and 23.5% for the three months ended March 31, 2023, and 2022, respectively. The year-over-year decrease in the effective income tax rate is primarily due to the recognition of a non-taxable gain in the 2023 quarter.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Segment</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Members</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Membership:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,153,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,538,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,956,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,607,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(650,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,620,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,707,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,900)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,400&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,400)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,930,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,027,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medical Membership</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,154,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,139,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Specialty Membership </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,114,700&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,182,600&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67,900)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a) We provide a full range of insured specialty products including dental, vision, and life insurance benefits marketed to individuals and groups. Members included in these products may not be unique to each product since members have the ability to enroll in a medical product and one or more specialty products.</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.525%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2023 vs 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Premiums and Services Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,847&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums and services revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,885&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from operations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance segment income from operations increased $0.3 billion, or 33.2%, from $1.0 billion in the 2022 quarter to $1.3 billion in the 2023 quarter primarily due to the same factors impacting the segment's lower benefit ratio offset by the segment's higher operating cost ratio as more fully described below.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Enrollment </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual Medicare Advantage membership increased 614,800 members, or 13.5%, from March 31, 2022 to March&#160;31, 2023 primarily due to membership additions associated with the most recent Annual Election Period, or AEP. The year-over-year growth was further impacted by continued enrollment resulting from special elections, age-ins, and Dual Eligible Special Need Plans, or D-SNP, membership. Individual Medicare Advantage membership includes 782,100 D-SNP members as of March&#160;31, 2023, a net increase of 141,500, or 22.1%, from 640,600 as of March 31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Group Medicare Advantage membership decreased 51,000 members, or 9.1%, from March 31, 2022 to March&#160;31, 2023 reflecting the net loss of certain large accounts partially offset by continued growth in small group accounts. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare stand-alone PDP membership decreased 650,700 members, or 18.0%, from March 31, 2022 to March&#160;31, 2023 primarily due to continued intensified competition for Medicare stand-alone PDP offerings.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid and other membership increased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 361,200 members, or 35.8%, from March 31, 2022 to March&#160;31, 2023 reflecting the impact of membership additions associated with the implementation of the Louisiana and Ohio contracts effective January 2023 and February 2023, respectively. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial fully-insured medical membership decreased 101,800 members, or 16.3%, from March 31, 2022 to March&#160;31, 2023 and commercial </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASO medical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">membership decreased 37,000 members, or 8.2%, from March 31, 2022 to March&#160;31, 2023. These decreases reflect our planned exit of the Employer Group Commercial Medical Products business, which includes all fully insured, self-funded and Federal Employee Health Benefit medical plans, as well as associated wellness and rewards programs. The exit from this line of business will be phased over the next 18 to 24 months.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Military membership decreased 96,800 members, or 1.6%, from March 31, 2022 to March&#160;31, 2023. Membership includes military service members, retirees, and their families to whom we are providing healthcare services under the current TRICARE East Region contract. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">p</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ecialty membership decreased 67,900 members, or 1.3%, from March 31, 2022 to March&#160;31, 2023 primarily due to the loss of dental and vision groups cross-sold with medical, as reflected in the loss of group fully-insured commercial medical membership above.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance segment premiums revenue increased $2.8 billion, or 12.5%, from $22.7 billion in the 2022 quarter to $25.6 billion in the 2023 quarter primarily due to individual Medicare Advantage and state-based contracts membership growth and higher per member individual Medicare Advantage premiums. These factors were partially offset by the phase-out of COVID-19 sequestration relief in 2022, as well as the year-over-year decline in membership associated with group commercial medical, group Medicare Advantage and stand-alone PDP products. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance segment services revenue increased $38 million, or 18.6%, from $204 million in the 2022 quarter to $242 million in the 2023 quarter.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Benefits Expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment benefit ratio decreased 80 basis points from 86.9% for the 2022 quarter to 86.1% for the 2023 quarter primarily due to increased individual Medicare Advantage premium yield, lower COVID-19 inpatient utilization in the 2023 quarter, and the corresponding decrease in average unit cost given the additional 20% payment on these admissions during the Public Health Emergency, as well as higher favorable prior-period medical claims reserve development in the 2023 quarter. These factors were partially offset by investments in the benefit design of our products for 2023. Further, the 2023 quarter ratio continues to reflect a shift in line of business mix, with growth in individual Medicare Advantage and state-based contracts and other membership, which can carry a higher benefits expense ratio. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment benefits expense included $522 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of favorable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> prior-period medical claims reserve development in the 2023 quarter and $360 million of favorable prior-period medical claims reserve development in the 2022 quarter.  Prior-period medical claims reserve development decreased the Insurance segment benefit ratio by approximately 200 basis points in the 2023 quarter and decreased the Insurance segment benefit ratio by approximately 160 basis points in the 2022 quarter. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment operating cost ratio increased 30 basis points from 9.1% for the 2022 quarter to 9.4% for the 2023 quarter primarily due to an increase in commissions for brokers related to the individual Medicare Advantage membership growth during the 2023 AEP and OEP, as well as the favorable impact to revenues in the 2022 quarter as a result of sequestration relief. These factors were partially offset by scale efficiencies associate with growth in the individual Medicare Advantage membership and the impact of initiatives related to the previously-disclosed value creation plan.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CenterWell Segment</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.938%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.941%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2023 vs 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services and intersegment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,505&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,363&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from operations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell income from operations decreased $40 million, or 10.8%, from $370 million in the 2022 quarter to $330 million in the 2023 quarter primarily due to the same factors impacting the segment's higher operating cost ratio offset by the segment's increase in revenues as more fully described below.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Services Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell services revenue decreased $0.3 billion, or 28.6%, from $1.1 billion in the 2022 quarter to $0.8 billion in the 2023 quarter</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to the divestiture of the 60% ownership of Gentiva Hospice in August 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intersegment Revenues</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell intersegment revenues increased $0.4 billion, or 13.5%, from $3.3 billion in the 2022 quarter to $3.7 billion in the 2023 quarter primarily due to individual Medicare Advantage membership growth, which led to higher pharmacy revenues, higher revenues associated with growth in the provider business, and greater intersegment revenues associated with the home solutions business as a result of the expansion of the value-based care home model in the 2023 quarter compared to the 2022 quarter. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CenterWell segment operating cost ratio increased 110 basis points from 90.5% for the 2022 quarter to 91.6% for the 2023 quarter primarily due the divestiture of the 60% ownership of Gentiva Hospice in August 2022, which carried a lower operating cost ratio compared to other businesses within the segment, the expansion of the value-based care model within the home solutions business, which carries a higher ratio compared to the core fee-for-service business, along with growth in the core fee-for-service business, as well as further investments within the home solutions business to abate the pressures of the current nursing labor environment. These increases were partially offset by an improving ratio in the provider business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_88"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, our primary sources of cash have included receipts of premiums, services revenue, and investment and other income, as well as proceeds from the sale or maturity of our investment securities, and borrowings. Our primary uses of cash historically have included disbursements for claims payments, operating costs, interest on borrowings, taxes, purchases of investment securities, acquisitions, capital expenditures, repayments on borrowings, dividends, and share repurchases. As premiums generally are collected in advance of claim payments by a period of up to several months, our business normally should produce positive cash flows during periods of increasing premiums and enrollment. Conversely, cash flows would be negatively impacted during periods of decreasing premiums and enrollment. From period to period, our cash flows may also be affected by the timing of working capital items including premiums receivable, benefits payable, and other receivables and payables. Our cash flows are impacted by the timing of payments to and receipts from CMS associated with Medicare Part D subsidies for which we do not assume risk. The use of cash flows may be limited by regulatory requirements of state departments of insurance (or comparable state regulators) which require, among other items, that our regulated subsidiaries maintain minimum levels of capital and seek approval before paying dividends from the subsidiaries to the parent. Our use of cash flows derived from our non-insurance subsidiaries, such as in our CenterWell segment, is generally not restricted by state departments of insurance (or comparable state regulators).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our liquidity risk, refer to Part I, Item 1A, "Risk Factors" in our 2022 Form 10-K and Part II, Item 1A, "Risk Factors" of this Form 10-Q.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents increased to approximately $13.7 billion at March&#160;31, 2023 from $5.1 billion at December 31, 2022. The change in cash and cash equivalents for the three months ended March 31, 2023 and 2022 is summarized as follows:</span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:70.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(648)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in cash and cash equivalents</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,674&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,470&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow from Operating Activities </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows provided by operations of $6.7 billion in the 2023 quarter increased $6.4&#160;billion from cash flows provided by operations of $302 million in the 2022 quarter. Our operating cash flows for the 2023 quarter were significantly impacted by the early receipt of the Medicare premium remittance of $6.6&#160;billion in March 2023 because the payment date for April 2023 fell on a weekend. Generally, when the first day of a month falls on a weekend or holiday, with the exception of January 1 (New Year's Day), we receive this payment at the end of the previous month. This also resulted in an increase to unearned revenues in our condensed consolidated balance sheet at March 31, 2023. Our operating cash flows for the 2023 quarter were further negatively impacted by working capital items in the quarter compared to the 2022 quarter.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant drivers of changes in our working capital are typically the timing of payments of benefits expense and receipts for premiums. Benefits expense includes claim payments, capitation payments, pharmacy costs net of rebates, allocations of certain centralized expenses and various other costs incurred to provide health insurance coverage to members, as well as estimates of future payments to hospitals and others for medical care and other supplemental benefits provided on or prior to the balance sheet date. For additional information regarding our benefits payable and benefits expense recognition, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The detail of total net receivables at March&#160;31, 2023 and December 31, 2022 and reconciliation to cash flow for the three months ended March 31, 2023 and 2022 was as follows:</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:44.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.565%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 Quarter Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 Quarter Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,433&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,360&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   The changes in Medicare receivables for both the 2023 quarter and the 2022 quarter reflect individual Medicare Advantage membership growth and the typical pattern caused by the timing of accruals and related collections associated with the CMS risk-adjustment model. Significant collections occur with the mid-year and final settlements with CMS in the second and third quarter. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow from Investing Activities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the 2023 quarter, we acquired various businesses totaling to approximately $73 million, net of cash received.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the 2022 quarter, we acquired various health and wellness related businesses for cash consideration of approximately $74 million, net of cash received. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ongoing capital expenditures primarily relate to our information technology initiatives, support of services in our provider services operations including medical and administrative facility improvements necessary for activities such as the provision of care to members, claims processing, billing and collections, wellness solutions, care coordination, regulatory compliance and customer service. Total capital expenditures, excluding acquisitions, were $223 million in the 2023 quarter and $295 million in the 2022 quarter.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net purchases of investment securities were $1.0 billion in the 2023 quarter and net purchases of investment securities were $279&#160;million in the 2022 quarter.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow from Financing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receipts from CMS associated with Medicare Part D claim subsidies for which we do not assume risk were higher than claim payments by $3.03 billion and $2.48 billion in the 2023 and 2022 quarters, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under our administrative services only TRICARE contracts, health care costs payments for which we do not assume risk exceeded reimbursements from the federal government by $29 million and $2 million in the 2023 and 2022 quarters, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net repayments from the issuance of com</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mercial paper were $177 million in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 quarter</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and net repayments from the issuance of commercial paper were $265 million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the 2022 quarter. The maximum principal amount outstanding at any one time during the 2023 quarter was $626 million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  In March 2023, we issued $500&#160;million of 5.700% unsecured senior notes due March 13, 2026 and $750&#160;million of 5.500% unsecured senior notes due March 15, 2053. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $1.2&#160;billion. We used the net proceeds to repay outstanding amounts under our $500&#160;million Delayed Draw Term Loan. The remaining net proceeds will be used for general corporate purposes, which include the repayment of existing indebtedness, including borrowings under our commercial paper program.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2022, we issued $750&#160;million of 3.700% unsecured senior notes due March 23, 2029. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $744&#160;million. </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2023, we entered into a Rule 10b5-1 Repurchase Plan, or the Plan, to repurchase a portion of our $1.5&#160;billion aggregate principal amount of 0.650% senior notes maturing in August 2023 and our $600&#160;million aggregate principal amount of 3.850% senior notes maturing in October 2024 during the Plan period beginning on March 13, 2023 and ending on June 15, 2023. At March 31, 2023, we repurchased $61&#160;million, for cash totaling approximately $60&#160;million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We repurchased common shares for $67&#160;million and $1.0 billion in the 2023 quarter and 2022 quarter, respectively, under share repurchase plans authorized by the Board of Directors. We also acquired common shares in connection with employee stock plans for $27 million and $24 million in the 2023 quarter and 2022 quarter, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid dividends to stockholders of $100 million during the 2023 quarter and $91 million during the 2022 quarter.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remainder of the cash used in or provided by financing activities in 2023 and 2022 primarily resulted from  the change in book overdraft.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_91"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Sources and Uses of Liquidity</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our dividends to stockholders, refer to Note 10 to the unaudited Consolidated Financial Statements included in Part I, Item 1, "Financial Statements" of this Form 10-Q.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding stock repurchases, refer to Note 10 to the unaudited Consolidated Financial Statements included in Part I, Item 1, "Financial Statements" of this Form 10-Q.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding debt, including our senior notes, term loans, revolving credit agreements, commercial paper program and other short-term borrowings, refer to Note 12 to the unaudited Consolidated Financial Statements included in Part I, Item 1, "Financial Statements" of this Form 10-Q.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 11, 2022, we completed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the sale of a 60% i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterest in Gentiva Hospice to CD&amp;R, for cash proceeds of approximately $2.7&#160;billion, net of cash disposed, including debt repayments from Gentiva Hospice to Humana of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.9&#160;billion. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale we recognized a pre-tax gain, net of transaction costs, of $237&#160;million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding the divestiture, refer to Note 3 to the unaudited Consolidated Financial Statements included in Part I, Item 1, "Financial Statements" of this Form 10-Q.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity Requirements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our cash balances, investment securities, operating cash flows, and funds available under our credit agreement and our commercial paper program or from other public or private financing sources, taken together, provide adequate resources to fund ongoing operating and regulatory requirements, acquisitions, future expansion opportunities, and capital expenditures for at least the next twelve months, as well as to refinance or repay debt, and repurchase shares. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse changes in our credit rating may increase the rate of interest we pay and may impact the amount of credit available to us in the future. Our investment-grade credit rating at March&#160;31, 2023 was BBB+ according to Standard&#160;&amp; Poor&#8217;s Rating Services, or S&amp;P, and Baa3 according to Moody&#8217;s Investors Services, Inc., or Moody&#8217;s. A downgrade by S&amp;P to BB+ or by Moody&#8217;s to Ba1 triggers an interest rate increase of 25 basis points with respect to </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$250 million of our senior notes. Successive one notch downgrades increase the interest rate an additional 25 basis points, or annual interest expense by less than $1 million, up to a maximum 100 basis points, or annual interest expense by $3 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we operate as a holding company in a highly regulated industry. Humana Inc., our parent company, is dependent upon dividends and administrative expense reimbursements from our subsidiaries, most of which are subject to regulatory restrictions. We continue to maintain significant levels of aggregate excess statutory capital and surplus in our state-regulated operating subsidiaries. Cash, cash equivalents, and short-term investments at the parent company were $909 million at March&#160;31, 2023 compared to $934 million at December 31, 2022. This decrease primarily reflects common stock repurchases, repayment of the delayed draw term loan, repayment of maturing senior notes, capital expenditures, repayment of borrowings under the commercial paper program, capital contributions to certain subsidiaries, cash dividends to shareholders and acquisitions, partially offset by net proceeds from the issuance of senior notes and the sale of investment securities.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our use of operating cash derived from our non-insurance subsidiaries, such as our CenterWell segment, is generally not restricted by departments of insurance (or comparable state regulators). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Requirements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our subsidiaries operate in states that regulate the payment of dividends, loans, or other cash transfers to Humana Inc., our parent company, and require minimum levels of equity as well as limit investments to approved securities. The amount of dividends that may be paid to Humana Inc. by these subsidiaries, without prior approval by state regulatory authorities, or ordinary dividends, is limited based on the entity&#8217;s level of statutory income and statutory capital and surplus. If the dividend, together with other dividends paid within the preceding twelve months, exceeds a specified statutory limit or is paid from sources other than earned surplus, it is generally considered an extraordinary dividend requiring prior regulatory approval. In most states, prior notification is provided before paying a dividend even if approval is not required.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although minimum required levels of equity are largely based on premium volume, product mix, and the quality of assets held, minimum requirements vary significantly at the state level. Based on the most recently filed statutory financial statements as of December 31, 2022, our state regulated subsidiaries had aggregate statutory capital and surplus of approximately $11.3 billion, which exceeded aggregate minimum regulatory requirements of $8.4 billion. The amount of ordinary dividends that may be paid to our parent company in 2023 is approximately $1.8&#160;billion in the aggregate. The amount, timing and mix of ordinary and extraordinary dividend payments will vary due to state regulatory requirements, the level of excess statutory capital and surplus and expected future surplus requirements related to, for example, premium volume and product mix. Actual dividends paid to our parent company were approximately $1.3&#160;billion in 2022. </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_106"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our earnings and financial position are exposed to financial market risk, including those resulting from changes in interest rates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate risk also represents a market risk factor affecting our consolidated financial position due to our significant investment portfolio, consisting primarily of fixed maturity securities of investment-grade quality with a weighted average S&amp;P credit rating of AA at March&#160;31, 2023. Our net unrealized position increased $248 million from a net unrealized loss position of $1.7 billion at December 31, 2022 to a net unrealized loss position of $1.4 billion at March&#160;31, 2023. At March&#160;31, 2023, we had gross unrealized losses of $1.5 billion on our investment portfolio primarily due to an increase in market interest rates since the time the securities were purchased. There w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ere no material credit allowances d</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uring the three months ended March 31, 2023. While we believe that these securities in an unrealized loss will recover in value over time and we currently do not have the intent to sell such securities, given the current market conditions and the significant judgments involved, there is a continuing risk that future declines in fair value may occur and material realized losses from sales or credit allowances may be recorded in future periods.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Duration is the time-weighted average of the present value of the bond portfolio&#8217;s cash flow. Duration is indicative of the relationship between changes in fair value and changes in interest rates, providing a general indication of the sensitivity of the fair values of our fixed maturity securities to changes in interest rates. However, actual fair values may differ significantly from estimates based on duration. The average duration of our investment portfolio, including cash and cash equivalents, was approximately 3.2 years as of March&#160;31, 2023 and December 31, 2022. Based on the duration, including cash equivalents, a 1% increase in interest rates would generally decrease the fair value of our securities by approximately $656 million at March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_109"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision and with the participation of our Chief Executive Officer, or CEO, our Chief Financial Officer, or CFO, and our Principal Accounting Officer, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures for the quarter ended March&#160;31, 2023.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our evaluation, our CEO, CFO, and our Principal Accounting Officer concluded that our disclosure controls and procedures are effective to provide reasonable assurance that information the Company is required to disclose in its reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, including, without limitation, ensuring that such information is accumulated and communicated to the Company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in the Company&#8217;s internal control over financial reporting during the quarter ended March&#160;31, 2023 that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_112"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">T</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">a</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">ble of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II. Other Information</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_115"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. &#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding legal proceedings pending against us and certain other pending or threatened litigation, investigations or other matters, refer to &#8220;Legal Proceedings and Certain Regulatory Matters&#8221; in Note 13 to the unaudited Consolidated Financial Statements included in Part I, Item 1, "Financial Statements" of this Form 10-Q.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_118"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A.       Risk Factors</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes to the risk factors included in our 2022 Form 10-K.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_121"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. &#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">None.</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">N/A</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The following table provides information about our purchases of equity securities that are registered by us pursuant to Section&#160;12 of the Securities Exchange Act of 1934, as amended, during the three months ended March 31, 2023:</span></div><div style="margin-bottom:1pt;padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.294%"><tr><td style="width:1.0%"></td><td style="width:21.903%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number<br/>of Shares<br/>Purchased (1)(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>Price&#160;Paid<br/>per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of<br/>Shares&#160;Purchased<br/>as Part of Publicly<br/>Announced Plans<br/>or&#160;Programs&#160;(1)(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollar Value of<br/>Shares that May<br/>Yet&#160;Be&#160;Purchased<br/>Under the Plans<br/>or Programs (1) (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,933,335,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,490&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495.68&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,490&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On February 15, 2023, the Board of Directors replaced the previous share repurchase authorization of up to $3 billion (of which approximately $1 billion remained unused) with a new authorization for repurchases of up to $3 billion of our common shares exclusive of shares repurchased in connection with employee stock plans, expiring as of February 15, 2026. Our remaining repurchase authorization was $2.8&#160;billion as of April&#160;25, 2023.</span></div><div style="margin-bottom:9pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Excludes 52,434 shares repurchased in connection with employee stock plans.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_124"></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. &#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div style="margin-bottom:9pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt;text-indent:54pt"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_127"></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. &#160;&#160;&#160;&#160;Mine Safety Disclosures</span></div><div style="margin-bottom:9pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:6pt;text-indent:54pt"><span><br/></span></div><div id="i91c607a8fabc48adb102d5eefcab1efa_130"></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. &#160;&#160;&#160;&#160;Other Information</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_133"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">T</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">a</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">ble of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6: &#160;&#160;&#160;&#160;Exhibits</span></div><div style="margin-bottom:1pt;padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.615%"><tr><td style="width:1.0%"></td><td style="width:17.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3(i)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restated Certificate of Incorporation of Humana Inc. filed with the Secretary of State of Delaware on November&#160;9, 1989, as restated to incorporate the amendment of January&#160;9, 1992, and the correction of March&#160;23, 1992 (incorporated herein by reference to Exhibit 4(i) to Humana Inc.&#8217;s Post-Effective Amendment No. 1 to the Registration Statement on&#160;Form S-8 (Reg. No. 33-49305) filed February&#160;2, 1994).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000004907122000083/exhibit3bhumanaincamendeda.htm">3(ii)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana Inc. Amended and Restated By-laws, effective as of December 8, 2022 (incorporated herein by reference to Exhibit 3(b) to Humana Inc.&#8217;s Current Report on Form 8-K filed on December 8, 2022).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000119312523069153/d484848dex42.htm">10.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Twenty-Fourth Supplemental Indenture, dated March 13, 2023, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.2 to Humana Inc.&#8217;s Current Report on Form 8-K filed on March 13, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000119312523069153/d484848dex44.htm">10.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Twenty-Fifth Supplemental Indenture, dated March 13, 2023, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.4 to Humana Inc.&#8217;s Current Report on Form 8-K filed on March 13, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="humanaseverancepolicyfinal.htm">10.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana Inc. Executive Severance Policy, effective as of March 1, 2023.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hum-20230331xex31x1.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Executive Officer certification pursuant to Section 302 of Sarbanes&#8211;Oxley Act of 2002.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hum-20230331xex31x2.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Financial Officer certification pursuant to Section 302 of Sarbanes&#8211;Oxley Act of 2002.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hum-20230331xex32.htm">32</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Executive Officer and Principal Financial Officer certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from Humana Inc.'s Quarterly Report on Form 10-Q formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets at March 31, 2023 and December 31, 2022; (ii) the Condensed Consolidated Statements of Income for the three months ended March 31, 2023 and 2022; (iii) the Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2023 and 2022; (iv) the Consolidated Statements of Stockholders' Equity for the three months ended March 31, 2023 and 2022; (v) the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022; and (vi) Notes to Condensed Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File formatted in Inline XBRL and contained in Exhibit 101. </span></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i91c607a8fabc48adb102d5eefcab1efa_139"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">T</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">a</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i91c607a8fabc48adb102d5eefcab1efa_7">ble of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HUMANA INC.</span></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 26, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ JOHN-PAUL W. FELTER</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John-Paul W. Felter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Accounting Officer and Controller (Principal Accounting Officer)</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>2
<FILENAME>humanaseverancepolicyfinal.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i276db49bc94d4f41912135ed9ab509bf_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">HUMANA INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTIVE SEVERANCE POLICY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Humana Inc. Executive Severance Policy has been adopted by the Organization &#38; Compensation Committee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of the Board of Directors of the Company to apply to selected executive employees of the Company. Executives will be eligible for coverage under the Policy for the payment of severance benefits upon termination of employment under certain circumstances, subject to the conditions set forth below. This Policy shall be effective as of the Effective Date as provided herein.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For purposes of this Policy, the following terms shall have the following meaning&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Annual Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean an Executive&#8217;s stated annual compensation without regard to any bonus, perquisite or other benefits.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the annual bonus or incentive compensation payable to Executive under the Company&#8217;s annual bonus or incentive compensation program in which Executive participates from time to time.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) a felony conviction of Executive, (ii) the failure of Executive to contest prosecution for a felony, or (iii) Executive&#8217;s willful misconduct or dishonesty, any of which is determined by the Compensation Committee to be directly and materially harmful to the business or reputation of the Company or any of its subsidiaries.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Company&#8217;s President and Chief Executive Officer.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;CEO Direct Reports&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall mean Executive Officers of the Company who are direct reports to the Company&#8217;s President and Chief Executive Officer.</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Humana Inc., a Delaware corporation.</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Organization and Compensation Committee of the Board of Directors of the Company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Date of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the effective date of the relevant Executive&#8217;s termination of employment with the Company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means March 1, 2023, or such later date as determined by the Compensation Committee with respect to an Executive.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Executive Officers of the Company (including the CEO) and such other individuals as identified by the Compensation Committee, in each case employed by the Company or an affiliate of the Company on a full-time or part-time basis. Individuals will continue to be deemed an &#8220;Executive&#8221; eligible for the rights and benefits under this Policy for a period of twelve (12) months following a change in role or title at the Company that would otherwise have caused the individual to cease to be an eligible Executive Officer or other individual identified by the Compensation Committee as eligible.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall include those executive officers designated by the Board under Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 &#124; </font><font style="color:#808080;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means this Humana Inc. Executive Severance Policy.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Separation from Service&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means a termination of the employment relationship of the Executive with the Company or an affiliate within the meaning of Section 409A of the Code and Treasury Regulation section 1.409A-1(h) or any successor thereto.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Severance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) for the CEO, twenty-four (24) months following the Date of Termination, (ii) for CEO Direct Reports, eighteen (18) months following the Date of Termination and (iii) for all other Executives, six (6) months plus two (2) weeks per year of completed service.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Severance Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means (i) for the CEO, the CEO&#8217;s then current Annual Base Salary plus the target annual bonus or incentive compensation which could have been earned by the CEO, calculated as if all relevant goals had been met during the Company&#8217;s then-current fiscal year pursuant to the terms of the incentive compensation plan in which the CEO participates, and (ii) for all of Executives, such Executive&#8217;s then current Annual Base Salary.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Term of Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The term of this Policy shall begin on the Effective Date and shall continue in effect until modified or terminated by the Company pursuant to Section&#160;13 hereof.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company may terminate the employment of Executive for any reason and at any time. In the event that the Company terminates the employment of Executive without Cause, Executive shall be entitled to the following rights and benefits under this Section&#160;3&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to Executive&#8217;s compliance with all terms of this Policy, including, without limitation, Sections 5 and 6 hereof&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Salary Continuation Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will pay Executive salary continuation through the Severance Period at an annual rate equal to such Executive&#8217;s Severance Rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that any payments that would otherwise be paid during the Severance Period that remain outstanding as of March 15 of the year following the year during which the Date of Termination occurred shall be paid in a lump sum on such date. Salary continuation under this Section&#160;3.1 shall be paid on a bi-weekly basis in accordance with the Company&#8217;s customary payroll practices with the first payment to be made in accordance with Section 5 hereof, subject to the accelerated payment of the remaining amounts in accordance with the prior sentence.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt;text-decoration:underline">Pro-Rata Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will pay Executive an amount equal to the product of (A) the Annual Bonus, if any, that Executive would have earned for the calendar year in which the Date of Termination occurs, based on achievement of the applicable performance goals for each such calendar year, as uniformly applied to other Executives who remain employed through the end of the applicable performance period and (B) a fraction, the numerator of which is the number of days Executive was employed by the Company during the calendar year of termination, and the denominator of which is the number of days in such calendar year. This amount shall be paid on the date that Annual Bonuses are normally paid, but in no event later than March 15th of the year following the year in which the Date of Termination occurs.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Continued Health Benefit Coverage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will provide to each Executive and Executive&#8217;s eligible dependents, through the end of the (i) applicable Severance Period for such Executive, or (ii) the effective date of Executive&#8217;s coverage under equivalent benefits from a new employer (provided that no such equivalent benefits shall be considered effective unless and until all pre-existing condition limitations and waiting period </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2 &#124; </font><font style="color:#808080;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">restrictions have been waived or have otherwise lapsed), at the Compensation Committee&#8217;s option, either (A) continued medical and dental coverage under the Company&#8217;s health care plan at the same level of coverage to which such Executive was entitled on the Date of Termination, subject to eligibility requirements and other conditions contained in the plan, including the requirement that Executive continue to pay the &#8220;employee portion&#8221; of the cost thereof, or (B) equivalent benefits (or equivalent cash value, payable on an after-tax basis), as determined in the sole reasonable discretion of the Compensation Committee.  The coverage provided pursuant to this Section 3.1(iii) shall be in satisfaction of the Company&#8217;s obligation to provide coverage under the Consolidated Omnibus Budget Reconciliation Act (COBRA).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt;text-decoration:underline">Outplacement Services&#59; Financial Planning</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will provide an Executive who is the CEO or a CEO Direct Report or otherwise designated by the Committee (i) with financial planning services during the one year period immediately following the Date of Termination on the same terms as the financial planning services were provided to such Executive immediately prior to the Date of Termination, and (ii) with outplacement services through an outplacement firm of the Company&#8217;s choosing at a level of services to be determined by the Company, with such services to extend until the earlier of (A) one year following the Date of Termination or (B) the date Executive secures full time employment.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Accrued Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Within fifteen (15) business days following the Date of Termination, the Company will pay or provide Executive with (i) all accrued but unpaid base salary through the Date of Termination, (ii) vacation pay accrued but not used in accordance with the Company&#8217;s vacation pay policy, (iii) any previously awarded but unpaid Annual Bonus for a completed calendar year prior to the Date of Termination, (iv) any unreimbursed business expenses that are reimbursable under the Company&#8217;s business expense policy, and (v) all rights and benefits under the employee benefit plans of the Company in which Executive is then participating, (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accrued Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">No Additional Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as provided in this Section&#160;3, Executive&#8217;s participation under any benefit plan, program, policy or arrangement sponsored or maintained by the Company shall be treated in accordance with the terms of the applicable plan. Without limiting the generality of the foregoing, Executive&#8217;s eligibility for and active participation in any of the retirement plans maintained by the Company will end on the Date of Termination and Executive will earn no additional benefits, including, without limitation, any additional service credit, under those plans after that date. Executive shall be treated as a terminated employee for purposes of all such benefit plans and programs effective as of the Date of Termination, and shall receive all payments and benefits due under such plans and programs in accordance with the terms and conditions thereof.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Other Terminations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company may terminate the employment of Executive for any reason and at any time.  In the event that the Company terminates the employment of Executive during the term of the Policy, other than a termination of employment by the Company for Cause, the Company will pay or provide Executive with all Accrued Rights.  Executive may terminate his or her employment for any reason and at any time and shall not be entitled to any payments or benefits under this Policy by reason of such termination of employment from the Company. This Policy shall have no effect on the rights and benefits to which an Executive is entitled upon retirement under (without limitation) any retirement or savings plan of the Company, which shall be governed exclusively by the terms of such plans and agreements, as applicable.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">As a condition precedent to receiving the payments and benefits as provided herein, Executive will execute (and not revoke) a general release of claims (the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3 &#124; </font><font style="color:#808080;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), in a form provided by the Company. If Executive fails to execute and deliver the Release, or revokes the Release, Executive agrees that he shall not be entitled to receive the payments and benefits described herein. For purposes of this Policy, the Release shall be considered to have been executed by Executive if it is signed by Executive&#8217;s legal representative in the case of legal incompetence or on behalf of Executive&#8217;s estate in the case of Executive&#8217;s death.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">Except as otherwise specified or agreed to by Executive and the Company, payment of any amounts described hereunder that are subject to the Release will begin on the 60th day following the Date of Termination, with the first such payment to include any amounts attributable to payroll intervals occurring prior to such date, provided, however, that, to the extent that the payments are exempt from Section&#160;409A of the Code, such exempt payments shall be made beginning with the first payroll date following the effectiveness of the Release.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In consideration of Executive&#8217;s employment by the Company and the rights and benefits of Executive provided by this Policy, Executive hereby agrees and acknowledges that the covenants attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereto are effective as of the Effective Date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictive Covenants Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), with the restricted period for such non-competition and non-solicitation covenants to be the applicable Severance Period for the Executive, commencing upon the Date of Termination.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Section&#160;409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. It is intended that this Policy be exempt from the provisions of Section&#160;409A of the Code and this Policy shall be construed, administered, and governed in a manner consistent with this intent. If and to the extent that any payment or benefit under this Policy is determined by the Company to constitute &#8220;non-qualified deferred compensation&#8221; subject to Section&#160;409A of the Code and is payable to Executive by reason of Executive&#8217;s termination of employment, then such payment or benefit shall be made or provided to Executive only upon a Separation from Service as defined for purposes of Section&#160;409A of the Code. Each severance payment under this Policy will be considered a &#8220;separate payment&#8221; and not one of a series of payments for purposes of Section&#160;409A of the Code.  To the extent that any benefits to be provided to Executive pursuant to this Policy are considered nonqualified deferred compensation and are reimbursements subject to Treasury Regulation Section 1.409A-3(i)(1)(iv), then (i) the reimbursement of eligible expenses related to such benefits shall be made on or before the last day of the Executive&#8217;s taxable year following the Executive&#8217;s taxable year in which the expense was incurred and (ii) notwithstanding anything to the contrary in this Policy or any plan providing for such benefits, the amount of expenses eligible for reimbursement during any taxable year of the Executive shall not affect the expenses eligible for reimbursement in any other taxable year.  Nothing in this Policy will provide a basis for any person to take action against the Company or its affiliates based on matters covered by Section 409A of the Code and in no event will the Company or its affiliates be liable for any additional tax, interest or penalties that may be imposed on Executive under Section&#160;409A of the Code or any damages for failing to comply with Section&#160;409A of the Code.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Six Month Delay for Specified Executives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent that any amount payable or benefit to be provided under this Policy constitutes a nonexempt &#8220;nonqualified deferred compensation plan&#8221; (as defined in Section 409A of the Code) upon a Separation from Service, and to the extent an Executive is deemed to be a &#8220;specified employee&#8221; (as that term is defined in Section 409A of the Code and pursuant to procedures established by the Company) on the Date of Termination, notwithstanding any other provision in this Policy to the contrary, such payment or benefit provision will not be made to the Executive during the six month period immediately following the Date of Termination. Instead, on the first day of the seventh month following the Date of Termination, all amounts that otherwise would have been paid or provided </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4 &#124; </font><font style="color:#808080;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">to the Executive during the six month period, but were not paid or provided because of this Section 7.2, will be paid or provided to the Executive at such time without interest. This six month delay will cease to be applicable if the Executive incurs a Separation from Service due to death or if the Executive dies before the six month period has expired.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All compensation payable pursuant to this Policy shall be subject to reduction by all applicable withholding, social security and other federal, state and local taxes and deductions, and the Company shall be authorized to make all such withholdings to the extent it determines necessary under applicable law.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Acknowledgment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Executive acknowledges that this Policy does not constitute a contract of employment or impose on the Company any obligation to retain Executive as an employee and that this Policy does not prevent Executive from terminating employment at any time.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Non-Duplication of Benefits&#59; CIC Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The severance benefit under this Policy is not intended to duplicate any other benefits provided by the Company in connection with the termination of an employee&#8217;s employment, such as wage replacement benefits, pay-in-lieu-of-notice, severance pay, or similar benefits under any other benefit plans, severance programs, employment contracts, or applicable federal or state laws, such as the WARN Acts. Should such other benefits be payable, the severance benefit under this Policy will be reduced accordingly or, alternatively, severance benefits previously paid under this Policy will be treated as having been paid to satisfy such other benefit obligations. In either case, the Company will determine how to apply this provision and may override other provisions in this Policy in doing so. In addition, and notwithstanding anything else provided herein, to the extent Executive is entitled to severance payments and benefits upon termination of employment pursuant to the Company&#8217;s Change in Control Policy or any other change in control arrangements, this Policy will cease to apply and Executive&#8217;s entitlement to severance benefits shall be governed solely by the Change in Control Policy.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Compensation Committee is responsible for the administration of this Policy and shall have all powers and duties necessary to fulfill its responsibilities. The Compensation Committee shall determine any and all questions of fact, resolve all questions of interpretation of the Policy which may arise, and exercise all other powers and discretion necessary to be exercised under the terms of the Policy which it is herein given or for which no contrary provision is made. The Compensation Committee shall have full power and discretion to interpret the Policy and related documents, to resolve ambiguities, inconsistencies and omissions, to determine any question of fact, and to determine the rights and benefits, if any, of any Executive or other employee, in accordance with the provisions of the Policy. The Compensation Committee&#8217;s decision with respect to any matter shall be final and binding on all parties concerned. The validity of any such interpretation, construction, decision, or finding of fact shall not be given de novo review if challenged in court, by arbitration, or in any other forum, and shall be upheld unless clearly arbitrary or capricious. The Compensation Committee may, from time to time, by action of its appropriate officers, delegate to designated persons or entities the right to exercise any of its powers or the obligation to carry out its duties under the Policy.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Amendment and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company reserves the right to amend or terminate this Policy at any time and in any manner, without consent or advance notice to Executives or other employees.  No amendment or termination of the Policy shall affect the rights of an Executive whose Date of Termination has occurred prior to the date of such amendment or termination of the Policy and who remains entitled to severance payments or benefits under this Policy. </font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5 &#124; </font><font style="color:#808080;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Adopted by the Board of Directors on February 15, 2023</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6 &#124; </font><font style="color:#808080;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictive Covenants</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Confidential Information and Trade Secrets</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The Executive recognizes that the Executive&#8217;s position with the Company requires considerable responsibility and trust, and, in reliance on the Executive&#8217;s loyalty, the Company may entrust the Executive with highly sensitive confidential, restricted and proprietary information involving Trade Secrets and Confidential Information. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Trade Secret</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; shall be defined as any scientific or technical information, design, process, procedure, formula or improvement that is valuable and not generally known to competitors of the Company. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; is any data or information, other than Trade Secrets, that is important, competitively sensitive, and not generally known by the public, including, but not limited to, the Company&#8217;s business plans, business prospects, training manuals, product development plans, bidding and pricing procedures, market strategies, internal performance statistics, financial data, confidential personnel information concerning employees of the Company, supplier data, operational or administrative plans, policy manuals, and terms and conditions of contracts and agreements. The terms &#8220;Trade Secrets&#8221; and &#8220;Confidential Information&#8221; shall not apply to information which is (i)&#160;already in the Executive&#8217;s possession (unless such information was used in connection with formulating the Company&#8217;s business plans, obtained by the Executive from the Company or was obtained by the Executive in the course of the Executive&#8217;s employment by the Company), or (ii)&#160;required to be disclosed by any applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Except as may be required by law or legal process or an order of a court of competent jurisdiction, the Executive will not use or disclose any Trade Secrets or Confidential Information of the Company at any time after termination of employment and prior to such time as they cease to be Trade Secrets or Confidential Information through no act of the Executive in violation of this Section.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Upon termination of employment, Executive will surrender to the Company all memoranda, notes, records, plans, manuals or other documents pertaining to the Company&#8217;s business or the Executive&#8217;s employment (including all copies thereof). The Executive will also leave with the Company all materials involving Trade Secrets or Confidential Information of the Company. All such information and materials, whether or not made or developed by the Executive, shall be the sole and exclusive property of the Company, and the Executive hereby assigns to the Company all of the Executive&#8217;s right, title and interest in and to any and all of such information and materials.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Agreement Not to Compete and Agreement Not to Solicit</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The Executive hereby covenants and agrees that, for a period commencing on the Restrictive Covenants Effective Date and ending at the conclusion of the applicable Severance Period (as defined in the Humana Inc. Executive Severance Policy (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;)), the Executive, directly or indirectly, personally, or as an employee, officer, director, partner, member, owner, stockholder, investor or principal of, or consultant or independent contractor with, another entity, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7 &#124; </font><font style="color:#808080;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">shall not participate in any business which competes with the Company including, without limitation, health maintenance organizations, insurance companies or prepaid health plan businesses in which the Company has been actively engaged during any part of the two (2)&#160;year period immediately preceding the Date of Termination  (as defined in the Policy) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Company Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), in any Geographic Area (as defined below) in which the Company and&#47;or any of its Affiliates is then doing business.  For purposes of this Policy, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Geographic Area</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; means any state, commonwealth or territory of the United States or any equivalent entity in any foreign country.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The Executive hereby covenants and agrees that, for a period commencing on the Restrictive Covenants Effective Date and ending at the conclusion of the applicable Severance Period, the Executive, directly or indirectly, personally, or as an employee, officer, director, partner, member, owner, stockholder, investor or principal of, or consultant or independent contractor with, another entity, shall not&#58; (1) interfere with the relationship of the Company and any of its employees, agents, representatives, consultants or advisors&#59; (2) divert, or attempt to cause the diversion from the Company, any Company Business, nor interfere with relationships of the Company with its policyholders, agents, brokers, dealers, distributors, marketers, sources of supply or customers&#59; or (3) solicit, recruit or otherwise induce or influence any employee of the Company to accept employment in any business which competes with the Company Business, in any Geographic Area in which the Company and&#47;or any of its Affiliates is then doing business.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8 &#124; </font><font style="color:#808080;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</font></div></td></tr></table></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>hum-20230331xex31x1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib2667638715241218a56107eb14f4532_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Bruce D. Broussard, principal executive officer of Humana Inc., certify that&#58;</font></div><div style="text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1. I have reviewed this Report of Humana Inc. (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) on Form 10-Q for the period ending March&#160;31, 2023&#59;</font></div><div style="text-indent:24.75pt"><font><br></font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:22.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.474%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 26, 2023</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Bruce D. Broussard</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bruce D. Broussard<br>Principal Executive Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>hum-20230331xex31x2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i971cfef65880467394da5e630d9bda3f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Susan M. Diamond, principal financial officer of Humana Inc., certify that&#58;</font></div><div style="text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1. I have reviewed this Report of Humana Inc. (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) on Form 10-Q for the period ending March&#160;31, 2023&#59;</font></div><div style="text-indent:24.75pt"><font><br></font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:19.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.475%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 26, 2023</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Susan M. Diamond</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Susan M. Diamond<br>Principal Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>hum-20230331xex32.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ief259b1133414628a0bff10fcb36fea5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Report of Humana Inc. (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) on Form 10-Q for the period ending March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Report</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), each of the undersigned hereby certifies, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, in their capacity as an officer of Humana Inc., that&#58;</font></div><div style="text-indent:24.75pt"><font><br></font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:9pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Bruce D. Broussard</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bruce D. Broussard<br>Principal Executive Officer</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 26, 2023</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Susan M. Diamond</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Susan M. Diamond<br>Principal Financial Officer</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 26, 2023</font></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to Humana Inc. and will be retained by Humana Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>hum-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a7548c89-cbcc-4020-9549-0b2a193c2a02,g:7564a905-24e2-4ab4-9ab3-db550d1e5638-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hum="http://www.humana.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.humana.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.humana.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDSIGNIFICANTEVENTS" roleURI="http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTS">
        <link:definition>0000008 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTS" roleURI="http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTS">
        <link:definition>0000009 - Disclosure - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURES" roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES">
        <link:definition>0000010 - Disclosure - ACQUISITIONS AND DIVESTITURES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIES" roleURI="http://www.humana.com/role/INVESTMENTSECURITIES">
        <link:definition>0000011 - Disclosure - INVESTMENT SECURITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUE" roleURI="http://www.humana.com/role/FAIRVALUE">
        <link:definition>0000012 - Disclosure - FAIR VALUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MEDICAREPARTD" roleURI="http://www.humana.com/role/MEDICAREPARTD">
        <link:definition>0000013 - Disclosure - MEDICARE PART D</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>0000014 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BENEFITSPAYABLE" roleURI="http://www.humana.com/role/BENEFITSPAYABLE">
        <link:definition>0000015 - Disclosure - BENEFITS PAYABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERCOMMONSHARECOMPUTATION" roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION">
        <link:definition>0000016 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITY">
        <link:definition>0000017 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.humana.com/role/INCOMETAXES">
        <link:definition>0000018 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.humana.com/role/DEBT">
        <link:definition>0000019 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSGUARANTEESANDCONTINGENCIES" roleURI="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES">
        <link:definition>0000020 - Disclosure - COMMITMENTS, GUARANTEES AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://www.humana.com/role/SEGMENTINFORMATION">
        <link:definition>0000021 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDSIGNIFICANTEVENTSPolicies" roleURI="http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSPolicies">
        <link:definition>0000022 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT EVENTS (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESTables" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESTables">
        <link:definition>0000023 - Disclosure - INVESTMENT SECURITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUETables" roleURI="http://www.humana.com/role/FAIRVALUETables">
        <link:definition>0000024 - Disclosure - FAIR VALUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MEDICAREPARTDTables" roleURI="http://www.humana.com/role/MEDICAREPARTDTables">
        <link:definition>0000025 - Disclosure - MEDICARE PART D (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>0000026 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BENEFITSPAYABLETables" roleURI="http://www.humana.com/role/BENEFITSPAYABLETables">
        <link:definition>0000027 - Disclosure - BENEFITS PAYABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERCOMMONSHARECOMPUTATIONTables" roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables">
        <link:definition>0000028 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>0000029 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://www.humana.com/role/DEBTTables">
        <link:definition>0000030 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.humana.com/role/SEGMENTINFORMATIONTables">
        <link:definition>0000031 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails" roleURI="http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails">
        <link:definition>0000032 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails" roleURI="http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails">
        <link:definition>0000033 - Disclosure - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESDetails" roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails">
        <link:definition>0000034 - Disclosure - ACQUISITIONS AND DIVESTITURES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails">
        <link:definition>0000035 - Disclosure - INVESTMENT SECURITIES - Securities Classified as Current and Long-Term (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESNarrativeDetails" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails">
        <link:definition>0000036 - Disclosure - INVESTMENT SECURITIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails">
        <link:definition>0000037 - Disclosure - INVESTMENT SECURITIES - Gross Unrealized Losses and Fair Values of Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails">
        <link:definition>0000038 - Disclosure - INVESTMENT SECURITIES - Gains (Losses) Within Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails">
        <link:definition>0000039 - Disclosure - INVESTMENT SECURITIES - Gains and Losses Related to Equity Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails">
        <link:definition>0000040 - Disclosure - INVESTMENT SECURITIES - Contractual Maturities of Debt Securities Available for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" roleURI="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails">
        <link:definition>0000041 - Disclosure - FAIR VALUE - Financial Assets Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUENarrativeDetails" roleURI="http://www.humana.com/role/FAIRVALUENarrativeDetails">
        <link:definition>0000042 - Disclosure - FAIR VALUE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUESignificantUnobservableInputsLevel3Details" roleURI="http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details">
        <link:definition>0000043 - Disclosure - FAIR VALUE - Significant Unobservable Inputs (Level 3) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails" roleURI="http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails">
        <link:definition>0000044 - Disclosure - FAIR VALUE - Put and Call Options Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MEDICAREPARTDDetails" roleURI="http://www.humana.com/role/MEDICAREPARTDDetails">
        <link:definition>0000045 - Disclosure - MEDICARE PART D (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails" roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails">
        <link:definition>0000046 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Goodwill by Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails" roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails">
        <link:definition>0000047 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Other Intangible Assets Subject to Amortization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails_1" roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails_1">
        <link:definition>0000047 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Other Intangible Assets Subject to Amortization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails">
        <link:definition>0000048 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails" roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails">
        <link:definition>0000049 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Amortization and Estimated Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BENEFITSPAYABLEActivityinBenefitsPayableDetails" roleURI="http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails">
        <link:definition>0000050 - Disclosure - BENEFITS PAYABLE - Activity in Benefits Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERCOMMONSHARECOMPUTATIONDetails" roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails">
        <link:definition>0000051 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYDividendsDetails" roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYDividendsDetails">
        <link:definition>0000052 - Disclosure - STOCKHOLDERS' EQUITY - Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeDetails" roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails">
        <link:definition>0000053 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.humana.com/role/INCOMETAXESDetails">
        <link:definition>0000054 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTDebtOutstandingDetails" roleURI="http://www.humana.com/role/DEBTDebtOutstandingDetails">
        <link:definition>0000055 - Disclosure - DEBT - Debt Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSeniorNotesDetails" roleURI="http://www.humana.com/role/DEBTSeniorNotesDetails">
        <link:definition>0000056 - Disclosure - DEBT - Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTRevolvingCreditAgreementsDetails" roleURI="http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails">
        <link:definition>0000057 - Disclosure - DEBT - Revolving Credit Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTCommercialPaperandOtherShorttermBorrowingsDetails" roleURI="http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails">
        <link:definition>0000058 - Disclosure - DEBT - Commercial Paper and Other Short-term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSGUARANTEESANDCONTINGENCIESDetails" roleURI="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails">
        <link:definition>0000059 - Disclosure - COMMITMENTS, GUARANTEES AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONNarrativeDetails" roleURI="http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails">
        <link:definition>0000060 - Disclosure - SEGMENT INFORMATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONSegmentResultsDetails" roleURI="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails">
        <link:definition>0000061 - Disclosure - SEGMENT INFORMATION - Segment Results (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member" abstract="true" name="A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_MedicareAdvantageMember" abstract="true" name="MedicareAdvantageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_FairValueRiskMember" abstract="true" name="FairValueRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A450PercentSeniorNotesDueApril2025Member" abstract="true" name="A450PercentSeniorNotesDueApril2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_MedicareStandAlonePrescriptionDrugPlanMember" abstract="true" name="MedicareStandAlonePrescriptionDrugPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_FinancialAssetsFairValueDisclosure" abstract="false" name="FinancialAssetsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_MilitaryServiceMember" abstract="true" name="MilitaryServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_ProviderServicesMember" abstract="true" name="ProviderServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A550PercentSeniorNotesDueMarch2053Member" abstract="true" name="A550PercentSeniorNotesDueMarch2053Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_CmsSubsidiesOrDiscountsMember" abstract="true" name="CmsSubsidiesOrDiscountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A3700PercentSeniorNotesDueMarch2029Member" abstract="true" name="A3700PercentSeniorNotesDueMarch2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_PercentageOfTotalPremiumAndServicesRevenues" abstract="false" name="PercentageOfTotalPremiumAndServicesRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_CommercialFullyInsuredMember" abstract="true" name="CommercialFullyInsuredMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_TermLoanDueOctober2023Member" abstract="true" name="TermLoanDueOctober2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NoncompetesAndOtherMember" abstract="true" name="NoncompetesAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NumberOfTRICAREBeneficiaries" abstract="false" name="NumberOfTRICAREBeneficiaries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_A570PercentSeniorNotesDueMarch2026Member" abstract="true" name="A570PercentSeniorNotesDueMarch2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_InsuranceSegmentMember" abstract="true" name="InsuranceSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A065PercentSeniorNotesDueAugust2023Member" abstract="true" name="A065PercentSeniorNotesDueAugust2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A395PercentSeniorNotesDueAugust2049Member" abstract="true" name="A395PercentSeniorNotesDueAugust2049Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NumberOfStatesComprisingTRICAREBeneficiaries" abstract="false" name="NumberOfStatesComprisingTRICAREBeneficiaries" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_MedicarePartDDisclosureTextBlock" abstract="false" name="MedicarePartDDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_MedicareSupplementProductMember" abstract="true" name="MedicareSupplementProductMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_PharmacySolutionsMember" abstract="true" name="PharmacySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_RevenueExitMultipleMember" abstract="true" name="RevenueExitMultipleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_TermLoanAndCommercialPaperMember" abstract="true" name="TermLoanAndCommercialPaperMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" abstract="false" name="ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hum_BookOverdraftLiability" abstract="false" name="BookOverdraftLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_TRICARE2017EastRegionContractMember" abstract="true" name="TRICARE2017EastRegionContractMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_TRICAREManagedCareSupportContractEffective2024Member" abstract="true" name="TRICAREManagedCareSupportContractEffective2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NetCurrentLiabilityAsset" abstract="false" name="NetCurrentLiabilityAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_GovernmentAndHealthPlanMemberSubsidiesAmount" abstract="false" name="GovernmentAndHealthPlanMemberSubsidiesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_A135PercentSeniorNotesDueFebruary2027Member" abstract="true" name="A135PercentSeniorNotesDueFebruary2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_MedicaidAndOtherMember" abstract="true" name="MedicaidAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_GroupMedicareAdvantageMember" abstract="true" name="GroupMedicareAdvantageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" abstract="false" name="NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_DebtSecuritiesRealizedGainGross" abstract="false" name="DebtSecuritiesRealizedGainGross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_CommercialASOMember" abstract="true" name="CommercialASOMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" abstract="false" name="ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_CorporateAndEliminationsMember" abstract="true" name="CorporateAndEliminationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" abstract="false" name="TRICAREManagedCareSupportContractNumberOfOptionPeriods" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock" abstract="false" name="BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" abstract="false" name="NumberOfTRICAREManagedCareSupportContractBeneficiaries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_CenterWellSegmentMember" abstract="true" name="CenterWellSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A4.625PercentSeniorNotesDueDecember2042Member" abstract="true" name="A4.625PercentSeniorNotesDueDecember2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A4.95PercentSeniorNotesDueOctober2044Member" abstract="true" name="A4.95PercentSeniorNotesDueOctober2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_TRICAREContractDomain" abstract="true" name="TRICAREContractDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DepreciationAndAmortizationIncomeStatement" abstract="false" name="DepreciationAndAmortizationIncomeStatement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_DelayedDrawTermLoanMay2024Member" abstract="true" name="DelayedDrawTermLoanMay2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" abstract="true" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" abstract="false" name="DepreciationAndAmortizationClassifiedAsBenefitExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_A5750PercentSeniorNotesDueMarch2028Member" abstract="true" name="A5750PercentSeniorNotesDueMarch2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_RevolvingCreditAgreementJune2021OneYearMember" abstract="true" name="RevolvingCreditAgreementJune2021OneYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_PaymentsForProceedsFromContractDeposits" abstract="false" name="PaymentsForProceedsFromContractDeposits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" abstract="false" name="PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_MilitaryAndOtherMember" abstract="true" name="MilitaryAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DiscontinuedOperationsSegmentPhaseOutPeriod" abstract="false" name="DiscontinuedOperationsSegmentPhaseOutPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" abstract="false" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" abstract="false" name="NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_SpecialtyBenefitsMember" abstract="true" name="SpecialtyBenefitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A3125PercentSeniorNotesDueAugust2029Member" abstract="true" name="A3125PercentSeniorNotesDueAugust2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A2021ShareRepurchaseAuthorizationMember" abstract="true" name="A2021ShareRepurchaseAuthorizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_TRICAREManagedCareSupportContractTermWithOptionExercises" abstract="false" name="TRICAREManagedCareSupportContractTermWithOptionExercises" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" abstract="false" name="NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_RiskCorridorSettlementsMedicarePartDMember" abstract="true" name="RiskCorridorSettlementsMedicarePartDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_DelayedDrawTermLoanMember" abstract="true" name="DelayedDrawTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_CertificateOfNeedMember" abstract="true" name="CertificateOfNeedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_HomeSolutionsMember" abstract="true" name="HomeSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A3.95PercentSeniorNotesDueMarch2027Member" abstract="true" name="A3.95PercentSeniorNotesDueMarch2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" abstract="false" name="DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_LineOfCreditFacilityUncommittedIncrementalCapacity" abstract="false" name="LineOfCreditFacilityUncommittedIncrementalCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" abstract="false" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_A4.80PercentSeniorNotesDueMarch2047Member" abstract="true" name="A4.80PercentSeniorNotesDueMarch2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NetNoncurrentAssetLiability" abstract="false" name="NetNoncurrentAssetLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_A4875PercentSeniorNotesDueApril2030Member" abstract="true" name="A4875PercentSeniorNotesDueApril2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_MedicaidMember" abstract="true" name="MedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NetAssetLiability" abstract="false" name="NetAssetLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_A2023ShareRepurchaseAuthorizationMember" abstract="true" name="A2023ShareRepurchaseAuthorizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DebtSecuritiesRealizedLossGross" abstract="false" name="DebtSecuritiesRealizedLossGross" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_MedicareMember" abstract="true" name="MedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" abstract="false" name="DebtInstrumentCovenantDebtToCapitalizationPercentageActual" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_RevolvingCreditAgreementJune2021FiveYearMember" abstract="true" name="RevolvingCreditAgreementJune2021FiveYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" abstract="false" name="MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_GentivaHospiceMember" abstract="true" name="GentivaHospiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A588PercentSeniorNotesDueMarch2033Member" abstract="true" name="A588PercentSeniorNotesDueMarch2033Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" abstract="false" name="DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_A8.15PercentSeniorNotesDueJune2038Member" abstract="true" name="A8.15PercentSeniorNotesDueJune2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_TRICAREManagedCareSupportContractBaseTerm" abstract="false" name="TRICAREManagedCareSupportContractBaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_A3.85PercentSeniorNotesDueOctober2024Member" abstract="true" name="A3.85PercentSeniorNotesDueOctober2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_ValueCreationInitiativesMember" abstract="true" name="ValueCreationInitiativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_TRICAREContractAxis" abstract="true" name="TRICAREContractAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="hum_A215PercentSeniorNotesDueFebruary2032Member" abstract="true" name="A215PercentSeniorNotesDueFebruary2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>hum-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a7548c89-cbcc-4020-9549-0b2a193c2a02,g:7564a905-24e2-4ab4-9ab3-db550d1e5638-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="hum-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8bfcf4fb-7c83-4ff5-b654-bd0ac5056cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fd620615-aac8-4348-88a2-09ba7bf02512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8bfcf4fb-7c83-4ff5-b654-bd0ac5056cc8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fd620615-aac8-4348-88a2-09ba7bf02512" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_ba77f859-4ce5-42f8-a89c-673c3b5b7eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8bfcf4fb-7c83-4ff5-b654-bd0ac5056cc8" xlink:to="loc_us-gaap_TreasuryStockCommonValue_ba77f859-4ce5-42f8-a89c-673c3b5b7eb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5f6ec738-48b2-4c30-a84c-5e803a434848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8bfcf4fb-7c83-4ff5-b654-bd0ac5056cc8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5f6ec738-48b2-4c30-a84c-5e803a434848" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_183ce115-b5d9-4e03-90f9-3c13398651e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8bfcf4fb-7c83-4ff5-b654-bd0ac5056cc8" xlink:to="loc_us-gaap_CommonStockValue_183ce115-b5d9-4e03-90f9-3c13398651e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_644ef6ad-2b4c-4c42-b4ce-b05087bdb644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8bfcf4fb-7c83-4ff5-b654-bd0ac5056cc8" xlink:to="loc_us-gaap_PreferredStockValue_644ef6ad-2b4c-4c42-b4ce-b05087bdb644" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_2a763432-0afd-4610-8596-cf8c65aa6210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8bfcf4fb-7c83-4ff5-b654-bd0ac5056cc8" xlink:to="loc_us-gaap_MinorityInterest_2a763432-0afd-4610-8596-cf8c65aa6210" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6631bc7b-2c98-4ffa-9295-da62b37c4f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8bfcf4fb-7c83-4ff5-b654-bd0ac5056cc8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6631bc7b-2c98-4ffa-9295-da62b37c4f0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ab95df1a-350e-4ac0-a1bc-33a295463d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_160bda26-c076-4527-88fc-de98eb8c93c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ab95df1a-350e-4ac0-a1bc-33a295463d7e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_160bda26-c076-4527-88fc-de98eb8c93c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_573a452a-4cec-47e7-aaa4-669c230c7469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ab95df1a-350e-4ac0-a1bc-33a295463d7e" xlink:to="loc_us-gaap_Goodwill_573a452a-4cec-47e7-aaa4-669c230c7469" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4461f197-b1d4-4450-9ed9-3469ab836aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ab95df1a-350e-4ac0-a1bc-33a295463d7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4461f197-b1d4-4450-9ed9-3469ab836aa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_8244bafd-669a-46c5-b41c-6ad75d1f57a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ab95df1a-350e-4ac0-a1bc-33a295463d7e" xlink:to="loc_us-gaap_EquityMethodInvestments_8244bafd-669a-46c5-b41c-6ad75d1f57a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e37707d0-3029-4a37-aa53-e573bb6e7756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ab95df1a-350e-4ac0-a1bc-33a295463d7e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e37707d0-3029-4a37-aa53-e573bb6e7756" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1d5947db-deb1-474b-b312-5961a838d1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ab95df1a-350e-4ac0-a1bc-33a295463d7e" xlink:to="loc_us-gaap_AssetsCurrent_1d5947db-deb1-474b-b312-5961a838d1cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_678b7dbc-f9c6-4f71-bcfb-f7d68d68d711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_800fb36c-d148-43be-ae33-c43095cb34da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_678b7dbc-f9c6-4f71-bcfb-f7d68d68d711" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_800fb36c-d148-43be-ae33-c43095cb34da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_1d9328e7-3e22-4a43-9cf0-4932c84e81dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_678b7dbc-f9c6-4f71-bcfb-f7d68d68d711" xlink:to="loc_us-gaap_DebtCurrent_1d9328e7-3e22-4a43-9cf0-4932c84e81dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BookOverdraftLiability_3a502a67-5952-46ef-91d9-adda608ebd28" xlink:href="hum-20230331.xsd#hum_BookOverdraftLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_678b7dbc-f9c6-4f71-bcfb-f7d68d68d711" xlink:to="loc_hum_BookOverdraftLiability_3a502a67-5952-46ef-91d9-adda608ebd28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_e54274ad-6888-46e0-8f37-58e15a1d5251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_678b7dbc-f9c6-4f71-bcfb-f7d68d68d711" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_e54274ad-6888-46e0-8f37-58e15a1d5251" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_87764801-4cdf-481c-8a01-bbf54110f586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_678b7dbc-f9c6-4f71-bcfb-f7d68d68d711" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_87764801-4cdf-481c-8a01-bbf54110f586" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e69b31bb-784f-4a50-abc8-4f2d272fc4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_fa8dd0b5-92a8-4215-9bf2-fc4ff08e11fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e69b31bb-784f-4a50-abc8-4f2d272fc4fa" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_fa8dd0b5-92a8-4215-9bf2-fc4ff08e11fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cb24be7e-4b81-4b27-b9ea-c4253d98e05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e69b31bb-784f-4a50-abc8-4f2d272fc4fa" xlink:to="loc_us-gaap_LiabilitiesCurrent_cb24be7e-4b81-4b27-b9ea-c4253d98e05d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e5525411-1e2f-4b3c-b467-7262b46613a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e69b31bb-784f-4a50-abc8-4f2d272fc4fa" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e5525411-1e2f-4b3c-b467-7262b46613a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a5f09a69-f57a-47a1-b5e3-ab92b4fd3483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_d9e9ff90-d8b7-4036-bb61-7a1a55ab45e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a5f09a69-f57a-47a1-b5e3-ab92b4fd3483" xlink:to="loc_us-gaap_OtherAssetsCurrent_d9e9ff90-d8b7-4036-bb61-7a1a55ab45e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_bd5b5947-f0f7-42ee-8bcb-55442a272cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a5f09a69-f57a-47a1-b5e3-ab92b4fd3483" xlink:to="loc_us-gaap_ShortTermInvestments_bd5b5947-f0f7-42ee-8bcb-55442a272cd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3724f6e1-19e5-485a-92d0-b364cfa4d26d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a5f09a69-f57a-47a1-b5e3-ab92b4fd3483" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3724f6e1-19e5-485a-92d0-b364cfa4d26d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_a058a1d3-2d55-4027-bf9b-ffb20ef26322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a5f09a69-f57a-47a1-b5e3-ab92b4fd3483" xlink:to="loc_us-gaap_ReceivablesNetCurrent_a058a1d3-2d55-4027-bf9b-ffb20ef26322" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_820bfc15-bf08-47c9-9463-cb2d2c08dbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_27b1114f-63f9-4393-9e0e-df7e8492474a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_820bfc15-bf08-47c9-9463-cb2d2c08dbe6" xlink:to="loc_us-gaap_Liabilities_27b1114f-63f9-4393-9e0e-df7e8492474a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_372381f2-b5c4-49d7-bb34-0415147dc795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_820bfc15-bf08-47c9-9463-cb2d2c08dbe6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_372381f2-b5c4-49d7-bb34-0415147dc795" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4c996540-7b1a-4b94-9d5a-b64265722c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5d5ddb68-433b-4de6-82f0-23d23326f83c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4c996540-7b1a-4b94-9d5a-b64265722c0a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5d5ddb68-433b-4de6-82f0-23d23326f83c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_d7240915-af25-41e1-a852-a00ce82293b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4c996540-7b1a-4b94-9d5a-b64265722c0a" xlink:to="loc_us-gaap_TreasuryStockCommonValue_d7240915-af25-41e1-a852-a00ce82293b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_afc48d7e-d4bb-40e9-9b80-2831f768e113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4c996540-7b1a-4b94-9d5a-b64265722c0a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_afc48d7e-d4bb-40e9-9b80-2831f768e113" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a30f594b-f220-423a-8589-d31ae37531da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4c996540-7b1a-4b94-9d5a-b64265722c0a" xlink:to="loc_us-gaap_CommonStockValue_a30f594b-f220-423a-8589-d31ae37531da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_67e90902-24e6-4f43-86e9-b0d174d7810c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4c996540-7b1a-4b94-9d5a-b64265722c0a" xlink:to="loc_us-gaap_PreferredStockValue_67e90902-24e6-4f43-86e9-b0d174d7810c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ee093f2b-610c-42e3-ab9e-cd40401e5d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4c996540-7b1a-4b94-9d5a-b64265722c0a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ee093f2b-610c-42e3-ab9e-cd40401e5d74" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="hum-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_71f20cb8-99c9-4a6b-bcc9-94f08db97c25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_75304a49-c330-4f89-9307-2283b9b8738c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_71f20cb8-99c9-4a6b-bcc9-94f08db97c25" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_75304a49-c330-4f89-9307-2283b9b8738c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0b8ab614-d0ef-413b-9851-6cf5fbad924d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_71f20cb8-99c9-4a6b-bcc9-94f08db97c25" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0b8ab614-d0ef-413b-9851-6cf5fbad924d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5dacc791-faac-4381-8bd2-18d7d47a96ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_71f20cb8-99c9-4a6b-bcc9-94f08db97c25" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5dacc791-faac-4381-8bd2-18d7d47a96ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2676987a-f40d-43c5-9190-69f1b8b811b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f29dba23-b423-40f7-b241-a66df7f4828e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2676987a-f40d-43c5-9190-69f1b8b811b4" xlink:to="loc_us-gaap_OperatingIncomeLoss_f29dba23-b423-40f7-b241-a66df7f4828e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6db7074a-c771-4197-b6a1-30f78f59966f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2676987a-f40d-43c5-9190-69f1b8b811b4" xlink:to="loc_us-gaap_InterestExpense_6db7074a-c771-4197-b6a1-30f78f59966f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3d3576bf-e708-458a-9d30-d1d088718b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2676987a-f40d-43c5-9190-69f1b8b811b4" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3d3576bf-e708-458a-9d30-d1d088718b51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9db85bce-6fe9-4c04-9012-1a091cab63b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_40a7a797-1727-4373-a0ec-da0718e86d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_9db85bce-6fe9-4c04-9012-1a091cab63b2" xlink:to="loc_us-gaap_PremiumsEarnedNet_40a7a797-1727-4373-a0ec-da0718e86d97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_e8bbda06-7e07-4389-b642-d6a5223c9cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_9db85bce-6fe9-4c04-9012-1a091cab63b2" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_e8bbda06-7e07-4389-b642-d6a5223c9cfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_29acacde-24c5-4435-8fee-0e1b697caccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_9db85bce-6fe9-4c04-9012-1a091cab63b2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_29acacde-24c5-4435-8fee-0e1b697caccc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6c5119c0-e5ef-4c30-8d24-5ae9ba4f6003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5ae81990-44e8-4c5a-89e8-2d613a22f09f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6c5119c0-e5ef-4c30-8d24-5ae9ba4f6003" xlink:to="loc_us-gaap_Revenues_5ae81990-44e8-4c5a-89e8-2d613a22f09f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_1717e302-0c0d-4b2e-b6b8-9e74006a8704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6c5119c0-e5ef-4c30-8d24-5ae9ba4f6003" xlink:to="loc_us-gaap_BenefitsLossesAndExpenses_1717e302-0c0d-4b2e-b6b8-9e74006a8704" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_d0fcc526-9efd-4968-97b3-c5b4d434926f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8bfe823b-a978-426d-8039-08df8c475a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_d0fcc526-9efd-4968-97b3-c5b4d434926f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8bfe823b-a978-426d-8039-08df8c475a69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_9f008aed-4846-4d8f-8d4d-fd552f5683b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_d0fcc526-9efd-4968-97b3-c5b4d434926f" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_9f008aed-4846-4d8f-8d4d-fd552f5683b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationIncomeStatement_a4339985-c10c-4cf2-87f4-388e3fc1655c" xlink:href="hum-20230331.xsd#hum_DepreciationAndAmortizationIncomeStatement"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_d0fcc526-9efd-4968-97b3-c5b4d434926f" xlink:to="loc_hum_DepreciationAndAmortizationIncomeStatement_a4339985-c10c-4cf2-87f4-388e3fc1655c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7fc85801-c432-4cd7-a007-03938d9ad0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_48deabe0-85f1-4230-a020-e8d8559692ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7fc85801-c432-4cd7-a007-03938d9ad0ba" xlink:to="loc_us-gaap_ProfitLoss_48deabe0-85f1-4230-a020-e8d8559692ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_650abfd3-6adb-41b6-a93d-80b0fcd625e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7fc85801-c432-4cd7-a007-03938d9ad0ba" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_650abfd3-6adb-41b6-a93d-80b0fcd625e2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="hum-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_cd6a202f-1e4b-4993-90f1-e3fa062f4513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_25779317-3b5f-4299-b156-34d5f2acc631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cd6a202f-1e4b-4993-90f1-e3fa062f4513" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_25779317-3b5f-4299-b156-34d5f2acc631" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_26445fcb-3000-470d-993b-ff4dd92b8af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cd6a202f-1e4b-4993-90f1-e3fa062f4513" xlink:to="loc_us-gaap_NetIncomeLoss_26445fcb-3000-470d-993b-ff4dd92b8af6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6f8df727-8a95-4a81-8542-c71756da347d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_04fbae4f-216d-4f34-bb09-3acd3fdbc573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6f8df727-8a95-4a81-8542-c71756da347d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_04fbae4f-216d-4f34-bb09-3acd3fdbc573" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_11b5f8ec-a141-4cf1-bbbe-2db8a74ce4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6f8df727-8a95-4a81-8542-c71756da347d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_11b5f8ec-a141-4cf1-bbbe-2db8a74ce4b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_88695fdc-7565-41ed-81f0-4003d73531bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_958c79da-584a-416d-a7b5-388b780c83eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_88695fdc-7565-41ed-81f0-4003d73531bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_958c79da-584a-416d-a7b5-388b780c83eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_4efcee71-89fa-4442-9cde-d642faa67d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_88695fdc-7565-41ed-81f0-4003d73531bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_4efcee71-89fa-4442-9cde-d642faa67d9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_759f74b0-212b-4bd8-956a-7e1aa0bc9b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_dc7a353d-c7a7-4460-a449-327e9b901c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_759f74b0-212b-4bd8-956a-7e1aa0bc9b46" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_dc7a353d-c7a7-4460-a449-327e9b901c1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_a371da28-06ec-4ab2-adc5-a8682c0f155a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_759f74b0-212b-4bd8-956a-7e1aa0bc9b46" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_a371da28-06ec-4ab2-adc5-a8682c0f155a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="hum-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b8eb4995-dde7-4ce1-9418-386919a11b97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0abd2562-74bd-41a9-aabd-e4ca3d5e7e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b8eb4995-dde7-4ce1-9418-386919a11b97" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0abd2562-74bd-41a9-aabd-e4ca3d5e7e48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_eefeaceb-f9d4-47da-8f66-ef7e56607316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b8eb4995-dde7-4ce1-9418-386919a11b97" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_eefeaceb-f9d4-47da-8f66-ef7e56607316" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_67503848-e0ee-4789-b79d-4e4b8eabcc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b8eb4995-dde7-4ce1-9418-386919a11b97" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_67503848-e0ee-4789-b79d-4e4b8eabcc7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_a9a9093c-c8dd-435e-96bd-b9665aa41ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b8eb4995-dde7-4ce1-9418-386919a11b97" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_a9a9093c-c8dd-435e-96bd-b9665aa41ce3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8da5f6da-a124-4529-aa79-a16d573b26ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b8eb4995-dde7-4ce1-9418-386919a11b97" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8da5f6da-a124-4529-aa79-a16d573b26ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42adffb1-9046-48ad-8537-e42f2409ac66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ee9b1deb-f015-4b27-8a34-2c593a51877f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42adffb1-9046-48ad-8537-e42f2409ac66" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ee9b1deb-f015-4b27-8a34-2c593a51877f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3f349ca1-6d8a-4d51-8e76-52e5d7372262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42adffb1-9046-48ad-8537-e42f2409ac66" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3f349ca1-6d8a-4d51-8e76-52e5d7372262" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_94ba7ef5-69cc-404b-a1e1-0fcb462ed4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42adffb1-9046-48ad-8537-e42f2409ac66" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_94ba7ef5-69cc-404b-a1e1-0fcb462ed4b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_eeb98ca7-7a3f-4aac-92b8-2e1239be157b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42adffb1-9046-48ad-8537-e42f2409ac66" xlink:to="loc_us-gaap_AdjustmentForAmortization_eeb98ca7-7a3f-4aac-92b8-2e1239be157b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_6f09f878-e029-4bee-9f25-180f781b8af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42adffb1-9046-48ad-8537-e42f2409ac66" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_6f09f878-e029-4bee-9f25-180f781b8af9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ed81bd8a-5c73-46b7-80d8-e6d3cbd2ec7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42adffb1-9046-48ad-8537-e42f2409ac66" xlink:to="loc_us-gaap_ProfitLoss_ed81bd8a-5c73-46b7-80d8-e6d3cbd2ec7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_9cccb0e1-6bf6-4a64-9c1b-adeffb84968b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42adffb1-9046-48ad-8537-e42f2409ac66" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_9cccb0e1-6bf6-4a64-9c1b-adeffb84968b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6d8b2afc-c607-44f6-9975-748c53f949ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42adffb1-9046-48ad-8537-e42f2409ac66" xlink:to="loc_us-gaap_ShareBasedCompensation_6d8b2afc-c607-44f6-9975-748c53f949ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_546e834d-08e2-4d5c-8ac1-3afa51d325cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42adffb1-9046-48ad-8537-e42f2409ac66" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_546e834d-08e2-4d5c-8ac1-3afa51d325cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_a5a54ca8-3e74-4311-8944-fc27dd49c13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42adffb1-9046-48ad-8537-e42f2409ac66" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_a5a54ca8-3e74-4311-8944-fc27dd49c13a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_5c4a4895-8e59-40f3-8c53-feacd9c3e0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42adffb1-9046-48ad-8537-e42f2409ac66" xlink:to="loc_us-gaap_Depreciation_5c4a4895-8e59-40f3-8c53-feacd9c3e0c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_d5df73df-dd5b-484d-a0e4-cbdde7be1b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42adffb1-9046-48ad-8537-e42f2409ac66" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_d5df73df-dd5b-484d-a0e4-cbdde7be1b4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5e36dc94-f341-4808-b773-becf369dbd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc50bbc7-b855-4644-85dc-58ace5c21c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5e36dc94-f341-4808-b773-becf369dbd24" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc50bbc7-b855-4644-85dc-58ace5c21c7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e4773397-027f-45ac-9f17-44b0cf6b5f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5e36dc94-f341-4808-b773-becf369dbd24" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e4773397-027f-45ac-9f17-44b0cf6b5f27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dfc4f3ac-b64d-43ff-8736-77ec3c4b711d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5e36dc94-f341-4808-b773-becf369dbd24" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dfc4f3ac-b64d-43ff-8736-77ec3c4b711d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3fd1eb9-ff18-4ffe-9fd2-3e34699ceb57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PaymentsForProceedsFromContractDeposits_85755501-f1cd-4f6b-8982-abb5f3c8d0e0" xlink:href="hum-20230331.xsd#hum_PaymentsForProceedsFromContractDeposits"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3fd1eb9-ff18-4ffe-9fd2-3e34699ceb57" xlink:to="loc_hum_PaymentsForProceedsFromContractDeposits_85755501-f1cd-4f6b-8982-abb5f3c8d0e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_68bbaae1-f71f-41ff-827d-ea2997624bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3fd1eb9-ff18-4ffe-9fd2-3e34699ceb57" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_68bbaae1-f71f-41ff-827d-ea2997624bc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f3f07ea0-dd45-47e7-9af5-9867eff67027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3fd1eb9-ff18-4ffe-9fd2-3e34699ceb57" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f3f07ea0-dd45-47e7-9af5-9867eff67027" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_05537067-7904-4e34-a2d3-aeaa16cd80ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3fd1eb9-ff18-4ffe-9fd2-3e34699ceb57" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_05537067-7904-4e34-a2d3-aeaa16cd80ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_776b269f-c2f1-49da-8090-090e5447f44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3fd1eb9-ff18-4ffe-9fd2-3e34699ceb57" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_776b269f-c2f1-49da-8090-090e5447f44e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_467fdc1c-46ba-4c7f-8f53-474a2af6f1db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3fd1eb9-ff18-4ffe-9fd2-3e34699ceb57" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_467fdc1c-46ba-4c7f-8f53-474a2af6f1db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_c833751e-796c-4757-8ca7-e733581a0748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3fd1eb9-ff18-4ffe-9fd2-3e34699ceb57" xlink:to="loc_us-gaap_PaymentsOfDividends_c833751e-796c-4757-8ca7-e733581a0748" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInBookOverdrafts_d1d6ed85-a292-4722-b00c-106282486c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInBookOverdrafts"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3fd1eb9-ff18-4ffe-9fd2-3e34699ceb57" xlink:to="loc_us-gaap_IncreaseDecreaseInBookOverdrafts_d1d6ed85-a292-4722-b00c-106282486c31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_27323f85-2c09-4be7-a928-f9deb35d9e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3fd1eb9-ff18-4ffe-9fd2-3e34699ceb57" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_27323f85-2c09-4be7-a928-f9deb35d9e8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_5ea4fb62-c83c-45ff-a894-ce47911f4db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3fd1eb9-ff18-4ffe-9fd2-3e34699ceb57" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_5ea4fb62-c83c-45ff-a894-ce47911f4db3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dde23d24-6842-4f79-b0d1-b3a5ab2391d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_705137de-bf2b-4534-a129-0ab9499801b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dde23d24-6842-4f79-b0d1-b3a5ab2391d6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_705137de-bf2b-4534-a129-0ab9499801b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5715505e-09cc-4793-b3b5-38b5c1b17608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dde23d24-6842-4f79-b0d1-b3a5ab2391d6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5715505e-09cc-4793-b3b5-38b5c1b17608" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ecb9a019-323d-406d-8921-7f3775e5c822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dde23d24-6842-4f79-b0d1-b3a5ab2391d6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ecb9a019-323d-406d-8921-7f3775e5c822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_56c50418-54ae-427d-883b-01408465d30b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a7c700b6-6aa7-47c3-ab60-8b8ec189be50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_56c50418-54ae-427d-883b-01408465d30b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a7c700b6-6aa7-47c3-ab60-8b8ec189be50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_ec874ba8-1dad-4741-8c7b-a185eaa9eba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_56c50418-54ae-427d-883b-01408465d30b" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_ec874ba8-1dad-4741-8c7b-a185eaa9eba3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_22f75e19-c82f-41d3-a4f1-77325bb6c3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_93b74f5a-97b7-4585-be68-75b6d993ce75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_22f75e19-c82f-41d3-a4f1-77325bb6c3e1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_93b74f5a-97b7-4585-be68-75b6d993ce75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e090a491-8c71-4f0c-973d-93f6fb393ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_22f75e19-c82f-41d3-a4f1-77325bb6c3e1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e090a491-8c71-4f0c-973d-93f6fb393ab0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_4e607b39-eb56-4312-b4f9-09ee0dcfbedf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_cc300856-1e08-4ada-8477-49c9926ac912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_4e607b39-eb56-4312-b4f9-09ee0dcfbedf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_cc300856-1e08-4ada-8477-49c9926ac912" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_9261f14e-7a37-438d-a0b6-11750675f620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_4e607b39-eb56-4312-b4f9-09ee0dcfbedf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_9261f14e-7a37-438d-a0b6-11750675f620" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_a565c6b5-4a03-4e08-abe9-047ef0696d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtSecuritiesRealizedGainGross_a6d01bca-bb45-4400-a6a3-bca80e9ffdc9" xlink:href="hum-20230331.xsd#hum_DebtSecuritiesRealizedGainGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_a565c6b5-4a03-4e08-abe9-047ef0696d31" xlink:to="loc_hum_DebtSecuritiesRealizedGainGross_a6d01bca-bb45-4400-a6a3-bca80e9ffdc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtSecuritiesRealizedLossGross_fcc26b56-699d-4e9b-9cb5-5c4dc3434a3f" xlink:href="hum-20230331.xsd#hum_DebtSecuritiesRealizedLossGross"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_a565c6b5-4a03-4e08-abe9-047ef0696d31" xlink:to="loc_hum_DebtSecuritiesRealizedLossGross_fcc26b56-699d-4e9b-9cb5-5c4dc3434a3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_ed4d2da2-e5a4-4092-9538-67740acf216c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_a565c6b5-4a03-4e08-abe9-047ef0696d31" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_ed4d2da2-e5a4-4092-9538-67740acf216c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_38a3218a-db91-45cc-bf96-0f8f4c421a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_a565c6b5-4a03-4e08-abe9-047ef0696d31" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_38a3218a-db91-45cc-bf96-0f8f4c421a9c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a5d372cf-bcb0-42ff-ad4f-bd0deb9736f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_2ac12a2b-19d3-4bcf-9a65-66f328b8651c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a5d372cf-bcb0-42ff-ad4f-bd0deb9736f0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_2ac12a2b-19d3-4bcf-9a65-66f328b8651c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_0663f288-f2ba-4398-af22-f493212481ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a5d372cf-bcb0-42ff-ad4f-bd0deb9736f0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_0663f288-f2ba-4398-af22-f493212481ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6abfaf2f-9276-4a58-aab4-7b3f6e654d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0dd1c3a1-1380-42d3-83a3-a75fa01d363d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6abfaf2f-9276-4a58-aab4-7b3f6e654d57" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0dd1c3a1-1380-42d3-83a3-a75fa01d363d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_748f2f2a-c629-412f-936d-57b4fd815492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6abfaf2f-9276-4a58-aab4-7b3f6e654d57" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_748f2f2a-c629-412f-936d-57b4fd815492" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_03c7ce1f-da6d-4193-bac2-66f210ee269b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6abfaf2f-9276-4a58-aab4-7b3f6e654d57" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_03c7ce1f-da6d-4193-bac2-66f210ee269b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_d917bea4-9155-46c2-99ab-6fdad1430d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6abfaf2f-9276-4a58-aab4-7b3f6e654d57" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_d917bea4-9155-46c2-99ab-6fdad1430d5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_5eb7c397-4577-4418-a59f-0c82c7a6fb15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6abfaf2f-9276-4a58-aab4-7b3f6e654d57" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_5eb7c397-4577-4418-a59f-0c82c7a6fb15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_03560b8a-af40-41e3-97b9-a3c1893ba378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_14f7285e-c85d-482d-a11b-e7bdc2b1529d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_03560b8a-af40-41e3-97b9-a3c1893ba378" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_14f7285e-c85d-482d-a11b-e7bdc2b1529d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_7c131290-9ae1-459d-af28-060f1ebf9339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_03560b8a-af40-41e3-97b9-a3c1893ba378" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_7c131290-9ae1-459d-af28-060f1ebf9339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_9f25b0b3-575c-4075-a848-d3c87fb6da48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_03560b8a-af40-41e3-97b9-a3c1893ba378" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_9f25b0b3-575c-4075-a848-d3c87fb6da48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_066ba014-9258-4262-8f3e-ef7de39c69f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_03560b8a-af40-41e3-97b9-a3c1893ba378" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_066ba014-9258-4262-8f3e-ef7de39c69f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_9dbc125b-3ca8-48da-ad0a-2ff1d153c8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_03560b8a-af40-41e3-97b9-a3c1893ba378" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_9dbc125b-3ca8-48da-ad0a-2ff1d153c8ee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_499ba2c9-0cef-40e9-91cc-df8c1de1d34b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_69a90312-d332-4276-baa6-e4401a0a5461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_499ba2c9-0cef-40e9-91cc-df8c1de1d34b" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_69a90312-d332-4276-baa6-e4401a0a5461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9e8730c4-6a35-40ad-84d6-1a4dce302f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_499ba2c9-0cef-40e9-91cc-df8c1de1d34b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9e8730c4-6a35-40ad-84d6-1a4dce302f13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_c7d39d34-9b59-47e4-b89a-8d8785201d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_499ba2c9-0cef-40e9-91cc-df8c1de1d34b" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_c7d39d34-9b59-47e4-b89a-8d8785201d1b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/MEDICAREPARTDDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#MEDICAREPARTDDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/MEDICAREPARTDDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetCurrentLiabilityAsset_573f8903-6e3d-4906-b815-3c8bb57c6614" xlink:href="hum-20230331.xsd#hum_NetCurrentLiabilityAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a280573f-544b-4fd9-942a-1a471bcfd942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_NetCurrentLiabilityAsset_573f8903-6e3d-4906-b815-3c8bb57c6614" xlink:to="loc_us-gaap_OtherAssetsCurrent_a280573f-544b-4fd9-942a-1a471bcfd942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b3232949-2c98-4455-8d7a-054525d3c16d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_NetCurrentLiabilityAsset_573f8903-6e3d-4906-b815-3c8bb57c6614" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b3232949-2c98-4455-8d7a-054525d3c16d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetNoncurrentAssetLiability_5e669f13-38ac-4e33-ae7f-ba07e7063918" xlink:href="hum-20230331.xsd#hum_NetNoncurrentAssetLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bcce6f4a-0179-4956-85f0-b965521ac7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_NetNoncurrentAssetLiability_5e669f13-38ac-4e33-ae7f-ba07e7063918" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bcce6f4a-0179-4956-85f0-b965521ac7b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1994d083-5daf-46e8-bfcf-30ec296b93f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_NetNoncurrentAssetLiability_5e669f13-38ac-4e33-ae7f-ba07e7063918" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1994d083-5daf-46e8-bfcf-30ec296b93f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetAssetLiability_c3dff4ac-8a40-44a2-ad7c-ce0c1e09d8e2" xlink:href="hum-20230331.xsd#hum_NetAssetLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetCurrentLiabilityAsset_72091d19-b68d-4cdc-ba7f-4473c1b6629f" xlink:href="hum-20230331.xsd#hum_NetCurrentLiabilityAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_NetAssetLiability_c3dff4ac-8a40-44a2-ad7c-ce0c1e09d8e2" xlink:to="loc_hum_NetCurrentLiabilityAsset_72091d19-b68d-4cdc-ba7f-4473c1b6629f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetNoncurrentAssetLiability_8998e40f-d5a1-4186-aeaf-07bed9acf661" xlink:href="hum-20230331.xsd#hum_NetNoncurrentAssetLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_NetAssetLiability_c3dff4ac-8a40-44a2-ad7c-ce0c1e09d8e2" xlink:to="loc_hum_NetNoncurrentAssetLiability_8998e40f-d5a1-4186-aeaf-07bed9acf661" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a232742e-022a-422e-b6d3-2e9cb0bb6207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a6d60eb8-81ad-4ae0-8c55-6dac16399cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a232742e-022a-422e-b6d3-2e9cb0bb6207" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a6d60eb8-81ad-4ae0-8c55-6dac16399cf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_be4535a8-55a0-4d9e-a33e-4f83d5534d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a232742e-022a-422e-b6d3-2e9cb0bb6207" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_be4535a8-55a0-4d9e-a33e-4f83d5534d56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5578c929-a959-4037-9e40-874cae7ca9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4502819d-280c-4d50-9182-19ee49a9304a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5578c929-a959-4037-9e40-874cae7ca9d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4502819d-280c-4d50-9182-19ee49a9304a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_de3a4542-5a92-4745-a6ac-2f0ca520e5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5578c929-a959-4037-9e40-874cae7ca9d5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_de3a4542-5a92-4745-a6ac-2f0ca520e5ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_82841ff2-dc83-4cf2-9735-4cdce225994c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0d12e6d7-b4e8-4f99-a628-8c6da2bcc3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_82841ff2-dc83-4cf2-9735-4cdce225994c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0d12e6d7-b4e8-4f99-a628-8c6da2bcc3b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_573d654e-85eb-4ca5-ad16-ba6063af0ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_82841ff2-dc83-4cf2-9735-4cdce225994c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_573d654e-85eb-4ca5-ad16-ba6063af0ed7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails_1" xlink:type="simple" xlink:href="hum-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails_1"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6d47c271-b342-4c53-92f5-ab4499f51592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c14c7a16-83fd-45f2-b527-51e95796d116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6d47c271-b342-4c53-92f5-ab4499f51592" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c14c7a16-83fd-45f2-b527-51e95796d116" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e121a341-085b-4118-a961-a85fade9d8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6d47c271-b342-4c53-92f5-ab4499f51592" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e121a341-085b-4118-a961-a85fade9d8e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#BENEFITSPAYABLEActivityinBenefitsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_c4a290d8-a4a3-47be-9279-05d853efc31b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_b5e0f34b-1fea-4175-bac5-d9b7f9de8d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_c4a290d8-a4a3-47be-9279-05d853efc31b" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_b5e0f34b-1fea-4175-bac5-d9b7f9de8d19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_759d9f36-3f6f-4074-b1f7-c23f153bfa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_c4a290d8-a4a3-47be-9279-05d853efc31b" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_759d9f36-3f6f-4074-b1f7-c23f153bfa2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_0659f9b0-4ebf-43ff-817a-fc51cc809998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_370e81a9-7407-496c-b2e5-d1bedc3927f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_0659f9b0-4ebf-43ff-817a-fc51cc809998" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_370e81a9-7407-496c-b2e5-d1bedc3927f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_f00f8aef-c192-4985-9af6-0efc8c1f0d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_0659f9b0-4ebf-43ff-817a-fc51cc809998" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_f00f8aef-c192-4985-9af6-0efc8c1f0d99" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#EARNINGSPERCOMMONSHARECOMPUTATIONDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9a759c2a-fa04-4dbd-952d-7b5d0a57cdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0dbc5b39-7ba2-4d40-9ced-04f386529fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9a759c2a-fa04-4dbd-952d-7b5d0a57cdd8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0dbc5b39-7ba2-4d40-9ced-04f386529fea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_66900df1-bc26-4300-aacd-e1b8dba41096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9a759c2a-fa04-4dbd-952d-7b5d0a57cdd8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_66900df1-bc26-4300-aacd-e1b8dba41096" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTDebtOutstandingDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#DEBTDebtOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/DEBTDebtOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_c1e991ea-58d9-4d7b-b7d0-e5a86c412920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_40ee93b4-65f2-48b6-8fbb-0ed8b76c0125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_c1e991ea-58d9-4d7b-b7d0-e5a86c412920" xlink:to="loc_us-gaap_LongTermDebtCurrent_40ee93b4-65f2-48b6-8fbb-0ed8b76c0125" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_b692bfa5-92b2-4cd8-96b8-65cecd6fda2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_c1e991ea-58d9-4d7b-b7d0-e5a86c412920" xlink:to="loc_us-gaap_ShortTermBorrowings_b692bfa5-92b2-4cd8-96b8-65cecd6fda2c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#SEGMENTINFORMATIONSegmentResultsDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_d79601cc-ca43-4230-99a4-0660777f55f3" xlink:href="hum-20230331.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_06018e40-9c69-4620-9126-9865d072d1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_d79601cc-ca43-4230-99a4-0660777f55f3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_06018e40-9c69-4620-9126-9865d072d1f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_9c98cf51-a285-42b0-8c20-9f9b3e8257da" xlink:href="hum-20230331.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_d79601cc-ca43-4230-99a4-0660777f55f3" xlink:to="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_9c98cf51-a285-42b0-8c20-9f9b3e8257da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_32a48403-370d-4fa6-91cf-f54c020776c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1fa38835-d428-4525-8933-696bd10d440a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_32a48403-370d-4fa6-91cf-f54c020776c8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1fa38835-d428-4525-8933-696bd10d440a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7329f2bf-a43c-4713-9891-bf5379f5cc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_32a48403-370d-4fa6-91cf-f54c020776c8" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7329f2bf-a43c-4713-9891-bf5379f5cc9d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>hum-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a7548c89-cbcc-4020-9549-0b2a193c2a02,g:7564a905-24e2-4ab4-9ab3-db550d1e5638-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="hum-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i1224b57f716441b1bc1c99257502d78c_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_abab4939-3ecb-43f4-8bd4-2ea6eb9b14a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abab4939-3ecb-43f4-8bd4-2ea6eb9b14a3" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c4ce5aaf-2258-4e6e-9bab-c6926b3ca9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c4ce5aaf-2258-4e6e-9bab-c6926b3ca9ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0e8847d1-3dbc-4166-8756-d317ee2b3a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0e8847d1-3dbc-4166-8756-d317ee2b3a0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9a567519-0ea4-4413-87e9-907b99977c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_ProfitLoss_9a567519-0ea4-4413-87e9-907b99977c84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_35a1e9e7-1613-4460-a362-332fcf2fcd12" xlink:href="hum-20230331.xsd#hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_35a1e9e7-1613-4460-a362-332fcf2fcd12" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_b7293b1a-96a1-491f-97ff-89c2c3e1569c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_b7293b1a-96a1-491f-97ff-89c2c3e1569c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_899f2e80-52a6-4257-aa56-30a78083aa38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_899f2e80-52a6-4257-aa56-30a78083aa38" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ca3ee1bf-7144-481a-b694-ff089da3d917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ca3ee1bf-7144-481a-b694-ff089da3d917" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_d9bebb20-6416-43e1-b8f2-7f26d2ce3778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_DividendsCommonStockCash_d9bebb20-6416-43e1-b8f2-7f26d2ce3778" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f5fc463f-4eb2-4859-ae70-61a8cac06a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f5fc463f-4eb2-4859-ae70-61a8cac06a99" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_d0b0f694-8aaf-47f4-92b5-61df12f0a4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_d0b0f694-8aaf-47f4-92b5-61df12f0a4ad" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_23f5ccb4-e784-4a4a-b25d-b2338763c5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_23f5ccb4-e784-4a4a-b25d-b2338763c5ee" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_baa781ac-4b0e-41ab-9518-9c8d0fa71e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_48666a09-a4a1-4fec-bc3b-b8f478634626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4cc4781f-fca7-41bb-9a67-fce0b6d111e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_abab4939-3ecb-43f4-8bd4-2ea6eb9b14a3" xlink:to="loc_us-gaap_StatementTable_4cc4781f-fca7-41bb-9a67-fce0b6d111e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_59ff95f4-2d7d-4552-a2f5-409460817dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4cc4781f-fca7-41bb-9a67-fce0b6d111e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_59ff95f4-2d7d-4552-a2f5-409460817dc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_59ff95f4-2d7d-4552-a2f5-409460817dc3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_59ff95f4-2d7d-4552-a2f5-409460817dc3" xlink:to="loc_us-gaap_EquityComponentDomain_59ff95f4-2d7d-4552-a2f5-409460817dc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dbb0c0d5-e9ee-4715-9991-930b8dad29ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_59ff95f4-2d7d-4552-a2f5-409460817dc3" xlink:to="loc_us-gaap_EquityComponentDomain_dbb0c0d5-e9ee-4715-9991-930b8dad29ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dbb0c0d5-e9ee-4715-9991-930b8dad29ea" xlink:to="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c9eadda1-e24a-4ee2-aadc-ff96bc9c0663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:to="loc_us-gaap_CommonStockMember_c9eadda1-e24a-4ee2-aadc-ff96bc9c0663" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_950aeab2-c1cd-489f-a7b1-cdd88b5317c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_950aeab2-c1cd-489f-a7b1-cdd88b5317c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8551ae0f-69e2-4d55-a034-55de024aad99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:to="loc_us-gaap_RetainedEarningsMember_8551ae0f-69e2-4d55-a034-55de024aad99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_01d99da6-5d59-4ba6-97c8-5277f7189b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_01d99da6-5d59-4ba6-97c8-5277f7189b6d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_c7d32cd5-597c-43fb-a4af-ca3bea89a18f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:to="loc_us-gaap_TreasuryStockCommonMember_c7d32cd5-597c-43fb-a4af-ca3bea89a18f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b86bb00a-4e7f-4608-8fc4-4725c63fcf23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dbb0c0d5-e9ee-4715-9991-930b8dad29ea" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b86bb00a-4e7f-4608-8fc4-4725c63fcf23" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails" xlink:type="extended" id="i4f1e28883c824872819733e5ca8f091f_BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DiscontinuedOperationsSegmentPhaseOutPeriod_93f7d89a-749e-4a5c-9230-c1aa483ce632" xlink:href="hum-20230331.xsd#hum_DiscontinuedOperationsSegmentPhaseOutPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:to="loc_hum_DiscontinuedOperationsSegmentPhaseOutPeriod_93f7d89a-749e-4a5c-9230-c1aa483ce632" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_60344011-b029-4c30-8932-4b80c82dbf1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_60344011-b029-4c30-8932-4b80c82dbf1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_e02cef12-7b4e-4926-b1ac-38e1d1dc83ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_e02cef12-7b4e-4926-b1ac-38e1d1dc83ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_cac0f0d7-a361-48f4-bee1-7c017c566d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:to="loc_us-gaap_SeveranceCosts1_cac0f0d7-a361-48f4-bee1-7c017c566d55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_79ded02e-97d9-4df5-93fd-1875b3fb38d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_79ded02e-97d9-4df5-93fd-1875b3fb38d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_73701e26-7e4b-4da5-800b-bdb27aee4874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_73701e26-7e4b-4da5-800b-bdb27aee4874" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ce26175e-5c0b-47be-be4e-5aa4ffb9f879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_73701e26-7e4b-4da5-800b-bdb27aee4874" xlink:to="loc_us-gaap_RestructuringPlanAxis_ce26175e-5c0b-47be-be4e-5aa4ffb9f879" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_ce26175e-5c0b-47be-be4e-5aa4ffb9f879_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_ce26175e-5c0b-47be-be4e-5aa4ffb9f879" xlink:to="loc_us-gaap_RestructuringPlanDomain_ce26175e-5c0b-47be-be4e-5aa4ffb9f879_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_021c0147-67f3-40e7-b382-c271fd9a6a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_ce26175e-5c0b-47be-be4e-5aa4ffb9f879" xlink:to="loc_us-gaap_RestructuringPlanDomain_021c0147-67f3-40e7-b382-c271fd9a6a0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ValueCreationInitiativesMember_aafe9bdd-0617-49ee-8087-d34ad6730a6e" xlink:href="hum-20230331.xsd#hum_ValueCreationInitiativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_021c0147-67f3-40e7-b382-c271fd9a6a0b" xlink:to="loc_hum_ValueCreationInitiativesMember_aafe9bdd-0617-49ee-8087-d34ad6730a6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3653c263-b5cc-44ac-a76d-11de2c56dc65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_73701e26-7e4b-4da5-800b-bdb27aee4874" xlink:to="loc_srt_ProductOrServiceAxis_3653c263-b5cc-44ac-a76d-11de2c56dc65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3653c263-b5cc-44ac-a76d-11de2c56dc65_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3653c263-b5cc-44ac-a76d-11de2c56dc65" xlink:to="loc_srt_ProductsAndServicesDomain_3653c263-b5cc-44ac-a76d-11de2c56dc65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_be736fb8-d5dd-4cc7-baa8-9d88bd3ba60c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3653c263-b5cc-44ac-a76d-11de2c56dc65" xlink:to="loc_srt_ProductsAndServicesDomain_be736fb8-d5dd-4cc7-baa8-9d88bd3ba60c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_eef344ca-6346-42b5-9c72-aad48d742a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_be736fb8-d5dd-4cc7-baa8-9d88bd3ba60c" xlink:to="loc_us-gaap_ServiceMember_eef344ca-6346-42b5-9c72-aad48d742a0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fcbcf096-5ea8-4ec3-96fa-82566abee2d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_73701e26-7e4b-4da5-800b-bdb27aee4874" xlink:to="loc_srt_RangeAxis_fcbcf096-5ea8-4ec3-96fa-82566abee2d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fcbcf096-5ea8-4ec3-96fa-82566abee2d7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fcbcf096-5ea8-4ec3-96fa-82566abee2d7" xlink:to="loc_srt_RangeMember_fcbcf096-5ea8-4ec3-96fa-82566abee2d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_19e2b937-528f-48fe-aac6-9888b3fe917b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fcbcf096-5ea8-4ec3-96fa-82566abee2d7" xlink:to="loc_srt_RangeMember_19e2b937-528f-48fe-aac6-9888b3fe917b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fff7fabf-ae3c-4f4f-887b-0e63faf36abe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_19e2b937-528f-48fe-aac6-9888b3fe917b" xlink:to="loc_srt_MinimumMember_fff7fabf-ae3c-4f4f-887b-0e63faf36abe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c5d370a3-e5d2-49b1-8c8b-30389fc5665d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_19e2b937-528f-48fe-aac6-9888b3fe917b" xlink:to="loc_srt_MaximumMember_c5d370a3-e5d2-49b1-8c8b-30389fc5665d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails" xlink:type="extended" id="i6ac4b86190d34f5e86a618ebec2fc706_RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_d7d02e15-20e1-4115-9e7b-4a5226f4ef56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_065ce8ae-01ba-44d5-b452-83c3c711bee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d7d02e15-20e1-4115-9e7b-4a5226f4ef56" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_065ce8ae-01ba-44d5-b452-83c3c711bee9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_d8540f09-55f9-4044-8050-4af5ad1081c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d7d02e15-20e1-4115-9e7b-4a5226f4ef56" xlink:to="loc_us-gaap_ConcentrationRiskTable_d8540f09-55f9-4044-8050-4af5ad1081c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_71474668-7b8f-4046-a313-60cfc3ed7223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d8540f09-55f9-4044-8050-4af5ad1081c1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_71474668-7b8f-4046-a313-60cfc3ed7223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_71474668-7b8f-4046-a313-60cfc3ed7223_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_71474668-7b8f-4046-a313-60cfc3ed7223" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_71474668-7b8f-4046-a313-60cfc3ed7223_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b9b3457b-d02c-452b-bd79-c01f97a720aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_71474668-7b8f-4046-a313-60cfc3ed7223" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b9b3457b-d02c-452b-bd79-c01f97a720aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_da28b973-b2fc-4dc7-8c77-d6963f7d8f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b9b3457b-d02c-452b-bd79-c01f97a720aa" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_da28b973-b2fc-4dc7-8c77-d6963f7d8f5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_09c99809-8ca8-468e-a7f4-53789f71960c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d8540f09-55f9-4044-8050-4af5ad1081c1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_09c99809-8ca8-468e-a7f4-53789f71960c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_09c99809-8ca8-468e-a7f4-53789f71960c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_09c99809-8ca8-468e-a7f4-53789f71960c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_09c99809-8ca8-468e-a7f4-53789f71960c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_bce27307-7507-4062-b332-e26e27893de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_09c99809-8ca8-468e-a7f4-53789f71960c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_bce27307-7507-4062-b332-e26e27893de1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_8cea8677-d78f-438d-9128-0c04a8d35436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_bce27307-7507-4062-b332-e26e27893de1" xlink:to="loc_us-gaap_SalesRevenueNetMember_8cea8677-d78f-438d-9128-0c04a8d35436" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8efdb7a4-572c-4f41-b235-12ea0756011b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d8540f09-55f9-4044-8050-4af5ad1081c1" xlink:to="loc_srt_ProductOrServiceAxis_8efdb7a4-572c-4f41-b235-12ea0756011b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8efdb7a4-572c-4f41-b235-12ea0756011b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8efdb7a4-572c-4f41-b235-12ea0756011b" xlink:to="loc_srt_ProductsAndServicesDomain_8efdb7a4-572c-4f41-b235-12ea0756011b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7b28f50e-b943-4007-a5cc-e94a51530503" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8efdb7a4-572c-4f41-b235-12ea0756011b" xlink:to="loc_srt_ProductsAndServicesDomain_7b28f50e-b943-4007-a5cc-e94a51530503" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareSupplementProductMember_55671778-fa7c-4391-b54b-1f693a176a6a" xlink:href="hum-20230331.xsd#hum_MedicareSupplementProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7b28f50e-b943-4007-a5cc-e94a51530503" xlink:to="loc_hum_MedicareSupplementProductMember_55671778-fa7c-4391-b54b-1f693a176a6a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#ACQUISITIONSANDDIVESTITURESDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails" xlink:type="extended" id="ie585828689004b039878da90e2f42b81_ACQUISITIONSANDDIVESTITURESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_445f73a8-231b-42e4-9936-2f50ee24d892" xlink:href="hum-20230331.xsd#hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:to="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_445f73a8-231b-42e4-9936-2f50ee24d892" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_64aba830-67fc-4fc1-a901-1acd06eac065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_64aba830-67fc-4fc1-a901-1acd06eac065" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_71424802-ddc1-450c-9399-37d08e92b5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:to="loc_us-gaap_RepaymentsOfDebt_71424802-ddc1-450c-9399-37d08e92b5dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_4f93c9f6-7e9e-4890-99fc-7598b806d4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_4f93c9f6-7e9e-4890-99fc-7598b806d4ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_57c83f21-da85-4288-b9ad-d08d04896716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_57c83f21-da85-4288-b9ad-d08d04896716" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax_92398448-99a5-46f8-a5d1-e591a08c06a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:to="loc_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax_92398448-99a5-46f8-a5d1-e591a08c06a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae1cb1c0-ce99-412a-ad51-2ccfd0604098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae1cb1c0-ce99-412a-ad51-2ccfd0604098" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_63ef0eab-083c-4dce-b732-117c2a7eaebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae1cb1c0-ce99-412a-ad51-2ccfd0604098" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_63ef0eab-083c-4dce-b732-117c2a7eaebc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_63ef0eab-083c-4dce-b732-117c2a7eaebc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_63ef0eab-083c-4dce-b732-117c2a7eaebc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_63ef0eab-083c-4dce-b732-117c2a7eaebc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4f4e1b6a-8180-4e79-ba58-b616213d38bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_63ef0eab-083c-4dce-b732-117c2a7eaebc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4f4e1b6a-8180-4e79-ba58-b616213d38bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_bfe9b993-70b3-4362-9632-237b8d366049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_4f4e1b6a-8180-4e79-ba58-b616213d38bd" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_bfe9b993-70b3-4362-9632-237b8d366049" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3f6458bc-69b7-47e5-9e21-a01ac7b06d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae1cb1c0-ce99-412a-ad51-2ccfd0604098" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3f6458bc-69b7-47e5-9e21-a01ac7b06d47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3f6458bc-69b7-47e5-9e21-a01ac7b06d47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3f6458bc-69b7-47e5-9e21-a01ac7b06d47" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3f6458bc-69b7-47e5-9e21-a01ac7b06d47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac392a89-9ca8-46ba-96c4-e16715137267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3f6458bc-69b7-47e5-9e21-a01ac7b06d47" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac392a89-9ca8-46ba-96c4-e16715137267" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GentivaHospiceMember_4a6588be-a692-490c-8deb-881538b3c072" xlink:href="hum-20230331.xsd#hum_GentivaHospiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac392a89-9ca8-46ba-96c4-e16715137267" xlink:to="loc_hum_GentivaHospiceMember_4a6588be-a692-490c-8deb-881538b3c072" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f68ce70b-97a0-4bdf-af4a-630c0d90b6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae1cb1c0-ce99-412a-ad51-2ccfd0604098" xlink:to="loc_us-gaap_DebtInstrumentAxis_f68ce70b-97a0-4bdf-af4a-630c0d90b6e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f68ce70b-97a0-4bdf-af4a-630c0d90b6e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f68ce70b-97a0-4bdf-af4a-630c0d90b6e4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f68ce70b-97a0-4bdf-af4a-630c0d90b6e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3736d2c8-279c-473d-9131-d2b7cf2058bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f68ce70b-97a0-4bdf-af4a-630c0d90b6e4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3736d2c8-279c-473d-9131-d2b7cf2058bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanDueOctober2023Member_737859aa-bd71-4c0f-9bcc-c506dfc54658" xlink:href="hum-20230331.xsd#hum_TermLoanDueOctober2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3736d2c8-279c-473d-9131-d2b7cf2058bc" xlink:to="loc_hum_TermLoanDueOctober2023Member_737859aa-bd71-4c0f-9bcc-c506dfc54658" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b0332cca-6578-4639-b521-76c08e9fe8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae1cb1c0-ce99-412a-ad51-2ccfd0604098" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b0332cca-6578-4639-b521-76c08e9fe8f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b0332cca-6578-4639-b521-76c08e9fe8f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b0332cca-6578-4639-b521-76c08e9fe8f0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b0332cca-6578-4639-b521-76c08e9fe8f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f7721376-c9de-4097-be76-ee4849be587c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b0332cca-6578-4639-b521-76c08e9fe8f0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f7721376-c9de-4097-be76-ee4849be587c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_78450763-f25e-4a52-9ba7-e65d377bb52e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f7721376-c9de-4097-be76-ee4849be587c" xlink:to="loc_us-gaap_LoansPayableMember_78450763-f25e-4a52-9ba7-e65d377bb52e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails" xlink:type="extended" id="ic000496b3a444a1cb22e8baf18049758_INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0864bde1-8536-41db-9d3b-33b93db3c80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0864bde1-8536-41db-9d3b-33b93db3c80b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0d58a9ff-84b1-4038-90c7-f8fbff3c2a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0d58a9ff-84b1-4038-90c7-f8fbff3c2a3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_35f93933-9f90-4510-aa22-0f22114c7cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_35f93933-9f90-4510-aa22-0f22114c7cdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9abead6f-7c7f-42ab-8692-fcef96993256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9abead6f-7c7f-42ab-8692-fcef96993256" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9b38a1db-ce48-433b-843c-cc6d2070af57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9b38a1db-ce48-433b-843c-cc6d2070af57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_23e2631f-78d2-47cd-bd47-7c04cae4d5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_23e2631f-78d2-47cd-bd47-7c04cae4d5c0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_4b183bdb-6464-4f0e-86c4-f9d40376e02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:to="loc_us-gaap_Investments_4b183bdb-6464-4f0e-86c4-f9d40376e02d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_805057e6-737f-4d01-b21a-cf568917a283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0864bde1-8536-41db-9d3b-33b93db3c80b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_805057e6-737f-4d01-b21a-cf568917a283" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e95ea388-db32-4a98-b11d-e9264ab9fa6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_805057e6-737f-4d01-b21a-cf568917a283" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e95ea388-db32-4a98-b11d-e9264ab9fa6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e95ea388-db32-4a98-b11d-e9264ab9fa6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e95ea388-db32-4a98-b11d-e9264ab9fa6c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e95ea388-db32-4a98-b11d-e9264ab9fa6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e95ea388-db32-4a98-b11d-e9264ab9fa6c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_1a76fae2-9b73-4177-9487-6c2b333cc4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_1a76fae2-9b73-4177-9487-6c2b333cc4cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_49d39506-71e9-4394-aca5-a2cf2c60e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_49d39506-71e9-4394-aca5-a2cf2c60e7f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember_15b428b6-7a4b-4f4e-92c6-ebcf530d05d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_NontaxableMunicipalNotesMember_15b428b6-7a4b-4f4e-92c6-ebcf530d05d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_1670c6eb-d615-4005-9230-514c9b0afd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_1670c6eb-d615-4005-9230-514c9b0afd5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_5b506d5a-f1b6-4f54-9874-761cf83e7b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_5b506d5a-f1b6-4f54-9874-761cf83e7b12" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_f4df6e44-1edb-46f6-9cf0-600afee67b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_f4df6e44-1edb-46f6-9cf0-600afee67b02" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_062493a4-1ab3-44dd-b8dc-1ddf9396e98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_062493a4-1ab3-44dd-b8dc-1ddf9396e98a" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails" xlink:type="extended" id="i6925e1f92fcb4c39abcd7291e9b8fa8a_INVESTMENTSECURITIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6c2aad9a-4bdd-4eb8-bde4-d03c629ee17c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6c2aad9a-4bdd-4eb8-bde4-d03c629ee17c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_07f75edd-a5eb-49b3-bb0f-390b514c0bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_07f75edd-a5eb-49b3-bb0f-390b514c0bd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_880e7f9a-9862-4d8a-9be2-5efcd4fc7efc" xlink:href="hum-20230331.xsd#hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:to="loc_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_880e7f9a-9862-4d8a-9be2-5efcd4fc7efc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_ef52f362-a419-4825-a40f-0eb4f504b8d8" xlink:href="hum-20230331.xsd#hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:to="loc_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_ef52f362-a419-4825-a40f-0eb4f504b8d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ea4a83c9-7bf4-49ea-8a5d-3c4b036e89ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ea4a83c9-7bf4-49ea-8a5d-3c4b036e89ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_2473d71f-826c-45ca-ba2f-6b5c7bcf64eb" xlink:href="hum-20230331.xsd#hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:to="loc_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_2473d71f-826c-45ca-ba2f-6b5c7bcf64eb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_3507f469-1a74-4e35-9638-be0ae79e9a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_3507f469-1a74-4e35-9638-be0ae79e9a73" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_9f06d845-031c-4274-8c9e-603cccfd5d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_3507f469-1a74-4e35-9638-be0ae79e9a73" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_9f06d845-031c-4274-8c9e-603cccfd5d0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9f06d845-031c-4274-8c9e-603cccfd5d0b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9f06d845-031c-4274-8c9e-603cccfd5d0b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9f06d845-031c-4274-8c9e-603cccfd5d0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d8079327-456c-4beb-8623-be4df7251285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9f06d845-031c-4274-8c9e-603cccfd5d0b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d8079327-456c-4beb-8623-be4df7251285" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_117c4d18-638e-486b-9449-89effd99f8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d8079327-456c-4beb-8623-be4df7251285" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_117c4d18-638e-486b-9449-89effd99f8c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bf2ebd6-595b-430a-bd8d-2238facb906d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_3507f469-1a74-4e35-9638-be0ae79e9a73" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bf2ebd6-595b-430a-bd8d-2238facb906d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6bf2ebd6-595b-430a-bd8d-2238facb906d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bf2ebd6-595b-430a-bd8d-2238facb906d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6bf2ebd6-595b-430a-bd8d-2238facb906d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fe74161a-08a5-4f09-90bb-dd2ba0fc8278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bf2ebd6-595b-430a-bd8d-2238facb906d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fe74161a-08a5-4f09-90bb-dd2ba0fc8278" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GentivaHospiceMember_f5ed3cef-0b10-49ba-bd6f-c74b4093a210" xlink:href="hum-20230331.xsd#hum_GentivaHospiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fe74161a-08a5-4f09-90bb-dd2ba0fc8278" xlink:to="loc_hum_GentivaHospiceMember_f5ed3cef-0b10-49ba-bd6f-c74b4093a210" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingStandardPoorsAxis_1d83802e-67f8-4748-a9d9-0b5b039a42a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingStandardPoorsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_3507f469-1a74-4e35-9638-be0ae79e9a73" xlink:to="loc_srt_CreditRatingStandardPoorsAxis_1d83802e-67f8-4748-a9d9-0b5b039a42a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember_1d83802e-67f8-4748-a9d9-0b5b039a42a2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CreditRatingStandardPoorsAxis_1d83802e-67f8-4748-a9d9-0b5b039a42a2" xlink:to="loc_srt_ExternalCreditRatingStandardPoorsMember_1d83802e-67f8-4748-a9d9-0b5b039a42a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember_030546cb-12f0-4536-8891-075ddf511070" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CreditRatingStandardPoorsAxis_1d83802e-67f8-4748-a9d9-0b5b039a42a2" xlink:to="loc_srt_ExternalCreditRatingStandardPoorsMember_030546cb-12f0-4536-8891-075ddf511070" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsAARatingMember_ea3e6c7e-2690-48e8-aaa0-b660da53ce96" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StandardPoorsAARatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_030546cb-12f0-4536-8891-075ddf511070" xlink:to="loc_srt_StandardPoorsAARatingMember_ea3e6c7e-2690-48e8-aaa0-b660da53ce96" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" xlink:type="extended" id="if67b44f772194f46beca0c6abaa68283_INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_ccda1eea-cc24-4683-8e93-c47d0e29fc81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_227744ab-6f7a-4a19-88b3-c04e1005577b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_ccda1eea-cc24-4683-8e93-c47d0e29fc81" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_227744ab-6f7a-4a19-88b3-c04e1005577b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_5905d828-b283-4b27-8e1b-9aeddb608dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_227744ab-6f7a-4a19-88b3-c04e1005577b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_5905d828-b283-4b27-8e1b-9aeddb608dcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_39ab4d25-61e8-4b5a-9f13-dc5cf98603ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_227744ab-6f7a-4a19-88b3-c04e1005577b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_39ab4d25-61e8-4b5a-9f13-dc5cf98603ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a2c86f50-6bf6-4cf5-8824-9807b292edd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_227744ab-6f7a-4a19-88b3-c04e1005577b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a2c86f50-6bf6-4cf5-8824-9807b292edd7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_56c795eb-3dc6-47f5-9071-7c3cf1acfcd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_ccda1eea-cc24-4683-8e93-c47d0e29fc81" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_56c795eb-3dc6-47f5-9071-7c3cf1acfcd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_b1f9dc5c-fe9f-4d4b-bdfc-fe08e631c7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_56c795eb-3dc6-47f5-9071-7c3cf1acfcd9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_b1f9dc5c-fe9f-4d4b-bdfc-fe08e631c7ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_f370607e-4d2f-4c0e-8902-66b6576ef554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_56c795eb-3dc6-47f5-9071-7c3cf1acfcd9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_f370607e-4d2f-4c0e-8902-66b6576ef554" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_d7b32bf3-bae4-4826-9e7d-c798711e3db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_56c795eb-3dc6-47f5-9071-7c3cf1acfcd9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_d7b32bf3-bae4-4826-9e7d-c798711e3db9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_957052c2-af31-4398-bf36-d6984dfdc074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_ccda1eea-cc24-4683-8e93-c47d0e29fc81" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_957052c2-af31-4398-bf36-d6984dfdc074" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_66142161-0163-477a-91ee-e5b7c33b2640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_957052c2-af31-4398-bf36-d6984dfdc074" xlink:to="loc_us-gaap_FinancialInstrumentAxis_66142161-0163-477a-91ee-e5b7c33b2640" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_66142161-0163-477a-91ee-e5b7c33b2640_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_66142161-0163-477a-91ee-e5b7c33b2640" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_66142161-0163-477a-91ee-e5b7c33b2640_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_66142161-0163-477a-91ee-e5b7c33b2640" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_a0c3b0ad-6394-4c7c-9844-047338445373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_a0c3b0ad-6394-4c7c-9844-047338445373" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_59f55fe5-7908-4c17-8876-f16b5f17faf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_59f55fe5-7908-4c17-8876-f16b5f17faf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember_b73fbe3e-5f39-4fcf-a538-f85b5d776ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_NontaxableMunicipalNotesMember_b73fbe3e-5f39-4fcf-a538-f85b5d776ea1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_91bbfd8f-0bbd-4b95-9fde-fd23a9b471ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_91bbfd8f-0bbd-4b95-9fde-fd23a9b471ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8cdde5a9-2284-443b-a8bb-f6765c1d9441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8cdde5a9-2284-443b-a8bb-f6765c1d9441" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_e2f4105b-296f-4227-959e-de6235f487f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_e2f4105b-296f-4227-959e-de6235f487f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_352c7688-4d11-434e-b2cb-74f4bd6ffe29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_352c7688-4d11-434e-b2cb-74f4bd6ffe29" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="extended" id="i5226a811b5554ebba420974720d9c7b1_FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b14740ae-5dcc-439d-8db7-cb39e40951b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e9af1136-b6e2-4496-bf2a-608f1d2ca275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b14740ae-5dcc-439d-8db7-cb39e40951b3" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e9af1136-b6e2-4496-bf2a-608f1d2ca275" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5e43e64c-28f9-4fe0-89b8-e263befd7f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b14740ae-5dcc-439d-8db7-cb39e40951b3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5e43e64c-28f9-4fe0-89b8-e263befd7f77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_c7d7135d-beca-4505-8f83-c864998c2f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b14740ae-5dcc-439d-8db7-cb39e40951b3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_c7d7135d-beca-4505-8f83-c864998c2f8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_4d22e961-bfdb-4fdc-9cd6-358a96b7677e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b14740ae-5dcc-439d-8db7-cb39e40951b3" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_4d22e961-bfdb-4fdc-9cd6-358a96b7677e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b36e5cf-abdc-4f65-8717-9b5555be44bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b14740ae-5dcc-439d-8db7-cb39e40951b3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b36e5cf-abdc-4f65-8717-9b5555be44bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_394a10d2-fc2c-41ab-a1e5-b8e91838a146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b36e5cf-abdc-4f65-8717-9b5555be44bf" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_394a10d2-fc2c-41ab-a1e5-b8e91838a146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_394a10d2-fc2c-41ab-a1e5-b8e91838a146_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_394a10d2-fc2c-41ab-a1e5-b8e91838a146" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_394a10d2-fc2c-41ab-a1e5-b8e91838a146_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e73652c7-9be1-43b1-9d23-9488299ae30b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_394a10d2-fc2c-41ab-a1e5-b8e91838a146" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e73652c7-9be1-43b1-9d23-9488299ae30b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d1a0bef6-8daf-4f48-8188-faedc54b8803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e73652c7-9be1-43b1-9d23-9488299ae30b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d1a0bef6-8daf-4f48-8188-faedc54b8803" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bbc70229-ed98-4477-9227-6b1a65d95cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b36e5cf-abdc-4f65-8717-9b5555be44bf" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bbc70229-ed98-4477-9227-6b1a65d95cb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bbc70229-ed98-4477-9227-6b1a65d95cb5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bbc70229-ed98-4477-9227-6b1a65d95cb5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bbc70229-ed98-4477-9227-6b1a65d95cb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92d16543-eadf-4588-974e-070a433eaf3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bbc70229-ed98-4477-9227-6b1a65d95cb5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92d16543-eadf-4588-974e-070a433eaf3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b8eaca21-c29a-4076-b4c0-83aa093ca6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92d16543-eadf-4588-974e-070a433eaf3e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b8eaca21-c29a-4076-b4c0-83aa093ca6b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_690078a4-472c-4aaa-88a3-cf3637abf4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92d16543-eadf-4588-974e-070a433eaf3e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_690078a4-472c-4aaa-88a3-cf3637abf4e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d404ea74-17a4-42c6-ba99-4ee12e87d2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92d16543-eadf-4588-974e-070a433eaf3e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d404ea74-17a4-42c6-ba99-4ee12e87d2b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f2d38fdb-06f7-4f04-b02f-b745aa7e300f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b36e5cf-abdc-4f65-8717-9b5555be44bf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f2d38fdb-06f7-4f04-b02f-b745aa7e300f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f2d38fdb-06f7-4f04-b02f-b745aa7e300f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f2d38fdb-06f7-4f04-b02f-b745aa7e300f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f2d38fdb-06f7-4f04-b02f-b745aa7e300f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f2d38fdb-06f7-4f04-b02f-b745aa7e300f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_79010dec-bffb-4d48-a281-d73fb333a888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_79010dec-bffb-4d48-a281-d73fb333a888" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_71b8f01b-2a45-4287-9477-a323b6516b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_71b8f01b-2a45-4287-9477-a323b6516b3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember_6ab824d6-7c5b-4fd8-b923-dc6e5499b8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_NontaxableMunicipalNotesMember_6ab824d6-7c5b-4fd8-b923-dc6e5499b8b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_0ba39cfa-502f-421a-9a2f-4fc8702780c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_0ba39cfa-502f-421a-9a2f-4fc8702780c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_0115176d-6030-4631-924c-e4a552f7c171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_0115176d-6030-4631-924c-e4a552f7c171" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_4bac8d13-1d93-4870-8a0c-34fffe7da624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_4bac8d13-1d93-4870-8a0c-34fffe7da624" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_8040056e-4a19-461f-9bc9-d3e5da54d6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_8040056e-4a19-461f-9bc9-d3e5da54d6e5" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUENarrativeDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#FAIRVALUENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/FAIRVALUENarrativeDetails" xlink:type="extended" id="i8e8e99dbc524414994a0c9b2e845d3a1_FAIRVALUENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_cd627700-0edb-4e58-bc90-f6e35f3212aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_cd627700-0edb-4e58-bc90-f6e35f3212aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_9f367059-864d-4b23-b8c9-3242c27feb84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_9f367059-864d-4b23-b8c9-3242c27feb84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_de02bfb6-1ff8-4a77-baa0-6c7ae0e22835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:to="loc_us-gaap_DebtInstrumentFairValue_de02bfb6-1ff8-4a77-baa0-6c7ae0e22835" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_61414a9d-18d2-4cd7-9445-5482927f57fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:to="loc_us-gaap_ShortTermBorrowings_61414a9d-18d2-4cd7-9445-5482927f57fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_4a445913-1246-4bcb-b733-8cc88707438e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_4a445913-1246-4bcb-b733-8cc88707438e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FinancialAssetsFairValueDisclosure_7b717a80-d236-45c4-a662-fb385e22efa1" xlink:href="hum-20230331.xsd#hum_FinancialAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:to="loc_hum_FinancialAssetsFairValueDisclosure_7b717a80-d236-45c4-a662-fb385e22efa1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2006a084-7ef3-44b9-93fd-7e9b2e6764b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2006a084-7ef3-44b9-93fd-7e9b2e6764b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2006a084-7ef3-44b9-93fd-7e9b2e6764b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2006a084-7ef3-44b9-93fd-7e9b2e6764b7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2006a084-7ef3-44b9-93fd-7e9b2e6764b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa9cff9-1f44-4d50-8f23-635cb2653ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2006a084-7ef3-44b9-93fd-7e9b2e6764b7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa9cff9-1f44-4d50-8f23-635cb2653ac2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d17734fd-5748-4190-ad7e-d1bb6e7b1937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa9cff9-1f44-4d50-8f23-635cb2653ac2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d17734fd-5748-4190-ad7e-d1bb6e7b1937" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_94549ce7-02a7-41a6-9c89-16cd4ce0ab9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_94549ce7-02a7-41a6-9c89-16cd4ce0ab9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_94549ce7-02a7-41a6-9c89-16cd4ce0ab9a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_94549ce7-02a7-41a6-9c89-16cd4ce0ab9a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_94549ce7-02a7-41a6-9c89-16cd4ce0ab9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d837640e-c314-4c83-88f4-d2af685894a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_94549ce7-02a7-41a6-9c89-16cd4ce0ab9a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d837640e-c314-4c83-88f4-d2af685894a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_47ee6cc8-6c85-471b-9ce9-34a04118367a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d837640e-c314-4c83-88f4-d2af685894a5" xlink:to="loc_us-gaap_InvestmentsMember_47ee6cc8-6c85-471b-9ce9-34a04118367a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7a859586-8ad2-4990-92fc-108dd7cef912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7a859586-8ad2-4990-92fc-108dd7cef912" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7a859586-8ad2-4990-92fc-108dd7cef912_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7a859586-8ad2-4990-92fc-108dd7cef912" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7a859586-8ad2-4990-92fc-108dd7cef912_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_23dae28c-7851-4466-8f7f-de039c3d58dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7a859586-8ad2-4990-92fc-108dd7cef912" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_23dae28c-7851-4466-8f7f-de039c3d58dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FairValueRiskMember_c4fefb09-7493-4389-9fda-feb645b66852" xlink:href="hum-20230331.xsd#hum_FairValueRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_23dae28c-7851-4466-8f7f-de039c3d58dd" xlink:to="loc_hum_FairValueRiskMember_c4fefb09-7493-4389-9fda-feb645b66852" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_363f7cb9-e616-4f82-b4df-34eedabe8a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_363f7cb9-e616-4f82-b4df-34eedabe8a3c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_363f7cb9-e616-4f82-b4df-34eedabe8a3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_363f7cb9-e616-4f82-b4df-34eedabe8a3c" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_363f7cb9-e616-4f82-b4df-34eedabe8a3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b9fd7d24-6d53-43ad-a117-c8ec628c6cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_363f7cb9-e616-4f82-b4df-34eedabe8a3c" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b9fd7d24-6d53-43ad-a117-c8ec628c6cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a416ce9b-fcb2-4e21-b8b1-6befe90502d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b9fd7d24-6d53-43ad-a117-c8ec628c6cbc" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a416ce9b-fcb2-4e21-b8b1-6befe90502d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_f5d9b2e3-1d24-43fe-b6d5-a0e9651f8d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a416ce9b-fcb2-4e21-b8b1-6befe90502d6" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_f5d9b2e3-1d24-43fe-b6d5-a0e9651f8d7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3352264d-9ae1-4b7a-a649-39c0d92326b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a416ce9b-fcb2-4e21-b8b1-6befe90502d6" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3352264d-9ae1-4b7a-a649-39c0d92326b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_f72922bb-4b28-474a-9460-6cf130f4dbb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_f72922bb-4b28-474a-9460-6cf130f4dbb6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_f72922bb-4b28-474a-9460-6cf130f4dbb6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_f72922bb-4b28-474a-9460-6cf130f4dbb6" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_f72922bb-4b28-474a-9460-6cf130f4dbb6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3dc57a46-8836-4f00-b123-d49e7e416e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_f72922bb-4b28-474a-9460-6cf130f4dbb6" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3dc57a46-8836-4f00-b123-d49e7e416e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanAndCommercialPaperMember_97f1a377-5b9d-4e1b-b68b-caa54a9df1ee" xlink:href="hum-20230331.xsd#hum_TermLoanAndCommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_3dc57a46-8836-4f00-b123-d49e7e416e87" xlink:to="loc_hum_TermLoanAndCommercialPaperMember_97f1a377-5b9d-4e1b-b68b-caa54a9df1ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_73d0c8dd-4973-4468-be8b-4df713e5e5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_73d0c8dd-4973-4468-be8b-4df713e5e5c7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_73d0c8dd-4973-4468-be8b-4df713e5e5c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_73d0c8dd-4973-4468-be8b-4df713e5e5c7" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_73d0c8dd-4973-4468-be8b-4df713e5e5c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_b9a519ad-f16d-45a6-88a9-14baeb0312ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_73d0c8dd-4973-4468-be8b-4df713e5e5c7" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_b9a519ad-f16d-45a6-88a9-14baeb0312ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember_f8f0bc6a-2664-4389-8e46-dab2b042ebef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PutOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_b9a519ad-f16d-45a6-88a9-14baeb0312ea" xlink:to="loc_us-gaap_PutOptionMember_f8f0bc6a-2664-4389-8e46-dab2b042ebef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_e0f4456a-3796-4da1-a01d-6d22e97a1277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_b9a519ad-f16d-45a6-88a9-14baeb0312ea" xlink:to="loc_us-gaap_CallOptionMember_e0f4456a-3796-4da1-a01d-6d22e97a1277" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails" xlink:type="extended" id="i5736c7300a824e8396000db78d718fa9_FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_84a32caa-e4cf-409e-8241-126f72a1a3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_c0cdc5c6-47fb-4e16-b54a-3a3c6b1467b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetLiabilityNetMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_84a32caa-e4cf-409e-8241-126f72a1a3ee" xlink:to="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_c0cdc5c6-47fb-4e16-b54a-3a3c6b1467b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a038b757-12cd-4265-b1df-6c4d85dd5152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_84a32caa-e4cf-409e-8241-126f72a1a3ee" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a038b757-12cd-4265-b1df-6c4d85dd5152" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4ab77b6a-fc0f-470b-b8e1-c3de11b16e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a038b757-12cd-4265-b1df-6c4d85dd5152" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4ab77b6a-fc0f-470b-b8e1-c3de11b16e55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ab77b6a-fc0f-470b-b8e1-c3de11b16e55_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4ab77b6a-fc0f-470b-b8e1-c3de11b16e55" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ab77b6a-fc0f-470b-b8e1-c3de11b16e55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eea72279-0a95-4670-95d3-adff201452f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4ab77b6a-fc0f-470b-b8e1-c3de11b16e55" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eea72279-0a95-4670-95d3-adff201452f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionOnSecuritiesMember_2ba4e87a-edab-44f7-80f6-e6daa2679638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionOnSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eea72279-0a95-4670-95d3-adff201452f4" xlink:to="loc_us-gaap_OptionOnSecuritiesMember_2ba4e87a-edab-44f7-80f6-e6daa2679638" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d22b9f0a-0caa-4170-99fd-15f201782e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a038b757-12cd-4265-b1df-6c4d85dd5152" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d22b9f0a-0caa-4170-99fd-15f201782e95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d22b9f0a-0caa-4170-99fd-15f201782e95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d22b9f0a-0caa-4170-99fd-15f201782e95" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d22b9f0a-0caa-4170-99fd-15f201782e95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d659bb11-4441-4039-88fc-e6988e8c7b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d22b9f0a-0caa-4170-99fd-15f201782e95" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d659bb11-4441-4039-88fc-e6988e8c7b64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4737f2f5-7336-47c2-9ca8-43eb315c6fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d659bb11-4441-4039-88fc-e6988e8c7b64" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4737f2f5-7336-47c2-9ca8-43eb315c6fe6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_5502bdbc-d4e3-4f57-aaa9-d07f7994465e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a038b757-12cd-4265-b1df-6c4d85dd5152" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_5502bdbc-d4e3-4f57-aaa9-d07f7994465e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_5502bdbc-d4e3-4f57-aaa9-d07f7994465e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_5502bdbc-d4e3-4f57-aaa9-d07f7994465e" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_5502bdbc-d4e3-4f57-aaa9-d07f7994465e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_5502bdbc-d4e3-4f57-aaa9-d07f7994465e" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputOptionVolatilityMember_139652f3-d8a5-474f-a8b0-f2a62c2b85da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputOptionVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:to="loc_us-gaap_MeasurementInputOptionVolatilityMember_139652f3-d8a5-474f-a8b0-f2a62c2b85da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditSpreadOptionMember_1588263e-ab50-4a7a-ba38-181ea6e7af27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditSpreadOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:to="loc_us-gaap_CreditSpreadOptionMember_1588263e-ab50-4a7a-ba38-181ea6e7af27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevenueExitMultipleMember_0619ddde-0844-478d-8b8b-382efcdfc5ba" xlink:href="hum-20230331.xsd#hum_RevenueExitMultipleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:to="loc_hum_RevenueExitMultipleMember_0619ddde-0844-478d-8b8b-382efcdfc5ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_2fc1d8a0-0cef-4bec-bb82-fc7d14bb2297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_2fc1d8a0-0cef-4bec-bb82-fc7d14bb2297" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_dca862cc-8130-4809-ac6b-5fd683b49b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_dca862cc-8130-4809-ac6b-5fd683b49b3b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_29787a1a-fce2-4c1b-ae1a-a67c9f19b890" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a038b757-12cd-4265-b1df-6c4d85dd5152" xlink:to="loc_srt_RangeAxis_29787a1a-fce2-4c1b-ae1a-a67c9f19b890" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29787a1a-fce2-4c1b-ae1a-a67c9f19b890_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_29787a1a-fce2-4c1b-ae1a-a67c9f19b890" xlink:to="loc_srt_RangeMember_29787a1a-fce2-4c1b-ae1a-a67c9f19b890_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8338eb58-3ff8-4c52-9a89-c444340d63e1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_29787a1a-fce2-4c1b-ae1a-a67c9f19b890" xlink:to="loc_srt_RangeMember_8338eb58-3ff8-4c52-9a89-c444340d63e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ee6ff17e-2593-4e43-9116-4ab8124a7f47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8338eb58-3ff8-4c52-9a89-c444340d63e1" xlink:to="loc_srt_MinimumMember_ee6ff17e-2593-4e43-9116-4ab8124a7f47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_109e1efb-8f6e-43f4-b21a-663002aee6f5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8338eb58-3ff8-4c52-9a89-c444340d63e1" xlink:to="loc_srt_MaximumMember_109e1efb-8f6e-43f4-b21a-663002aee6f5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/MEDICAREPARTDDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#MEDICAREPARTDDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/MEDICAREPARTDDetails" xlink:type="extended" id="i9b5835d3a1d847aaaf3096070ea08bb7_MEDICAREPARTDDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c6b6ca38-fa24-42c5-a398-a5e30fc5b125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_us-gaap_OtherAssetsCurrent_c6b6ca38-fa24-42c5-a398-a5e30fc5b125" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_05da5bd5-4e86-48a9-8918-ed518ecd1edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_05da5bd5-4e86-48a9-8918-ed518ecd1edd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetCurrentLiabilityAsset_164cdfa7-8090-474f-bfa2-a5e1d34f2192" xlink:href="hum-20230331.xsd#hum_NetCurrentLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_hum_NetCurrentLiabilityAsset_164cdfa7-8090-474f-bfa2-a5e1d34f2192" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7d926fd9-7c33-4ba6-9ef8-db7d82b586d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7d926fd9-7c33-4ba6-9ef8-db7d82b586d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f4d838e1-7dce-4e9f-92b6-b87696da9d64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f4d838e1-7dce-4e9f-92b6-b87696da9d64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetNoncurrentAssetLiability_ec1d8447-f076-4887-b7a9-dbf82f3164ff" xlink:href="hum-20230331.xsd#hum_NetNoncurrentAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_hum_NetNoncurrentAssetLiability_ec1d8447-f076-4887-b7a9-dbf82f3164ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetAssetLiability_153918ca-7740-4094-b376-9e34cfb4084f" xlink:href="hum-20230331.xsd#hum_NetAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_hum_NetAssetLiability_153918ca-7740-4094-b376-9e34cfb4084f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8f072891-3d27-4b23-a130-e80b002f169d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8f072891-3d27-4b23-a130-e80b002f169d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8f710ee-443e-46a6-91ac-a3908aeebd00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8f072891-3d27-4b23-a130-e80b002f169d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8f710ee-443e-46a6-91ac-a3908aeebd00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f8f710ee-443e-46a6-91ac-a3908aeebd00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8f710ee-443e-46a6-91ac-a3908aeebd00" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f8f710ee-443e-46a6-91ac-a3908aeebd00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bd0c6f5-34a2-4410-8e3b-e15c1fec9e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8f710ee-443e-46a6-91ac-a3908aeebd00" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bd0c6f5-34a2-4410-8e3b-e15c1fec9e2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RiskCorridorSettlementsMedicarePartDMember_7ddeb805-ce0d-424e-80a9-4108a671899f" xlink:href="hum-20230331.xsd#hum_RiskCorridorSettlementsMedicarePartDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bd0c6f5-34a2-4410-8e3b-e15c1fec9e2c" xlink:to="loc_hum_RiskCorridorSettlementsMedicarePartDMember_7ddeb805-ce0d-424e-80a9-4108a671899f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CmsSubsidiesOrDiscountsMember_53d39e17-672c-4bcd-a1c6-567a44eb1e07" xlink:href="hum-20230331.xsd#hum_CmsSubsidiesOrDiscountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bd0c6f5-34a2-4410-8e3b-e15c1fec9e2c" xlink:to="loc_hum_CmsSubsidiesOrDiscountsMember_53d39e17-672c-4bcd-a1c6-567a44eb1e07" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails" xlink:type="extended" id="i8e54ac97c2974d548d34ff0c0c97f6cf_GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_82f02872-c85f-4598-acc2-7c12d890e8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_788be57b-d7c0-4566-b1f4-2c145ef58245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_82f02872-c85f-4598-acc2-7c12d890e8b1" xlink:to="loc_us-gaap_GoodwillRollForward_788be57b-d7c0-4566-b1f4-2c145ef58245" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_136fd036-4128-4156-9198-ee4c0f049ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_788be57b-d7c0-4566-b1f4-2c145ef58245" xlink:to="loc_us-gaap_Goodwill_136fd036-4128-4156-9198-ee4c0f049ee1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_5c881d18-3310-4818-8d41-5946e34a75c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_788be57b-d7c0-4566-b1f4-2c145ef58245" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_5c881d18-3310-4818-8d41-5946e34a75c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5f10258a-f8ff-4629-a73c-981596213bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_cc129e80-2568-4ac3-afb6-836e871050f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_82f02872-c85f-4598-acc2-7c12d890e8b1" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_cc129e80-2568-4ac3-afb6-836e871050f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6717eff5-6df0-4c87-8334-71147b5c71dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_cc129e80-2568-4ac3-afb6-836e871050f8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6717eff5-6df0-4c87-8334-71147b5c71dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6717eff5-6df0-4c87-8334-71147b5c71dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6717eff5-6df0-4c87-8334-71147b5c71dd" xlink:to="loc_us-gaap_SegmentDomain_6717eff5-6df0-4c87-8334-71147b5c71dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6e9eb85e-23d5-47d3-8fd7-2c441f456aec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6717eff5-6df0-4c87-8334-71147b5c71dd" xlink:to="loc_us-gaap_SegmentDomain_6e9eb85e-23d5-47d3-8fd7-2c441f456aec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InsuranceSegmentMember_48eae9cc-857d-494a-aeaf-666012b6d512" xlink:href="hum-20230331.xsd#hum_InsuranceSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6e9eb85e-23d5-47d3-8fd7-2c441f456aec" xlink:to="loc_hum_InsuranceSegmentMember_48eae9cc-857d-494a-aeaf-666012b6d512" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CenterWellSegmentMember_a3602a0c-8f50-4674-bd39-c2f467ff4843" xlink:href="hum-20230331.xsd#hum_CenterWellSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6e9eb85e-23d5-47d3-8fd7-2c441f456aec" xlink:to="loc_hum_CenterWellSegmentMember_a3602a0c-8f50-4674-bd39-c2f467ff4843" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails" xlink:type="extended" id="i32b8c3fb93bb4a0a90029fca7448c7db_GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41aa4f04-21d4-4a03-b24c-1de793a7b8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b4a0d502-b6bd-4fb8-80af-1a9135cae581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41aa4f04-21d4-4a03-b24c-1de793a7b8a0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b4a0d502-b6bd-4fb8-80af-1a9135cae581" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_76c84ea0-04f4-4e82-b5e8-171c842852b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41aa4f04-21d4-4a03-b24c-1de793a7b8a0" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_76c84ea0-04f4-4e82-b5e8-171c842852b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_89ca0c4e-ad5e-4252-bcdc-1c8c06714ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_76c84ea0-04f4-4e82-b5e8-171c842852b3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_89ca0c4e-ad5e-4252-bcdc-1c8c06714ff1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_89ca0c4e-ad5e-4252-bcdc-1c8c06714ff1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_89ca0c4e-ad5e-4252-bcdc-1c8c06714ff1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_89ca0c4e-ad5e-4252-bcdc-1c8c06714ff1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_58ccc060-82c2-46cb-b1fc-07cc455ddd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_89ca0c4e-ad5e-4252-bcdc-1c8c06714ff1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_58ccc060-82c2-46cb-b1fc-07cc455ddd9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CertificateOfNeedMember_c72a2fb7-25bf-4c52-ae1d-eb72cf7671d3" xlink:href="hum-20230331.xsd#hum_CertificateOfNeedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_58ccc060-82c2-46cb-b1fc-07cc455ddd9e" xlink:to="loc_hum_CertificateOfNeedMember_c72a2fb7-25bf-4c52-ae1d-eb72cf7671d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_952c339c-5be3-4789-bafa-a0d57bccd048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_58ccc060-82c2-46cb-b1fc-07cc455ddd9e" xlink:to="loc_us-gaap_LicensingAgreementsMember_952c339c-5be3-4789-bafa-a0d57bccd048" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d0eaf2f7-e013-4737-b49f-dd2f65da0cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d0eaf2f7-e013-4737-b49f-dd2f65da0cd3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_f007d421-bf16-48e2-8bbe-1ec0765f60ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_f007d421-bf16-48e2-8bbe-1ec0765f60ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a3cfe47d-4353-46d5-80d9-c64ea049713a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a3cfe47d-4353-46d5-80d9-c64ea049713a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5528401a-2500-4de5-9967-f33a073b9e86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5528401a-2500-4de5-9967-f33a073b9e86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c6ac5b68-1779-4703-ad90-60d8a1ba0d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c6ac5b68-1779-4703-ad90-60d8a1ba0d3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_82fe93de-d763-4f62-a5e8-c4a3826e6c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_82fe93de-d763-4f62-a5e8-c4a3826e6c33" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1682a193-dc56-41a0-a31c-de27751d253b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1682a193-dc56-41a0-a31c-de27751d253b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1780cc9c-5f76-4a79-8751-21d5ca02fa08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d0eaf2f7-e013-4737-b49f-dd2f65da0cd3" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1780cc9c-5f76-4a79-8751-21d5ca02fa08" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_669506dc-b168-4658-9420-cfe0f703dc29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1780cc9c-5f76-4a79-8751-21d5ca02fa08" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_669506dc-b168-4658-9420-cfe0f703dc29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_669506dc-b168-4658-9420-cfe0f703dc29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_669506dc-b168-4658-9420-cfe0f703dc29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_669506dc-b168-4658-9420-cfe0f703dc29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_558a61bd-aaa8-47b5-b340-a51ba9d859ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_669506dc-b168-4658-9420-cfe0f703dc29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_558a61bd-aaa8-47b5-b340-a51ba9d859ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_9cf34468-d554-412c-b45e-7cb22e4a0230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_558a61bd-aaa8-47b5-b340-a51ba9d859ba" xlink:to="loc_us-gaap_CustomerContractsMember_9cf34468-d554-412c-b45e-7cb22e4a0230" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ca79d8a6-dab1-4239-a8d1-3111fc5d22b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_558a61bd-aaa8-47b5-b340-a51ba9d859ba" xlink:to="loc_us-gaap_TradeNamesMember_ca79d8a6-dab1-4239-a8d1-3111fc5d22b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_c2d051d6-d78a-423a-8af3-dee02a34847c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_558a61bd-aaa8-47b5-b340-a51ba9d859ba" xlink:to="loc_us-gaap_ContractualRightsMember_c2d051d6-d78a-423a-8af3-dee02a34847c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncompetesAndOtherMember_539128b9-10c1-4848-b2f4-46b4df873499" xlink:href="hum-20230331.xsd#hum_NoncompetesAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_558a61bd-aaa8-47b5-b340-a51ba9d859ba" xlink:to="loc_hum_NoncompetesAndOtherMember_539128b9-10c1-4848-b2f4-46b4df873499" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#EARNINGSPERCOMMONSHARECOMPUTATIONDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails" xlink:type="extended" id="i85898e09877d45d09e3ec37dab6861f4_EARNINGSPERCOMMONSHARECOMPUTATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0f483e99-84ed-46ff-9e2e-a06be71982ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_NetIncomeLoss_0f483e99-84ed-46ff-9e2e-a06be71982ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c6ccd527-82e6-4d9a-8069-fd3edd9b9b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c6ccd527-82e6-4d9a-8069-fd3edd9b9b6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3e7ba099-1a38-481d-af11-963c7ae09a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3e7ba099-1a38-481d-af11-963c7ae09a66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fb80563b-429c-46d3-9a9d-75e91b938ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fb80563b-429c-46d3-9a9d-75e91b938ee0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f8f7b66c-bbf9-4d58-a991-8ee287b39d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_EarningsPerShareBasic_f8f7b66c-bbf9-4d58-a991-8ee287b39d2a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1930a15c-3017-4f7e-8334-7ead001d0b54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1930a15c-3017-4f7e-8334-7ead001d0b54" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6d5bca5f-1ed3-467a-9680-1f00f63ed3e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6d5bca5f-1ed3-467a-9680-1f00f63ed3e6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_47ed2d2d-fa93-47e2-9668-95c7fffc4cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_47ed2d2d-fa93-47e2-9668-95c7fffc4cc4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4882c4d2-00dc-4f27-8ea1-ea2acac9cc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_47ed2d2d-fa93-47e2-9668-95c7fffc4cc4" xlink:to="loc_us-gaap_AwardTypeAxis_4882c4d2-00dc-4f27-8ea1-ea2acac9cc5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4882c4d2-00dc-4f27-8ea1-ea2acac9cc5f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4882c4d2-00dc-4f27-8ea1-ea2acac9cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4882c4d2-00dc-4f27-8ea1-ea2acac9cc5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e407586d-26c6-45e4-a580-2ed567ed9f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4882c4d2-00dc-4f27-8ea1-ea2acac9cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e407586d-26c6-45e4-a580-2ed567ed9f1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c5a23f7a-831d-4813-8cbc-2feb801e1da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e407586d-26c6-45e4-a580-2ed567ed9f1e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c5a23f7a-831d-4813-8cbc-2feb801e1da9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_90ad1732-1fbf-426b-a94c-725ca7aba60f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e407586d-26c6-45e4-a580-2ed567ed9f1e" xlink:to="loc_us-gaap_RestrictedStockMember_90ad1732-1fbf-426b-a94c-725ca7aba60f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended" id="ia74ca09020204deca16793ae73216e2c_STOCKHOLDERSEQUITYNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_ddc054c3-3f6f-4e1c-8a63-616d81b6d500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_ddc054c3-3f6f-4e1c-8a63-616d81b6d500" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8041c7dd-2918-4d7a-b6ab-a50a1b1def4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8041c7dd-2918-4d7a-b6ab-a50a1b1def4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_34c286b6-eb71-460d-a50c-88352f4ed452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_34c286b6-eb71-460d-a50c-88352f4ed452" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_784f8a73-1cf5-46fa-aa5b-2e42a37bd63a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_784f8a73-1cf5-46fa-aa5b-2e42a37bd63a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_70d3753a-8a04-4faf-b4e0-26e999818cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_70d3753a-8a04-4faf-b4e0-26e999818cd6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_57a3bade-c08a-4b0d-b10c-078b2ba68d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_57a3bade-c08a-4b0d-b10c-078b2ba68d0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_b9319a11-24c4-472c-b141-272a1406ffbe" xlink:href="hum-20230331.xsd#hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_b9319a11-24c4-472c-b141-272a1406ffbe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_fff8c862-77b2-4074-8fb4-1a710a02f84d" xlink:href="hum-20230331.xsd#hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_fff8c862-77b2-4074-8fb4-1a710a02f84d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_10872a54-4b53-46d6-a771-3d34e7124f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_10872a54-4b53-46d6-a771-3d34e7124f1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a7343c12-38c0-4df8-906b-5886bcc996f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_10872a54-4b53-46d6-a771-3d34e7124f1b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a7343c12-38c0-4df8-906b-5886bcc996f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a7343c12-38c0-4df8-906b-5886bcc996f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a7343c12-38c0-4df8-906b-5886bcc996f5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a7343c12-38c0-4df8-906b-5886bcc996f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8dcef57f-b38a-4665-9adb-ae21a5799e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a7343c12-38c0-4df8-906b-5886bcc996f5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8dcef57f-b38a-4665-9adb-ae21a5799e29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6ee067bd-bbe9-4777-aef4-74b0ea931468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8dcef57f-b38a-4665-9adb-ae21a5799e29" xlink:to="loc_us-gaap_SubsequentEventMember_6ee067bd-bbe9-4777-aef4-74b0ea931468" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_c293ebf6-0735-4f0e-a01b-5bddddca99de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_10872a54-4b53-46d6-a771-3d34e7124f1b" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_c293ebf6-0735-4f0e-a01b-5bddddca99de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_c293ebf6-0735-4f0e-a01b-5bddddca99de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_c293ebf6-0735-4f0e-a01b-5bddddca99de" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_c293ebf6-0735-4f0e-a01b-5bddddca99de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_67ee78e9-f8f3-4881-b6d8-b3ecbb9cf762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_c293ebf6-0735-4f0e-a01b-5bddddca99de" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_67ee78e9-f8f3-4881-b6d8-b3ecbb9cf762" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2021ShareRepurchaseAuthorizationMember_5d78eacd-c881-4687-bf6c-d778d87674d5" xlink:href="hum-20230331.xsd#hum_A2021ShareRepurchaseAuthorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_67ee78e9-f8f3-4881-b6d8-b3ecbb9cf762" xlink:to="loc_hum_A2021ShareRepurchaseAuthorizationMember_5d78eacd-c881-4687-bf6c-d778d87674d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2023ShareRepurchaseAuthorizationMember_30da9ca6-cf55-4e07-9614-528a24f07b00" xlink:href="hum-20230331.xsd#hum_A2023ShareRepurchaseAuthorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_67ee78e9-f8f3-4881-b6d8-b3ecbb9cf762" xlink:to="loc_hum_A2023ShareRepurchaseAuthorizationMember_30da9ca6-cf55-4e07-9614-528a24f07b00" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTDebtOutstandingDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#DEBTDebtOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/DEBTDebtOutstandingDetails" xlink:type="extended" id="i585237cb04a447d0b3271a6c0fdd235a_DEBTDebtOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b0506788-33ba-47c4-a65a-bbc1af6fa2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b0506788-33ba-47c4-a65a-bbc1af6fa2ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e963db6b-ddf5-45a2-8c7a-e32cbbf86f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e963db6b-ddf5-45a2-8c7a-e32cbbf86f52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_3c53ad3a-3ed9-4158-9551-88b58533082e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:to="loc_us-gaap_ShortTermBorrowings_3c53ad3a-3ed9-4158-9551-88b58533082e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_2b2d3b85-6dcc-4624-aa2f-64c70e2d6f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:to="loc_us-gaap_LongTermDebtCurrent_2b2d3b85-6dcc-4624-aa2f-64c70e2d6f46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_93569d8a-9cef-48a1-ad52-7b6d861c21bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:to="loc_us-gaap_DebtCurrent_93569d8a-9cef-48a1-ad52-7b6d861c21bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e284c8aa-b935-4b81-ae60-adb49d12616f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e284c8aa-b935-4b81-ae60-adb49d12616f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_aaafac33-bd77-4836-8b47-54a2e8b6d1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:to="loc_us-gaap_DebtInstrumentTable_aaafac33-bd77-4836-8b47-54a2e8b6d1d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_378e0bec-91df-47f0-9640-b0ed4f9e931a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_aaafac33-bd77-4836-8b47-54a2e8b6d1d8" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_378e0bec-91df-47f0-9640-b0ed4f9e931a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_378e0bec-91df-47f0-9640-b0ed4f9e931a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_378e0bec-91df-47f0-9640-b0ed4f9e931a" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_378e0bec-91df-47f0-9640-b0ed4f9e931a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_64d92bde-631c-4c94-86fd-c3439e7b8b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_378e0bec-91df-47f0-9640-b0ed4f9e931a" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_64d92bde-631c-4c94-86fd-c3439e7b8b69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_97c95631-2432-4cdc-82ae-89983a74ad31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_64d92bde-631c-4c94-86fd-c3439e7b8b69" xlink:to="loc_us-gaap_CommercialPaperMember_97c95631-2432-4cdc-82ae-89983a74ad31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_57812941-8ed4-4aaa-b05d-afcf453da3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_aaafac33-bd77-4836-8b47-54a2e8b6d1d8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_57812941-8ed4-4aaa-b05d-afcf453da3c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_57812941-8ed4-4aaa-b05d-afcf453da3c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_57812941-8ed4-4aaa-b05d-afcf453da3c6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_57812941-8ed4-4aaa-b05d-afcf453da3c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_825c8f6c-cd63-4dee-9c14-ec3401e6811b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_57812941-8ed4-4aaa-b05d-afcf453da3c6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_825c8f6c-cd63-4dee-9c14-ec3401e6811b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ccc6f3a6-677d-4421-af09-42ef71a47202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_825c8f6c-cd63-4dee-9c14-ec3401e6811b" xlink:to="loc_us-gaap_SeniorNotesMember_ccc6f3a6-677d-4421-af09-42ef71a47202" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_c8ca061b-e30c-45ff-8ea5-f973d6824f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_825c8f6c-cd63-4dee-9c14-ec3401e6811b" xlink:to="loc_us-gaap_LoansPayableMember_c8ca061b-e30c-45ff-8ea5-f973d6824f71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c2ca69b9-2d4a-4747-bdb1-9aa3d310d1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_aaafac33-bd77-4836-8b47-54a2e8b6d1d8" xlink:to="loc_us-gaap_DebtInstrumentAxis_c2ca69b9-2d4a-4747-bdb1-9aa3d310d1d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c2ca69b9-2d4a-4747-bdb1-9aa3d310d1d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c2ca69b9-2d4a-4747-bdb1-9aa3d310d1d1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c2ca69b9-2d4a-4747-bdb1-9aa3d310d1d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c2ca69b9-2d4a-4747-bdb1-9aa3d310d1d1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A065PercentSeniorNotesDueAugust2023Member_33677683-14d4-4157-b1df-a00137a5cff8" xlink:href="hum-20230331.xsd#hum_A065PercentSeniorNotesDueAugust2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A065PercentSeniorNotesDueAugust2023Member_33677683-14d4-4157-b1df-a00137a5cff8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member_94c6e306-d414-41a1-91d6-7b412b897409" xlink:href="hum-20230331.xsd#hum_A3.85PercentSeniorNotesDueOctober2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member_94c6e306-d414-41a1-91d6-7b412b897409" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A450PercentSeniorNotesDueApril2025Member_0fad0d9d-1659-4294-8ddb-99531cbc85c2" xlink:href="hum-20230331.xsd#hum_A450PercentSeniorNotesDueApril2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A450PercentSeniorNotesDueApril2025Member_0fad0d9d-1659-4294-8ddb-99531cbc85c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A570PercentSeniorNotesDueMarch2026Member_5c377efc-0ae5-4016-babd-ffbc1b5d3162" xlink:href="hum-20230331.xsd#hum_A570PercentSeniorNotesDueMarch2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A570PercentSeniorNotesDueMarch2026Member_5c377efc-0ae5-4016-babd-ffbc1b5d3162" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A135PercentSeniorNotesDueFebruary2027Member_7ccc6429-35b4-4d53-9727-a9b890d386e0" xlink:href="hum-20230331.xsd#hum_A135PercentSeniorNotesDueFebruary2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A135PercentSeniorNotesDueFebruary2027Member_7ccc6429-35b4-4d53-9727-a9b890d386e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.95PercentSeniorNotesDueMarch2027Member_9b378ad2-bbed-4831-acf2-1bcf66b2f4f4" xlink:href="hum-20230331.xsd#hum_A3.95PercentSeniorNotesDueMarch2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A3.95PercentSeniorNotesDueMarch2027Member_9b378ad2-bbed-4831-acf2-1bcf66b2f4f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A5750PercentSeniorNotesDueMarch2028Member_c6dc94cc-ca70-4cb2-9054-45698b53adf1" xlink:href="hum-20230331.xsd#hum_A5750PercentSeniorNotesDueMarch2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A5750PercentSeniorNotesDueMarch2028Member_c6dc94cc-ca70-4cb2-9054-45698b53adf1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3700PercentSeniorNotesDueMarch2029Member_a7e189a4-4bad-4507-8000-18507d3550f0" xlink:href="hum-20230331.xsd#hum_A3700PercentSeniorNotesDueMarch2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A3700PercentSeniorNotesDueMarch2029Member_a7e189a4-4bad-4507-8000-18507d3550f0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3125PercentSeniorNotesDueAugust2029Member_56535730-1947-4f9f-b132-36079710bdfa" xlink:href="hum-20230331.xsd#hum_A3125PercentSeniorNotesDueAugust2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A3125PercentSeniorNotesDueAugust2029Member_56535730-1947-4f9f-b132-36079710bdfa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4875PercentSeniorNotesDueApril2030Member_0604d674-d2ef-41fc-b711-bc8972625ea8" xlink:href="hum-20230331.xsd#hum_A4875PercentSeniorNotesDueApril2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A4875PercentSeniorNotesDueApril2030Member_0604d674-d2ef-41fc-b711-bc8972625ea8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A215PercentSeniorNotesDueFebruary2032Member_ee52c347-e2d4-456a-95e1-207b52a701a5" xlink:href="hum-20230331.xsd#hum_A215PercentSeniorNotesDueFebruary2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A215PercentSeniorNotesDueFebruary2032Member_ee52c347-e2d4-456a-95e1-207b52a701a5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A588PercentSeniorNotesDueMarch2033Member_0b876daf-ab2a-4e87-bf4d-3dc6764780a4" xlink:href="hum-20230331.xsd#hum_A588PercentSeniorNotesDueMarch2033Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A588PercentSeniorNotesDueMarch2033Member_0b876daf-ab2a-4e87-bf4d-3dc6764780a4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A8.15PercentSeniorNotesDueJune2038Member_1cd25542-6d14-4713-939e-7a643fef0864" xlink:href="hum-20230331.xsd#hum_A8.15PercentSeniorNotesDueJune2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A8.15PercentSeniorNotesDueJune2038Member_1cd25542-6d14-4713-939e-7a643fef0864" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.625PercentSeniorNotesDueDecember2042Member_404340a0-b703-4ebe-b33f-106bf0adb406" xlink:href="hum-20230331.xsd#hum_A4.625PercentSeniorNotesDueDecember2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A4.625PercentSeniorNotesDueDecember2042Member_404340a0-b703-4ebe-b33f-106bf0adb406" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.95PercentSeniorNotesDueOctober2044Member_2eafda95-94f5-4392-aaae-294dedb644ed" xlink:href="hum-20230331.xsd#hum_A4.95PercentSeniorNotesDueOctober2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A4.95PercentSeniorNotesDueOctober2044Member_2eafda95-94f5-4392-aaae-294dedb644ed" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.80PercentSeniorNotesDueMarch2047Member_74bd2435-78fe-44fd-9038-11da5e6d324f" xlink:href="hum-20230331.xsd#hum_A4.80PercentSeniorNotesDueMarch2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A4.80PercentSeniorNotesDueMarch2047Member_74bd2435-78fe-44fd-9038-11da5e6d324f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A395PercentSeniorNotesDueAugust2049Member_dc9e8c5b-6337-4b1d-ac86-c42bc2e1ed45" xlink:href="hum-20230331.xsd#hum_A395PercentSeniorNotesDueAugust2049Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A395PercentSeniorNotesDueAugust2049Member_dc9e8c5b-6337-4b1d-ac86-c42bc2e1ed45" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A550PercentSeniorNotesDueMarch2053Member_c6b52ab0-e18f-4bdd-b895-28d4fd841609" xlink:href="hum-20230331.xsd#hum_A550PercentSeniorNotesDueMarch2053Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A550PercentSeniorNotesDueMarch2053Member_c6b52ab0-e18f-4bdd-b895-28d4fd841609" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DelayedDrawTermLoanMay2024Member_2cda1d25-daea-4b0c-93cb-0a9e1caa2b6b" xlink:href="hum-20230331.xsd#hum_DelayedDrawTermLoanMay2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_DelayedDrawTermLoanMay2024Member_2cda1d25-daea-4b0c-93cb-0a9e1caa2b6b" xlink:type="arc" order="18"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTSeniorNotesDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#DEBTSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/DEBTSeniorNotesDetails" xlink:type="extended" id="id4d7b62cc0784c2f97e62e8083c6c8af_DEBTSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9d6d74d5-e440-4087-9a1e-4e9cb88bb20d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9d6d74d5-e440-4087-9a1e-4e9cb88bb20d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_29c7a399-c545-40f8-9575-17ffcf692fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_29c7a399-c545-40f8-9575-17ffcf692fda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_be924aa4-d132-4574-9a7f-145fd77e8572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_be924aa4-d132-4574-9a7f-145fd77e8572" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_3c395c2a-6d48-405e-87de-3e994c2726f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_3c395c2a-6d48-405e-87de-3e994c2726f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_fcd188be-5971-4a31-a17d-352dee43fdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_fcd188be-5971-4a31-a17d-352dee43fdb4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8edcc922-39bb-489a-a90c-6a613c84d791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:to="loc_us-gaap_DebtInstrumentTable_8edcc922-39bb-489a-a90c-6a613c84d791" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0a042e0f-731d-447a-9429-7e1cb0fc9092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8edcc922-39bb-489a-a90c-6a613c84d791" xlink:to="loc_us-gaap_DebtInstrumentAxis_0a042e0f-731d-447a-9429-7e1cb0fc9092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0a042e0f-731d-447a-9429-7e1cb0fc9092_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0a042e0f-731d-447a-9429-7e1cb0fc9092" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0a042e0f-731d-447a-9429-7e1cb0fc9092_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0aaec230-900e-4f07-a1a6-db5b48c68f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0a042e0f-731d-447a-9429-7e1cb0fc9092" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0aaec230-900e-4f07-a1a6-db5b48c68f7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member_b98ddee7-c7c8-49a7-b3e8-eeee1fb4c065" xlink:href="hum-20230331.xsd#hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0aaec230-900e-4f07-a1a6-db5b48c68f7b" xlink:to="loc_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member_b98ddee7-c7c8-49a7-b3e8-eeee1fb4c065" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A570PercentSeniorNotesDueMarch2026Member_dd3799d8-9492-44ef-9cf9-d0b287cd919f" xlink:href="hum-20230331.xsd#hum_A570PercentSeniorNotesDueMarch2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member_b98ddee7-c7c8-49a7-b3e8-eeee1fb4c065" xlink:to="loc_hum_A570PercentSeniorNotesDueMarch2026Member_dd3799d8-9492-44ef-9cf9-d0b287cd919f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A550PercentSeniorNotesDueMarch2053Member_5c8bee1e-2146-4f1b-b449-98eb62cc9318" xlink:href="hum-20230331.xsd#hum_A550PercentSeniorNotesDueMarch2053Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member_b98ddee7-c7c8-49a7-b3e8-eeee1fb4c065" xlink:to="loc_hum_A550PercentSeniorNotesDueMarch2053Member_5c8bee1e-2146-4f1b-b449-98eb62cc9318" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A065PercentSeniorNotesDueAugust2023Member_06298d37-677e-440d-a299-4995b2302b6a" xlink:href="hum-20230331.xsd#hum_A065PercentSeniorNotesDueAugust2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0aaec230-900e-4f07-a1a6-db5b48c68f7b" xlink:to="loc_hum_A065PercentSeniorNotesDueAugust2023Member_06298d37-677e-440d-a299-4995b2302b6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member_a5f276d8-7ed7-4d47-92bb-7b89066c8968" xlink:href="hum-20230331.xsd#hum_A3.85PercentSeniorNotesDueOctober2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0aaec230-900e-4f07-a1a6-db5b48c68f7b" xlink:to="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member_a5f276d8-7ed7-4d47-92bb-7b89066c8968" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DelayedDrawTermLoanMember_3c1b5238-f081-4fae-a627-7d9a221d748e" xlink:href="hum-20230331.xsd#hum_DelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0aaec230-900e-4f07-a1a6-db5b48c68f7b" xlink:to="loc_hum_DelayedDrawTermLoanMember_3c1b5238-f081-4fae-a627-7d9a221d748e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6b9a42e2-0305-4709-8b1d-e2d760518044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8edcc922-39bb-489a-a90c-6a613c84d791" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6b9a42e2-0305-4709-8b1d-e2d760518044" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6b9a42e2-0305-4709-8b1d-e2d760518044_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6b9a42e2-0305-4709-8b1d-e2d760518044" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6b9a42e2-0305-4709-8b1d-e2d760518044_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_61edb3f2-ff1a-47c5-8990-1a364e123702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6b9a42e2-0305-4709-8b1d-e2d760518044" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_61edb3f2-ff1a-47c5-8990-1a364e123702" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_89fd906d-8dd3-4e54-b7dd-606367dce784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_61edb3f2-ff1a-47c5-8990-1a364e123702" xlink:to="loc_us-gaap_SeniorNotesMember_89fd906d-8dd3-4e54-b7dd-606367dce784" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_4e4b12d8-8764-4d58-a444-ebf2b67009cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_61edb3f2-ff1a-47c5-8990-1a364e123702" xlink:to="loc_us-gaap_LoansPayableMember_4e4b12d8-8764-4d58-a444-ebf2b67009cd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#DEBTRevolvingCreditAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails" xlink:type="extended" id="ib93fbce389a04a799c9cd9de770dce34_DEBTRevolvingCreditAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_80a1b308-669c-449e-a909-02f89c925e86" xlink:href="hum-20230331.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:to="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_80a1b308-669c-449e-a909-02f89c925e86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_13ec8e61-0eaa-40c5-86fe-b6d18dfa548f" xlink:href="hum-20230331.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:to="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_13ec8e61-0eaa-40c5-86fe-b6d18dfa548f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_14296e94-d95e-4671-b74f-02dc64f32177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:to="loc_us-gaap_LinesOfCreditCurrent_14296e94-d95e-4671-b74f-02dc64f32177" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_521ec618-f8a4-48d0-8040-cb1b1163d1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_521ec618-f8a4-48d0-8040-cb1b1163d1c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_85aa8c99-4bae-4250-ae1e-2d335fe30014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:to="loc_us-gaap_DebtInstrumentTerm_85aa8c99-4bae-4250-ae1e-2d335fe30014" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_3b968fad-827b-4aa6-a2f8-27d45ff988f1" xlink:href="hum-20230331.xsd#hum_LineOfCreditFacilityUncommittedIncrementalCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:to="loc_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_3b968fad-827b-4aa6-a2f8-27d45ff988f1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_93289923-1210-4315-96c7-d408889d5318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_93289923-1210-4315-96c7-d408889d5318" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_684b4f8f-8698-4ba3-bfea-3a088944c516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_93289923-1210-4315-96c7-d408889d5318" xlink:to="loc_us-gaap_CreditFacilityAxis_684b4f8f-8698-4ba3-bfea-3a088944c516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_684b4f8f-8698-4ba3-bfea-3a088944c516_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_684b4f8f-8698-4ba3-bfea-3a088944c516" xlink:to="loc_us-gaap_CreditFacilityDomain_684b4f8f-8698-4ba3-bfea-3a088944c516_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a2e6fe59-fc0d-4e24-ac8e-ccf75d8ecd11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_684b4f8f-8698-4ba3-bfea-3a088944c516" xlink:to="loc_us-gaap_CreditFacilityDomain_a2e6fe59-fc0d-4e24-ac8e-ccf75d8ecd11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ddb14568-4d0c-404b-bc34-fc227bd5bfcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a2e6fe59-fc0d-4e24-ac8e-ccf75d8ecd11" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ddb14568-4d0c-404b-bc34-fc227bd5bfcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_cd6a4006-4557-4dfd-8475-9ea049015d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a2e6fe59-fc0d-4e24-ac8e-ccf75d8ecd11" xlink:to="loc_us-gaap_LetterOfCreditMember_cd6a4006-4557-4dfd-8475-9ea049015d3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_17ae9d96-e4a3-42ed-9137-ad6343eac7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_93289923-1210-4315-96c7-d408889d5318" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_17ae9d96-e4a3-42ed-9137-ad6343eac7d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_17ae9d96-e4a3-42ed-9137-ad6343eac7d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17ae9d96-e4a3-42ed-9137-ad6343eac7d8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_17ae9d96-e4a3-42ed-9137-ad6343eac7d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a7cf0995-4b68-45f2-b65d-2b0941ad092a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17ae9d96-e4a3-42ed-9137-ad6343eac7d8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a7cf0995-4b68-45f2-b65d-2b0941ad092a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_258975ff-a0ec-4017-9fe0-239c410fdd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a7cf0995-4b68-45f2-b65d-2b0941ad092a" xlink:to="loc_us-gaap_LoansPayableMember_258975ff-a0ec-4017-9fe0-239c410fdd7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c64b5f13-74fe-47a9-891e-dd76d94b76a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_93289923-1210-4315-96c7-d408889d5318" xlink:to="loc_us-gaap_DebtInstrumentAxis_c64b5f13-74fe-47a9-891e-dd76d94b76a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c64b5f13-74fe-47a9-891e-dd76d94b76a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c64b5f13-74fe-47a9-891e-dd76d94b76a0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c64b5f13-74fe-47a9-891e-dd76d94b76a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_62fe93f0-5828-4a63-a670-d7c49797111e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c64b5f13-74fe-47a9-891e-dd76d94b76a0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_62fe93f0-5828-4a63-a670-d7c49797111e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevolvingCreditAgreementJune2021FiveYearMember_9105f7b9-b601-44b1-840b-9afc00547853" xlink:href="hum-20230331.xsd#hum_RevolvingCreditAgreementJune2021FiveYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62fe93f0-5828-4a63-a670-d7c49797111e" xlink:to="loc_hum_RevolvingCreditAgreementJune2021FiveYearMember_9105f7b9-b601-44b1-840b-9afc00547853" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevolvingCreditAgreementJune2021OneYearMember_51caca34-b923-44f3-895b-40997968e56f" xlink:href="hum-20230331.xsd#hum_RevolvingCreditAgreementJune2021OneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62fe93f0-5828-4a63-a670-d7c49797111e" xlink:to="loc_hum_RevolvingCreditAgreementJune2021OneYearMember_51caca34-b923-44f3-895b-40997968e56f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#DEBTCommercialPaperandOtherShorttermBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails" xlink:type="extended" id="ia0b60959b2ef4460b500ce9707cbf8b2_DEBTCommercialPaperandOtherShorttermBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_38f0afe0-e81f-4ba0-aa32-0be01e04ec77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_a4cf3d31-6aa9-4edd-9e76-b115667402fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_38f0afe0-e81f-4ba0-aa32-0be01e04ec77" xlink:to="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_a4cf3d31-6aa9-4edd-9e76-b115667402fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_be74bbb7-e301-4f66-8ec3-1e9a5e1d5e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_38f0afe0-e81f-4ba0-aa32-0be01e04ec77" xlink:to="loc_us-gaap_ShortTermBorrowings_be74bbb7-e301-4f66-8ec3-1e9a5e1d5e55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_062ddfa9-9243-44fa-b335-e680f9fb9ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_38f0afe0-e81f-4ba0-aa32-0be01e04ec77" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_062ddfa9-9243-44fa-b335-e680f9fb9ab6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_69acea61-839f-460d-b99b-70a54e97ec58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_38f0afe0-e81f-4ba0-aa32-0be01e04ec77" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_69acea61-839f-460d-b99b-70a54e97ec58" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_3d698145-2a0f-4fcc-b9f4-4628214136bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_69acea61-839f-460d-b99b-70a54e97ec58" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_3d698145-2a0f-4fcc-b9f4-4628214136bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3d698145-2a0f-4fcc-b9f4-4628214136bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_3d698145-2a0f-4fcc-b9f4-4628214136bd" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3d698145-2a0f-4fcc-b9f4-4628214136bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_bdc84417-78fd-428c-b719-7dc5e5795a45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_3d698145-2a0f-4fcc-b9f4-4628214136bd" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_bdc84417-78fd-428c-b719-7dc5e5795a45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_af335811-8fa7-42a1-b14e-ca40b1298b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_bdc84417-78fd-428c-b719-7dc5e5795a45" xlink:to="loc_us-gaap_CommercialPaperMember_af335811-8fa7-42a1-b14e-ca40b1298b50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember_2b187309-0d36-49f3-ae4e-ec8de3afd961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_bdc84417-78fd-428c-b719-7dc5e5795a45" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMember_2b187309-0d36-49f3-ae4e-ec8de3afd961" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails" xlink:type="extended" id="i9b00f1b3d07f4e4cbb8550b1ea0aecc8_COMMITMENTSGUARANTEESANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfTotalPremiumAndServicesRevenues_fa7776ae-8f6a-4034-bd94-fdf5a6a2a283" xlink:href="hum-20230331.xsd#hum_PercentageOfTotalPremiumAndServicesRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_PercentageOfTotalPremiumAndServicesRevenues_fa7776ae-8f6a-4034-bd94-fdf5a6a2a283" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfStatesComprisingTRICAREBeneficiaries_1dc4f16e-d586-4c01-a74b-bb3e1334ddf0" xlink:href="hum-20230331.xsd#hum_NumberOfStatesComprisingTRICAREBeneficiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_NumberOfStatesComprisingTRICAREBeneficiaries_1dc4f16e-d586-4c01-a74b-bb3e1334ddf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfTRICAREBeneficiaries_7efa2357-e6c3-41e3-8661-4b4ca36b3aa3" xlink:href="hum-20230331.xsd#hum_NumberOfTRICAREBeneficiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_NumberOfTRICAREBeneficiaries_7efa2357-e6c3-41e3-8661-4b4ca36b3aa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_c96d2fe3-38c8-4596-99c9-a69853d7ac27" xlink:href="hum-20230331.xsd#hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_c96d2fe3-38c8-4596-99c9-a69853d7ac27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_d2712a59-0ddd-4159-a61d-3ecf7adcef32" xlink:href="hum-20230331.xsd#hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_d2712a59-0ddd-4159-a61d-3ecf7adcef32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractBaseTerm_20b41743-ae6d-4034-8bc3-0642dae49203" xlink:href="hum-20230331.xsd#hum_TRICAREManagedCareSupportContractBaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_TRICAREManagedCareSupportContractBaseTerm_20b41743-ae6d-4034-8bc3-0642dae49203" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_03355b7a-c000-4e8b-af60-b8fe1a3c2e39" xlink:href="hum-20230331.xsd#hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_03355b7a-c000-4e8b-af60-b8fe1a3c2e39" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_eeb2c659-6370-4825-8878-4d46369498bd" xlink:href="hum-20230331.xsd#hum_TRICAREManagedCareSupportContractTermWithOptionExercises"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_eeb2c659-6370-4825-8878-4d46369498bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_058e9c7d-0b3d-44af-827d-0cbfb287d4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_us-gaap_LossContingenciesTable_058e9c7d-0b3d-44af-827d-0cbfb287d4b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_9a860546-b6cc-468a-8c21-3ad9bc849554" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_058e9c7d-0b3d-44af-827d-0cbfb287d4b5" xlink:to="loc_srt_MajorCustomersAxis_9a860546-b6cc-468a-8c21-3ad9bc849554" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_9a860546-b6cc-468a-8c21-3ad9bc849554_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_9a860546-b6cc-468a-8c21-3ad9bc849554" xlink:to="loc_srt_NameOfMajorCustomerDomain_9a860546-b6cc-468a-8c21-3ad9bc849554_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cd1db5a3-0096-473d-aadf-c987f4ded0aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_9a860546-b6cc-468a-8c21-3ad9bc849554" xlink:to="loc_srt_NameOfMajorCustomerDomain_cd1db5a3-0096-473d-aadf-c987f4ded0aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareMember_15134c70-6082-4bac-a740-02d30d4ae904" xlink:href="hum-20230331.xsd#hum_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cd1db5a3-0096-473d-aadf-c987f4ded0aa" xlink:to="loc_hum_MedicareMember_15134c70-6082-4bac-a740-02d30d4ae904" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicaidMember_edb0eb3f-9524-40ae-867f-dfc818bb8424" xlink:href="hum-20230331.xsd#hum_MedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cd1db5a3-0096-473d-aadf-c987f4ded0aa" xlink:to="loc_hum_MedicaidMember_edb0eb3f-9524-40ae-867f-dfc818bb8424" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MilitaryServiceMember_a18839d7-c3ca-4671-8076-9ccb1259d5ed" xlink:href="hum-20230331.xsd#hum_MilitaryServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cd1db5a3-0096-473d-aadf-c987f4ded0aa" xlink:to="loc_hum_MilitaryServiceMember_a18839d7-c3ca-4671-8076-9ccb1259d5ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREContractAxis_6a983664-d0c1-4f2d-a8c9-5a503bb2a667" xlink:href="hum-20230331.xsd#hum_TRICAREContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_058e9c7d-0b3d-44af-827d-0cbfb287d4b5" xlink:to="loc_hum_TRICAREContractAxis_6a983664-d0c1-4f2d-a8c9-5a503bb2a667" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREContractDomain_6a983664-d0c1-4f2d-a8c9-5a503bb2a667_default" xlink:href="hum-20230331.xsd#hum_TRICAREContractDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_hum_TRICAREContractAxis_6a983664-d0c1-4f2d-a8c9-5a503bb2a667" xlink:to="loc_hum_TRICAREContractDomain_6a983664-d0c1-4f2d-a8c9-5a503bb2a667_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREContractDomain_e5676ac5-d6a9-4601-90fc-3ebb6741bb43" xlink:href="hum-20230331.xsd#hum_TRICAREContractDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_hum_TRICAREContractAxis_6a983664-d0c1-4f2d-a8c9-5a503bb2a667" xlink:to="loc_hum_TRICAREContractDomain_e5676ac5-d6a9-4601-90fc-3ebb6741bb43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICARE2017EastRegionContractMember_16559360-2ca1-4c75-87e6-46546a714076" xlink:href="hum-20230331.xsd#hum_TRICARE2017EastRegionContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_TRICAREContractDomain_e5676ac5-d6a9-4601-90fc-3ebb6741bb43" xlink:to="loc_hum_TRICARE2017EastRegionContractMember_16559360-2ca1-4c75-87e6-46546a714076" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractEffective2024Member_323f7314-d940-42ac-b186-fc98a8a08dbb" xlink:href="hum-20230331.xsd#hum_TRICAREManagedCareSupportContractEffective2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_TRICAREContractDomain_e5676ac5-d6a9-4601-90fc-3ebb6741bb43" xlink:to="loc_hum_TRICAREManagedCareSupportContractEffective2024Member_323f7314-d940-42ac-b186-fc98a8a08dbb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#SEGMENTINFORMATIONSegmentResultsDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails" xlink:type="extended" id="i9853b0b85d0a42bfbffbf58c5a4595bb_SEGMENTINFORMATIONSegmentResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_13a6be5c-10cd-4b8c-b69f-ee20c1c0c25b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_PremiumsEarnedNet_13a6be5c-10cd-4b8c-b69f-ee20c1c0c25b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4e8dd91a-5b3c-4e99-82d6-1caa16ae466f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4e8dd91a-5b3c-4e99-82d6-1caa16ae466f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0744e4ee-5df9-47e1-b0cd-3218c239aca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_Revenues_0744e4ee-5df9-47e1-b0cd-3218c239aca4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_ebc44c7b-a21c-47e9-8bc7-9d0840efda08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_NetInvestmentIncome_ebc44c7b-a21c-47e9-8bc7-9d0840efda08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_adeb7a54-77ed-49a9-bb80-7c68c041f909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_adeb7a54-77ed-49a9-bb80-7c68c041f909" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_399932be-7436-4070-af04-d5e1a173de37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_399932be-7436-4070-af04-d5e1a173de37" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationIncomeStatement_a688422d-ec1e-42c2-bbe2-80b0630a9f53" xlink:href="hum-20230331.xsd#hum_DepreciationAndAmortizationIncomeStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_hum_DepreciationAndAmortizationIncomeStatement_a688422d-ec1e-42c2-bbe2-80b0630a9f53" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_bd25ed73-46e2-49a9-b9f4-fd9f991b92b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_BenefitsLossesAndExpenses_bd25ed73-46e2-49a9-b9f4-fd9f991b92b7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_be9d6d0a-0606-486e-b7c5-951d99fa8aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_OperatingIncomeLoss_be9d6d0a-0606-486e-b7c5-951d99fa8aa7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d6af140a-ee8f-4a5a-a91d-f47860571be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_InterestExpense_d6af140a-ee8f-4a5a-a91d-f47860571be1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_618844ff-6d63-403f-b3e5-f6f284c4d61f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_618844ff-6d63-403f-b3e5-f6f284c4d61f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_397de5bd-2021-4a14-be70-ab566a597a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_397de5bd-2021-4a14-be70-ab566a597a6a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_cedadbc4-f2ce-42e1-8bc5-2dfb96fb93b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_cedadbc4-f2ce-42e1-8bc5-2dfb96fb93b1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f763a80c-9f31-44d9-aef3-e7fabb0b6262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f763a80c-9f31-44d9-aef3-e7fabb0b6262" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_04b2ce36-34f6-4518-aace-3bd44fda895d" xlink:href="hum-20230331.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_04b2ce36-34f6-4518-aace-3bd44fda895d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_1697c7dd-7a9f-454c-864d-b25c51d6eca6" xlink:href="hum-20230331.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_1697c7dd-7a9f-454c-864d-b25c51d6eca6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_561d850a-3d7b-4bf3-9154-fb25e99ed365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_561d850a-3d7b-4bf3-9154-fb25e99ed365" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_511c9591-ccd6-4ee8-b299-cda364d7252b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_561d850a-3d7b-4bf3-9154-fb25e99ed365" xlink:to="loc_srt_ConsolidationItemsAxis_511c9591-ccd6-4ee8-b299-cda364d7252b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_511c9591-ccd6-4ee8-b299-cda364d7252b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_511c9591-ccd6-4ee8-b299-cda364d7252b" xlink:to="loc_srt_ConsolidationItemsDomain_511c9591-ccd6-4ee8-b299-cda364d7252b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_07f5a490-e52e-4d26-bbce-0d90ad345168" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_511c9591-ccd6-4ee8-b299-cda364d7252b" xlink:to="loc_srt_ConsolidationItemsDomain_07f5a490-e52e-4d26-bbce-0d90ad345168" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_672c3a81-f6b9-46cf-8db8-4dec3d171bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_07f5a490-e52e-4d26-bbce-0d90ad345168" xlink:to="loc_us-gaap_OperatingSegmentsMember_672c3a81-f6b9-46cf-8db8-4dec3d171bb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CorporateAndEliminationsMember_f0bd8ed4-3d01-493e-a6bd-8d773b16a302" xlink:href="hum-20230331.xsd#hum_CorporateAndEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_07f5a490-e52e-4d26-bbce-0d90ad345168" xlink:to="loc_hum_CorporateAndEliminationsMember_f0bd8ed4-3d01-493e-a6bd-8d773b16a302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_1a630b45-2052-4128-984b-3ef3275c8d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_07f5a490-e52e-4d26-bbce-0d90ad345168" xlink:to="loc_us-gaap_IntersegmentEliminationMember_1a630b45-2052-4128-984b-3ef3275c8d9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ab3ff6ab-de81-4dfe-bcf8-9ddc55398791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_561d850a-3d7b-4bf3-9154-fb25e99ed365" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ab3ff6ab-de81-4dfe-bcf8-9ddc55398791" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ab3ff6ab-de81-4dfe-bcf8-9ddc55398791_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab3ff6ab-de81-4dfe-bcf8-9ddc55398791" xlink:to="loc_us-gaap_SegmentDomain_ab3ff6ab-de81-4dfe-bcf8-9ddc55398791_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ebfc9e62-1cca-44a5-a4ea-894e578a9ede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab3ff6ab-de81-4dfe-bcf8-9ddc55398791" xlink:to="loc_us-gaap_SegmentDomain_ebfc9e62-1cca-44a5-a4ea-894e578a9ede" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InsuranceSegmentMember_8abc3851-de3a-4009-8b7b-4aef950ade02" xlink:href="hum-20230331.xsd#hum_InsuranceSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ebfc9e62-1cca-44a5-a4ea-894e578a9ede" xlink:to="loc_hum_InsuranceSegmentMember_8abc3851-de3a-4009-8b7b-4aef950ade02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CenterWellSegmentMember_e33c1e94-0e3a-4611-bb4d-63bf5567abde" xlink:href="hum-20230331.xsd#hum_CenterWellSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ebfc9e62-1cca-44a5-a4ea-894e578a9ede" xlink:to="loc_hum_CenterWellSegmentMember_e33c1e94-0e3a-4611-bb4d-63bf5567abde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_35d131dc-f7dc-4195-9a1a-44b4424a55e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_561d850a-3d7b-4bf3-9154-fb25e99ed365" xlink:to="loc_srt_ProductOrServiceAxis_35d131dc-f7dc-4195-9a1a-44b4424a55e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_35d131dc-f7dc-4195-9a1a-44b4424a55e4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_35d131dc-f7dc-4195-9a1a-44b4424a55e4" xlink:to="loc_srt_ProductsAndServicesDomain_35d131dc-f7dc-4195-9a1a-44b4424a55e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a37a6094-3a3c-4471-b3f7-f7ce7a49f675" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_35d131dc-f7dc-4195-9a1a-44b4424a55e4" xlink:to="loc_srt_ProductsAndServicesDomain_a37a6094-3a3c-4471-b3f7-f7ce7a49f675" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_7da43a07-af5b-41ab-b1c0-06e14bcde115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a37a6094-3a3c-4471-b3f7-f7ce7a49f675" xlink:to="loc_us-gaap_ServiceMember_7da43a07-af5b-41ab-b1c0-06e14bcde115" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_c349b2ee-5739-4a91-8601-85d4362d5c95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a37a6094-3a3c-4471-b3f7-f7ce7a49f675" xlink:to="loc_us-gaap_ProductMember_c349b2ee-5739-4a91-8601-85d4362d5c95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_08f901c7-c607-4cbf-85b6-ed7b91e98d65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_561d850a-3d7b-4bf3-9154-fb25e99ed365" xlink:to="loc_srt_MajorCustomersAxis_08f901c7-c607-4cbf-85b6-ed7b91e98d65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_08f901c7-c607-4cbf-85b6-ed7b91e98d65_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_08f901c7-c607-4cbf-85b6-ed7b91e98d65" xlink:to="loc_srt_NameOfMajorCustomerDomain_08f901c7-c607-4cbf-85b6-ed7b91e98d65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_08f901c7-c607-4cbf-85b6-ed7b91e98d65" xlink:to="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareAdvantageMember_e26a12bf-a967-4c74-beef-097116a872c9" xlink:href="hum-20230331.xsd#hum_MedicareAdvantageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_MedicareAdvantageMember_e26a12bf-a967-4c74-beef-097116a872c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GroupMedicareAdvantageMember_0e1eb3bf-20ad-4565-a69e-75aa203f62ab" xlink:href="hum-20230331.xsd#hum_GroupMedicareAdvantageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_GroupMedicareAdvantageMember_0e1eb3bf-20ad-4565-a69e-75aa203f62ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareStandAlonePrescriptionDrugPlanMember_889a745e-784c-48cc-a4ce-ccfed6fd2e6f" xlink:href="hum-20230331.xsd#hum_MedicareStandAlonePrescriptionDrugPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_MedicareStandAlonePrescriptionDrugPlanMember_889a745e-784c-48cc-a4ce-ccfed6fd2e6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareMember_cf6851dd-4dba-496e-88a6-ddb85a021fd1" xlink:href="hum-20230331.xsd#hum_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_MedicareMember_cf6851dd-4dba-496e-88a6-ddb85a021fd1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CommercialFullyInsuredMember_48f4aa44-9bdf-4b0c-8fc2-a6a836714fff" xlink:href="hum-20230331.xsd#hum_CommercialFullyInsuredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_CommercialFullyInsuredMember_48f4aa44-9bdf-4b0c-8fc2-a6a836714fff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SpecialtyBenefitsMember_d0586b97-540c-4b45-9b35-cda49ba51631" xlink:href="hum-20230331.xsd#hum_SpecialtyBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_SpecialtyBenefitsMember_d0586b97-540c-4b45-9b35-cda49ba51631" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareSupplementProductMember_ae7f7927-56b3-493c-a3d4-c107dd2bf4b0" xlink:href="hum-20230331.xsd#hum_MedicareSupplementProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_MedicareSupplementProductMember_ae7f7927-56b3-493c-a3d4-c107dd2bf4b0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicaidAndOtherMember_b15e035c-099b-497c-8cc7-c6cfdf24f783" xlink:href="hum-20230331.xsd#hum_MedicaidAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_MedicaidAndOtherMember_b15e035c-099b-497c-8cc7-c6cfdf24f783" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HomeSolutionsMember_4fc9a600-88ab-4e87-b19b-f314c38ca645" xlink:href="hum-20230331.xsd#hum_HomeSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_HomeSolutionsMember_4fc9a600-88ab-4e87-b19b-f314c38ca645" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProviderServicesMember_5a9bbaee-7f3c-4519-9515-f3d0fb4d5a68" xlink:href="hum-20230331.xsd#hum_ProviderServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_ProviderServicesMember_5a9bbaee-7f3c-4519-9515-f3d0fb4d5a68" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CommercialASOMember_42f2fd62-d321-456a-8fe2-7a3dcfff6667" xlink:href="hum-20230331.xsd#hum_CommercialASOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_CommercialASOMember_42f2fd62-d321-456a-8fe2-7a3dcfff6667" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MilitaryAndOtherMember_0ca96c12-d56f-42a0-a719-66f2588321ce" xlink:href="hum-20230331.xsd#hum_MilitaryAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_MilitaryAndOtherMember_0ca96c12-d56f-42a0-a719-66f2588321ce" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PharmacySolutionsMember_4400d0a3-cf36-41da-818a-bd9903b8e5ea" xlink:href="hum-20230331.xsd#hum_PharmacySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_PharmacySolutionsMember_4400d0a3-cf36-41da-818a-bd9903b8e5ea" xlink:type="arc" order="12"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>hum-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a7548c89-cbcc-4020-9549-0b2a193c2a02,g:7564a905-24e2-4ab4-9ab3-db550d1e5638-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_ec1aba5a-6dc6-4b2c-937b-b1511ed5f379_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4981b150-a3a3-4db0-971a-c2292731a5fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_40316958-da41-4022-bddd-6e465f62054a_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_0bf05e84-27b7-4b2f-a70b-d2a562f6a092_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c8cf5760-e271-4e4f-b5a2-e8558d3b44fa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_bbce74f2-0ebe-461d-80ce-99b97cc937d9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset (Liability) Net, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetLiabilityNetMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:to="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TRICARE2017EastRegionContractMember_25ac6d7b-3a4b-4874-988c-3e4c83b10b97_terseLabel_en-US" xlink:label="lab_hum_TRICARE2017EastRegionContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">T2017 East Region</link:label>
    <link:label id="lab_hum_TRICARE2017EastRegionContractMember_label_en-US" xlink:label="lab_hum_TRICARE2017EastRegionContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE 2017 East Region Contract [Member]</link:label>
    <link:label id="lab_hum_TRICARE2017EastRegionContractMember_documentation_en-US" xlink:label="lab_hum_TRICARE2017EastRegionContractMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE 2017 East Region Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICARE2017EastRegionContractMember" xlink:href="hum-20230331.xsd#hum_TRICARE2017EastRegionContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TRICARE2017EastRegionContractMember" xlink:to="lab_hum_TRICARE2017EastRegionContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_04fc0260-db1b-472c-a4f9-3df7e11034eb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Benefits Payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_426bee52-6a9f-4b66-97b3-823f03e3f31e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_42f80419-5883-4aef-a1f9-2e6d8fc39056_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Intangible Assets, Indefinite-Lived</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TermLoanDueOctober2023Member_5aa278f0-6455-4674-bd08-8bc6c2d8cd83_terseLabel_en-US" xlink:label="lab_hum_TermLoanDueOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due October 2023</link:label>
    <link:label id="lab_hum_TermLoanDueOctober2023Member_label_en-US" xlink:label="lab_hum_TermLoanDueOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due October 2023 [Member]</link:label>
    <link:label id="lab_hum_TermLoanDueOctober2023Member_documentation_en-US" xlink:label="lab_hum_TermLoanDueOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due October 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanDueOctober2023Member" xlink:href="hum-20230331.xsd#hum_TermLoanDueOctober2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TermLoanDueOctober2023Member" xlink:to="lab_hum_TermLoanDueOctober2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_9f0bbc12-5bb5-401e-857c-6e1e6b82b044_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_5c5646f4-8029-498c-ba5e-9be37055e9f9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_c68a3739-f2e7-4455-ab88-c4dee70c590e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember_2e6bca72-1bf5-4ed3-9755-d59a13c1015a_terseLabel_en-US" xlink:label="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare stand-alone PDP</link:label>
    <link:label id="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember_label_en-US" xlink:label="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Stand Alone Prescription Drug Plan [Member]</link:label>
    <link:label id="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember_documentation_en-US" xlink:label="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Stand Alone Prescription Drug Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareStandAlonePrescriptionDrugPlanMember" xlink:href="hum-20230331.xsd#hum_MedicareStandAlonePrescriptionDrugPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicareStandAlonePrescriptionDrugPlanMember" xlink:to="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractEffective2024Member_cda4c215-5673-4e9d-95d8-bcaf0832486a_terseLabel_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractEffective2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">T-5, Effective 2024</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractEffective2024Member_label_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractEffective2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Effective 2024 [Member]</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractEffective2024Member_documentation_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractEffective2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Effective 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractEffective2024Member" xlink:href="hum-20230331.xsd#hum_TRICAREManagedCareSupportContractEffective2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TRICAREManagedCareSupportContractEffective2024Member" xlink:to="lab_hum_TRICAREManagedCareSupportContractEffective2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_e73c566a-4dd1-4cfe-ad94-740ec2d46a35_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_a57ef83c-9ac6-4f58-bada-46bff337fbba_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances, beginning of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1e1fcbbf-0375-4f98-a0e2-8a0338c8ca04_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_5d1f96cc-cd28-47eb-9103-4a4245543046_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member_f8043c85-4d71-4e16-a483-b2fd33f9953b_terseLabel_en-US" xlink:label="lab_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.70 Percent Senior Notes Due March 2026 and 5.50 Percent Senior Notes Due March 2053</link:label>
    <link:label id="lab_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member_label_en-US" xlink:label="lab_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.70 Percent Senior Notes Due March 2026 And 5.50 Percent Senior Notes Due March 2053 [Member]</link:label>
    <link:label id="lab_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member_documentation_en-US" xlink:label="lab_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.70 Percent Senior Notes Due March 2026 And 5.50 Percent Senior Notes Due March 2053</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member" xlink:href="hum-20230331.xsd#hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member" xlink:to="lab_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_31e945a6-7ee8-4416-9ac3-3e8323276ca8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_125658be-cfcc-4bcf-93fd-46fdb012633d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fae0f8a5-4827-4e3b-93eb-d5bab6daf0dc_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_54f625c8-ee2e-4106-aa36-8d8e5692078d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_eb18e1bc-454e-46f9-8267-e6810375d5ba_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7019774b-e2eb-486c-b97f-9d1cf1436599_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_d3eb48f6-f3cf-4eab-a99c-ca7d6e77d8e2_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_65edc7dc-8ad0-469c-b072-207ce447e37c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_c41fd89e-c87e-45c1-b417-f3dbcd04d72d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_ad89f956-88b4-4ee5-bb50-9bce6ed18946_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A135PercentSeniorNotesDueFebruary2027Member_10e2e7c6-fb2c-4033-bfd7-c9291067e05e_terseLabel_en-US" xlink:label="lab_hum_A135PercentSeniorNotesDueFebruary2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750&#160;million, 1.350% due February 3, 2027</link:label>
    <link:label id="lab_hum_A135PercentSeniorNotesDueFebruary2027Member_label_en-US" xlink:label="lab_hum_A135PercentSeniorNotesDueFebruary2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.35 Percent Senior Notes Due February 2027 [Member]</link:label>
    <link:label id="lab_hum_A135PercentSeniorNotesDueFebruary2027Member_documentation_en-US" xlink:label="lab_hum_A135PercentSeniorNotesDueFebruary2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.35 Percent Senior Notes Due February 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A135PercentSeniorNotesDueFebruary2027Member" xlink:href="hum-20230331.xsd#hum_A135PercentSeniorNotesDueFebruary2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A135PercentSeniorNotesDueFebruary2027Member" xlink:to="lab_hum_A135PercentSeniorNotesDueFebruary2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount_0a6a0104-ccfa-4b47-a971-03e526729d78_terseLabel_en-US" xlink:label="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Member co-share amounts and government subsidies</link:label>
    <link:label id="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount_label_en-US" xlink:label="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government And Health Plan Member Subsidies Amount</link:label>
    <link:label id="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount_documentation_en-US" xlink:label="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of member co-share amounts and government subsidies that are excluded from benefits expense because the health plans do not bear responsibility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GovernmentAndHealthPlanMemberSubsidiesAmount" xlink:href="hum-20230331.xsd#hum_GovernmentAndHealthPlanMemberSubsidiesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_GovernmentAndHealthPlanMemberSubsidiesAmount" xlink:to="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_f472efb5-a825-4e9c-8e2f-a744cd5b2a4a_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_9a37d925-d1f9-494b-97d7-e046882a18a9_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_b8d6b9ff-d91c-4e3f-b436-e8468f9fbaf4_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_a4c3ce4e-9bfe-4954-b643-a5f536b4c876_negatedTerseLabel_en-US" xlink:label="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (income) attributable to noncontrolling interests</link:label>
    <link:label id="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) From Continuing Operations Before Income Taxes, Attributable To Noncontrolling Interest</link:label>
    <link:label id="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_documentation_en-US" xlink:label="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) From Continuing Operations Before Income Taxes, Attributable To Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" xlink:href="hum-20230331.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" xlink:to="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_54d5ffbf-0c8a-4f45-a53e-4de73beba20a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5ec7c1b6-bff0-46dc-91b8-339e36bdcff7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_e2dfd00f-4f40-4d0f-9ba0-7d07c81d586e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Humana</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_74f424c5-ee45-42fa-9bd6-370047c463cc_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Humana</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_91a4d879-cfb5-4b59-a153-309ef66ddd40_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income available for common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_dab9dced-bfa0-49a6-9d9e-584717710c26_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_45029756-c8c6-430b-82f4-933a3e661511_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of antidilutive stock options and restricted stock excluded from computation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0f8429cf-5464-42fd-94d1-282c5ceca94e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_fb9296fd-91f0-4dfe-85bc-c0000d74f93d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_afa81c16-77c4-486c-9dbb-49fae3dd4891_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total reclassification adjustment, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A065PercentSeniorNotesDueAugust2023Member_0318e7d6-9ef1-4fec-a5f7-b1c508f5410d_terseLabel_en-US" xlink:label="lab_hum_A065PercentSeniorNotesDueAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1.5&#160;billion, 0.650% due August 3, 2023</link:label>
    <link:label id="lab_hum_A065PercentSeniorNotesDueAugust2023Member_label_en-US" xlink:label="lab_hum_A065PercentSeniorNotesDueAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.65 Percent Senior Notes Due August 2023 [Member]</link:label>
    <link:label id="lab_hum_A065PercentSeniorNotesDueAugust2023Member_documentation_en-US" xlink:label="lab_hum_A065PercentSeniorNotesDueAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.65 Percent Senior Notes Due August 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A065PercentSeniorNotesDueAugust2023Member" xlink:href="hum-20230331.xsd#hum_A065PercentSeniorNotesDueAugust2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A065PercentSeniorNotesDueAugust2023Member" xlink:to="lab_hum_A065PercentSeniorNotesDueAugust2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_cba45004-bea0-4c35-91ae-3f5690b683f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentIncome_63e4cea8-b72d-4802-b689-38faae5ea96e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income (loss)</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_263fc20c-e00f-4b92-a9aa-3403b54b1a54_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_91de61e6-2a7b-4ce0-8186-788742bf286e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_2ea00667-ed50-42f8-9e66-e15475808c54_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average cost of capital</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_16724508-4422-4811-b74f-591890241d36_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_c2f08b3b-1460-4deb-b304-1b318af6f1f5_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total invested assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_fb2fb129-a739-4e59-8d7a-5a0927de9dbe_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_7068df90-6341-4897-8b24-bf4edcf16fe6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A4875PercentSeniorNotesDueApril2030Member_7974b3d0-27a0-472e-ac2e-eb8d654e9774_terseLabel_en-US" xlink:label="lab_hum_A4875PercentSeniorNotesDueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$500&#160;million, 4.875% due April 1, 2030</link:label>
    <link:label id="lab_hum_A4875PercentSeniorNotesDueApril2030Member_label_en-US" xlink:label="lab_hum_A4875PercentSeniorNotesDueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.875 Percent Senior Notes Due April 2030 [Member]</link:label>
    <link:label id="lab_hum_A4875PercentSeniorNotesDueApril2030Member_documentation_en-US" xlink:label="lab_hum_A4875PercentSeniorNotesDueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A 4.875 Percent Senior Notes Due April 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4875PercentSeniorNotesDueApril2030Member" xlink:href="hum-20230331.xsd#hum_A4875PercentSeniorNotesDueApril2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A4875PercentSeniorNotesDueApril2030Member" xlink:to="lab_hum_A4875PercentSeniorNotesDueApril2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_PaymentsForProceedsFromContractDeposits_f1df6791-2439-40d1-ab1b-12d5065c4dc0_negatedTerseLabel_en-US" xlink:label="lab_hum_PaymentsForProceedsFromContractDeposits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipts from contract deposits, net</link:label>
    <link:label id="lab_hum_PaymentsForProceedsFromContractDeposits_label_en-US" xlink:label="lab_hum_PaymentsForProceedsFromContractDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Proceeds From Contract Deposits</link:label>
    <link:label id="lab_hum_PaymentsForProceedsFromContractDeposits_documentation_en-US" xlink:label="lab_hum_PaymentsForProceedsFromContractDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Proceeds From Contract Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PaymentsForProceedsFromContractDeposits" xlink:href="hum-20230331.xsd#hum_PaymentsForProceedsFromContractDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_PaymentsForProceedsFromContractDeposits" xlink:to="lab_hum_PaymentsForProceedsFromContractDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_47edf951-ede3-44fc-9a91-65b2c01349e0_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost, 73,721,604 shares at March&#160;31, 2023 and 73,691,955 shares at December 31, 2022</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A395PercentSeniorNotesDueAugust2049Member_a2b28290-1f85-4f93-bebf-1ada58debfd0_terseLabel_en-US" xlink:label="lab_hum_A395PercentSeniorNotesDueAugust2049Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$500 million, 3.950% due August 15, 2049</link:label>
    <link:label id="lab_hum_A395PercentSeniorNotesDueAugust2049Member_label_en-US" xlink:label="lab_hum_A395PercentSeniorNotesDueAugust2049Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95 Percent Senior Notes Due August 2049 [Member]</link:label>
    <link:label id="lab_hum_A395PercentSeniorNotesDueAugust2049Member_documentation_en-US" xlink:label="lab_hum_A395PercentSeniorNotesDueAugust2049Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95 Percent Senior Notes Due August 2049 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A395PercentSeniorNotesDueAugust2049Member" xlink:href="hum-20230331.xsd#hum_A395PercentSeniorNotesDueAugust2049Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A395PercentSeniorNotesDueAugust2049Member" xlink:to="lab_hum_A395PercentSeniorNotesDueAugust2049Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_af6b3fda-3fbd-4fe0-81c4-36c97fdb7ed4_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_89201217-2e88-45b2-b65a-b94849385834_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5cfb6c0e-c6b9-4a55-9a04-e541446927cc_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c38eb20f-5c2a-4f85-9f76-2c6c9bab341b_netLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A3125PercentSeniorNotesDueAugust2029Member_9a6f79fd-7c97-4b37-8d71-557a02d95c78_terseLabel_en-US" xlink:label="lab_hum_A3125PercentSeniorNotesDueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$500&#160;million, 3.125% due August 15, 2029</link:label>
    <link:label id="lab_hum_A3125PercentSeniorNotesDueAugust2029Member_label_en-US" xlink:label="lab_hum_A3125PercentSeniorNotesDueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125 Percent Senior Notes Due August 2029 [Member]</link:label>
    <link:label id="lab_hum_A3125PercentSeniorNotesDueAugust2029Member_documentation_en-US" xlink:label="lab_hum_A3125PercentSeniorNotesDueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A 3.125 Percent Senior Notes Due August 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3125PercentSeniorNotesDueAugust2029Member" xlink:href="hum-20230331.xsd#hum_A3125PercentSeniorNotesDueAugust2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A3125PercentSeniorNotesDueAugust2029Member" xlink:to="lab_hum_A3125PercentSeniorNotesDueAugust2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_76453c96-5cae-4123-a22c-eab7f8d0a7da_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow disclosures:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_b4c879a8-b6b7-4d2d-a4b1-1c22b943db20_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total IBNR included in benefits payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_0a3d1111-3acc-4b51-a143-de44136d4d1f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_97d4c78d-3e8b-4f16-a9fa-9c441b4ef287_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8f09fb90-183a-40b4-a371-602ed40b5b34_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_561519c8-1ae3-4c7b-82b0-a753dae05c94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer out</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_a99ae5b4-3cab-46fb-ab5d-99dcb37607f1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Prices in Active Markets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_6e3b8885-5c4f-4f26-bdc3-4cf75a2c4aa5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average annual interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member_8dbd7d28-85ef-4d0f-8e4e-1d33d94715cc_terseLabel_en-US" xlink:label="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$600&#160;million, 3.850% due October 1, 2024</link:label>
    <link:label id="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member_label_en-US" xlink:label="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.85 Percent Senior Notes Due October 2024 [Member]</link:label>
    <link:label id="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member_documentation_en-US" xlink:label="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.85 Percent Senior Notes Due October 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member" xlink:href="hum-20230331.xsd#hum_A3.85PercentSeniorNotesDueOctober2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member" xlink:to="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_fb5779a9-2904-4814-82e2-b92ea5f29c2c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b9a83c6d-c443-47c1-98e5-d9bd181c53bf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A4.625PercentSeniorNotesDueDecember2042Member_a6a64ceb-f07d-40b2-93f5-2770f81cb4ce_terseLabel_en-US" xlink:label="lab_hum_A4.625PercentSeniorNotesDueDecember2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$400&#160;million, 4.625% due December&#160;1, 2042</link:label>
    <link:label id="lab_hum_A4.625PercentSeniorNotesDueDecember2042Member_label_en-US" xlink:label="lab_hum_A4.625PercentSeniorNotesDueDecember2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625 Percent Senior Notes Due December 2042 [Member]</link:label>
    <link:label id="lab_hum_A4.625PercentSeniorNotesDueDecember2042Member_documentation_en-US" xlink:label="lab_hum_A4.625PercentSeniorNotesDueDecember2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625 Percent Senior Notes Due December 2042 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.625PercentSeniorNotesDueDecember2042Member" xlink:href="hum-20230331.xsd#hum_A4.625PercentSeniorNotesDueDecember2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A4.625PercentSeniorNotesDueDecember2042Member" xlink:to="lab_hum_A4.625PercentSeniorNotesDueDecember2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DebtSecuritiesRealizedLossGross_9d681a7b-6e3e-4f8f-bbb4-06c9377bfadd_negatedTerseLabel_en-US" xlink:label="lab_hum_DebtSecuritiesRealizedLossGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross losses on investment securities</link:label>
    <link:label id="lab_hum_DebtSecuritiesRealizedLossGross_label_en-US" xlink:label="lab_hum_DebtSecuritiesRealizedLossGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Realized Loss, Gross</link:label>
    <link:label id="lab_hum_DebtSecuritiesRealizedLossGross_documentation_en-US" xlink:label="lab_hum_DebtSecuritiesRealizedLossGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Realized Loss, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtSecuritiesRealizedLossGross" xlink:href="hum-20230331.xsd#hum_DebtSecuritiesRealizedLossGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DebtSecuritiesRealizedLossGross" xlink:to="lab_hum_DebtSecuritiesRealizedLossGross" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MilitaryServiceMember_804e86e2-3c96-482a-b7f4-f4d1cd18d119_terseLabel_en-US" xlink:label="lab_hum_MilitaryServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Military services</link:label>
    <link:label id="lab_hum_MilitaryServiceMember_label_en-US" xlink:label="lab_hum_MilitaryServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Military Service [Member]</link:label>
    <link:label id="lab_hum_MilitaryServiceMember_documentation_en-US" xlink:label="lab_hum_MilitaryServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Military Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MilitaryServiceMember" xlink:href="hum-20230331.xsd#hum_MilitaryServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MilitaryServiceMember" xlink:to="lab_hum_MilitaryServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_3dad55b9-59f0-47bf-aad5-db9685611310_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7364a6-f9a9-47b1-ac11-5af654d917d4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_73a2dfe1-eacf-4333-b1ba-9811f754f090_verboseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-Backed Securities, Issued by US Government Sponsored Enterprises [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_95d6112e-1ef9-4aa1-9165-b7670298fb5b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables and Other [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_07d6f717-d40e-4b70-b7db-cab69c5b2ff0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_bb6e6c96-6eee-4c6a-8b74-14f152568465_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_d303c839-dc2f-4689-841b-8ecb2ddd7198_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e96f9af0-8b06-4b54-b27e-3b0f8a39e390_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_e4f41167-8229-4629-b919-7ec5e5a55533_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_767f4383-d522-422f-9874-790033cd0c57_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_abf1a2b3-40cb-4eeb-b3f2-bfccedd36aa4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CommercialASOMember_e6d5c2c2-2882-4d23-a6c6-2d69ffa33bbf_terseLabel_en-US" xlink:label="lab_hum_CommercialASOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial ASO</link:label>
    <link:label id="lab_hum_CommercialASOMember_label_en-US" xlink:label="lab_hum_CommercialASOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial ASO [Member]</link:label>
    <link:label id="lab_hum_CommercialASOMember_documentation_en-US" xlink:label="lab_hum_CommercialASOMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial ASO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CommercialASOMember" xlink:href="hum-20230331.xsd#hum_CommercialASOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CommercialASOMember" xlink:to="lab_hum_CommercialASOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_159848db-61f1-4ae0-a2bb-1d14cb1afcb9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and impairment charge</link:label>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_6e637683-8dfc-4934-b391-7c00a1dda46e_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax_afb03753-2fdf-4bfa-877e-760a499c5b5d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pretax earnings</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Individually Significant Component Disposed of or Held-for-sale, Excluding Discontinued Operations, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax" xlink:to="lab_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_67c3c908-b3b2-4fcb-aba7-260da76c54b8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_69effe63-59cf-45bf-9282-177d72c8e174_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d704b3be-3fc5-41e0-a666-418b39a9edab_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_f7c44b17-6307-47c5-a364-1e129a119a31_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c02482aa-0efe-4ec5-8a06-cda6d02838a9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_6088d6b8-490d-4afd-a876-93d63a6cad4b_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_6049d84a-77f7-41d5-8187-5096660ef6e3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract_d26f3999-4c6f-44fa-9f2c-6571e3c11930_terseLabel_en-US" xlink:label="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gains or losses:</link:label>
    <link:label id="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract_label_en-US" xlink:label="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) [Abstract]</link:label>
    <link:label id="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract_documentation_en-US" xlink:label="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" xlink:href="hum-20230331.xsd#hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" xlink:to="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_7c5d4d40-9398-40da-9e61-f1603479f993_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_e96cff78-bea8-4f4a-b4f6-b52b8a6ff24d_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_20fb2e7d-a0bc-41e5-a91e-f57012fb2c44_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_5ab8f02a-a5d5-4d39-8952-9aab85c95606_terseLabel_en-US" xlink:label="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of TRICARE managed care support contract beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_label_en-US" xlink:label="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of TRICARE Managed Care Support Contract Beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_documentation_en-US" xlink:label="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of TRICARE Managed Care Support Contract Beneficiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" xlink:href="hum-20230331.xsd#hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" xlink:to="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_e56fa728-7e38-44fb-95e8-e6f8ca4f13eb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_1e8612b2-5cf2-42e8-83a0-d8db0178d5b6_terseLabel_en-US" xlink:label="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest to be sold</link:label>
    <link:label id="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_label_en-US" xlink:label="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Equity Interest Sold</link:label>
    <link:label id="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_documentation_en-US" xlink:label="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Equity Interest Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" xlink:href="hum-20230331.xsd#hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" xlink:to="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_671a27d1-56ba-449f-8e63-f4faf6974c5f_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_f9f89351-085b-448d-b7af-2c4ea9ae7a00_terseLabel_en-US" xlink:label="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities, number of positions</link:label>
    <link:label id="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_label_en-US" xlink:label="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Securities, Available-For-Sale, Securities, Number Of Positions</link:label>
    <link:label id="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_documentation_en-US" xlink:label="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Securities, Number Of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" xlink:href="hum-20230331.xsd#hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" xlink:to="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense_c31ba0d6-d4fb-4046-98f1-b91dcb638920_terseLabel_en-US" xlink:label="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization classified as benefit expense</link:label>
    <link:label id="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense_label_en-US" xlink:label="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation And Amortization Classified As Benefit Expense</link:label>
    <link:label id="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense_documentation_en-US" xlink:label="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense that has been reclassified to be included with benefit expenses. The reclassification is the result of depreciation and amortization expense associated primarily from the delivery of pharmacy services by our wholly-owned pharmacy business included in our Healthcare Services segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" xlink:href="hum-20230331.xsd#hum_DepreciationAndAmortizationClassifiedAsBenefitExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" xlink:to="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_a3f6a8bf-9680-478d-941b-72f36d44e909_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_f1014e22-767c-46af-9da2-39213648a544_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_4184412e-9552-42cc-a98f-545c411ec49b_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_bbd1f25e-79e2-4fee-b6a4-718d8b2b0e55_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_aa88f1c4-18f9-4231-ab60-28d50a4b3f9a_terseLabel_en-US" xlink:label="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to capitalization percentage, maximum</link:label>
    <link:label id="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_label_en-US" xlink:label="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt To Capitalization Percentage, Maximum</link:label>
    <link:label id="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_documentation_en-US" xlink:label="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt To Capitalization Percentage, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" xlink:href="hum-20230331.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" xlink:to="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d66c60b0-c44c-4487-b90e-443be981099f_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PutOptionMember_c09ef7d0-5a9c-4a46-8f11-89deecfcb518_terseLabel_en-US" xlink:label="lab_us-gaap_PutOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put option</link:label>
    <link:label id="lab_us-gaap_PutOptionMember_label_en-US" xlink:label="lab_us-gaap_PutOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PutOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PutOptionMember" xlink:to="lab_us-gaap_PutOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A2021ShareRepurchaseAuthorizationMember_4e13c861-4edd-46f8-ae7a-720da9aa1e3d_terseLabel_en-US" xlink:label="lab_hum_A2021ShareRepurchaseAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Share Repurchase Authorization</link:label>
    <link:label id="lab_hum_A2021ShareRepurchaseAuthorizationMember_label_en-US" xlink:label="lab_hum_A2021ShareRepurchaseAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Share Repurchase Authorization [Member]</link:label>
    <link:label id="lab_hum_A2021ShareRepurchaseAuthorizationMember_documentation_en-US" xlink:label="lab_hum_A2021ShareRepurchaseAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Share Repurchase Authorization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2021ShareRepurchaseAuthorizationMember" xlink:href="hum-20230331.xsd#hum_A2021ShareRepurchaseAuthorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A2021ShareRepurchaseAuthorizationMember" xlink:to="lab_hum_A2021ShareRepurchaseAuthorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_08303ee1-a262-4458-97d8-e07b8558e0b7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_433525b3-10d3-4ccc-9629-4f5efb968213_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_cca7cc58-ebc1-4552-907e-511d89c72c6e_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_502c0674-35c2-4e7d-91f6-30a116eee8ab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_12b64b9b-7967-4eda-aa5a-f84f9d0c3560_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMember_0119e626-cb26-4496-87ab-85892d843624_terseLabel_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FHLB borrowings</link:label>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMember_label_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Advances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:to="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_4bec0ab3-c4e8-4e57-a0b7-8d917789d0f2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in gross unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_dd12953e-0e96-42a1-94de-5b6eb6972965_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_e39d79ae-5683-45d3-8a08-65a529d03800_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total senior notes</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_685fdf43-d59d-4d8f-8442-5ef88494b18d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_532271ea-aa8d-47bb-ab74-9ce01a431b30_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase authorization</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_9d13f5e7-cf7a-446d-bcd8-a9fa13a59289_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_63c6360e-eb4c-4e0c-9b11-03760fd774bf_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_5e95a9d5-12c7-4f20-93a9-e6b39f7db47e_terseLabel_en-US" xlink:label="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares acquired in connection with employee stock plans, amount</link:label>
    <link:label id="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_label_en-US" xlink:label="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases Related To Employee Stock Based Compensation Awards Value</link:label>
    <link:label id="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_documentation_en-US" xlink:label="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of common stock that were repurchased in the administration of our employee share-based compensation plans. Under the terms of these plans, we accept shares of common stock from option holders if they elect to surrender previously-owned shares upon exercise of the option to cover the exercise price of the options or, in the case of restricted shares of common stock, the withholding of shares to satisfy tax withholding obligations associated with the vesting of such shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" xlink:href="hum-20230331.xsd#hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" xlink:to="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98fb16f0-4771-412e-88af-04ec570b6e6b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment earnings (loss)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_7a60940c-98b3-4d3c-b62d-48d9986d9e61_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_04ef1ae7-fb33-475c-8d90-3f69543c6c3c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CorporateAndEliminationsMember_b8a73b36-e25a-4c06-98f0-e44edd0a2199_terseLabel_en-US" xlink:label="lab_hum_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliminations/ Corporate</link:label>
    <link:label id="lab_hum_CorporateAndEliminationsMember_label_en-US" xlink:label="lab_hum_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate And Eliminations [Member]</link:label>
    <link:label id="lab_hum_CorporateAndEliminationsMember_documentation_en-US" xlink:label="lab_hum_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate And Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CorporateAndEliminationsMember" xlink:href="hum-20230331.xsd#hum_CorporateAndEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CorporateAndEliminationsMember" xlink:to="lab_hum_CorporateAndEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_352cff21-4e1e-4fc4-9248-2405054bbb89_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_c771f97f-938b-4bb1-8f9a-7dc4bd3475d7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER COMMON SHARE COMPUTATION</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_2f5dbd5a-27c9-4095-9587-cb1706129300_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_e0266192-b06d-457e-abd7-9a09eb368679_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_abec4952-8461-4229-ad1e-c3fe156ce4e2_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_1882c110-a0fd-45b5-a020-6f838d7f9e67_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dispositions</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_8c11fb8a-18db-42f8-9ed1-27d4fc037dac_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_0fb61648-e497-45b3-83df-f9b6487eb218_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11d84bb9-6cfe-43aa-b5ef-490a86340563_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_c538633f-ac44-4600-9c7c-7ee94bddf443_terseLabel_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential</link:label>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ec205867-0d2f-41bf-a8d9-97edc8c780bf_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A570PercentSeniorNotesDueMarch2026Member_9c7ae463-68d1-4f58-929e-dce3aaa205c2_terseLabel_en-US" xlink:label="lab_hum_A570PercentSeniorNotesDueMarch2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$500 million, 5.700% due March 13, 2026</link:label>
    <link:label id="lab_hum_A570PercentSeniorNotesDueMarch2026Member_label_en-US" xlink:label="lab_hum_A570PercentSeniorNotesDueMarch2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.70 Percent Senior Notes Due March 2026 [Member]</link:label>
    <link:label id="lab_hum_A570PercentSeniorNotesDueMarch2026Member_documentation_en-US" xlink:label="lab_hum_A570PercentSeniorNotesDueMarch2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.70 Percent Senior Notes Due March 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A570PercentSeniorNotesDueMarch2026Member" xlink:href="hum-20230331.xsd#hum_A570PercentSeniorNotesDueMarch2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A570PercentSeniorNotesDueMarch2026Member" xlink:to="lab_hum_A570PercentSeniorNotesDueMarch2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_20945a91-fbb3-48fe-b86c-2bc705a33a77_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_99cd9aae-4875-4c07-8bf3-aaa915cd9a44_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Intangible Assets, Amortizable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_b089b264-fd97-4611-a2b6-a6fdf59fb888_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock unit vesting</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A588PercentSeniorNotesDueMarch2033Member_07bf09b7-7e63-4e7f-9526-bb61f4bccf57_terseLabel_en-US" xlink:label="lab_hum_A588PercentSeniorNotesDueMarch2033Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750 million, 5.880% due March 1, 2033</link:label>
    <link:label id="lab_hum_A588PercentSeniorNotesDueMarch2033Member_label_en-US" xlink:label="lab_hum_A588PercentSeniorNotesDueMarch2033Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.88 Percent Senior Notes Due March 2033 [Member]</link:label>
    <link:label id="lab_hum_A588PercentSeniorNotesDueMarch2033Member_documentation_en-US" xlink:label="lab_hum_A588PercentSeniorNotesDueMarch2033Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.88 Percent Senior Notes Due March 2033</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A588PercentSeniorNotesDueMarch2033Member" xlink:href="hum-20230331.xsd#hum_A588PercentSeniorNotesDueMarch2033Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A588PercentSeniorNotesDueMarch2033Member" xlink:to="lab_hum_A588PercentSeniorNotesDueMarch2033Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TRICAREContractDomain_6b076627-7bd9-43ad-ba0e-23bab24799b4_terseLabel_en-US" xlink:label="lab_hum_TRICAREContractDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Contract [Domain]</link:label>
    <link:label id="lab_hum_TRICAREContractDomain_label_en-US" xlink:label="lab_hum_TRICAREContractDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Contract [Domain]</link:label>
    <link:label id="lab_hum_TRICAREContractDomain_documentation_en-US" xlink:label="lab_hum_TRICAREContractDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREContractDomain" xlink:href="hum-20230331.xsd#hum_TRICAREContractDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TRICAREContractDomain" xlink:to="lab_hum_TRICAREContractDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_3719dd2b-9689-4eae-9b60-93969cce51ae_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4c77b9a5-6ef1-4d5c-b038-56da30357675_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services revenue:</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bf640cd7-07ab-40b2-92bd-5a98a0ea6ecc_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_abde4ad5-b44b-4a51-8a94-6cb781e3357a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, repurchased face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_31919a09-f165-4538-9023-2fde07f1a0cb_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member_ee1ac8eb-be22-41e9-9f53-623acd6f93ec_terseLabel_en-US" xlink:label="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$600&#160;million, 3.950% due March 15, 2027</link:label>
    <link:label id="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member_label_en-US" xlink:label="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95 Percent Senior Notes Due March 2027 [Member]</link:label>
    <link:label id="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member_documentation_en-US" xlink:label="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95 Percent Senior Notes Due March 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.95PercentSeniorNotesDueMarch2027Member" xlink:href="hum-20230331.xsd#hum_A3.95PercentSeniorNotesDueMarch2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A3.95PercentSeniorNotesDueMarch2027Member" xlink:to="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7af0a0bd-cbc8-42f1-b78a-31ab0eec9dc1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_9c99ef18-6195-4313-9c43-a27b6cb414d0_terseLabel_en-US" xlink:label="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual debt to capitalization percentage</link:label>
    <link:label id="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_label_en-US" xlink:label="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt To Capitalization Percentage, Actual</link:label>
    <link:label id="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_documentation_en-US" xlink:label="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt To Capitalization Percentage, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" xlink:href="hum-20230331.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" xlink:to="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3031f8d7-af51-4cd3-acf4-d916bec23e92_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage and asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A450PercentSeniorNotesDueApril2025Member_2b72a1dd-5a49-4b75-9442-7e8d2dffa598_terseLabel_en-US" xlink:label="lab_hum_A450PercentSeniorNotesDueApril2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$600&#160;million, 4.500% due April 1, 2025</link:label>
    <link:label id="lab_hum_A450PercentSeniorNotesDueApril2025Member_label_en-US" xlink:label="lab_hum_A450PercentSeniorNotesDueApril2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Senior Notes Due April 2025 [Member]</link:label>
    <link:label id="lab_hum_A450PercentSeniorNotesDueApril2025Member_documentation_en-US" xlink:label="lab_hum_A450PercentSeniorNotesDueApril2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A 4.50 Percent Senior Notes Due April 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A450PercentSeniorNotesDueApril2025Member" xlink:href="hum-20230331.xsd#hum_A450PercentSeniorNotesDueApril2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A450PercentSeniorNotesDueApril2025Member" xlink:to="lab_hum_A450PercentSeniorNotesDueApril2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_c39494ab-a462-4e07-b0bc-ff7abeec0932_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ceb999de-8e96-424e-a876-88ff9a54231e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0c42000d-d939-4878-aeca-0609be35f7dd_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4592c1aa-100a-4bf2-a457-cdfeb141d6f9_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_1a5f7517-0787-491e-bab0-a47d2bd42729_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_53770efa-a802-4d41-a4df-1467c057a5a4_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_bbe05150-ed04-4878-ade1-410a240195b2_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_a7e544e6-ed9c-4982-9206-6ba0b720d0e5_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_8ab153bb-1592-491a-a34e-b05b6b6a4d71_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_41361a07-eb58-4cc3-9e30-ea8fa8ee4adb_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries_61fadcdb-db2e-4bc1-8f21-c436a8b65445_terseLabel_en-US" xlink:label="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states comprising TRICARE beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries_label_en-US" xlink:label="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of States Comprising TRICARE Beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries_documentation_en-US" xlink:label="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of States Comprising TRICARE Beneficiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfStatesComprisingTRICAREBeneficiaries" xlink:href="hum-20230331.xsd#hum_NumberOfStatesComprisingTRICAREBeneficiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NumberOfStatesComprisingTRICAREBeneficiaries" xlink:to="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_5b4dae22-13a1-435b-973b-0da2225892ff_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a21c6d8f-5f1d-4176-bf61-00c68cf61707_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_743f3d33-5a3a-46df-a5e5-15c02b62355c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_83260bc0-92e4-462f-a651-3263c1ac59e3_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_81d4fc48-e544-4325-a1e7-49598ef333db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_470f5687-41da-4a4b-9607-0f9b41b3d8ba_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a042ab0b-0513-4d0f-bdf2-0a2f44ed578e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_662eab02-c0b8-4f48-8fc1-0d3101b9a990_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_98ef7302-dedb-43af-b3f6-f41c24bd4d44_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase average price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_3c049ad4-3512-4e35-b794-dfce93add09c_terseLabel_en-US" xlink:label="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares acquired in connection with employee stock plans (in shares)</link:label>
    <link:label id="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_label_en-US" xlink:label="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases Related To Employee Stock Based Compensation Awards Shares</link:label>
    <link:label id="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_documentation_en-US" xlink:label="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares of common stock that were repurchased in the administration of our employee share-based compensation plans. Under the terms of these plans, we accept shares of common stock from option holders if they elect to surrender previously-owned shares upon exercise of the option to cover the exercise price of the options or, in the case of restricted shares of common stock, the withholding of shares to satisfy tax withholding obligations associated with the vesting of such shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" xlink:href="hum-20230331.xsd#hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" xlink:to="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_2c7a0aa4-4070-47f1-baf1-fcc8ea329e53_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_207563e3-a042-4116-8c8f-2dfd0e795828_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_51d19b04-235f-46e0-969d-e808b66ba29e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ExternalCreditRatingStandardPoorsMember_355e1f56-7e5b-402c-9754-7a245c02ae61_terseLabel_en-US" xlink:label="lab_srt_ExternalCreditRatingStandardPoorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating, Standard &amp; Poor's [Domain]</link:label>
    <link:label id="lab_srt_ExternalCreditRatingStandardPoorsMember_label_en-US" xlink:label="lab_srt_ExternalCreditRatingStandardPoorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating, Standard &amp; Poor's [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember" xlink:to="lab_srt_ExternalCreditRatingStandardPoorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2f420bc1-c6e5-4fde-9253-b6b62ead42cf_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_b41d329a-500f-42cc-bfc1-c12a7938d4c6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_51b4a3b2-8e75-4595-b95f-7661f1d86073_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax gain, net of transaction costs</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_146b10f4-93e2-430a-98ea-e7b0bfcc39a4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_13aa6036-44e6-47d2-847b-f467887c7b10_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, less than (percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_1899c125-d426-400b-bf5d-85f14fe262d0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk (percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_2d7b773f-a043-4a03-8a0b-6ffe462f4378_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_c669cbbd-c449-454a-bb27-b1babc7914e6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_3562a431-87e4-414e-ad66-e6289ad2570e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENT SECURITIES</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_1d204f81-f036-46ec-83d3-76123a73bf65_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_cf63e6c9-fec4-4f47-bd9a-63cd711fa419_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_9d55d43a-eea1-48ff-8aaf-2f84a9d5eee4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12 months or more</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_b480e449-4c55-49a2-a429-49b3aebfa025_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d502ea7c-bf40-4776-af74-6fbaabb18c26_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other intangible assets, cost</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_366bbbb1-0969-41ea-903a-89f39acb735e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_a816e738-3e80-4928-942e-66c146885d27_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Carrying Amount of Goodwill By Reportable Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_ec46a951-ed73-4280-9b42-061b5e15a0b9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4508bfdb-5418-4760-ac0f-aa6dbe05d286_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A3700PercentSeniorNotesDueMarch2029Member_95247c2d-85b9-4b2d-8ad5-464de76ca22f_terseLabel_en-US" xlink:label="lab_hum_A3700PercentSeniorNotesDueMarch2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750 million, 3.700% due March 23, 2029</link:label>
    <link:label id="lab_hum_A3700PercentSeniorNotesDueMarch2029Member_label_en-US" xlink:label="lab_hum_A3700PercentSeniorNotesDueMarch2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700 Percent Senior Notes Due March 2029 [Member]</link:label>
    <link:label id="lab_hum_A3700PercentSeniorNotesDueMarch2029Member_documentation_en-US" xlink:label="lab_hum_A3700PercentSeniorNotesDueMarch2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700 Percent Senior Notes Due March 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3700PercentSeniorNotesDueMarch2029Member" xlink:href="hum-20230331.xsd#hum_A3700PercentSeniorNotesDueMarch2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A3700PercentSeniorNotesDueMarch2029Member" xlink:to="lab_hum_A3700PercentSeniorNotesDueMarch2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_d36e269e-0c2d-4c64-9612-b4bd1c70672e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments from issuance of commercial paper, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceDisclosureTextBlock_08414a0d-824a-4c14-9d5b-e1da5fd1fa89_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BENEFITS PAYABLE</link:label>
    <link:label id="lab_us-gaap_InsuranceDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InsuranceDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceDisclosureTextBlock" xlink:to="lab_us-gaap_InsuranceDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DelayedDrawTermLoanMay2024Member_2da9b018-4d82-4b47-8a5e-111d6e9704b5_terseLabel_en-US" xlink:label="lab_hum_DelayedDrawTermLoanMay2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed draw term loan, due May 28, 2024</link:label>
    <link:label id="lab_hum_DelayedDrawTermLoanMay2024Member_label_en-US" xlink:label="lab_hum_DelayedDrawTermLoanMay2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loan May 2024 [Member]</link:label>
    <link:label id="lab_hum_DelayedDrawTermLoanMay2024Member_documentation_en-US" xlink:label="lab_hum_DelayedDrawTermLoanMay2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loan May 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DelayedDrawTermLoanMay2024Member" xlink:href="hum-20230331.xsd#hum_DelayedDrawTermLoanMay2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DelayedDrawTermLoanMay2024Member" xlink:to="lab_hum_DelayedDrawTermLoanMay2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_24816855-35b2-42ed-a9dc-42d6433b605f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d1d35770-63a6-449c-a87d-a91f337be1a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7dbdbed2-51f8-4567-9742-28ad69d85c9e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_fb8735bd-5aab-4087-bdad-7235951b440d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_e2feec3d-8641-4653-a09c-5958ca378738_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsMember_46c06a99-ec85-47a5-8d0c-7c910d87d1be_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsMember_label_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsMember" xlink:to="lab_us-gaap_InvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_eda1bb1e-afa7-41bd-9132-086d0df653e9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_BookOverdraftLiability_7c5621a6-0699-4eb5-8ee1-f8480c0552db_terseLabel_en-US" xlink:label="lab_hum_BookOverdraftLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book overdraft</link:label>
    <link:label id="lab_hum_BookOverdraftLiability_label_en-US" xlink:label="lab_hum_BookOverdraftLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book Overdraft Liability</link:label>
    <link:label id="lab_hum_BookOverdraftLiability_documentation_en-US" xlink:label="lab_hum_BookOverdraftLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book Overdraft Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BookOverdraftLiability" xlink:href="hum-20230331.xsd#hum_BookOverdraftLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_BookOverdraftLiability" xlink:to="lab_hum_BookOverdraftLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_0fdb1c8a-5347-45a5-b1f9-37893d74434b_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_9c276fe5-38cf-4746-88bf-0f3c5f8ea887_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f3125556-a80f-45e5-ad58-8be33df6c33e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_7caa6c79-2e8c-4bf1-a393-ce6a8dce7bd7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86d4d135-9b5f-4cb1-9995-d64366915546_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of effect of businesses acquired and disposed:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_1b5214c0-5ffe-426d-8942-fc7eb1e0fb87_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_ae32b089-be7b-4e57-95f4-c4ec9109872f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_0120f7aa-b1ff-4d26-a32d-20f85fa4ca5c_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_91f1f018-8fe6-4dac-883f-920e90b7d79d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_6e1c99fa-1cd2-43f5-a858-d236afb8dbac_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_7c59b041-2738-4cd9-be24-ccf197f033b0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_de997d01-0751-48b5-8652-50637646231f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends and dividend equivalents</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_b5ec2f36-ddb5-48de-978f-dd487a28d65e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization remaining for the years ending December 31,</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_1995deba-8775-4f9f-a599-01abd6676919_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_534d9455-75ed-4ef8-8da8-077a53d77e56_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_1c6bcb14-d672-4ffd-b0a9-03d39c2150fb_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NetNoncurrentAssetLiability_867d9de4-3fb2-409b-b79d-dc8db1e73f38_totalLabel_en-US" xlink:label="lab_hum_NetNoncurrentAssetLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net long-term asset (liability)</link:label>
    <link:label id="lab_hum_NetNoncurrentAssetLiability_label_en-US" xlink:label="lab_hum_NetNoncurrentAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Noncurrent Asset (Liability)</link:label>
    <link:label id="lab_hum_NetNoncurrentAssetLiability_documentation_en-US" xlink:label="lab_hum_NetNoncurrentAssetLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Noncurrent Asset (Liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetNoncurrentAssetLiability" xlink:href="hum-20230331.xsd#hum_NetNoncurrentAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NetNoncurrentAssetLiability" xlink:to="lab_hum_NetNoncurrentAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_2c49cfd0-d32c-4c08-918a-7b036b974b3f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_6559e7a5-f625-42ee-9189-0c00fe73546a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_57336b96-f589-422b-a329-296131e47872_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems_e87db0eb-00f5-4f7f-ae9c-c34701fc3cba_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Line Items]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:to="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_d1ad1888-7afe-44a3-9c75-cdfe21ee974e_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net of allowances of $69 in 2023 and $70 in 2022</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_8e43b792-784e-4a2a-af48-e2d7db562990_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_d3292ade-96a8-4154-b619-61cc27bf90ca_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_d69e6079-4271-4c7e-b313-5988377826fd_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NontaxableMunicipalNotesMember_78093266-ca22-42ec-ab3d-b5156ac97f2f_terseLabel_en-US" xlink:label="lab_us-gaap_NontaxableMunicipalNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax-exempt municipal securities</link:label>
    <link:label id="lab_us-gaap_NontaxableMunicipalNotesMember_label_en-US" xlink:label="lab_us-gaap_NontaxableMunicipalNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nontaxable Municipal Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NontaxableMunicipalNotesMember" xlink:to="lab_us-gaap_NontaxableMunicipalNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_f1a48a76-5afb-49f0-950f-578de09cc5a8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used For Inputs In Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_87ad93b4-eb3b-4aa1-8d35-eb324a41e63b_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_5d7bc25c-405c-4b3a-ad35-9c183e34a553_terseLabel_en-US" xlink:label="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states comprising of TRICARE managed care support contract beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_label_en-US" xlink:label="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of States Comprising Of TRICARE Managed Care Support Contract Beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_documentation_en-US" xlink:label="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of States Comprising Of TRICARE Managed Care Support Contract Beneficiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" xlink:href="hum-20230331.xsd#hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" xlink:to="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_7098b7be-492a-409d-85e4-a5e2b0e4f4a0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_345aee6f-614b-4577-9f3f-17e2d53895ee_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net gains (losses) recognized on equity securities sold during the period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGain_9e29ebfb-c23e-4c4e-93a3-2e9d1211dbd8_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross gains on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGain_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b159a1a4-4e7b-4276-8186-62eaa7c90492_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A2023ShareRepurchaseAuthorizationMember_38a4ab33-c8f3-4437-829b-9cbfda3f0b37_terseLabel_en-US" xlink:label="lab_hum_A2023ShareRepurchaseAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Share Repurchase Authorization</link:label>
    <link:label id="lab_hum_A2023ShareRepurchaseAuthorizationMember_label_en-US" xlink:label="lab_hum_A2023ShareRepurchaseAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Share Repurchase Authorization [Member]</link:label>
    <link:label id="lab_hum_A2023ShareRepurchaseAuthorizationMember_documentation_en-US" xlink:label="lab_hum_A2023ShareRepurchaseAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Share Repurchase Authorization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2023ShareRepurchaseAuthorizationMember" xlink:href="hum-20230331.xsd#hum_A2023ShareRepurchaseAuthorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A2023ShareRepurchaseAuthorizationMember" xlink:to="lab_hum_A2023ShareRepurchaseAuthorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0ede989f-27e6-4c05-a90c-84a488015f98_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9c3fb8e5-3b8e-4194-b084-c8bcf5230830_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_1165aa9e-db7f-448d-abbe-b42c74afd2fb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_e3b1c8db-e3e7-4fd6-8d99-8184b6f38908_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_fd842d7b-1c69-43c1-839a-9818b6572566_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cb04858f-0726-4771-98d3-5d6f244f667d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_ad760364-2b2f-469f-b857-1e503a22b696_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasury and agency obligations</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_3ca4feae-d896-4a68-abc9-c24bda19287d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_0b4a7d53-b6b7-4a43-ad54-4509194bd2c4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DiscontinuedOperationsSegmentPhaseOutPeriod_10d5245e-a6e6-49e1-b3f2-a539c17d6147_terseLabel_en-US" xlink:label="lab_hum_DiscontinuedOperationsSegmentPhaseOutPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business segment phase out period</link:label>
    <link:label id="lab_hum_DiscontinuedOperationsSegmentPhaseOutPeriod_label_en-US" xlink:label="lab_hum_DiscontinuedOperationsSegmentPhaseOutPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Segment Phase Out Period</link:label>
    <link:label id="lab_hum_DiscontinuedOperationsSegmentPhaseOutPeriod_documentation_en-US" xlink:label="lab_hum_DiscontinuedOperationsSegmentPhaseOutPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Segment Phase Out Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DiscontinuedOperationsSegmentPhaseOutPeriod" xlink:href="hum-20230331.xsd#hum_DiscontinuedOperationsSegmentPhaseOutPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DiscontinuedOperationsSegmentPhaseOutPeriod" xlink:to="lab_hum_DiscontinuedOperationsSegmentPhaseOutPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_761c98c8-ed20-429e-ae94-5e92a5b40288_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_1c48fbcc-d334-4abc-bdfe-40c9922e4936_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_82649d11-76a9-4286-95e6-321d79d5f13f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5cda8e47-e80c-4122-a45c-e352cd5fd323_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_21546000-4efc-4113-af2e-294f362a1ca7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_373f3760-3bb0-4b4a-8041-87e5b078b016_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_541d5ce2-3689-4b16-9dd7-e016a3e0bc9e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired, net of cash and cash equivalents acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_aa38e533-353b-4e0b-8814-fb1d9d325840_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration to be received</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_119fb873-f66b-4dcc-baa8-725d71b04d3e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_3c25342c-6aea-4364-9765-de68a30f2464_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable intangible assets, cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_32465db0-1c44-423e-8488-7315336d1fab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_364c668e-e30d-4cea-8fa7-e65a782f88fa_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_d5aa81f5-9fe2-42ef-9d59-8f081c4f1fd5_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_09e7cb86-5daf-4839-8ddc-c0be0caa2d70_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_58e9298d-0fe3-4737-9c38-dcf419f41a40_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a92d8243-9531-4919-b0ee-769452a61692_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8a38b3d0-ca44-4969-8a27-92c99e71241f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_FairValueRiskMember_f2774321-bc88-46cc-b7f9-3a149463931d_terseLabel_en-US" xlink:label="lab_hum_FairValueRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Risk</link:label>
    <link:label id="lab_hum_FairValueRiskMember_label_en-US" xlink:label="lab_hum_FairValueRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Risk [Member]</link:label>
    <link:label id="lab_hum_FairValueRiskMember_documentation_en-US" xlink:label="lab_hum_FairValueRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FairValueRiskMember" xlink:href="hum-20230331.xsd#hum_FairValueRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_FairValueRiskMember" xlink:to="lab_hum_FairValueRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CmsSubsidiesOrDiscountsMember_3ec9ef3a-466a-4048-ae1e-0f5cb7e49a03_terseLabel_en-US" xlink:label="lab_hum_CmsSubsidiesOrDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS Subsidies/ Discounts</link:label>
    <link:label id="lab_hum_CmsSubsidiesOrDiscountsMember_label_en-US" xlink:label="lab_hum_CmsSubsidiesOrDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cms Subsidies Or Discounts [Member]</link:label>
    <link:label id="lab_hum_CmsSubsidiesOrDiscountsMember_documentation_en-US" xlink:label="lab_hum_CmsSubsidiesOrDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS Subsidies Or Discounts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CmsSubsidiesOrDiscountsMember" xlink:href="hum-20230331.xsd#hum_CmsSubsidiesOrDiscountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CmsSubsidiesOrDiscountsMember" xlink:to="lab_hum_CmsSubsidiesOrDiscountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_aac5f20d-2fb6-477d-88e0-7633a023c132_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment for net realized losses (gains)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_5f497149-3282-4e1e-b02f-4185edcc5519_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_21c2152f-f6be-4afe-a812-58c2cf5fb857_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_ea1f8dc8-e000-4c93-93fa-a207dae462f6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_64718720-4c6c-4024-93f7-98b977d27f26_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b2361b3b-59ae-45c0-a929-a2eadb5b71cc_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_26cca2c7-065d-40e7-b6a1-75a3dc0c496d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputOptionVolatilityMember_4e848ac1-c68f-4e0d-9c2d-3db1be31d31a_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputOptionVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annualized volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputOptionVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputOptionVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Option Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputOptionVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputOptionVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputOptionVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputOptionVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_9a9f22fc-af5f-47a3-bea2-ad495bee4c1a_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_2a6905ae-3a3e-448c-b69e-5804bfe0821a_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_c6abc6e7-1ba8-41fe-ad57-eda21272137b_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_c5996c30-63e1-4297-b9b0-e3559214febe_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A215PercentSeniorNotesDueFebruary2032Member_7ba7c06a-f424-4903-a382-b532fa8da566_terseLabel_en-US" xlink:label="lab_hum_A215PercentSeniorNotesDueFebruary2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750&#160;million, 2.150% due February 3, 2032</link:label>
    <link:label id="lab_hum_A215PercentSeniorNotesDueFebruary2032Member_label_en-US" xlink:label="lab_hum_A215PercentSeniorNotesDueFebruary2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.15 Percent Senior Notes Due February 2032 [Member]</link:label>
    <link:label id="lab_hum_A215PercentSeniorNotesDueFebruary2032Member_documentation_en-US" xlink:label="lab_hum_A215PercentSeniorNotesDueFebruary2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.15 Percent Senior Notes Due February 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A215PercentSeniorNotesDueFebruary2032Member" xlink:href="hum-20230331.xsd#hum_A215PercentSeniorNotesDueFebruary2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A215PercentSeniorNotesDueFebruary2032Member" xlink:to="lab_hum_A215PercentSeniorNotesDueFebruary2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a8afaba-b934-4209-ac4b-2359f031940e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_bdb4c018-f1c2-4d63-866c-9964baaa0741_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5005ec55-d2d4-4350-bbdf-58e33c6b0b3c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_0a5cea15-3114-425d-a24e-7c3364b89c11_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_a8efeb78-7fd6-4f2c-90a8-32435cfe2230_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_5e0ee9c6-b5f3-4de0-9b2f-d2d526697751_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital&#160;In Excess&#160;of Par Value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_982d9520-6fcc-4d5a-af68-00c109cd6ca2_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare licenses</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_171a07ff-7336-4682-afc0-537309a540d8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_0fc257b9-32d4-4001-a1c6-aa6597cf0010_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Gain (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss_8f4debcf-b72e-4366-9a8a-933584580c5c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross losses on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicareAdvantageMember_9b59768d-49b7-4c35-a766-37097ca94f0c_verboseLabel_en-US" xlink:label="lab_hum_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Medicare Advantage</link:label>
    <link:label id="lab_hum_MedicareAdvantageMember_label_en-US" xlink:label="lab_hum_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Advantage [Member]</link:label>
    <link:label id="lab_hum_MedicareAdvantageMember_documentation_en-US" xlink:label="lab_hum_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Advantage [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareAdvantageMember" xlink:href="hum-20230331.xsd#hum_MedicareAdvantageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicareAdvantageMember" xlink:to="lab_hum_MedicareAdvantageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8b6cdb14-759c-4cf4-b4f3-66fdd558fe51_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted earnings per common share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_RevolvingCreditAgreementJune2021OneYearMember_762902eb-0996-47aa-97b9-04689ad404a4_terseLabel_en-US" xlink:label="lab_hum_RevolvingCreditAgreementJune2021OneYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">364-day unsecured revolving credit agreement</link:label>
    <link:label id="lab_hum_RevolvingCreditAgreementJune2021OneYearMember_label_en-US" xlink:label="lab_hum_RevolvingCreditAgreementJune2021OneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreement June 2021 One Year [Member]</link:label>
    <link:label id="lab_hum_RevolvingCreditAgreementJune2021OneYearMember_documentation_en-US" xlink:label="lab_hum_RevolvingCreditAgreementJune2021OneYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreement June 2021 One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevolvingCreditAgreementJune2021OneYearMember" xlink:href="hum-20230331.xsd#hum_RevolvingCreditAgreementJune2021OneYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_RevolvingCreditAgreementJune2021OneYearMember" xlink:to="lab_hum_RevolvingCreditAgreementJune2021OneYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_4126a4d5-f5fa-47eb-beaa-33d2475054a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Fair value of liabilities assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_64ed4e66-a61f-4420-b854-d0831ecbe697_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8d2e657f-8a74-4334-9aa0-5f41157fc883_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_ec4e97d1-1cbe-44f8-93e2-06b82dfb5ce6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Securities Classified as Current and Long-Term</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_b6528a99-1f99-4afa-b2a5-7de501efc57b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount per Share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2dec7cee-983d-4771-9511-ed430ca77442_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_29cfb7b8-2bc8-4753-92b4-5a6cc9bf2381_negatedLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_c2f8d163-d441-4379-8541-3acf983822cd_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investment securities</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_a0b99a39-66ca-49c3-8639-63bff17aa373_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at March&#160;31, 2023 and December 31, 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_468e1b1f-dabf-4a10-a320-6b3c24cfa40f_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_8303e5fe-252e-4b38-ac89-4dd73af56584_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term growth rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Long-Term Revenue Growth Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:to="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_e29f671c-6058-4700-a681-3f3b1e9c46ea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ProviderServicesMember_da1886a0-1fbf-4ba5-a280-abcc8aabd098_terseLabel_en-US" xlink:label="lab_hum_ProviderServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider services</link:label>
    <link:label id="lab_hum_ProviderServicesMember_label_en-US" xlink:label="lab_hum_ProviderServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Services [Member]</link:label>
    <link:label id="lab_hum_ProviderServicesMember_documentation_en-US" xlink:label="lab_hum_ProviderServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProviderServicesMember" xlink:href="hum-20230331.xsd#hum_ProviderServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ProviderServicesMember" xlink:to="lab_hum_ProviderServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_5e10ef64-d56c-4f82-8e89-d5d1c7694edc_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes:</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_06b9255c-d9ee-42cf-88d6-1253ab356768_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_f6e82fd4-9845-440e-a355-0e14e1e0003f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_759cca28-6f94-461e-b732-b46137d91156_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_b70eb505-9985-47f0-bd84-d1d3f50a5175_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_1c807f21-2593-4762-b967-6be0c2c1a3b3_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e6a464d3-3c9a-4c85-9cbf-e16a947b5500_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_42040806-fe64-45bb-97ff-3389f4721747_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_285e61fc-5dbe-4e2c-9d1f-dc46309a6ffc_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_67844e0d-cea2-4d5a-94b9-2722c69464fa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_6ad4d94b-567d-4324-bb1d-3fc2e4363b0f_terseLabel_en-US" xlink:label="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of debt securities considered to be of investment-grade (percent)</link:label>
    <link:label id="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_label_en-US" xlink:label="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Total Debt Securities, Investment Grade Quality</link:label>
    <link:label id="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_documentation_en-US" xlink:label="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Total Debt Securities, Investment Grade Quality</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" xlink:href="hum-20230331.xsd#hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" xlink:to="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_fdcef0fb-4172-40c1-a043-7754df1a2633_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_adec500a-f3c0-4c59-a610-24ef1143cc6d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A550PercentSeniorNotesDueMarch2053Member_1464de1f-5104-4800-b5e0-a33efc55815b_terseLabel_en-US" xlink:label="lab_hum_A550PercentSeniorNotesDueMarch2053Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750 million, 5.500% due March 15, 2053</link:label>
    <link:label id="lab_hum_A550PercentSeniorNotesDueMarch2053Member_label_en-US" xlink:label="lab_hum_A550PercentSeniorNotesDueMarch2053Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50 Percent Senior Notes Due March 2053 [Member]</link:label>
    <link:label id="lab_hum_A550PercentSeniorNotesDueMarch2053Member_documentation_en-US" xlink:label="lab_hum_A550PercentSeniorNotesDueMarch2053Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50 Percent Senior Notes Due March 2053</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A550PercentSeniorNotesDueMarch2053Member" xlink:href="hum-20230331.xsd#hum_A550PercentSeniorNotesDueMarch2053Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A550PercentSeniorNotesDueMarch2053Member" xlink:to="lab_hum_A550PercentSeniorNotesDueMarch2053Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_e000420f-f6ed-4a4b-a427-dd5e9ec2ff83_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInBookOverdrafts_f3170819-0538-454c-8a37-f2763700568e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInBookOverdrafts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in book overdraft</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInBookOverdrafts_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInBookOverdrafts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Book Overdrafts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInBookOverdrafts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInBookOverdrafts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInBookOverdrafts" xlink:to="lab_us-gaap_IncreaseDecreaseInBookOverdrafts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_683b2084-a16c-4b79-b0c5-26ddef684a75_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_fd017914-0b90-471f-bf2c-1d03ea2bb993_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenues</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_6d06766c-c048-4f3c-b0cc-f924a059f3a6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gross Unrealized Losses and Fair Value of Securities</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_a1f8a872-21dd-4a53-8a01-9643e8b4d601_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_FinancialAssetsFairValueDisclosure_9caec245-15d5-443d-aeec-a6475bf3bcad_terseLabel_en-US" xlink:label="lab_hum_FinancialAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial asset</link:label>
    <link:label id="lab_hum_FinancialAssetsFairValueDisclosure_label_en-US" xlink:label="lab_hum_FinancialAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_hum_FinancialAssetsFairValueDisclosure_documentation_en-US" xlink:label="lab_hum_FinancialAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FinancialAssetsFairValueDisclosure" xlink:href="hum-20230331.xsd#hum_FinancialAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_FinancialAssetsFairValueDisclosure" xlink:to="lab_hum_FinancialAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_PercentageOfTotalPremiumAndServicesRevenues_9cfae069-3ef3-4a80-bde9-f1509c9e97f2_terseLabel_en-US" xlink:label="lab_hum_PercentageOfTotalPremiumAndServicesRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of premiums and services revenue</link:label>
    <link:label id="lab_hum_PercentageOfTotalPremiumAndServicesRevenues_label_en-US" xlink:label="lab_hum_PercentageOfTotalPremiumAndServicesRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Total Premium And Services Revenues</link:label>
    <link:label id="lab_hum_PercentageOfTotalPremiumAndServicesRevenues_documentation_en-US" xlink:label="lab_hum_PercentageOfTotalPremiumAndServicesRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Total Premium And Services Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfTotalPremiumAndServicesRevenues" xlink:href="hum-20230331.xsd#hum_PercentageOfTotalPremiumAndServicesRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_PercentageOfTotalPremiumAndServicesRevenues" xlink:to="lab_hum_PercentageOfTotalPremiumAndServicesRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_55b02c88-ba3d-4e1e-9f28-c82d3d02f0a9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ec69f00c-5f1b-46ec-a5ab-4fa687177959_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities in unrealized loss positions, number of positions</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_9982e17b-22af-44d6-ba61-9d9c086091ba_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_9be51278-acb0-4576-9608-30b1aafa2882_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_91f3732a-0386-4ca4-b6de-1b0a2692d2ac_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average life (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_725b6e7e-cd69-439a-ae1e-f2964105ac88_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractBaseTerm_e052cd84-8d4b-4a36-b15d-fcd788b228cc_terseLabel_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractBaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract base term</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractBaseTerm_label_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractBaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Base Term</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractBaseTerm_documentation_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractBaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Base Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractBaseTerm" xlink:href="hum-20230331.xsd#hum_TRICAREManagedCareSupportContractBaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TRICAREManagedCareSupportContractBaseTerm" xlink:to="lab_hum_TRICAREManagedCareSupportContractBaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_1e327450-604a-456d-946c-840d2659c1cd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionOnSecuritiesMember_ded76072-402c-4671-904b-5477749714dd_terseLabel_en-US" xlink:label="lab_us-gaap_OptionOnSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_OptionOnSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OptionOnSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option on Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionOnSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionOnSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionOnSecuritiesMember" xlink:to="lab_us-gaap_OptionOnSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_3aa441e5-0151-4618-b404-d8bd98fb5edd_terseLabel_en-US" xlink:label="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum individual state general bond obligation as a percentage of total debt securities (percent)</link:label>
    <link:label id="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_label_en-US" xlink:label="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Individual State General Bond Obligation, As Percentage Of Total Debt Securities</link:label>
    <link:label id="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_documentation_en-US" xlink:label="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Individual State General Bond Obligation, As Percentage Of Total Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" xlink:href="hum-20230331.xsd#hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" xlink:to="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f389b022-5414-4e18-a1ef-1adc80fa7fd4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_fc4158d4-b91f-4cf8-8b14-70e0d3c2d635_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Humana</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_0b05ef7c-9ee9-4f9a-90b3-bbce596f30b2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_60db5430-12ce-417d-9882-dbdda262d7b4_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS AND DIVESTITURES</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_fcdc434e-1dd1-4af8-94f1-806979d9ade7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Results</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5dfea8b1-aab8-4557-a988-e8fd402054ec_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_293705ab-df94-4883-92e2-41207612c51f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for abandonment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_8d3a39b0-f865-4094-919b-f7d84cf528d7_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_42fc2a54-23b4-4fd1-b3fe-cd901463fe47_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8617a5ae-2c3f-4708-8a80-18f587082532_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_cfd3378f-e2c9-469a-915b-c171195975db_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_PharmacySolutionsMember_85596896-df85-4b44-9e31-1232d3ce0591_terseLabel_en-US" xlink:label="lab_hum_PharmacySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy solutions</link:label>
    <link:label id="lab_hum_PharmacySolutionsMember_label_en-US" xlink:label="lab_hum_PharmacySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Solutions [Member]</link:label>
    <link:label id="lab_hum_PharmacySolutionsMember_documentation_en-US" xlink:label="lab_hum_PharmacySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PharmacySolutionsMember" xlink:href="hum-20230331.xsd#hum_PharmacySolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_PharmacySolutionsMember" xlink:to="lab_hum_PharmacySolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRealizedGainLossTableTextBlock_2339a3c3-fa07-4cf4-9a5a-8750834a81be_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRealizedGainLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Realized Gains (Losses) Related to Investment Securities Included Within Investment Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRealizedGainLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRealizedGainLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Realized Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealizedGainLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRealizedGainLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRealizedGainLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRealizedGainLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_9cd9d511-bbba-4240-87a0-d932c815f133_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid related to:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_7173700b-9151-42d1-895b-7d61c943636a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_e5205a90-8ea2-421b-8cd7-b1aa80f874b2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of senior notes, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_HomeSolutionsMember_1e4d0aaa-b0fb-4406-a62d-97e73873fd9e_terseLabel_en-US" xlink:label="lab_hum_HomeSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home solutions</link:label>
    <link:label id="lab_hum_HomeSolutionsMember_label_en-US" xlink:label="lab_hum_HomeSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Solutions [Member]</link:label>
    <link:label id="lab_hum_HomeSolutionsMember_documentation_en-US" xlink:label="lab_hum_HomeSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HomeSolutionsMember" xlink:href="hum-20230331.xsd#hum_HomeSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_HomeSolutionsMember" xlink:to="lab_hum_HomeSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_6f818741-718a-46f2-a3eb-837c9281fbaf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Health Care Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_888d837a-f0fe-458b-8488-f49f3e1d556a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_db969528-07ea-45bf-b8a6-fe06620eb455_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3b464d91-08b3-4696-8146-ada9eeb0831a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_ef40f469-687e-4602-9694-0d8b1d4c0615_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_23031989-8470-4918-a9ca-9b06623a7c7f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_9a192346-52eb-4e4e-8434-99a71a6c4f60_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Details of Dividend Payments</link:label>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:to="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_dc644aa1-129a-43fd-b562-5e3bc376ec84_terseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amount</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7b7027c5-203c-47a6-a96b-b6d666bb4e5f_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net of allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c8b26546-c53a-469e-a191-5c2de90afdc7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option exercises</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_d2a1e21a-f98f-4030-b355-e3031519d5b6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_80471ab3-e004-445a-8465-915a7c9aa723_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_2025ef1b-e78d-4aff-b374-4997037b3ed5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock_a64fc0a0-f5ff-4cc7-ba18-d0ee59222ea8_terseLabel_en-US" xlink:label="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Balance Sheet Amounts Associated With Medicare Part D</link:label>
    <link:label id="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock_label_en-US" xlink:label="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Account Associated With Medicare Part D Table [Table Text Block]</link:label>
    <link:label id="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock_documentation_en-US" xlink:label="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Account Associated With Medicare Part D</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock" xlink:href="hum-20230331.xsd#hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock" xlink:to="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_364842bb-61c8-4483-8db2-cdf1797e9c16_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_126e9e78-25a6-4f44-b0d1-9917e0a92ad8_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_49d68ed5-c85a-48f3-831e-3ba7ab4c9714_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e7d0791a-adf0-492b-926f-a4d242736342_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicarePartDDisclosureTextBlock_701158c3-edb3-4795-a07b-31ef15f8b459_terseLabel_en-US" xlink:label="lab_hum_MedicarePartDDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MEDICARE PART D</link:label>
    <link:label id="lab_hum_MedicarePartDDisclosureTextBlock_label_en-US" xlink:label="lab_hum_MedicarePartDDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Disclosure [Text Block]</link:label>
    <link:label id="lab_hum_MedicarePartDDisclosureTextBlock_documentation_en-US" xlink:label="lab_hum_MedicarePartDDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance sheet amounts associated with Medicare Part D.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicarePartDDisclosureTextBlock" xlink:href="hum-20230331.xsd#hum_MedicarePartDDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicarePartDDisclosureTextBlock" xlink:to="lab_hum_MedicarePartDDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c67ec017-e8b7-4548-8528-fd817a57631f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_2d9853f7-f49f-4840-bce8-375b481215c3_totalLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gains (losses) recognized on equity securities during the period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_3a2a3fce-9da6-4032-8684-67c9c74c529c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenues</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_305a2517-ef0f-483e-a747-0c861d8d9c5c_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_1ebb7ed3-2cbd-4b27-a6ad-daf1289f6e04_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets:</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_ec683178-27d2-409c-91cb-1f351bd7d935_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payments (refund), net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_e9e371be-14a3-43fe-8e52-2e1ace01a828_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_4dca7374-f905-46a4-b88e-2fd34317941a_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_2929a1b9-f922-4708-88ff-85b0b3644733_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_32624cbe-15ed-4c98-8e81-7f8360769f4c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_97b1aee6-b19d-4464-b15b-da1c98effcab_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_952538ae-6291-480c-8fba-c446a9fc5023_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_947d59eb-9832-4b5b-8f6d-34ace0427413_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_6baeafdb-a4c5-4b3f-a34b-7720af5bc154_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_5d1a994e-59b6-4ac2-b295-8542efe18c68_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_5d79a7cb-8909-4c6d-a400-e78642907593_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Assets Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_94d47754-769e-4729-8425-7e631da493ef_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investment securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_78153ee6-61bd-4ace-9e8f-6b6a96f04b8b_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_b378d5b3-91f1-4b13-bcf9-f4a563f1b2bc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage and asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DebtSecuritiesRealizedGainGross_5ce25b8d-7cbe-4232-83b4-0ffe64f883b7_terseLabel_en-US" xlink:label="lab_hum_DebtSecuritiesRealizedGainGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross gains on investment securities</link:label>
    <link:label id="lab_hum_DebtSecuritiesRealizedGainGross_label_en-US" xlink:label="lab_hum_DebtSecuritiesRealizedGainGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Realized Gain, Gross</link:label>
    <link:label id="lab_hum_DebtSecuritiesRealizedGainGross_documentation_en-US" xlink:label="lab_hum_DebtSecuritiesRealizedGainGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Realized Gain, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtSecuritiesRealizedGainGross" xlink:href="hum-20230331.xsd#hum_DebtSecuritiesRealizedGainGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DebtSecuritiesRealizedGainGross" xlink:to="lab_hum_DebtSecuritiesRealizedGainGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_462b9ee1-db25-42a1-82de-b230ba3dab30_terseLabel_en-US" xlink:label="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum amount outstanding during period</link:label>
    <link:label id="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_label_en-US" xlink:label="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Maximum Amount Outstanding During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:to="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_e161c5e7-6b9f-4080-9461-640bc49eccc7_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_d89e450f-831d-4f3e-bfc8-ef041eda1eb7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt outstanding</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_8569724c-7f77-419c-a68c-1b00b9e6d33e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_4f8e37e7-7338-4e2c-9378-4c4c8eca4cce_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION AND SIGNIFICANT EVENTS</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_6f5df4ad-dc53-48a6-b2ba-557fcbc9f8b5_totalLabel_en-US" xlink:label="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment earnings (loss) attributable to Humana</link:label>
    <link:label id="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_label_en-US" xlink:label="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) From Continuing Operations Before Income Taxes, Attributable To Parent</link:label>
    <link:label id="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_documentation_en-US" xlink:label="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) From Continuing Operations Before Income Taxes, Attributable To Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" xlink:href="hum-20230331.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" xlink:to="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_SpecialtyBenefitsMember_c1920e87-0772-48eb-9a85-fa698840a33d_terseLabel_en-US" xlink:label="lab_hum_SpecialtyBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty benefits</link:label>
    <link:label id="lab_hum_SpecialtyBenefitsMember_label_en-US" xlink:label="lab_hum_SpecialtyBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Benefits [Member]</link:label>
    <link:label id="lab_hum_SpecialtyBenefitsMember_documentation_en-US" xlink:label="lab_hum_SpecialtyBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SpecialtyBenefitsMember" xlink:href="hum-20230331.xsd#hum_SpecialtyBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_SpecialtyBenefitsMember" xlink:to="lab_hum_SpecialtyBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_22adc2ed-60b6-467f-ac21-76fa4c9b2e24_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, repurchase amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_4a14220f-9706-4c60-8bf1-8125aca3c597_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_85b41ea2-66cc-4a77-8476-ebde7b86c33b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_87f83a2b-e600-4ad1-9b9d-5790841e5610_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NumberOfTRICAREBeneficiaries_3abbf220-2fad-47c6-828b-f79d471b7e80_terseLabel_en-US" xlink:label="lab_hum_NumberOfTRICAREBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of TRICARE beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfTRICAREBeneficiaries_label_en-US" xlink:label="lab_hum_NumberOfTRICAREBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of TRICARE Beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfTRICAREBeneficiaries_documentation_en-US" xlink:label="lab_hum_NumberOfTRICAREBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of TRICARE Beneficiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfTRICAREBeneficiaries" xlink:href="hum-20230331.xsd#hum_NumberOfTRICAREBeneficiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NumberOfTRICAREBeneficiaries" xlink:to="lab_hum_NumberOfTRICAREBeneficiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_285098a8-e987-410f-9673-9190ab38be06_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member_16284119-bc4e-440a-ab9b-89dd6bdd82c1_terseLabel_en-US" xlink:label="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$400&#160;million, 4.800% due March 15, 2047</link:label>
    <link:label id="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member_label_en-US" xlink:label="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.80 Percent Senior Notes Due March 2047 [Member]</link:label>
    <link:label id="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member_documentation_en-US" xlink:label="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.80 Percent Senior Notes Due March 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.80PercentSeniorNotesDueMarch2047Member" xlink:href="hum-20230331.xsd#hum_A4.80PercentSeniorNotesDueMarch2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A4.80PercentSeniorNotesDueMarch2047Member" xlink:to="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_9b1c55fd-4e90-45ed-836e-8cfec79e21b5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_0bd06b0d-e725-4c2f-985d-3444984a834b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issue costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TermLoanAndCommercialPaperMember_d20baba6-2b84-4722-aa35-ebf9ba4d9e69_terseLabel_en-US" xlink:label="lab_hum_TermLoanAndCommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan And Commercial Paper</link:label>
    <link:label id="lab_hum_TermLoanAndCommercialPaperMember_label_en-US" xlink:label="lab_hum_TermLoanAndCommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan And Commercial Paper [Member]</link:label>
    <link:label id="lab_hum_TermLoanAndCommercialPaperMember_documentation_en-US" xlink:label="lab_hum_TermLoanAndCommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan And Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanAndCommercialPaperMember" xlink:href="hum-20230331.xsd#hum_TermLoanAndCommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TermLoanAndCommercialPaperMember" xlink:to="lab_hum_TermLoanAndCommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_31b678a7-1dd9-442a-b684-85430fd3f330_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_be239c89-a0d3-4560-ba85-cd2bba864699_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS, GUARANTEES AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Contingencies and Guarantees [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:to="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NoncompetesAndOtherMember_d6ea46e8-0c2b-43f7-a4cc-4f89ee337c0d_terseLabel_en-US" xlink:label="lab_hum_NoncompetesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompetes and other</link:label>
    <link:label id="lab_hum_NoncompetesAndOtherMember_label_en-US" xlink:label="lab_hum_NoncompetesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompetes And Other [Member]</link:label>
    <link:label id="lab_hum_NoncompetesAndOtherMember_documentation_en-US" xlink:label="lab_hum_NoncompetesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompetes and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncompetesAndOtherMember" xlink:href="hum-20230331.xsd#hum_NoncompetesAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NoncompetesAndOtherMember" xlink:to="lab_hum_NoncompetesAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_69a994ce-1114-4f8c-8551-aae665074380_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a7ae2665-f79b-455d-915b-02a2ddbd1f06_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_8cb0965e-0f12-4f07-850e-21d63fa0f193_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12 months or more</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d394891c-5731-4656-a3b1-f1b0b04119c4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_ae9c9352-c3c5-4f82-b6dc-c276dd0fcc46_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_InsuranceSegmentMember_ca4c0c20-0fd6-4599-8823-95fab91c87ee_terseLabel_en-US" xlink:label="lab_hum_InsuranceSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance</link:label>
    <link:label id="lab_hum_InsuranceSegmentMember_label_en-US" xlink:label="lab_hum_InsuranceSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Segment [Member]</link:label>
    <link:label id="lab_hum_InsuranceSegmentMember_documentation_en-US" xlink:label="lab_hum_InsuranceSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InsuranceSegmentMember" xlink:href="hum-20230331.xsd#hum_InsuranceSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_InsuranceSegmentMember" xlink:to="lab_hum_InsuranceSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06efc197-7650-401e-ae5e-d976944bef80_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_86125105-6c99-4ba1-b0f5-db1ec37806d7_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_39381204-2c40-4501-9f4c-29a4b6a64121_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_42fa0e4e-8787-45bb-93a2-5b45ae1a0869_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_20f264bc-e24e-4310-af3b-833072d3d71d_terseLabel_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract term with exercises</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_label_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Term With Option Exercises</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_documentation_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Term With Option Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractTermWithOptionExercises" xlink:href="hum-20230331.xsd#hum_TRICAREManagedCareSupportContractTermWithOptionExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TRICAREManagedCareSupportContractTermWithOptionExercises" xlink:to="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_7e00e6c1-627f-4da7-84e7-e2d137d75ea2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider contracts</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_fc1ddbe7-451d-492d-a90b-7991345723c5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CreditRatingStandardPoorsAxis_1acc9b30-1c15-444a-8e3f-4b0cf78e214f_terseLabel_en-US" xlink:label="lab_srt_CreditRatingStandardPoorsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, Standard &amp; Poor's [Axis]</link:label>
    <link:label id="lab_srt_CreditRatingStandardPoorsAxis_label_en-US" xlink:label="lab_srt_CreditRatingStandardPoorsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, Standard &amp; Poor's [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingStandardPoorsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingStandardPoorsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CreditRatingStandardPoorsAxis" xlink:to="lab_srt_CreditRatingStandardPoorsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditSpreadOptionMember_b2bf4922-05ba-4d7b-a901-9c5fb022c14c_terseLabel_en-US" xlink:label="lab_us-gaap_CreditSpreadOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit spread</link:label>
    <link:label id="lab_us-gaap_CreditSpreadOptionMember_label_en-US" xlink:label="lab_us-gaap_CreditSpreadOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Spread Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditSpreadOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditSpreadOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditSpreadOptionMember" xlink:to="lab_us-gaap_CreditSpreadOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_6a2b273c-23f2-462a-b699-dd4d358654de_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contractual Maturity of Debt Securities Available for Sale</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_c6c40b02-e9d3-4367-83ca-cd6807e2d8ec_terseLabel_en-US" xlink:label="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution from (to) noncontrolling interest holders, net</link:label>
    <link:label id="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) From Contributions Or Distributions To Noncontrolling Interest Holders</link:label>
    <link:label id="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) From Contributions Or Distributions To Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" xlink:href="hum-20230331.xsd#hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" xlink:to="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_aee631f3-cfb7-416c-8cfd-12dad64a46ad_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c30eec5b-149b-4a35-bdce-ea0ef53a459f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average outstanding shares of common stock used to compute basic earnings per common share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_RiskCorridorSettlementsMedicarePartDMember_85b31f44-c9cf-48c6-b293-e3976af36b87_terseLabel_en-US" xlink:label="lab_hum_RiskCorridorSettlementsMedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Corridor Settlement</link:label>
    <link:label id="lab_hum_RiskCorridorSettlementsMedicarePartDMember_label_en-US" xlink:label="lab_hum_RiskCorridorSettlementsMedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Corridor Settlements Medicare Part D [Member]</link:label>
    <link:label id="lab_hum_RiskCorridorSettlementsMedicarePartDMember_documentation_en-US" xlink:label="lab_hum_RiskCorridorSettlementsMedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Corridor Settlements - Medicare Part D [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RiskCorridorSettlementsMedicarePartDMember" xlink:href="hum-20230331.xsd#hum_RiskCorridorSettlementsMedicarePartDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_RiskCorridorSettlementsMedicarePartDMember" xlink:to="lab_hum_RiskCorridorSettlementsMedicarePartDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicareMember_0b26dcad-02d0-48d4-8d3f-cd4c9f4dfb5a_verboseLabel_en-US" xlink:label="lab_hum_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_hum_MedicareMember_406f09b6-897f-4eda-b501-f3ba271b62bd_terseLabel_en-US" xlink:label="lab_hum_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Medicare</link:label>
    <link:label id="lab_hum_MedicareMember_label_en-US" xlink:label="lab_hum_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:label id="lab_hum_MedicareMember_documentation_en-US" xlink:label="lab_hum_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareMember" xlink:href="hum-20230331.xsd#hum_MedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicareMember" xlink:to="lab_hum_MedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_GentivaHospiceMember_fb741e55-6832-4f2b-92cd-2d2e101ff833_terseLabel_en-US" xlink:label="lab_hum_GentivaHospiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gentiva Hospice</link:label>
    <link:label id="lab_hum_GentivaHospiceMember_label_en-US" xlink:label="lab_hum_GentivaHospiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gentiva Hospice [Member]</link:label>
    <link:label id="lab_hum_GentivaHospiceMember_documentation_en-US" xlink:label="lab_hum_GentivaHospiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gentiva Hospice</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GentivaHospiceMember" xlink:href="hum-20230331.xsd#hum_GentivaHospiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_GentivaHospiceMember" xlink:to="lab_hum_GentivaHospiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_7f638a13-3209-49af-bc6f-427024a059bc_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_81063329-7924-42ef-98f8-41181612d48a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of businesses acquired in purchase transactions:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_c2e31eaa-bde3-408a-91bb-590d98ced678_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired_1fbf7577-adbd-42ee-8389-b9b794446ec7_negatedTerseLabel_en-US" xlink:label="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Noncontrolling interests acquired</link:label>
    <link:label id="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired_label_en-US" xlink:label="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Noncontrolling Interest Acquired</link:label>
    <link:label id="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired_documentation_en-US" xlink:label="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Noncontrolling Interest Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" xlink:href="hum-20230331.xsd#hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" xlink:to="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_057da53f-e04c-4f98-b1a2-16d86fc7e85d_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on investment securities, net</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_80ec243d-ce11-4baa-b0d4-db58bc55aead_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net recognized losses on investment securities</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A8.15PercentSeniorNotesDueJune2038Member_6e2adb8f-c754-4271-933e-3db620441b53_terseLabel_en-US" xlink:label="lab_hum_A8.15PercentSeniorNotesDueJune2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$250&#160;million, 8.150% due June&#160;15, 2038</link:label>
    <link:label id="lab_hum_A8.15PercentSeniorNotesDueJune2038Member_label_en-US" xlink:label="lab_hum_A8.15PercentSeniorNotesDueJune2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">8.15 Percent Senior Notes Due June 2038 [Member]</link:label>
    <link:label id="lab_hum_A8.15PercentSeniorNotesDueJune2038Member_documentation_en-US" xlink:label="lab_hum_A8.15PercentSeniorNotesDueJune2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">8.15 Percent Senior Notes Due June 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A8.15PercentSeniorNotesDueJune2038Member" xlink:href="hum-20230331.xsd#hum_A8.15PercentSeniorNotesDueJune2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A8.15PercentSeniorNotesDueJune2038Member" xlink:to="lab_hum_A8.15PercentSeniorNotesDueJune2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4e0d1027-a73c-40b0-a696-b22ae8e93b4f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_581751c1-11ca-4738-adb0-5fd95c4c4718_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $1 par; 10,000,000 shares authorized; none issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_43f3f2d5-f44f-4999-a472-eb0df1566e0c_terseLabel_en-US" xlink:label="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted incremental loan facility</link:label>
    <link:label id="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_label_en-US" xlink:label="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Uncommitted Incremental Capacity</link:label>
    <link:label id="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_documentation_en-US" xlink:label="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Uncommitted Incremental Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LineOfCreditFacilityUncommittedIncrementalCapacity" xlink:href="hum-20230331.xsd#hum_LineOfCreditFacilityUncommittedIncrementalCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_LineOfCreditFacilityUncommittedIncrementalCapacity" xlink:to="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_6d167746-6694-4990-aad5-ecdab99afa95_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_fb350990-249c-4c66-bf84-fea623ef06d0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Securities, Available-for-sale Amortized Cost to Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_6fa3deef-de3f-4f35-a12a-3a6d48075a2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Value of Debt Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_8ef7d0f5-2c0e-4a94-9cc5-4d7287e81ef7_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_4956f39f-9650-4f3e-bd07-a18490959098_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_718f257e-fa95-44e2-ab0b-4a362456b49f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_d84a085e-8c1b-4b4b-825a-2dbd01c5b163_totalLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total short-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_8edc37f7-2750-4377-8274-70dc484e605e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_2e71aa6c-12ba-4e29-939c-b5e3325ae94b_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_2826876a-2be9-4e14-8ce9-2833b6199814_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_6765d123-4898-405c-bfcb-c38d9c4963db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_64820a87-c064-4280-85de-bbb7834e34ab_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3 fair value measurement</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_09661629-8b73-4536-b95d-12858714d8d2_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes and equity in net losses</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_7f60f255-66a6-4431-b9b2-e35162b70257_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investment securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_13a46e8c-9f4a-4b75-abc1-d0409e5a6594_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CallOptionMember_0563be5d-8339-4467-993c-ff0d12be3a7d_terseLabel_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call option</link:label>
    <link:label id="lab_us-gaap_CallOptionMember_label_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CallOptionMember" xlink:to="lab_us-gaap_CallOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3ad6c586-7593-4291-84d1-d5ec43066b82_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_16fe4b8a-59c4-49e9-95ce-cc8f5c1c61f7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred related to:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ValueCreationInitiativesMember_7088a7d9-9821-4694-a4b5-7fdd77a4ac98_terseLabel_en-US" xlink:label="lab_hum_ValueCreationInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Creation Initiatives</link:label>
    <link:label id="lab_hum_ValueCreationInitiativesMember_label_en-US" xlink:label="lab_hum_ValueCreationInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Creation Initiatives [Member]</link:label>
    <link:label id="lab_hum_ValueCreationInitiativesMember_documentation_en-US" xlink:label="lab_hum_ValueCreationInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Creation Initiatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ValueCreationInitiativesMember" xlink:href="hum-20230331.xsd#hum_ValueCreationInitiativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ValueCreationInitiativesMember" xlink:to="lab_hum_ValueCreationInitiativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_e5d0c0aa-fb47-4363-b0cd-bb1400cb504d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_328e16c6-aa99-48b7-bd27-a7e18a221843_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_f3512fd6-6fa1-433a-a51b-1ab62926625a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term (in years)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_00365ae5-0675-4acf-886a-282c5f2af25e_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_74676bbc-b9bb-468e-b63b-289609b6db45_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_e37d3ae5-18b6-481b-a125-5e7783fd7515_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8de24a5a-cbb1-48af-a688-843a4a00a2fc_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d278e7c3-7fe6-46af-b9fc-e71e1ccd3839_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of employee stock options and restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_fe17768a-1b54-4b9d-bd29-06ad05f62e51_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d52435cc-1541-468e-901c-ad6c5012eb1f_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerContractsMember_3aece672-8700-4d4f-b5f6-b13c6d54ef70_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contracts/ relationships</link:label>
    <link:label id="lab_us-gaap_CustomerContractsMember_label_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerContractsMember" xlink:to="lab_us-gaap_CustomerContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_50bc9d3d-cfd4-4bf0-b0f3-d56441cbc7ea_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_aa35a602-6ab5-48a2-a267-b470828b2e76_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash and cash equivalents acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6c26a60d-b8af-457e-b3da-3d32cf99cd17_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquired businesses, net of cash and cash equivalents acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_22d5a72d-7d54-4f50-aa22-b6a072221364_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_77e4d985-119e-4be7-b3d2-634f07db31cf_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_22d0edb9-53b8-49e9-bfcb-21efb4ee298f_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_487425ae-ed70-41d9-8c9c-731b155a8709_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_GroupMedicareAdvantageMember_2ae828a4-4c45-4cab-8239-d8118b21782d_terseLabel_en-US" xlink:label="lab_hum_GroupMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Medicare Advantage</link:label>
    <link:label id="lab_hum_GroupMedicareAdvantageMember_label_en-US" xlink:label="lab_hum_GroupMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Medicare Advantage [Member]</link:label>
    <link:label id="lab_hum_GroupMedicareAdvantageMember_documentation_en-US" xlink:label="lab_hum_GroupMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Medicare Advantage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GroupMedicareAdvantageMember" xlink:href="hum-20230331.xsd#hum_GroupMedicareAdvantageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_GroupMedicareAdvantageMember" xlink:to="lab_hum_GroupMedicareAdvantageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_3320af21-9a98-4bff-a427-a2f656b439d8_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_d617d2cf-5870-42da-a824-d8fef5bbf367_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_355b1731-e7ed-4536-9b6c-fda391e8d75f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_fd363e01-1b61-4de6-8af3-e739e74a2120_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_54729ceb-601a-4172-b241-d306d879706c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_ef6545bc-de65-48d1-977c-63b5ac6f9c37_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_fc2a3537-dcc7-4092-94fe-7c5581cc0494_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ceb698c2-374c-4f98-b733-0af9802bb236_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember_22321b0e-a804-421d-892b-746215665d02_terseLabel_en-US" xlink:label="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5-year unsecured revolving credit agreement</link:label>
    <link:label id="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember_label_en-US" xlink:label="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreement June 2021 Five Year [Member]</link:label>
    <link:label id="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember_documentation_en-US" xlink:label="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreement June 2021 Five Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevolvingCreditAgreementJune2021FiveYearMember" xlink:href="hum-20230331.xsd#hum_RevolvingCreditAgreementJune2021FiveYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_RevolvingCreditAgreementJune2021FiveYearMember" xlink:to="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_ef672835-de48-49f4-bdd7-62a5a6eb7b24_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_1bb6f580-4d11-41f8-97ee-a436c0efe850_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DepreciationAndAmortizationIncomeStatement_cf073ebb-ae7e-4211-be7e-36e9e1d16401_terseLabel_en-US" xlink:label="lab_hum_DepreciationAndAmortizationIncomeStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_hum_DepreciationAndAmortizationIncomeStatement_label_en-US" xlink:label="lab_hum_DepreciationAndAmortizationIncomeStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation And Amortization Income Statement</link:label>
    <link:label id="lab_hum_DepreciationAndAmortizationIncomeStatement_documentation_en-US" xlink:label="lab_hum_DepreciationAndAmortizationIncomeStatement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense excluding depreciation and amortization primarily from the delivery of pharmacy services by our wholly-owned pharmacy business (included in our Healthcare Services segment) which has been reclassified to benefit expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationIncomeStatement" xlink:href="hum-20230331.xsd#hum_DepreciationAndAmortizationIncomeStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DepreciationAndAmortizationIncomeStatement" xlink:to="lab_hum_DepreciationAndAmortizationIncomeStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MilitaryAndOtherMember_0ae32c0d-ef6e-4058-ab04-35c317c8f172_terseLabel_en-US" xlink:label="lab_hum_MilitaryAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Military and other</link:label>
    <link:label id="lab_hum_MilitaryAndOtherMember_label_en-US" xlink:label="lab_hum_MilitaryAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Military And Other [Member]</link:label>
    <link:label id="lab_hum_MilitaryAndOtherMember_documentation_en-US" xlink:label="lab_hum_MilitaryAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Military And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MilitaryAndOtherMember" xlink:href="hum-20230331.xsd#hum_MilitaryAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MilitaryAndOtherMember" xlink:to="lab_hum_MilitaryAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_8c54c5fb-53ab-415b-b1dc-1820c8ebf9f3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member_2496beb6-0af1-4a31-9a81-1ccc2f6eac2b_terseLabel_en-US" xlink:label="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750&#160;million, 4.950% due October 1, 2044</link:label>
    <link:label id="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member_label_en-US" xlink:label="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.95 Percent Senior Notes Due October 2044 [Member]</link:label>
    <link:label id="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member_documentation_en-US" xlink:label="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.95 Percent Senior Notes Due October 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.95PercentSeniorNotesDueOctober2044Member" xlink:href="hum-20230331.xsd#hum_A4.95PercentSeniorNotesDueOctober2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A4.95PercentSeniorNotesDueOctober2044Member" xlink:to="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_c18c53c0-8b0c-4e5a-b419-d56dd2a42339_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_38caaed6-3e51-4187-b677-cacd45b9a3ef_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_8601a6af-7d8b-4514-ad91-62e4498cbc71_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses recognized on equity securities still held at the end of the period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_acd048fb-e5ac-48c8-8024-fc78769042f2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_ce976087-ccd5-43ee-8475-a341c8d4e2ed_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_f283be53-40b8-4709-bccb-f2e52f50e79d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpenses_fec0b286-56ee-433e-b9d5-68f86a313804_totalLabel_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpenses_label_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits, Losses and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses" xlink:to="lab_us-gaap_BenefitsLossesAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_075d2150-616a-4cb6-86b3-a6a3cee3604b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_dfac7e05-0179-4410-8baa-17ba3eed880f_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_bf7fb6a7-60dc-48b7-bb9e-f5cf5003dd2b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_c49a4eb0-ec24-4ab7-8ed5-cf288667378d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_722f32a1-2623-4a69-a771-ae69a1979e75_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_5d517ffe-bef8-4718-a135-500fd49bd7f6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StandardPoorsAARatingMember_55458ab2-b128-4265-8907-05e84a9a7b8f_terseLabel_en-US" xlink:label="lab_srt_StandardPoorsAARatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard &amp; Poor's, AA Rating</link:label>
    <link:label id="lab_srt_StandardPoorsAARatingMember_label_en-US" xlink:label="lab_srt_StandardPoorsAARatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard &amp; Poor's, AA Rating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsAARatingMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StandardPoorsAARatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StandardPoorsAARatingMember" xlink:to="lab_srt_StandardPoorsAARatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_06548d69-d6b1-4e85-ad97-99039e39a41a_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names and technology</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_6526da86-0872-46e2-b3ef-1f2ab2eb9096_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c6964423-c3b1-450f-bb56-1a501baa10d8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total change in unrealized investment gains (losses), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CertificateOfNeedMember_e1b33977-1639-4d6d-ad92-d86f12dbdfcb_terseLabel_en-US" xlink:label="lab_hum_CertificateOfNeedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of need</link:label>
    <link:label id="lab_hum_CertificateOfNeedMember_label_en-US" xlink:label="lab_hum_CertificateOfNeedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificate Of Need [Member]</link:label>
    <link:label id="lab_hum_CertificateOfNeedMember_documentation_en-US" xlink:label="lab_hum_CertificateOfNeedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificate Of Need</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CertificateOfNeedMember" xlink:href="hum-20230331.xsd#hum_CertificateOfNeedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CertificateOfNeedMember" xlink:to="lab_hum_CertificateOfNeedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_60a0fe3c-72f2-439d-871d-8d72d8ee860b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NetAssetLiability_77f578ef-5c77-470a-8904-58adf773335f_totalLabel_en-US" xlink:label="lab_hum_NetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net asset (liability)</link:label>
    <link:label id="lab_hum_NetAssetLiability_label_en-US" xlink:label="lab_hum_NetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Asset (Liability)</link:label>
    <link:label id="lab_hum_NetAssetLiability_documentation_en-US" xlink:label="lab_hum_NetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Asset (Liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetAssetLiability" xlink:href="hum-20230331.xsd#hum_NetAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NetAssetLiability" xlink:to="lab_hum_NetAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_712048c9-73dd-46a4-b801-e27b7b471e49_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_925cf785-8535-49af-8065-4b0c25074c95_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CenterWellSegmentMember_21e73707-5898-490e-9730-ec6858cf5c4e_terseLabel_en-US" xlink:label="lab_hum_CenterWellSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CenterWell</link:label>
    <link:label id="lab_hum_CenterWellSegmentMember_label_en-US" xlink:label="lab_hum_CenterWellSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CenterWell Segment [Member]</link:label>
    <link:label id="lab_hum_CenterWellSegmentMember_documentation_en-US" xlink:label="lab_hum_CenterWellSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CenterWell Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CenterWellSegmentMember" xlink:href="hum-20230331.xsd#hum_CenterWellSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CenterWellSegmentMember" xlink:to="lab_hum_CenterWellSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_31c59215-e680-4d8a-a8fe-3393a35a9f11_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicareSupplementProductMember_3a474617-391f-4c90-a3da-9030d36eb2ab_terseLabel_en-US" xlink:label="lab_hum_MedicareSupplementProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Supplement</link:label>
    <link:label id="lab_hum_MedicareSupplementProductMember_label_en-US" xlink:label="lab_hum_MedicareSupplementProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Supplement Product [Member]</link:label>
    <link:label id="lab_hum_MedicareSupplementProductMember_documentation_en-US" xlink:label="lab_hum_MedicareSupplementProductMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Supplement Product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareSupplementProductMember" xlink:href="hum-20230331.xsd#hum_MedicareSupplementProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicareSupplementProductMember" xlink:to="lab_hum_MedicareSupplementProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_babbfa2b-a423-4bb2-9e66-2fc99dc61330_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TRICAREContractAxis_ab4a3793-6021-4f03-8f53-15cca1f69359_terseLabel_en-US" xlink:label="lab_hum_TRICAREContractAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Contract [Axis]</link:label>
    <link:label id="lab_hum_TRICAREContractAxis_label_en-US" xlink:label="lab_hum_TRICAREContractAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Contract [Axis]</link:label>
    <link:label id="lab_hum_TRICAREContractAxis_documentation_en-US" xlink:label="lab_hum_TRICAREContractAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREContractAxis" xlink:href="hum-20230331.xsd#hum_TRICAREContractAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TRICAREContractAxis" xlink:to="lab_hum_TRICAREContractAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_0a301a86-76be-4578-8b08-ad16361a0d1d_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3f5adfe1-e095-4406-bf0e-33e4740063da_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_bbf5815f-8f8f-4d2f-9fff-af8f1c39b0b3_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_44d236da-e90e-4cdf-a8b3-0ec146866de9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NetCurrentLiabilityAsset_5b87be9e-2b79-4fd1-867b-1fef51cb50ac_totalLabel_en-US" xlink:label="lab_hum_NetCurrentLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current (liability) asset</link:label>
    <link:label id="lab_hum_NetCurrentLiabilityAsset_label_en-US" xlink:label="lab_hum_NetCurrentLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Current (Liability) Asset</link:label>
    <link:label id="lab_hum_NetCurrentLiabilityAsset_documentation_en-US" xlink:label="lab_hum_NetCurrentLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current (liability) asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetCurrentLiabilityAsset" xlink:href="hum-20230331.xsd#hum_NetCurrentLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NetCurrentLiabilityAsset" xlink:to="lab_hum_NetCurrentLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicaidMember_af9ca643-bc05-49a7-9f31-21cc00a926dc_terseLabel_en-US" xlink:label="lab_hum_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_hum_MedicaidMember_label_en-US" xlink:label="lab_hum_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid [Member]</link:label>
    <link:label id="lab_hum_MedicaidMember_documentation_en-US" xlink:label="lab_hum_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicaidMember" xlink:href="hum-20230331.xsd#hum_MedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicaidMember" xlink:to="lab_hum_MedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_13f6a2c0-efbd-458d-a7e1-dbbd51459576_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_41183ade-ec75-4a81-93fa-6e4bbf1369b1_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_RevenueExitMultipleMember_bd4490e9-8695-459d-9497-643c211848b3_terseLabel_en-US" xlink:label="lab_hum_RevenueExitMultipleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue exit multiple</link:label>
    <link:label id="lab_hum_RevenueExitMultipleMember_label_en-US" xlink:label="lab_hum_RevenueExitMultipleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Exit Multiple [Member]</link:label>
    <link:label id="lab_hum_RevenueExitMultipleMember_documentation_en-US" xlink:label="lab_hum_RevenueExitMultipleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Exit Multiple</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevenueExitMultipleMember" xlink:href="hum-20230331.xsd#hum_RevenueExitMultipleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_RevenueExitMultipleMember" xlink:to="lab_hum_RevenueExitMultipleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_0ea0a6e7-3c89-41a5-b5eb-1acab42113f2_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_481386c0-e379-456c-b1e4-294298005c9b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_bcb662eb-a1e9-4e55-a44e-f63e7653d5e1_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_1502dca4-ae64-4a1c-be13-b8287ad9a7f2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_dea7a1c8-176f-463c-9c34-a94a2b0caaec_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding borrowings</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_d2df537a-63eb-4ba4-9086-b3031b0db0bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:to="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_316286b0-1090-4275-a21c-cf7264734c00_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_e20b0a35-96ca-4afe-9b75-b47103e569be_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance at January&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_42231741-3b71-4dad-b9ed-23ce8f341e26_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at March 31</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_7f9b1312-cd02-4d27-8d11-7a5538b1ab36_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_9ac3632b-9fc5-47e2-b8c0-8be3428ac033_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eb9e458e-a006-44f2-bd1f-690887a1a413_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_90788265-f0cb-4303-aa2b-8991fd43c94d_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain (Loss) on Equity Securities</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_6d0352ae-5f5d-4909-a2c3-2bea16490594_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial liability</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_acde0702-7ea9-45d4-895a-0d3b853f5f90_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_26c83a7e-88ca-476e-a0c0-05bff86d1e0d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of senior notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicaidAndOtherMember_12dd7bbf-749e-4636-aad7-53fbae274145_terseLabel_en-US" xlink:label="lab_hum_MedicaidAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and other</link:label>
    <link:label id="lab_hum_MedicaidAndOtherMember_label_en-US" xlink:label="lab_hum_MedicaidAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid And Other [Member]</link:label>
    <link:label id="lab_hum_MedicaidAndOtherMember_documentation_en-US" xlink:label="lab_hum_MedicaidAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicaidAndOtherMember" xlink:href="hum-20230331.xsd#hum_MedicaidAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicaidAndOtherMember" xlink:to="lab_hum_MedicaidAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_4f5524b3-a840-4854-896a-c7d2c31c1ecb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_f6608e8e-3a7f-41d1-ac46-c1b03d0c4db0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_3b639601-cf4b-4bbe-8b67-fa53d008e1d0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net losses</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_69a68b95-acb1-4b49-80a2-1a7f9ee4d66b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net losses</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_a8d1e701-c4b9-4c66-b595-11915d6e6c6a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_011ae605-79c9-4600-854a-f0c439f3d02a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4a5ae2aa-5808-4ed6-b501-12e9b19b9e17_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DelayedDrawTermLoanMember_1d1c8fd1-3cff-4b1f-9723-1538a4123bf6_terseLabel_en-US" xlink:label="lab_hum_DelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loan</link:label>
    <link:label id="lab_hum_DelayedDrawTermLoanMember_label_en-US" xlink:label="lab_hum_DelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_hum_DelayedDrawTermLoanMember_documentation_en-US" xlink:label="lab_hum_DelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DelayedDrawTermLoanMember" xlink:href="hum-20230331.xsd#hum_DelayedDrawTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DelayedDrawTermLoanMember" xlink:to="lab_hum_DelayedDrawTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A5750PercentSeniorNotesDueMarch2028Member_d65f5cb8-a489-4980-80e0-340479389990_terseLabel_en-US" xlink:label="lab_hum_A5750PercentSeniorNotesDueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$500 million, 5.750% due March 1, 2028</link:label>
    <link:label id="lab_hum_A5750PercentSeniorNotesDueMarch2028Member_label_en-US" xlink:label="lab_hum_A5750PercentSeniorNotesDueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.750 Percent Senior Notes Due March 2028 [Member]</link:label>
    <link:label id="lab_hum_A5750PercentSeniorNotesDueMarch2028Member_documentation_en-US" xlink:label="lab_hum_A5750PercentSeniorNotesDueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.750 Percent Senior Notes Due March 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A5750PercentSeniorNotesDueMarch2028Member" xlink:href="hum-20230331.xsd#hum_A5750PercentSeniorNotesDueMarch2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A5750PercentSeniorNotesDueMarch2028Member" xlink:to="lab_hum_A5750PercentSeniorNotesDueMarch2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6c720c18-4b69-41e2-8352-1d6e0c7bf3fb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5c7d989d-0446-48eb-9ce8-d41bdf53b235_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Details Supporting Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_7cd1c1c1-cbba-4c8d-82ef-035d30ac5fa6_terseLabel_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual option periods</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_label_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Number Of Option Periods</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_documentation_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Number Of Option Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" xlink:href="hum-20230331.xsd#hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" xlink:to="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_f8bac4bf-ba02-41d8-bf85-9a80ca583958_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CommercialFullyInsuredMember_eced828e-b7fa-42db-bcfe-4b1b6c5406fe_terseLabel_en-US" xlink:label="lab_hum_CommercialFullyInsuredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial fully-insured</link:label>
    <link:label id="lab_hum_CommercialFullyInsuredMember_label_en-US" xlink:label="lab_hum_CommercialFullyInsuredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Fully-Insured [Member]</link:label>
    <link:label id="lab_hum_CommercialFullyInsuredMember_documentation_en-US" xlink:label="lab_hum_CommercialFullyInsuredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Fully-Insured</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CommercialFullyInsuredMember" xlink:href="hum-20230331.xsd#hum_CommercialFullyInsuredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CommercialFullyInsuredMember" xlink:to="lab_hum_CommercialFullyInsuredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareMember_label_en-US" xlink:label="lab_us-gaap_HealthCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareMember" xlink:to="lab_us-gaap_HealthCareMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>hum-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a7548c89-cbcc-4020-9549-0b2a193c2a02,g:7564a905-24e2-4ab4-9ab3-db550d1e5638-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.humana.com/role/Cover" xlink:type="simple" xlink:href="hum-20230331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_686f0ab5-1200-40ac-87cf-15e9d3f1d92b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_DocumentType_686f0ab5-1200-40ac-87cf-15e9d3f1d92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_ff3bbd82-8a10-468b-a99a-f9a60c1e1fcc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_DocumentQuarterlyReport_ff3bbd82-8a10-468b-a99a-f9a60c1e1fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4304abb6-ba83-4e93-b87d-ab955a1e544c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_DocumentPeriodEndDate_4304abb6-ba83-4e93-b87d-ab955a1e544c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_e1be7eaf-c434-48fc-b3a3-9ecc1c5a7386" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_DocumentTransitionReport_e1be7eaf-c434-48fc-b3a3-9ecc1c5a7386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_917c8860-7076-4a58-80ca-2235c3e324a5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityFileNumber_917c8860-7076-4a58-80ca-2235c3e324a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_404dcef3-910e-4ab6-b3db-adfae7c99201" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityRegistrantName_404dcef3-910e-4ab6-b3db-adfae7c99201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_cda3d225-89be-4d5b-baf4-26501977e03f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityIncorporationStateCountryCode_cda3d225-89be-4d5b-baf4-26501977e03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e0a9a1aa-438e-4a77-b110-b8f77bb93d04" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityTaxIdentificationNumber_e0a9a1aa-438e-4a77-b110-b8f77bb93d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_4605d0e6-7881-4b37-9234-ae6d99063a06" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityAddressAddressLine1_4605d0e6-7881-4b37-9234-ae6d99063a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_33ef21bf-38d8-4f20-a06e-261969b92561" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityAddressCityOrTown_33ef21bf-38d8-4f20-a06e-261969b92561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c4114e23-87cf-4670-a555-2cc6827abdac" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityAddressStateOrProvince_c4114e23-87cf-4670-a555-2cc6827abdac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8787240c-7d0e-4801-af1c-9c5d95c7236d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityAddressPostalZipCode_8787240c-7d0e-4801-af1c-9c5d95c7236d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3194597d-2fbe-447f-aa14-450d9e7bff7e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_CityAreaCode_3194597d-2fbe-447f-aa14-450d9e7bff7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5a015786-95f9-4137-b69e-d7d11ad5eb22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_LocalPhoneNumber_5a015786-95f9-4137-b69e-d7d11ad5eb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_cd5b17e0-3d27-43a1-a0d9-6a601f515865" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_Security12bTitle_cd5b17e0-3d27-43a1-a0d9-6a601f515865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_806a33c7-72ca-489d-92a9-e7b332e886a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_TradingSymbol_806a33c7-72ca-489d-92a9-e7b332e886a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_9c758e0b-5949-4f9e-a183-0b6a53e27308" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_SecurityExchangeName_9c758e0b-5949-4f9e-a183-0b6a53e27308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_98b92955-f2f0-47b7-8fbd-ffb7cbaaabbf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityCurrentReportingStatus_98b92955-f2f0-47b7-8fbd-ffb7cbaaabbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ce3cbb8d-999b-4982-9781-421dae657142" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityInteractiveDataCurrent_ce3cbb8d-999b-4982-9781-421dae657142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_0f1908f5-ae53-4e2d-bd58-d147b5fa86ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityFilerCategory_0f1908f5-ae53-4e2d-bd58-d147b5fa86ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_b3f69261-a910-4bb5-9a71-22dfae6ee147" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntitySmallBusiness_b3f69261-a910-4bb5-9a71-22dfae6ee147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_0168573a-c1d3-477f-8131-60753b72873b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityEmergingGrowthCompany_0168573a-c1d3-477f-8131-60753b72873b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_2a94bd69-beda-4ac0-ad0d-fea09608c971" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityShellCompany_2a94bd69-beda-4ac0-ad0d-fea09608c971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_71a68a53-5eb7-4579-a84d-e3fc2bab3123" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_71a68a53-5eb7-4579-a84d-e3fc2bab3123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_17656815-2ec8-41c6-a64e-8f7ea696975f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_EntityCentralIndexKey_17656815-2ec8-41c6-a64e-8f7ea696975f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f20db6fb-60a3-4c48-b6ce-ea7e05c4a7ec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_CurrentFiscalYearEndDate_f20db6fb-60a3-4c48-b6ce-ea7e05c4a7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7ef9af5c-354c-4b28-a751-900be1e58aa7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_DocumentFiscalYearFocus_7ef9af5c-354c-4b28-a751-900be1e58aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8ee85186-10a1-4c58-bdfc-601731ad8287" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8ee85186-10a1-4c58-bdfc-601731ad8287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f2bca140-3b63-435c-8587-c61dc3e0d466" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c85169b0-25a6-447a-9b29-a03bf7cc06ea" xlink:to="loc_dei_AmendmentFlag_f2bca140-3b63-435c-8587-c61dc3e0d466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="hum-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_520d65d8-88f7-4a7c-83a5-0ae6335992dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_3c5dbadf-20fb-4221-a87b-e4df0d5be60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_520d65d8-88f7-4a7c-83a5-0ae6335992dc" xlink:to="loc_us-gaap_AssetsAbstract_3c5dbadf-20fb-4221-a87b-e4df0d5be60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_a1506222-a60f-43b8-a61a-b6d159d6b2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3c5dbadf-20fb-4221-a87b-e4df0d5be60e" xlink:to="loc_us-gaap_AssetsCurrentAbstract_a1506222-a60f-43b8-a61a-b6d159d6b2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_612682ef-7f59-401b-96bb-3cc1e4c1bf2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a1506222-a60f-43b8-a61a-b6d159d6b2ab" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_612682ef-7f59-401b-96bb-3cc1e4c1bf2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_e5adcb71-e0d6-429e-8645-9f052d6c61fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a1506222-a60f-43b8-a61a-b6d159d6b2ab" xlink:to="loc_us-gaap_ShortTermInvestments_e5adcb71-e0d6-429e-8645-9f052d6c61fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_346a05ba-0e56-47c1-a50a-1dd58d12e12c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a1506222-a60f-43b8-a61a-b6d159d6b2ab" xlink:to="loc_us-gaap_ReceivablesNetCurrent_346a05ba-0e56-47c1-a50a-1dd58d12e12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_3a547dfa-4621-4bba-b570-0cdd97255ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a1506222-a60f-43b8-a61a-b6d159d6b2ab" xlink:to="loc_us-gaap_OtherAssetsCurrent_3a547dfa-4621-4bba-b570-0cdd97255ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8d560e41-7db7-47fa-809c-7f9612d15569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a1506222-a60f-43b8-a61a-b6d159d6b2ab" xlink:to="loc_us-gaap_AssetsCurrent_8d560e41-7db7-47fa-809c-7f9612d15569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_df08ef1b-b161-47a4-8768-286c08e8f790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3c5dbadf-20fb-4221-a87b-e4df0d5be60e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_df08ef1b-b161-47a4-8768-286c08e8f790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_e0310f28-b5f3-49cd-a047-2562eaffb922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3c5dbadf-20fb-4221-a87b-e4df0d5be60e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_e0310f28-b5f3-49cd-a047-2562eaffb922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_5ab3ad09-49c0-4006-ba60-494e29d75eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3c5dbadf-20fb-4221-a87b-e4df0d5be60e" xlink:to="loc_us-gaap_EquityMethodInvestments_5ab3ad09-49c0-4006-ba60-494e29d75eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c15d2196-6a1e-4466-99fd-a0e02b131dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3c5dbadf-20fb-4221-a87b-e4df0d5be60e" xlink:to="loc_us-gaap_Goodwill_c15d2196-6a1e-4466-99fd-a0e02b131dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ed8c2328-edff-4943-8330-c7dd719eb5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3c5dbadf-20fb-4221-a87b-e4df0d5be60e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ed8c2328-edff-4943-8330-c7dd719eb5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3d9d7d1e-9564-489e-8aae-de63f0b67074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3c5dbadf-20fb-4221-a87b-e4df0d5be60e" xlink:to="loc_us-gaap_Assets_3d9d7d1e-9564-489e-8aae-de63f0b67074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_009cd83a-dd8c-458c-8c90-08bc1202d40f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_520d65d8-88f7-4a7c-83a5-0ae6335992dc" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_009cd83a-dd8c-458c-8c90-08bc1202d40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_a0401299-5437-49d3-a6a2-5954a23147b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_009cd83a-dd8c-458c-8c90-08bc1202d40f" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_a0401299-5437-49d3-a6a2-5954a23147b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_68f221f3-e403-4a71-9ebe-a20d9ed4fa79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0401299-5437-49d3-a6a2-5954a23147b4" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_68f221f3-e403-4a71-9ebe-a20d9ed4fa79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_fb638c6c-fc13-4c65-be92-81c26459c71a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0401299-5437-49d3-a6a2-5954a23147b4" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_fb638c6c-fc13-4c65-be92-81c26459c71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BookOverdraftLiability_8f3eab9c-6025-48ad-8173-d6f9ce2fc1f9" xlink:href="hum-20230331.xsd#hum_BookOverdraftLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0401299-5437-49d3-a6a2-5954a23147b4" xlink:to="loc_hum_BookOverdraftLiability_8f3eab9c-6025-48ad-8173-d6f9ce2fc1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c0e28654-2957-4e2b-bf29-1a11cde23b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0401299-5437-49d3-a6a2-5954a23147b4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c0e28654-2957-4e2b-bf29-1a11cde23b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_ee9e1e79-d6bc-45df-bf86-db3f917f950d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0401299-5437-49d3-a6a2-5954a23147b4" xlink:to="loc_us-gaap_DebtCurrent_ee9e1e79-d6bc-45df-bf86-db3f917f950d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e27cba58-4440-46b7-bc22-060c448f91a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0401299-5437-49d3-a6a2-5954a23147b4" xlink:to="loc_us-gaap_LiabilitiesCurrent_e27cba58-4440-46b7-bc22-060c448f91a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_9f8c0551-c414-4139-90f0-d12cd4e957aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_009cd83a-dd8c-458c-8c90-08bc1202d40f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_9f8c0551-c414-4139-90f0-d12cd4e957aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a1f7fcca-1a3f-476b-98ed-0ec52f2134f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_009cd83a-dd8c-458c-8c90-08bc1202d40f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a1f7fcca-1a3f-476b-98ed-0ec52f2134f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b8bc77e0-e793-4d38-bc66-bc2b22693d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_009cd83a-dd8c-458c-8c90-08bc1202d40f" xlink:to="loc_us-gaap_Liabilities_b8bc77e0-e793-4d38-bc66-bc2b22693d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6c7520e6-65ca-4d70-b581-c83182ef1526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_009cd83a-dd8c-458c-8c90-08bc1202d40f" xlink:to="loc_us-gaap_StockholdersEquityAbstract_6c7520e6-65ca-4d70-b581-c83182ef1526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_793c3e0a-cdec-4013-abb1-382a17c308ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6c7520e6-65ca-4d70-b581-c83182ef1526" xlink:to="loc_us-gaap_PreferredStockValue_793c3e0a-cdec-4013-abb1-382a17c308ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3bd51fe6-d1c4-4b82-a1a5-de4c7c7ec5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6c7520e6-65ca-4d70-b581-c83182ef1526" xlink:to="loc_us-gaap_CommonStockValue_3bd51fe6-d1c4-4b82-a1a5-de4c7c7ec5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_797399ae-231b-4c78-be71-8586e00e827f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6c7520e6-65ca-4d70-b581-c83182ef1526" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_797399ae-231b-4c78-be71-8586e00e827f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ef9e6263-5415-4f00-ab46-33056e480ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6c7520e6-65ca-4d70-b581-c83182ef1526" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ef9e6263-5415-4f00-ab46-33056e480ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e6f91668-996a-4a8c-897b-f52cd89514db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6c7520e6-65ca-4d70-b581-c83182ef1526" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e6f91668-996a-4a8c-897b-f52cd89514db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_4876c374-934d-4be1-aec6-e0b2a724a3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6c7520e6-65ca-4d70-b581-c83182ef1526" xlink:to="loc_us-gaap_TreasuryStockCommonValue_4876c374-934d-4be1-aec6-e0b2a724a3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9e927cbf-b08c-44b1-9e84-c6422674d91c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6c7520e6-65ca-4d70-b581-c83182ef1526" xlink:to="loc_us-gaap_StockholdersEquity_9e927cbf-b08c-44b1-9e84-c6422674d91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e1bcd1bf-9ec9-4990-9680-a378fc125af2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6c7520e6-65ca-4d70-b581-c83182ef1526" xlink:to="loc_us-gaap_MinorityInterest_e1bcd1bf-9ec9-4990-9680-a378fc125af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e60d7474-d079-4c61-93d5-3cc8ad54accd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6c7520e6-65ca-4d70-b581-c83182ef1526" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e60d7474-d079-4c61-93d5-3cc8ad54accd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_945a2a5f-b688-47d8-b9b9-9844b1fcc0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_009cd83a-dd8c-458c-8c90-08bc1202d40f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_945a2a5f-b688-47d8-b9b9-9844b1fcc0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="hum-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_dbb12136-69f3-4f8a-9850-ae35fd9533bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3429ec17-404d-4e9b-a323-0d673fb56ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbb12136-69f3-4f8a-9850-ae35fd9533bd" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3429ec17-404d-4e9b-a323-0d673fb56ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6ca62876-c02e-48af-9adb-eb7fcb9581d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbb12136-69f3-4f8a-9850-ae35fd9533bd" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6ca62876-c02e-48af-9adb-eb7fcb9581d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_93d5f0e1-0785-43ff-99d7-8df33209194e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbb12136-69f3-4f8a-9850-ae35fd9533bd" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_93d5f0e1-0785-43ff-99d7-8df33209194e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_ccac6482-c474-4b8a-a9d0-54139a50ae40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbb12136-69f3-4f8a-9850-ae35fd9533bd" xlink:to="loc_us-gaap_PreferredStockSharesIssued_ccac6482-c474-4b8a-a9d0-54139a50ae40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_e0cf7636-7a07-4d83-abea-73be2453fa1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbb12136-69f3-4f8a-9850-ae35fd9533bd" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_e0cf7636-7a07-4d83-abea-73be2453fa1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f640e891-0111-44dd-88a6-b0a7206e6928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbb12136-69f3-4f8a-9850-ae35fd9533bd" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f640e891-0111-44dd-88a6-b0a7206e6928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d71aeacb-2a3a-4978-a6c1-43677823c512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbb12136-69f3-4f8a-9850-ae35fd9533bd" xlink:to="loc_us-gaap_CommonStockSharesIssued_d71aeacb-2a3a-4978-a6c1-43677823c512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_f34034c3-755c-4846-99ff-9c50728ffa6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbb12136-69f3-4f8a-9850-ae35fd9533bd" xlink:to="loc_us-gaap_TreasuryStockCommonShares_f34034c3-755c-4846-99ff-9c50728ffa6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="hum-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_82687def-788f-441c-887c-d6261f72bc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_82687def-788f-441c-887c-d6261f72bc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_3dd402fe-6da8-4ce5-b9fb-c9afa010786b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_RevenuesAbstract_3dd402fe-6da8-4ce5-b9fb-c9afa010786b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_923dcee3-4692-4eba-bbba-ba4cd19fafae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_3dd402fe-6da8-4ce5-b9fb-c9afa010786b" xlink:to="loc_us-gaap_PremiumsEarnedNet_923dcee3-4692-4eba-bbba-ba4cd19fafae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_108dbde4-d1b6-431a-a7ee-a69619312791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_3dd402fe-6da8-4ce5-b9fb-c9afa010786b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_108dbde4-d1b6-431a-a7ee-a69619312791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_bc72519b-9855-4219-a884-117ac91b8e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_3dd402fe-6da8-4ce5-b9fb-c9afa010786b" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_bc72519b-9855-4219-a884-117ac91b8e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_026d5267-b985-420a-a30f-61d136b45776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_3dd402fe-6da8-4ce5-b9fb-c9afa010786b" xlink:to="loc_us-gaap_Revenues_026d5267-b985-420a-a30f-61d136b45776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_b9e33dd7-bc72-4e03-b8f8-b36f9201d263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_OperatingExpensesAbstract_b9e33dd7-bc72-4e03-b8f8-b36f9201d263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_febbd606-1e8c-4ff0-8c72-8d47780cb6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b9e33dd7-bc72-4e03-b8f8-b36f9201d263" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_febbd606-1e8c-4ff0-8c72-8d47780cb6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e2bc5769-fffd-403e-9458-87f1337049bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b9e33dd7-bc72-4e03-b8f8-b36f9201d263" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e2bc5769-fffd-403e-9458-87f1337049bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationIncomeStatement_35635981-68cc-4d4a-bde5-2f267438f72c" xlink:href="hum-20230331.xsd#hum_DepreciationAndAmortizationIncomeStatement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b9e33dd7-bc72-4e03-b8f8-b36f9201d263" xlink:to="loc_hum_DepreciationAndAmortizationIncomeStatement_35635981-68cc-4d4a-bde5-2f267438f72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_f407ea21-7813-4080-8fd5-d19efd42e721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b9e33dd7-bc72-4e03-b8f8-b36f9201d263" xlink:to="loc_us-gaap_BenefitsLossesAndExpenses_f407ea21-7813-4080-8fd5-d19efd42e721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f5dabe4a-ca14-455c-8ad2-8182f91be51c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_OperatingIncomeLoss_f5dabe4a-ca14-455c-8ad2-8182f91be51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_23f790b5-4d70-466d-9652-6ba218582feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_InterestExpense_23f790b5-4d70-466d-9652-6ba218582feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c532255e-da11-4096-9e25-9e1035b0f1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c532255e-da11-4096-9e25-9e1035b0f1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2a7b32ef-f300-4c05-aed4-9a0ef253f61c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2a7b32ef-f300-4c05-aed4-9a0ef253f61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8012459c-68a2-4fb5-a9c5-a6c084c7f59d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8012459c-68a2-4fb5-a9c5-a6c084c7f59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7190671f-91ea-4848-b64c-d818298441be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7190671f-91ea-4848-b64c-d818298441be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b8631570-feb1-435b-8a61-faaf77ba06e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_ProfitLoss_b8631570-feb1-435b-8a61-faaf77ba06e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6540e054-be28-4c2f-923a-480eee9dd1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6540e054-be28-4c2f-923a-480eee9dd1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f874bdf9-03f0-4621-aa86-bc6e6dcaf740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_NetIncomeLoss_f874bdf9-03f0-4621-aa86-bc6e6dcaf740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_da419fde-cc96-4e93-a3e6-4bd1b5073489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_EarningsPerShareBasic_da419fde-cc96-4e93-a3e6-4bd1b5073489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bbfd7697-ac44-450a-a693-32b626c77f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9bb80ec9-067f-4653-87a4-65228eda6e6e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bbfd7697-ac44-450a-a693-32b626c77f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="hum-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_34486f6c-6a22-4ed0-9ecc-30314b09e521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f726407e-6f3a-4c41-a0f8-a1b33b69d26e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_34486f6c-6a22-4ed0-9ecc-30314b09e521" xlink:to="loc_us-gaap_NetIncomeLoss_f726407e-6f3a-4c41-a0f8-a1b33b69d26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8577312f-d6d7-419b-ad1a-4eb234b80788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_34486f6c-6a22-4ed0-9ecc-30314b09e521" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8577312f-d6d7-419b-ad1a-4eb234b80788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_d30a3588-f1f1-463d-b06c-b4aa5bec975b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8577312f-d6d7-419b-ad1a-4eb234b80788" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_d30a3588-f1f1-463d-b06c-b4aa5bec975b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_b0ea2c12-c6c2-4838-80ae-696886176db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8577312f-d6d7-419b-ad1a-4eb234b80788" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_b0ea2c12-c6c2-4838-80ae-696886176db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1a774ea4-577b-490b-92c8-c69fb015ca4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8577312f-d6d7-419b-ad1a-4eb234b80788" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1a774ea4-577b-490b-92c8-c69fb015ca4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_dce433b6-cb5d-4982-9e61-25112a385b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8577312f-d6d7-419b-ad1a-4eb234b80788" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_dce433b6-cb5d-4982-9e61-25112a385b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_031f4088-2066-42ad-a08e-422d757a74cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8577312f-d6d7-419b-ad1a-4eb234b80788" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_031f4088-2066-42ad-a08e-422d757a74cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_fa806060-8332-4e8f-a034-473448cb0ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8577312f-d6d7-419b-ad1a-4eb234b80788" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_fa806060-8332-4e8f-a034-473448cb0ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ec283c41-4907-437c-8581-f39d42c3ca4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8577312f-d6d7-419b-ad1a-4eb234b80788" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ec283c41-4907-437c-8581-f39d42c3ca4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_9df6c860-ac83-4979-ad4c-a5534e130b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_34486f6c-6a22-4ed0-9ecc-30314b09e521" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_9df6c860-ac83-4979-ad4c-a5534e130b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="hum-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_720f1c06-3aca-4956-ba8d-c019ddb7c7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4cc4781f-fca7-41bb-9a67-fce0b6d111e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_720f1c06-3aca-4956-ba8d-c019ddb7c7c9" xlink:to="loc_us-gaap_StatementTable_4cc4781f-fca7-41bb-9a67-fce0b6d111e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_59ff95f4-2d7d-4552-a2f5-409460817dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4cc4781f-fca7-41bb-9a67-fce0b6d111e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_59ff95f4-2d7d-4552-a2f5-409460817dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dbb0c0d5-e9ee-4715-9991-930b8dad29ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_59ff95f4-2d7d-4552-a2f5-409460817dc3" xlink:to="loc_us-gaap_EquityComponentDomain_dbb0c0d5-e9ee-4715-9991-930b8dad29ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dbb0c0d5-e9ee-4715-9991-930b8dad29ea" xlink:to="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c9eadda1-e24a-4ee2-aadc-ff96bc9c0663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:to="loc_us-gaap_CommonStockMember_c9eadda1-e24a-4ee2-aadc-ff96bc9c0663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_950aeab2-c1cd-489f-a7b1-cdd88b5317c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_950aeab2-c1cd-489f-a7b1-cdd88b5317c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8551ae0f-69e2-4d55-a034-55de024aad99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:to="loc_us-gaap_RetainedEarningsMember_8551ae0f-69e2-4d55-a034-55de024aad99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_01d99da6-5d59-4ba6-97c8-5277f7189b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_01d99da6-5d59-4ba6-97c8-5277f7189b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_c7d32cd5-597c-43fb-a4af-ca3bea89a18f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_f3a60417-54ea-41bf-aa8e-fea61013d245" xlink:to="loc_us-gaap_TreasuryStockCommonMember_c7d32cd5-597c-43fb-a4af-ca3bea89a18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b86bb00a-4e7f-4608-8fc4-4725c63fcf23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dbb0c0d5-e9ee-4715-9991-930b8dad29ea" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b86bb00a-4e7f-4608-8fc4-4725c63fcf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_abab4939-3ecb-43f4-8bd4-2ea6eb9b14a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4cc4781f-fca7-41bb-9a67-fce0b6d111e7" xlink:to="loc_us-gaap_StatementLineItems_abab4939-3ecb-43f4-8bd4-2ea6eb9b14a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abab4939-3ecb-43f4-8bd4-2ea6eb9b14a3" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c4ce5aaf-2258-4e6e-9bab-c6926b3ca9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c4ce5aaf-2258-4e6e-9bab-c6926b3ca9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0e8847d1-3dbc-4166-8756-d317ee2b3a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0e8847d1-3dbc-4166-8756-d317ee2b3a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9a567519-0ea4-4413-87e9-907b99977c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_ProfitLoss_9a567519-0ea4-4413-87e9-907b99977c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_35a1e9e7-1613-4460-a362-332fcf2fcd12" xlink:href="hum-20230331.xsd#hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_35a1e9e7-1613-4460-a362-332fcf2fcd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_b7293b1a-96a1-491f-97ff-89c2c3e1569c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_b7293b1a-96a1-491f-97ff-89c2c3e1569c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_899f2e80-52a6-4257-aa56-30a78083aa38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_899f2e80-52a6-4257-aa56-30a78083aa38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ca3ee1bf-7144-481a-b694-ff089da3d917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ca3ee1bf-7144-481a-b694-ff089da3d917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_d9bebb20-6416-43e1-b8f2-7f26d2ce3778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_DividendsCommonStockCash_d9bebb20-6416-43e1-b8f2-7f26d2ce3778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f5fc463f-4eb2-4859-ae70-61a8cac06a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f5fc463f-4eb2-4859-ae70-61a8cac06a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_d0b0f694-8aaf-47f4-92b5-61df12f0a4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_d0b0f694-8aaf-47f4-92b5-61df12f0a4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_23f5ccb4-e784-4a4a-b25d-b2338763c5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_23f5ccb4-e784-4a4a-b25d-b2338763c5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_baa781ac-4b0e-41ab-9518-9c8d0fa71e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_baa781ac-4b0e-41ab-9518-9c8d0fa71e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_48666a09-a4a1-4fec-bc3b-b8f478634626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5c36819-8501-493f-9994-4bde58f85529" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_48666a09-a4a1-4fec-bc3b-b8f478634626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="hum-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_476b3c88-daa3-4662-a6ec-66b90ff81764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9f11e16e-8913-4e4f-be76-9dc5895e9083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_476b3c88-daa3-4662-a6ec-66b90ff81764" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9f11e16e-8913-4e4f-be76-9dc5895e9083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_27621e38-5619-4dbf-87c6-203c29a9b89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9f11e16e-8913-4e4f-be76-9dc5895e9083" xlink:to="loc_us-gaap_ProfitLoss_27621e38-5619-4dbf-87c6-203c29a9b89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_745da9c7-c715-41f5-8487-b136bb4530d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9f11e16e-8913-4e4f-be76-9dc5895e9083" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_745da9c7-c715-41f5-8487-b136bb4530d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_a658eba4-28e9-48e7-944c-e3299406bd37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_745da9c7-c715-41f5-8487-b136bb4530d6" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_a658eba4-28e9-48e7-944c-e3299406bd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7840db1c-75ad-4225-b221-1218180eafbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_745da9c7-c715-41f5-8487-b136bb4530d6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7840db1c-75ad-4225-b221-1218180eafbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d8f4e379-b47d-4391-bad1-e8c3c401796e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_745da9c7-c715-41f5-8487-b136bb4530d6" xlink:to="loc_us-gaap_ShareBasedCompensation_d8f4e379-b47d-4391-bad1-e8c3c401796e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_fa94ee34-0eb4-49c6-981a-a67456067689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_745da9c7-c715-41f5-8487-b136bb4530d6" xlink:to="loc_us-gaap_Depreciation_fa94ee34-0eb4-49c6-981a-a67456067689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_be51ecb5-ff45-4b76-afc5-c5c58d618a81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_745da9c7-c715-41f5-8487-b136bb4530d6" xlink:to="loc_us-gaap_AdjustmentForAmortization_be51ecb5-ff45-4b76-afc5-c5c58d618a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d725eb25-3f85-43de-b05e-eb3bb4e057a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_745da9c7-c715-41f5-8487-b136bb4530d6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d725eb25-3f85-43de-b05e-eb3bb4e057a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_05094df6-e0c1-4a31-b510-f2bca7738003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d725eb25-3f85-43de-b05e-eb3bb4e057a0" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_05094df6-e0c1-4a31-b510-f2bca7738003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_597f0eed-ea1f-4817-a319-a6c710fb16dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d725eb25-3f85-43de-b05e-eb3bb4e057a0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_597f0eed-ea1f-4817-a319-a6c710fb16dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_99d29764-b5db-4494-a2d3-6870270dd37b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d725eb25-3f85-43de-b05e-eb3bb4e057a0" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_99d29764-b5db-4494-a2d3-6870270dd37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_212b0979-feeb-486c-9aab-17271fe063b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d725eb25-3f85-43de-b05e-eb3bb4e057a0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_212b0979-feeb-486c-9aab-17271fe063b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_845fb364-7ac6-42f4-bb1a-cb3368bf9c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d725eb25-3f85-43de-b05e-eb3bb4e057a0" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_845fb364-7ac6-42f4-bb1a-cb3368bf9c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_ca96834a-98bc-4dc3-8278-8f2b774cc049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_745da9c7-c715-41f5-8487-b136bb4530d6" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_ca96834a-98bc-4dc3-8278-8f2b774cc049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d466b45b-6495-4ca2-aa61-6014566c9cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9f11e16e-8913-4e4f-be76-9dc5895e9083" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d466b45b-6495-4ca2-aa61-6014566c9cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_878992a1-f21d-4ccc-b92e-856b7a33bd21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_476b3c88-daa3-4662-a6ec-66b90ff81764" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_878992a1-f21d-4ccc-b92e-856b7a33bd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7668b99a-f04a-4bf3-ad44-711eaeaff9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_878992a1-f21d-4ccc-b92e-856b7a33bd21" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7668b99a-f04a-4bf3-ad44-711eaeaff9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e5044ca7-c675-4057-8299-a3cc5d642ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_878992a1-f21d-4ccc-b92e-856b7a33bd21" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e5044ca7-c675-4057-8299-a3cc5d642ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_2f732717-c54c-4ed1-8a51-952b2c85d580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_878992a1-f21d-4ccc-b92e-856b7a33bd21" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_2f732717-c54c-4ed1-8a51-952b2c85d580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_d1424706-f8a5-470f-a40a-7bc8bc2da2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_878992a1-f21d-4ccc-b92e-856b7a33bd21" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_d1424706-f8a5-470f-a40a-7bc8bc2da2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_bcd496bf-65dd-431f-b874-4b3b1fa38438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_878992a1-f21d-4ccc-b92e-856b7a33bd21" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_bcd496bf-65dd-431f-b874-4b3b1fa38438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3eeb864b-a843-4d4c-becd-c3112d86997e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_878992a1-f21d-4ccc-b92e-856b7a33bd21" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3eeb864b-a843-4d4c-becd-c3112d86997e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ffbf4c37-0126-4feb-aed6-8540bb7f7e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_476b3c88-daa3-4662-a6ec-66b90ff81764" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ffbf4c37-0126-4feb-aed6-8540bb7f7e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PaymentsForProceedsFromContractDeposits_8e6f6ce6-a705-4c49-a580-52c3c274b273" xlink:href="hum-20230331.xsd#hum_PaymentsForProceedsFromContractDeposits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ffbf4c37-0126-4feb-aed6-8540bb7f7e4e" xlink:to="loc_hum_PaymentsForProceedsFromContractDeposits_8e6f6ce6-a705-4c49-a580-52c3c274b273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_9a5b9084-85c4-41c1-9ac1-062690f9959a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ffbf4c37-0126-4feb-aed6-8540bb7f7e4e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_9a5b9084-85c4-41c1-9ac1-062690f9959a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_bf836c9c-4804-4b41-9d04-b5afdf1103a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ffbf4c37-0126-4feb-aed6-8540bb7f7e4e" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_bf836c9c-4804-4b41-9d04-b5afdf1103a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_c43ea575-b414-48e5-ab00-f3b213537454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ffbf4c37-0126-4feb-aed6-8540bb7f7e4e" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_c43ea575-b414-48e5-ab00-f3b213537454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_fb3bc5f1-c606-4620-930a-557ab01f59fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ffbf4c37-0126-4feb-aed6-8540bb7f7e4e" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_fb3bc5f1-c606-4620-930a-557ab01f59fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_54615704-c028-4803-9f3c-ef47c833e4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ffbf4c37-0126-4feb-aed6-8540bb7f7e4e" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_54615704-c028-4803-9f3c-ef47c833e4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInBookOverdrafts_c86bcd62-8249-4aec-8c59-259200c5af36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInBookOverdrafts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ffbf4c37-0126-4feb-aed6-8540bb7f7e4e" xlink:to="loc_us-gaap_IncreaseDecreaseInBookOverdrafts_c86bcd62-8249-4aec-8c59-259200c5af36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e049ca2e-764d-4601-b5b2-8f137ddd2b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ffbf4c37-0126-4feb-aed6-8540bb7f7e4e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e049ca2e-764d-4601-b5b2-8f137ddd2b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_df7f311a-a1c6-42af-a8f4-d25ead16cb17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ffbf4c37-0126-4feb-aed6-8540bb7f7e4e" xlink:to="loc_us-gaap_PaymentsOfDividends_df7f311a-a1c6-42af-a8f4-d25ead16cb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_80b9687c-203a-4b2e-9fe3-8d3f9c28227e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ffbf4c37-0126-4feb-aed6-8540bb7f7e4e" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_80b9687c-203a-4b2e-9fe3-8d3f9c28227e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_346f6eb1-326a-4b4a-bcb5-a79e3a0fdaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ffbf4c37-0126-4feb-aed6-8540bb7f7e4e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_346f6eb1-326a-4b4a-bcb5-a79e3a0fdaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_447e7dad-be8a-462c-b742-9d12725a9b04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_476b3c88-daa3-4662-a6ec-66b90ff81764" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_447e7dad-be8a-462c-b742-9d12725a9b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_58436e62-9278-4e38-b2f9-ce281a81de2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_476b3c88-daa3-4662-a6ec-66b90ff81764" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_58436e62-9278-4e38-b2f9-ce281a81de2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9a06f6b8-3a25-4fda-a274-54b828308c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_476b3c88-daa3-4662-a6ec-66b90ff81764" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9a06f6b8-3a25-4fda-a274-54b828308c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_545a9c05-9251-4566-a3a4-d62bc3b363d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_476b3c88-daa3-4662-a6ec-66b90ff81764" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_545a9c05-9251-4566-a3a4-d62bc3b363d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_4004b171-98fc-4193-9882-0a75e51b158a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_545a9c05-9251-4566-a3a4-d62bc3b363d3" xlink:to="loc_us-gaap_InterestPaidNet_4004b171-98fc-4193-9882-0a75e51b158a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_80582d89-b42b-484e-8bdd-750cfb085ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_545a9c05-9251-4566-a3a4-d62bc3b363d3" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_80582d89-b42b-484e-8bdd-750cfb085ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4a894e73-6e1b-4e86-bab2-97dfd2e183df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_476b3c88-daa3-4662-a6ec-66b90ff81764" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4a894e73-6e1b-4e86-bab2-97dfd2e183df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_765aa5b2-f5cf-46e0-9291-4807fb0b124e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4a894e73-6e1b-4e86-bab2-97dfd2e183df" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_765aa5b2-f5cf-46e0-9291-4807fb0b124e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_afd371d0-b95f-4647-be3c-245d15bca48a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4a894e73-6e1b-4e86-bab2-97dfd2e183df" xlink:to="loc_us-gaap_LiabilitiesAssumed1_afd371d0-b95f-4647-be3c-245d15bca48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired_4b766677-47e4-47fd-8d46-339cc0e1a7ca" xlink:href="hum-20230331.xsd#hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4a894e73-6e1b-4e86-bab2-97dfd2e183df" xlink:to="loc_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired_4b766677-47e4-47fd-8d46-339cc0e1a7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d5800824-177f-4380-9377-bb16f6c63a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4a894e73-6e1b-4e86-bab2-97dfd2e183df" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d5800824-177f-4380-9377-bb16f6c63a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTS" xlink:type="simple" xlink:href="hum-20230331.xsd#BASISOFPRESENTATIONANDSIGNIFICANTEVENTS"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_505bddd9-82aa-403d-b470-61581ca46597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_a1b18afb-ff85-4d19-a1a5-716800b4d402" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_505bddd9-82aa-403d-b470-61581ca46597" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_a1b18afb-ff85-4d19-a1a5-716800b4d402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTS" xlink:type="simple" xlink:href="hum-20230331.xsd#RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTS"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_823e3258-8077-4b09-ae12-001648facd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f83486bc-071c-4bd4-a44b-60ea12ae6739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_823e3258-8077-4b09-ae12-001648facd0c" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f83486bc-071c-4bd4-a44b-60ea12ae6739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES" xlink:type="simple" xlink:href="hum-20230331.xsd#ACQUISITIONSANDDIVESTITURES"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a63d75b1-1065-4759-a47e-0cf80dc2ed6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_50958f43-f090-4d68-aa80-2a69637b2037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a63d75b1-1065-4759-a47e-0cf80dc2ed6a" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_50958f43-f090-4d68-aa80-2a69637b2037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIES" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIES"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_cbad0492-5e34-4701-8df0-c45a2408985e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_a9a8854f-cffe-4c4d-bdb9-3d98eca746bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_cbad0492-5e34-4701-8df0-c45a2408985e" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_a9a8854f-cffe-4c4d-bdb9-3d98eca746bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUE" xlink:type="simple" xlink:href="hum-20230331.xsd#FAIRVALUE"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/FAIRVALUE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f430c347-7f2d-42ea-a564-09bd026c9053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_f4abe23e-3672-4ac3-874f-1a0404f4b481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f430c347-7f2d-42ea-a564-09bd026c9053" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_f4abe23e-3672-4ac3-874f-1a0404f4b481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/MEDICAREPARTD" xlink:type="simple" xlink:href="hum-20230331.xsd#MEDICAREPARTD"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/MEDICAREPARTD" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_2ef96045-2b71-4a6a-9c01-c21593a14872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicarePartDDisclosureTextBlock_69dc8994-c3d6-4396-afc0-710fe1f4d43a" xlink:href="hum-20230331.xsd#hum_MedicarePartDDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_2ef96045-2b71-4a6a-9c01-c21593a14872" xlink:to="loc_hum_MedicarePartDDisclosureTextBlock_69dc8994-c3d6-4396-afc0-710fe1f4d43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="hum-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fc2527ab-fc72-4469-afac-8b8b4083c78e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_420f581f-df85-4bdf-9193-a6993d028d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fc2527ab-fc72-4469-afac-8b8b4083c78e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_420f581f-df85-4bdf-9193-a6993d028d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/BENEFITSPAYABLE" xlink:type="simple" xlink:href="hum-20230331.xsd#BENEFITSPAYABLE"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/BENEFITSPAYABLE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_0633bb63-a7d5-43e7-ad01-6d5406798dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceDisclosureTextBlock_948ab134-c963-475a-bb89-d80230bb15c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_0633bb63-a7d5-43e7-ad01-6d5406798dec" xlink:to="loc_us-gaap_InsuranceDisclosureTextBlock_948ab134-c963-475a-bb89-d80230bb15c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION" xlink:type="simple" xlink:href="hum-20230331.xsd#EARNINGSPERCOMMONSHARECOMPUTATION"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2285342e-d702-4168-9c2d-2abbbf43b0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_fd279b0c-6a06-4565-aeba-d241826b4590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2285342e-d702-4168-9c2d-2abbbf43b0cb" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_fd279b0c-6a06-4565-aeba-d241826b4590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="hum-20230331.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_aa8ba557-f5c3-4194-9eb7-e83ba6d01b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_599f02a2-1486-4165-8b08-c5cf332d38f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_aa8ba557-f5c3-4194-9eb7-e83ba6d01b08" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_599f02a2-1486-4165-8b08-c5cf332d38f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INCOMETAXES" xlink:type="simple" xlink:href="hum-20230331.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f4f99edb-de81-4fd8-8b8f-2c6c6200d43d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_4ba09fe3-4d28-4f1d-8991-34e0caeffe22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f4f99edb-de81-4fd8-8b8f-2c6c6200d43d" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_4ba09fe3-4d28-4f1d-8991-34e0caeffe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBT" xlink:type="simple" xlink:href="hum-20230331.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_81ee365c-7abe-4c68-bc83-a4188d6813c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_da8fa7d6-d348-4a02-a98a-fd8eb4513af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_81ee365c-7abe-4c68-bc83-a4188d6813c6" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_da8fa7d6-d348-4a02-a98a-fd8eb4513af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES" xlink:type="simple" xlink:href="hum-20230331.xsd#COMMITMENTSGUARANTEESANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3630718a-c06a-465a-95b3-3dd9e7ad0c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_0bab6215-8d3e-4924-9ab5-8ca9199cc04f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3630718a-c06a-465a-95b3-3dd9e7ad0c24" xlink:to="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_0bab6215-8d3e-4924-9ab5-8ca9199cc04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="hum-20230331.xsd#SEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2f25c56e-c280-461e-8175-f5614249f08f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_c6075b31-2437-4ff1-bd1f-1b96b9838cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2f25c56e-c280-461e-8175-f5614249f08f" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_c6075b31-2437-4ff1-bd1f-1b96b9838cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSPolicies" xlink:type="simple" xlink:href="hum-20230331.xsd#BASISOFPRESENTATIONANDSIGNIFICANTEVENTSPolicies"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e984c343-8147-43af-a7c7-d6359b9ade16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_bcb1784a-0ff8-4031-a8b6-5cf561995130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e984c343-8147-43af-a7c7-d6359b9ade16" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_bcb1784a-0ff8-4031-a8b6-5cf561995130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_be55fe6b-0b96-41ee-ab95-1b0c175a3b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e984c343-8147-43af-a7c7-d6359b9ade16" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_be55fe6b-0b96-41ee-ab95-1b0c175a3b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_95dfa313-c28d-4305-bb1d-bb9ebdb5ecac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e984c343-8147-43af-a7c7-d6359b9ade16" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_95dfa313-c28d-4305-bb1d-bb9ebdb5ecac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESTables" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0d3f2a2c-4f7f-4a12-aaa8-b0c3954bd6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_8d20a162-340c-453c-9889-a3899c21731d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0d3f2a2c-4f7f-4a12-aaa8-b0c3954bd6cf" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_8d20a162-340c-453c-9889-a3899c21731d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_552498a1-6225-4b8f-ab4c-a7d08e8cf2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0d3f2a2c-4f7f-4a12-aaa8-b0c3954bd6cf" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_552498a1-6225-4b8f-ab4c-a7d08e8cf2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealizedGainLossTableTextBlock_d2dbe55f-0277-4310-90b5-311568a51d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRealizedGainLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0d3f2a2c-4f7f-4a12-aaa8-b0c3954bd6cf" xlink:to="loc_us-gaap_ScheduleOfRealizedGainLossTableTextBlock_d2dbe55f-0277-4310-90b5-311568a51d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock_62067480-75e3-4366-b7fa-4e591cefefb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0d3f2a2c-4f7f-4a12-aaa8-b0c3954bd6cf" xlink:to="loc_us-gaap_GainLossOnInvestmentsTextBlock_62067480-75e3-4366-b7fa-4e591cefefb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_aa1e7684-c5c9-42a2-9e35-cd665021a915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0d3f2a2c-4f7f-4a12-aaa8-b0c3954bd6cf" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_aa1e7684-c5c9-42a2-9e35-cd665021a915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUETables" xlink:type="simple" xlink:href="hum-20230331.xsd#FAIRVALUETables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/FAIRVALUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_981db92c-be1f-4de2-8a49-9cef9eb1d05f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_ac195f24-7f90-474a-bcd5-3bf54f7224ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_981db92c-be1f-4de2-8a49-9cef9eb1d05f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_ac195f24-7f90-474a-bcd5-3bf54f7224ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_5e9db913-574c-4e3e-8601-46def98aec31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_981db92c-be1f-4de2-8a49-9cef9eb1d05f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_5e9db913-574c-4e3e-8601-46def98aec31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_c7f3a337-d31e-4546-bd15-d9100313d4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_981db92c-be1f-4de2-8a49-9cef9eb1d05f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_c7f3a337-d31e-4546-bd15-d9100313d4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/MEDICAREPARTDTables" xlink:type="simple" xlink:href="hum-20230331.xsd#MEDICAREPARTDTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/MEDICAREPARTDTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_e6a65428-3b1b-4a8a-beb5-4f5f0cccb82c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock_63ded463-2e66-4308-8691-53eec690caf1" xlink:href="hum-20230331.xsd#hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e6a65428-3b1b-4a8a-beb5-4f5f0cccb82c" xlink:to="loc_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock_63ded463-2e66-4308-8691-53eec690caf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="hum-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b623668e-aae8-4d5f-94a2-f663be9999f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_5765380b-5e6d-4084-ae36-cf8b37eca689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b623668e-aae8-4d5f-94a2-f663be9999f5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_5765380b-5e6d-4084-ae36-cf8b37eca689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_428af971-27e6-485a-81d0-7fc54a38cc09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b623668e-aae8-4d5f-94a2-f663be9999f5" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_428af971-27e6-485a-81d0-7fc54a38cc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3153e52a-23f2-451b-afa6-cbb0db64d358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b623668e-aae8-4d5f-94a2-f663be9999f5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3153e52a-23f2-451b-afa6-cbb0db64d358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_46c522dc-28f1-457a-bbdf-1074cb6757b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b623668e-aae8-4d5f-94a2-f663be9999f5" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_46c522dc-28f1-457a-bbdf-1074cb6757b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/BENEFITSPAYABLETables" xlink:type="simple" xlink:href="hum-20230331.xsd#BENEFITSPAYABLETables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/BENEFITSPAYABLETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_83ddf8ca-52e3-4a6a-898f-6a82a834fcd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_358c5557-4cba-4bad-bfa7-cc22d3a9d42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_83ddf8ca-52e3-4a6a-898f-6a82a834fcd8" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_358c5557-4cba-4bad-bfa7-cc22d3a9d42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables" xlink:type="simple" xlink:href="hum-20230331.xsd#EARNINGSPERCOMMONSHARECOMPUTATIONTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_db79472e-92ad-4e37-a3d4-b2220b67d0af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_84e75696-afc0-4366-9c32-92837e3c1c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_db79472e-92ad-4e37-a3d4-b2220b67d0af" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_84e75696-afc0-4366-9c32-92837e3c1c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="hum-20230331.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_57a92b05-d510-4b68-a3c8-fb826a982e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock_5f5a6749-b724-432f-ae9d-8f8d39045334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_57a92b05-d510-4b68-a3c8-fb826a982e5d" xlink:to="loc_us-gaap_DividendsDeclaredTableTextBlock_5f5a6749-b724-432f-ae9d-8f8d39045334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTTables" xlink:type="simple" xlink:href="hum-20230331.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ef71b49b-a425-417a-b6e7-ed77c1961dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_fd6897fe-945e-4abc-b63a-fcfd1f2becf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ef71b49b-a425-417a-b6e7-ed77c1961dc6" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_fd6897fe-945e-4abc-b63a-fcfd1f2becf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="hum-20230331.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f0c7b46f-310c-4248-8353-fda34212921c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_afb15106-91d4-451a-a394-d1583e9c2675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f0c7b46f-310c-4248-8353-fda34212921c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_afb15106-91d4-451a-a394-d1583e9c2675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1b1191ed-eae8-4e2e-bfa1-dd9801451e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_73701e26-7e4b-4da5-800b-bdb27aee4874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1b1191ed-eae8-4e2e-bfa1-dd9801451e13" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_73701e26-7e4b-4da5-800b-bdb27aee4874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ce26175e-5c0b-47be-be4e-5aa4ffb9f879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_73701e26-7e4b-4da5-800b-bdb27aee4874" xlink:to="loc_us-gaap_RestructuringPlanAxis_ce26175e-5c0b-47be-be4e-5aa4ffb9f879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_021c0147-67f3-40e7-b382-c271fd9a6a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_ce26175e-5c0b-47be-be4e-5aa4ffb9f879" xlink:to="loc_us-gaap_RestructuringPlanDomain_021c0147-67f3-40e7-b382-c271fd9a6a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ValueCreationInitiativesMember_aafe9bdd-0617-49ee-8087-d34ad6730a6e" xlink:href="hum-20230331.xsd#hum_ValueCreationInitiativesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_021c0147-67f3-40e7-b382-c271fd9a6a0b" xlink:to="loc_hum_ValueCreationInitiativesMember_aafe9bdd-0617-49ee-8087-d34ad6730a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3653c263-b5cc-44ac-a76d-11de2c56dc65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_73701e26-7e4b-4da5-800b-bdb27aee4874" xlink:to="loc_srt_ProductOrServiceAxis_3653c263-b5cc-44ac-a76d-11de2c56dc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_be736fb8-d5dd-4cc7-baa8-9d88bd3ba60c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3653c263-b5cc-44ac-a76d-11de2c56dc65" xlink:to="loc_srt_ProductsAndServicesDomain_be736fb8-d5dd-4cc7-baa8-9d88bd3ba60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_eef344ca-6346-42b5-9c72-aad48d742a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_be736fb8-d5dd-4cc7-baa8-9d88bd3ba60c" xlink:to="loc_us-gaap_ServiceMember_eef344ca-6346-42b5-9c72-aad48d742a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fcbcf096-5ea8-4ec3-96fa-82566abee2d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_73701e26-7e4b-4da5-800b-bdb27aee4874" xlink:to="loc_srt_RangeAxis_fcbcf096-5ea8-4ec3-96fa-82566abee2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_19e2b937-528f-48fe-aac6-9888b3fe917b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fcbcf096-5ea8-4ec3-96fa-82566abee2d7" xlink:to="loc_srt_RangeMember_19e2b937-528f-48fe-aac6-9888b3fe917b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fff7fabf-ae3c-4f4f-887b-0e63faf36abe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_19e2b937-528f-48fe-aac6-9888b3fe917b" xlink:to="loc_srt_MinimumMember_fff7fabf-ae3c-4f4f-887b-0e63faf36abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c5d370a3-e5d2-49b1-8c8b-30389fc5665d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_19e2b937-528f-48fe-aac6-9888b3fe917b" xlink:to="loc_srt_MaximumMember_c5d370a3-e5d2-49b1-8c8b-30389fc5665d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_73701e26-7e4b-4da5-800b-bdb27aee4874" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DiscontinuedOperationsSegmentPhaseOutPeriod_93f7d89a-749e-4a5c-9230-c1aa483ce632" xlink:href="hum-20230331.xsd#hum_DiscontinuedOperationsSegmentPhaseOutPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:to="loc_hum_DiscontinuedOperationsSegmentPhaseOutPeriod_93f7d89a-749e-4a5c-9230-c1aa483ce632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_60344011-b029-4c30-8932-4b80c82dbf1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_60344011-b029-4c30-8932-4b80c82dbf1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_e02cef12-7b4e-4926-b1ac-38e1d1dc83ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_e02cef12-7b4e-4926-b1ac-38e1d1dc83ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_cac0f0d7-a361-48f4-bee1-7c017c566d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:to="loc_us-gaap_SeveranceCosts1_cac0f0d7-a361-48f4-bee1-7c017c566d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_79ded02e-97d9-4df5-93fd-1875b3fb38d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_3017b926-ca08-472e-8582-1bc30b948da5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_79ded02e-97d9-4df5-93fd-1875b3fb38d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_62396f9b-aac6-42fb-8e68-eee952efdee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_d8540f09-55f9-4044-8050-4af5ad1081c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_62396f9b-aac6-42fb-8e68-eee952efdee6" xlink:to="loc_us-gaap_ConcentrationRiskTable_d8540f09-55f9-4044-8050-4af5ad1081c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_71474668-7b8f-4046-a313-60cfc3ed7223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d8540f09-55f9-4044-8050-4af5ad1081c1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_71474668-7b8f-4046-a313-60cfc3ed7223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b9b3457b-d02c-452b-bd79-c01f97a720aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_71474668-7b8f-4046-a313-60cfc3ed7223" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b9b3457b-d02c-452b-bd79-c01f97a720aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_da28b973-b2fc-4dc7-8c77-d6963f7d8f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b9b3457b-d02c-452b-bd79-c01f97a720aa" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_da28b973-b2fc-4dc7-8c77-d6963f7d8f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_09c99809-8ca8-468e-a7f4-53789f71960c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d8540f09-55f9-4044-8050-4af5ad1081c1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_09c99809-8ca8-468e-a7f4-53789f71960c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_bce27307-7507-4062-b332-e26e27893de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_09c99809-8ca8-468e-a7f4-53789f71960c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_bce27307-7507-4062-b332-e26e27893de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_8cea8677-d78f-438d-9128-0c04a8d35436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_bce27307-7507-4062-b332-e26e27893de1" xlink:to="loc_us-gaap_SalesRevenueNetMember_8cea8677-d78f-438d-9128-0c04a8d35436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8efdb7a4-572c-4f41-b235-12ea0756011b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d8540f09-55f9-4044-8050-4af5ad1081c1" xlink:to="loc_srt_ProductOrServiceAxis_8efdb7a4-572c-4f41-b235-12ea0756011b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7b28f50e-b943-4007-a5cc-e94a51530503" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8efdb7a4-572c-4f41-b235-12ea0756011b" xlink:to="loc_srt_ProductsAndServicesDomain_7b28f50e-b943-4007-a5cc-e94a51530503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareSupplementProductMember_55671778-fa7c-4391-b54b-1f693a176a6a" xlink:href="hum-20230331.xsd#hum_MedicareSupplementProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7b28f50e-b943-4007-a5cc-e94a51530503" xlink:to="loc_hum_MedicareSupplementProductMember_55671778-fa7c-4391-b54b-1f693a176a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_d7d02e15-20e1-4115-9e7b-4a5226f4ef56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d8540f09-55f9-4044-8050-4af5ad1081c1" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_d7d02e15-20e1-4115-9e7b-4a5226f4ef56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_065ce8ae-01ba-44d5-b452-83c3c711bee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d7d02e15-20e1-4115-9e7b-4a5226f4ef56" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_065ce8ae-01ba-44d5-b452-83c3c711bee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#ACQUISITIONSANDDIVESTITURESDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_156de71f-3a67-4e21-8f0b-dcacc54daf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae1cb1c0-ce99-412a-ad51-2ccfd0604098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_156de71f-3a67-4e21-8f0b-dcacc54daf8f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae1cb1c0-ce99-412a-ad51-2ccfd0604098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_63ef0eab-083c-4dce-b732-117c2a7eaebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae1cb1c0-ce99-412a-ad51-2ccfd0604098" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_63ef0eab-083c-4dce-b732-117c2a7eaebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4f4e1b6a-8180-4e79-ba58-b616213d38bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_63ef0eab-083c-4dce-b732-117c2a7eaebc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4f4e1b6a-8180-4e79-ba58-b616213d38bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_bfe9b993-70b3-4362-9632-237b8d366049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_4f4e1b6a-8180-4e79-ba58-b616213d38bd" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_bfe9b993-70b3-4362-9632-237b8d366049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3f6458bc-69b7-47e5-9e21-a01ac7b06d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae1cb1c0-ce99-412a-ad51-2ccfd0604098" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3f6458bc-69b7-47e5-9e21-a01ac7b06d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac392a89-9ca8-46ba-96c4-e16715137267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3f6458bc-69b7-47e5-9e21-a01ac7b06d47" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac392a89-9ca8-46ba-96c4-e16715137267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GentivaHospiceMember_4a6588be-a692-490c-8deb-881538b3c072" xlink:href="hum-20230331.xsd#hum_GentivaHospiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac392a89-9ca8-46ba-96c4-e16715137267" xlink:to="loc_hum_GentivaHospiceMember_4a6588be-a692-490c-8deb-881538b3c072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f68ce70b-97a0-4bdf-af4a-630c0d90b6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae1cb1c0-ce99-412a-ad51-2ccfd0604098" xlink:to="loc_us-gaap_DebtInstrumentAxis_f68ce70b-97a0-4bdf-af4a-630c0d90b6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3736d2c8-279c-473d-9131-d2b7cf2058bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f68ce70b-97a0-4bdf-af4a-630c0d90b6e4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3736d2c8-279c-473d-9131-d2b7cf2058bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanDueOctober2023Member_737859aa-bd71-4c0f-9bcc-c506dfc54658" xlink:href="hum-20230331.xsd#hum_TermLoanDueOctober2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3736d2c8-279c-473d-9131-d2b7cf2058bc" xlink:to="loc_hum_TermLoanDueOctober2023Member_737859aa-bd71-4c0f-9bcc-c506dfc54658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b0332cca-6578-4639-b521-76c08e9fe8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae1cb1c0-ce99-412a-ad51-2ccfd0604098" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b0332cca-6578-4639-b521-76c08e9fe8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f7721376-c9de-4097-be76-ee4849be587c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b0332cca-6578-4639-b521-76c08e9fe8f0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f7721376-c9de-4097-be76-ee4849be587c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_78450763-f25e-4a52-9ba7-e65d377bb52e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f7721376-c9de-4097-be76-ee4849be587c" xlink:to="loc_us-gaap_LoansPayableMember_78450763-f25e-4a52-9ba7-e65d377bb52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ae1cb1c0-ce99-412a-ad51-2ccfd0604098" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_445f73a8-231b-42e4-9936-2f50ee24d892" xlink:href="hum-20230331.xsd#hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:to="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_445f73a8-231b-42e4-9936-2f50ee24d892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_64aba830-67fc-4fc1-a901-1acd06eac065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_64aba830-67fc-4fc1-a901-1acd06eac065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_71424802-ddc1-450c-9399-37d08e92b5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:to="loc_us-gaap_RepaymentsOfDebt_71424802-ddc1-450c-9399-37d08e92b5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_4f93c9f6-7e9e-4890-99fc-7598b806d4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_4f93c9f6-7e9e-4890-99fc-7598b806d4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_57c83f21-da85-4288-b9ad-d08d04896716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_57c83f21-da85-4288-b9ad-d08d04896716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax_92398448-99a5-46f8-a5d1-e591a08c06a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6706aa37-9303-411f-ba6d-d730074d1a26" xlink:to="loc_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax_92398448-99a5-46f8-a5d1-e591a08c06a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d4354b47-05bb-4765-96c0-404037d14ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_805057e6-737f-4d01-b21a-cf568917a283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d4354b47-05bb-4765-96c0-404037d14ba5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_805057e6-737f-4d01-b21a-cf568917a283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e95ea388-db32-4a98-b11d-e9264ab9fa6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_805057e6-737f-4d01-b21a-cf568917a283" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e95ea388-db32-4a98-b11d-e9264ab9fa6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e95ea388-db32-4a98-b11d-e9264ab9fa6c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_1a76fae2-9b73-4177-9487-6c2b333cc4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_1a76fae2-9b73-4177-9487-6c2b333cc4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_49d39506-71e9-4394-aca5-a2cf2c60e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_49d39506-71e9-4394-aca5-a2cf2c60e7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember_15b428b6-7a4b-4f4e-92c6-ebcf530d05d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_NontaxableMunicipalNotesMember_15b428b6-7a4b-4f4e-92c6-ebcf530d05d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_1670c6eb-d615-4005-9230-514c9b0afd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_1670c6eb-d615-4005-9230-514c9b0afd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_5b506d5a-f1b6-4f54-9874-761cf83e7b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_5b506d5a-f1b6-4f54-9874-761cf83e7b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_f4df6e44-1edb-46f6-9cf0-600afee67b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_f4df6e44-1edb-46f6-9cf0-600afee67b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_062493a4-1ab3-44dd-b8dc-1ddf9396e98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621fd513-5d93-4f62-ab3f-e76726342164" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_062493a4-1ab3-44dd-b8dc-1ddf9396e98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0864bde1-8536-41db-9d3b-33b93db3c80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_805057e6-737f-4d01-b21a-cf568917a283" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0864bde1-8536-41db-9d3b-33b93db3c80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0864bde1-8536-41db-9d3b-33b93db3c80b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0d58a9ff-84b1-4038-90c7-f8fbff3c2a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0d58a9ff-84b1-4038-90c7-f8fbff3c2a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_35f93933-9f90-4510-aa22-0f22114c7cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_35f93933-9f90-4510-aa22-0f22114c7cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9abead6f-7c7f-42ab-8692-fcef96993256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9abead6f-7c7f-42ab-8692-fcef96993256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9b38a1db-ce48-433b-843c-cc6d2070af57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9b38a1db-ce48-433b-843c-cc6d2070af57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_23e2631f-78d2-47cd-bd47-7c04cae4d5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_23e2631f-78d2-47cd-bd47-7c04cae4d5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_4b183bdb-6464-4f0e-86c4-f9d40376e02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_c2bd833e-2b23-4875-81ab-b37c6eb62fd5" xlink:to="loc_us-gaap_Investments_4b183bdb-6464-4f0e-86c4-f9d40376e02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_57c534b6-a8e6-472b-bf0a-f29719bd28d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_3507f469-1a74-4e35-9638-be0ae79e9a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_57c534b6-a8e6-472b-bf0a-f29719bd28d1" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_3507f469-1a74-4e35-9638-be0ae79e9a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_9f06d845-031c-4274-8c9e-603cccfd5d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_3507f469-1a74-4e35-9638-be0ae79e9a73" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_9f06d845-031c-4274-8c9e-603cccfd5d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d8079327-456c-4beb-8623-be4df7251285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9f06d845-031c-4274-8c9e-603cccfd5d0b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d8079327-456c-4beb-8623-be4df7251285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_117c4d18-638e-486b-9449-89effd99f8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d8079327-456c-4beb-8623-be4df7251285" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_117c4d18-638e-486b-9449-89effd99f8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bf2ebd6-595b-430a-bd8d-2238facb906d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_3507f469-1a74-4e35-9638-be0ae79e9a73" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bf2ebd6-595b-430a-bd8d-2238facb906d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fe74161a-08a5-4f09-90bb-dd2ba0fc8278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bf2ebd6-595b-430a-bd8d-2238facb906d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fe74161a-08a5-4f09-90bb-dd2ba0fc8278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GentivaHospiceMember_f5ed3cef-0b10-49ba-bd6f-c74b4093a210" xlink:href="hum-20230331.xsd#hum_GentivaHospiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fe74161a-08a5-4f09-90bb-dd2ba0fc8278" xlink:to="loc_hum_GentivaHospiceMember_f5ed3cef-0b10-49ba-bd6f-c74b4093a210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingStandardPoorsAxis_1d83802e-67f8-4748-a9d9-0b5b039a42a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingStandardPoorsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_3507f469-1a74-4e35-9638-be0ae79e9a73" xlink:to="loc_srt_CreditRatingStandardPoorsAxis_1d83802e-67f8-4748-a9d9-0b5b039a42a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember_030546cb-12f0-4536-8891-075ddf511070" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CreditRatingStandardPoorsAxis_1d83802e-67f8-4748-a9d9-0b5b039a42a2" xlink:to="loc_srt_ExternalCreditRatingStandardPoorsMember_030546cb-12f0-4536-8891-075ddf511070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsAARatingMember_ea3e6c7e-2690-48e8-aaa0-b660da53ce96" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StandardPoorsAARatingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_030546cb-12f0-4536-8891-075ddf511070" xlink:to="loc_srt_StandardPoorsAARatingMember_ea3e6c7e-2690-48e8-aaa0-b660da53ce96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_3507f469-1a74-4e35-9638-be0ae79e9a73" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6c2aad9a-4bdd-4eb8-bde4-d03c629ee17c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6c2aad9a-4bdd-4eb8-bde4-d03c629ee17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_07f75edd-a5eb-49b3-bb0f-390b514c0bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_07f75edd-a5eb-49b3-bb0f-390b514c0bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_880e7f9a-9862-4d8a-9be2-5efcd4fc7efc" xlink:href="hum-20230331.xsd#hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:to="loc_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_880e7f9a-9862-4d8a-9be2-5efcd4fc7efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_ef52f362-a419-4825-a40f-0eb4f504b8d8" xlink:href="hum-20230331.xsd#hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:to="loc_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_ef52f362-a419-4825-a40f-0eb4f504b8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ea4a83c9-7bf4-49ea-8a5d-3c4b036e89ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ea4a83c9-7bf4-49ea-8a5d-3c4b036e89ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_2473d71f-826c-45ca-ba2f-6b5c7bcf64eb" xlink:href="hum-20230331.xsd#hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_97edc3f9-d3ce-4005-9648-342c16674b00" xlink:to="loc_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_2473d71f-826c-45ca-ba2f-6b5c7bcf64eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_af1e8f06-366e-4c61-b101-8f09b71dfbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_957052c2-af31-4398-bf36-d6984dfdc074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_af1e8f06-366e-4c61-b101-8f09b71dfbf7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_957052c2-af31-4398-bf36-d6984dfdc074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_66142161-0163-477a-91ee-e5b7c33b2640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_957052c2-af31-4398-bf36-d6984dfdc074" xlink:to="loc_us-gaap_FinancialInstrumentAxis_66142161-0163-477a-91ee-e5b7c33b2640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_66142161-0163-477a-91ee-e5b7c33b2640" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_a0c3b0ad-6394-4c7c-9844-047338445373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_a0c3b0ad-6394-4c7c-9844-047338445373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_59f55fe5-7908-4c17-8876-f16b5f17faf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_59f55fe5-7908-4c17-8876-f16b5f17faf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember_b73fbe3e-5f39-4fcf-a538-f85b5d776ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_NontaxableMunicipalNotesMember_b73fbe3e-5f39-4fcf-a538-f85b5d776ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_91bbfd8f-0bbd-4b95-9fde-fd23a9b471ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_91bbfd8f-0bbd-4b95-9fde-fd23a9b471ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8cdde5a9-2284-443b-a8bb-f6765c1d9441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8cdde5a9-2284-443b-a8bb-f6765c1d9441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_e2f4105b-296f-4227-959e-de6235f487f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_e2f4105b-296f-4227-959e-de6235f487f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_352c7688-4d11-434e-b2cb-74f4bd6ffe29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ccd87b5-c754-4781-bd00-14c69497385c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_352c7688-4d11-434e-b2cb-74f4bd6ffe29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_ccda1eea-cc24-4683-8e93-c47d0e29fc81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_957052c2-af31-4398-bf36-d6984dfdc074" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_ccda1eea-cc24-4683-8e93-c47d0e29fc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_227744ab-6f7a-4a19-88b3-c04e1005577b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_ccda1eea-cc24-4683-8e93-c47d0e29fc81" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_227744ab-6f7a-4a19-88b3-c04e1005577b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_5905d828-b283-4b27-8e1b-9aeddb608dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_227744ab-6f7a-4a19-88b3-c04e1005577b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_5905d828-b283-4b27-8e1b-9aeddb608dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_39ab4d25-61e8-4b5a-9f13-dc5cf98603ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_227744ab-6f7a-4a19-88b3-c04e1005577b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_39ab4d25-61e8-4b5a-9f13-dc5cf98603ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a2c86f50-6bf6-4cf5-8824-9807b292edd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_227744ab-6f7a-4a19-88b3-c04e1005577b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a2c86f50-6bf6-4cf5-8824-9807b292edd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_56c795eb-3dc6-47f5-9071-7c3cf1acfcd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_ccda1eea-cc24-4683-8e93-c47d0e29fc81" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_56c795eb-3dc6-47f5-9071-7c3cf1acfcd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_b1f9dc5c-fe9f-4d4b-bdfc-fe08e631c7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_56c795eb-3dc6-47f5-9071-7c3cf1acfcd9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_b1f9dc5c-fe9f-4d4b-bdfc-fe08e631c7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_f370607e-4d2f-4c0e-8902-66b6576ef554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_56c795eb-3dc6-47f5-9071-7c3cf1acfcd9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_f370607e-4d2f-4c0e-8902-66b6576ef554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_d7b32bf3-bae4-4826-9e7d-c798711e3db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_56c795eb-3dc6-47f5-9071-7c3cf1acfcd9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_d7b32bf3-bae4-4826-9e7d-c798711e3db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_641fb3f9-6b8c-4d09-9c19-56cd1ad9f3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtSecuritiesRealizedGainGross_d379596e-9b26-492c-abb5-5e52e7d37dec" xlink:href="hum-20230331.xsd#hum_DebtSecuritiesRealizedGainGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_641fb3f9-6b8c-4d09-9c19-56cd1ad9f3bb" xlink:to="loc_hum_DebtSecuritiesRealizedGainGross_d379596e-9b26-492c-abb5-5e52e7d37dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtSecuritiesRealizedLossGross_1e9480f8-7bd8-4d93-af33-ea7198495476" xlink:href="hum-20230331.xsd#hum_DebtSecuritiesRealizedLossGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_641fb3f9-6b8c-4d09-9c19-56cd1ad9f3bb" xlink:to="loc_hum_DebtSecuritiesRealizedLossGross_1e9480f8-7bd8-4d93-af33-ea7198495476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_4b92bf84-128d-484b-9e87-7f8d5bce7c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_641fb3f9-6b8c-4d09-9c19-56cd1ad9f3bb" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_4b92bf84-128d-484b-9e87-7f8d5bce7c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_962ec9ef-f9ae-4cd4-b165-d3c1431ee171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_641fb3f9-6b8c-4d09-9c19-56cd1ad9f3bb" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_962ec9ef-f9ae-4cd4-b165-d3c1431ee171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_4a05fded-9b58-4d0c-989e-3506feaea377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_641fb3f9-6b8c-4d09-9c19-56cd1ad9f3bb" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_4a05fded-9b58-4d0c-989e-3506feaea377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_2bcf43fa-d7d8-4c25-a47c-0a234a342baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_01996908-2051-4ce1-92e6-d274c5546628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_2bcf43fa-d7d8-4c25-a47c-0a234a342baf" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_01996908-2051-4ce1-92e6-d274c5546628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_dc405c94-1a7a-4149-822b-06da10e1343e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_2bcf43fa-d7d8-4c25-a47c-0a234a342baf" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_dc405c94-1a7a-4149-822b-06da10e1343e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_d583aeb6-8dae-4d10-91d9-9e82f9defe54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_2bcf43fa-d7d8-4c25-a47c-0a234a342baf" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_d583aeb6-8dae-4d10-91d9-9e82f9defe54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_24cd8091-21b2-47e5-a24d-6e89756b4306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_67d4a633-5f68-4fb5-872f-5c0dad8d92f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_24cd8091-21b2-47e5-a24d-6e89756b4306" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_67d4a633-5f68-4fb5-872f-5c0dad8d92f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_bf082983-4458-43aa-be76-9b75050f13d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_67d4a633-5f68-4fb5-872f-5c0dad8d92f6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_bf082983-4458-43aa-be76-9b75050f13d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_bf9d163c-53c3-406d-bd50-c1218ce2f5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_67d4a633-5f68-4fb5-872f-5c0dad8d92f6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_bf9d163c-53c3-406d-bd50-c1218ce2f5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_16701a70-792f-4132-923f-8de43d79712e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_67d4a633-5f68-4fb5-872f-5c0dad8d92f6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_16701a70-792f-4132-923f-8de43d79712e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_accc0176-e291-4f3e-937b-d8aed8cb8ded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_67d4a633-5f68-4fb5-872f-5c0dad8d92f6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_accc0176-e291-4f3e-937b-d8aed8cb8ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_9ff9d33f-b9bf-49de-8919-94cdfeb3bde4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_67d4a633-5f68-4fb5-872f-5c0dad8d92f6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_9ff9d33f-b9bf-49de-8919-94cdfeb3bde4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_badb38b1-0b61-46e6-bef1-2892c8dfdbea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_67d4a633-5f68-4fb5-872f-5c0dad8d92f6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_badb38b1-0b61-46e6-bef1-2892c8dfdbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17148c68-3f62-47ad-bfb9-c674fe79c0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_24cd8091-21b2-47e5-a24d-6e89756b4306" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17148c68-3f62-47ad-bfb9-c674fe79c0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_54ea0fff-5945-4f7d-bc80-f84c6ea81f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17148c68-3f62-47ad-bfb9-c674fe79c0e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_54ea0fff-5945-4f7d-bc80-f84c6ea81f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_a17992b8-c116-4116-b8a7-7bf4c1c5bc02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17148c68-3f62-47ad-bfb9-c674fe79c0e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_a17992b8-c116-4116-b8a7-7bf4c1c5bc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_94a0b206-1747-4b40-a83a-1c5ffb0b110c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17148c68-3f62-47ad-bfb9-c674fe79c0e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_94a0b206-1747-4b40-a83a-1c5ffb0b110c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_fee0b528-8baa-4150-9369-7e1226e9b420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17148c68-3f62-47ad-bfb9-c674fe79c0e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_fee0b528-8baa-4150-9369-7e1226e9b420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_af703d13-51ae-46e8-9178-ea9eb6e0e086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17148c68-3f62-47ad-bfb9-c674fe79c0e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_af703d13-51ae-46e8-9178-ea9eb6e0e086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_268793a7-7d21-45f1-b5a1-425a6e7660d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17148c68-3f62-47ad-bfb9-c674fe79c0e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_268793a7-7d21-45f1-b5a1-425a6e7660d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ca6ea54c-73ee-4e66-b610-79a8f4bbb4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b36e5cf-abdc-4f65-8717-9b5555be44bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ca6ea54c-73ee-4e66-b610-79a8f4bbb4ab" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b36e5cf-abdc-4f65-8717-9b5555be44bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_394a10d2-fc2c-41ab-a1e5-b8e91838a146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b36e5cf-abdc-4f65-8717-9b5555be44bf" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_394a10d2-fc2c-41ab-a1e5-b8e91838a146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e73652c7-9be1-43b1-9d23-9488299ae30b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_394a10d2-fc2c-41ab-a1e5-b8e91838a146" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e73652c7-9be1-43b1-9d23-9488299ae30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d1a0bef6-8daf-4f48-8188-faedc54b8803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e73652c7-9be1-43b1-9d23-9488299ae30b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d1a0bef6-8daf-4f48-8188-faedc54b8803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bbc70229-ed98-4477-9227-6b1a65d95cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b36e5cf-abdc-4f65-8717-9b5555be44bf" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bbc70229-ed98-4477-9227-6b1a65d95cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92d16543-eadf-4588-974e-070a433eaf3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bbc70229-ed98-4477-9227-6b1a65d95cb5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92d16543-eadf-4588-974e-070a433eaf3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b8eaca21-c29a-4076-b4c0-83aa093ca6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92d16543-eadf-4588-974e-070a433eaf3e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b8eaca21-c29a-4076-b4c0-83aa093ca6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_690078a4-472c-4aaa-88a3-cf3637abf4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92d16543-eadf-4588-974e-070a433eaf3e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_690078a4-472c-4aaa-88a3-cf3637abf4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d404ea74-17a4-42c6-ba99-4ee12e87d2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92d16543-eadf-4588-974e-070a433eaf3e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d404ea74-17a4-42c6-ba99-4ee12e87d2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f2d38fdb-06f7-4f04-b02f-b745aa7e300f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b36e5cf-abdc-4f65-8717-9b5555be44bf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f2d38fdb-06f7-4f04-b02f-b745aa7e300f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f2d38fdb-06f7-4f04-b02f-b745aa7e300f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_79010dec-bffb-4d48-a281-d73fb333a888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_79010dec-bffb-4d48-a281-d73fb333a888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_71b8f01b-2a45-4287-9477-a323b6516b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_71b8f01b-2a45-4287-9477-a323b6516b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember_6ab824d6-7c5b-4fd8-b923-dc6e5499b8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_NontaxableMunicipalNotesMember_6ab824d6-7c5b-4fd8-b923-dc6e5499b8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_0ba39cfa-502f-421a-9a2f-4fc8702780c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_0ba39cfa-502f-421a-9a2f-4fc8702780c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_0115176d-6030-4631-924c-e4a552f7c171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_0115176d-6030-4631-924c-e4a552f7c171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_4bac8d13-1d93-4870-8a0c-34fffe7da624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_4bac8d13-1d93-4870-8a0c-34fffe7da624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_8040056e-4a19-461f-9bc9-d3e5da54d6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d30d947-b94f-478f-9a23-5c31bacf1844" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_8040056e-4a19-461f-9bc9-d3e5da54d6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b14740ae-5dcc-439d-8db7-cb39e40951b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b36e5cf-abdc-4f65-8717-9b5555be44bf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b14740ae-5dcc-439d-8db7-cb39e40951b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e9af1136-b6e2-4496-bf2a-608f1d2ca275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b14740ae-5dcc-439d-8db7-cb39e40951b3" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e9af1136-b6e2-4496-bf2a-608f1d2ca275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5e43e64c-28f9-4fe0-89b8-e263befd7f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b14740ae-5dcc-439d-8db7-cb39e40951b3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5e43e64c-28f9-4fe0-89b8-e263befd7f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_c7d7135d-beca-4505-8f83-c864998c2f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b14740ae-5dcc-439d-8db7-cb39e40951b3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_c7d7135d-beca-4505-8f83-c864998c2f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_4d22e961-bfdb-4fdc-9cd6-358a96b7677e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b14740ae-5dcc-439d-8db7-cb39e40951b3" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_4d22e961-bfdb-4fdc-9cd6-358a96b7677e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUENarrativeDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#FAIRVALUENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/FAIRVALUENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_172e0b21-1218-4404-ac49-9e2b24919326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_172e0b21-1218-4404-ac49-9e2b24919326" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2006a084-7ef3-44b9-93fd-7e9b2e6764b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2006a084-7ef3-44b9-93fd-7e9b2e6764b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa9cff9-1f44-4d50-8f23-635cb2653ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2006a084-7ef3-44b9-93fd-7e9b2e6764b7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa9cff9-1f44-4d50-8f23-635cb2653ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d17734fd-5748-4190-ad7e-d1bb6e7b1937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa9cff9-1f44-4d50-8f23-635cb2653ac2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d17734fd-5748-4190-ad7e-d1bb6e7b1937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_94549ce7-02a7-41a6-9c89-16cd4ce0ab9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_94549ce7-02a7-41a6-9c89-16cd4ce0ab9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d837640e-c314-4c83-88f4-d2af685894a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_94549ce7-02a7-41a6-9c89-16cd4ce0ab9a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d837640e-c314-4c83-88f4-d2af685894a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_47ee6cc8-6c85-471b-9ce9-34a04118367a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d837640e-c314-4c83-88f4-d2af685894a5" xlink:to="loc_us-gaap_InvestmentsMember_47ee6cc8-6c85-471b-9ce9-34a04118367a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7a859586-8ad2-4990-92fc-108dd7cef912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7a859586-8ad2-4990-92fc-108dd7cef912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_23dae28c-7851-4466-8f7f-de039c3d58dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7a859586-8ad2-4990-92fc-108dd7cef912" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_23dae28c-7851-4466-8f7f-de039c3d58dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FairValueRiskMember_c4fefb09-7493-4389-9fda-feb645b66852" xlink:href="hum-20230331.xsd#hum_FairValueRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_23dae28c-7851-4466-8f7f-de039c3d58dd" xlink:to="loc_hum_FairValueRiskMember_c4fefb09-7493-4389-9fda-feb645b66852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_363f7cb9-e616-4f82-b4df-34eedabe8a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_363f7cb9-e616-4f82-b4df-34eedabe8a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b9fd7d24-6d53-43ad-a117-c8ec628c6cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_363f7cb9-e616-4f82-b4df-34eedabe8a3c" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b9fd7d24-6d53-43ad-a117-c8ec628c6cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a416ce9b-fcb2-4e21-b8b1-6befe90502d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b9fd7d24-6d53-43ad-a117-c8ec628c6cbc" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a416ce9b-fcb2-4e21-b8b1-6befe90502d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_f5d9b2e3-1d24-43fe-b6d5-a0e9651f8d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a416ce9b-fcb2-4e21-b8b1-6befe90502d6" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_f5d9b2e3-1d24-43fe-b6d5-a0e9651f8d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3352264d-9ae1-4b7a-a649-39c0d92326b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a416ce9b-fcb2-4e21-b8b1-6befe90502d6" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3352264d-9ae1-4b7a-a649-39c0d92326b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_f72922bb-4b28-474a-9460-6cf130f4dbb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_f72922bb-4b28-474a-9460-6cf130f4dbb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3dc57a46-8836-4f00-b123-d49e7e416e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_f72922bb-4b28-474a-9460-6cf130f4dbb6" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3dc57a46-8836-4f00-b123-d49e7e416e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanAndCommercialPaperMember_97f1a377-5b9d-4e1b-b68b-caa54a9df1ee" xlink:href="hum-20230331.xsd#hum_TermLoanAndCommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_3dc57a46-8836-4f00-b123-d49e7e416e87" xlink:to="loc_hum_TermLoanAndCommercialPaperMember_97f1a377-5b9d-4e1b-b68b-caa54a9df1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_73d0c8dd-4973-4468-be8b-4df713e5e5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_73d0c8dd-4973-4468-be8b-4df713e5e5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_b9a519ad-f16d-45a6-88a9-14baeb0312ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_73d0c8dd-4973-4468-be8b-4df713e5e5c7" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_b9a519ad-f16d-45a6-88a9-14baeb0312ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember_f8f0bc6a-2664-4389-8e46-dab2b042ebef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PutOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_b9a519ad-f16d-45a6-88a9-14baeb0312ea" xlink:to="loc_us-gaap_PutOptionMember_f8f0bc6a-2664-4389-8e46-dab2b042ebef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_e0f4456a-3796-4da1-a01d-6d22e97a1277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_b9a519ad-f16d-45a6-88a9-14baeb0312ea" xlink:to="loc_us-gaap_CallOptionMember_e0f4456a-3796-4da1-a01d-6d22e97a1277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_38320a8c-8431-4b01-9b65-023e14db4d88" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_cd627700-0edb-4e58-bc90-f6e35f3212aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_cd627700-0edb-4e58-bc90-f6e35f3212aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_9f367059-864d-4b23-b8c9-3242c27feb84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_9f367059-864d-4b23-b8c9-3242c27feb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_de02bfb6-1ff8-4a77-baa0-6c7ae0e22835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:to="loc_us-gaap_DebtInstrumentFairValue_de02bfb6-1ff8-4a77-baa0-6c7ae0e22835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_61414a9d-18d2-4cd7-9445-5482927f57fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:to="loc_us-gaap_ShortTermBorrowings_61414a9d-18d2-4cd7-9445-5482927f57fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_4a445913-1246-4bcb-b733-8cc88707438e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_4a445913-1246-4bcb-b733-8cc88707438e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FinancialAssetsFairValueDisclosure_7b717a80-d236-45c4-a662-fb385e22efa1" xlink:href="hum-20230331.xsd#hum_FinancialAssetsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_34a8e847-2363-47a3-a490-d1b039eb815e" xlink:to="loc_hum_FinancialAssetsFairValueDisclosure_7b717a80-d236-45c4-a662-fb385e22efa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details" xlink:type="simple" xlink:href="hum-20230331.xsd#FAIRVALUESignificantUnobservableInputsLevel3Details"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d4fa33af-20c0-4633-9a61-4575eee14988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_14527a48-b8c0-414a-b017-9e57d9be3ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d4fa33af-20c0-4633-9a61-4575eee14988" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_14527a48-b8c0-414a-b017-9e57d9be3ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_62a034a6-d654-405e-b8e9-9c824cd1fb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_14527a48-b8c0-414a-b017-9e57d9be3ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_62a034a6-d654-405e-b8e9-9c824cd1fb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract_a3a85b42-bb5a-4d98-8afe-ce0908213e0b" xlink:href="hum-20230331.xsd#hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_14527a48-b8c0-414a-b017-9e57d9be3ca4" xlink:to="loc_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract_a3a85b42-bb5a-4d98-8afe-ce0908213e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_d8bbe7d5-12bf-481e-95b3-cf7a0d401cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract_a3a85b42-bb5a-4d98-8afe-ce0908213e0b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_d8bbe7d5-12bf-481e-95b3-cf7a0d401cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_c500a514-1a5a-4558-8908-137d260dd85f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_14527a48-b8c0-414a-b017-9e57d9be3ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_c500a514-1a5a-4558-8908-137d260dd85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1585f72d-e9ca-4e4d-8b71-269b586ce525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_14527a48-b8c0-414a-b017-9e57d9be3ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1585f72d-e9ca-4e4d-8b71-269b586ce525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_44834f22-e7eb-4e99-8c7f-f905cb921345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_14527a48-b8c0-414a-b017-9e57d9be3ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_44834f22-e7eb-4e99-8c7f-f905cb921345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0d54b81f-134c-44ec-8dd6-3095da1d41ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_14527a48-b8c0-414a-b017-9e57d9be3ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0d54b81f-134c-44ec-8dd6-3095da1d41ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_945cebf9-ba3e-46c8-a9e5-b25854a7671b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a038b757-12cd-4265-b1df-6c4d85dd5152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_945cebf9-ba3e-46c8-a9e5-b25854a7671b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a038b757-12cd-4265-b1df-6c4d85dd5152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4ab77b6a-fc0f-470b-b8e1-c3de11b16e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a038b757-12cd-4265-b1df-6c4d85dd5152" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4ab77b6a-fc0f-470b-b8e1-c3de11b16e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eea72279-0a95-4670-95d3-adff201452f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4ab77b6a-fc0f-470b-b8e1-c3de11b16e55" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eea72279-0a95-4670-95d3-adff201452f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionOnSecuritiesMember_2ba4e87a-edab-44f7-80f6-e6daa2679638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionOnSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eea72279-0a95-4670-95d3-adff201452f4" xlink:to="loc_us-gaap_OptionOnSecuritiesMember_2ba4e87a-edab-44f7-80f6-e6daa2679638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d22b9f0a-0caa-4170-99fd-15f201782e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a038b757-12cd-4265-b1df-6c4d85dd5152" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d22b9f0a-0caa-4170-99fd-15f201782e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d659bb11-4441-4039-88fc-e6988e8c7b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d22b9f0a-0caa-4170-99fd-15f201782e95" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d659bb11-4441-4039-88fc-e6988e8c7b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4737f2f5-7336-47c2-9ca8-43eb315c6fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d659bb11-4441-4039-88fc-e6988e8c7b64" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4737f2f5-7336-47c2-9ca8-43eb315c6fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_5502bdbc-d4e3-4f57-aaa9-d07f7994465e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a038b757-12cd-4265-b1df-6c4d85dd5152" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_5502bdbc-d4e3-4f57-aaa9-d07f7994465e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_5502bdbc-d4e3-4f57-aaa9-d07f7994465e" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputOptionVolatilityMember_139652f3-d8a5-474f-a8b0-f2a62c2b85da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputOptionVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:to="loc_us-gaap_MeasurementInputOptionVolatilityMember_139652f3-d8a5-474f-a8b0-f2a62c2b85da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditSpreadOptionMember_1588263e-ab50-4a7a-ba38-181ea6e7af27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditSpreadOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:to="loc_us-gaap_CreditSpreadOptionMember_1588263e-ab50-4a7a-ba38-181ea6e7af27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevenueExitMultipleMember_0619ddde-0844-478d-8b8b-382efcdfc5ba" xlink:href="hum-20230331.xsd#hum_RevenueExitMultipleMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:to="loc_hum_RevenueExitMultipleMember_0619ddde-0844-478d-8b8b-382efcdfc5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_2fc1d8a0-0cef-4bec-bb82-fc7d14bb2297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_2fc1d8a0-0cef-4bec-bb82-fc7d14bb2297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_dca862cc-8130-4809-ac6b-5fd683b49b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6caf394a-2e9f-45e8-8a87-61d26b40f4b2" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_dca862cc-8130-4809-ac6b-5fd683b49b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_29787a1a-fce2-4c1b-ae1a-a67c9f19b890" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a038b757-12cd-4265-b1df-6c4d85dd5152" xlink:to="loc_srt_RangeAxis_29787a1a-fce2-4c1b-ae1a-a67c9f19b890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8338eb58-3ff8-4c52-9a89-c444340d63e1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_29787a1a-fce2-4c1b-ae1a-a67c9f19b890" xlink:to="loc_srt_RangeMember_8338eb58-3ff8-4c52-9a89-c444340d63e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ee6ff17e-2593-4e43-9116-4ab8124a7f47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8338eb58-3ff8-4c52-9a89-c444340d63e1" xlink:to="loc_srt_MinimumMember_ee6ff17e-2593-4e43-9116-4ab8124a7f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_109e1efb-8f6e-43f4-b21a-663002aee6f5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8338eb58-3ff8-4c52-9a89-c444340d63e1" xlink:to="loc_srt_MaximumMember_109e1efb-8f6e-43f4-b21a-663002aee6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_84a32caa-e4cf-409e-8241-126f72a1a3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a038b757-12cd-4265-b1df-6c4d85dd5152" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_84a32caa-e4cf-409e-8241-126f72a1a3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_c0cdc5c6-47fb-4e16-b54a-3a3c6b1467b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetLiabilityNetMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_84a32caa-e4cf-409e-8241-126f72a1a3ee" xlink:to="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_c0cdc5c6-47fb-4e16-b54a-3a3c6b1467b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/MEDICAREPARTDDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#MEDICAREPARTDDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/MEDICAREPARTDDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_cf76b207-6f02-4425-a52e-70c31d1075b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8f072891-3d27-4b23-a130-e80b002f169d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_cf76b207-6f02-4425-a52e-70c31d1075b9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8f072891-3d27-4b23-a130-e80b002f169d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8f710ee-443e-46a6-91ac-a3908aeebd00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8f072891-3d27-4b23-a130-e80b002f169d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8f710ee-443e-46a6-91ac-a3908aeebd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bd0c6f5-34a2-4410-8e3b-e15c1fec9e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8f710ee-443e-46a6-91ac-a3908aeebd00" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bd0c6f5-34a2-4410-8e3b-e15c1fec9e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RiskCorridorSettlementsMedicarePartDMember_7ddeb805-ce0d-424e-80a9-4108a671899f" xlink:href="hum-20230331.xsd#hum_RiskCorridorSettlementsMedicarePartDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bd0c6f5-34a2-4410-8e3b-e15c1fec9e2c" xlink:to="loc_hum_RiskCorridorSettlementsMedicarePartDMember_7ddeb805-ce0d-424e-80a9-4108a671899f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CmsSubsidiesOrDiscountsMember_53d39e17-672c-4bcd-a1c6-567a44eb1e07" xlink:href="hum-20230331.xsd#hum_CmsSubsidiesOrDiscountsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bd0c6f5-34a2-4410-8e3b-e15c1fec9e2c" xlink:to="loc_hum_CmsSubsidiesOrDiscountsMember_53d39e17-672c-4bcd-a1c6-567a44eb1e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8f072891-3d27-4b23-a130-e80b002f169d" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c6b6ca38-fa24-42c5-a398-a5e30fc5b125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_us-gaap_OtherAssetsCurrent_c6b6ca38-fa24-42c5-a398-a5e30fc5b125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_05da5bd5-4e86-48a9-8918-ed518ecd1edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_05da5bd5-4e86-48a9-8918-ed518ecd1edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetCurrentLiabilityAsset_164cdfa7-8090-474f-bfa2-a5e1d34f2192" xlink:href="hum-20230331.xsd#hum_NetCurrentLiabilityAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_hum_NetCurrentLiabilityAsset_164cdfa7-8090-474f-bfa2-a5e1d34f2192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7d926fd9-7c33-4ba6-9ef8-db7d82b586d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7d926fd9-7c33-4ba6-9ef8-db7d82b586d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f4d838e1-7dce-4e9f-92b6-b87696da9d64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f4d838e1-7dce-4e9f-92b6-b87696da9d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetNoncurrentAssetLiability_ec1d8447-f076-4887-b7a9-dbf82f3164ff" xlink:href="hum-20230331.xsd#hum_NetNoncurrentAssetLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_hum_NetNoncurrentAssetLiability_ec1d8447-f076-4887-b7a9-dbf82f3164ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetAssetLiability_153918ca-7740-4094-b376-9e34cfb4084f" xlink:href="hum-20230331.xsd#hum_NetAssetLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4344951d-0e61-4778-a436-a23be1ef2a2d" xlink:to="loc_hum_NetAssetLiability_153918ca-7740-4094-b376-9e34cfb4084f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e613353e-ee81-467c-9419-2b5805751c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_cc129e80-2568-4ac3-afb6-836e871050f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e613353e-ee81-467c-9419-2b5805751c43" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_cc129e80-2568-4ac3-afb6-836e871050f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6717eff5-6df0-4c87-8334-71147b5c71dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_cc129e80-2568-4ac3-afb6-836e871050f8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6717eff5-6df0-4c87-8334-71147b5c71dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6e9eb85e-23d5-47d3-8fd7-2c441f456aec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6717eff5-6df0-4c87-8334-71147b5c71dd" xlink:to="loc_us-gaap_SegmentDomain_6e9eb85e-23d5-47d3-8fd7-2c441f456aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InsuranceSegmentMember_48eae9cc-857d-494a-aeaf-666012b6d512" xlink:href="hum-20230331.xsd#hum_InsuranceSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6e9eb85e-23d5-47d3-8fd7-2c441f456aec" xlink:to="loc_hum_InsuranceSegmentMember_48eae9cc-857d-494a-aeaf-666012b6d512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CenterWellSegmentMember_a3602a0c-8f50-4674-bd39-c2f467ff4843" xlink:href="hum-20230331.xsd#hum_CenterWellSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6e9eb85e-23d5-47d3-8fd7-2c441f456aec" xlink:to="loc_hum_CenterWellSegmentMember_a3602a0c-8f50-4674-bd39-c2f467ff4843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_82f02872-c85f-4598-acc2-7c12d890e8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_cc129e80-2568-4ac3-afb6-836e871050f8" xlink:to="loc_us-gaap_GoodwillLineItems_82f02872-c85f-4598-acc2-7c12d890e8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_788be57b-d7c0-4566-b1f4-2c145ef58245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_82f02872-c85f-4598-acc2-7c12d890e8b1" xlink:to="loc_us-gaap_GoodwillRollForward_788be57b-d7c0-4566-b1f4-2c145ef58245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_136fd036-4128-4156-9198-ee4c0f049ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_788be57b-d7c0-4566-b1f4-2c145ef58245" xlink:to="loc_us-gaap_Goodwill_136fd036-4128-4156-9198-ee4c0f049ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_5c881d18-3310-4818-8d41-5946e34a75c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_788be57b-d7c0-4566-b1f4-2c145ef58245" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_5c881d18-3310-4818-8d41-5946e34a75c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5f10258a-f8ff-4629-a73c-981596213bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_788be57b-d7c0-4566-b1f4-2c145ef58245" xlink:to="loc_us-gaap_Goodwill_5f10258a-f8ff-4629-a73c-981596213bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_99a6f9dd-cccb-4a2a-baca-ba5b9756c59f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_76c84ea0-04f4-4e82-b5e8-171c842852b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_99a6f9dd-cccb-4a2a-baca-ba5b9756c59f" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_76c84ea0-04f4-4e82-b5e8-171c842852b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_89ca0c4e-ad5e-4252-bcdc-1c8c06714ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_76c84ea0-04f4-4e82-b5e8-171c842852b3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_89ca0c4e-ad5e-4252-bcdc-1c8c06714ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_58ccc060-82c2-46cb-b1fc-07cc455ddd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_89ca0c4e-ad5e-4252-bcdc-1c8c06714ff1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_58ccc060-82c2-46cb-b1fc-07cc455ddd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CertificateOfNeedMember_c72a2fb7-25bf-4c52-ae1d-eb72cf7671d3" xlink:href="hum-20230331.xsd#hum_CertificateOfNeedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_58ccc060-82c2-46cb-b1fc-07cc455ddd9e" xlink:to="loc_hum_CertificateOfNeedMember_c72a2fb7-25bf-4c52-ae1d-eb72cf7671d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_952c339c-5be3-4789-bafa-a0d57bccd048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_58ccc060-82c2-46cb-b1fc-07cc455ddd9e" xlink:to="loc_us-gaap_LicensingAgreementsMember_952c339c-5be3-4789-bafa-a0d57bccd048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41aa4f04-21d4-4a03-b24c-1de793a7b8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_76c84ea0-04f4-4e82-b5e8-171c842852b3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41aa4f04-21d4-4a03-b24c-1de793a7b8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b4a0d502-b6bd-4fb8-80af-1a9135cae581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41aa4f04-21d4-4a03-b24c-1de793a7b8a0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b4a0d502-b6bd-4fb8-80af-1a9135cae581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1780cc9c-5f76-4a79-8751-21d5ca02fa08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_99a6f9dd-cccb-4a2a-baca-ba5b9756c59f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1780cc9c-5f76-4a79-8751-21d5ca02fa08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_669506dc-b168-4658-9420-cfe0f703dc29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1780cc9c-5f76-4a79-8751-21d5ca02fa08" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_669506dc-b168-4658-9420-cfe0f703dc29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_558a61bd-aaa8-47b5-b340-a51ba9d859ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_669506dc-b168-4658-9420-cfe0f703dc29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_558a61bd-aaa8-47b5-b340-a51ba9d859ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_9cf34468-d554-412c-b45e-7cb22e4a0230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_558a61bd-aaa8-47b5-b340-a51ba9d859ba" xlink:to="loc_us-gaap_CustomerContractsMember_9cf34468-d554-412c-b45e-7cb22e4a0230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ca79d8a6-dab1-4239-a8d1-3111fc5d22b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_558a61bd-aaa8-47b5-b340-a51ba9d859ba" xlink:to="loc_us-gaap_TradeNamesMember_ca79d8a6-dab1-4239-a8d1-3111fc5d22b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_c2d051d6-d78a-423a-8af3-dee02a34847c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_558a61bd-aaa8-47b5-b340-a51ba9d859ba" xlink:to="loc_us-gaap_ContractualRightsMember_c2d051d6-d78a-423a-8af3-dee02a34847c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncompetesAndOtherMember_539128b9-10c1-4848-b2f4-46b4df873499" xlink:href="hum-20230331.xsd#hum_NoncompetesAndOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_558a61bd-aaa8-47b5-b340-a51ba9d859ba" xlink:to="loc_hum_NoncompetesAndOtherMember_539128b9-10c1-4848-b2f4-46b4df873499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d0eaf2f7-e013-4737-b49f-dd2f65da0cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1780cc9c-5f76-4a79-8751-21d5ca02fa08" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d0eaf2f7-e013-4737-b49f-dd2f65da0cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d0eaf2f7-e013-4737-b49f-dd2f65da0cd3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_f007d421-bf16-48e2-8bbe-1ec0765f60ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_f007d421-bf16-48e2-8bbe-1ec0765f60ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a3cfe47d-4353-46d5-80d9-c64ea049713a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a3cfe47d-4353-46d5-80d9-c64ea049713a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5528401a-2500-4de5-9967-f33a073b9e86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5528401a-2500-4de5-9967-f33a073b9e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c6ac5b68-1779-4703-ad90-60d8a1ba0d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c6ac5b68-1779-4703-ad90-60d8a1ba0d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_82fe93de-d763-4f62-a5e8-c4a3826e6c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_82fe93de-d763-4f62-a5e8-c4a3826e6c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1682a193-dc56-41a0-a31c-de27751d253b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_233e2f30-4cf9-4b7d-b772-6126f900e04c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1682a193-dc56-41a0-a31c-de27751d253b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails_1" xlink:type="simple" xlink:href="hum-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails_1"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_36e07f86-c9ba-4595-a2ec-1de87ef5b922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f764f447-5236-425f-9a68-084c987dab17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_36e07f86-c9ba-4595-a2ec-1de87ef5b922" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f764f447-5236-425f-9a68-084c987dab17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4716d179-08d1-4c01-baf8-a182bce8179c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d2c91250-c3f1-4e5c-8bae-0f2953032a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4716d179-08d1-4c01-baf8-a182bce8179c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d2c91250-c3f1-4e5c-8bae-0f2953032a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_54dae2b3-53a2-4fbc-9d4d-1a9ab6cd8cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d2c91250-c3f1-4e5c-8bae-0f2953032a3e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_54dae2b3-53a2-4fbc-9d4d-1a9ab6cd8cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_39da9ea3-0b64-42c9-9a09-ffe4f6db10b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d2c91250-c3f1-4e5c-8bae-0f2953032a3e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_39da9ea3-0b64-42c9-9a09-ffe4f6db10b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ae8cd1ce-0891-47db-89b0-2ca40a59b72b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d2c91250-c3f1-4e5c-8bae-0f2953032a3e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ae8cd1ce-0891-47db-89b0-2ca40a59b72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6a3648cb-3e46-4929-bf7c-42e5f93e9c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d2c91250-c3f1-4e5c-8bae-0f2953032a3e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6a3648cb-3e46-4929-bf7c-42e5f93e9c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a45a0016-449f-4d20-95a5-a84b2400a431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d2c91250-c3f1-4e5c-8bae-0f2953032a3e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a45a0016-449f-4d20-95a5-a84b2400a431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_6496f8f6-4e6a-45a0-8e24-ce0679983141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d2c91250-c3f1-4e5c-8bae-0f2953032a3e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_6496f8f6-4e6a-45a0-8e24-ce0679983141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#BENEFITSPAYABLEActivityinBenefitsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_1a2879ee-7f16-4858-b3b1-567be2dce973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_5e7fe84d-b995-4935-a946-60402297d001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_1a2879ee-7f16-4858-b3b1-567be2dce973" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_5e7fe84d-b995-4935-a946-60402297d001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_25c4e3c3-3806-4059-a068-35de86e04ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_5e7fe84d-b995-4935-a946-60402297d001" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_25c4e3c3-3806-4059-a068-35de86e04ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b9f3cafa-8b1c-4e9c-82f2-7ec4e773f34c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_5e7fe84d-b995-4935-a946-60402297d001" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b9f3cafa-8b1c-4e9c-82f2-7ec4e773f34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_25c0f31e-8b21-4a63-a2cf-d38e200b3790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b9f3cafa-8b1c-4e9c-82f2-7ec4e773f34c" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_25c0f31e-8b21-4a63-a2cf-d38e200b3790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_6f5156ac-2f18-4869-a9ae-0698c95b18ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b9f3cafa-8b1c-4e9c-82f2-7ec4e773f34c" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_6f5156ac-2f18-4869-a9ae-0698c95b18ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_4d3b5781-3196-4535-a17f-b3a3246474c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b9f3cafa-8b1c-4e9c-82f2-7ec4e773f34c" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_4d3b5781-3196-4535-a17f-b3a3246474c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_3205c131-fdd0-4f00-a4bc-90241a41d080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_5e7fe84d-b995-4935-a946-60402297d001" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_3205c131-fdd0-4f00-a4bc-90241a41d080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_2071c31d-6f2e-4fdb-a672-812501cf42ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_3205c131-fdd0-4f00-a4bc-90241a41d080" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_2071c31d-6f2e-4fdb-a672-812501cf42ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_ca731a65-e8ad-4a00-a161-2cb74dd528f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_3205c131-fdd0-4f00-a4bc-90241a41d080" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_ca731a65-e8ad-4a00-a161-2cb74dd528f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_9897b624-56e7-4d25-b2bc-32980468b80f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_3205c131-fdd0-4f00-a4bc-90241a41d080" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_9897b624-56e7-4d25-b2bc-32980468b80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_d782f446-cdad-403b-bf0f-4cec18c0ecc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_5e7fe84d-b995-4935-a946-60402297d001" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_d782f446-cdad-403b-bf0f-4cec18c0ecc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_c5feb24e-72f4-467c-a2e2-11d7ee67b13b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_1a2879ee-7f16-4858-b3b1-567be2dce973" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_c5feb24e-72f4-467c-a2e2-11d7ee67b13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#EARNINGSPERCOMMONSHARECOMPUTATIONDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3ac7e33e-4348-4ef7-b35b-b7357fe10b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_47ed2d2d-fa93-47e2-9668-95c7fffc4cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3ac7e33e-4348-4ef7-b35b-b7357fe10b42" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_47ed2d2d-fa93-47e2-9668-95c7fffc4cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4882c4d2-00dc-4f27-8ea1-ea2acac9cc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_47ed2d2d-fa93-47e2-9668-95c7fffc4cc4" xlink:to="loc_us-gaap_AwardTypeAxis_4882c4d2-00dc-4f27-8ea1-ea2acac9cc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e407586d-26c6-45e4-a580-2ed567ed9f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4882c4d2-00dc-4f27-8ea1-ea2acac9cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e407586d-26c6-45e4-a580-2ed567ed9f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c5a23f7a-831d-4813-8cbc-2feb801e1da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e407586d-26c6-45e4-a580-2ed567ed9f1e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c5a23f7a-831d-4813-8cbc-2feb801e1da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_90ad1732-1fbf-426b-a94c-725ca7aba60f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e407586d-26c6-45e4-a580-2ed567ed9f1e" xlink:to="loc_us-gaap_RestrictedStockMember_90ad1732-1fbf-426b-a94c-725ca7aba60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_47ed2d2d-fa93-47e2-9668-95c7fffc4cc4" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0f483e99-84ed-46ff-9e2e-a06be71982ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_NetIncomeLoss_0f483e99-84ed-46ff-9e2e-a06be71982ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c6ccd527-82e6-4d9a-8069-fd3edd9b9b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c6ccd527-82e6-4d9a-8069-fd3edd9b9b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3e7ba099-1a38-481d-af11-963c7ae09a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3e7ba099-1a38-481d-af11-963c7ae09a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fb80563b-429c-46d3-9a9d-75e91b938ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fb80563b-429c-46d3-9a9d-75e91b938ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f8f7b66c-bbf9-4d58-a991-8ee287b39d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_EarningsPerShareBasic_f8f7b66c-bbf9-4d58-a991-8ee287b39d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1930a15c-3017-4f7e-8334-7ead001d0b54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1930a15c-3017-4f7e-8334-7ead001d0b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6d5bca5f-1ed3-467a-9680-1f00f63ed3e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_529adf68-b109-4d9a-8aeb-8c93163f7443" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6d5bca5f-1ed3-467a-9680-1f00f63ed3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYDividendsDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#STOCKHOLDERSEQUITYDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/STOCKHOLDERSEQUITYDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_fe3bbadb-c258-4393-ac35-ff430f8d7723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_0afdcbda-8a82-444e-bcec-cc63406e912c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fe3bbadb-c258-4393-ac35-ff430f8d7723" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_0afdcbda-8a82-444e-bcec-cc63406e912c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_e445d2ad-6c09-40f3-aaa8-4e2f0cff409c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fe3bbadb-c258-4393-ac35-ff430f8d7723" xlink:to="loc_us-gaap_Dividends_e445d2ad-6c09-40f3-aaa8-4e2f0cff409c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7e107511-04ab-4b74-b6a0-263a5f809f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_10872a54-4b53-46d6-a771-3d34e7124f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7e107511-04ab-4b74-b6a0-263a5f809f2b" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_10872a54-4b53-46d6-a771-3d34e7124f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a7343c12-38c0-4df8-906b-5886bcc996f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_10872a54-4b53-46d6-a771-3d34e7124f1b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a7343c12-38c0-4df8-906b-5886bcc996f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8dcef57f-b38a-4665-9adb-ae21a5799e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a7343c12-38c0-4df8-906b-5886bcc996f5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8dcef57f-b38a-4665-9adb-ae21a5799e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6ee067bd-bbe9-4777-aef4-74b0ea931468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8dcef57f-b38a-4665-9adb-ae21a5799e29" xlink:to="loc_us-gaap_SubsequentEventMember_6ee067bd-bbe9-4777-aef4-74b0ea931468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_c293ebf6-0735-4f0e-a01b-5bddddca99de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_10872a54-4b53-46d6-a771-3d34e7124f1b" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_c293ebf6-0735-4f0e-a01b-5bddddca99de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_67ee78e9-f8f3-4881-b6d8-b3ecbb9cf762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_c293ebf6-0735-4f0e-a01b-5bddddca99de" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_67ee78e9-f8f3-4881-b6d8-b3ecbb9cf762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2021ShareRepurchaseAuthorizationMember_5d78eacd-c881-4687-bf6c-d778d87674d5" xlink:href="hum-20230331.xsd#hum_A2021ShareRepurchaseAuthorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_67ee78e9-f8f3-4881-b6d8-b3ecbb9cf762" xlink:to="loc_hum_A2021ShareRepurchaseAuthorizationMember_5d78eacd-c881-4687-bf6c-d778d87674d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2023ShareRepurchaseAuthorizationMember_30da9ca6-cf55-4e07-9614-528a24f07b00" xlink:href="hum-20230331.xsd#hum_A2023ShareRepurchaseAuthorizationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_67ee78e9-f8f3-4881-b6d8-b3ecbb9cf762" xlink:to="loc_hum_A2023ShareRepurchaseAuthorizationMember_30da9ca6-cf55-4e07-9614-528a24f07b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_10872a54-4b53-46d6-a771-3d34e7124f1b" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_ddc054c3-3f6f-4e1c-8a63-616d81b6d500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_ddc054c3-3f6f-4e1c-8a63-616d81b6d500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8041c7dd-2918-4d7a-b6ab-a50a1b1def4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8041c7dd-2918-4d7a-b6ab-a50a1b1def4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_34c286b6-eb71-460d-a50c-88352f4ed452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_34c286b6-eb71-460d-a50c-88352f4ed452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_784f8a73-1cf5-46fa-aa5b-2e42a37bd63a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_784f8a73-1cf5-46fa-aa5b-2e42a37bd63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_70d3753a-8a04-4faf-b4e0-26e999818cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_70d3753a-8a04-4faf-b4e0-26e999818cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_57a3bade-c08a-4b0d-b10c-078b2ba68d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_57a3bade-c08a-4b0d-b10c-078b2ba68d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_b9319a11-24c4-472c-b141-272a1406ffbe" xlink:href="hum-20230331.xsd#hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_b9319a11-24c4-472c-b141-272a1406ffbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_fff8c862-77b2-4074-8fb4-1a710a02f84d" xlink:href="hum-20230331.xsd#hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f2dfc1f7-76b2-4ca5-8bf2-2d5bb27cb225" xlink:to="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_fff8c862-77b2-4074-8fb4-1a710a02f84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1af6a287-6c21-444e-b277-bc272d39d1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b2816866-56e8-432b-9f24-8a982944bafa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1af6a287-6c21-444e-b277-bc272d39d1c8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b2816866-56e8-432b-9f24-8a982944bafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTDebtOutstandingDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#DEBTDebtOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBTDebtOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d2531421-6f98-434d-998f-a8fa11380e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_aaafac33-bd77-4836-8b47-54a2e8b6d1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d2531421-6f98-434d-998f-a8fa11380e98" xlink:to="loc_us-gaap_DebtInstrumentTable_aaafac33-bd77-4836-8b47-54a2e8b6d1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_378e0bec-91df-47f0-9640-b0ed4f9e931a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_aaafac33-bd77-4836-8b47-54a2e8b6d1d8" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_378e0bec-91df-47f0-9640-b0ed4f9e931a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_64d92bde-631c-4c94-86fd-c3439e7b8b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_378e0bec-91df-47f0-9640-b0ed4f9e931a" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_64d92bde-631c-4c94-86fd-c3439e7b8b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_97c95631-2432-4cdc-82ae-89983a74ad31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_64d92bde-631c-4c94-86fd-c3439e7b8b69" xlink:to="loc_us-gaap_CommercialPaperMember_97c95631-2432-4cdc-82ae-89983a74ad31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_57812941-8ed4-4aaa-b05d-afcf453da3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_aaafac33-bd77-4836-8b47-54a2e8b6d1d8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_57812941-8ed4-4aaa-b05d-afcf453da3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_825c8f6c-cd63-4dee-9c14-ec3401e6811b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_57812941-8ed4-4aaa-b05d-afcf453da3c6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_825c8f6c-cd63-4dee-9c14-ec3401e6811b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ccc6f3a6-677d-4421-af09-42ef71a47202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_825c8f6c-cd63-4dee-9c14-ec3401e6811b" xlink:to="loc_us-gaap_SeniorNotesMember_ccc6f3a6-677d-4421-af09-42ef71a47202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_c8ca061b-e30c-45ff-8ea5-f973d6824f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_825c8f6c-cd63-4dee-9c14-ec3401e6811b" xlink:to="loc_us-gaap_LoansPayableMember_c8ca061b-e30c-45ff-8ea5-f973d6824f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c2ca69b9-2d4a-4747-bdb1-9aa3d310d1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_aaafac33-bd77-4836-8b47-54a2e8b6d1d8" xlink:to="loc_us-gaap_DebtInstrumentAxis_c2ca69b9-2d4a-4747-bdb1-9aa3d310d1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c2ca69b9-2d4a-4747-bdb1-9aa3d310d1d1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A065PercentSeniorNotesDueAugust2023Member_33677683-14d4-4157-b1df-a00137a5cff8" xlink:href="hum-20230331.xsd#hum_A065PercentSeniorNotesDueAugust2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A065PercentSeniorNotesDueAugust2023Member_33677683-14d4-4157-b1df-a00137a5cff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member_94c6e306-d414-41a1-91d6-7b412b897409" xlink:href="hum-20230331.xsd#hum_A3.85PercentSeniorNotesDueOctober2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member_94c6e306-d414-41a1-91d6-7b412b897409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A450PercentSeniorNotesDueApril2025Member_0fad0d9d-1659-4294-8ddb-99531cbc85c2" xlink:href="hum-20230331.xsd#hum_A450PercentSeniorNotesDueApril2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A450PercentSeniorNotesDueApril2025Member_0fad0d9d-1659-4294-8ddb-99531cbc85c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A570PercentSeniorNotesDueMarch2026Member_5c377efc-0ae5-4016-babd-ffbc1b5d3162" xlink:href="hum-20230331.xsd#hum_A570PercentSeniorNotesDueMarch2026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A570PercentSeniorNotesDueMarch2026Member_5c377efc-0ae5-4016-babd-ffbc1b5d3162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A135PercentSeniorNotesDueFebruary2027Member_7ccc6429-35b4-4d53-9727-a9b890d386e0" xlink:href="hum-20230331.xsd#hum_A135PercentSeniorNotesDueFebruary2027Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A135PercentSeniorNotesDueFebruary2027Member_7ccc6429-35b4-4d53-9727-a9b890d386e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.95PercentSeniorNotesDueMarch2027Member_9b378ad2-bbed-4831-acf2-1bcf66b2f4f4" xlink:href="hum-20230331.xsd#hum_A3.95PercentSeniorNotesDueMarch2027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A3.95PercentSeniorNotesDueMarch2027Member_9b378ad2-bbed-4831-acf2-1bcf66b2f4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A5750PercentSeniorNotesDueMarch2028Member_c6dc94cc-ca70-4cb2-9054-45698b53adf1" xlink:href="hum-20230331.xsd#hum_A5750PercentSeniorNotesDueMarch2028Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A5750PercentSeniorNotesDueMarch2028Member_c6dc94cc-ca70-4cb2-9054-45698b53adf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3700PercentSeniorNotesDueMarch2029Member_a7e189a4-4bad-4507-8000-18507d3550f0" xlink:href="hum-20230331.xsd#hum_A3700PercentSeniorNotesDueMarch2029Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A3700PercentSeniorNotesDueMarch2029Member_a7e189a4-4bad-4507-8000-18507d3550f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3125PercentSeniorNotesDueAugust2029Member_56535730-1947-4f9f-b132-36079710bdfa" xlink:href="hum-20230331.xsd#hum_A3125PercentSeniorNotesDueAugust2029Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A3125PercentSeniorNotesDueAugust2029Member_56535730-1947-4f9f-b132-36079710bdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4875PercentSeniorNotesDueApril2030Member_0604d674-d2ef-41fc-b711-bc8972625ea8" xlink:href="hum-20230331.xsd#hum_A4875PercentSeniorNotesDueApril2030Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A4875PercentSeniorNotesDueApril2030Member_0604d674-d2ef-41fc-b711-bc8972625ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A215PercentSeniorNotesDueFebruary2032Member_ee52c347-e2d4-456a-95e1-207b52a701a5" xlink:href="hum-20230331.xsd#hum_A215PercentSeniorNotesDueFebruary2032Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A215PercentSeniorNotesDueFebruary2032Member_ee52c347-e2d4-456a-95e1-207b52a701a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A588PercentSeniorNotesDueMarch2033Member_0b876daf-ab2a-4e87-bf4d-3dc6764780a4" xlink:href="hum-20230331.xsd#hum_A588PercentSeniorNotesDueMarch2033Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A588PercentSeniorNotesDueMarch2033Member_0b876daf-ab2a-4e87-bf4d-3dc6764780a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A8.15PercentSeniorNotesDueJune2038Member_1cd25542-6d14-4713-939e-7a643fef0864" xlink:href="hum-20230331.xsd#hum_A8.15PercentSeniorNotesDueJune2038Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A8.15PercentSeniorNotesDueJune2038Member_1cd25542-6d14-4713-939e-7a643fef0864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.625PercentSeniorNotesDueDecember2042Member_404340a0-b703-4ebe-b33f-106bf0adb406" xlink:href="hum-20230331.xsd#hum_A4.625PercentSeniorNotesDueDecember2042Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A4.625PercentSeniorNotesDueDecember2042Member_404340a0-b703-4ebe-b33f-106bf0adb406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.95PercentSeniorNotesDueOctober2044Member_2eafda95-94f5-4392-aaae-294dedb644ed" xlink:href="hum-20230331.xsd#hum_A4.95PercentSeniorNotesDueOctober2044Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A4.95PercentSeniorNotesDueOctober2044Member_2eafda95-94f5-4392-aaae-294dedb644ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.80PercentSeniorNotesDueMarch2047Member_74bd2435-78fe-44fd-9038-11da5e6d324f" xlink:href="hum-20230331.xsd#hum_A4.80PercentSeniorNotesDueMarch2047Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A4.80PercentSeniorNotesDueMarch2047Member_74bd2435-78fe-44fd-9038-11da5e6d324f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A395PercentSeniorNotesDueAugust2049Member_dc9e8c5b-6337-4b1d-ac86-c42bc2e1ed45" xlink:href="hum-20230331.xsd#hum_A395PercentSeniorNotesDueAugust2049Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A395PercentSeniorNotesDueAugust2049Member_dc9e8c5b-6337-4b1d-ac86-c42bc2e1ed45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A550PercentSeniorNotesDueMarch2053Member_c6b52ab0-e18f-4bdd-b895-28d4fd841609" xlink:href="hum-20230331.xsd#hum_A550PercentSeniorNotesDueMarch2053Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_A550PercentSeniorNotesDueMarch2053Member_c6b52ab0-e18f-4bdd-b895-28d4fd841609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DelayedDrawTermLoanMay2024Member_2cda1d25-daea-4b0c-93cb-0a9e1caa2b6b" xlink:href="hum-20230331.xsd#hum_DelayedDrawTermLoanMay2024Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_498b8dc4-1d4d-484e-973c-ca4e5ef9fb02" xlink:to="loc_hum_DelayedDrawTermLoanMay2024Member_2cda1d25-daea-4b0c-93cb-0a9e1caa2b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_aaafac33-bd77-4836-8b47-54a2e8b6d1d8" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b0506788-33ba-47c4-a65a-bbc1af6fa2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b0506788-33ba-47c4-a65a-bbc1af6fa2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e963db6b-ddf5-45a2-8c7a-e32cbbf86f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e963db6b-ddf5-45a2-8c7a-e32cbbf86f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_3c53ad3a-3ed9-4158-9551-88b58533082e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:to="loc_us-gaap_ShortTermBorrowings_3c53ad3a-3ed9-4158-9551-88b58533082e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_2b2d3b85-6dcc-4624-aa2f-64c70e2d6f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:to="loc_us-gaap_LongTermDebtCurrent_2b2d3b85-6dcc-4624-aa2f-64c70e2d6f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_93569d8a-9cef-48a1-ad52-7b6d861c21bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:to="loc_us-gaap_DebtCurrent_93569d8a-9cef-48a1-ad52-7b6d861c21bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e284c8aa-b935-4b81-ae60-adb49d12616f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d7a826c8-bcb9-49d6-8fca-ef7262db66f3" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e284c8aa-b935-4b81-ae60-adb49d12616f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTSeniorNotesDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#DEBTSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBTSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8ac24732-f5c8-4e6a-acb1-cd74ab94cf13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8edcc922-39bb-489a-a90c-6a613c84d791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8ac24732-f5c8-4e6a-acb1-cd74ab94cf13" xlink:to="loc_us-gaap_DebtInstrumentTable_8edcc922-39bb-489a-a90c-6a613c84d791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0a042e0f-731d-447a-9429-7e1cb0fc9092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8edcc922-39bb-489a-a90c-6a613c84d791" xlink:to="loc_us-gaap_DebtInstrumentAxis_0a042e0f-731d-447a-9429-7e1cb0fc9092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0aaec230-900e-4f07-a1a6-db5b48c68f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0a042e0f-731d-447a-9429-7e1cb0fc9092" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0aaec230-900e-4f07-a1a6-db5b48c68f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member_b98ddee7-c7c8-49a7-b3e8-eeee1fb4c065" xlink:href="hum-20230331.xsd#hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0aaec230-900e-4f07-a1a6-db5b48c68f7b" xlink:to="loc_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member_b98ddee7-c7c8-49a7-b3e8-eeee1fb4c065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A570PercentSeniorNotesDueMarch2026Member_dd3799d8-9492-44ef-9cf9-d0b287cd919f" xlink:href="hum-20230331.xsd#hum_A570PercentSeniorNotesDueMarch2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member_b98ddee7-c7c8-49a7-b3e8-eeee1fb4c065" xlink:to="loc_hum_A570PercentSeniorNotesDueMarch2026Member_dd3799d8-9492-44ef-9cf9-d0b287cd919f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A550PercentSeniorNotesDueMarch2053Member_5c8bee1e-2146-4f1b-b449-98eb62cc9318" xlink:href="hum-20230331.xsd#hum_A550PercentSeniorNotesDueMarch2053Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member_b98ddee7-c7c8-49a7-b3e8-eeee1fb4c065" xlink:to="loc_hum_A550PercentSeniorNotesDueMarch2053Member_5c8bee1e-2146-4f1b-b449-98eb62cc9318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A065PercentSeniorNotesDueAugust2023Member_06298d37-677e-440d-a299-4995b2302b6a" xlink:href="hum-20230331.xsd#hum_A065PercentSeniorNotesDueAugust2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0aaec230-900e-4f07-a1a6-db5b48c68f7b" xlink:to="loc_hum_A065PercentSeniorNotesDueAugust2023Member_06298d37-677e-440d-a299-4995b2302b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member_a5f276d8-7ed7-4d47-92bb-7b89066c8968" xlink:href="hum-20230331.xsd#hum_A3.85PercentSeniorNotesDueOctober2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0aaec230-900e-4f07-a1a6-db5b48c68f7b" xlink:to="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member_a5f276d8-7ed7-4d47-92bb-7b89066c8968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DelayedDrawTermLoanMember_3c1b5238-f081-4fae-a627-7d9a221d748e" xlink:href="hum-20230331.xsd#hum_DelayedDrawTermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0aaec230-900e-4f07-a1a6-db5b48c68f7b" xlink:to="loc_hum_DelayedDrawTermLoanMember_3c1b5238-f081-4fae-a627-7d9a221d748e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6b9a42e2-0305-4709-8b1d-e2d760518044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8edcc922-39bb-489a-a90c-6a613c84d791" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6b9a42e2-0305-4709-8b1d-e2d760518044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_61edb3f2-ff1a-47c5-8990-1a364e123702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6b9a42e2-0305-4709-8b1d-e2d760518044" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_61edb3f2-ff1a-47c5-8990-1a364e123702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_89fd906d-8dd3-4e54-b7dd-606367dce784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_61edb3f2-ff1a-47c5-8990-1a364e123702" xlink:to="loc_us-gaap_SeniorNotesMember_89fd906d-8dd3-4e54-b7dd-606367dce784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_4e4b12d8-8764-4d58-a444-ebf2b67009cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_61edb3f2-ff1a-47c5-8990-1a364e123702" xlink:to="loc_us-gaap_LoansPayableMember_4e4b12d8-8764-4d58-a444-ebf2b67009cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8edcc922-39bb-489a-a90c-6a613c84d791" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9d6d74d5-e440-4087-9a1e-4e9cb88bb20d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9d6d74d5-e440-4087-9a1e-4e9cb88bb20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_29c7a399-c545-40f8-9575-17ffcf692fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_29c7a399-c545-40f8-9575-17ffcf692fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_be924aa4-d132-4574-9a7f-145fd77e8572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_be924aa4-d132-4574-9a7f-145fd77e8572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_3c395c2a-6d48-405e-87de-3e994c2726f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_3c395c2a-6d48-405e-87de-3e994c2726f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_fcd188be-5971-4a31-a17d-352dee43fdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bfd30cde-8a5d-447b-8a26-06d4150a4d90" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_fcd188be-5971-4a31-a17d-352dee43fdb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#DEBTRevolvingCreditAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6bcabfd2-b017-4a2d-9cc4-67c933d2e9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_93289923-1210-4315-96c7-d408889d5318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6bcabfd2-b017-4a2d-9cc4-67c933d2e9ef" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_93289923-1210-4315-96c7-d408889d5318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_684b4f8f-8698-4ba3-bfea-3a088944c516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_93289923-1210-4315-96c7-d408889d5318" xlink:to="loc_us-gaap_CreditFacilityAxis_684b4f8f-8698-4ba3-bfea-3a088944c516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a2e6fe59-fc0d-4e24-ac8e-ccf75d8ecd11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_684b4f8f-8698-4ba3-bfea-3a088944c516" xlink:to="loc_us-gaap_CreditFacilityDomain_a2e6fe59-fc0d-4e24-ac8e-ccf75d8ecd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ddb14568-4d0c-404b-bc34-fc227bd5bfcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a2e6fe59-fc0d-4e24-ac8e-ccf75d8ecd11" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ddb14568-4d0c-404b-bc34-fc227bd5bfcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_cd6a4006-4557-4dfd-8475-9ea049015d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a2e6fe59-fc0d-4e24-ac8e-ccf75d8ecd11" xlink:to="loc_us-gaap_LetterOfCreditMember_cd6a4006-4557-4dfd-8475-9ea049015d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_17ae9d96-e4a3-42ed-9137-ad6343eac7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_93289923-1210-4315-96c7-d408889d5318" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_17ae9d96-e4a3-42ed-9137-ad6343eac7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a7cf0995-4b68-45f2-b65d-2b0941ad092a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17ae9d96-e4a3-42ed-9137-ad6343eac7d8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a7cf0995-4b68-45f2-b65d-2b0941ad092a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_258975ff-a0ec-4017-9fe0-239c410fdd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a7cf0995-4b68-45f2-b65d-2b0941ad092a" xlink:to="loc_us-gaap_LoansPayableMember_258975ff-a0ec-4017-9fe0-239c410fdd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c64b5f13-74fe-47a9-891e-dd76d94b76a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_93289923-1210-4315-96c7-d408889d5318" xlink:to="loc_us-gaap_DebtInstrumentAxis_c64b5f13-74fe-47a9-891e-dd76d94b76a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_62fe93f0-5828-4a63-a670-d7c49797111e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c64b5f13-74fe-47a9-891e-dd76d94b76a0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_62fe93f0-5828-4a63-a670-d7c49797111e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevolvingCreditAgreementJune2021FiveYearMember_9105f7b9-b601-44b1-840b-9afc00547853" xlink:href="hum-20230331.xsd#hum_RevolvingCreditAgreementJune2021FiveYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62fe93f0-5828-4a63-a670-d7c49797111e" xlink:to="loc_hum_RevolvingCreditAgreementJune2021FiveYearMember_9105f7b9-b601-44b1-840b-9afc00547853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevolvingCreditAgreementJune2021OneYearMember_51caca34-b923-44f3-895b-40997968e56f" xlink:href="hum-20230331.xsd#hum_RevolvingCreditAgreementJune2021OneYearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62fe93f0-5828-4a63-a670-d7c49797111e" xlink:to="loc_hum_RevolvingCreditAgreementJune2021OneYearMember_51caca34-b923-44f3-895b-40997968e56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_93289923-1210-4315-96c7-d408889d5318" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_80a1b308-669c-449e-a909-02f89c925e86" xlink:href="hum-20230331.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:to="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_80a1b308-669c-449e-a909-02f89c925e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_13ec8e61-0eaa-40c5-86fe-b6d18dfa548f" xlink:href="hum-20230331.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:to="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_13ec8e61-0eaa-40c5-86fe-b6d18dfa548f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_14296e94-d95e-4671-b74f-02dc64f32177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:to="loc_us-gaap_LinesOfCreditCurrent_14296e94-d95e-4671-b74f-02dc64f32177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_521ec618-f8a4-48d0-8040-cb1b1163d1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_521ec618-f8a4-48d0-8040-cb1b1163d1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_85aa8c99-4bae-4250-ae1e-2d335fe30014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:to="loc_us-gaap_DebtInstrumentTerm_85aa8c99-4bae-4250-ae1e-2d335fe30014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_3b968fad-827b-4aa6-a2f8-27d45ff988f1" xlink:href="hum-20230331.xsd#hum_LineOfCreditFacilityUncommittedIncrementalCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_26dd6f1a-202b-4a06-9795-2691461df5ce" xlink:to="loc_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_3b968fad-827b-4aa6-a2f8-27d45ff988f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#DEBTCommercialPaperandOtherShorttermBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b6cfcea8-70f7-4c25-aaf9-0f8be9264a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_69acea61-839f-460d-b99b-70a54e97ec58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b6cfcea8-70f7-4c25-aaf9-0f8be9264a92" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_69acea61-839f-460d-b99b-70a54e97ec58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_3d698145-2a0f-4fcc-b9f4-4628214136bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_69acea61-839f-460d-b99b-70a54e97ec58" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_3d698145-2a0f-4fcc-b9f4-4628214136bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_bdc84417-78fd-428c-b719-7dc5e5795a45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_3d698145-2a0f-4fcc-b9f4-4628214136bd" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_bdc84417-78fd-428c-b719-7dc5e5795a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_af335811-8fa7-42a1-b14e-ca40b1298b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_bdc84417-78fd-428c-b719-7dc5e5795a45" xlink:to="loc_us-gaap_CommercialPaperMember_af335811-8fa7-42a1-b14e-ca40b1298b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember_2b187309-0d36-49f3-ae4e-ec8de3afd961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_bdc84417-78fd-428c-b719-7dc5e5795a45" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMember_2b187309-0d36-49f3-ae4e-ec8de3afd961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_38f0afe0-e81f-4ba0-aa32-0be01e04ec77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_69acea61-839f-460d-b99b-70a54e97ec58" xlink:to="loc_us-gaap_ShortTermDebtLineItems_38f0afe0-e81f-4ba0-aa32-0be01e04ec77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_a4cf3d31-6aa9-4edd-9e76-b115667402fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_38f0afe0-e81f-4ba0-aa32-0be01e04ec77" xlink:to="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_a4cf3d31-6aa9-4edd-9e76-b115667402fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_be74bbb7-e301-4f66-8ec3-1e9a5e1d5e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_38f0afe0-e81f-4ba0-aa32-0be01e04ec77" xlink:to="loc_us-gaap_ShortTermBorrowings_be74bbb7-e301-4f66-8ec3-1e9a5e1d5e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_062ddfa9-9243-44fa-b335-e680f9fb9ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_38f0afe0-e81f-4ba0-aa32-0be01e04ec77" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_062ddfa9-9243-44fa-b335-e680f9fb9ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8798c204-7249-49d0-a049-acc20f208583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_058e9c7d-0b3d-44af-827d-0cbfb287d4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8798c204-7249-49d0-a049-acc20f208583" xlink:to="loc_us-gaap_LossContingenciesTable_058e9c7d-0b3d-44af-827d-0cbfb287d4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_9a860546-b6cc-468a-8c21-3ad9bc849554" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_058e9c7d-0b3d-44af-827d-0cbfb287d4b5" xlink:to="loc_srt_MajorCustomersAxis_9a860546-b6cc-468a-8c21-3ad9bc849554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cd1db5a3-0096-473d-aadf-c987f4ded0aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_9a860546-b6cc-468a-8c21-3ad9bc849554" xlink:to="loc_srt_NameOfMajorCustomerDomain_cd1db5a3-0096-473d-aadf-c987f4ded0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareMember_15134c70-6082-4bac-a740-02d30d4ae904" xlink:href="hum-20230331.xsd#hum_MedicareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cd1db5a3-0096-473d-aadf-c987f4ded0aa" xlink:to="loc_hum_MedicareMember_15134c70-6082-4bac-a740-02d30d4ae904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicaidMember_edb0eb3f-9524-40ae-867f-dfc818bb8424" xlink:href="hum-20230331.xsd#hum_MedicaidMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cd1db5a3-0096-473d-aadf-c987f4ded0aa" xlink:to="loc_hum_MedicaidMember_edb0eb3f-9524-40ae-867f-dfc818bb8424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MilitaryServiceMember_a18839d7-c3ca-4671-8076-9ccb1259d5ed" xlink:href="hum-20230331.xsd#hum_MilitaryServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cd1db5a3-0096-473d-aadf-c987f4ded0aa" xlink:to="loc_hum_MilitaryServiceMember_a18839d7-c3ca-4671-8076-9ccb1259d5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREContractAxis_6a983664-d0c1-4f2d-a8c9-5a503bb2a667" xlink:href="hum-20230331.xsd#hum_TRICAREContractAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_058e9c7d-0b3d-44af-827d-0cbfb287d4b5" xlink:to="loc_hum_TRICAREContractAxis_6a983664-d0c1-4f2d-a8c9-5a503bb2a667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREContractDomain_e5676ac5-d6a9-4601-90fc-3ebb6741bb43" xlink:href="hum-20230331.xsd#hum_TRICAREContractDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_TRICAREContractAxis_6a983664-d0c1-4f2d-a8c9-5a503bb2a667" xlink:to="loc_hum_TRICAREContractDomain_e5676ac5-d6a9-4601-90fc-3ebb6741bb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICARE2017EastRegionContractMember_16559360-2ca1-4c75-87e6-46546a714076" xlink:href="hum-20230331.xsd#hum_TRICARE2017EastRegionContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_TRICAREContractDomain_e5676ac5-d6a9-4601-90fc-3ebb6741bb43" xlink:to="loc_hum_TRICARE2017EastRegionContractMember_16559360-2ca1-4c75-87e6-46546a714076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractEffective2024Member_323f7314-d940-42ac-b186-fc98a8a08dbb" xlink:href="hum-20230331.xsd#hum_TRICAREManagedCareSupportContractEffective2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_TRICAREContractDomain_e5676ac5-d6a9-4601-90fc-3ebb6741bb43" xlink:to="loc_hum_TRICAREManagedCareSupportContractEffective2024Member_323f7314-d940-42ac-b186-fc98a8a08dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_058e9c7d-0b3d-44af-827d-0cbfb287d4b5" xlink:to="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfTotalPremiumAndServicesRevenues_fa7776ae-8f6a-4034-bd94-fdf5a6a2a283" xlink:href="hum-20230331.xsd#hum_PercentageOfTotalPremiumAndServicesRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_PercentageOfTotalPremiumAndServicesRevenues_fa7776ae-8f6a-4034-bd94-fdf5a6a2a283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfStatesComprisingTRICAREBeneficiaries_1dc4f16e-d586-4c01-a74b-bb3e1334ddf0" xlink:href="hum-20230331.xsd#hum_NumberOfStatesComprisingTRICAREBeneficiaries"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_NumberOfStatesComprisingTRICAREBeneficiaries_1dc4f16e-d586-4c01-a74b-bb3e1334ddf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfTRICAREBeneficiaries_7efa2357-e6c3-41e3-8661-4b4ca36b3aa3" xlink:href="hum-20230331.xsd#hum_NumberOfTRICAREBeneficiaries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_NumberOfTRICAREBeneficiaries_7efa2357-e6c3-41e3-8661-4b4ca36b3aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_c96d2fe3-38c8-4596-99c9-a69853d7ac27" xlink:href="hum-20230331.xsd#hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_c96d2fe3-38c8-4596-99c9-a69853d7ac27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_d2712a59-0ddd-4159-a61d-3ecf7adcef32" xlink:href="hum-20230331.xsd#hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_d2712a59-0ddd-4159-a61d-3ecf7adcef32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractBaseTerm_20b41743-ae6d-4034-8bc3-0642dae49203" xlink:href="hum-20230331.xsd#hum_TRICAREManagedCareSupportContractBaseTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_TRICAREManagedCareSupportContractBaseTerm_20b41743-ae6d-4034-8bc3-0642dae49203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_03355b7a-c000-4e8b-af60-b8fe1a3c2e39" xlink:href="hum-20230331.xsd#hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_03355b7a-c000-4e8b-af60-b8fe1a3c2e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_eeb2c659-6370-4825-8878-4d46369498bd" xlink:href="hum-20230331.xsd#hum_TRICAREManagedCareSupportContractTermWithOptionExercises"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf570fce-9a15-47f4-baee-7728c355686b" xlink:to="loc_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_eeb2c659-6370-4825-8878-4d46369498bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#SEGMENTINFORMATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_16b02bf6-d8f0-4bd7-bce6-b68f0eaa3922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_dada4830-b36c-4176-aabf-3cfe74358b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_16b02bf6-d8f0-4bd7-bce6-b68f0eaa3922" xlink:to="loc_us-gaap_NumberOfReportableSegments_dada4830-b36c-4176-aabf-3cfe74358b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GovernmentAndHealthPlanMemberSubsidiesAmount_eec30578-cf7f-467b-952c-8d4ab9757834" xlink:href="hum-20230331.xsd#hum_GovernmentAndHealthPlanMemberSubsidiesAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_16b02bf6-d8f0-4bd7-bce6-b68f0eaa3922" xlink:to="loc_hum_GovernmentAndHealthPlanMemberSubsidiesAmount_eec30578-cf7f-467b-952c-8d4ab9757834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense_10e873e1-3428-44b6-a547-e1940c8cba5d" xlink:href="hum-20230331.xsd#hum_DepreciationAndAmortizationClassifiedAsBenefitExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_16b02bf6-d8f0-4bd7-bce6-b68f0eaa3922" xlink:to="loc_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense_10e873e1-3428-44b6-a547-e1940c8cba5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails" xlink:type="simple" xlink:href="hum-20230331.xsd#SEGMENTINFORMATIONSegmentResultsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9dcc59b5-ab63-426b-a43b-43a3daf24123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_561d850a-3d7b-4bf3-9154-fb25e99ed365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9dcc59b5-ab63-426b-a43b-43a3daf24123" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_561d850a-3d7b-4bf3-9154-fb25e99ed365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_511c9591-ccd6-4ee8-b299-cda364d7252b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_561d850a-3d7b-4bf3-9154-fb25e99ed365" xlink:to="loc_srt_ConsolidationItemsAxis_511c9591-ccd6-4ee8-b299-cda364d7252b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_07f5a490-e52e-4d26-bbce-0d90ad345168" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_511c9591-ccd6-4ee8-b299-cda364d7252b" xlink:to="loc_srt_ConsolidationItemsDomain_07f5a490-e52e-4d26-bbce-0d90ad345168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_672c3a81-f6b9-46cf-8db8-4dec3d171bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_07f5a490-e52e-4d26-bbce-0d90ad345168" xlink:to="loc_us-gaap_OperatingSegmentsMember_672c3a81-f6b9-46cf-8db8-4dec3d171bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CorporateAndEliminationsMember_f0bd8ed4-3d01-493e-a6bd-8d773b16a302" xlink:href="hum-20230331.xsd#hum_CorporateAndEliminationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_07f5a490-e52e-4d26-bbce-0d90ad345168" xlink:to="loc_hum_CorporateAndEliminationsMember_f0bd8ed4-3d01-493e-a6bd-8d773b16a302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_1a630b45-2052-4128-984b-3ef3275c8d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_07f5a490-e52e-4d26-bbce-0d90ad345168" xlink:to="loc_us-gaap_IntersegmentEliminationMember_1a630b45-2052-4128-984b-3ef3275c8d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ab3ff6ab-de81-4dfe-bcf8-9ddc55398791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_561d850a-3d7b-4bf3-9154-fb25e99ed365" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ab3ff6ab-de81-4dfe-bcf8-9ddc55398791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ebfc9e62-1cca-44a5-a4ea-894e578a9ede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab3ff6ab-de81-4dfe-bcf8-9ddc55398791" xlink:to="loc_us-gaap_SegmentDomain_ebfc9e62-1cca-44a5-a4ea-894e578a9ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InsuranceSegmentMember_8abc3851-de3a-4009-8b7b-4aef950ade02" xlink:href="hum-20230331.xsd#hum_InsuranceSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ebfc9e62-1cca-44a5-a4ea-894e578a9ede" xlink:to="loc_hum_InsuranceSegmentMember_8abc3851-de3a-4009-8b7b-4aef950ade02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CenterWellSegmentMember_e33c1e94-0e3a-4611-bb4d-63bf5567abde" xlink:href="hum-20230331.xsd#hum_CenterWellSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ebfc9e62-1cca-44a5-a4ea-894e578a9ede" xlink:to="loc_hum_CenterWellSegmentMember_e33c1e94-0e3a-4611-bb4d-63bf5567abde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_35d131dc-f7dc-4195-9a1a-44b4424a55e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_561d850a-3d7b-4bf3-9154-fb25e99ed365" xlink:to="loc_srt_ProductOrServiceAxis_35d131dc-f7dc-4195-9a1a-44b4424a55e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a37a6094-3a3c-4471-b3f7-f7ce7a49f675" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_35d131dc-f7dc-4195-9a1a-44b4424a55e4" xlink:to="loc_srt_ProductsAndServicesDomain_a37a6094-3a3c-4471-b3f7-f7ce7a49f675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_7da43a07-af5b-41ab-b1c0-06e14bcde115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a37a6094-3a3c-4471-b3f7-f7ce7a49f675" xlink:to="loc_us-gaap_ServiceMember_7da43a07-af5b-41ab-b1c0-06e14bcde115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_c349b2ee-5739-4a91-8601-85d4362d5c95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a37a6094-3a3c-4471-b3f7-f7ce7a49f675" xlink:to="loc_us-gaap_ProductMember_c349b2ee-5739-4a91-8601-85d4362d5c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_08f901c7-c607-4cbf-85b6-ed7b91e98d65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_561d850a-3d7b-4bf3-9154-fb25e99ed365" xlink:to="loc_srt_MajorCustomersAxis_08f901c7-c607-4cbf-85b6-ed7b91e98d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_08f901c7-c607-4cbf-85b6-ed7b91e98d65" xlink:to="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareAdvantageMember_e26a12bf-a967-4c74-beef-097116a872c9" xlink:href="hum-20230331.xsd#hum_MedicareAdvantageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_MedicareAdvantageMember_e26a12bf-a967-4c74-beef-097116a872c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GroupMedicareAdvantageMember_0e1eb3bf-20ad-4565-a69e-75aa203f62ab" xlink:href="hum-20230331.xsd#hum_GroupMedicareAdvantageMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_GroupMedicareAdvantageMember_0e1eb3bf-20ad-4565-a69e-75aa203f62ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareStandAlonePrescriptionDrugPlanMember_889a745e-784c-48cc-a4ce-ccfed6fd2e6f" xlink:href="hum-20230331.xsd#hum_MedicareStandAlonePrescriptionDrugPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_MedicareStandAlonePrescriptionDrugPlanMember_889a745e-784c-48cc-a4ce-ccfed6fd2e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareMember_cf6851dd-4dba-496e-88a6-ddb85a021fd1" xlink:href="hum-20230331.xsd#hum_MedicareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_MedicareMember_cf6851dd-4dba-496e-88a6-ddb85a021fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CommercialFullyInsuredMember_48f4aa44-9bdf-4b0c-8fc2-a6a836714fff" xlink:href="hum-20230331.xsd#hum_CommercialFullyInsuredMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_CommercialFullyInsuredMember_48f4aa44-9bdf-4b0c-8fc2-a6a836714fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SpecialtyBenefitsMember_d0586b97-540c-4b45-9b35-cda49ba51631" xlink:href="hum-20230331.xsd#hum_SpecialtyBenefitsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_SpecialtyBenefitsMember_d0586b97-540c-4b45-9b35-cda49ba51631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareSupplementProductMember_ae7f7927-56b3-493c-a3d4-c107dd2bf4b0" xlink:href="hum-20230331.xsd#hum_MedicareSupplementProductMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_MedicareSupplementProductMember_ae7f7927-56b3-493c-a3d4-c107dd2bf4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicaidAndOtherMember_b15e035c-099b-497c-8cc7-c6cfdf24f783" xlink:href="hum-20230331.xsd#hum_MedicaidAndOtherMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_MedicaidAndOtherMember_b15e035c-099b-497c-8cc7-c6cfdf24f783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HomeSolutionsMember_4fc9a600-88ab-4e87-b19b-f314c38ca645" xlink:href="hum-20230331.xsd#hum_HomeSolutionsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_HomeSolutionsMember_4fc9a600-88ab-4e87-b19b-f314c38ca645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProviderServicesMember_5a9bbaee-7f3c-4519-9515-f3d0fb4d5a68" xlink:href="hum-20230331.xsd#hum_ProviderServicesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_ProviderServicesMember_5a9bbaee-7f3c-4519-9515-f3d0fb4d5a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CommercialASOMember_42f2fd62-d321-456a-8fe2-7a3dcfff6667" xlink:href="hum-20230331.xsd#hum_CommercialASOMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_CommercialASOMember_42f2fd62-d321-456a-8fe2-7a3dcfff6667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MilitaryAndOtherMember_0ca96c12-d56f-42a0-a719-66f2588321ce" xlink:href="hum-20230331.xsd#hum_MilitaryAndOtherMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_MilitaryAndOtherMember_0ca96c12-d56f-42a0-a719-66f2588321ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PharmacySolutionsMember_4400d0a3-cf36-41da-818a-bd9903b8e5ea" xlink:href="hum-20230331.xsd#hum_PharmacySolutionsMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a1c5c856-9764-4171-a250-e81207488b89" xlink:to="loc_hum_PharmacySolutionsMember_4400d0a3-cf36-41da-818a-bd9903b8e5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_561d850a-3d7b-4bf3-9154-fb25e99ed365" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_13a6be5c-10cd-4b8c-b69f-ee20c1c0c25b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_PremiumsEarnedNet_13a6be5c-10cd-4b8c-b69f-ee20c1c0c25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4e8dd91a-5b3c-4e99-82d6-1caa16ae466f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4e8dd91a-5b3c-4e99-82d6-1caa16ae466f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0744e4ee-5df9-47e1-b0cd-3218c239aca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_Revenues_0744e4ee-5df9-47e1-b0cd-3218c239aca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_ebc44c7b-a21c-47e9-8bc7-9d0840efda08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_NetInvestmentIncome_ebc44c7b-a21c-47e9-8bc7-9d0840efda08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_adeb7a54-77ed-49a9-bb80-7c68c041f909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_adeb7a54-77ed-49a9-bb80-7c68c041f909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_399932be-7436-4070-af04-d5e1a173de37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_399932be-7436-4070-af04-d5e1a173de37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationIncomeStatement_a688422d-ec1e-42c2-bbe2-80b0630a9f53" xlink:href="hum-20230331.xsd#hum_DepreciationAndAmortizationIncomeStatement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_hum_DepreciationAndAmortizationIncomeStatement_a688422d-ec1e-42c2-bbe2-80b0630a9f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_bd25ed73-46e2-49a9-b9f4-fd9f991b92b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_BenefitsLossesAndExpenses_bd25ed73-46e2-49a9-b9f4-fd9f991b92b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_be9d6d0a-0606-486e-b7c5-951d99fa8aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_OperatingIncomeLoss_be9d6d0a-0606-486e-b7c5-951d99fa8aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d6af140a-ee8f-4a5a-a91d-f47860571be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_InterestExpense_d6af140a-ee8f-4a5a-a91d-f47860571be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_618844ff-6d63-403f-b3e5-f6f284c4d61f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_618844ff-6d63-403f-b3e5-f6f284c4d61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_397de5bd-2021-4a14-be70-ab566a597a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_397de5bd-2021-4a14-be70-ab566a597a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_cedadbc4-f2ce-42e1-8bc5-2dfb96fb93b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_cedadbc4-f2ce-42e1-8bc5-2dfb96fb93b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f763a80c-9f31-44d9-aef3-e7fabb0b6262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f763a80c-9f31-44d9-aef3-e7fabb0b6262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_04b2ce36-34f6-4518-aace-3bd44fda895d" xlink:href="hum-20230331.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_04b2ce36-34f6-4518-aace-3bd44fda895d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_1697c7dd-7a9f-454c-864d-b25c51d6eca6" xlink:href="hum-20230331.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f007c6d-9520-4b95-9c10-d1dc5eea73cf" xlink:to="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_1697c7dd-7a9f-454c-864d-b25c51d6eca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040916035536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-5975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HUMANA INC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">61-0647538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 West Main Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Louisville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">KY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">40202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">580-1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.16 2/3 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HUM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">124,944,994<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000049071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040916039744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 13,735<span></span>
</td>
<td class="nump">$ 5,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investment securities</a></td>
<td class="nump">14,932<span></span>
</td>
<td class="nump">13,881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net of allowances of $69 in 2023 and $70 in 2022</a></td>
<td class="nump">3,107<span></span>
</td>
<td class="nump">1,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,758<span></span>
</td>
<td class="nump">5,567<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">37,532<span></span>
</td>
<td class="nump">26,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,234<span></span>
</td>
<td class="nump">3,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">739<span></span>
</td>
<td class="nump">749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,320<span></span>
</td>
<td class="nump">9,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">3,580<span></span>
</td>
<td class="nump">3,380<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">54,776<span></span>
</td>
<td class="nump">43,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Benefits payable</a></td>
<td class="nump">10,018<span></span>
</td>
<td class="nump">9,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Trade accounts payable and accrued expenses</a></td>
<td class="nump">7,431<span></span>
</td>
<td class="nump">5,238<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_BookOverdraftLiability', window );">Book overdraft</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenues</a></td>
<td class="nump">7,220<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term debt</a></td>
<td class="nump">1,867<span></span>
</td>
<td class="nump">2,092<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">26,942<span></span>
</td>
<td class="nump">17,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">9,743<span></span>
</td>
<td class="nump">9,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">1,457<span></span>
</td>
<td class="nump">1,473<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">38,142<span></span>
</td>
<td class="nump">27,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $1 par; 10,000,000 shares authorized; none issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at March&#160;31, 2023 and December 31, 2022</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Capital in excess of par value</a></td>
<td class="nump">3,262<span></span>
</td>
<td class="nump">3,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">26,619<span></span>
</td>
<td class="nump">25,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,113)<span></span>
</td>
<td class="num">(1,304)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 73,721,604 shares at March&#160;31, 2023 and 73,691,955 shares at December 31, 2022</a></td>
<td class="num">(12,224)<span></span>
</td>
<td class="num">(12,156)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">16,577<span></span>
</td>
<td class="nump">15,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">16,634<span></span>
</td>
<td class="nump">15,370<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 54,776<span></span>
</td>
<td class="nump">$ 43,055<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_BookOverdraftLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Book Overdraft Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_BookOverdraftLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040913163744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Receivables, net of allowances</a></td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par (in dollars per share)</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par (in dollars per share)</a></td>
<td class="nump">$ 0.1667<span></span>
</td>
<td class="nump">$ 0.1667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">198,666,598<span></span>
</td>
<td class="nump">198,666,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">73,721,604<span></span>
</td>
<td class="nump">73,691,955<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040920550944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList', window );">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</a></td>
<td class="text">Health Care [Member]<span></span>
</td>
<td class="text">Health Care [Member]<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 25,550<span></span>
</td>
<td class="nump">$ 22,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services</a></td>
<td class="nump">999<span></span>
</td>
<td class="nump">1,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment income</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">26,742<span></span>
</td>
<td class="nump">23,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefits</a></td>
<td class="nump">21,858<span></span>
</td>
<td class="nump">19,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">2,979<span></span>
</td>
<td class="nump">2,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DepreciationAndAmortizationIncomeStatement', window );">Depreciation and amortization</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">25,023<span></span>
</td>
<td class="nump">22,681<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">1,719<span></span>
</td>
<td class="nump">1,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net losses</a></td>
<td class="nump">1,614<span></span>
</td>
<td class="nump">1,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net losses</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,238<span></span>
</td>
<td class="nump">930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interests</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Humana</a></td>
<td class="nump">$ 1,239<span></span>
</td>
<td class="nump">$ 930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 9.91<span></span>
</td>
<td class="nump">$ 7.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 9.87<span></span>
</td>
<td class="nump">$ 7.29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DepreciationAndAmortizationIncomeStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation and amortization expense excluding depreciation and amortization primarily from the delivery of pharmacy services by our wholly-owned pharmacy business (included in our Healthcare Services segment) which has been reclassified to benefit expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DepreciationAndAmortizationIncomeStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BenefitsLossesAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5,6,7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BenefitsLossesAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140041011171440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Humana</a></td>
<td class="nump">$ 1,239<span></span>
</td>
<td class="nump">$ 930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Change in gross unrealized investment gains (losses)</a></td>
<td class="nump">188<span></span>
</td>
<td class="num">(769)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Effect of income taxes</a></td>
<td class="num">(43)<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Total change in unrealized investment gains (losses), net of tax</a></td>
<td class="nump">145<span></span>
</td>
<td class="num">(593)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Reclassification adjustment for net realized losses (gains)</a></td>
<td class="nump">61<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax', window );">Effect of income taxes</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Total reclassification adjustment, net of tax</a></td>
<td class="nump">46<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">191<span></span>
</td>
<td class="num">(614)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Humana</a></td>
<td class="nump">$ 1,430<span></span>
</td>
<td class="nump">$ 316<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040913259376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Stockholders' Equity</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Capital&#160;In Excess&#160;of Par Value</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (loss)</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balances at Dec. 31, 2021</a></td>
<td class="nump">$ 16,103<span></span>
</td>
<td class="nump">$ 16,080<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 3,082<span></span>
</td>
<td class="nump">$ 23,086<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="num">$ (10,163)<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">930<span></span>
</td>
<td class="nump">930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(614)<span></span>
</td>
<td class="num">(614)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(614)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="num">(1,024)<span></span>
</td>
<td class="num">(1,024)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,024)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends and dividend equivalents</a></td>
<td class="num">(101)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Restricted stock unit vesting</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercises</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balances at Mar. 31, 2022</a></td>
<td class="nump">15,342<span></span>
</td>
<td class="nump">15,319<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">3,103<span></span>
</td>
<td class="nump">23,915<span></span>
</td>
<td class="num">(572)<span></span>
</td>
<td class="num">(11,160)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balances at Dec. 31, 2022</a></td>
<td class="nump">15,370<span></span>
</td>
<td class="nump">15,311<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">3,246<span></span>
</td>
<td class="nump">25,492<span></span>
</td>
<td class="num">(1,304)<span></span>
</td>
<td class="num">(12,156)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,238<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders', window );">Distribution from (to) noncontrolling interest holders, net</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Acquisition</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="num">(94)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends and dividend equivalents</a></td>
<td class="num">(112)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Restricted stock unit vesting</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercises</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balances at Mar. 31, 2023</a></td>
<td class="nump">$ 16,634<span></span>
</td>
<td class="nump">$ 16,577<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 3,262<span></span>
</td>
<td class="nump">$ 26,619<span></span>
</td>
<td class="num">$ (1,113)<span></span>
</td>
<td class="num">$ (12,224)<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase (Decrease) From Contributions Or Distributions To Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040912228864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,238<span></span>
</td>
<td class="nump">$ 930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Loss on investment securities, net</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net losses</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effect of businesses acquired and disposed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="num">(1,433)<span></span>
</td>
<td class="num">(1,360)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(907)<span></span>
</td>
<td class="num">(628)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities', window );">Benefits payable</a></td>
<td class="nump">754<span></span>
</td>
<td class="nump">1,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(238)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Unearned revenues</a></td>
<td class="nump">6,934<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">6,687<span></span>
</td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash and cash equivalents acquired</a></td>
<td class="num">(73)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment, net</a></td>
<td class="num">(223)<span></span>
</td>
<td class="num">(295)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of investment securities</a></td>
<td class="num">(1,313)<span></span>
</td>
<td class="num">(2,161)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of investment securities</a></td>
<td class="nump">267<span></span>
</td>
<td class="nump">588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales of investment securities</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">1,294<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,292)<span></span>
</td>
<td class="num">(648)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_PaymentsForProceedsFromContractDeposits', window );">Receipts from contract deposits, net</a></td>
<td class="nump">2,997<span></span>
</td>
<td class="nump">2,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of senior notes, net</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayments of senior notes</a></td>
<td class="num">(60)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">Repayments from issuance of commercial paper, net</a></td>
<td class="num">(177)<span></span>
</td>
<td class="num">(265)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of term loan</a></td>
<td class="num">(500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issue costs</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInBookOverdrafts', window );">Change in book overdraft</a></td>
<td class="nump">108<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchases</a></td>
<td class="num">(94)<span></span>
</td>
<td class="num">(1,024)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(100)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">3,279<span></span>
</td>
<td class="nump">1,816<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase in cash and cash equivalents</a></td>
<td class="nump">8,674<span></span>
</td>
<td class="nump">1,470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">5,061<span></span>
</td>
<td class="nump">3,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">13,735<span></span>
</td>
<td class="nump">4,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest payments</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income tax payments (refund), net</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Details of businesses acquired in purchase transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired, net of cash and cash equivalents acquired</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Less: Fair value of liabilities assumed</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired', window );">Less: Noncontrolling interests acquired</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquired businesses, net of cash and cash equivalents acquired</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash or Part Noncash Acquisition, Noncontrolling Interest Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_PaymentsForProceedsFromContractDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Proceeds From Contract Deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_PaymentsForProceedsFromContractDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInBookOverdrafts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash during the period due to the net increase or decrease in book overdrafts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInBookOverdrafts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in health care insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040919217088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SIGNIFICANT EVENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BASIS OF PRESENTATION AND SIGNIFICANT EVENTS</a></td>
<td class="text">BASIS OF PRESENTATION AND SIGNIFICANT EVENTS<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements are presented in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the disclosures normally required by accounting principles generally accepted in the United States of America, or GAAP, or those normally made in an Annual Report on Form 10-K. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. For further information, the reader of this Form 10-Q should refer to our Form 10-K for the year ended December 31, 2022, that was filed with the Securities and Exchange Commission, or the SEC, on February&#160;16, 2023. We refer to this Form 10-K as the &#8220;2022 Form 10-K&#8221; in this document. References throughout this document to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Company,&#8221; and &#8220;Humana&#8221; mean Humana Inc. and its subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our condensed consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The areas involving the most significant use of estimates are the estimation of benefits payable, the impact of risk adjustment provisions related to our Medicare contracts, the valuation and related impairment recognition of investment securities, and the valuation and related impairment recognition of long-lived assets, including goodwill and indefinite-lived intangible assets. These estimates are based on knowledge of current events and anticipated future events, and accordingly, actual results may ultimately differ materially from those estimates. For additional information regarding accounting policies considered in preparing our consolidated financial statements, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial information has been prepared in accordance with our customary accounting practices and has not been audited. In our opinion, the information presented reflects all adjustments necessary for a fair statement of interim results. All such adjustments are of a normal and recurring nature.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Employer Group Commercial Medical Products Business Exit</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, we announced our planned exit from the Employer Group Commercial Medical Products business, which includes all fully insured, self-funded and Federal Employee Health Benefit medical plans, as well as associated wellness and rewards programs. No other Humana health plan offerings are materially affected. Following a strategic review, we determined the Employer Group Commercial Medical Products business was no longer positioned to sustainably meet the needs of commercial members over the long term or support our long-term strategic plans. The exit from this line of business will be phased over the next 18 to 24 months.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Creation Initiatives </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, in order to create capacity to fund growth and investment in our Medicare Advantage business and further expansion of our healthcare services capabilities in 2023, we committed to drive additional value for the enterprise through cost saving, productivity initiatives, and value acceleration from previous investments. As a result of these initiatives, we recorded charges of $473 million for the year-ended December 31, 2022. These charges primarily relate to $248&#160;million in asset impairments, including software and abandonment, and $116&#160;million of severance charges in connection with workforce optimization. The remainder of the charges primarily relate to external consulting fees. These charges were recorded at the corporate level and not allocated to the segments. We did not record any charges in the first quarter of 2022, with no recurring charges in 2023.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The emergence and spread of the novel coronavirus, or COVID-19, beginning in the first quarter of 2020 has impacted our business. During periods of increased incidences of COVID-19, a reduction in non-COVID-19 hospital admissions for non-emergent and elective medical care have resulted in lower overall healthcare system utilization. At the same time, COVID-19 treatment and testing costs increased utilization. During 2022, we experienced lower overall utilization of the healthcare system than anticipated, as the reduction in COVID-19 utilization following the increased incidence associated with the Omicron variant outpaced the increase in non-COVID-19 utilization. The significant disruption in utilization during 2020 also impacted our ability to implement clinical initiatives to manage health care costs and chronic conditions of our members, and appropriately document their risk profiles, and, as such, significantly affected our 2021 revenue under the risk adjustment payment model for Medicare Advantage plans. Finally, changes in utilization patterns and actions taken in 2021 as a result of the COVID-19 pandemic, including the suspension of certain financial recovery programs for a period of time and shifting the timing of claim payments and provider capitation surplus payments, impacted our claim reserve development and operating cash flows for 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 National Emergency declared in 2020 was terminated on April 10, 2023 and the Public Health Emergency is set to expire on May 11, 2023.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues include premiums and services revenue. Services revenue includes administrative service fees that are recorded based upon established per member per month rates and the number of members for the month and are recognized as services are provided for the month. Additionally, services revenue includes net patient services revenue that are recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For additional information regarding our revenues, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. For additional information regarding disaggregation of revenue by segment and type, refer to Note 14 to the unaudited Condensed Consolidated Financial Statements included in Part I, Item 1, "Financial Statements" of this Form 10-Q.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, accounts receivable related to services were $246&#160;million. For the three months ended March 31, 2023, we had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the condensed consolidated balance sheet at March&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, services revenue recognized from performance obligations related to prior periods, such as due to changes in transaction price, was not material. Further, services revenue expected to be recognized in any future year related to remaining performance obligations was not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040918880064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTSIn November 2020, the FASB issued Accounting Standards Update No. 2020-11, Financial Services&#8212;Insurance (Topic 944): Effective Date and Early Application (&#8220;ASU 2020-11&#8221;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12, Financial Services&#8212;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (&#8220;ASU 2018-12&#8221;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The new guidance relates to accounting for long-duration contracts of insurers which revises key elements of the measurement models and disclosure requirements for long-duration contracts issued by insurers, including the amortization of deferred contract acquisition costs and the measurement of liabilities for future policy benefits using current, rather than locked-in, assumptions. The new guidance, limited to our Medicare Supplement product which represent less than 1% of consolidated premiums and services revenue, became effective for us beginning January 1, 2023 and is to be applied to contracts in force on the basis of their existing carrying value amounts at the beginning of the earliest period presented. The adoption of the new standard in 2023 did not have a material impact on our consolidated results of operations, financial position or cash flows.There are no other recently issued accounting standards that apply to us or that are expected to have a material impact on our results of operations, financial condition, or cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040919048256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">ACQUISITIONS AND DIVESTITURES</a></td>
<td class="text">ACQUISITIONS AND DIVESTITURES <div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 11, 2022, we completed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the sale of a 60% i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterest in Gentiva, formerly Kindred, Hospice to Clayton, Dubilier &amp; Rice, or CD&amp;R, for cash proceeds of approximately $2.7&#160;billion, net of cash disposed, including debt repayments from Gentiva Hospice to Humana of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.9&#160;billion. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale we recognized a pre-tax gain, net of transaction costs, of $237&#160;million. For the three months ended March 31, 2022, the accompanying condensed consolidated statement of income includes revenues related to Gentiva Hospice of $382&#160;million and pretax earnings of $62&#160;million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023 and 2022, we acquired various health and wellness related businesses which, individually or in the aggregate, have not had a material impact on our results of operations, financial condition, or cash flows. The results of operations and financial condition of these businesses acquired in 2023 and 2022 have been included in our condensed consolidated statements of income and condensed consolidated balance sheets from the respective acquisition dates. Acquisition-related costs recognized in 2023 and 2022 were not material to our results of operations. For asset acquisitions, the goodwill acquired is partially amortizable as deductible expenses for tax purposes. The pro forma financial information assuming the acquisitions had occurred as of the beginning of the calendar year prior to the year of acquisition, as well as the revenues and earnings generated during the year of acquisition, were not material for disclosure purposes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140041003066752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT SECURITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">INVESTMENT SECURITIES</a></td>
<td class="text">INVESTMENT SECURITIES<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities classified as current and long-term were as follows at March&#160;31, 2023 and December 31, 2022, respectively:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.551%"><tr><td style="width:1.0%"/><td style="width:43.476%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.120%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.120%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.120%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government<br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(423)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,479)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(828)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,701)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We held certain corporate debt securities of Gentiva Hospice at March&#160;31, 2023 with amortized cost and fair value of approximately $281&#160;million and $286&#160;million, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross unrealized losses and fair values aggregated by investment category and length of time of individual debt securities that have been in a continuous unrealized loss position for which no allowances for credit loss has been recorded were as follows at March&#160;31, 2023 and December 31, 2022, respectively:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.085%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or more</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(423)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(649)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,680&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,082&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,381)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,479)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(828)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,419&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,431)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,381&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,701)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 98% of our debt securities were investment-grade quality, with a weighted average credit rating of AA by Standard &amp; Poor's Rating Service, or S&amp;P, at March&#160;31, 2023. Most of the debt securities that were below investment-grade were rated BB-, the higher end of the below investment-grade rating scale. Tax-exempt municipal securities were diversified among general obligation bonds of states and local municipalities in the United States as well as special revenue bonds issued by municipalities to finance specific public works projects such as utilities, water and sewer, transportation, or education.&#160;Our general obligation bonds are diversified across the United States with no individual state exceeding 1% of our total debt securities. Our investment policy limits investments in a single issuer and requires diversification among various asset types.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our unrealized losses from all debt securities were generated from approximately 1,550 positions out of a total of approximately 1,950 positions at March&#160;31, 2023. All issuers of debt securities we own that were trading at an unrealized loss at March&#160;31, 2023 remain current on all contractual payments. After taking into account these and </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other factors previously described, we believe these unrealized losses primarily were caused by an increase in market interest rates in the current markets since the time these debt securities were purchased. At March&#160;31, 2023, we did not intend to sell any debt securities with an unrealized loss position in accumulated other comprehensive income, and it is not likely that we will be required to sell these debt securities before recovery of their amortized cost basis. Additionally, we did not record any material credit allowances for debt securities that were in an unrealized loss position for the three months ended March 31, 2023 or 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The detail of (losses) gains related to investment securities and included within investment income was as follows for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:4pt;margin-top:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"/><td style="width:70.913%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.484%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.618%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.485%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains on investment securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses on investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains on equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net recognized losses on investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses related to equity securities for the three months ended March 31, 2023 and 2022 was as follows:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"/><td style="width:71.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.330%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.332%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains (losses) recognized on equity securities during the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net gains (losses) recognized on equity securities sold during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses recognized on equity securities still held at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of debt securities available for sale at March&#160;31, 2023, regardless of their balance sheet classification, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:70.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.704%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,941&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage and asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,747&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,303&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>For additional information regarding our investment securities, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140041026393680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE</a></td>
<td class="text">FAIR VALUE<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our fair value measurements at March&#160;31, 2023 and December 31, 2022, respectively, for financial assets measured at fair value on a recurring basis:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:49.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.617%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.617%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.617%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government<br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 66.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total invested assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,916&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,613&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government<br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,254&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,153&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 66.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total invested assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,093&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,839&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,153&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Level 3 assets had a fair value of $99 million at March&#160;31, 2023, or 0.3% of our total invested assets. During the year ended March&#160;31, 2023, the changes in the fair value of the assets measured using significant unobservable inputs (Level 3) were comprised of the following:</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.944%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.946%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Private Placements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance at January&#160;1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gains or losses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized in other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer out</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Liabilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt is recorded at carrying value in our consolidated balance sheets. The carrying value of our senior notes debt outstanding, net of unamortized debt issuance costs, was $11.2 billion at March&#160;31, 2023 and $10.0 billion at December 31, 2022. The fair value of our senior notes debt was $10.9 billion at March&#160;31, 2023 and $9.4 billion at December 31, 2022. The fair value of our senior notes debt is determined based on Level 2 inputs, including quoted market prices for the same or similar debt, or if no quoted market prices are available, on the current prices estimated to be available to us for debt with similar terms and remaining maturities. Carrying value approximates fair value for our term loans and commercial paper borrowings. The commercial paper borrowings were $426 million at March&#160;31, 2023. The term loans and commercial paper borrowings were $1.1 billion at December 31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Put and Call Options Measured at Fair Value</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our put and call options associated with our equity method investments are measured at fair value each period using a Monte Carlo simulation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The put and call options fair values associated with our Primary Care Organization strategic partnership with  Welsh, Carson, Anderson &amp; Stowe, or WCAS, which are exercisable at a fixed revenue exit multiple and provide a minimum return on WCAS' investment if exercised, are measured at fair value each reporting period using a Monte Carlo simulation. The put and call options fair values, derived from the Monte Carlo simulation, were $318 million and $8 million, respectively, at March&#160;31, 2023. The put and call options fair values, derived from the Monte Carlo simulation, were $267 million and $10 million, respectively, at December 31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant unobservable inputs utilized in these Level 3 fair value measurements (and selected values) include the enterprise value, annualized volatility and credit spread. Enterprise value was derived from a discounted cash flow model, which utilized significant unobservable inputs for long-term revenue, to measure underlying cash flows, weighted average cost of capital and long term growth rate. The table below presents the assumptions used for each reporting period.</span></div><div style="margin-bottom:9pt;text-align:right;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:59.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.805%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7% - 19.3%</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7% - 20.8%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit spread</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2% - 1.4%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3% - 1.5%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue exit multiple</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5x - 2.5x</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5x - 2.5x</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average cost of capital</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0% - 13.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5% - 12.5%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term growth rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used for annualized volatility, credit spread and weighted average cost of capital reflect the lowest and highest values where they differ significantly across the series of put and call options due to their expected exercise dates.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Assets and Liabilities Measured at Fair Value</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities are measured at fair value on a non-recurring basis subject to fair value adjustment only in certain circumstances. As disclosed in Note 3, we acquired various health and wellness related businesses during 2023. The net assets acquired and resulting goodwill and other intangible assets were recorded at fair value primarily using Level 3 inputs. The net tangible assets including receivables and accrued liabilities were recorded at their carrying value which approximated their fair value due to their short term nature. The fair value of goodwill and other intangible assets were internally estimated based primarily on the income approach. The income approach estimates fair value based on the present value of cash flow that the assets could be expected to generate in the future. We developed internal estimates for expected cash flows in the present value calculation using inputs and significant assumptions that include historical revenues and earnings, revenue growth rates, the amount and timing of future cash flows, discount rates, contributory asset charges and future tax rates, among others. The excess purchase price over the fair value of assets and liabilities acquired is recorded as goodwill.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed in Note 3, we completed the sale of Gentiva Hospice on August 11, 2022. The carrying value of the assets and liabilities of Gentiva Hospice disposed approximates fair value. The amount of goodwill included in the carrying value is based on the relative fair value of the Home Solutions reporting unit included within the CenterWell segment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the assets and liabilities acquired during 2023, there were no other material assets or liabilities measured at fair value on a recurring or nonrecurring basis during 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our fair value measurements, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140041012262000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MEDICARE PART D<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_MedicarePartDDisclosureTextBlock', window );">MEDICARE PART D</a></td>
<td class="text">MEDICARE PART D<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with the Centers for Medicare and Medicaid Services, or CMS. The accompanying condensed consolidated balance sheets include the following amounts associated with Medicare Part D at March&#160;31, 2023 and December 31, 2022. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers. For additional information regarding our prescription drug benefits coverage in accordance with Medicare Part D, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:41.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.570%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk<br/>Corridor<br/>Settlement</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CMS<br/>Subsidies/<br/>Discounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk<br/>Corridor<br/>Settlement</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CMS<br/>Subsidies/<br/>Discounts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable and accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,805)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,236)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current (liability) asset</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,566)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net long-term asset (liability)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net asset (liability)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,566)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_MedicarePartDDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balance sheet amounts associated with Medicare Part D.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_MedicarePartDDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140041026393680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill for our reportable segments for the three months ended March 31, 2023 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.557%"><tr><td style="width:1.0%"/><td style="width:55.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.613%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.722%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,742&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,320&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents details of our other intangible assets included in other long-term assets in the accompanying condensed consolidated balance sheets at March&#160;31, 2023 and December 31, 2022:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.156%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.681%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of need</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/<br/>&#160;&#160;&#160;&#160;relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names and <br/>&#160;&#160;&#160;&#160;technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetes and <br/>&#160;&#160;&#160;&#160;other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible <br/>&#160;&#160;&#160;&#160;assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,641&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March 31, 2023 and 2022, amortization expense for other intangible assets was approximately $18 million. The following table presents our estimate of amortization expense remaining for 2023 and each of the five next succeeding years at March&#160;31, 2023:</span></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:88.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.351%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the years ending December 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our goodwill and intangible assets, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140041002995008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BENEFITS PAYABLE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceDisclosureTextBlock', window );">BENEFITS PAYABLE</a></td>
<td class="text">BENEFITS PAYABLE<div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a consolidated basis, which represents our Insurance segment net of eliminations, activity in benefits payable was as follows for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:6pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.435%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.103%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.106%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(522)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(360)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,104)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,536)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,378&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total estimate of benefits payable for claims incurred but not reported, or IBNR, is included within the net incurred claims amounts. At March&#160;31, 2023, benefits payable included IBNR of approximately $6.3 billion, primarily associated with claims incurred in 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts incurred related to prior periods vary from previously estimated liabilities as the claims ultimately are settled. Negative amounts reported for incurred related to prior years result from claims being ultimately settled for amounts less than originally estimated (favorable development). </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reserving practice is to consistently recognize the actuarial best estimate of our ultimate liability for claims. Actuarial standards require the use of assumptions based on moderately adverse experience, which generally results in favorable reserve development, or reserves that are considered redundant. For additional information regarding our benefits payable and benefits expense recognition, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI https://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040918912416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER COMMON SHARE COMPUTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER COMMON SHARE COMPUTATION</a></td>
<td class="text">EARNINGS PER COMMON SHARE COMPUTATION<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Detail supporting the computation of basic and diluted earnings per common share was as follows for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.955%"><tr><td style="width:1.0%"/><td style="width:57.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.395%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.398%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions, except per common share results; number of shares in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income available for common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average outstanding shares of common stock <br/>&#160;&#160;&#160;&#160;used to compute basic earnings per common share</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,005&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,938&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute diluted earnings per common share</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,564&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,474&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.91&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.32&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.87&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.29&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of antidilutive stock options and restricted stock <br/>&#160;&#160;&#160;&#160;excluded from computation</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>For additional information regarding earnings per common share, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040919170592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of dividend payments, excluding dividend equivalent rights for unvested stock awards, during 2023 under our Board approved quarterly cash dividend policy:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"/><td style="width:23.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record<br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment<br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/30/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/27/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Board declared a cash dividend of $0.885 per share payable on April 28, 2023 to stockholders of record on March 31, 2023. In April 2023, the Board declared a cash dividend of $0.885 per share payable on July 28, 2023 to stockholders of record as of the close of business on June&#160;30, 2023. Declaration and payment of future quarterly dividends are at the discretion of our Board and may be adjusted as business needs or market conditions change.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our Board of Directors may authorize the purchase of our common stock shares. Under the share repurchase authorization, shares may be purchased from time to time at prevailing prices in the open market, by block purchases, through plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, or in privately-negotiated transactions, including pursuant to accelerated share repurchase agreements with investment banks, subject to certain regulatory restrictions on volume, pricing, and timing.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 15, 2023, the Board of Directors replaced the previous share repurchase authorization of up to $3&#160;billion (of which approximately $1&#160;billion remained unused) with a new authorization for repurchases of up to $3&#160;billion of our common shares exclusive of shares repurchased in connection with employee stock plans, expiring as of February 15, 2026. During the three months ended March 31, 2023, we repurchased 0.1&#160;million shares in open market transactions for $67&#160;million at an average price of $495.68 under the current share repurchase authorization. During the three months ended March 31, 2022 we did not repurchase shares in open market transactions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our remaining repurchase authorization was $2.8&#160;billion as of April&#160;25, 2023.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with employee stock plans, we acquired 0.05 million common shares for $27 million and 0.06&#160;million common shares for $24 million during the three months ended March 31, 2023 and 2022, respectively.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our stockholders' equity, refer to Note 16 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140041082136480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate was&#160;22.5% and 23.5% for the three months ended March 31, 2023 and 2022, respectively. The year-over-year decrease in the effective income tax rate is primarily due to the recognition of a non-taxable gain in the 2023 quarter. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For additional information regarding income taxes, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040918966096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of debt outstanding, net of unamortized debt issuance costs, was as follows at March&#160;31, 2023 and December 31, 2022:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:62.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.5&#160;billion, 0.650% due August 3, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior notes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600&#160;million, 3.850% due October 1, 2024</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600&#160;million, 4.500% due April 1, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million, 5.700% due March 13, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 1.350% due February 3, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600&#160;million, 3.950% due March 15, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million, 5.750% due March 1, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million, 3.700% due March 23, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million, 3.125% due August 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million, 4.875% due April 1, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 2.150% due February 3, 2032</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million, 5.880% due March 1, 2033</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$250&#160;million, 8.150% due June&#160;15, 2038</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$400&#160;million, 4.625% due December&#160;1, 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 4.950% due October 1, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$400&#160;million, 4.800% due March 15, 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million, 3.950% due August 15, 2049</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million, 5.500% due March 15, 2053</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,743&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,534&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delayed draw term loan, due May 28, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total term loans</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,743&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,034&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> In March 2023, we issued $500&#160;million of 5.700% unsecured senior notes due March 13, 2026 and $750&#160;million of 5.500% unsecured senior notes due March 15, 2053. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $1.2&#160;billion. We used the net proceeds to repay outstanding amounts under our $500&#160;million Delayed Draw Term Loan. The remaining net proceeds will be used for general corporate purposes, which include the repayment of existing indebtedness, including borrowings under our commercial paper program.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2023, we entered into a Rule 10b5-1 Repurchase Plan, or the Plan, to repurchase a portion of our $1.5&#160;billion aggregate principal amount of 0.650% senior notes maturing in August 2023 and our $600&#160;million </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">aggregate principal amount of 3.850% senior notes maturing in October 2024 during the Plan period beginning on March 13, 2023 and ending on June 15, 2023. During the three months ended March 31, 2023, we repurchased $61&#160;million aggregate principal amount, for cash totaling approximately $60&#160;million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For additional information regarding our Senior Notes, refer to Note 13 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revolving Credit Agreements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit agreements contain customary restrictive covenants and a financial covenant regarding maximum debt to capitalization of 60%, as well as customary events of default. We are in compliance with this financial covenant, with actual debt to capitalization of 41.1% as measured in accordance with the revolving credit agreements as of March&#160;31, 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, we had no borrowings and approximately $39 million of letters of credit outstanding under the revolving credit agreements, including those of KAH. Accordingly, as of March&#160;31, 2023, we had $2.4 billion of remaining borrowing capacity under the 5-year revolving credit agreement and $1.5&#160;billion of remaining borrowing capacity under the 364-day revolving credit agreement (which excludes the uncommitted $750 million of incremental loan facilities), none of which would be restricted by our financial covenant compliance requirement. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For additional information regarding our Revolving Credit Agreements, refer to Note 13 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Commercial Paper</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under our commercial paper program we may issue short-term, unsecured commercial paper notes privately placed on a discount basis through certain broker dealers at any time. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The net proceeds of issuances have been and are expected to be used for general corporate purposes. The maximum principal amount outstanding at any one time during the three months ended March 31, 2023 was $626 million, with $426 million outstanding at March&#160;31, 2023 compared to $595 million outstanding at December 31, 2022. The outstanding commercial paper at March&#160;31, 2023 had a weighted average annual interest rate of 5.45%.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For additional information regarding our Commercial Paper refer to Note 13 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Short-term Borrowings</span></div>We are a member, through one subsidiary, of the Federal Home Loan Bank of Cincinnati, or FHLB. As a member we have the ability to obtain short-term cash advances, subject to certain minimum collateral requirements. At March&#160;31, 2023 we had no outstanding short-term FHLB borrowings.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040918947728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS, GUARANTEES AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock', window );">COMMITMENTS, GUARANTEES AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS, GUARANTEES AND CONTINGENCIES<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Contracts</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicare products, which accounted for approximately 84% of our total premiums and services revenue for the three months ended March 31, 2023, primarily consisted of products covered under the Medicare Advantage and Medicare Part D Prescription Drug Plan contracts with the federal government. These contracts are renewed generally for a calendar year term unless CMS notifies us of its decision not to renew by May 1 of the calendar year in which the contract would end, or we notify CMS of our decision not to renew by the first Monday in June of the calendar year in which the contract would end. All material contracts between Humana and CMS relating to our Medicare products have been renewed for 2023, and all of our product offerings filed with CMS for 2023 have been approved.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS uses a risk-adjustment model which adjusts premiums paid to Medicare Advantage, or MA, plans according to health status of covered members. The risk-adjustment model, which CMS implemented pursuant to the Balanced Budget Act of 1997, or BBA, and the Benefits Improvement and Protection Act of 2000, or BIPA, generally pays more where a plan's membership has higher expected costs. Under this model, rates paid to MA plans are based on actuarially determined bids, which include a process whereby our prospective payments are based on our estimated cost of providing standard Medicare-covered benefits to an enrollee with a "national average risk profile." That baseline payment amount is adjusted to account for certain demographic characteristics and health status of our enrolled members. Under the risk-adjustment methodology, all MA plans must collect from providers and submit the necessary diagnosis code information to CMS within prescribed deadlines. The CMS risk-adjustment model uses the diagnosis data, collected from providers, to calculate the health status-related risk-adjusted premium payment to MA plans, which CMS further adjusts for coding pattern differences between the health plans and the government fee-for-service, or FFS, program. We generally rely on providers, including certain providers in our network who are our employees, to code their claim submissions with appropriate diagnoses, which we send to CMS as the basis for our health status-adjusted payment received from CMS under the actuarial risk-adjustment model. We also rely on these providers to document appropriately all medical data, including the diagnosis data submitted with claims. In addition, we conduct medical record reviews as part of our data and payment accuracy compliance efforts, to more accurately reflect diagnosis conditions under the risk adjustment model.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS and the Office of the Inspector General of Health and Human Services, or HHS-OIG, perform audits of various companies&#8217; risk adjustment diagnosis data submissions. We refer to these audits as Risk-Adjustment Data Validation Audits, or RADV audits. RADV audits review medical records in an attempt to validate provider medical record documentation and coding practices that influence the calculation of health status-related premium payments to MA plans. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS released an MA contract-level RADV methodology that would extrapolate the results of each CMS RADV audit sample to the audited MA contract&#8217;s entire health status-related risk adjusted premium amount for the year under audit.  In doing so, CMS recognized &#8220;that the documentation standard used in RADV audits to determine a contract&#8217;s payment error (medical records) is different from the documentation standard used to develop the Part C risk-adjustment model (FFS claims).&#8221; To correct for this difference, CMS stated that it would apply a &#8220;Fee-for-Service Adjuster (FFS Adjuster)&#8221; as &#8220;an offset to the preliminary recovery amount.&#8221; This adjuster would be &#8220;calculated by CMS based on a RADV-like review of records submitted to support FFS claims data.&#8221;  CMS stated that this methodology would apply to audits beginning with PY 2011. Humana relied on CMS&#8217;s 2012 guidance in submitting MA bids to CMS.  Humana also launched a &#8220;Self-Audits&#8221; program in 2013 that applied CMS&#8217;s 2012 RADV audit methodology and included an estimated FFS Adjuster.  Humana completed Self-Audits for PYs 2011-2016 and reported results to CMS. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, however, CMS issued a proposed rule announcing possible changes to the RADV audit methodology, including elimination of the FFS Adjuster.  CMS proposed applying its revised methodology, including extrapolated recoveries without application of a FFS Adjuster, to RADV audits dating back to PY 2011.  On January 30, 2023, CMS published a final rule related to the RADV audit methodology (Final RADV Rule).  The Final RADV Rule confirmed CMS&#8217;s decision to eliminate the FFS Adjuster. The Final RADV Rule states CMS&#8217;s intention to extrapolate results from CMS and HHS-OIG RADV audits beginning with PY 2018, rather than PY 2011 as proposed.  However, CMS&#8217;s Final RADV Rule does not adopt a specific sampling, extrapolation or audit methodology.  CMS instead stated its general plan to rely on &#8220;any statistically valid method . . . that is determined to be well-suited to a particular audit.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana is considering its legal options with respect to CMS&#8217;s changed position on the FFS Adjuster and seeking clarity regarding our compliance obligations in light of the Final RADV Rule. We believe that the Final RADV Rule fails to address adequately the statutory requirement of actuarial equivalence. Further, Humana&#8217;s actuarially certified bids through PY 2023 preserved Humana&#8217;s position that CMS should apply an FFS Adjuster in any RADV audit that CMS intends to extrapolate. We expect CMS to apply the Final RADV Rule, including the first application of extrapolated audit results to determine audit settlements without a FFS Adjuster, to CMS and HHS-OIG RADV audits conducted for PY 2018 and subsequent years.  The Final RADV Rule, including the lack of </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a FFS Adjuster, and any related regulatory, industry or company reactions, could have a material adverse effect on our results of operations, financial position, or cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as part of our internal compliance efforts, we routinely perform ordinary course reviews of our internal business processes related to, among other things, our risk coding and data submissions in connection with the risk adjustment model. These reviews may also result in the identification of errors and the submission of corrections to CMS that may, either individually or in the aggregate, be material. As such, the result of these reviews may have a material adverse effect on our results of operations, financial position, or cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we explore our legal options and compliance obligations, we remain committed to working alongside CMS to promote the integrity of the MA program as well as affordability and cost certainty for our members.  It is critical that MA plans are paid accurately and that payment model principles, including the application of a FFS Adjuster, are in accordance with the requirements of the Social Security Act, which, if not implemented correctly could have a material adverse effect on our results of operations, financial position, or cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our state-based Medicaid business, which accounted for approximately 7% of our total premiums and services revenue for the three months ended March 31, 2023 primarily consisted of serving members enrolled in Medicaid, and in certain circumstances members who qualify for both Medicaid and Medicare, under contracts with various states. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At March&#160;31, 2023, our Military business, which accounted for approximately 1% of our total premiums and services revenue for the three months ended March 31, 2023, primarily consisted of the TRICARE T2017 East Region contract. The T2017 East Region contract comprising 32 states and approximately 6 million TRICARE beneficiaries, under which delivery of health care services commenced on January 1, 2018. The T2017 East Region contract, which was originally set to expire on December 31, 2022, was subsequently extended by the DoD and is currently scheduled to expire on December 31, 2023, unless further extended. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, we were awarded the next generation of TRICARE Managed Care Support Contracts, or T-5, for the TRICARE East Region by the Defense Health Agency of the DoD. The contract is expected to go into effect in 2024. Until then the T2017 contract remains in place. Under the terms of the award, our service area covers approximately 4.6&#160;million beneficiaries in a region consisting of 24 states and Washington, D.C. The length of the contract is <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTA5OTUxMTY1MjExMw_2669b125-bc7d-4903-8a53-f6a32cfce9ee">one</span> base year with eight annual option periods, which, if all options are exercised, would result in a total contract length of nine years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of any of the contracts above or significant changes in these programs as a result of legislative or regulatory action, including reductions in premium payments to us, regulatory restrictions on profitability, including reviews by regulatory bodies that may compare our Medicare Advantage profitability to our non-Medicare Advantage business profitability, or compare the profitability of various products within our Medicare Advantage business, and require that they remain within certain ranges of each other, or increases in member benefits or member eligibility criteria without corresponding increases in premium payments to us, may have a material adverse effect on our results of operations, financial position, and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings and Certain Regulatory Matters</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, the Civil Division of the United States Department of Justice provided us with an information request in December 2014, concerning our Medicare Part C risk adjustment practices. The request relates to our oversight and submission of risk adjustment data generated by providers in our Medicare Advantage network, as well as to our business and compliance practices related to risk adjustment data generated by our providers and by us, including medical record reviews conducted as part of our data and payment accuracy compliance efforts, the use of health and well-being assessments, and our fraud detection efforts. We believe that this request for information is in connection with a wider review of Medicare Risk Adjustment generally that includes a number of Medicare Advantage plans, providers and vendors. We cooperated with the Department of Justice, and we have not heard from the Department of Justice on this matter since 2020. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, on January 19, 2016, an individual filed a qui tam suit captioned United States of America ex rel. Steven Scott v. Humana, Inc., in United States District Court, Central District of California, Western Division. The complaint alleges certain civil violations by us in connection with the actuarial equivalence of the plan benefits under Humana&#8217;s Basic PDP plan, a prescription drug plan offered by us under Medicare Part D. The action seeks damages and penalties on behalf of the United States under the False Claims Act. The court ordered the qui tam action unsealed on September 13, 2017, so that the relator could proceed, following notice from the U.S. Government that it was not intervening at that time. On January 29, 2018, the suit was transferred to the United States District Court, Western District of Kentucky, Louisville Division. We have substantially completed discovery with the relator who has pursued the matter on behalf of the United States following its unsealing. On March 31, 2022, the Court denied the parties' Motions for Summary Judgement. We take seriously our obligations to comply with applicable CMS requirements and actuarial standards of practice, and continue to vigorously defend against these allegations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Lawsuits and Regulatory Matters</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current and past business practices are subject to review or other investigations by various state insurance and health care regulatory authorities and other state and federal regulatory authorities. These authorities regularly scrutinize the business practices of health insurance, health care delivery and benefits companies. These reviews focus on numerous facets of our business, including claims payment practices, statutory capital requirements, provider contracting, risk adjustment, competitive practices, commission payments, privacy issues, utilization management practices, pharmacy benefits, access to care, sales practices, and provision of care by our healthcare services businesses, among others. Some of these reviews have historically resulted in fines imposed on us and some have required changes to some of our practices. We continue to be subject to these reviews, which could result in additional fines or other sanctions being imposed on us or additional changes in some of our practices.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also are involved in various other lawsuits that arise, for the most part, in the ordinary course of our business operations, certain of which may be styled as class-action lawsuits. Among other matters, this litigation may include employment matters, claims of medical malpractice, bad faith, nonacceptance or termination of providers, anticompetitive practices, improper rate setting, provider contract rate and payment disputes, including disputes over reimbursement rates required by statute, disputes arising from competitive procurement process, general contractual matters, intellectual property matters, and challenges to subrogation practices. Under state guaranty assessment laws, including those related to state cooperative failures in the industry, we may be assessed (up to prescribed limits) for certain obligations to the policyholders and claimants of insolvent insurance companies that write the same line or lines of business as we do.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a government contractor, we may also be subject to false claims litigation, such as qui tam lawsuits brought by individuals who seek to sue on behalf of the government, alleging that the government contractor submitted false claims to the government or related overpayments from the government, including, among other allegations, those resulting from coding and review practices under the Medicare risk adjustment model. Qui tam litigation is filed under seal to allow the government an opportunity to investigate and to decide if it wishes to intervene and assume control of the litigation. If the government does not intervene, the individual may continue to prosecute the action on his or her own, on behalf of the government. We also are subject to other allegations of nonperformance of contractual obligations to providers, members, and others, including failure to properly pay claims, improper policy terminations, challenges to our implementation of the Medicare Part D prescription drug program and other litigation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited number of the claims asserted against us are subject to insurance coverage. Personal injury claims, claims for extra contractual damages, care delivery malpractice, and claims arising from medical benefit denials are covered by insurance from our wholly owned captive insurance subsidiary and excess carriers, except to the extent that claimants seek punitive damages, which may not be covered by insurance in certain states in which insurance coverage for punitive damages is not permitted. In addition, insurance coverage for all or certain forms of liability has become increasingly costly and may become unavailable or prohibitively expensive in the future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record accruals for the contingencies discussed in the sections above to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described above because of the inherently unpredictable nature of legal proceedings, which also may be exacerbated by various factors, including: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties (including where it is uncertain how liability, if any, will be shared among multiple defendants); or (vii) there is a wide range of potential outcomes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outcome of any current or future litigation or governmental or internal investigations, including the matters described above, cannot be accurately predicted, nor can we predict any resulting judgments, penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities or as a result of actions by third parties. Nevertheless, it is reasonably possible that any such outcome of litigation, judgments, penalties, fines or other sanctions could be substantial, and the outcome of these matters may have a material adverse effect on our results of operations, financial position, and cash flows, and may also affect our reputation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments, contingencies, and guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI https://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040922883424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATION<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During December 2022, we realigned our businesses into two distinct segments: Insurance and CenterWell. The Insurance segment includes the businesses that were previously included in the Retail and Group and Specialty segments, as well as the Pharmacy Benefit Manager, or PBM, business which was previously included in the Healthcare Services segment. The CenterWell segment (formerly Healthcare Services) represents our payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. In addition to the new segment classifications being utilized to assess performance and allocate resources, we believe this simpler structure will create greater collaboration across the Insurance and CenterWell businesses and will accelerate work that is underway to centralize and integrate operations within the organization.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period segment financial information has been recast to conform to the 2023 presentation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our two reportable segments, Insurance and CenterWell, are based on a combination of the type of health plan customer and adjacent businesses centered on well-being solutions for our health plans and other customers, as described below. These segment groupings are consistent with information used by our Chief Executive Officer, the Chief Operating Decision Maker, to assess performance and allocate resources. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as our contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which we refer to collectively as our state-based contracts. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only, or ASO. In addition, our Insurance segment includes our Military business, primarily our T-2017 East Region contract, as well as the operations of our PBM business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CenterWell segment includes our pharmacy, provider services, and home solutions operations. The segment also includes our strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as our minority ownership interest in hospice operations. Services offered by this segment are designed to enhance the overall healthcare experience. These services may lead to lower utilization associated with improved member health and/or lower drug costs. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CenterWell intersegment revenues primarily relate to the operations of CenterWell Pharmacy (our mail- order pharmacy business), CenterWell Specialty Pharmacy, and retail pharmacies jointly located within CenterWell Senior Primary Care clinics. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our CenterWell intersegment revenues include revenues earned by certain owned providers derived from certain value-based arrangements with our health plans. Under these value-based arrangements, our owned providers enter into agreements with our health plans to stand ready to deliver, integrate, direct and control the administration and management of certain health care services for our members. In exchange, the owned provider receives a premium that is typically paid on a per-member per-month basis. These value-based arrangements represent a single performance obligation where revenues are recognized in the period in which we are obligated to provide integrated health care services to our members. Fee-for-service revenue is recognized at agreed upon rates, net of contractual allowances, as the performance obligation is completed on the date of service.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We present our condensed consolidated results of operations from the perspective of the health plans. As a result, the cost of providing benefits to our members, whether provided via a third party provider or internally through a stand-alone subsidiary, is classified as benefits expense and excludes the portion of the cost for which the health plans do not bear responsibility, including member co-share amounts and government subsidies of $4.0&#160;billion and $4.0 billion for the three months ended March 31, 2023 and 2022, respectively. In addition, depreciation and amortization expense associated with certain businesses delivering benefits to our members, primarily associated with our provider services and pharmacy operations, are included with benefits expense. The amount of this expense was $33 million and $30 million for the three months ended March 31, 2023 and 2022, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than those described previously, the accounting policies of each segment are the same. For additional information regarding our accounting policies refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. Transactions between reportable segments primarily consist of sales of services rendered by our CenterWell segment, primarily pharmacy, provider, and home services, to our Insurance segment customers. Intersegment sales and expenses are recorded at fair value and eliminated in consolidation. Members served by our segments often use the same provider networks, enabling us in some instances to obtain more favorable contract terms with providers. Our segments also share indirect costs and assets. As a result, the profitability of each segment is interdependent. We allocate most operating expenses to our segments. Assets and certain corporate income and expenses are not allocated to the segments, including the portion of investment income not supporting segment operations, interest expense on corporate debt, and certain other corporate expenses. These items are managed at a corporate level. These corporate amounts are reported separately from our reportable segments and are included with intersegment eliminations in the tables presenting segment results below. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our segment results were as follows for the three months ended March 31, 2023 and 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:52.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.851%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.800%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:52.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External revenues </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,762)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,666)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,175&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,728)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,023&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity in net losses </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss) attributable to Humana</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:54.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.370%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.012%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.975%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.979%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="21" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External Revenues  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,907&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,967&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(871)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,446)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,317)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,967&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,362)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,995&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,285)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,289&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity in net losses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss (income) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss) attributable to Humana</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040915833008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SIGNIFICANT EVENTS (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements are presented in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the disclosures normally required by accounting principles generally accepted in the United States of America, or GAAP, or those normally made in an Annual Report on Form 10-K. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. For further information, the reader of this Form 10-Q should refer to our Form 10-K for the year ended December 31, 2022, that was filed with the Securities and Exchange Commission, or the SEC, on February&#160;16, 2023. We refer to this Form 10-K as the &#8220;2022 Form 10-K&#8221; in this document. References throughout this document to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Company,&#8221; and &#8220;Humana&#8221; mean Humana Inc. and its subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our condensed consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The areas involving the most significant use of estimates are the estimation of benefits payable, the impact of risk adjustment provisions related to our Medicare contracts, the valuation and related impairment recognition of investment securities, and the valuation and related impairment recognition of long-lived assets, including goodwill and indefinite-lived intangible assets. These estimates are based on knowledge of current events and anticipated future events, and accordingly, actual results may ultimately differ materially from those estimates. For additional information regarding accounting policies considered in preparing our consolidated financial statements, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial information has been prepared in accordance with our customary accounting practices and has not been audited. In our opinion, the information presented reflects all adjustments necessary for a fair statement of interim results. All such adjustments are of a normal and recurring nature.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Employer Group Commercial Medical Products Business Exit</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, we announced our planned exit from the Employer Group Commercial Medical Products business, which includes all fully insured, self-funded and Federal Employee Health Benefit medical plans, as well as associated wellness and rewards programs. No other Humana health plan offerings are materially affected. Following a strategic review, we determined the Employer Group Commercial Medical Products business was no longer positioned to sustainably meet the needs of commercial members over the long term or support our long-term strategic plans. The exit from this line of business will be phased over the next 18 to 24 months.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Creation Initiatives </span></div>During 2022, in order to create capacity to fund growth and investment in our Medicare Advantage business and further expansion of our healthcare services capabilities in 2023, we committed to drive additional value for the enterprise through cost saving, productivity initiatives, and value acceleration from previous investments. As a result of these initiatives, we recorded charges of $473 million for the year-ended December 31, 2022. These charges primarily relate to $248&#160;million in asset impairments, including software and abandonment, and $116&#160;million of severance charges in connection with workforce optimization. The remainder of the charges primarily relate to external consulting fees. These charges were recorded at the corporate level and not allocated to the segments. We did not record any charges in the first quarter of 2022, with no recurring charges in 2023.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues include premiums and services revenue. Services revenue includes administrative service fees that are recorded based upon established per member per month rates and the number of members for the month and are recognized as services are provided for the month. Additionally, services revenue includes net patient services revenue that are recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For additional information regarding our revenues, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. For additional information regarding disaggregation of revenue by segment and type, refer to Note 14 to the unaudited Condensed Consolidated Financial Statements included in Part I, Item 1, "Financial Statements" of this Form 10-Q.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text">In November 2020, the FASB issued Accounting Standards Update No. 2020-11, Financial Services&#8212;Insurance (Topic 944): Effective Date and Early Application (&#8220;ASU 2020-11&#8221;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12, Financial Services&#8212;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (&#8220;ASU 2018-12&#8221;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The new guidance relates to accounting for long-duration contracts of insurers which revises key elements of the measurement models and disclosure requirements for long-duration contracts issued by insurers, including the amortization of deferred contract acquisition costs and the measurement of liabilities for future policy benefits using current, rather than locked-in, assumptions. The new guidance, limited to our Medicare Supplement product which represent less than 1% of consolidated premiums and services revenue, became effective for us beginning January 1, 2023 and is to be applied to contracts in force on the basis of their existing carrying value amounts at the beginning of the earliest period presented. The adoption of the new standard in 2023 did not have a material impact on our consolidated results of operations, financial position or cash flows.There are no other recently issued accounting standards that apply to us or that are expected to have a material impact on our results of operations, financial condition, or cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040915874400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT SECURITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Investment Securities Classified as Current and Long-Term</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities classified as current and long-term were as follows at March&#160;31, 2023 and December 31, 2022, respectively:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.551%"><tr><td style="width:1.0%"/><td style="width:43.476%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.120%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.120%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.120%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government<br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(423)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,479)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(828)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,701)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock', window );">Schedule of Gross Unrealized Losses and Fair Value of Securities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross unrealized losses and fair values aggregated by investment category and length of time of individual debt securities that have been in a continuous unrealized loss position for which no allowances for credit loss has been recorded were as follows at March&#160;31, 2023 and December 31, 2022, respectively:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.085%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or more</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(423)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(649)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,680&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,082&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,381)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,479)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(828)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,419&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,431)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,381&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,701)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRealizedGainLossTableTextBlock', window );">Schedule of Realized Gains (Losses) Related to Investment Securities Included Within Investment Income</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The detail of (losses) gains related to investment securities and included within investment income was as follows for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:4pt;margin-top:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"/><td style="width:70.913%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.484%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.618%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.485%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains on investment securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses on investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains on equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net recognized losses on investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Schedule of Gain (Loss) on Equity Securities</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses related to equity securities for the three months ended March 31, 2023 and 2022 was as follows:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"/><td style="width:71.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.330%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.332%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains (losses) recognized on equity securities during the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net gains (losses) recognized on equity securities sold during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses recognized on equity securities still held at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Contractual Maturity of Debt Securities Available for Sale</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of debt securities available for sale at March&#160;31, 2023, regardless of their balance sheet classification, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:70.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.704%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,941&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage and asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,747&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,303&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRealizedGainLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the proceeds from sales of available-for-sale securities and the gross realized gains and gross realized losses that have been included in earnings as a result of those sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRealizedGainLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrealized gains and losses on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040913254272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Financial Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our fair value measurements at March&#160;31, 2023 and December 31, 2022, respectively, for financial assets measured at fair value on a recurring basis:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:49.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.617%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.617%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.617%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government<br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 66.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total invested assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,916&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,613&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government<br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,254&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,153&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 66.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total invested assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,093&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,839&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,153&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text">During the year ended March&#160;31, 2023, the changes in the fair value of the assets measured using significant unobservable inputs (Level 3) were comprised of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.944%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.946%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Private Placements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance at January&#160;1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gains or losses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized in other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer out</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Assumptions Used For Inputs In Fair Value Measurement</a></td>
<td class="text">The table below presents the assumptions used for each reporting period.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:59.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.805%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7% - 19.3%</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7% - 20.8%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit spread</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2% - 1.4%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3% - 1.5%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue exit multiple</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5x - 2.5x</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5x - 2.5x</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average cost of capital</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0% - 13.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5% - 12.5%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term growth rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040919055280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MEDICARE PART D (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock', window );">Schedule of Balance Sheet Amounts Associated With Medicare Part D</a></td>
<td class="text">The accompanying condensed consolidated balance sheets include the following amounts associated with Medicare Part D at March&#160;31, 2023 and December 31, 2022. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers. For additional information regarding our prescription drug benefits coverage in accordance with Medicare Part D, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:41.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.570%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk<br/>Corridor<br/>Settlement</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CMS<br/>Subsidies/<br/>Discounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk<br/>Corridor<br/>Settlement</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CMS<br/>Subsidies/<br/>Discounts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable and accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,805)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,236)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current (liability) asset</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,566)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net long-term asset (liability)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net asset (liability)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,566)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balance Sheet Account Associated With Medicare Part D</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040915917984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Changes in Carrying Amount of Goodwill By Reportable Segments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill for our reportable segments for the three months ended March 31, 2023 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.557%"><tr><td style="width:1.0%"/><td style="width:55.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.613%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.722%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,742&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,320&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Other Intangible Assets, Indefinite-Lived</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents details of our other intangible assets included in other long-term assets in the accompanying condensed consolidated balance sheets at March&#160;31, 2023 and December 31, 2022:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.156%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.681%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of need</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/<br/>&#160;&#160;&#160;&#160;relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names and <br/>&#160;&#160;&#160;&#160;technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetes and <br/>&#160;&#160;&#160;&#160;other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible <br/>&#160;&#160;&#160;&#160;assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,641&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Other Intangible Assets, Amortizable</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents details of our other intangible assets included in other long-term assets in the accompanying condensed consolidated balance sheets at March&#160;31, 2023 and December 31, 2022:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.156%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.681%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of need</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/<br/>&#160;&#160;&#160;&#160;relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names and <br/>&#160;&#160;&#160;&#160;technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetes and <br/>&#160;&#160;&#160;&#160;other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible <br/>&#160;&#160;&#160;&#160;assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,641&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense</a></td>
<td class="text">The following table presents our estimate of amortization expense remaining for 2023 and each of the five next succeeding years at March&#160;31, 2023:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:88.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.351%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the years ending December 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040918930784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BENEFITS PAYABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Activity in Benefits Payable</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a consolidated basis, which represents our Insurance segment net of eliminations, activity in benefits payable was as follows for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:6pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.435%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.103%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.106%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(522)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(360)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,104)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,536)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,378&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040918916000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER COMMON SHARE COMPUTATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Details Supporting Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Detail supporting the computation of basic and diluted earnings per common share was as follows for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.955%"><tr><td style="width:1.0%"/><td style="width:57.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.395%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.398%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions, except per common share results; number of shares in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income available for common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average outstanding shares of common stock <br/>&#160;&#160;&#160;&#160;used to compute basic earnings per common share</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,005&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,938&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute diluted earnings per common share</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,564&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,474&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.91&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.32&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.87&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.29&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of antidilutive stock options and restricted stock <br/>&#160;&#160;&#160;&#160;excluded from computation</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040918983984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsDeclaredTableTextBlock', window );">Schedule of Details of Dividend Payments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of dividend payments, excluding dividend equivalent rights for unvested stock awards, during 2023 under our Board approved quarterly cash dividend policy:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"/><td style="width:23.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record<br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment<br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/30/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/27/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsDeclaredTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsDeclaredTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040918966096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Carrying Value of Debt Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of debt outstanding, net of unamortized debt issuance costs, was as follows at March&#160;31, 2023 and December 31, 2022:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:62.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.5&#160;billion, 0.650% due August 3, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior notes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600&#160;million, 3.850% due October 1, 2024</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600&#160;million, 4.500% due April 1, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million, 5.700% due March 13, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 1.350% due February 3, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600&#160;million, 3.950% due March 15, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million, 5.750% due March 1, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million, 3.700% due March 23, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million, 3.125% due August 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million, 4.875% due April 1, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 2.150% due February 3, 2032</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million, 5.880% due March 1, 2033</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$250&#160;million, 8.150% due June&#160;15, 2038</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$400&#160;million, 4.625% due December&#160;1, 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 4.950% due October 1, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$400&#160;million, 4.800% due March 15, 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million, 3.950% due August 15, 2049</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million, 5.500% due March 15, 2053</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,743&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,534&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delayed draw term loan, due May 28, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total term loans</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,743&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,034&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040918914416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Results</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our segment results were as follows for the three months ended March 31, 2023 and 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:52.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.851%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.800%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:52.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External revenues </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,762)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,666)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,175&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,728)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,023&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity in net losses </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss) attributable to Humana</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:54.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.370%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.012%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.975%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.979%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="21" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External Revenues  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,907&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,967&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(871)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,446)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,317)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,967&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,362)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,995&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,285)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,289&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity in net losses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss (income) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss) attributable to Humana</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040913072704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SIGNIFICANT EVENTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Receivables and Other [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DiscontinuedOperationsSegmentPhaseOutPeriod', window );">Business segment phase out period</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Receivables and Other [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DiscontinuedOperationsSegmentPhaseOutPeriod', window );">Business segment phase out period</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Receivables and Other [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 246,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=hum_ValueCreationInitiativesMember', window );">Value Creation Initiatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Receivables and Other [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Restructuring and impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 473,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Assets held for abandonment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">248,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DiscontinuedOperationsSegmentPhaseOutPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operations, Segment Phase Out Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DiscontinuedOperationsSegmentPhaseOutPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=hum_ValueCreationInitiativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=hum_ValueCreationInitiativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040922405088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk | Revenue Benchmark | Medicare Supplement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, less than (percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hum_MedicareSupplementProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hum_MedicareSupplementProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040914404304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES (Details) - Disposal Group, Disposed of by Sale, Not Discontinued Operations - Gentiva Hospice - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 11, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold', window );">Equity interest to be sold</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Consideration to be received</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax', window );">Pre-tax gain, net of transaction costs</a></td>
<td class="nump">237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax', window );">Pretax earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Term Loan Due October 2023 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of debt</a></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Equity Interest Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from an individually significant component disposed of or held-for-sale including the portion attributable to the noncontrolling interest. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_GentivaHospiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_GentivaHospiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_TermLoanDueOctober2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_TermLoanDueOctober2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040913028784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENT SECURITIES - Securities Classified as Current and Long-Term (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Investment Securities, Available-for-sale Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 16,747<span></span>
</td>
<td class="nump">$ 15,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,479)<span></span>
</td>
<td class="num">(1,701)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">15,303<span></span>
</td>
<td class="nump">14,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total investment securities</a></td>
<td class="nump">15,303<span></span>
</td>
<td class="nump">14,261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Investment Securities, Available-for-sale Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,394<span></span>
</td>
<td class="nump">1,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,356<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Investment Securities, Available-for-sale Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">3,919<span></span>
</td>
<td class="nump">3,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(423)<span></span>
</td>
<td class="num">(471)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">3,503<span></span>
</td>
<td class="nump">3,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember', window );">Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Investment Securities, Available-for-sale Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">762<span></span>
</td>
<td class="nump">765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">736<span></span>
</td>
<td class="nump">728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Investment Securities, Available-for-sale Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(73)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">397<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Investment Securities, Available-for-sale Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,562<span></span>
</td>
<td class="nump">1,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(149)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,413<span></span>
</td>
<td class="nump">1,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Investment Securities, Available-for-sale Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,915<span></span>
</td>
<td class="nump">1,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,853<span></span>
</td>
<td class="nump">1,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Investment Securities, Available-for-sale Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">6,725<span></span>
</td>
<td class="nump">6,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(696)<span></span>
</td>
<td class="num">(828)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 6,045<span></span>
</td>
<td class="nump">$ 5,726<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040912964240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT SECURITIES - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>position</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentLineItems', window );"><strong>Financing Receivable, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Book value</a></td>
<td class="nump">$ 16,747<span></span>
</td>
<td class="nump">$ 15,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair value</a></td>
<td class="nump">$ 15,303<span></span>
</td>
<td class="nump">$ 14,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities', window );">Maximum individual state general bond obligation as a percentage of total debt securities (percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Securities in unrealized loss positions, number of positions | position</a></td>
<td class="nump">1,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions', window );">Securities, number of positions | position</a></td>
<td class="nump">1,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsAARatingMember', window );">Standard &amp; Poor's, AA Rating</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentLineItems', window );"><strong>Financing Receivable, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality', window );">Percentage of debt securities considered to be of investment-grade (percent)</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Dispositions | Gentiva Hospice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentLineItems', window );"><strong>Financing Receivable, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Book value</a></td>
<td class="nump">$ 281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair value</a></td>
<td class="nump">$ 286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Securities, Number Of Positions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum Individual State General Bond Obligation, As Percentage Of Total Debt Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Total Debt Securities, Investment Grade Quality</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsAARatingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsAARatingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_GentivaHospiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_GentivaHospiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040920452912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENT SECURITIES - Gross Unrealized Losses and Fair Values of Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">$ 3,680<span></span>
</td>
<td class="nump">$ 4,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">9,082<span></span>
</td>
<td class="nump">8,962<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">12,762<span></span>
</td>
<td class="nump">13,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(98)<span></span>
</td>
<td class="num">(270)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(1,381)<span></span>
</td>
<td class="num">(1,431)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(1,479)<span></span>
</td>
<td class="num">(1,701)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">290<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">396<span></span>
</td>
<td class="nump">397<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">686<span></span>
</td>
<td class="nump">909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">867<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">2,123<span></span>
</td>
<td class="nump">1,683<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">2,990<span></span>
</td>
<td class="nump">2,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(406)<span></span>
</td>
<td class="num">(367)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(423)<span></span>
</td>
<td class="num">(471)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember', window );">Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">343<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">314<span></span>
</td>
<td class="nump">615<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">657<span></span>
</td>
<td class="nump">679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">369<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">394<span></span>
</td>
<td class="nump">398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(71)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(73)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">1,275<span></span>
</td>
<td class="nump">1,157<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">1,394<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(145)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(149)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">583<span></span>
</td>
<td class="nump">620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">971<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">1,554<span></span>
</td>
<td class="nump">1,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">1,453<span></span>
</td>
<td class="nump">1,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">3,634<span></span>
</td>
<td class="nump">3,825<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">5,087<span></span>
</td>
<td class="nump">5,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(649)<span></span>
</td>
<td class="num">(730)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">$ (696)<span></span>
</td>
<td class="num">$ (828)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040920543056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT SECURITIES - Gains (Losses) Within Investment Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DebtSecuritiesRealizedGainGross', window );">Gross gains on investment securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DebtSecuritiesRealizedLossGross', window );">Gross losses on investment securities</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGain', window );">Gross gains on equity securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedLoss', window );">Gross losses on equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Net recognized losses on investment securities</a></td>
<td class="num">$ (60)<span></span>
</td>
<td class="num">$ (76)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DebtSecuritiesRealizedGainGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Realized Gain, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DebtSecuritiesRealizedGainGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DebtSecuritiesRealizedLossGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Realized Loss, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DebtSecuritiesRealizedLossGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040922786416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT SECURITIES - Gains and Losses Related to Equity Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Net gains (losses) recognized on equity securities during the period</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">$ (108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Less: Net gains (losses) recognized on equity securities sold during the period</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized losses recognized on equity securities still held at the end of the period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (49)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040913655344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENT SECURITIES - Contractual Maturities of Debt Securities Available for Sale (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due within one year</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years</a></td>
<td class="nump">4,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">Due after five years through ten years</a></td>
<td class="nump">3,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">Due after ten years</a></td>
<td class="nump">1,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Mortgage and asset-backed securities</a></td>
<td class="nump">7,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">16,747<span></span>
</td>
<td class="nump">$ 15,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due within one year</a></td>
<td class="nump">495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">3,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Due after five years through ten years</a></td>
<td class="nump">2,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Due after ten years</a></td>
<td class="nump">1,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Mortgage and asset-backed securities</a></td>
<td class="nump">7,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 15,303<span></span>
</td>
<td class="nump">$ 14,254<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040913302304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE - Financial Assets Measured on Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">$ 15,303<span></span>
</td>
<td class="nump">$ 14,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">1,356<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">3,503<span></span>
</td>
<td class="nump">3,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember', window );">Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">736<span></span>
</td>
<td class="nump">728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">397<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">1,413<span></span>
</td>
<td class="nump">1,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">1,853<span></span>
</td>
<td class="nump">1,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">6,045<span></span>
</td>
<td class="nump">5,726<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">13,613<span></span>
</td>
<td class="nump">4,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">15,303<span></span>
</td>
<td class="nump">14,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total invested assets</a></td>
<td class="nump">28,916<span></span>
</td>
<td class="nump">19,093<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">1,356<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">3,503<span></span>
</td>
<td class="nump">3,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">736<span></span>
</td>
<td class="nump">728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">397<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">1,413<span></span>
</td>
<td class="nump">1,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">1,853<span></span>
</td>
<td class="nump">1,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">6,045<span></span>
</td>
<td class="nump">5,726<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">13,613<span></span>
</td>
<td class="nump">4,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total invested assets</a></td>
<td class="nump">13,613<span></span>
</td>
<td class="nump">4,839<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">15,204<span></span>
</td>
<td class="nump">14,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total invested assets</a></td>
<td class="nump">15,204<span></span>
</td>
<td class="nump">14,153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">1,356<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">3,503<span></span>
</td>
<td class="nump">3,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">736<span></span>
</td>
<td class="nump">728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">397<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">1,413<span></span>
</td>
<td class="nump">1,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">1,853<span></span>
</td>
<td class="nump">1,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">5,946<span></span>
</td>
<td class="nump">5,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total invested assets</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total debt securities</a></td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040913101824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value</a></td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_PutOptionMember', window );">Put option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Fair value of financial liability</a></td>
<td class="nump">318<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember', window );">Call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_FinancialAssetsFairValueDisclosure', window );">Fair value of financial asset</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=hum_TermLoanAndCommercialPaperMember', window );">Term Loan And Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">426<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt outstanding</a></td>
<td class="nump">11,200<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt outstanding</a></td>
<td class="nump">$ 10,900<span></span>
</td>
<td class="nump">$ 9,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) | Investments | Fair Value Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (percent)</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_FinancialAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Assets, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_FinancialAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_PutOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_PutOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=hum_TermLoanAndCommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=hum_TermLoanAndCommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_InvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_InvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=hum_FairValueRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=hum_FairValueRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040921334560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE - Significant Unobservable Inputs (Level 3) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance at January&#160;1</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract', window );"><strong>Total gains or losses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Unrealized in other comprehensive income</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfer out</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at March 31</a></td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140041093640736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE - Put and Call Options Measured at Fair Value (Details) - Options - Level 3 fair value measurement<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Annualized volatility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.167<span></span>
</td>
<td class="nump">0.167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Annualized volatility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.193<span></span>
</td>
<td class="nump">0.208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Credit spread | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.012<span></span>
</td>
<td class="nump">0.013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Credit spread | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.014<span></span>
</td>
<td class="nump">0.015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Revenue exit multiple | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Revenue exit multiple | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Weighted average cost of capital | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.120<span></span>
</td>
<td class="nump">0.115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Weighted average cost of capital | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.130<span></span>
</td>
<td class="nump">0.125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Long term growth rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.030<span></span>
</td>
<td class="nump">0.030<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure net derivative asset (liability).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetLiabilityNetMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_CreditSpreadOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_CreditSpreadOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=hum_RevenueExitMultipleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=hum_RevenueExitMultipleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040921567280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MEDICARE PART D (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">$ 5,758<span></span>
</td>
<td class="nump">$ 5,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Trade accounts payable and accrued expenses</a></td>
<td class="num">(7,431)<span></span>
</td>
<td class="num">(5,238)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">3,580<span></span>
</td>
<td class="nump">3,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="num">(1,457)<span></span>
</td>
<td class="num">(1,473)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=hum_RiskCorridorSettlementsMedicarePartDMember', window );">Risk Corridor Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Trade accounts payable and accrued expenses</a></td>
<td class="num">(147)<span></span>
</td>
<td class="num">(166)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NetCurrentLiabilityAsset', window );">Net current (liability) asset</a></td>
<td class="num">(61)<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="num">(93)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NetNoncurrentAssetLiability', window );">Net long-term asset (liability)</a></td>
<td class="nump">214<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NetAssetLiability', window );">Total net asset (liability)</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=hum_CmsSubsidiesOrDiscountsMember', window );">CMS Subsidies/ Discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Trade accounts payable and accrued expenses</a></td>
<td class="num">(3,805)<span></span>
</td>
<td class="num">(1,236)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NetCurrentLiabilityAsset', window );">Net current (liability) asset</a></td>
<td class="num">(3,566)<span></span>
</td>
<td class="num">(540)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NetNoncurrentAssetLiability', window );">Net long-term asset (liability)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NetAssetLiability', window );">Total net asset (liability)</a></td>
<td class="num">$ (3,566)<span></span>
</td>
<td class="num">$ (540)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Asset (Liability)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NetCurrentLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net current (liability) asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NetCurrentLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NetNoncurrentAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Noncurrent Asset (Liability)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NetNoncurrentAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=hum_RiskCorridorSettlementsMedicarePartDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=hum_RiskCorridorSettlementsMedicarePartDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=hum_CmsSubsidiesOrDiscountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=hum_CmsSubsidiesOrDiscountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040914651808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Goodwill by Segments (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 9,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">9,320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hum_InsuranceSegmentMember', window );">Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">2,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">2,578<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hum_CenterWellSegmentMember', window );">CenterWell</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">6,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 6,742<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hum_InsuranceSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hum_InsuranceSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hum_CenterWellSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hum_CenterWellSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040920453872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Other Intangible Assets Subject to Amortization (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Other intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average life (in years)</a></td>
<td class="text">9 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Total other intangible assets, cost</a></td>
<td class="nump">$ 2,641<span></span>
</td>
<td class="nump">$ 2,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Amortizable intangible assets, accumulated amortization</a></td>
<td class="nump">887<span></span>
</td>
<td class="nump">883<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total other intangible assets, net</a></td>
<td class="nump">1,754<span></span>
</td>
<td class="nump">1,765<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=hum_CertificateOfNeedMember', window );">Certificates of need</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">1,132<span></span>
</td>
<td class="nump">1,132<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Medicare licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">$ 286<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer contracts/ relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Other intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average life (in years)</a></td>
<td class="text">9 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, cost</a></td>
<td class="nump">$ 932<span></span>
</td>
<td class="nump">929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Amortizable intangible assets, accumulated amortization</a></td>
<td class="nump">685<span></span>
</td>
<td class="nump">673<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortizable intangible assets, net</a></td>
<td class="nump">$ 247<span></span>
</td>
<td class="nump">256<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names and technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Other intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average life (in years)</a></td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, cost</a></td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Amortizable intangible assets, accumulated amortization</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortizable intangible assets, net</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Provider contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Other intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average life (in years)</a></td>
<td class="text">11 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, cost</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Amortizable intangible assets, accumulated amortization</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortizable intangible assets, net</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hum_NoncompetesAndOtherMember', window );">Noncompetes and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Other intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average life (in years)</a></td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, cost</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Amortizable intangible assets, accumulated amortization</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortizable intangible assets, net</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=hum_CertificateOfNeedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=hum_CertificateOfNeedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hum_NoncompetesAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hum_NoncompetesAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040913204880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040913081472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Amortization and Estimated Future Amortization Expense (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Estimated amortization remaining for the years ending December 31,</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">$ 27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040913744960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BENEFITS PAYABLE - Activity in Benefits Payable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Balances, beginning of period</a></td>
<td class="nump">$ 9,264<span></span>
</td>
<td class="nump">$ 8,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Incurred related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">22,380<span></span>
</td>
<td class="nump">19,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(522)<span></span>
</td>
<td class="num">(360)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred</a></td>
<td class="nump">21,858<span></span>
</td>
<td class="nump">19,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Paid related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="num">(14,203)<span></span>
</td>
<td class="num">(12,284)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="num">(6,901)<span></span>
</td>
<td class="num">(6,252)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total paid</a></td>
<td class="num">(21,104)<span></span>
</td>
<td class="num">(18,536)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Balances, end of period</a></td>
<td class="nump">10,018<span></span>
</td>
<td class="nump">$ 9,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount', window );">Total IBNR included in benefits payable</a></td>
<td class="nump">$ 6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.W)<br> -URI https://asc.fasb.org/extlink&amp;oid=27015833&amp;loc=d3e570705-122907<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040913076096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER COMMON SHARE COMPUTATION (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income available for common stockholders</a></td>
<td class="nump">$ 1,239<span></span>
</td>
<td class="nump">$ 930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average outstanding shares of common stock used to compute basic earnings per common share (in shares)</a></td>
<td class="nump">125,005<span></span>
</td>
<td class="nump">126,938<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted earnings per common share (in shares)</a></td>
<td class="nump">125,564<span></span>
</td>
<td class="nump">127,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 9.91<span></span>
</td>
<td class="nump">$ 7.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 9.87<span></span>
</td>
<td class="nump">$ 7.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Number of antidilutive stock options and restricted stock excluded from computation (in shares)</a></td>
<td class="nump">538<span></span>
</td>
<td class="nump">626<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of employee stock options and restricted stock (in shares)</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of employee stock options and restricted stock (in shares)</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">496<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040922419536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Dividends (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 27, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Amount per Share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.7900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount | $</a></td>
<td class="nump">$ 98<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040916022352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Apr. 25, 2023</div></th>
<th class="th"><div>Feb. 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94,000,000<span></span>
</td>
<td class="nump">$ 1,024,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares', window );">Common shares acquired in connection with employee stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000.00<span></span>
</td>
<td class="nump">60,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue', window );">Common shares acquired in connection with employee stock plans, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,000,000<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=hum_A2021ShareRepurchaseAuthorizationMember', window );">2021 Share Repurchase Authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=hum_A2023ShareRepurchaseAuthorizationMember', window );">2023 Share Repurchase Authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Stock repurchase average price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (in dollars per share)</a></td>
<td class="nump">$ 0.885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock that were repurchased in the administration of our employee share-based compensation plans. Under the terms of these plans, we accept shares of common stock from option holders if they elect to surrender previously-owned shares upon exercise of the option to cover the exercise price of the options or, in the case of restricted shares of common stock, the withholding of shares to satisfy tax withholding obligations associated with the vesting of such shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of common stock that were repurchased in the administration of our employee share-based compensation plans. Under the terms of these plans, we accept shares of common stock from option holders if they elect to surrender previously-owned shares upon exercise of the option to cover the exercise price of the options or, in the case of restricted shares of common stock, the withholding of shares to satisfy tax withholding obligations associated with the vesting of such shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=hum_A2021ShareRepurchaseAuthorizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=hum_A2021ShareRepurchaseAuthorizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=hum_A2023ShareRepurchaseAuthorizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=hum_A2023ShareRepurchaseAuthorizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040914623728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (percent)</a></td>
<td class="nump">22.50%<span></span>
</td>
<td class="nump">23.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040913905104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Debt Outstanding (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Total short-term debt</a></td>
<td class="nump">$ 1,867,000,000<span></span>
</td>
<td class="nump">$ 2,092,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">9,743,000,000<span></span>
</td>
<td class="nump">9,034,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_A570PercentSeniorNotesDueMarch2026Member', window );">$500 million, 5.700% due March 13, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">5.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 497,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_A588PercentSeniorNotesDueMarch2033Member', window );">$750 million, 5.880% due March 1, 2033</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">5.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 740,000,000<span></span>
</td>
<td class="nump">739,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_A550PercentSeniorNotesDueMarch2053Member', window );">$750 million, 5.500% due March 15, 2053</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 714,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Total senior notes</a></td>
<td class="nump">1,441,000,000<span></span>
</td>
<td class="nump">1,497,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">9,743,000,000<span></span>
</td>
<td class="nump">8,534,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $1.5&#160;billion, 0.650% due August 3, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">0.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Total senior notes</a></td>
<td class="nump">$ 1,441,000,000<span></span>
</td>
<td class="nump">1,497,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $600&#160;million, 3.850% due October 1, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 595,000,000<span></span>
</td>
<td class="nump">599,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $600&#160;million, 4.500% due April 1, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 597,000,000<span></span>
</td>
<td class="nump">597,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $500 million, 5.700% due March 13, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">5.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $750&#160;million, 1.350% due February 3, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">1.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 745,000,000<span></span>
</td>
<td class="nump">745,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $600&#160;million, 3.950% due March 15, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 597,000,000<span></span>
</td>
<td class="nump">597,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $500 million, 5.750% due March 1, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 494,000,000<span></span>
</td>
<td class="nump">494,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $750 million, 3.700% due March 23, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 743,000,000<span></span>
</td>
<td class="nump">743,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $500&#160;million, 3.125% due August 15, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 496,000,000<span></span>
</td>
<td class="nump">496,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $500&#160;million, 4.875% due April 1, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 496,000,000<span></span>
</td>
<td class="nump">495,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $750&#160;million, 2.150% due February 3, 2032</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">2.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 743,000,000<span></span>
</td>
<td class="nump">743,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $250&#160;million, 8.150% due June&#160;15, 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">8.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 261,000,000<span></span>
</td>
<td class="nump">261,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $400&#160;million, 4.625% due December&#160;1, 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 396,000,000<span></span>
</td>
<td class="nump">396,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $750&#160;million, 4.950% due October 1, 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">4.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 740,000,000<span></span>
</td>
<td class="nump">740,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $400&#160;million, 4.800% due March 15, 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 396,000,000<span></span>
</td>
<td class="nump">396,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $500 million, 3.950% due August 15, 2049</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 493,000,000<span></span>
</td>
<td class="nump">493,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes: | $750 million, 5.500% due March 15, 2053</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loan | Delayed draw term loan, due May 28, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">$ 426,000,000<span></span>
</td>
<td class="nump">$ 595,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A570PercentSeniorNotesDueMarch2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A570PercentSeniorNotesDueMarch2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A588PercentSeniorNotesDueMarch2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A588PercentSeniorNotesDueMarch2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A550PercentSeniorNotesDueMarch2053Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A550PercentSeniorNotesDueMarch2053Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A065PercentSeniorNotesDueAugust2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A065PercentSeniorNotesDueAugust2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A3.85PercentSeniorNotesDueOctober2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A3.85PercentSeniorNotesDueOctober2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A450PercentSeniorNotesDueApril2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A450PercentSeniorNotesDueApril2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A135PercentSeniorNotesDueFebruary2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A135PercentSeniorNotesDueFebruary2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A3.95PercentSeniorNotesDueMarch2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A3.95PercentSeniorNotesDueMarch2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A5750PercentSeniorNotesDueMarch2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A5750PercentSeniorNotesDueMarch2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A3700PercentSeniorNotesDueMarch2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A3700PercentSeniorNotesDueMarch2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A3125PercentSeniorNotesDueAugust2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A3125PercentSeniorNotesDueAugust2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A4875PercentSeniorNotesDueApril2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A4875PercentSeniorNotesDueApril2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A215PercentSeniorNotesDueFebruary2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A215PercentSeniorNotesDueFebruary2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A8.15PercentSeniorNotesDueJune2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A8.15PercentSeniorNotesDueJune2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A4.625PercentSeniorNotesDueDecember2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A4.625PercentSeniorNotesDueDecember2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A4.95PercentSeniorNotesDueOctober2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A4.95PercentSeniorNotesDueOctober2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A4.80PercentSeniorNotesDueMarch2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A4.80PercentSeniorNotesDueMarch2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A395PercentSeniorNotesDueAugust2049Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A395PercentSeniorNotesDueAugust2049Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_DelayedDrawTermLoanMay2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_DelayedDrawTermLoanMay2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040912766320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Senior Notes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of senior notes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,215,000,000<span></span>
</td>
<td class="nump">$ 744,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt instrument, repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member', window );">5.70 Percent Senior Notes Due March 2026 and 5.50 Percent Senior Notes Due March 2053 | Senior notes:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of senior notes, net</a></td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_A570PercentSeniorNotesDueMarch2026Member', window );">$500 million, 5.700% due March 13, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_A570PercentSeniorNotesDueMarch2026Member', window );">$500 million, 5.700% due March 13, 2026 | Senior notes:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_A550PercentSeniorNotesDueMarch2053Member', window );">$750 million, 5.500% due March 15, 2053</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_A550PercentSeniorNotesDueMarch2053Member', window );">$750 million, 5.500% due March 15, 2053 | Senior notes:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_A065PercentSeniorNotesDueAugust2023Member', window );">$1.5&#160;billion, 0.650% due August 3, 2023 | Senior notes:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_A3.85PercentSeniorNotesDueOctober2024Member', window );">$600&#160;million, 3.850% due October 1, 2024 | Senior notes:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_DelayedDrawTermLoanMember', window );">Delayed Draw Term Loan | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A570PercentSeniorNotesDueMarch2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A570PercentSeniorNotesDueMarch2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A550PercentSeniorNotesDueMarch2053Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A550PercentSeniorNotesDueMarch2053Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A065PercentSeniorNotesDueAugust2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A065PercentSeniorNotesDueAugust2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A3.85PercentSeniorNotesDueOctober2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A3.85PercentSeniorNotesDueOctober2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_DelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_DelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040914154016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Revolving Credit Agreements (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual', window );">Actual debt to capitalization percentage</a></td>
<td class="nump">41.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum', window );">Debt to capitalization percentage, maximum</a></td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Outstanding borrowings</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_LineOfCreditFacilityUncommittedIncrementalCapacity', window );">Uncommitted incremental loan facility</a></td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | 5-year unsecured revolving credit agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining borrowing capacity</a></td>
<td class="nump">$ 2,400,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | 364-day unsecured revolving credit agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining borrowing capacity</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term (in years)</a></td>
<td class="text">364 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Outstanding borrowings</a></td>
<td class="nump">$ 39,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Debt To Capitalization Percentage, Actual</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Debt To Capitalization Percentage, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_LineOfCreditFacilityUncommittedIncrementalCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Uncommitted Incremental Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_LineOfCreditFacilityUncommittedIncrementalCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_RevolvingCreditAgreementJune2021FiveYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_RevolvingCreditAgreementJune2021FiveYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_RevolvingCreditAgreementJune2021OneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_RevolvingCreditAgreementJune2021OneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040915962640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Commercial Paper and Other Short-term Borrowings (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod', window );">Maximum amount outstanding during period</a></td>
<td class="nump">$ 626,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt outstanding</a></td>
<td class="nump">$ 426,000,000<span></span>
</td>
<td class="nump">$ 595,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtWeightedAverageInterestRate', window );">Weighted average annual interest rate (percent)</a></td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember', window );">FHLB borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of short-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the form of debt having an initial term of less than one year or less than the normal operating cycle, if longer, the maximum amount borrowed at any time during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040914929856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS, GUARANTEES AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>state </div>
<div>option_period </div>
<div>beneficiary</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>beneficiary </div>
<div>state</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_TRICAREContractAxis=hum_TRICARE2017EastRegionContractMember', window );">T2017 East Region</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NumberOfStatesComprisingTRICAREBeneficiaries', window );">Number of states comprising TRICARE beneficiaries | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NumberOfTRICAREBeneficiaries', window );">Number of TRICARE beneficiaries | beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_TRICAREContractAxis=hum_TRICAREManagedCareSupportContractEffective2024Member', window );">T-5, Effective 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries', window );">Number of TRICARE managed care support contract beneficiaries | beneficiary</a></td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries', window );">Number of states comprising of TRICARE managed care support contract beneficiaries | state</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_TRICAREManagedCareSupportContractBaseTerm', window );">Contract base term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods', window );">Annual option periods | option_period</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_TRICAREManagedCareSupportContractTermWithOptionExercises', window );">Contract term with exercises</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_MedicareMember', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_PercentageOfTotalPremiumAndServicesRevenues', window );">Percentage of premiums and services revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_MedicaidMember', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_PercentageOfTotalPremiumAndServicesRevenues', window );">Percentage of premiums and services revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_MilitaryServiceMember', window );">Military services | T2017 East Region</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_PercentageOfTotalPremiumAndServicesRevenues', window );">Percentage of premiums and services revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of States Comprising Of TRICARE Managed Care Support Contract Beneficiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NumberOfStatesComprisingTRICAREBeneficiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of States Comprising TRICARE Beneficiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NumberOfStatesComprisingTRICAREBeneficiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NumberOfTRICAREBeneficiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of TRICARE Beneficiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NumberOfTRICAREBeneficiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of TRICARE Managed Care Support Contract Beneficiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_PercentageOfTotalPremiumAndServicesRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Total Premium And Services Revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_PercentageOfTotalPremiumAndServicesRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_TRICAREManagedCareSupportContractBaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>TRICARE Managed Care Support Contract, Base Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_TRICAREManagedCareSupportContractBaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>TRICARE Managed Care Support Contract, Number Of Option Periods</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_TRICAREManagedCareSupportContractTermWithOptionExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>TRICARE Managed Care Support Contract, Term With Option Exercises</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_TRICAREManagedCareSupportContractTermWithOptionExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_TRICAREContractAxis=hum_TRICARE2017EastRegionContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_TRICAREContractAxis=hum_TRICARE2017EastRegionContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_TRICAREContractAxis=hum_TRICAREManagedCareSupportContractEffective2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_TRICAREContractAxis=hum_TRICAREManagedCareSupportContractEffective2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MilitaryServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MilitaryServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040922753424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_GovernmentAndHealthPlanMemberSubsidiesAmount', window );">Member co-share amounts and government subsidies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense', window );">Depreciation and amortization classified as benefit expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation and amortization expense that has been reclassified to be included with benefit expenses. The reclassification is the result of depreciation and amortization expense associated primarily from the delivery of pharmacy services by our wholly-owned pharmacy business included in our Healthcare Services segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DepreciationAndAmortizationClassifiedAsBenefitExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_GovernmentAndHealthPlanMemberSubsidiesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of member co-share amounts and government subsidies that are excluded from benefits expense because the health plans do not bear responsibility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_GovernmentAndHealthPlanMemberSubsidiesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140040909913104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Segment Results (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 25,550<span></span>
</td>
<td class="nump">$ 22,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">999<span></span>
</td>
<td class="nump">1,264<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">26,742<span></span>
</td>
<td class="nump">23,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Investment income (loss)</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefits</a></td>
<td class="nump">21,858<span></span>
</td>
<td class="nump">19,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">2,979<span></span>
</td>
<td class="nump">2,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DepreciationAndAmortizationIncomeStatement', window );">Depreciation and amortization</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">25,023<span></span>
</td>
<td class="nump">22,681<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">1,719<span></span>
</td>
<td class="nump">1,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net losses</a></td>
<td class="nump">1,614<span></span>
</td>
<td class="nump">1,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net losses</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Segment earnings (loss)</a></td>
<td class="nump">1,597<span></span>
</td>
<td class="nump">1,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest', window );">Net loss (income) attributable to noncontrolling interests</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent', window );">Segment earnings (loss) attributable to Humana</a></td>
<td class="nump">1,598<span></span>
</td>
<td class="nump">1,216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hum_InsuranceSegmentMember', window );">Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">25,903<span></span>
</td>
<td class="nump">22,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Investment income (loss)</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">24,576<span></span>
</td>
<td class="nump">21,971<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hum_CenterWellSegmentMember', window );">CenterWell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">4,505<span></span>
</td>
<td class="nump">4,365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">4,175<span></span>
</td>
<td class="nump">3,995<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">25,550<span></span>
</td>
<td class="nump">22,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">999<span></span>
</td>
<td class="nump">1,264<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">26,549<span></span>
</td>
<td class="nump">23,967<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Individual Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">19,809<span></span>
</td>
<td class="nump">17,052<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Group Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">1,765<span></span>
</td>
<td class="nump">1,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Medicare stand-alone PDP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">616<span></span>
</td>
<td class="nump">639<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Total Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">22,190<span></span>
</td>
<td class="nump">19,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Commercial fully-insured</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">1,018<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Specialty benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Medicare Supplement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Medicaid and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">1,909<span></span>
</td>
<td class="nump">1,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Home solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">314<span></span>
</td>
<td class="nump">726<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Provider services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Commercial ASO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Military and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Pharmacy solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">242<span></span>
</td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">25,550<span></span>
</td>
<td class="nump">22,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">242<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">25,792<span></span>
</td>
<td class="nump">22,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefits</a></td>
<td class="nump">21,993<span></span>
</td>
<td class="nump">19,734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">2,418<span></span>
</td>
<td class="nump">2,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DepreciationAndAmortizationIncomeStatement', window );">Depreciation and amortization</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">1,327<span></span>
</td>
<td class="nump">996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net losses</a></td>
<td class="nump">1,327<span></span>
</td>
<td class="nump">996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Segment earnings (loss)</a></td>
<td class="nump">1,324<span></span>
</td>
<td class="nump">996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest', window );">Net loss (income) attributable to noncontrolling interests</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent', window );">Segment earnings (loss) attributable to Humana</a></td>
<td class="nump">1,325<span></span>
</td>
<td class="nump">996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance | Individual Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">19,809<span></span>
</td>
<td class="nump">17,052<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance | Group Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">1,765<span></span>
</td>
<td class="nump">1,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance | Medicare stand-alone PDP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">616<span></span>
</td>
<td class="nump">639<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance | Total Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">22,190<span></span>
</td>
<td class="nump">19,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance | Commercial fully-insured</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">1,018<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance | Specialty benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance | Medicare Supplement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance | Medicaid and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">1,909<span></span>
</td>
<td class="nump">1,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance | Home solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance | Provider services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance | Commercial ASO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance | Military and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Insurance | Pharmacy solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">757<span></span>
</td>
<td class="nump">1,060<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">757<span></span>
</td>
<td class="nump">1,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">4,126<span></span>
</td>
<td class="nump">3,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DepreciationAndAmortizationIncomeStatement', window );">Depreciation and amortization</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">330<span></span>
</td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net losses</a></td>
<td class="nump">330<span></span>
</td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net losses</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Segment earnings (loss)</a></td>
<td class="nump">316<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest', window );">Net loss (income) attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent', window );">Segment earnings (loss) attributable to Humana</a></td>
<td class="nump">316<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell | Individual Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell | Group Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell | Medicare stand-alone PDP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell | Total Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell | Commercial fully-insured</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell | Specialty benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell | Medicare Supplement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell | Medicaid and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell | Home solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">314<span></span>
</td>
<td class="nump">726<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell | Provider services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell | Commercial ASO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell | Military and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | CenterWell | Pharmacy solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue:</a></td>
<td class="nump">242<span></span>
</td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(3,666)<span></span>
</td>
<td class="num">(3,362)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Investment income (loss)</a></td>
<td class="nump">96<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefits</a></td>
<td class="num">(135)<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="num">(3,565)<span></span>
</td>
<td class="num">(3,149)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DepreciationAndAmortizationIncomeStatement', window );">Depreciation and amortization</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Total operating expenses</a></td>
<td class="num">(3,728)<span></span>
</td>
<td class="num">(3,285)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">62<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net losses</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(146)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Segment earnings (loss)</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(146)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest', window );">Net loss (income) attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent', window );">Segment earnings (loss) attributable to Humana</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(146)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate | Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate | Insurance | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate | Insurance | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate | CenterWell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">3,748<span></span>
</td>
<td class="nump">3,303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate | CenterWell | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,133<span></span>
</td>
<td class="nump">857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate | CenterWell | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,615<span></span>
</td>
<td class="nump">2,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(3,762)<span></span>
</td>
<td class="num">(3,317)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(1,147)<span></span>
</td>
<td class="num">(871)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">$ (2,615)<span></span>
</td>
<td class="num">$ (2,446)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DepreciationAndAmortizationIncomeStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation and amortization expense excluding depreciation and amortization primarily from the delivery of pharmacy services by our wholly-owned pharmacy business (included in our Healthcare Services segment) which has been reclassified to benefit expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DepreciationAndAmortizationIncomeStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) From Continuing Operations Before Income Taxes, Attributable To Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) From Continuing Operations Before Income Taxes, Attributable To Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BenefitsLossesAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5,6,7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BenefitsLossesAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hum_InsuranceSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hum_InsuranceSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hum_CenterWellSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hum_CenterWellSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MedicareAdvantageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MedicareAdvantageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_GroupMedicareAdvantageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_GroupMedicareAdvantageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MedicareStandAlonePrescriptionDrugPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MedicareStandAlonePrescriptionDrugPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_CommercialFullyInsuredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_CommercialFullyInsuredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_SpecialtyBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_SpecialtyBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MedicareSupplementProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MedicareSupplementProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MedicaidAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MedicaidAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_HomeSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_HomeSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_ProviderServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_ProviderServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_CommercialASOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_CommercialASOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MilitaryAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MilitaryAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_PharmacySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_PharmacySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>hum-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:hum="http://www.humana.com/20230331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hum-20230331.xsd" xlink:type="simple"/>
    <context id="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib0b3e6cb82b043229c6de3f534953330_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i192cbe1b72e34457bc41adff9b0e5179_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i67be62ec4a604c6baeeae7c8acfa32da_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie80b91c2c2c84ebb871c1ba1a0f82413_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2f0bb767b8b44c9bb4b925e7d6846b4c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib43b2bdef5554a95a305773800d5f4f6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0c80fc54c1ed425abb2f454166ba8b76_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieef509857c8e4467a2fc109e0bf10f4b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie764c2fbaa0e46349d4f04c484a4ae01_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaee9f0e494b544da926fe616f385aac5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7b281d1bbb96464f86dd82da174e2334_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie0d2f28ca1ea4a64ae9ed5eee0ba5068_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie8a695ef6e9d487ab733b856a3f72501_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iff79ee49692740f8b35cbc8e80b347a0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id4750367ee1e4a689f97fa9022bdf5e4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i33bde0043da6450e8ef28277a10de49e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id38d4d0509824793b1c7ea2b970a5957_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie443272811ed49d6a8d422744f898488_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i00969cc0983a4871891aca903e70709b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibb4314807c944d55b84b257f3f3dc4cc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i608d6a1b874146d8b2906b872c802885_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id52b99f262dd4f5fbc64485fdc490c62_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i070b3a983b8d4c1c9d6d883ff6c49107_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0fb1c5dba70e4995a50495bdf4c7e1d3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd32fea20e5e4fba97023cd2a12758d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8a2924212fff4b95a06c6336134700a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide04b81f591a460480759551ea2d4c60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1f1a85fe48643ddad4b2657effc5ddc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if66f7e3bde694a2fa6f2b9ad88e258ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i69b771e99aeb411385b87bc78aba0005_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iefba7d8c1a25422f8083be1c96fbf1fd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id26120571436434494bfb975fa78d99e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ice488527531041f1bea3aaf535bacb76_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0da5c588273f46f9b2f1a42b9dd81da4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i342c27c8ea80488ba306fb99128b5cf4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5f2a8ed54eca45fba1b5a8a2a7875edb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i623ed6554dfa4892b099de29261154be_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3d833c58d6684d1fbe8a6b639c1c2914_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9be79b2b55e54535aff3cbec252b67f5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia1bd06ce061245718d7a679efdb9836b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i55a5772c9e08479ba75577876ccf8013_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2449d3dd94054171a333473a8b30e8d9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iffa2d44aeefe49eb901d869a778d954f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i86b101ff14884b76ba0a3e3909ff5915_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hum:ValueCreationInitiativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iba36eec577cb4c97b3c20a998f977679_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hum:ValueCreationInitiativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifa05aa9eea8340d1a4b6993427e169a6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6dfc221ac14a4241a352cd2c7e2133be_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iec2ff4cf5f8a4840a5cfda8104745276_I20220811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:GentivaHospiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-11</instant>
        </period>
    </context>
    <context id="i1f3a5a6a5bd240fd8dc9dddaaf415109_D20220811-20220811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:TermLoanDueOctober2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:GentivaHospiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-11</startDate>
            <endDate>2022-08-11</endDate>
        </period>
    </context>
    <context id="i774b70cfc8b949b4b88dc4f2aefa89c5_D20220811-20220811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:GentivaHospiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-11</startDate>
            <endDate>2022-08-11</endDate>
        </period>
    </context>
    <context id="i7411361d05ab46818cbd5d7ff1e21d74_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:GentivaHospiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i47c85cc668754e14a243b50fa57763f4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id0051509dd034287a67b025711d2b730_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i15abec1371de4cf7bf934abdac554c41_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie2aab95a3fa1453f9e1ad63604416346_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib51726213f4349ada57bbe678b9ecbe9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i54bb3ec275a04853bd67cc69eda788a6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i81fc15fb6f8747a3b130af075be61c68_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i390f059dfaec48feb01a156d8783fc91_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i890ddd7992a2436fb3eeb7c9589676f4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i87f38b14697145628ecc307a28156bc7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i39a81466c1f7403098573c8663478092_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i996180d89c8e4507a623f2af94aa1a1b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i29186f806c58412193bb9d3fb6965e02_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if809f4ba53f94156aaf6671a93356b6a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:GentivaHospiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8260b100247b44eea92f3356e1b28db7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsAARatingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i96e6af2307314f46be9d1d0b03502013_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibc24f5c05d5441b6ac8827d88f991c2e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if1a5f1cccae8416f9bc599fff3f8e1d4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9b13e4a05827464d8b24ae1ead744fbd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if65bf87d9361462aaf0a0ac5f9556c38_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9a47acf1908a40b2af4d3cd0d68e3910_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4d921a49fc8e435386aef2bf71f59872_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia6bbb7d6ca004e8a908a13b5eed703ec_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id68f6d863b0042c2b99dadf26d204628_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if14d9ee3acf541a8a80edb1dae2c5c51_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i450207aa5894438f9c2c646c0ce9982d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i857c0bd469ed4f57a4d62245b9c850ad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i82a7da6de90f4292a75b4ff142ac0839_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i904a6646c1c74766ad237ced5460d3b7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i81015bdf666841988a8d3083b77b955b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifb95cb15ca9b431f83fabb95130459cb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia8862232402c4d6eaf52edf65048202e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i72d189fde50f4d818a6f390bc4fc11a1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7b4080af65ca47cfb1edb387d17a5d36_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic00c16389c034f59895277e520697c6f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie692d3daf2da432f84a4d2bba4f54421_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i37b5903d02c84da3b134cc8b5828e4e6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id2d2e19b91464e48b9c851e183850d14_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib1ff90bae9d54e1e973a6a3fee17c018_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i72ea4b788a8f48c185d7fda9b12db75c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1d6e7427cc38408f801653d6fe0309ba_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib81031dfb7aa4eef857cf826a330605d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifbc4c8c594954395822ec239de2a59f9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idc8d3332e21f4115ad4811a1901d881a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i340393b9ebe54ab2b5864af5e584548c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i10a5e9db863849bcad9826c573d3ad01_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9fbc3e66d57845169e1aff68c77b3197_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i92ee919d2f184cf7949d0916d4f1ccb1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f44fd8b7d7943429ac546aea13d21f6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0f045e713b3f4183a844967854a098d2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id0a9a1917c8f47a5836ac770133b8421_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i70628c781dab4482bf2a82089e58407c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i60e56a4abb3148b3a47ea17e821ce331_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb9d324ecf5045808b96815c38a7eaaf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9a9a3430ebaf429886fbd03e394bb465_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifa02a4a665234d36b7de271c9e9e73b4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b2bd12e6e20458f8f4892b3040ac67e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6dddf02ed2304674986163307e834a6c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if3c66b776082466ea556dce65306d942_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0ec9bf427d0d47a3b08bf8a294f9efd9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4a211d5ff9bb4a4589e60af4080172f9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i060d5600c50d4d6093631349614ca333_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic732fa8df9034ee0a649c2601e5b6cff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9037b2b16c75430caac0e82c3c767c2e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifc036307c91f4c9593abeaff015430b2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic82ffec88c8042de8e8a1dbf644279a5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i73062b9f6c3946998028a6772ce9264f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i37d0240334144c13b97f059cadb7034b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icd5d6eb79ea5478c9f1ec177266b62cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6858edb4103a4d41ae1249f6acf86c38_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i779b10a8a0554fe5a72d0d42c1badb15_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idd635cbfddf44141945808c29cbc55eb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia39754b4e45940db8cb97fe1ff3d7880_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5c84525d35214f6c9815e8351adfd02a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i39fc8e1461704c80aef7a77108d678a7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2e057100f4124140bac2dcc36e38be91_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i03be5b990dcd41ed91f338937639131a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i581027d290ae46cfa11f5ee26717a967_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib330972c763d4fdfab8db010a1908b51_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2516335975c48cf807e97640b5043bf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">hum:FairValueRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iba4807ab291b411ba709086ff2b0ca6b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic4b60d2223724b5b852a7861a92b748d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64b0b2cce9c4429eb7e08589df09657a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib2298c1aedcf4c389d4500f8dfca5cd7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id7dfa681e84e4a328abd29adc43edeb8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">hum:TermLoanAndCommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iffacfea7d72c41969e8c61520fc3f3fe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">hum:TermLoanAndCommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8aecae41941c4949a148814d02c27b4c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6c4cd7500ddd4042987e2f54456204e8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9241eb7b1705466a9f42cbc6c027a7e3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia9c5e672fb5646a5b6ef97e6cd7e5fe2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib841b2af88bc479392f83bdf0da74d8a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i86e34249f19741d8bfc9dfb0d72a9a0a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i213d04e139894278bd43204227e8da44_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i52c5649fd533485aa955d121bd05719e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i57134d84c2ac447a84c8200c372a35f8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8a0d174b8c8d4fe0ba5550e6b43544fa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idee655553fa24a6bbe52a7b3d4ca04ad_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i20d1e957c4434a06af24cf6ac0397e7f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2f0f9995f95947629017ed8fed503fa1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i61634fa707254b90a8db03c0fa13102a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic46ba81be64948dfb5b93511ef5de0cb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i580fb323c37c4b618f287b4d6dfa7f5a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i000d5227848d42249813688992aac2b1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i377cc2a8446b4761b2676862a02afc19_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i93acdee7a8de48d2ad5e50b6216e5223_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6060040f6de2440d9e22ed16c9c48f07_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i32ddf5d36d5045038d50eaf21c6818b2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8f173f5f0d7a4516ad1a0ff666bedec2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i17047b60198b4741bd5ebeea3412295e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">hum:RiskCorridorSettlementsMedicarePartDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i62763ccb5eac4f28974a0b1010e8a360_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">hum:CmsSubsidiesOrDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i22ea645d881244feb48020446f2c6961_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">hum:RiskCorridorSettlementsMedicarePartDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1755902072d64e9cb2f6181073517a64_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">hum:CmsSubsidiesOrDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2ccf77cbd704aa9a50f730c09b643b5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i93e22a22917143fb9f847c7288ff5d00_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic69f76c986f34f1b9ba9eb7a9c317d65_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i83bf3dc5af6c4f2eb6caaad2ac9f84b8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i602a0549ee5e4de58fd4f6d95c040179_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i54bd717275cd4a1ba7a908f4c92495ab_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idd572f2390164976be20fe3a140197cd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">hum:CertificateOfNeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7d23511b94f84defb1f54af0330dc9e3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">hum:CertificateOfNeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3178f9117bab4d4788c41331f0e1dc09_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic0802607a67b4c848b58734b6b762529_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i150ea53c09e74fcb851b6053b9e40298_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8054b45e04e441f6b73aeb7346969a3c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3f7aaf3b0b0d4b86bbe081d04e1b0c0e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2d0ef9aa2df04dada2b6de53639369a3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i48b4610f5eff4676ae8a83d142ee62a3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i58b795c8e2a749b195affd66d768c0f8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i209ef83489cc4686aca29a75e66a999e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i355b7a91cbe642259e6c7b0a6b9415a5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i586b2df071664278b33320a690171b5a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7208e156cf594c919494eb2550d73a05_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:NoncompetesAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1186c96f23294e26be46ab0face47239_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:NoncompetesAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i88f55df1f8fe486285179afd07008365_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:NoncompetesAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a2c0126f2424bb8ab0ee87fe08cb666_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0e434f71448049a284869f73abeb0b98_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i930b18f4afe34fec9820ff5a19092628_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7542e08ec319422a9b4c757d3a9accd0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0b9ac383e9ea4b719311556136d97415_D20230127-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2023-01-27</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i855926020dce4bea9a6964c5647f3657_D20230201-20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="i22b1e29a3e1c4bc98acae1e9ce50b759_D20230401-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="iab7b66d9b316428980dce49fe22290b3_I20230215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:A2021ShareRepurchaseAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-15</instant>
        </period>
    </context>
    <context id="i1c95ac6806e14b6bbfa8a1f730d7bb0b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:A2023ShareRepurchaseAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2b88da85e02742d1b115a353bcae6004_I20230425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-25</instant>
        </period>
    </context>
    <context id="ie5378147acd6413d98ab4a87badd98a5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i66bc861b6d684110a1c01760cf75a9d9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia745190caecb4ad18029594fbd44dad9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A065PercentSeniorNotesDueAugust2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia91bce3ad2614069b112478f13ea4bbd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A065PercentSeniorNotesDueAugust2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0baef8994ca946c49745a0878f83ccea_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i86bac7559acf4a0a8e9e4af23f7cc8ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3a64f9f747cc4b969bd58c5a210d96b8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.85PercentSeniorNotesDueOctober2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie8ee81e69e7d4f708f12b170210cf50e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.85PercentSeniorNotesDueOctober2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia2dbfa0791a746e891144da65c98163c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A450PercentSeniorNotesDueApril2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i601f7293934844dd8581d285010fe8a3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A450PercentSeniorNotesDueApril2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2f93bb52470a423f83007bbe6311ef88_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A570PercentSeniorNotesDueMarch2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i769a17d71bce4bc9ad29794468e1d407_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A570PercentSeniorNotesDueMarch2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f1e6a5d467542119ee41abdb08e8bfe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A135PercentSeniorNotesDueFebruary2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ice043f0edb0b45ebb9871681a935057d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A135PercentSeniorNotesDueFebruary2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if56c1215e57f42b58ee613738b0f54df_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.95PercentSeniorNotesDueMarch2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9826367b47364f6383b302d5941fb1b3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.95PercentSeniorNotesDueMarch2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idc6dc428ebc14290b36d57fb1719bf13_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A5750PercentSeniorNotesDueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i352c829a0e07400faa05ac2176bc9839_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A5750PercentSeniorNotesDueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i26e5ceadc3fd4816b11932771a952db5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3700PercentSeniorNotesDueMarch2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia978a4df05104b8d9e0c86ae761b25a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3700PercentSeniorNotesDueMarch2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icf8ec40657e04aa2b23060d00732bdef_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3125PercentSeniorNotesDueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib78aa39252ea44aea1a09bb8f388149d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3125PercentSeniorNotesDueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i14cc50d065954e1287d2acb52e3f4d75_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4875PercentSeniorNotesDueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifbbf8eeed67d47678e97ce557e665c35_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4875PercentSeniorNotesDueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaf517366f109416a81eaf87157f208a6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A215PercentSeniorNotesDueFebruary2032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i091bf184716543a691cccbef4e0a6911_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A215PercentSeniorNotesDueFebruary2032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1987ecea13f144a6b016db1433b4edad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A588PercentSeniorNotesDueMarch2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4828bda4e27e4c81a26419b5e9fcf71d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A588PercentSeniorNotesDueMarch2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7c2bb3882bf541f0b41f0a999f57989e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A8.15PercentSeniorNotesDueJune2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iecb222c03b6b4488b13789f1508b415c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A8.15PercentSeniorNotesDueJune2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic9d6ead9d85d451e8b8a7651924f9bc1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.625PercentSeniorNotesDueDecember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i11064c69b1ae4ba6a3588922076a07a4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.625PercentSeniorNotesDueDecember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7717d896545c4a218cf32e09098785e2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.95PercentSeniorNotesDueOctober2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id7032ea7ab0740d38bc437206fc5d938_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.95PercentSeniorNotesDueOctober2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifd3cf22ac75d404380d62b35ce279abb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.80PercentSeniorNotesDueMarch2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i287c4ed0af71453dbafbd6c72bda52cd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.80PercentSeniorNotesDueMarch2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i15cd5b523c8b45408ca5a4cfbcaadc77_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A395PercentSeniorNotesDueAugust2049Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie58ccd3ad9cf4484869350e55c97daa9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A395PercentSeniorNotesDueAugust2049Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i81618d62a5464513a79e9149e2a960be_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A550PercentSeniorNotesDueMarch2053Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i44f39416bf6d42a18eb86f26dba70f57_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A550PercentSeniorNotesDueMarch2053Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i14a912e506d74aabb1927dc325a1b647_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9d06da66baf1438495bd1819635d56fc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia699014a8a7c45b4877ccab91d786647_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i80317ae1ece041a3be5e392acc5b7f32_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c6800fd78e7409d9fc9e4e3e89146b1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A570PercentSeniorNotesDueMarch2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5e6bb461948f467880d14a15c5c56cc4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A550PercentSeniorNotesDueMarch2053Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6722660df9ae426fba8939630f33aba2_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4600a55e099c4531bc7d43ae4f7b2b61_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if6ef86f63d5c4341b776612f407688ab_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if954b4dd458243c192b80a70934aab3b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i277382cd831d44e68146d96819af483f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idfe7731c31ef4c5d8ace727574933dbc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i16a8b22589364b0cabcaeebe88c025fd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iac8c9ca5d8d047529559c7212dd98d0a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1cfe16f46375489ab53b2a64c31248d4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic709c99d9e6e4394aec61e0022ddc186_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id20841ace72748718a4437b57f98c65a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icb617ce6644248ea8db1728a74bbbf53_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4480f878da3046eca330bf17a448e268_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hum:TRICAREContractAxis">hum:TRICARE2017EastRegionContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2ff845a818d94f94ab5d91f1b9bd6c7e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hum:TRICAREContractAxis">hum:TRICARE2017EastRegionContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0bc5a60bb99048cbad4400d49e4dcfe7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hum:TRICAREContractAxis">hum:TRICARE2017EastRegionContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie7875175150c464986253f694017f369_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hum:TRICAREContractAxis">hum:TRICAREManagedCareSupportContractEffective2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i78f2374ea9724509bf4c2fb579684e3f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hum:TRICAREContractAxis">hum:TRICAREManagedCareSupportContractEffective2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05af7d59e35843539a7b53e907c4cb75_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7aa8e3070afb4b448db7275ed5cf09ca_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if4319d9cb6494f90a71ae9662c3e17d5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i470b8c2f91574be1a05a696adddc73d9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i941da18a02fd4a139b8237908e1baf76_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i30d50dfae3c94d26a91ba9941b08ff7f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i81af849246674d489655377c62775fed_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i66882a36b65243afb23812e2ec2c1d48_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i41ce6672cc904de4a0fa8074bf62a0c4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia631787e98fd47d59231450f5a5d6e0c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i993a679845f947fab947d46e0ae0bc4a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0c8a4218c34d47a989b327c872bb0ba7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i05c27701e7bf4a9eb3938c2a39eb4494_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i85424f2642a04af48e0d21aa6e0a0e12_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialFullyInsuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i06996810dd5b475591115e20ef9e8d24_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialFullyInsuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia1aed85758234038bfaf99ea4aaa00a2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialFullyInsuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icfaab4185db447efbc4d239013c8fa8a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8a0dbdb752344a29bf7a8dc0c0719182_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib49f1498622e4c778b5d7aa7fc4c3199_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib9ac0ab1a1dc41678e04eee0f1f1ad54_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib4b77a33b1934d86a91aee24b2970f4d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie9c99fa97fdd46efa402ed8333894c1f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i96917ef2e24c4974a71ff8d5a0ea7000_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i22a98e5c970f455fa835963d955ebff1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i30b27af532384e309d0f76b56db9d08a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i902976e0e687455ea7079d0816405649_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6382c523c2c14c259a92f891ff8641e2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4bb29b1e903c42e8b12951e278dbb473_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i047ea355a1614e12b9cde7bc63efd653_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie6268a711de84001a5c09e366d9a3963_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic03ae8d1abd346bfa0535b979b06277d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7b40b350a7fb4e1d870155ce20f7d278_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i43a33ad615e44970a83fb6e045c08ff2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3dcae53256ef467fa83afa413e3c23fc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialASOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3bd5912c45d1492f813493782cbdbc80_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialASOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4acc50637daf4886ae4c4f6c103cb12c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialASOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic7da82ae3b48451ab567fe66a54b3194_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i94f607e57a414dbd88161908a6184c14_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i36acb1a7c1d345b3943ed7a3681da4d7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6cc60e9c797f4763ae37557308571d2b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacySolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4e3ed6555fe4401e81ef3b5e8e4a7609_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacySolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idfea55c447bc431e88f5dd8ccd9676b6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i809bb5ba4494400f9c6448d500364985_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4e8cff38f04f46889b1ef765ac327305_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5f7364cde4984551936b23d0ec98a423_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i83c34f3a227048a392485f67a2c322db_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i305512b6bb2e4e2e9206830a3cba8e75_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2682fa4c07b74a9c8032dd2cfde6c7b5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i924faf8bcd494d4faa31ef8543a91f5d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4e2db9b6b2644ba4bfd40bfe1aec493e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i918c5fb606154cbba2f8731c331034bd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i45e864ff071540b9b07efec659513ce6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3aa3a9ceced248e495a3ebf2f980dced_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id2b6b9a177e640c9b1223decda0a16fb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6e2b6793244a439ca56ce9a5219dc82d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib02c4523f3fe4bc4867f91bdf4482fc4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0b8563afa71d4ffebd8b2d1bf8f9abc9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibf26032dd8144e439cadbdd99e543c72_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i665f623ad1564c0f801b7a6398439b3f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9e6586aa7b7c4bfeb6055f8260cb2050_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibaeba68a15074c20a7a47147aa79fb77_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic0c10c27bb084521b8749197d596563b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i78789613dafe4a62a86c3ef058061f4c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i05630ac13ae84efdb04206d248841934_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifc8d8e3c20604d8987b4b3655c1d1355_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialFullyInsuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic3d1b9e97d684afc9b309b5a8dc2e4d6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialFullyInsuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if043a642b7914944bf349068b08d7044_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialFullyInsuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7a01bf5c57d243ffb4876ff5019fcd4e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6079fbef93f6490d97c24453e1658164_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie50e4586d40f4d86b9ebbc2912804444_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i065f8703eb4643deb20037003c705c1b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i00a4268e2aca40b19aab2ba00cb0f314_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia0f2b22146644209b8afa3fee32230c6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibb2fc93318814cb9b70dd7040ef479f3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7cd9580b0c9c484ea82d73c64b502501_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8e3541bbcdc747cbbd38489ad83936dc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8dcfae0532054fd79308e5a557cced34_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idb9f8bafe49f47b49a45569e1bcb1998_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3d60c49195f64463b8e21dd65e9c6e65_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibd6bb8d1d674435d811376f081f0a3dd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idc893a7474a44474861813dd6d84ae6e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i949a7d5c28cd498e91c058a16f06bbe6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i851a87a7f05942cdbf990ae5cd30af78_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic07c1d16537a42429449e7882849141c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialASOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i66f6101ae0774289b5b8751a4634d40e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialASOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1b2d48e3ac324ec08b2ca88ab3f53e55_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:CommercialASOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i335400f88d18407a92f768050cebbf44_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7edb8e82518e4dc5b3fb898234ab15cb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idf6ff2b013bb4cff8f0653d9c2b0488d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id7fbf5c1d49c42e5bed343c27eeb8965_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacySolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd793a27f90f404091d71353a03a9ae4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacySolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if2e0f4edd2b64c2e85362a841a3aa4c4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i91de43b8e733413cacc845a70df17963_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i717dfb30995240bb96ad4c44b5acfbad_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i027d84a6dd0d47719c06eedaeaa90374_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if2020e045c5147f5a45fe1de02a9f902_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i746462efde464666b16b26676cbe2082_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibf76fe4fdae4409e884a7ac6c029af9b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i97353868e33140a2b65bce298de17656_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i536c52251be647d6987d688d1febcad5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8b05f4d2446843fa8e4a6429ac7a6e41_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id04b5505b5b949b4b46f6df5221ff61b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia3ccf78d11e54281b041b1ad37820d52_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="position">
        <measure>hum:position</measure>
    </unit>
    <unit id="state">
        <measure>hum:state</measure>
    </unit>
    <unit id="beneficiary">
        <measure>hum:beneficiary</measure>
    </unit>
    <unit id="option_period">
        <measure>hum:option_period</measure>
    </unit>
    <unit id="segment">
        <measure>hum:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80L2ZyYWc6ZWFhNjNkMDg0MjJhNGQ3ZDg4NzYyOWNmZGJhOTE2OTgvdGFibGU6YzdkNWJkNDQxZGMzNDE2ZmI2OGJhNzI3YmE3NzU5ZTQvdGFibGVyYW5nZTpjN2Q1YmQ0NDFkYzM0MTZmYjY4YmE3MjdiYTc3NTllNF8yLTEtMS0xLTE3ODkyNQ_82a4fd8b-20a7-4395-9c04-a1f8c98c1a20">0000049071</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80L2ZyYWc6ZWFhNjNkMDg0MjJhNGQ3ZDg4NzYyOWNmZGJhOTE2OTgvdGFibGU6YzdkNWJkNDQxZGMzNDE2ZmI2OGJhNzI3YmE3NzU5ZTQvdGFibGVyYW5nZTpjN2Q1YmQ0NDFkYzM0MTZmYjY4YmE3MjdiYTc3NTllNF8zLTEtMS0xLTE3ODkyNQ_5dd11146-a110-41f0-8e22-d56173591ce8">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80L2ZyYWc6ZWFhNjNkMDg0MjJhNGQ3ZDg4NzYyOWNmZGJhOTE2OTgvdGFibGU6YzdkNWJkNDQxZGMzNDE2ZmI2OGJhNzI3YmE3NzU5ZTQvdGFibGVyYW5nZTpjN2Q1YmQ0NDFkYzM0MTZmYjY4YmE3MjdiYTc3NTllNF80LTEtMS0xLTE3ODkyNQ_e7bdfbf0-188e-4d08-b73e-6753a6abea2f">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80L2ZyYWc6ZWFhNjNkMDg0MjJhNGQ3ZDg4NzYyOWNmZGJhOTE2OTgvdGFibGU6YzdkNWJkNDQxZGMzNDE2ZmI2OGJhNzI3YmE3NzU5ZTQvdGFibGVyYW5nZTpjN2Q1YmQ0NDFkYzM0MTZmYjY4YmE3MjdiYTc3NTllNF81LTEtMS0xLTE3ODkyNQ_247d0609-2408-4b85-8d5b-f890d6f89ac8">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80L2ZyYWc6ZWFhNjNkMDg0MjJhNGQ3ZDg4NzYyOWNmZGJhOTE2OTgvdGFibGU6YzdkNWJkNDQxZGMzNDE2ZmI2OGJhNzI3YmE3NzU5ZTQvdGFibGVyYW5nZTpjN2Q1YmQ0NDFkYzM0MTZmYjY4YmE3MjdiYTc3NTllNF82LTEtMS0xLTE3ODkyNQ_759c20de-77ea-4d65-80cc-a351eef95d49">false</dei:AmendmentFlag>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMy9mcmFnOmNlZDMzMmVmNmU1MTQ3NzA4MzYwYmZjM2M1NTk3ODgyL3RhYmxlOjhmZmFmZjRhYjU5NjQxM2ViYTY2MTQzMzdiNmFiOTQ3L3RhYmxlcmFuZ2U6OGZmYWZmNGFiNTk2NDEzZWJhNjYxNDMzN2I2YWI5NDdfMy0xLTEtMS0xNzg5MjU_8872b42b-6f36-4675-a1a3-a9798c2ff68c"
      unitRef="usdPerShare">0.1667</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMy9mcmFnOmNlZDMzMmVmNmU1MTQ3NzA4MzYwYmZjM2M1NTk3ODgyL3RhYmxlOjhmZmFmZjRhYjU5NjQxM2ViYTY2MTQzMzdiNmFiOTQ3L3RhYmxlcmFuZ2U6OGZmYWZmNGFiNTk2NDEzZWJhNjYxNDMzN2I2YWI5NDdfMy0yLTEtMS0xNzg5MjU_a87f0a3e-d9d4-455b-8f20-9e992376e001"
      unitRef="usdPerShare">0.1667</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNS0wLTEtMS0xNzg5MjU_c2bb13b4-0c36-4c9b-9e4c-42a20ef7d4d9">http://fasb.org/us-gaap/2022#HealthCareMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNS0wLTEtMS0xNzg5MjU_fb53923e-7f4e-463e-930a-0bbb5507b029">http://fasb.org/us-gaap/2022#HealthCareMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <hum:TRICAREManagedCareSupportContractBaseTerm
      contextRef="ie7875175150c464986253f694017f369_D20221201-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTA5OTUxMTY1MjExMw_2669b125-bc7d-4903-8a53-f6a32cfce9ee">P1Y</hum:TRICAREManagedCareSupportContractBaseTerm>
    <dei:DocumentType
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDEy_1019ebb1-ae6a-4dc2-ad9d-b39363ef0350">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6YWM1NTllZGU5YTE2NGEyYTg4Nzk5ODk5ZDhmMTJiODQvdGFibGVyYW5nZTphYzU1OWVkZTlhMTY0YTJhODg3OTk4OTlkOGYxMmI4NF8wLTAtMS0xLTE3ODkyNQ_a005e5ed-d416-48c3-9d16-e636f96f0b54">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8xMjA_6b59d3f3-4eea-4446-9fc0-3ae975be7be6">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6Y2FiMjQ4YTgzM2M5NDcwMGJjYzdlNjE4YjJiODkyYjcvdGFibGVyYW5nZTpjYWIyNDhhODMzYzk0NzAwYmNjN2U2MThiMmI4OTJiN18wLTAtMS0xLTE3ODkyNQ_f8631d37-d870-4b8f-915a-16ce16ec0323">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDE2_db261277-57e7-4187-9ad1-99291f922427">1-5975</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDE5_ad7f65ed-4d19-46c8-a941-ecca8ada3943">HUMANA INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6MDI5YmFmODE2OGRjNGRlMzkyOTk0NmU2YzVmY2Y3ZjMvdGFibGVyYW5nZTowMjliYWY4MTY4ZGM0ZGUzOTI5OTQ2ZTZjNWZjZjdmM18wLTAtMS0xLTE3ODkyNQ_f5e73ec9-d0be-4d0f-8b62-33a291fe9bb4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6MDI5YmFmODE2OGRjNGRlMzkyOTk0NmU2YzVmY2Y3ZjMvdGFibGVyYW5nZTowMjliYWY4MTY4ZGM0ZGUzOTI5OTQ2ZTZjNWZjZjdmM18wLTItMS0xLTE3ODkyNQ_5d48d8b0-d751-4ffe-b7cb-ca6b3caa4239">61-0647538</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDE3_4835b3bf-b108-4bbe-a040-b010f2574e27">500 West Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDE4_0d5eac2c-7b28-45be-8a03-8f99c42827cf">Louisville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDIw_febe48b4-4cb0-4e01-b4ec-63327eae3aa1">KY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDEw_16a48804-60b3-44be-81c2-2faa299bc4a1">40202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDIx_8abac877-08b4-471e-8453-174537b77239">502</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDEz_54788b5c-fd38-46ae-934c-914b542d28aa">580-1000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6Y2VmNDBjZDM4MDc4NDRhYmFiY2E1ZTlkYTc0YmQ5MjYvdGFibGVyYW5nZTpjZWY0MGNkMzgwNzg0NGFiYWJjYTVlOWRhNzRiZDkyNl8xLTAtMS0xLTE3ODkyNQ_68d975ca-5f32-40a6-89f4-47837f22ebcb">Common stock, $0.16 2/3 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6Y2VmNDBjZDM4MDc4NDRhYmFiY2E1ZTlkYTc0YmQ5MjYvdGFibGVyYW5nZTpjZWY0MGNkMzgwNzg0NGFiYWJjYTVlOWRhNzRiZDkyNl8xLTEtMS0xLTE3ODkyNQ_7353389e-7d40-4bcc-b9bb-347734deea86">HUM</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6Y2VmNDBjZDM4MDc4NDRhYmFiY2E1ZTlkYTc0YmQ5MjYvdGFibGVyYW5nZTpjZWY0MGNkMzgwNzg0NGFiYWJjYTVlOWRhNzRiZDkyNl8xLTItMS0xLTE3ODkyNQ_ca334b17-bfb3-4d6c-a0ec-1ddd37bca68a">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDIy_770826ac-5d40-4c0c-8bdc-0c91a0be7e52">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDE0_66ecee93-daea-4974-8e8d-ef1d0f880fbd">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6NDZiODNmMjA5MzQxNDlkOThjZDAwYTdjNjFlYmQ5MGEvdGFibGVyYW5nZTo0NmI4M2YyMDkzNDE0OWQ5OGNkMDBhN2M2MWViZDkwYV8wLTAtMS0xLTE3ODkyNQ_1c43286a-5ed6-44a0-aa10-d8742a7da03c">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6NDZiODNmMjA5MzQxNDlkOThjZDAwYTdjNjFlYmQ5MGEvdGFibGVyYW5nZTo0NmI4M2YyMDkzNDE0OWQ5OGNkMDBhN2M2MWViZDkwYV8yLTQtMS0xLTE3ODkyNQ_85095901-6b93-48e1-a422-c73b9c491829">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6NDZiODNmMjA5MzQxNDlkOThjZDAwYTdjNjFlYmQ5MGEvdGFibGVyYW5nZTo0NmI4M2YyMDkzNDE0OWQ5OGNkMDBhN2M2MWViZDkwYV80LTEtMS0xLTE3ODkyNQ_a0af1fbe-11ff-4d25-a708-fae1e0e7f0c4">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGV4dHJlZ2lvbjo0ODgwMGU1ZjMxZjc0NWY3OTZkODI3MGIxZWU0MTJhYV8yMDIz_3b790461-988b-45c8-b854-d12b658ab075">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xL2ZyYWc6NDg4MDBlNWYzMWY3NDVmNzk2ZDgyNzBiMWVlNDEyYWEvdGFibGU6NzBkMWMyYzE5MjlhNGQ2MTlmOGVmOWJkNmZjMDY1NGIvdGFibGVyYW5nZTo3MGQxYzJjMTkyOWE0ZDYxOWY4ZWY5YmQ2ZmMwNjU0Yl8xLTEtMS0xLTE3ODkyNQ_217d8409-dfe3-446c-aec0-f0dafae06439"
      unitRef="shares">124944994</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNC0xLTEtMS0xNzg5MjU_16798679-e0de-42cc-a8f2-ef9e58ef5a54"
      unitRef="usd">13735000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNC0zLTEtMS0xNzg5MjU_c94e0f0e-f1d8-4050-b942-28b24b60a725"
      unitRef="usd">5061000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNS0xLTEtMS0xNzg5MjU_b86e4c53-dfc6-4fbb-8d23-78697a997c84"
      unitRef="usd">14932000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNS0zLTEtMS0xNzg5MjU_e47efcaf-035a-4070-b373-41434142276e"
      unitRef="usd">13881000000</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNi0wLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjo5ZjFiOTBjYzU0ZTM0ZGNkYWJiMGIxODdmZDliODQ3OV8zOA_bfc6350e-d51a-4dc0-acc6-ec0e2de3e512"
      unitRef="usd">69000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNi0wLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjo5ZjFiOTBjYzU0ZTM0ZGNkYWJiMGIxODdmZDliODQ3OV81NQ_5591a656-2b1e-4409-bcdf-0da3f1551bc2"
      unitRef="usd">70000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNi0xLTEtMS0xNzg5MjU_e4fae022-aff4-45bc-85c4-4f3d35d16a72"
      unitRef="usd">3107000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNi0zLTEtMS0xNzg5MjU_545eee4b-1fb1-46bf-9423-d9656f4bb23e"
      unitRef="usd">1674000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNy0xLTEtMS0xNzg5MjU_6b321d0f-befb-4a3b-b1cb-82dc4011c3df"
      unitRef="usd">5758000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNy0zLTEtMS0xNzg5MjU_987e3f1e-3118-4e12-a5ed-07dc8867927c"
      unitRef="usd">5567000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfOS0xLTEtMS0xNzg5MjU_d434a69e-91f6-4934-9b1e-0894041698cf"
      unitRef="usd">37532000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfOS0zLTEtMS0xNzg5MjU_e1ac4d9c-89b6-44b4-b68b-d027667a0557"
      unitRef="usd">26183000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTAtMS0xLTEtMTc4OTI1_b5332739-0e9b-487c-a2b5-0e09af0479fc"
      unitRef="usd">3234000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTAtMy0xLTEtMTc4OTI1_71136944-c900-47bb-aa3e-dbd75e167d1c"
      unitRef="usd">3221000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTEtMS0xLTEtMTc4OTI1_5524913e-34be-4c73-ba0f-46be9d544f66"
      unitRef="usd">371000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTEtMy0xLTEtMTc4OTI1_317514ae-99d6-49b3-bf3e-d4cf67d5e57d"
      unitRef="usd">380000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:EquityMethodInvestments
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTItMS0xLTEtMTc4OTI1_b71d9072-7d9b-4639-b000-f475294a83ae"
      unitRef="usd">739000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTItMy0xLTEtMTc4OTI1_ed31e41a-7931-4c13-8597-5dc816ecda2b"
      unitRef="usd">749000000</us-gaap:EquityMethodInvestments>
    <us-gaap:Goodwill
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTMtMS0xLTEtMTc4OTI1_0ff51e68-7d24-4eec-b99c-e38b77fb10f9"
      unitRef="usd">9320000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTMtMy0xLTEtMTc4OTI1_539157a7-8190-4759-b83d-c1fbd47430a7"
      unitRef="usd">9142000000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTQtMS0xLTEtMTc4OTI1_d4a9320b-0cf0-4e57-a0ec-7bb76c93aa48"
      unitRef="usd">3580000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTQtMy0xLTEtMTc4OTI1_6e89c20e-3287-4929-9a24-5c8979bf866c"
      unitRef="usd">3380000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTYtMS0xLTEtMTc4OTI1_369dde0c-e640-415d-b28f-ea2f163b81c4"
      unitRef="usd">54776000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTYtMy0xLTEtMTc4OTI1_abee0d4b-546e-44d2-ba88-3b12cefef5d8"
      unitRef="usd">43055000000</us-gaap:Assets>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTktMS0xLTEtMTc4OTI1_1f8537fa-76f2-406d-963b-af2ba437c725"
      unitRef="usd">10018000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMTktMy0xLTEtMTc4OTI1_c0f3dda7-a060-4c1a-9d2c-9261229641b3"
      unitRef="usd">9264000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjAtMS0xLTEtMTc4OTI1_5c71001b-4ed6-432d-a4f2-49905f69a742"
      unitRef="usd">7431000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjAtMy0xLTEtMTc4OTI1_331e36d5-affe-4829-8ce0-94dffa28d376"
      unitRef="usd">5238000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <hum:BookOverdraftLiability
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjEtMS0xLTEtMTc4OTI1_3001c210-a22a-411b-9189-308c3d56f0e0"
      unitRef="usd">406000000</hum:BookOverdraftLiability>
    <hum:BookOverdraftLiability
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjEtMy0xLTEtMTc4OTI1_9d9c8377-d179-4136-a07e-589a3e8fc0a2"
      unitRef="usd">298000000</hum:BookOverdraftLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjItMS0xLTEtMTc4OTI1_c64e8c0b-63f0-42bc-bd12-3bd61ed6a669"
      unitRef="usd">7220000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjItMy0xLTEtMTc4OTI1_ee8cfd68-2b11-47e4-825d-e6943b294b0d"
      unitRef="usd">286000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:DebtCurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjMtMS0xLTEtMTc4OTI1_be3e4309-db60-46c4-a409-bf5184b87327"
      unitRef="usd">1867000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjMtMy0xLTEtMTc4OTI1_40784010-eb59-4c93-a784-c798a32bf4f2"
      unitRef="usd">2092000000</us-gaap:DebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjUtMS0xLTEtMTc4OTI1_b24e3438-b96e-45e3-b2bd-2189e99049a9"
      unitRef="usd">26942000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjUtMy0xLTEtMTc4OTI1_72f9d41d-f507-4306-a01c-dbd6a65dbd95"
      unitRef="usd">17178000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjYtMS0xLTEtMTc4OTI1_e2031806-7efb-4cd4-85f1-d88a743daf12"
      unitRef="usd">9743000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjYtMy0xLTEtMTc4OTI1_9b0afdf2-5419-4ea0-b9d7-f5e0786ac336"
      unitRef="usd">9034000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjctMS0xLTEtMTc4OTI1_4d90328d-3c8f-435a-a9f8-482f150b8a69"
      unitRef="usd">1457000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjctMy0xLTEtMTc4OTI1_c3dc9e2c-4b19-4037-aa0e-f612046765fc"
      unitRef="usd">1473000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjktMS0xLTEtMTc4OTI1_68db1701-c3fa-4cfe-8ff5-3f392693b797"
      unitRef="usd">38142000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMjktMy0xLTEtMTc4OTI1_25b05b05-35e7-4949-b9be-8c052ee24528"
      unitRef="usd">27685000000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGI0ZDIxNjVhZDJhNGNhNmI0MjU1ZjZjNDJhNDc0NmNfMjE_3d04a88e-c135-43e6-97c3-73cdb092d183"
      unitRef="usdPerShare">1</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGI0ZDIxNjVhZDJhNGNhNmI0MjU1ZjZjNDJhNDc0NmNfMjE_523a6862-db74-4bcb-8c81-df598a96d0e3"
      unitRef="usdPerShare">1</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGI0ZDIxNjVhZDJhNGNhNmI0MjU1ZjZjNDJhNDc0NmNfMjk_6054283e-0b6e-4b7b-8360-0512748fa6e1"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGI0ZDIxNjVhZDJhNGNhNmI0MjU1ZjZjNDJhNDc0NmNfMjk_a530f4d0-b85d-4026-9793-75e9d77130c4"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGI0ZDIxNjVhZDJhNGNhNmI0MjU1ZjZjNDJhNDc0NmNfNTE_3e4bb2ab-f099-4fb5-85cc-1ea60bfc11a5"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGI0ZDIxNjVhZDJhNGNhNmI0MjU1ZjZjNDJhNDc0NmNfNTE_d16a5b04-afdc-4541-9b15-51dc8ede5d3f"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMS0xLTEtMTc4OTI1_d183b2c8-8e47-434f-9247-bf8dcbafbc9a"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzItMy0xLTEtMTc4OTI1_53627f08-3c94-4aa1-8830-0f73eee42474"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzMtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MmU0ZTExZDA4NGE3NDc2NThhNDA5ZDk5OWE2MjE0NjVfMzM_5f97e28a-70b0-4361-8eb9-5bd621e2b58c"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzMtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MmU0ZTExZDA4NGE3NDc2NThhNDA5ZDk5OWE2MjE0NjVfMzM_c430e72f-becc-4362-a559-f5042259797f"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzMtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MmU0ZTExZDA4NGE3NDc2NThhNDA5ZDk5OWE2MjE0NjVfNTg_8ae43282-43ba-4c11-bfdf-ec71736ee788"
      unitRef="shares">198666598</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzMtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MmU0ZTExZDA4NGE3NDc2NThhNDA5ZDk5OWE2MjE0NjVfNTg_faa060da-f0e5-4def-8d9e-fe1cf6ed0959"
      unitRef="shares">198666598</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzMtMS0xLTEtMTc4OTI1_5bf28321-80b7-4563-ab63-cbcba9f804cf"
      unitRef="usd">33000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzMtMy0xLTEtMTc4OTI1_9fc48ae8-41f4-4d9f-87f7-6e23a4b3f94d"
      unitRef="usd">33000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzQtMS0xLTEtMTc4OTI1_7f4fd255-7567-419c-aff9-8a405bc76f6c"
      unitRef="usd">3262000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzQtMy0xLTEtMTc4OTI1_dedd4423-abaf-44c9-acb4-e642549c6d86"
      unitRef="usd">3246000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzUtMS0xLTEtMTc4OTI1_d299fb5b-e3ca-403e-ad48-db5930c9bbb4"
      unitRef="usd">26619000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzUtMy0xLTEtMTc4OTI1_6a10e169-71bf-46d7-8a9b-bbb19f486670"
      unitRef="usd">25492000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzYtMS0xLTEtMTc4OTI1_343e8a9f-3e71-406b-9b8f-88514d1fb3ee"
      unitRef="usd">-1113000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzYtMy0xLTEtMTc4OTI1_65145e55-3a50-4498-a162-2d9940626d8b"
      unitRef="usd">-1304000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzctMC0xLTEtMTc4OTI1L3RleHRyZWdpb246Y2U5NzA0Nzk0NmYzNGFhZDk5OGQ4MDM2NGFiYmRiMWRfMjk_4b04636c-6f63-49ae-992c-ac37ebe562e7"
      unitRef="shares">73721604</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzctMC0xLTEtMTc4OTI1L3RleHRyZWdpb246Y2U5NzA0Nzk0NmYzNGFhZDk5OGQ4MDM2NGFiYmRiMWRfNTQ_5a8bc70f-2145-400d-ad4d-d026734c2a4c"
      unitRef="shares">73691955</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzctMS0xLTEtMTc4OTI1_48ceea04-6490-496a-b5f0-86c503b45745"
      unitRef="usd">12224000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzctMy0xLTEtMTc4OTI1_83395e7f-1557-403b-b12d-5ff2caf1c400"
      unitRef="usd">12156000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzgtMS0xLTEtMTg2Mjc5_954a4ddd-460c-4847-bb2c-1e4bbce0be9c"
      unitRef="usd">16577000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzgtMy0xLTEtMTg2Mjc5_64062288-c9fd-48bf-91d9-2399a26ed6db"
      unitRef="usd">15311000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzgtMS0xLTEtMTc4OTI1_ce45fbf5-8e24-4b47-8cfd-ee31b9dd316d"
      unitRef="usd">57000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzgtMy0xLTEtMTc4OTI1_3d068c75-a6bc-4a5a-be88-49690e1e97ed"
      unitRef="usd">59000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzktMS0xLTEtMTc4OTI1_0b8e69ab-0642-4d28-8b9e-355b1fb94ec7"
      unitRef="usd">16634000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfMzktMy0xLTEtMTc4OTI1_4c54df6b-6bc5-4911-bac0-246ba4061913"
      unitRef="usd">15370000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNDAtMS0xLTEtMTc4OTI1_37ae9014-8d3a-4481-9a54-acc295714799"
      unitRef="usd">54776000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xMC9mcmFnOjdhMTA0Mjg4M2NmNDRhMGRiYWI1OTZkMDRmMWUxZjQ4L3RhYmxlOmQ0ZDE1Y2JjYzA4NjRiMGRhZmZiNmZlYzA0YjE1MGI2L3RhYmxlcmFuZ2U6ZDRkMTVjYmNjMDg2NGIwZGFmZmI2ZmVjMDRiMTUwYjZfNDAtMy0xLTEtMTc4OTI1_0795a78a-ab25-45da-864b-f8851191b7f6"
      unitRef="usd">43055000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PremiumsEarnedNet
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNC0xLTEtMS0xNzg5MjU_3f9cc226-7804-438e-9d78-8d67ea47e597"
      unitRef="usd">25550000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNC0zLTEtMS0xNzg5MjU_bc8244f4-a3a9-4c1b-9683-bc849d12bf1b"
      unitRef="usd">22703000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNS0xLTEtMS0xNzg5MjU_972ab94b-79bc-4523-9dcd-6031a9a39647"
      unitRef="usd">999000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNS0zLTEtMS0xNzg5MjU_9817aed6-ffff-4b99-8ba4-1eb6d28e5f2e"
      unitRef="usd">1264000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNi0xLTEtMS0xNzg5MjU_426868a4-2cad-4079-b6a5-0402965c75a5"
      unitRef="usd">193000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNi0zLTEtMS0xNzg5MjU_fc487084-c047-476d-959b-6587b3ff5e0f"
      unitRef="usd">3000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNy0xLTEtMS0xNzg5MjU_63b7c29e-0bbf-40dd-b51e-b66000129493"
      unitRef="usd">26742000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfNy0zLTEtMS0xNzg5MjU_8de75cef-7dca-4ad3-b08b-43ec043c45f8"
      unitRef="usd">23970000000</us-gaap:Revenues>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfOS0xLTEtMS0xNzg5MjU_8fc36318-acdc-4fda-b76a-23ed5afd3300"
      unitRef="usd">21858000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfOS0zLTEtMS0xNzg5MjU_2a0485a2-892b-4711-b527-5d529407beea"
      unitRef="usd">19625000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTAtMS0xLTEtMTc4OTI1_63c00138-f8d7-4e5e-9d0c-c99bcd41ed70"
      unitRef="usd">2979000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTAtMy0xLTEtMTc4OTI1_96b8ffd7-dd1f-4271-8376-baf6461d7c90"
      unitRef="usd">2886000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTEtMS0xLTEtMTc4OTI1_7f23182a-e572-4f82-a3c1-7723ee05ff67"
      unitRef="usd">186000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTEtMy0xLTEtMTc4OTI1_6bd5d56e-52c2-4aa0-af88-95e91115a151"
      unitRef="usd">170000000</hum:DepreciationAndAmortizationIncomeStatement>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTItMS0xLTEtMTc4OTI1_1de3c3dc-9665-4e69-b92c-c87677c72409"
      unitRef="usd">25023000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTItMy0xLTEtMTc4OTI1_b7109df5-3b15-40fc-8b05-657c65a6777d"
      unitRef="usd">22681000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTMtMS0xLTEtMTc4OTI1_86ea24ec-49a3-4757-ac22-25c6ca8a5150"
      unitRef="usd">1719000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTMtMy0xLTEtMTc4OTI1_cefde9ff-3942-46af-8298-aa155869cce5"
      unitRef="usd">1289000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTUtMS0xLTEtMTc4OTI1_9babe27d-d8ae-46bf-84fd-9f6c7d2a1030"
      unitRef="usd">113000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTUtMy0xLTEtMTc4OTI1_985079bf-0232-499d-8ac9-93fa290e412b"
      unitRef="usd">90000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTYtMS0xLTEtMTc4OTI1_a1db8944-2142-45fa-a03d-a7d08b6328e0"
      unitRef="usd">8000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTYtMy0xLTEtMTc4OTI1_f0e13254-759d-4a31-9b1d-1c15a1ad1bae"
      unitRef="usd">21000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTctMS0xLTEtMTc4OTI1_1dd105c6-b4da-43ab-b57d-9b1fcb930e9c"
      unitRef="usd">1614000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTctMy0xLTEtMTc4OTI1_933b83a1-d5e5-492a-91f4-95ca51128793"
      unitRef="usd">1220000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTgtMS0xLTEtMTc4OTI1_5d8cbca1-1ccc-45da-8c20-bd58eadd6c25"
      unitRef="usd">359000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTgtMy0xLTEtMTc4OTI1_f6936ca2-dc26-4236-953b-2f260f2423e3"
      unitRef="usd">286000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTktMS0xLTEtMTc4OTI1_ba6873e4-320f-48e9-860e-a65294607cfc"
      unitRef="usd">-17000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMTktMy0xLTEtMTc4OTI1_18814769-3d46-410a-af69-120117c4934c"
      unitRef="usd">-4000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjAtMS0xLTEtMTc4OTI1_e71e2270-6de1-4c38-905c-e5d264eb1105"
      unitRef="usd">1238000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjAtMy0xLTEtMTc4OTI1_3b2cf6b7-7aa3-4491-884f-60ac618afbec"
      unitRef="usd">930000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjEtMS0xLTEtMTc4OTI1_2f75bcc7-8e49-4401-bb26-cc9991e5d04f"
      unitRef="usd">-1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjEtMy0xLTEtMTc4OTI1_7e1269e7-e589-4a81-86f9-d945f0953260"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjItMS0xLTEtMTc4OTI1_06511023-bef2-44de-8b03-35077e669047"
      unitRef="usd">1239000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjItMy0xLTEtMTc4OTI1_04329df4-987f-4cb1-a2ba-43b2d1cd7af2"
      unitRef="usd">930000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjMtMS0xLTEtMTc4OTI1_77bcccd5-0fa2-456e-b2da-793e6f79ff45"
      unitRef="usdPerShare">9.91</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjMtMy0xLTEtMTc4OTI1_7c188305-f913-41e5-86e9-dd61f1b53652"
      unitRef="usdPerShare">7.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjQtMS0xLTEtMTc4OTI1_6e910401-6413-4288-9fbb-616e45c8da9a"
      unitRef="usdPerShare">9.87</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xNi9mcmFnOjFkZTk2NmU4YTg3NjQ0MTdhNTA5NDFlMTg5NjVlYzkyL3RhYmxlOjJjNzAyZDE5NjRjNTRlZjM5NTE2MzBhNzlmMGU3NjViL3RhYmxlcmFuZ2U6MmM3MDJkMTk2NGM1NGVmMzk1MTYzMGE3OWYwZTc2NWJfMjQtMy0xLTEtMTc4OTI1_8546aeea-ba4d-42fa-b404-d0414adb5328"
      unitRef="usdPerShare">7.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMy0xLTEtMS0xNzg5MjU_ee0a543a-58f8-49e9-9982-ad60444070c2"
      unitRef="usd">1239000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMy0zLTEtMS0xNzg5MjU_b05451a2-80f9-448c-bc29-19960b55064b"
      unitRef="usd">930000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfNS0xLTEtMS0xNzg5MjU_5c83055b-1585-4e16-9370-2ca23a368fb9"
      unitRef="usd">188000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfNS0zLTEtMS0xNzg5MjU_2a615a93-cbc1-4bf5-873b-94be2ade3c6c"
      unitRef="usd">-769000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfNi0xLTEtMS0xNzg5MjU_d8d11d75-c5a3-4afd-98c2-95da3e9fa540"
      unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfNi0zLTEtMS0xNzg5MjU_e3e28a5b-0efe-4c2a-90ff-144c67f7d171"
      unitRef="usd">-176000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfNy0xLTEtMS0xNzg5MjU_58d88beb-8c38-47f4-bd1c-e3a2d3d5e246"
      unitRef="usd">145000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfNy0zLTEtMS0xNzg5MjU_dcc983f3-4842-4c3e-a357-7847d2f9b63c"
      unitRef="usd">-593000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfOC0xLTEtMS0xNzg5MjU_c88d3b60-6b8d-4716-b4b6-62f1df44ad49"
      unitRef="usd">-61000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfOC0zLTEtMS0xNzg5MjU_9c490bd7-cd32-4e25-9112-b4e7bddcab27"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfOS0xLTEtMS0xNzg5MjU_6a57ea4e-ab8f-411a-af64-73921574d51c"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfOS0zLTEtMS0xNzg5MjU_ff94badd-5add-4fcc-b6f1-89983a8048a1"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMTAtMS0xLTEtMTc4OTI1_0008702c-24e1-43a7-9bf8-9e87030192a4"
      unitRef="usd">-46000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMTAtMy0xLTEtMTc4OTI1_12075780-17d6-45c9-b0ca-661155fc93c5"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMTEtMS0xLTEtMTc4OTI1_09f30390-a7f0-4243-b158-c2fd1bee0051"
      unitRef="usd">191000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMTEtMy0xLTEtMTc4OTI1_590e3591-15fd-4ddc-9c54-bd8953378f1b"
      unitRef="usd">-614000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMTQtMS0xLTEtMTc4OTI1_f90de7bb-9b5f-4995-bc5f-a89707325ed0"
      unitRef="usd">1430000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8xOS9mcmFnOjEyYjE5NzQyOTdmMTRkZGJhNTNiMzIzNDBhMGYwNWY0L3RhYmxlOjZiZjQwMjhjOTMxZTQ3MDI4YjE1YjBmZjI3NzA4N2QxL3RhYmxlcmFuZ2U6NmJmNDAyOGM5MzFlNDcwMjhiMTViMGZmMjc3MDg3ZDFfMTQtMy0xLTEtMTc4OTI1_944e6709-8481-45b9-bd70-4b6ba8d5de9b"
      unitRef="usd">316000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i67be62ec4a604c6baeeae7c8acfa32da_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC0xLTEtMS0xNzg5MjU_fb166dec-9adb-4cc1-bee6-c5e42d04f9bb"
      unitRef="shares">198667000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i67be62ec4a604c6baeeae7c8acfa32da_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC0zLTEtMS0xNzg5MjU_22c88b32-fa5a-49b8-9921-4d10e908c7c2"
      unitRef="usd">33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie80b91c2c2c84ebb871c1ba1a0f82413_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC01LTEtMS0xNzg5MjU_9b202b92-7a37-465c-af12-c4877ae646ef"
      unitRef="usd">3246000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2f0bb767b8b44c9bb4b925e7d6846b4c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC03LTEtMS0xNzg5MjU_630fd096-ecf9-472f-aa92-03959a328497"
      unitRef="usd">25492000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib43b2bdef5554a95a305773800d5f4f6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC05LTEtMS0xNzg5MjU_ea7a49cf-f56e-43a4-a0be-4f65e1a94a7e"
      unitRef="usd">-1304000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0c80fc54c1ed425abb2f454166ba8b76_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC0xMS0xLTEtMTc4OTI1_f9920cb6-f47d-4865-85f7-e233ded0c73a"
      unitRef="usd">-12156000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieef509857c8e4467a2fc109e0bf10f4b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC0xMy0xLTEtMTg2Mjk1_6fec7763-ca08-4fb9-a931-569ac4711e9b"
      unitRef="usd">15311000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie764c2fbaa0e46349d4f04c484a4ae01_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC0xMy0xLTEtMTc4OTI1_ae056b33-d54d-462f-94d0-9d465ec8a64b"
      unitRef="usd">59000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNC0xNS0xLTEtMTc4OTI1_77c0fe2e-321a-4ecf-b585-0aa596cbb38e"
      unitRef="usd">15370000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="iaee9f0e494b544da926fe616f385aac5_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNS03LTEtMS0xNzg5MjU_4b12c783-9bb4-4061-a8d6-33fc268b2c8b"
      unitRef="usd">1239000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNS0xMy0xLTEtMTg2Mjk1_ccc9b949-87c2-41dc-b8c3-46cbf14921dd"
      unitRef="usd">1239000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7b281d1bbb96464f86dd82da174e2334_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNS0xMy0xLTEtMTc4OTI1_51022664-a363-4fed-8448-bb583c179cba"
      unitRef="usd">-1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNS0xNS0xLTEtMTc4OTI1_d1e9d8f8-1e19-4d11-8c40-6fd5c24fae4d"
      unitRef="usd">1238000000</us-gaap:ProfitLoss>
    <hum:NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders
      contextRef="i7b281d1bbb96464f86dd82da174e2334_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNi0xMy0xLTEtMTc4OTI1_a672421f-7fa1-4ada-b100-d714a9099a4e"
      unitRef="usd">4000000</hum:NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders>
    <hum:NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfNi0xNS0xLTEtMTc4OTI1_192d6b39-8c1b-4034-aa1c-911b3988e292"
      unitRef="usd">4000000</hum:NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i7b281d1bbb96464f86dd82da174e2334_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfOC0xMy0xLTEtMTc4OTI1_136943f8-d1e8-4c5a-8cdc-2bd5ea649256"
      unitRef="usd">5000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfOC0xNS0xLTEtMTc4OTI1_f104b668-b4d9-49a4-a640-ca8b46d0ab18"
      unitRef="usd">5000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie0d2f28ca1ea4a64ae9ed5eee0ba5068_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfOS05LTEtMS0xNzg5MjU_e544f264-e6c6-4bac-9693-ffa5b332ac06"
      unitRef="usd">191000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfOS0xMy0xLTEtMTg2Mjk1_5559f7f9-027a-4054-803a-599f04bb9d17"
      unitRef="usd">191000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfOS0xNS0xLTEtMTc4OTI1_eb719981-7dc0-45dc-b813-148bf0fdf709"
      unitRef="usd">191000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ie8a695ef6e9d487ab733b856a3f72501_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTAtMTEtMS0xLTE3ODkyNQ_d7ee167a-a097-4bb5-a33f-17d0b7f83578"
      unitRef="usd">94000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTAtMTMtMS0xLTE4NjI5NQ_b14b06f2-7311-4b40-9758-2c863384b64b"
      unitRef="usd">94000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTAtMTUtMS0xLTE3ODkyNQ_53363b62-c88e-4e52-aad8-c78d6d764b6d"
      unitRef="usd">94000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStockCash
      contextRef="iaee9f0e494b544da926fe616f385aac5_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTEtNy0xLTEtMTc4OTI1_0706cbe0-4ce8-43ae-8347-bef2f9cccef2"
      unitRef="usd">112000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTEtMTMtMS0xLTE4NjI5NQ_4f0d18f3-41e9-4d3a-a9ba-87abaf325e03"
      unitRef="usd">112000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTEtMTUtMS0xLTE3ODkyNQ_e4dcc34f-0b26-419b-b12c-c1b0548f51ee"
      unitRef="usd">112000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iff79ee49692740f8b35cbc8e80b347a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTItNS0xLTEtMTc4OTI1_526873b4-15a4-44d3-9ecf-515f70f5af7c"
      unitRef="usd">38000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTItMTMtMS0xLTE4NjI5NQ_dae10172-7d53-4737-9b64-ab5f2cedb6c5"
      unitRef="usd">38000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTItMTUtMS0xLTE3ODkyNQ_ed78a2a1-3c6b-4a6c-86ac-6d76f71cebc7"
      unitRef="usd">38000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="iff79ee49692740f8b35cbc8e80b347a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTMtNS0xLTEtMTc4OTI1_6dad67d8-8f35-4ac6-a6b8-3b8989609548"
      unitRef="usd">-24000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="ie8a695ef6e9d487ab733b856a3f72501_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTMtMTEtMS0xLTE3ODkyNQ_5920ab31-9895-4078-a70d-cc2db00b4450"
      unitRef="usd">24000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTMtMTUtMS0xLTE3ODkyNQ_704cc1f7-e297-46fc-bbbe-8758f49a8513"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iff79ee49692740f8b35cbc8e80b347a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTQtNS0xLTEtMTc4OTI1_d1441a7a-b604-46e2-a5ab-9990e618e55d"
      unitRef="usd">2000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie8a695ef6e9d487ab733b856a3f72501_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTQtMTEtMS0xLTE3ODkyNQ_76ef982f-2c48-4c21-affb-2863a2f1634d"
      unitRef="usd">2000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib1591f166e4a47589236f15f49870f4f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTQtMTMtMS0xLTE4NjI5NQ_984d9e01-124b-4625-b0c0-448a8094b06c"
      unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTQtMTUtMS0xLTE3ODkyNQ_7c4d04a3-f8af-453c-84df-f97f8e760da1"
      unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id4750367ee1e4a689f97fa9022bdf5e4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtMS0xLTEtMTc4OTI1_3e90813f-1e3f-4d2b-a7c5-deade9666d09"
      unitRef="shares">198667000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id4750367ee1e4a689f97fa9022bdf5e4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtMy0xLTEtMTc4OTI1_0faa06c9-219c-4d2c-baeb-41e61cf62c9c"
      unitRef="usd">33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i33bde0043da6450e8ef28277a10de49e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtNS0xLTEtMTc4OTI1_c2f1d36e-7bfc-4e84-b73b-f636e5194eb4"
      unitRef="usd">3262000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id38d4d0509824793b1c7ea2b970a5957_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtNy0xLTEtMTc4OTI1_0df807ea-ac62-4ca4-8e16-b84284d3874d"
      unitRef="usd">26619000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie443272811ed49d6a8d422744f898488_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtOS0xLTEtMTc4OTI1_d723bfaf-506c-440b-987a-69c4b5a2671c"
      unitRef="usd">-1113000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i00969cc0983a4871891aca903e70709b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtMTEtMS0xLTE3ODkyNQ_9a10fd61-895e-4583-a501-af79fedc69de"
      unitRef="usd">-12224000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb4314807c944d55b84b257f3f3dc4cc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtMTMtMS0xLTE4NjI5NQ_e835844a-580c-40d9-8a28-f0a86bd9f7ec"
      unitRef="usd">16577000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i608d6a1b874146d8b2906b872c802885_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtMTMtMS0xLTE3ODkyNQ_692b34f9-7ac6-4cd9-9cb6-2c737f36acdd"
      unitRef="usd">57000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTUtMTUtMS0xLTE3ODkyNQ_adedbe69-6b35-4d81-b48c-4d339d9b9f4c"
      unitRef="usd">16634000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id52b99f262dd4f5fbc64485fdc490c62_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtMS0xLTEtMTc4OTI1_8754fe06-a23f-423c-b34d-d8c9167bea3c"
      unitRef="shares">198649000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id52b99f262dd4f5fbc64485fdc490c62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtMy0xLTEtMTc4OTI1_c08ccf53-1e77-4501-89ca-94e9c251daa5"
      unitRef="usd">33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i070b3a983b8d4c1c9d6d883ff6c49107_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtNS0xLTEtMTc4OTI1_0aa64152-02ba-4340-b99a-56ba25e1d344"
      unitRef="usd">3082000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0fb1c5dba70e4995a50495bdf4c7e1d3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtNy0xLTEtMTc4OTI1_815e0599-3ed7-4dbd-8d94-00541e123c62"
      unitRef="usd">23086000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd32fea20e5e4fba97023cd2a12758d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtOS0xLTEtMTc4OTI1_fdd15f9f-10be-49f7-ba87-f74cad0dda6b"
      unitRef="usd">42000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8a2924212fff4b95a06c6336134700a1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtMTEtMS0xLTE3ODkyNQ_6f4618b0-8daf-4ad4-86c6-17806e6ed198"
      unitRef="usd">-10163000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ide04b81f591a460480759551ea2d4c60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtMTMtMS0xLTE4NjI5NQ_4be9cc59-fff4-420f-a3c0-ec5fd1f8859e"
      unitRef="usd">16080000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1f1a85fe48643ddad4b2657effc5ddc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtMTMtMS0xLTE3ODkyNQ_7f5a299d-4e6e-4c70-a397-be972bdf8e3c"
      unitRef="usd">23000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if66f7e3bde694a2fa6f2b9ad88e258ff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTgtMTUtMS0xLTE3ODkyNQ_a265a478-202d-4a2f-9e49-6757eb16c70a"
      unitRef="usd">16103000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i69b771e99aeb411385b87bc78aba0005_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTktNy0xLTEtMTc4OTI1_9c879693-e5ef-4a1e-a4ad-f4f3c6d9b992"
      unitRef="usd">930000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTktMTMtMS0xLTE4NjI5NQ_5fc32321-3d1f-426a-8b2c-32c08f17e978"
      unitRef="usd">930000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMTktMTUtMS0xLTE3ODkyNQ_3cf260c0-e217-4028-8502-841c73795be4"
      unitRef="usd">930000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iefba7d8c1a25422f8083be1c96fbf1fd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjMtOS0xLTEtMTc4OTI1_0c50aaa0-6143-4459-8356-94585d51764c"
      unitRef="usd">-614000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjMtMTMtMS0xLTE4NjI5NQ_5e6864b3-b23d-4ffb-95b7-d22028ee9f9c"
      unitRef="usd">-614000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjMtMTUtMS0xLTE3ODkyNQ_16717fa2-6c38-43a5-b071-39e3eb59e520"
      unitRef="usd">-614000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="id26120571436434494bfb975fa78d99e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjQtMTEtMS0xLTE3ODkyNQ_5547a838-2aea-485b-93f5-abe5b5f20d72"
      unitRef="usd">1024000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjQtMTMtMS0xLTE4NjI5NQ_ce6b28c8-c685-401b-95f2-370507dc22b6"
      unitRef="usd">1024000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjQtMTUtMS0xLTE3ODkyNQ_d671ccbb-3db2-40ff-997f-a5da8b375ce8"
      unitRef="usd">1024000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStockCash
      contextRef="i69b771e99aeb411385b87bc78aba0005_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjUtNy0xLTEtMTc4OTI1_9167b219-17a9-4a0c-a1b0-86b382cdc7e2"
      unitRef="usd">101000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjUtMTMtMS0xLTE4NjI5NQ_ba372ce4-3d9b-4a1e-b63e-8d04172a3a66"
      unitRef="usd">101000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjUtMTUtMS0xLTE3ODkyNQ_d9c0b091-331e-4a28-8e10-47f83a4e5750"
      unitRef="usd">101000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ice488527531041f1bea3aaf535bacb76_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjYtNS0xLTEtMTc4OTI1_85e3cfc2-8530-45bc-8fbd-8b9a2f9dff7f"
      unitRef="usd">43000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjYtMTMtMS0xLTE4NjI5NQ_f123e2fc-153e-4b6e-ba88-04f1d85581d7"
      unitRef="usd">43000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjYtMTUtMS0xLTE3ODkyNQ_0c2ff7b1-f6b2-4149-93ca-7aa514ac2990"
      unitRef="usd">43000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="ice488527531041f1bea3aaf535bacb76_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjctNS0xLTEtMTc4OTI1_6f33a1e3-a465-45ca-9d3b-e3dada86455d"
      unitRef="usd">-24000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="id26120571436434494bfb975fa78d99e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjctMTEtMS0xLTE3ODkyNQ_6ca74efd-1b6b-40b8-bc10-f662b917a638"
      unitRef="usd">24000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjctMTUtMS0xLTE3ODkyNQ_bde38881-c092-4fde-a47b-fc0199d62673"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ice488527531041f1bea3aaf535bacb76_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjgtNS0xLTEtMTc4OTI1_888b488f-74ee-4c82-bb0c-a2c75be06eb9"
      unitRef="usd">2000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id26120571436434494bfb975fa78d99e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjgtMTEtMS0xLTE3ODkyNQ_b9645116-8bbd-41fe-8e64-e5e51803dd4a"
      unitRef="usd">3000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i383b7672c965436fae36fe19594f7f3b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjgtMTMtMS0xLTE4NjI5NQ_8713a04a-f31f-499c-be5a-b1a4f6b49e6e"
      unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjgtMTUtMS0xLTE3ODkyNQ_43ac74ce-ae38-402b-8b51-461c4f47ad02"
      unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0da5c588273f46f9b2f1a42b9dd81da4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktMS0xLTEtMTc4OTI1_2da34cf9-0d76-4674-8998-c36bd0865711"
      unitRef="shares">198649000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0da5c588273f46f9b2f1a42b9dd81da4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktMy0xLTEtMTc4OTI1_38f67a98-1431-46a7-8335-a6bc5b9ceb73"
      unitRef="usd">33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i342c27c8ea80488ba306fb99128b5cf4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktNS0xLTEtMTc4OTI1_3d44d613-0b93-4e2a-be0b-5f771b1bfc36"
      unitRef="usd">3103000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5f2a8ed54eca45fba1b5a8a2a7875edb_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktNy0xLTEtMTc4OTI1_157dec4e-8d3f-4d63-a272-066ef398525f"
      unitRef="usd">23915000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i623ed6554dfa4892b099de29261154be_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktOS0xLTEtMTc4OTI1_c96b8bfd-7258-4f61-ad5e-4b23b944ae35"
      unitRef="usd">-572000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d833c58d6684d1fbe8a6b639c1c2914_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktMTEtMS0xLTE3ODkyNQ_c08bc48a-2f73-4c07-ab6f-f551f83526a7"
      unitRef="usd">-11160000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9be79b2b55e54535aff3cbec252b67f5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktMTMtMS0xLTE4NjI5NQ_533202a8-08e9-49b6-8225-ab0668ddb2fc"
      unitRef="usd">15319000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1bd06ce061245718d7a679efdb9836b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktMTMtMS0xLTE3ODkyNQ_4ab020cc-312b-49f9-809a-0afe49ce4ad5"
      unitRef="usd">23000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i55a5772c9e08479ba75577876ccf8013_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yMi9mcmFnOjAwOWE4ZGU1NGU2ZTQwNWJiNTlkYmQyNTUxNzMwZWIyL3RhYmxlOmRmYmZlYjQ3YWE5NTQzMjFiYjQ5N2Q1ZWM3YzUzM2FlL3RhYmxlcmFuZ2U6ZGZiZmViNDdhYTk1NDMyMWJiNDk3ZDVlYzdjNTMzYWVfMjktMTUtMS0xLTE3ODkyNQ_426da686-ec3f-449a-b474-7e801cfc761e"
      unitRef="usd">15342000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNC0xLTEtMS0xNzg5MjU_a954ccdd-c59d-4f6b-a369-009f323e6782"
      unitRef="usd">1238000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNC0zLTEtMS0xNzg5MjU_e5be6ce1-445c-4aae-bea4-1008026545fc"
      unitRef="usd">930000000</us-gaap:ProfitLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNy0xLTEtMS0xNzg5MjU_e5e74747-15b6-41d6-8882-2d2524fb5e92"
      unitRef="usd">-60000000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNy0zLTEtMS0xNzg5MjU_3a4f5eda-d2d9-4407-86c1-1f1aed21ac85"
      unitRef="usd">-76000000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfOS0xLTEtMS0xNzg5MjU_a991b60e-e36d-474e-89bd-a4c127136bc6"
      unitRef="usd">-17000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfOS0zLTEtMS0xNzg5MjU_98f4e2e3-50d7-4ad1-bc65-2dc858b26738"
      unitRef="usd">-4000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ShareBasedCompensation
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTAtMS0xLTEtMTc4OTI1_85bc8852-9404-408f-9d01-bd0c4f5004d8"
      unitRef="usd">38000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTAtMy0xLTEtMTc4OTI1_f8f4e987-2bf3-4fc2-9183-e6d7527bf790"
      unitRef="usd">43000000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTEtMS0xLTEtMTc4OTI1_de3c9c0d-de63-4afc-aa49-3e95610f2394"
      unitRef="usd">200000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTEtMy0xLTEtMTc4OTI1_334e29a5-484d-46fb-a641-9395fe228b5f"
      unitRef="usd">181000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTItMS0xLTEtMTc4OTI1_7733d596-090f-428f-8d63-134b96b69030"
      unitRef="usd">18000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTItMy0xLTEtMTc4OTI1_45b093bf-7a27-4585-8822-d0e13de3cb80"
      unitRef="usd">24000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTYtMS0xLTEtMTc4OTI1_999fb216-2337-4e89-a874-290bdfa3b523"
      unitRef="usd">1433000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTYtMy0xLTEtMTc4OTI1_d7508930-9595-42b1-bb86-cc43465d9328"
      unitRef="usd">1360000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTctMS0xLTEtMTc4OTI1_05d2d60a-0eac-4d82-b73c-d68af7c71daa"
      unitRef="usd">907000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTctMy0xLTEtMTc4OTI1_46b46a1d-8243-4ac4-a1eb-7ecdc17bf07c"
      unitRef="usd">628000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTgtMS0xLTEtMTc4OTI1_c9640c6a-8d28-448f-a279-ce1faa1a999a"
      unitRef="usd">754000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTgtMy0xLTEtMTc4OTI1_17129f74-353b-4909-870e-13204527b2a9"
      unitRef="usd">1089000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTktMS0xLTEtMTc4OTI1_fd9abc82-e760-476c-8d0f-3e21f0dbd263"
      unitRef="usd">-238000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMTktMy0xLTEtMTc4OTI1_8ed862e9-54f4-468b-81fd-65c49072777d"
      unitRef="usd">-103000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjAtMS0xLTEtMTc4OTI1_ad337cd1-6ea7-4a26-b033-e00de51a45fc"
      unitRef="usd">6934000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjAtMy0xLTEtMTc4OTI1_1b5928b6-7bd2-449b-9ec7-3e8edc9b5290"
      unitRef="usd">34000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjEtMS0xLTEtMTc4OTI1_84132bc2-ab5a-4c1b-81d8-3a9e65a642e1"
      unitRef="usd">6000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjEtMy0xLTEtMTc4OTI1_db3a35f6-619b-4ccd-a208-8b40590c0a92"
      unitRef="usd">12000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjItMS0xLTEtMTc4OTI1_0aea6c06-cb5c-4014-9d9a-9b407312a93d"
      unitRef="usd">6687000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjItMy0xLTEtMTc4OTI1_88cfa6a1-8f5f-4abb-91b4-83ac633074d1"
      unitRef="usd">302000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjUtMS0xLTEtMTc4OTI1_515c9287-8fbc-4326-a1aa-1f4ed084cc68"
      unitRef="usd">73000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjUtMy0xLTEtMTc4OTI1_981a5d95-a70e-44ff-b868-6797b4f9c2fc"
      unitRef="usd">74000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjYtMS0xLTEtMTc4OTI1_307e20a0-31e8-4c76-9c23-278fc8d27284"
      unitRef="usd">223000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjYtMy0xLTEtMTc4OTI1_2df741ca-53ef-4740-a9aa-1e54873c8029"
      unitRef="usd">295000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjctMS0xLTEtMTc4OTI1_028479d1-dd72-4b67-a2c0-616287deddb4"
      unitRef="usd">1313000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjctMy0xLTEtMTc4OTI1_983603da-38c1-40b5-9720-0645cbf2f0f2"
      unitRef="usd">2161000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjgtMS0xLTEtMTc4OTI1_34e4516e-ae2b-4f50-a6f3-c7fed21b6c45"
      unitRef="usd">267000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjgtMy0xLTEtMTc4OTI1_eabd4c86-386d-480c-9b03-d58ed986d63e"
      unitRef="usd">588000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjktMS0xLTEtMTc4OTI1_1516af18-a69e-4340-af4f-61ba240e18da"
      unitRef="usd">50000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMjktMy0xLTEtMTc4OTI1_e04eb62a-7be9-47f9-8341-dcdf2984d73e"
      unitRef="usd">1294000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzAtMS0xLTEtMTc4OTI1_1af4f15c-ff94-4e6f-a19c-51d06eacc0c1"
      unitRef="usd">-1292000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzAtMy0xLTEtMTc4OTI1_05664a7e-6218-4547-ad0d-6382a356b9a4"
      unitRef="usd">-648000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <hum:PaymentsForProceedsFromContractDeposits
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzItMS0xLTEtMTc4OTI1_e2140e90-47c8-4b69-9250-187202e1c3d7"
      unitRef="usd">-2997000000</hum:PaymentsForProceedsFromContractDeposits>
    <hum:PaymentsForProceedsFromContractDeposits
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzItMy0xLTEtMTc4OTI1_879524e1-4eca-4426-8252-8225a571803c"
      unitRef="usd">-2475000000</hum:PaymentsForProceedsFromContractDeposits>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzMtMS0xLTEtMTc4OTI1_1cc58827-ff12-4737-a72a-e661d58f3620"
      unitRef="usd">1215000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzMtMy0xLTEtMTc4OTI1_41fcedb2-52b1-47bc-aeb4-a87524602403"
      unitRef="usd">744000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzQtMS0xLTEtMTkyNDk1_4e7d6914-72ac-47d6-8643-d47393c4f712"
      unitRef="usd">60000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzQtMy0xLTEtMTkyNDk1_44618226-1287-4640-81e1-b52e2e313906"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzQtMS0xLTEtMTc4OTI1_fb0ee8c8-803f-45ad-8857-b947dfee876f"
      unitRef="usd">-177000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzQtMy0xLTEtMTc4OTI1_d318de8e-0a72-466d-822e-707e5fcda570"
      unitRef="usd">-265000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzYtMS0xLTEtMTc4OTI1_e1957073-1ded-4639-94d2-6afc64d5300d"
      unitRef="usd">500000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzYtMy0xLTEtMTc4OTI1_73a2459d-89d6-4d61-a446-8666e8704eca"
      unitRef="usd">0</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzctMS0xLTEtMTc4OTI1_593e6cee-78b0-4bf8-a168-3786eaf37cc1"
      unitRef="usd">4000000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzctMy0xLTEtMTc4OTI1_ce1e31fa-2e37-4d30-9eb6-b47c02ed35b2"
      unitRef="usd">1000000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:IncreaseDecreaseInBookOverdrafts
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzgtMS0xLTEtMTc4OTI1_e50767c9-507d-4761-8b32-bab0dbb8a365"
      unitRef="usd">108000000</us-gaap:IncreaseDecreaseInBookOverdrafts>
    <us-gaap:IncreaseDecreaseInBookOverdrafts
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzgtMy0xLTEtMTc4OTI1_2c284f7a-d528-4f9f-b1dc-3f4852f3d8ea"
      unitRef="usd">-9000000</us-gaap:IncreaseDecreaseInBookOverdrafts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzktMS0xLTEtMTc4OTI1_c87708cd-94ce-4214-8dd1-833391d47d0d"
      unitRef="usd">94000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfMzktMy0xLTEtMTc4OTI1_77f38ff4-3f80-4fd5-9c78-d3139dc001a9"
      unitRef="usd">1024000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDAtMS0xLTEtMTc4OTI1_01a351a3-f4cd-4ce6-a10c-4c19c11d978c"
      unitRef="usd">100000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDAtMy0xLTEtMTc4OTI1_b0f967c3-5586-470b-ad45-d56def4a375b"
      unitRef="usd">91000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDEtMS0xLTEtMTc4OTI1_5eaa3162-e0c5-43b4-98ae-0f527d939bed"
      unitRef="usd">-106000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDEtMy0xLTEtMTc4OTI1_61568bb7-0feb-45fe-8790-717c82ba12d1"
      unitRef="usd">-13000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDItMS0xLTEtMTc4OTI1_e9449eab-c4c5-4067-b471-73ac30d57de8"
      unitRef="usd">3279000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDItMy0xLTEtMTc4OTI1_3b235110-1ff6-499a-88c4-90ed755011ff"
      unitRef="usd">1816000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDMtMS0xLTEtMTc4OTI1_d1a285c9-a669-42d6-9d4d-8768d1ab9919"
      unitRef="usd">8674000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDMtMy0xLTEtMTc4OTI1_bd341f0a-ad31-4982-bff2-7992f58448ec"
      unitRef="usd">1470000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDQtMS0xLTEtMTc4OTI1_4a4209ef-ee1d-4c7c-83c6-4ceba55ad1a2"
      unitRef="usd">5061000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if66f7e3bde694a2fa6f2b9ad88e258ff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDQtMy0xLTEtMTc4OTI1_0b950996-c8ca-4a42-9642-f698346ca384"
      unitRef="usd">3394000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDUtMS0xLTEtMTc4OTI1_d5e6caf5-825c-40b1-a17e-0b05d1fe9ecb"
      unitRef="usd">13735000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i55a5772c9e08479ba75577876ccf8013_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmQ5ZjdkNmJjNjUxNzRjZjg4MTY4NjY2ZTUyMTZiMDBiL3RhYmxlcmFuZ2U6ZDlmN2Q2YmM2NTE3NGNmODgxNjg2NjZlNTIxNmIwMGJfNDUtMy0xLTEtMTc4OTI1_b625c142-50b7-4dfb-972d-9f739af46a94"
      unitRef="usd">4864000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfNC0xLTEtMS0xNzg5MjU_8b48dd5d-980a-428a-a2ca-c76f7b3bd84f"
      unitRef="usd">97000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfNC0zLTEtMS0xNzg5MjU_9d555765-b103-4032-842c-722adfc92d77"
      unitRef="usd">67000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfNS0xLTEtMS0xNzg5MjU_79ac2128-ada8-4a52-bf39-8ba385e3ffb7"
      unitRef="usd">6000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfNS0zLTEtMS0xNzg5MjU_8351eca2-6eb4-4077-b311-0a1c62675601"
      unitRef="usd">-20000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfNy0xLTEtMS0xNzg5MjU_e3df6645-158f-4230-9d87-75f90b7fc1e1"
      unitRef="usd">73000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfNy0zLTEtMS0xNzg5MjU_47066311-a219-4d44-9c64-36d0e978ad0f"
      unitRef="usd">84000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfOC0xLTEtMS0xNzg5MjU_07a8e047-41cf-445f-8cc2-435f574f0d37"
      unitRef="usd">5000000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfOC0zLTEtMS0xNzg5MjU_ed457ff8-4f13-4ffb-a169-fd0f6d2ea5bb"
      unitRef="usd">10000000</us-gaap:LiabilitiesAssumed1>
    <hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfOS0xLTEtMS0xNzg5MjU_d403ddcf-1ca8-4b13-b239-2622dbefbd18"
      unitRef="usd">-5000000</hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired>
    <hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfOS0zLTEtMS0xNzg5MjU_a6e3a0b9-22b5-4527-93ed-b4cda40e2250"
      unitRef="usd">0</hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfMTEtMS0xLTEtMTc4OTI1_6dee3666-63bf-4cfd-9134-556982bedaef"
      unitRef="usd">73000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8yNS9mcmFnOjRmM2EwYWJkYzQ2ODQ1ZTViNTYzNDhlMjMxNjc4ZGZkL3RhYmxlOmIwZTZlYTQ1MjJhYTRjNzA4MGM0MWIyMWJmMGEyYTBmL3RhYmxlcmFuZ2U6YjBlNmVhNDUyMmFhNGM3MDgwYzQxYjIxYmYwYTJhMGZfMTEtMy0xLTEtMTc4OTI1_e08aaf97-994b-4c38-a1da-8cfbea85a162"
      unitRef="usd">74000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfNjczMQ_7e5506f1-dcb1-4d0d-b7d9-0bf8aac0719e">BASIS OF PRESENTATION AND SIGNIFICANT EVENTS&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements are presented in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the disclosures normally required by accounting principles generally accepted in the United States of America, or GAAP, or those normally made in an Annual Report on Form 10-K. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. For further information, the reader of this Form 10-Q should refer to our Form 10-K for the year ended December 31, 2022, that was filed with the Securities and Exchange Commission, or the SEC, on February&#160;16, 2023. We refer to this Form 10-K as the &#x201c;2022 Form 10-K&#x201d; in this document. References throughout this document to &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; &#x201c;Company,&#x201d; and &#x201c;Humana&#x201d; mean Humana Inc. and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of our condensed consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The areas involving the most significant use of estimates are the estimation of benefits payable, the impact of risk adjustment provisions related to our Medicare contracts, the valuation and related impairment recognition of investment securities, and the valuation and related impairment recognition of long-lived assets, including goodwill and indefinite-lived intangible assets. These estimates are based on knowledge of current events and anticipated future events, and accordingly, actual results may ultimately differ materially from those estimates. For additional information regarding accounting policies considered in preparing our consolidated financial statements, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial information has been prepared in accordance with our customary accounting practices and has not been audited. In our opinion, the information presented reflects all adjustments necessary for a fair statement of interim results. All such adjustments are of a normal and recurring nature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%"&gt;Employer Group Commercial Medical Products Business Exit&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2023, we announced our planned exit from the Employer Group Commercial Medical Products business, which includes all fully insured, self-funded and Federal Employee Health Benefit medical plans, as well as associated wellness and rewards programs. No other Humana health plan offerings are materially affected. Following a strategic review, we determined the Employer Group Commercial Medical Products business was no longer positioned to sustainably meet the needs of commercial members over the long term or support our long-term strategic plans. The exit from this line of business will be phased over the next 18 to 24 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Value Creation Initiatives &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, in order to create capacity to fund growth and investment in our Medicare Advantage business and further expansion of our healthcare services capabilities in 2023, we committed to drive additional value for the enterprise through cost saving, productivity initiatives, and value acceleration from previous investments. As a result of these initiatives, we recorded charges of $473 million for the year-ended December 31, 2022. These charges primarily relate to $248&#160;million in asset impairments, including software and abandonment, and $116&#160;million of severance charges in connection with workforce optimization. The remainder of the charges primarily relate to external consulting fees. These charges were recorded at the corporate level and not allocated to the segments. We did not record any charges in the first quarter of 2022, with no recurring charges in 2023.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;COVID-19&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The emergence and spread of the novel coronavirus, or COVID-19, beginning in the first quarter of 2020 has impacted our business. During periods of increased incidences of COVID-19, a reduction in non-COVID-19 hospital admissions for non-emergent and elective medical care have resulted in lower overall healthcare system utilization. At the same time, COVID-19 treatment and testing costs increased utilization. During 2022, we experienced lower overall utilization of the healthcare system than anticipated, as the reduction in COVID-19 utilization following the increased incidence associated with the Omicron variant outpaced the increase in non-COVID-19 utilization. The significant disruption in utilization during 2020 also impacted our ability to implement clinical initiatives to manage health care costs and chronic conditions of our members, and appropriately document their risk profiles, and, as such, significantly affected our 2021 revenue under the risk adjustment payment model for Medicare Advantage plans. Finally, changes in utilization patterns and actions taken in 2021 as a result of the COVID-19 pandemic, including the suspension of certain financial recovery programs for a period of time and shifting the timing of claim payments and provider capitation surplus payments, impacted our claim reserve development and operating cash flows for 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 National Emergency declared in 2020 was terminated on April 10, 2023 and the Public Health Emergency is set to expire on May 11, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues include premiums and services revenue. Services revenue includes administrative service fees that are recorded based upon established per member per month rates and the number of members for the month and are recognized as services are provided for the month. Additionally, services revenue includes net patient services revenue that are recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For additional information regarding our revenues, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. For additional information regarding disaggregation of revenue by segment and type, refer to Note 14 to the unaudited Condensed Consolidated Financial Statements included in Part I, Item 1, "Financial Statements" of this Form 10-Q.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023, accounts receivable related to services were $246&#160;million. For the three months ended March 31, 2023, we had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the condensed consolidated balance sheet at March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2023, services revenue recognized from performance obligations related to prior periods, such as due to changes in transaction price, was not material. Further, services revenue expected to be recognized in any future year related to remaining performance obligations was not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfNjc0OQ_fc79885f-b7bc-4a74-bfc3-d185763caed2">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements are presented in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the disclosures normally required by accounting principles generally accepted in the United States of America, or GAAP, or those normally made in an Annual Report on Form 10-K. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. For further information, the reader of this Form 10-Q should refer to our Form 10-K for the year ended December 31, 2022, that was filed with the Securities and Exchange Commission, or the SEC, on February&#160;16, 2023. We refer to this Form 10-K as the &#x201c;2022 Form 10-K&#x201d; in this document. References throughout this document to &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; &#x201c;Company,&#x201d; and &#x201c;Humana&#x201d; mean Humana Inc. and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of our condensed consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The areas involving the most significant use of estimates are the estimation of benefits payable, the impact of risk adjustment provisions related to our Medicare contracts, the valuation and related impairment recognition of investment securities, and the valuation and related impairment recognition of long-lived assets, including goodwill and indefinite-lived intangible assets. These estimates are based on knowledge of current events and anticipated future events, and accordingly, actual results may ultimately differ materially from those estimates. For additional information regarding accounting policies considered in preparing our consolidated financial statements, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial information has been prepared in accordance with our customary accounting practices and has not been audited. In our opinion, the information presented reflects all adjustments necessary for a fair statement of interim results. All such adjustments are of a normal and recurring nature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%"&gt;Employer Group Commercial Medical Products Business Exit&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2023, we announced our planned exit from the Employer Group Commercial Medical Products business, which includes all fully insured, self-funded and Federal Employee Health Benefit medical plans, as well as associated wellness and rewards programs. No other Humana health plan offerings are materially affected. Following a strategic review, we determined the Employer Group Commercial Medical Products business was no longer positioned to sustainably meet the needs of commercial members over the long term or support our long-term strategic plans. The exit from this line of business will be phased over the next 18 to 24 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Value Creation Initiatives &lt;/span&gt;&lt;/div&gt;During 2022, in order to create capacity to fund growth and investment in our Medicare Advantage business and further expansion of our healthcare services capabilities in 2023, we committed to drive additional value for the enterprise through cost saving, productivity initiatives, and value acceleration from previous investments. As a result of these initiatives, we recorded charges of $473 million for the year-ended December 31, 2022. These charges primarily relate to $248&#160;million in asset impairments, including software and abandonment, and $116&#160;million of severance charges in connection with workforce optimization. The remainder of the charges primarily relate to external consulting fees. These charges were recorded at the corporate level and not allocated to the segments. We did not record any charges in the first quarter of 2022, with no recurring charges in 2023.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <hum:DiscontinuedOperationsSegmentPhaseOutPeriod
      contextRef="i2449d3dd94054171a333473a8b30e8d9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfMTY0OTI2NzQ2MDQ1Nw_12ddb789-2b93-4cd0-958d-aef59c33f8c1">P18M</hum:DiscontinuedOperationsSegmentPhaseOutPeriod>
    <hum:DiscontinuedOperationsSegmentPhaseOutPeriod
      contextRef="iffa2d44aeefe49eb901d869a778d954f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfMTY0OTI2NzQ2MDQ2MQ_92704fc5-c4f2-4285-8474-57e807c71ada">P24M</hum:DiscontinuedOperationsSegmentPhaseOutPeriod>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i86b101ff14884b76ba0a3e3909ff5915_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfMjkzMg_b6bd5dc7-ca50-4bd2-bccc-0ea987259ebc"
      unitRef="usd">473000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i86b101ff14884b76ba0a3e3909ff5915_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfMTA5OTUxMTYzNzI4OQ_f4ba852d-d180-4d67-b436-9a28007a8e6f"
      unitRef="usd">248000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:SeveranceCosts1
      contextRef="i86b101ff14884b76ba0a3e3909ff5915_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfMTA5OTUxMTYzNzI3NQ_db154284-5a9f-4a77-abc3-47984f6b12fa"
      unitRef="usd">116000000</us-gaap:SeveranceCosts1>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="iba36eec577cb4c97b3c20a998f977679_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfMTY0OTI2NzQ2MDQ2OA_374fdfc0-dff6-4545-b905-d3c088cd2524"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfNjcyOQ_88b23527-c21d-468d-ba82-d7c61f37f4d6">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues include premiums and services revenue. Services revenue includes administrative service fees that are recorded based upon established per member per month rates and the number of members for the month and are recognized as services are provided for the month. Additionally, services revenue includes net patient services revenue that are recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For additional information regarding our revenues, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. For additional information regarding disaggregation of revenue by segment and type, refer to Note 14 to the unaudited Condensed Consolidated Financial Statements included in Part I, Item 1, "Financial Statements" of this Form 10-Q.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ifa05aa9eea8340d1a4b6993427e169a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNC9mcmFnOmJjNDgzNmQ5NTBmNjQ4YThhZTBiODkwYTE5ZTBlYTk4L3RleHRyZWdpb246YmM0ODM2ZDk1MGY2NDhhOGFlMGI4OTBhMTllMGVhOThfNjIyNQ_f0c965b3-0275-4b4f-be72-91e966578a91"
      unitRef="usd">246000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNy9mcmFnOjFkMzgzNmVjNDJhYjQ3MzU5NWY2NDNkMzVlYmRhZWE1L3RleHRyZWdpb246MWQzODM2ZWM0MmFiNDczNTk1ZjY0M2QzNWViZGFlYTVfMTc5Mg_3a6816de-d0ae-4f46-8f43-3a6d20de9ef5">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTSIn November 2020, the FASB issued Accounting Standards Update No. 2020-11, Financial Services&#x2014;Insurance (Topic 944): Effective Date and Early Application (&#x201c;ASU 2020-11&#x201d;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12, Financial Services&#x2014;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (&#x201c;ASU 2018-12&#x201d;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The new guidance relates to accounting for long-duration contracts of insurers which revises key elements of the measurement models and disclosure requirements for long-duration contracts issued by insurers, including the amortization of deferred contract acquisition costs and the measurement of liabilities for future policy benefits using current, rather than locked-in, assumptions. The new guidance, limited to our Medicare Supplement product which represent less than 1% of consolidated premiums and services revenue, became effective for us beginning January 1, 2023 and is to be applied to contracts in force on the basis of their existing carrying value amounts at the beginning of the earliest period presented. The adoption of the new standard in 2023 did not have a material impact on our consolidated results of operations, financial position or cash flows.There are no other recently issued accounting standards that apply to us or that are expected to have a material impact on our results of operations, financial condition, or cash flows.</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNy9mcmFnOjFkMzgzNmVjNDJhYjQ3MzU5NWY2NDNkMzVlYmRhZWE1L3RleHRyZWdpb246MWQzODM2ZWM0MmFiNDczNTk1ZjY0M2QzNWViZGFlYTVfMTc5MQ_a1ffb293-54b3-4541-b156-7ad29455340c">In November 2020, the FASB issued Accounting Standards Update No. 2020-11, Financial Services&#x2014;Insurance (Topic 944): Effective Date and Early Application (&#x201c;ASU 2020-11&#x201d;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12, Financial Services&#x2014;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (&#x201c;ASU 2018-12&#x201d;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The new guidance relates to accounting for long-duration contracts of insurers which revises key elements of the measurement models and disclosure requirements for long-duration contracts issued by insurers, including the amortization of deferred contract acquisition costs and the measurement of liabilities for future policy benefits using current, rather than locked-in, assumptions. The new guidance, limited to our Medicare Supplement product which represent less than 1% of consolidated premiums and services revenue, became effective for us beginning January 1, 2023 and is to be applied to contracts in force on the basis of their existing carrying value amounts at the beginning of the earliest period presented. The adoption of the new standard in 2023 did not have a material impact on our consolidated results of operations, financial position or cash flows.There are no other recently issued accounting standards that apply to us or that are expected to have a material impact on our results of operations, financial condition, or cash flows.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6dfc221ac14a4241a352cd2c7e2133be_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV8zNy9mcmFnOjFkMzgzNmVjNDJhYjQ3MzU5NWY2NDNkMzVlYmRhZWE1L3RleHRyZWdpb246MWQzODM2ZWM0MmFiNDczNTk1ZjY0M2QzNWViZGFlYTVfMTA5OTUxMTY0MDcwNw_8ac9ae79-4764-4c54-8bc1-75a76bec6540"
      unitRef="number">0.01</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfMjcwMA_92682e4c-cb8e-4eb8-9a2f-fcc58bf53033">ACQUISITIONS AND DIVESTITURES &lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 11, 2022, we completed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the sale of a 60% i&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nterest in Gentiva, formerly Kindred, Hospice to Clayton, Dubilier &amp;amp; Rice, or CD&amp;amp;R, for cash proceeds of approximately $2.7&#160;billion, net of cash disposed, including debt repayments from Gentiva Hospice to Humana of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.9&#160;billion. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the sale we recognized a pre-tax gain, net of transaction costs, of $237&#160;million. For the three months ended March 31, 2022, the accompanying condensed consolidated statement of income includes revenues related to Gentiva Hospice of $382&#160;million and pretax earnings of $62&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2023 and 2022, we acquired various health and wellness related businesses which, individually or in the aggregate, have not had a material impact on our results of operations, financial condition, or cash flows. The results of operations and financial condition of these businesses acquired in 2023 and 2022 have been included in our condensed consolidated statements of income and condensed consolidated balance sheets from the respective acquisition dates. Acquisition-related costs recognized in 2023 and 2022 were not material to our results of operations. For asset acquisitions, the goodwill acquired is partially amortizable as deductible expenses for tax purposes. The pro forma financial information assuming the acquisitions had occurred as of the beginning of the calendar year prior to the year of acquisition, as well as the revenues and earnings generated during the year of acquisition, were not material for disclosure purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold
      contextRef="iec2ff4cf5f8a4840a5cfda8104745276_I20220811"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfODY_09951cdc-70a0-49ed-b1f2-d4aec94d638b"
      unitRef="number">0.60</hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="iec2ff4cf5f8a4840a5cfda8104745276_I20220811"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfMjM1_495cf04f-0bca-412b-ad92-10a1b5f64ba3"
      unitRef="usd">2700000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:RepaymentsOfDebt
      contextRef="i1f3a5a6a5bd240fd8dc9dddaaf415109_D20220811-20220811"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfMzE3_ed1d59bf-95f2-4810-a54d-d4f3e6c72894"
      unitRef="usd">1900000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="i774b70cfc8b949b4b88dc4f2aefa89c5_D20220811-20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfNDA4_b70cc4af-ab7b-4a41-bea9-084b8ba30960"
      unitRef="usd">237000000</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i7411361d05ab46818cbd5d7ff1e21d74_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfMzI5ODUzNDg4NzY4OQ_052a3d24-367b-43f4-87b4-63fcefb26201"
      unitRef="usd">382000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax
      contextRef="i7411361d05ab46818cbd5d7ff1e21d74_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80MC9mcmFnOjZmZmQyZDhkMzYwYjRiODJiZDJmODUwOWI5MjYzY2QxL3RleHRyZWdpb246NmZmZDJkOGQzNjBiNGI4MmJkMmY4NTA5YjkyNjNjZDFfMzI5ODUzNDg4NzcwMQ_295a3cd9-217c-4614-b4ae-f14fa35da991"
      unitRef="usd">62000000</us-gaap:IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMzE0MQ_62dd0037-0e82-429e-ae6c-050960fe783d">INVESTMENT SECURITIES&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment securities classified as current and long-term were as follows at March&#160;31, 2023 and December 31, 2022, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.551%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government&lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government &lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We held certain corporate debt securities of Gentiva Hospice at March&#160;31, 2023 with amortized cost and fair value of approximately $281&#160;million and $286&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross unrealized losses and fair values aggregated by investment category and length of time of individual debt securities that have been in a continuous unrealized loss position for which no allowances for credit loss has been recorded were as follows at March&#160;31, 2023 and December 31, 2022, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 months or more&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately 98% of our debt securities were investment-grade quality, with a weighted average credit rating of AA by Standard &amp;amp; Poor's Rating Service, or S&amp;amp;P, at March&#160;31, 2023. Most of the debt securities that were below investment-grade were rated BB-, the higher end of the below investment-grade rating scale. Tax-exempt municipal securities were diversified among general obligation bonds of states and local municipalities in the United States as well as special revenue bonds issued by municipalities to finance specific public works projects such as utilities, water and sewer, transportation, or education.&#160;Our general obligation bonds are diversified across the United States with no individual state exceeding 1% of our total debt securities. Our investment policy limits investments in a single issuer and requires diversification among various asset types.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our unrealized losses from all debt securities were generated from approximately 1,550 positions out of a total of approximately 1,950 positions at March&#160;31, 2023. All issuers of debt securities we own that were trading at an unrealized loss at March&#160;31, 2023 remain current on all contractual payments. After taking into account these and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;other factors previously described, we believe these unrealized losses primarily were caused by an increase in market interest rates in the current markets since the time these debt securities were purchased. At March&#160;31, 2023, we did not intend to sell any debt securities with an unrealized loss position in accumulated other comprehensive income, and it is not likely that we will be required to sell these debt securities before recovery of their amortized cost basis. Additionally, we did not record any material credit allowances for debt securities that were in an unrealized loss position for the three months ended March 31, 2023 or 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The detail of (losses) gains related to investment securities and included within investment income was as follows for the three months ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.618%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net recognized losses on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains and losses related to equity securities for the three months ended March 31, 2023 and 2022 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gains (losses) recognized on equity securities during the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net gains (losses) recognized on equity securities sold during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses recognized on equity securities still held at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contractual maturities of debt securities available for sale at March&#160;31, 2023, regardless of their balance sheet classification, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage and asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;For additional information regarding our investment securities, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMzExNQ_8dbf6202-d17d-4a46-8b1d-0a76fd601dc9">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment securities classified as current and long-term were as follows at March&#160;31, 2023 and December 31, 2022, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.551%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government&lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government &lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNC0xLTEtMS0xNzg5MjU_80af0a3e-9dcf-4549-ad7d-832078e18b9a"
      unitRef="usd">1394000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNC0zLTEtMS0xNzg5MjU_562a89ab-dc8d-4940-9a58-618640221599"
      unitRef="usd">9000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNC01LTEtMS0xNzg5MjU_d97c78d2-b0d5-4621-88f7-e191b8d605fe"
      unitRef="usd">47000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNC03LTEtMS0xNzg5MjU_4785c071-356d-4e7a-9686-66ebc5198dac"
      unitRef="usd">1356000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id0051509dd034287a67b025711d2b730_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNS0xLTEtMS0xNzg5MjU_13a9aedc-fb27-4d0c-87f0-56b7b441fce4"
      unitRef="usd">3919000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id0051509dd034287a67b025711d2b730_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNS0zLTEtMS0xNzg5MjU_7ec7abb1-e26f-45f7-a508-65c042357831"
      unitRef="usd">7000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id0051509dd034287a67b025711d2b730_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNS01LTEtMS0xNzg5MjU_0dae6436-9b25-4e0d-8f75-d078c5476331"
      unitRef="usd">423000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id0051509dd034287a67b025711d2b730_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNS03LTEtMS0xNzg5MjU_8a589018-e393-4742-b07b-bced07f9fa82"
      unitRef="usd">3503000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNi0xLTEtMS0xNzg5MjU_92379b3c-2af4-4dbd-b3db-87ee7934d9fe"
      unitRef="usd">762000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNi0zLTEtMS0xNzg5MjU_d1b267e1-457a-4e84-a139-566fafb4c1f5"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNi01LTEtMS0xNzg5MjU_6699dd06-c268-45e4-91de-a7b74def076c"
      unitRef="usd">27000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfNi03LTEtMS0xNzg5MjU_73c8ddbf-c9b5-4b38-8841-ee5463a9d6e5"
      unitRef="usd">736000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOC0xLTEtMS0xNzg5MjU_57a65baf-421a-4888-adba-e810f89b27c8"
      unitRef="usd">470000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOC0zLTEtMS0xNzg5MjU_8a0e8a31-baf1-4489-bbc9-296a4308e1ea"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOC01LTEtMS0xNzg5MjU_d636d7d4-793d-4239-ad4a-0719fd6ffa96"
      unitRef="usd">73000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOC03LTEtMS0xNzg5MjU_1efd561f-4cba-46be-abd8-cacdb45a9a71"
      unitRef="usd">397000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOS0xLTEtMS0xNzg5MjU_09b6dc73-c778-4b96-876a-255d73cc582c"
      unitRef="usd">1562000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOS0zLTEtMS0xNzg5MjU_96adeebd-4f46-4aa7-9e99-ac58a22c7c0a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOS01LTEtMS0xNzg5MjU_798dee22-986f-41fc-ac73-a939555657a4"
      unitRef="usd">149000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfOS03LTEtMS0xNzg5MjU_44aecebb-f9b9-4518-a8e6-882a43e258a4"
      unitRef="usd">1413000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTAtMS0xLTEtMTc4OTI1_9947a836-2de6-47e3-9fe4-c9b4ee0dc347"
      unitRef="usd">1915000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTAtMy0xLTEtMTc4OTI1_d238cfa5-6049-458c-8c29-98948f571b84"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTAtNS0xLTEtMTc4OTI1_150fed47-1045-4574-929f-159ffac288a7"
      unitRef="usd">64000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTAtNy0xLTEtMTc4OTI1_8ded9a7e-d6c9-4c20-b4be-2032ce876168"
      unitRef="usd">1853000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTEtMS0xLTEtMTc4OTI1_98e3de38-039d-47dd-9d34-f190c45ac0c7"
      unitRef="usd">6725000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTEtMy0xLTEtMTc4OTI1_771a27dd-cce2-494a-addb-60c4872453bb"
      unitRef="usd">16000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTEtNS0xLTEtMTc4OTI1_7935b312-e385-46fe-907b-1081c0a31831"
      unitRef="usd">696000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTEtNy0xLTEtMTc4OTI1_eaa57657-a888-4f3a-b667-4827159a7ff2"
      unitRef="usd">6045000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTItMS0xLTEtMTc4OTI1_0367892f-30c1-403b-9736-90f6e743cc88"
      unitRef="usd">16747000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTItMy0xLTEtMTc4OTI1_db70bb5f-1784-4059-aa87-081316202214"
      unitRef="usd">35000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTItNS0xLTEtMTc4OTI1_b165d356-108f-4764-a2f7-806492d09656"
      unitRef="usd">1479000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTItNy0xLTEtMTc4OTI1_da9beba0-3e68-4efa-a9c3-fb2113306ee6"
      unitRef="usd">15303000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTMtNy0xLTEtMTc4OTI1_9b048ce6-401d-4052-8b77-2952c7da1825"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:Investments
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTQtNy0xLTEtMTc4OTI1_f4845e8b-7c24-458b-ae80-6093abfcfc25"
      unitRef="usd">15303000000</us-gaap:Investments>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTgtMS0xLTEtMTc4OTI1_7d25ca7e-e305-4a4b-95f0-4d45820ae5f5"
      unitRef="usd">1093000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTgtMy0xLTEtMTc4OTI1_15bc583e-5d40-4d05-a86f-4b9c04dae5c4"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTgtNS0xLTEtMTc4OTI1_21835a86-e037-43ab-aa8c-bbb8c13d8a25"
      unitRef="usd">55000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTgtNy0xLTEtMTc4OTI1_7e1dbc60-4112-4889-a5f2-63bc5519ccff"
      unitRef="usd">1039000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTktMS0xLTEtMTc4OTI1_48827ad4-e2a4-495a-892f-4926d63a40c6"
      unitRef="usd">3697000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTktMy0xLTEtMTc4OTI1_252fcf01-3c2b-4041-ae39-47b5df317f4d"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTktNS0xLTEtMTc4OTI1_9a0ce769-be4a-44ab-ab65-376513634f08"
      unitRef="usd">471000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMTktNy0xLTEtMTc4OTI1_f0e57b64-5f29-45a6-9a77-f74538df59a7"
      unitRef="usd">3230000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjAtMS0xLTEtMTc4OTI1_8f0482b0-89e1-41ba-ae36-69e7affde170"
      unitRef="usd">765000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjAtMy0xLTEtMTc4OTI1_366f2938-2a69-4b01-a7f2-94de6da4b1ce"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjAtNS0xLTEtMTc4OTI1_d9cb6baf-c017-4333-b7e5-fb01f2dad6c9"
      unitRef="usd">37000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjAtNy0xLTEtMTc4OTI1_ced31fcd-177b-4472-9095-47657b3162e9"
      unitRef="usd">728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i87f38b14697145628ecc307a28156bc7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjItMS0xLTEtMTc4OTI1_bb24a943-53c1-4bbf-a1c7-6c2cd02c09af"
      unitRef="usd">477000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i87f38b14697145628ecc307a28156bc7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjItMy0xLTEtMTc4OTI1_df7e855e-9a86-4e2f-90e7-f851daadec57"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i87f38b14697145628ecc307a28156bc7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjItNS0xLTEtMTc4OTI1_6d9f7a08-6aca-478f-bb19-185754791e89"
      unitRef="usd">76000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i87f38b14697145628ecc307a28156bc7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjItNy0xLTEtMTc4OTI1_7be8648a-ccb9-4580-a3a5-dda2f0fd5275"
      unitRef="usd">401000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i39a81466c1f7403098573c8663478092_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjMtMS0xLTEtMTc4OTI1_2223454f-a311-4dfb-bbcb-e43b3b661590"
      unitRef="usd">1554000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i39a81466c1f7403098573c8663478092_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjMtMy0xLTEtMTc4OTI1_a4583a8f-56ce-4258-a636-b5b26e1e5cf9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i39a81466c1f7403098573c8663478092_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjMtNS0xLTEtMTc4OTI1_45d70c2e-6084-47f8-84cb-6b59622b36c8"
      unitRef="usd">155000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i39a81466c1f7403098573c8663478092_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjMtNy0xLTEtMTc4OTI1_1fe72646-8e77-45d5-a3ca-f57f8d2933dc"
      unitRef="usd">1399000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjQtMS0xLTEtMTc4OTI1_935a0b5c-a23f-4933-a3f3-f61230146861"
      unitRef="usd">1809000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjQtMy0xLTEtMTc4OTI1_9ffe378c-e0a6-4e37-ab63-232b61e91303"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjQtNS0xLTEtMTc4OTI1_a0b922c3-2b59-4fcd-a2d0-1eb441e722ba"
      unitRef="usd">79000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjQtNy0xLTEtMTc4OTI1_53874ce9-0731-4122-9a01-c4cfa58b4adf"
      unitRef="usd">1731000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjUtMS0xLTEtMTc4OTI1_1e8c6a16-2602-4d27-8db1-801dfba8fddc"
      unitRef="usd">6551000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjUtMy0xLTEtMTc4OTI1_1f3624ec-8c16-40bf-aad1-bc8247aeafd5"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjUtNS0xLTEtMTc4OTI1_115387c0-3efe-4535-abde-d3484e9d51cc"
      unitRef="usd">828000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjUtNy0xLTEtMTc4OTI1_51ed7baa-0711-4709-9d10-ca12f9748ed9"
      unitRef="usd">5726000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjYtMS0xLTEtMTc4OTI1_6ea3ad3e-36ed-449a-aab9-f7e0fe2bbfca"
      unitRef="usd">15946000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjYtMy0xLTEtMTc4OTI1_22e45c32-0f9b-4b76-8660-36d1dfc799a9"
      unitRef="usd">9000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjYtNS0xLTEtMTc4OTI1_843800c9-9938-4521-9bd2-ebc929eea08c"
      unitRef="usd">1701000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjYtNy0xLTEtMTc4OTI1_90d367ad-5207-42d4-a48d-393d472aa48e"
      unitRef="usd">14254000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjctNy0xLTEtMTc4OTI1_b99f5e47-f55e-4265-9016-e072c35c2777"
      unitRef="usd">7000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:Investments
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4YTZhZjEwMWFhMTQ5ZjA4NzA4MzQxOGVlYjE0OTVmL3RhYmxlcmFuZ2U6ZjhhNmFmMTAxYWExNDlmMDg3MDgzNDE4ZWViMTQ5NWZfMjgtNy0xLTEtMTc4OTI1_d53339a3-0a89-4067-b9ff-16ac5a115490"
      unitRef="usd">14261000000</us-gaap:Investments>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if809f4ba53f94156aaf6671a93356b6a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMjcw_eeaf2af6-4efe-4f5f-9c6b-d44944215f66"
      unitRef="usd">281000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if809f4ba53f94156aaf6671a93356b6a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMjc3_45fe6da2-858b-4198-a869-c79229ab887a"
      unitRef="usd">286000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMzE1Mg_89d7e77a-0f9f-41fa-946c-d9899a1830ee">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross unrealized losses and fair values aggregated by investment category and length of time of individual debt securities that have been in a continuous unrealized loss position for which no allowances for credit loss has been recorded were as follows at March&#160;31, 2023 and December 31, 2022, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 months or more&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNS0xLTEtMS0xNzg5MjU_d5e8739d-bd47-428e-832c-e07e78f08bcd"
      unitRef="usd">290000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNS0zLTEtMS0xNzg5MjU_991da004-8e51-4332-813a-9e6f9617ca9b"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNS01LTEtMS0xNzg5MjU_7095d1c7-0897-448b-b389-04898f7a2c7d"
      unitRef="usd">396000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNS03LTEtMS0xNzg5MjU_75000a7f-afe3-4d8a-b4ed-727f83900382"
      unitRef="usd">45000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNS05LTEtMS0xNzg5MjU_325fa703-671f-46b6-ba11-39e59dd63278"
      unitRef="usd">686000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i47c85cc668754e14a243b50fa57763f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNS0xMS0xLTEtMTc4OTI1_31ee96a5-bf69-4f48-98b5-5c37c720e410"
      unitRef="usd">47000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="id0051509dd034287a67b025711d2b730_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNi0xLTEtMS0xNzg5MjU_4e941270-a72c-4365-be3f-e45c78bddaf5"
      unitRef="usd">867000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="id0051509dd034287a67b025711d2b730_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNi0zLTEtMS0xNzg5MjU_c70487a7-238f-41a0-8b85-3193bb37ad2d"
      unitRef="usd">17000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="id0051509dd034287a67b025711d2b730_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNi01LTEtMS0xNzg5MjU_8db3f8fc-ee00-4550-ab90-ad1e81186cc6"
      unitRef="usd">2123000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="id0051509dd034287a67b025711d2b730_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNi03LTEtMS0xNzg5MjU_b1f6c6b4-4a62-4c7f-8c5a-2d483e88c229"
      unitRef="usd">406000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="id0051509dd034287a67b025711d2b730_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNi05LTEtMS0xNzg5MjU_cde104ce-74f5-4daf-a2d9-bd105aa3cfa4"
      unitRef="usd">2990000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="id0051509dd034287a67b025711d2b730_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNi0xMS0xLTEtMTc4OTI1_7f1777ea-506e-4924-8d58-ed881159a601"
      unitRef="usd">423000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNy0xLTEtMS0xNzg5MjU_acf5a7dc-ae1f-4169-b069-8cae00f337a4"
      unitRef="usd">343000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNy0zLTEtMS0xNzg5MjU_c8a2d65a-66e5-4c22-b9dc-cead27d55555"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNy01LTEtMS0xNzg5MjU_fefc5acc-2301-4c0a-8f5f-a91f3e5ea450"
      unitRef="usd">314000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNy03LTEtMS0xNzg5MjU_125a60dc-e4e8-47f0-b849-e9cdf3bce12a"
      unitRef="usd">22000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNy05LTEtMS0xNzg5MjU_0070a5aa-1875-481e-b839-c62b506e06d7"
      unitRef="usd">657000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i15abec1371de4cf7bf934abdac554c41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfNy0xMS0xLTEtMTc4OTI1_bcd5ba70-5ee7-4866-a905-37978f9f91da"
      unitRef="usd">27000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfOS0xLTEtMS0xNzg5MjU_eee821f6-cb71-4d1d-adb8-acb4b9beb02d"
      unitRef="usd">25000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfOS0zLTEtMS0xNzg5MjU_88646536-b9b4-4e7e-b6ed-71b1c0339234"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfOS01LTEtMS0xNzg5MjU_81fdeaf3-fbd2-43d9-8988-48218331f242"
      unitRef="usd">369000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfOS03LTEtMS0xNzg5MjU_f9ea9fc5-e213-4ee6-922f-0ca4eba99a38"
      unitRef="usd">71000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfOS05LTEtMS0xNzg5MjU_eaef8ae2-ef2b-4d40-87a2-c3244d822086"
      unitRef="usd">394000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ie2aab95a3fa1453f9e1ad63604416346_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfOS0xMS0xLTEtMTc4OTI1_c0fca5ef-9b0c-40ec-af4f-db13885a5d16"
      unitRef="usd">73000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTAtMS0xLTEtMTc4OTI1_4c5136d5-227d-4b4a-8c39-824bdca4de25"
      unitRef="usd">119000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTAtMy0xLTEtMTc4OTI1_e542fab2-96c3-4868-af30-5b0aaf8c8b92"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTAtNS0xLTEtMTc4OTI1_3415e0a4-dfee-4151-92f1-dcded6422232"
      unitRef="usd">1275000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTAtNy0xLTEtMTc4OTI1_0d6363dd-c5e4-4aad-aae1-ce873e9be6ea"
      unitRef="usd">145000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTAtOS0xLTEtMTc4OTI1_08ce3c5b-e2a9-4964-9b69-7289179d70cb"
      unitRef="usd">1394000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib51726213f4349ada57bbe678b9ecbe9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTAtMTEtMS0xLTE3ODkyNQ_3b99398b-9192-4ca7-bfd9-3c2ccc2028f8"
      unitRef="usd">149000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTEtMS0xLTEtMTc4OTI1_2729d4c5-76d6-43cd-a58d-59b4c69fab3f"
      unitRef="usd">583000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTEtMy0xLTEtMTc4OTI1_e5b1c9e5-1144-4f70-a172-1e112a332525"
      unitRef="usd">21000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTEtNS0xLTEtMTc4OTI1_ce40408c-36a2-430f-97ae-2dad65c92ff4"
      unitRef="usd">971000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTEtNy0xLTEtMTc4OTI1_aff6a244-2077-4f15-aff8-720a23f7a789"
      unitRef="usd">43000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTEtOS0xLTEtMTc4OTI1_337f8fea-b6fc-4609-b442-94ec1e249068"
      unitRef="usd">1554000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i54bb3ec275a04853bd67cc69eda788a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTEtMTEtMS0xLTE3ODkyNQ_ca4f594f-c787-4c6c-ad05-127e91c86236"
      unitRef="usd">64000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTItMS0xLTEtMTc4OTI1_e1a91212-277e-4d6e-8442-01a2ce8ec8ff"
      unitRef="usd">1453000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTItMy0xLTEtMTc4OTI1_6903d6dc-82e4-4c0b-a96c-d7ae5a6d35ba"
      unitRef="usd">47000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTItNS0xLTEtMTc4OTI1_d48e440e-99b5-4285-b181-055521399e33"
      unitRef="usd">3634000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTItNy0xLTEtMTc4OTI1_2270a9ec-a194-460a-b893-30044cc21f31"
      unitRef="usd">649000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTItOS0xLTEtMTc4OTI1_5ca67d2d-447e-47ce-8f34-0b01d2ca157d"
      unitRef="usd">5087000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i81fc15fb6f8747a3b130af075be61c68_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTItMTEtMS0xLTE3ODkyNQ_11bc0b9c-9e84-4fcb-a17e-c7c5ed48098b"
      unitRef="usd">696000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTMtMS0xLTEtMTc4OTI1_1b8bccb7-844c-46b3-9e0e-72631cbbba46"
      unitRef="usd">3680000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTMtMy0xLTEtMTc4OTI1_481cfd96-1e36-4b09-bc76-a814356d538d"
      unitRef="usd">98000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTMtNS0xLTEtMTc4OTI1_6c535b01-f4d3-46bf-8a9d-079671dfa3ee"
      unitRef="usd">9082000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTMtNy0xLTEtMTc4OTI1_69dbd014-c4f1-44cf-99c1-f742aa67bf07"
      unitRef="usd">1381000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTMtOS0xLTEtMTc4OTI1_6dc9e71e-a619-419f-8e1f-d06107bf6586"
      unitRef="usd">12762000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTMtMTEtMS0xLTE3ODkyNQ_6bb3ed0b-6dc0-4df1-b99f-e431d01433a2"
      unitRef="usd">1479000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTctMS0xLTEtMTc4OTI1_a1626378-d0b5-4cd2-b240-d3dcb5e20d9d"
      unitRef="usd">512000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTctMy0xLTEtMTc4OTI1_b140fe58-c803-486c-9f75-dfcbcae374e9"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTctNS0xLTEtMTc4OTI1_7fd74452-1614-4b8f-b65b-64b4e63316ac"
      unitRef="usd">397000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTctNy0xLTEtMTc4OTI1_36be3061-a7cd-4e4a-bb8d-a81ed379e71d"
      unitRef="usd">50000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTctOS0xLTEtMTc4OTI1_847c92fc-46be-4649-9f4a-b180b3eaee57"
      unitRef="usd">909000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i390f059dfaec48feb01a156d8783fc91_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTctMTEtMS0xLTE3ODkyNQ_012acf58-1e8c-4d1a-94b3-ac4b2231e613"
      unitRef="usd">55000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTgtMS0xLTEtMTc4OTI1_14ec9b66-a4e1-43a0-9820-468eb83f1aed"
      unitRef="usd">1231000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTgtMy0xLTEtMTc4OTI1_2cbd5fbc-359c-435b-81c9-c5672cb947ea"
      unitRef="usd">104000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTgtNS0xLTEtMTc4OTI1_ea81c2a3-6342-4192-9783-1a44f2653821"
      unitRef="usd">1683000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTgtNy0xLTEtMTc4OTI1_9075f495-e480-4130-b5d5-2faf798201fa"
      unitRef="usd">367000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTgtOS0xLTEtMTc4OTI1_ce53d365-704f-4b48-ad41-1f20eee7133e"
      unitRef="usd">2914000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i890ddd7992a2436fb3eeb7c9589676f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTgtMTEtMS0xLTE3ODkyNQ_d981ea3f-5e11-417b-8785-ed02d6870527"
      unitRef="usd">471000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTktMS0xLTEtMTc4OTI1_65fbddec-8dcd-4ab2-abbc-03db77f1be9f"
      unitRef="usd">64000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTktMy0xLTEtMTc4OTI1_df593d3b-3e23-4fdb-9fad-253810bcd0cc"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTktNS0xLTEtMTc4OTI1_330f0123-d222-4437-902b-b50d733cc8b9"
      unitRef="usd">615000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTktNy0xLTEtMTc4OTI1_342f7c01-0056-4abb-8960-cd72da6c9dba"
      unitRef="usd">36000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTktOS0xLTEtMTc4OTI1_471306d4-bb82-4f1c-8072-4c5777048872"
      unitRef="usd">679000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ic5bb1b5614c04eea823dee1b8e9a5550_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMTktMTEtMS0xLTE3ODkyNQ_5a769524-7713-4632-8df8-75889b480c38"
      unitRef="usd">38000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i87f38b14697145628ecc307a28156bc7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjEtMS0xLTEtMTc4OTI1_192bf3f6-f452-41b6-b05a-2c3772161820"
      unitRef="usd">124000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i87f38b14697145628ecc307a28156bc7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjEtMy0xLTEtMTc4OTI1_5d425c3d-45eb-4778-9742-61183d096de7"
      unitRef="usd">16000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i87f38b14697145628ecc307a28156bc7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjEtNS0xLTEtMTc4OTI1_1a503267-7a94-4b64-8d04-81df2903ee4d"
      unitRef="usd">274000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i87f38b14697145628ecc307a28156bc7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjEtNy0xLTEtMTc4OTI1_f7c658da-6e5c-4011-918b-27dcb3f0a773"
      unitRef="usd">60000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i87f38b14697145628ecc307a28156bc7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjEtOS0xLTEtMTc4OTI1_38bf3719-81c7-4b09-b157-832993718d99"
      unitRef="usd">398000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i87f38b14697145628ecc307a28156bc7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjEtMTEtMS0xLTE3ODkyNQ_2e17d0e8-22eb-4dcd-8d27-a2f270c78039"
      unitRef="usd">76000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i39a81466c1f7403098573c8663478092_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjItMS0xLTEtMTc4OTI1_44939845-7aa0-4b2d-9935-797293f33068"
      unitRef="usd">243000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i39a81466c1f7403098573c8663478092_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjItMy0xLTEtMTc4OTI1_2a16fbcc-cd60-448d-88d4-645fbc1ff5d5"
      unitRef="usd">13000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i39a81466c1f7403098573c8663478092_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjItNS0xLTEtMTc4OTI1_3150726f-5d7b-4d28-ae7d-bda7ecee1ac9"
      unitRef="usd">1157000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i39a81466c1f7403098573c8663478092_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjItNy0xLTEtMTc4OTI1_f3fba807-d17d-49bb-8e6f-ff66bed01f8d"
      unitRef="usd">142000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i39a81466c1f7403098573c8663478092_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjItOS0xLTEtMTc4OTI1_912bdb1e-4dcb-4018-a1d1-d5fb19cf9b68"
      unitRef="usd">1400000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i39a81466c1f7403098573c8663478092_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjItMTEtMS0xLTE3ODkyNQ_51afc760-d086-4c82-979d-fd3faa6d7b9d"
      unitRef="usd">155000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjMtMS0xLTEtMTc4OTI1_2fa4ee2a-723f-4d89-9a21-300337100e4d"
      unitRef="usd">620000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjMtMy0xLTEtMTc4OTI1_bda2ebf7-7c93-49dc-8964-fc6dcd639b5f"
      unitRef="usd">32000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjMtNS0xLTEtMTc4OTI1_0f631a34-0ffb-4fba-a502-db7ef8ad23af"
      unitRef="usd">1011000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjMtNy0xLTEtMTc4OTI1_f6d43aee-2133-4e86-960f-d3bdfa014971"
      unitRef="usd">46000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjMtOS0xLTEtMTc4OTI1_2dbc8f07-7d5c-4913-bbc6-00a07f7d8f6d"
      unitRef="usd">1631000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i996180d89c8e4507a623f2af94aa1a1b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjMtMTEtMS0xLTE3ODkyNQ_666b394e-31a1-4272-887c-e022e89e5eab"
      unitRef="usd">78000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjQtMS0xLTEtMTc4OTI1_3d49c7d7-cce9-4526-92da-79c20387b306"
      unitRef="usd">1625000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjQtMy0xLTEtMTc4OTI1_4884427e-dae1-44ea-9c3d-5ebfc3f53b63"
      unitRef="usd">98000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjQtNS0xLTEtMTc4OTI1_9eb01e6c-a1e2-43cd-ac58-4c4fb1bfd786"
      unitRef="usd">3825000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjQtNy0xLTEtMTc4OTI1_093ed19e-ce1d-4d88-93fb-13f96566b3bd"
      unitRef="usd">730000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjQtOS0xLTEtMTc4OTI1_380ec331-684c-4392-96bb-34dae2d4520f"
      unitRef="usd">5450000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i29186f806c58412193bb9d3fb6965e02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjQtMTEtMS0xLTE3ODkyNQ_9b9f2649-aaa9-403d-bc2e-88a5d2eb7e4b"
      unitRef="usd">828000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjUtMS0xLTEtMTc4OTI1_a7d2e01c-b9f2-407e-86f9-5090711f0ff5"
      unitRef="usd">4419000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjUtMy0xLTEtMTc4OTI1_6ff7624b-b10e-4252-be58-0063b3a1fe32"
      unitRef="usd">270000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjUtNS0xLTEtMTc4OTI1_140a67c3-8d54-4775-8a61-7843a2876ef7"
      unitRef="usd">8962000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjUtNy0xLTEtMTc4OTI1_d7ae2bf1-efbd-460a-9319-3227d2f6f070"
      unitRef="usd">1431000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjUtOS0xLTEtMTc4OTI1_0af37d1f-3fe5-4e06-a464-682f2ddbff4b"
      unitRef="usd">13381000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOmY4MjA0YWNjOTgyZjQ0NTI4NTg0NjBlZjA4NGVhZTQyL3RhYmxlcmFuZ2U6ZjgyMDRhY2M5ODJmNDQ1Mjg1ODQ2MGVmMDg0ZWFlNDJfMjUtMTEtMS0xLTE3ODkyNQ_42ce05b3-745c-43e6-97f7-2bbe16c8a779"
      unitRef="usd">1701000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <hum:PercentageOfTotalDebtSecuritiesInvestmentGradeQuality
      contextRef="i8260b100247b44eea92f3356e1b28db7_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfNjAw_16974207-359d-47a5-8895-74d930bc2ddc"
      unitRef="number">0.98</hum:PercentageOfTotalDebtSecuritiesInvestmentGradeQuality>
    <hum:MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMTI5NQ_d179e405-eb70-492a-9f75-bca436348ffb"
      unitRef="number">0.01</hum:MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMTUyNQ_2b214225-f152-4fae-b6da-c2c4708ef132"
      unitRef="position">1550</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <hum:DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMTU3MA_6103f2a3-aa09-4b5b-81f4-cf2dc313fd09"
      unitRef="position">1950</hum:DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions>
    <us-gaap:ScheduleOfRealizedGainLossTableTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMzE1Mw_6827aa48-76ef-461e-8b8f-fe22a8e16396">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The detail of (losses) gains related to investment securities and included within investment income was as follows for the three months ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.618%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net recognized losses on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRealizedGainLossTableTextBlock>
    <hum:DebtSecuritiesRealizedGainGross
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfMy0xLTEtMS0xNzg5MjU_e454f7b4-0eb4-4f5e-9ecf-3305b6bb9e24"
      unitRef="usd">0</hum:DebtSecuritiesRealizedGainGross>
    <hum:DebtSecuritiesRealizedGainGross
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfMy0zLTEtMS0xNzg5MjU_08fb2f50-1854-4073-836a-c9e5aa51a616"
      unitRef="usd">33000000</hum:DebtSecuritiesRealizedGainGross>
    <hum:DebtSecuritiesRealizedLossGross
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNC0xLTEtMS0xNzg5MjU_1caa1d33-65c8-4dd0-90d5-f5449f54fd5a"
      unitRef="usd">61000000</hum:DebtSecuritiesRealizedLossGross>
    <hum:DebtSecuritiesRealizedLossGross
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNC0zLTEtMS0xNzg5MjU_7592aaa3-7d78-4d94-9da5-c5fe73ae08f5"
      unitRef="usd">1000000</hum:DebtSecuritiesRealizedLossGross>
    <us-gaap:EquitySecuritiesFvNiRealizedGain
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNS0xLTEtMS0xNzg5MjU_531c95da-f0e0-4054-bc74-0b05e15c990d"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesFvNiRealizedGain>
    <us-gaap:EquitySecuritiesFvNiRealizedGain
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNS0zLTEtMS0xNzg5MjU_11835be6-7356-4c89-95f3-cb338c1d6628"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedGain>
    <us-gaap:EquitySecuritiesFvNiRealizedLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNi0xLTEtMS0xNzg5MjU_052fff34-3a47-4d91-8006-1f167f3d99ee"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNi0zLTEtMS0xNzg5MjU_7731f791-45c0-4613-85ba-2a2fcab6330d"
      unitRef="usd">108000000</us-gaap:EquitySecuritiesFvNiRealizedLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNy0xLTEtMS0xNzg5MjU_f6541d7b-8632-4eef-b9db-0c528e3fb8b2"
      unitRef="usd">-60000000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjBjOTU4N2QwMGIyYTQ4NjBhMGJlNjkzNDYzYzMzM2ZjL3RhYmxlcmFuZ2U6MGM5NTg3ZDAwYjJhNDg2MGEwYmU2OTM0NjNjMzMzZmNfNy0zLTEtMS0xNzg5MjU_2de92cc4-2426-414b-a676-abf99cc5d9b0"
      unitRef="usd">-76000000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:GainLossOnInvestmentsTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMzExNA_ae7f8a5c-53db-41c3-b429-4f54ef41b845">&lt;div style="margin-bottom:9pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains and losses related to equity securities for the three months ended March 31, 2023 and 2022 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gains (losses) recognized on equity securities during the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net gains (losses) recognized on equity securities sold during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses recognized on equity securities still held at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjQwODYxZmIxNmM1MDRjMjI5YjA0MTI2OTg5ZmY2MmI0L3RhYmxlcmFuZ2U6NDA4NjFmYjE2YzUwNGMyMjliMDQxMjY5ODlmZjYyYjRfMy0xLTEtMS0xNzg5MjU_a3e7f299-3dd3-407e-a4f7-6b4101b7ad5e"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjQwODYxZmIxNmM1MDRjMjI5YjA0MTI2OTg5ZmY2MmI0L3RhYmxlcmFuZ2U6NDA4NjFmYjE2YzUwNGMyMjliMDQxMjY5ODlmZjYyYjRfMy0zLTEtMS0xNzg5MjU_24099c4d-d5c8-465e-b4ab-25cacefeec6e"
      unitRef="usd">-108000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjQwODYxZmIxNmM1MDRjMjI5YjA0MTI2OTg5ZmY2MmI0L3RhYmxlcmFuZ2U6NDA4NjFmYjE2YzUwNGMyMjliMDQxMjY5ODlmZjYyYjRfNC0xLTEtMS0xNzg5MjU_271ba7d7-1185-4a6f-b228-82ca4361553a"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjQwODYxZmIxNmM1MDRjMjI5YjA0MTI2OTg5ZmY2MmI0L3RhYmxlcmFuZ2U6NDA4NjFmYjE2YzUwNGMyMjliMDQxMjY5ODlmZjYyYjRfNC0zLTEtMS0xNzg5MjU_f955614b-819f-430e-bc6b-a65d590098ef"
      unitRef="usd">-59000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjQwODYxZmIxNmM1MDRjMjI5YjA0MTI2OTg5ZmY2MmI0L3RhYmxlcmFuZ2U6NDA4NjFmYjE2YzUwNGMyMjliMDQxMjY5ODlmZjYyYjRfNS0xLTEtMS0xNzg5MjU_a26fac62-e5a0-4a55-a4f3-4acb69eb3c56"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjQwODYxZmIxNmM1MDRjMjI5YjA0MTI2OTg5ZmY2MmI0L3RhYmxlcmFuZ2U6NDA4NjFmYjE2YzUwNGMyMjliMDQxMjY5ODlmZjYyYjRfNS0zLTEtMS0xNzg5MjU_170c8a86-d341-4935-9b5d-a847aa3d3d66"
      unitRef="usd">-49000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RleHRyZWdpb246OTMwZmEwNmEwODA5NDllOWEwNjAxNmQ5ZTNiZDdjYzNfMzEzMA_dc10daa7-86bc-4d9d-adb6-ef6dcc9186b3">&lt;div style="margin-bottom:9pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contractual maturities of debt securities available for sale at March&#160;31, 2023, regardless of their balance sheet classification, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage and asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfMi0xLTEtMS0xNzg5MjU_3295d3a5-e0ab-40b6-ba4f-fbc4ff7b8c8a"
      unitRef="usd">500000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfMi0zLTEtMS0xNzg5MjU_f22ca371-b85d-4c34-b603-0431b9f20044"
      unitRef="usd">495000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfMy0xLTEtMS0xNzg5MjU_3671c4da-3dde-46a2-8ed4-ade485e5ca90"
      unitRef="usd">4116000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfMy0zLTEtMS0xNzg5MjU_03a3d042-09be-4bde-a667-239b2c3c7550"
      unitRef="usd">3941000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNC0xLTEtMS0xNzg5MjU_0b125cd8-c1a7-4ff3-835b-c6fda3055ef0"
      unitRef="usd">3014000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNC0zLTEtMS0xNzg5MjU_977ccc11-083a-4754-bb3b-359bd3926933"
      unitRef="usd">2650000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNS0xLTEtMS0xNzg5MjU_85aaab39-2849-4ce1-8002-c223a6d8d172"
      unitRef="usd">1251000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNS0zLTEtMS0xNzg5MjU_78543c63-66ec-4765-a398-fd13c9f0386b"
      unitRef="usd">1051000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNi0xLTEtMS0xNzg5MjU_ba38d7ab-8202-45eb-9b76-839d93f9e787"
      unitRef="usd">7866000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNi0zLTEtMS0xNzg5MjU_c3aa4830-1efb-42b6-bdbb-4db3b25292c8"
      unitRef="usd">7166000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNy0xLTEtMS0xNzg5MjU_3d1a619f-9f48-42a2-8bba-946930e5e02c"
      unitRef="usd">16747000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80My9mcmFnOjkzMGZhMDZhMDgwOTQ5ZTlhMDYwMTZkOWUzYmQ3Y2MzL3RhYmxlOjgxMDgyNmRmZmI3MDRhMGFiMTM0YTVjZWNjYWFlYjI4L3RhYmxlcmFuZ2U6ODEwODI2ZGZmYjcwNGEwYWIxMzRhNWNlY2NhYWViMjhfNy0zLTEtMS0xNzg5MjU_bad7abc0-ff28-42e6-a6b7-4d1716e25173"
      unitRef="usd">15303000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNDQ0NQ_eecfba80-d560-41d2-8c71-a560a76695de">FAIR VALUE&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our fair value measurements at March&#160;31, 2023 and December 31, 2022, respectively, for financial assets measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government&lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 66.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total invested assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government&lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 66.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total invested assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Level 3 assets had a fair value of $99 million at March&#160;31, 2023, or 0.3% of our total invested assets. During the year ended March&#160;31, 2023, the changes in the fair value of the assets measured using significant unobservable inputs (Level 3) were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Private Placements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance at January&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gains or losses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our debt is recorded at carrying value in our consolidated balance sheets. The carrying value of our senior notes debt outstanding, net of unamortized debt issuance costs, was $11.2 billion at March&#160;31, 2023 and $10.0 billion at December 31, 2022. The fair value of our senior notes debt was $10.9 billion at March&#160;31, 2023 and $9.4 billion at December 31, 2022. The fair value of our senior notes debt is determined based on Level 2 inputs, including quoted market prices for the same or similar debt, or if no quoted market prices are available, on the current prices estimated to be available to us for debt with similar terms and remaining maturities. Carrying value approximates fair value for our term loans and commercial paper borrowings. The commercial paper borrowings were $426 million at March&#160;31, 2023. The term loans and commercial paper borrowings were $1.1 billion at December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Put and Call Options Measured at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our put and call options associated with our equity method investments are measured at fair value each period using a Monte Carlo simulation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The put and call options fair values associated with our Primary Care Organization strategic partnership with  Welsh, Carson, Anderson &amp;amp; Stowe, or WCAS, which are exercisable at a fixed revenue exit multiple and provide a minimum return on WCAS' investment if exercised, are measured at fair value each reporting period using a Monte Carlo simulation. The put and call options fair values, derived from the Monte Carlo simulation, were $318 million and $8 million, respectively, at March&#160;31, 2023. The put and call options fair values, derived from the Monte Carlo simulation, were $267 million and $10 million, respectively, at December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant unobservable inputs utilized in these Level 3 fair value measurements (and selected values) include the enterprise value, annualized volatility and credit spread. Enterprise value was derived from a discounted cash flow model, which utilized significant unobservable inputs for long-term revenue, to measure underlying cash flows, weighted average cost of capital and long term growth rate. The table below presents the assumptions used for each reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:right;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7% - 19.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7% - 20.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2% - 1.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3% - 1.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue exit multiple&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5x - 2.5x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5x - 2.5x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average cost of capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0% - 13.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5% - 12.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term growth rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used for annualized volatility, credit spread and weighted average cost of capital reflect the lowest and highest values where they differ significantly across the series of put and call options due to their expected exercise dates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Assets and Liabilities Measured at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities are measured at fair value on a non-recurring basis subject to fair value adjustment only in certain circumstances. As disclosed in Note 3, we acquired various health and wellness related businesses during 2023. The net assets acquired and resulting goodwill and other intangible assets were recorded at fair value primarily using Level 3 inputs. The net tangible assets including receivables and accrued liabilities were recorded at their carrying value which approximated their fair value due to their short term nature. The fair value of goodwill and other intangible assets were internally estimated based primarily on the income approach. The income approach estimates fair value based on the present value of cash flow that the assets could be expected to generate in the future. We developed internal estimates for expected cash flows in the present value calculation using inputs and significant assumptions that include historical revenues and earnings, revenue growth rates, the amount and timing of future cash flows, discount rates, contributory asset charges and future tax rates, among others. The excess purchase price over the fair value of assets and liabilities acquired is recorded as goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As disclosed in Note 3, we completed the sale of Gentiva Hospice on August 11, 2022. The carrying value of the assets and liabilities of Gentiva Hospice disposed approximates fair value. The amount of goodwill included in the carrying value is based on the relative fair value of the Home Solutions reporting unit included within the CenterWell segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than the assets and liabilities acquired during 2023, there were no other material assets or liabilities measured at fair value on a recurring or nonrecurring basis during 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For additional information regarding our fair value measurements, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNDQ0Mg_40fc29a5-51fc-4ee6-9f63-9ac9fd9d2584">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our fair value measurements at March&#160;31, 2023 and December 31, 2022, respectively, for financial assets measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government&lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 66.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total invested assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government&lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 66.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total invested assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i96e6af2307314f46be9d1d0b03502013_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNC0xLTEtMS0xNzg5MjU_8e978c3d-725b-4ad3-9a8b-b11c31bf685e"
      unitRef="usd">13613000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibc24f5c05d5441b6ac8827d88f991c2e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNC0zLTEtMS0xNzg5MjU_e4e8e011-f889-4afc-8ac7-ffbff8b846f0"
      unitRef="usd">13613000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if1a5f1cccae8416f9bc599fff3f8e1d4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNC01LTEtMS0xNzg5MjU_bf364042-6912-48f1-b4c9-610a139b6302"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9b13e4a05827464d8b24ae1ead744fbd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNC03LTEtMS0xNzg5MjU_526c3ee9-e757-4378-87e0-2bddddd206f6"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if65bf87d9361462aaf0a0ac5f9556c38_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNy0xLTEtMS0xNzg5MjU_a82a9feb-fc6c-41ec-9e41-8091f11ad796"
      unitRef="usd">1356000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9a47acf1908a40b2af4d3cd0d68e3910_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNy0zLTEtMS0xNzg5MjU_d41a785f-03a1-4a6e-aef1-d74632e18492"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4d921a49fc8e435386aef2bf71f59872_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNy01LTEtMS0xNzg5MjU_a26a0007-a5b2-4664-a03b-dd5e41b23467"
      unitRef="usd">1356000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia6bbb7d6ca004e8a908a13b5eed703ec_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfNy03LTEtMS0xNzg5MjU_0e4f137a-6471-4376-9f36-4817ced82f66"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id68f6d863b0042c2b99dadf26d204628_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOC0xLTEtMS0xNzg5MjU_ff2c98e4-1407-4fac-8958-e4db92a77f6d"
      unitRef="usd">3503000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if14d9ee3acf541a8a80edb1dae2c5c51_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOC0zLTEtMS0xNzg5MjU_85f5db23-cd6f-4128-b68f-40aaa055eeb0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i450207aa5894438f9c2c646c0ce9982d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOC01LTEtMS0xNzg5MjU_1ceb18c7-394a-4787-8dfb-0fa887cf9a52"
      unitRef="usd">3503000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i857c0bd469ed4f57a4d62245b9c850ad_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOC03LTEtMS0xNzg5MjU_f4ff7737-0f04-4767-8530-9f5f7181ce19"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i82a7da6de90f4292a75b4ff142ac0839_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOS0xLTEtMS0xNzg5MjU_737e1c70-9523-4fd2-a312-ec177f5f2189"
      unitRef="usd">736000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i904a6646c1c74766ad237ced5460d3b7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOS0zLTEtMS0xNzg5MjU_820daced-13f3-413c-ab58-91c8bbf0b0fb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i81015bdf666841988a8d3083b77b955b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOS01LTEtMS0xNzg5MjU_ada967f4-05cd-4308-8612-7d370902761c"
      unitRef="usd">736000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifb95cb15ca9b431f83fabb95130459cb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfOS03LTEtMS0xNzg5MjU_ad02948c-fc18-4c59-87e6-a111bb54cd59"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia8862232402c4d6eaf52edf65048202e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTEtMS0xLTEtMTc4OTI1_143ea0a0-139d-432c-9ade-6015d2e92b55"
      unitRef="usd">397000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i72d189fde50f4d818a6f390bc4fc11a1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTEtMy0xLTEtMTc4OTI1_dd737b74-0509-4c9d-b4ff-26cb83db5cf2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7b4080af65ca47cfb1edb387d17a5d36_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTEtNS0xLTEtMTc4OTI1_cc30ecf3-3db8-4a58-8c3e-c46681e520e0"
      unitRef="usd">397000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic00c16389c034f59895277e520697c6f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTEtNy0xLTEtMTc4OTI1_03935553-8303-49ac-8154-6c154836bf17"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie692d3daf2da432f84a4d2bba4f54421_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTItMS0xLTEtMTc4OTI1_e72aa9eb-c1e9-41db-8c23-d9125e8804d3"
      unitRef="usd">1413000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i37b5903d02c84da3b134cc8b5828e4e6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTItMy0xLTEtMTc4OTI1_fd662a94-0129-4c28-9870-35f57102749d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id2d2e19b91464e48b9c851e183850d14_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTItNS0xLTEtMTc4OTI1_78dd25b8-cb57-4a06-80b1-97a5a4513c8a"
      unitRef="usd">1413000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib1ff90bae9d54e1e973a6a3fee17c018_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTItNy0xLTEtMTc4OTI1_b40f0cda-a899-43d7-91fa-6a78bedfa3f7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i72ea4b788a8f48c185d7fda9b12db75c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTMtMS0xLTEtMTc4OTI1_8c9f4cd7-45bf-4bce-818d-861956f738d3"
      unitRef="usd">1853000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1d6e7427cc38408f801653d6fe0309ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTMtMy0xLTEtMTc4OTI1_3a2a3896-0480-4b78-a0b1-981a7992dda8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib81031dfb7aa4eef857cf826a330605d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTMtNS0xLTEtMTc4OTI1_ce91de59-41e2-4a9d-9728-cf1ec8188532"
      unitRef="usd">1853000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifbc4c8c594954395822ec239de2a59f9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTMtNy0xLTEtMTc4OTI1_2794e1ad-b4ca-400c-a5b4-05134a55343b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idc8d3332e21f4115ad4811a1901d881a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTQtMS0xLTEtMTc4OTI1_d853d578-52d8-4328-84a8-0e03299c9f5d"
      unitRef="usd">6045000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i340393b9ebe54ab2b5864af5e584548c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTQtMy0xLTEtMTc4OTI1_27bc83c5-155e-4f2b-8dee-1f143e7098c7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i10a5e9db863849bcad9826c573d3ad01_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTQtNS0xLTEtMTc4OTI1_a40832c8-82a8-49b6-bb28-381c56551a44"
      unitRef="usd">5946000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9fbc3e66d57845169e1aff68c77b3197_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTQtNy0xLTEtMTc4OTI1_edd8bcfe-4937-4bdd-ab61-fb0f74817533"
      unitRef="usd">99000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i96e6af2307314f46be9d1d0b03502013_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTUtMS0xLTEtMTc4OTI1_1fdcc404-28c7-47c8-b2c2-b2940335aaf1"
      unitRef="usd">15303000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc24f5c05d5441b6ac8827d88f991c2e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTUtMy0xLTEtMTc4OTI1_739b8027-f82f-46c6-ab55-fae354cb5969"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if1a5f1cccae8416f9bc599fff3f8e1d4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTUtNS0xLTEtMTc4OTI1_edaa7190-8a06-4785-97ee-0f08d63db376"
      unitRef="usd">15204000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9b13e4a05827464d8b24ae1ead744fbd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTUtNy0xLTEtMTc4OTI1_fc5c2247-a869-4070-b058-05bd7f57ae3a"
      unitRef="usd">99000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i96e6af2307314f46be9d1d0b03502013_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTYtMS0xLTEtMTc4OTI1_71ffee1f-dafd-47e7-a8fd-826faed480c6"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ibc24f5c05d5441b6ac8827d88f991c2e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTYtMy0xLTEtMTc4OTI1_d256aeb2-0c7f-4e57-8f40-a8c1f087a997"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if1a5f1cccae8416f9bc599fff3f8e1d4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTYtNS0xLTEtMTc4OTI1_552874e3-93ce-46f9-8238-4242c6e229c8"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9b13e4a05827464d8b24ae1ead744fbd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTYtNy0xLTEtMTc4OTI1_8938d7a4-f0bd-493d-963e-332133539640"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i96e6af2307314f46be9d1d0b03502013_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTctMS0xLTEtMTc4OTI1_7024777d-8226-42c0-ae5d-510d512d9f18"
      unitRef="usd">28916000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibc24f5c05d5441b6ac8827d88f991c2e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTctMy0xLTEtMTc4OTI1_3db9f882-1c0d-4f03-9ebf-1fa310366acf"
      unitRef="usd">13613000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if1a5f1cccae8416f9bc599fff3f8e1d4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTctNS0xLTEtMTc4OTI1_45fcec4a-656d-490f-801a-45e8f76c1124"
      unitRef="usd">15204000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9b13e4a05827464d8b24ae1ead744fbd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMTctNy0xLTEtMTc4OTI1_c1c59519-6205-486c-a855-3523f6161d1b"
      unitRef="usd">99000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i92ee919d2f184cf7949d0916d4f1ccb1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjAtMS0xLTEtMTc4OTI1_d861c14e-62c5-47fd-a224-79499a323a2d"
      unitRef="usd">4832000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5f44fd8b7d7943429ac546aea13d21f6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjAtMy0xLTEtMTc4OTI1_088c1ace-3d72-4651-899f-c7e830dc37ef"
      unitRef="usd">4832000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0f045e713b3f4183a844967854a098d2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjAtNS0xLTEtMTc4OTI1_50dbebee-ecc5-4077-90ca-5acb1500ea08"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id0a9a1917c8f47a5836ac770133b8421_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjAtNy0xLTEtMTc4OTI1_99911d38-aacf-4528-84ac-9a5db248da34"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i70628c781dab4482bf2a82089e58407c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjMtMS0xLTEtMTc4OTI1_c5fb5ebc-c028-4143-8843-e5acf468f749"
      unitRef="usd">1039000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i60e56a4abb3148b3a47ea17e821ce331_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjMtMy0xLTEtMTc4OTI1_38c91b29-3f6d-4ce4-9cb3-7c1cb869fbcf"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idb9d324ecf5045808b96815c38a7eaaf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjMtNS0xLTEtMTc4OTI1_89513cf7-f922-4bb5-abf5-beb9e331aa9b"
      unitRef="usd">1039000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9a9a3430ebaf429886fbd03e394bb465_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjMtNy0xLTEtMTc4OTI1_08db4d8a-84c0-474f-9d03-45f0c3b2f6f5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa02a4a665234d36b7de271c9e9e73b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjQtMS0xLTEtMTc4OTI1_9d97c4ef-17c8-45fd-89cf-39677d90f1e7"
      unitRef="usd">3230000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6b2bd12e6e20458f8f4892b3040ac67e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjQtMy0xLTEtMTc4OTI1_7489ac7c-8712-4f5a-8273-6fd5fd437995"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6dddf02ed2304674986163307e834a6c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjQtNS0xLTEtMTc4OTI1_eef8ca9c-0226-415a-88db-197d247cc558"
      unitRef="usd">3230000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if3c66b776082466ea556dce65306d942_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjQtNy0xLTEtMTc4OTI1_13e08495-0223-4cb8-900e-616b49ec1513"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ec9bf427d0d47a3b08bf8a294f9efd9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjUtMS0xLTEtMTc4OTI1_0dfde96e-6267-44f0-912e-162df37280be"
      unitRef="usd">728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4a211d5ff9bb4a4589e60af4080172f9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjUtMy0xLTEtMTc4OTI1_92fc0c89-37c0-4a91-98a3-d2a92c8872fc"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i060d5600c50d4d6093631349614ca333_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjUtNS0xLTEtMTc4OTI1_5472f5ae-beac-422e-a8f0-ff85c513dba6"
      unitRef="usd">728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic732fa8df9034ee0a649c2601e5b6cff_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjUtNy0xLTEtMTc4OTI1_689b199c-96a3-4ca1-a5d2-6b437cb112ca"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9037b2b16c75430caac0e82c3c767c2e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjctMS0xLTEtMTc4OTI1_b56a238c-bea0-49e0-ae68-f3bbb04d7574"
      unitRef="usd">401000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifc036307c91f4c9593abeaff015430b2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjctMy0xLTEtMTc4OTI1_3fd00e21-d5be-4b16-ac9c-f0b5735cab57"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic82ffec88c8042de8e8a1dbf644279a5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjctNS0xLTEtMTc4OTI1_495723a4-9faf-4789-ab53-0f2ce90d8a55"
      unitRef="usd">401000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i73062b9f6c3946998028a6772ce9264f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjctNy0xLTEtMTc4OTI1_ea34bcfd-ed40-4e42-8731-6da9ed602fb4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i37d0240334144c13b97f059cadb7034b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjgtMS0xLTEtMTc4OTI1_99b1e6c4-ea10-45e0-9882-29ae7d730540"
      unitRef="usd">1399000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icd5d6eb79ea5478c9f1ec177266b62cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjgtMy0xLTEtMTc4OTI1_879805ce-f868-46c4-bd57-2621eeebcf83"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6858edb4103a4d41ae1249f6acf86c38_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjgtNS0xLTEtMTc4OTI1_9b2be9f1-de94-438a-8103-db5adfee7e22"
      unitRef="usd">1399000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i779b10a8a0554fe5a72d0d42c1badb15_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjgtNy0xLTEtMTc4OTI1_178ac3bf-2a37-4dcb-ada5-939c797eda05"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idd635cbfddf44141945808c29cbc55eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjktMS0xLTEtMTc4OTI1_a65a30a1-c49b-41cb-9787-c704903774bd"
      unitRef="usd">1731000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia39754b4e45940db8cb97fe1ff3d7880_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjktMy0xLTEtMTc4OTI1_32ecb90a-1de2-432a-adef-c4aca3aa8a6b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5c84525d35214f6c9815e8351adfd02a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjktNS0xLTEtMTc4OTI1_30305395-19c8-48cc-a876-15ff62f2bd4e"
      unitRef="usd">1731000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i39fc8e1461704c80aef7a77108d678a7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMjktNy0xLTEtMTc4OTI1_b3a99e25-7be9-432a-a7b7-c84c40e1aa46"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2e057100f4124140bac2dcc36e38be91_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzAtMS0xLTEtMTc4OTI1_6621bac4-d01e-4db1-a84a-6ecfcbc30bfe"
      unitRef="usd">5726000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i03be5b990dcd41ed91f338937639131a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzAtMy0xLTEtMTc4OTI1_ed9bd383-37fa-44ec-9869-825be893d1b2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i581027d290ae46cfa11f5ee26717a967_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzAtNS0xLTEtMTc4OTI1_868b446b-ea95-4fbd-8058-aad64ed1d99c"
      unitRef="usd">5625000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib330972c763d4fdfab8db010a1908b51_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzAtNy0xLTEtMTc4OTI1_7db57e3b-82e4-428f-b8cd-ec076c1c1be5"
      unitRef="usd">101000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i92ee919d2f184cf7949d0916d4f1ccb1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzEtMS0xLTEtMTc4OTI1_69601b13-d3d2-4b95-b8c9-32a49df69407"
      unitRef="usd">14254000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5f44fd8b7d7943429ac546aea13d21f6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzEtMy0xLTEtMTc4OTI1_af3652e4-5be7-4eb2-a309-7d0ea1f1a8d0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0f045e713b3f4183a844967854a098d2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzEtNS0xLTEtMTc4OTI1_fe56ce0a-bd5f-410e-866e-7f44af0473fd"
      unitRef="usd">14153000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id0a9a1917c8f47a5836ac770133b8421_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzEtNy0xLTEtMTc4OTI1_ed27505b-730f-489c-bff1-dc0e5f4ddf16"
      unitRef="usd">101000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i92ee919d2f184cf7949d0916d4f1ccb1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzItMS0xLTEtMTc4OTI1_da0e17c3-d74d-43fc-8ed1-94f090f897ef"
      unitRef="usd">7000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5f44fd8b7d7943429ac546aea13d21f6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzItMy0xLTEtMTc4OTI1_8be8c170-822b-40cc-b2a7-2fd66292d9f9"
      unitRef="usd">7000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i0f045e713b3f4183a844967854a098d2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzItNS0xLTEtMTc4OTI1_f94a5996-360b-4b78-a035-b1230bff448a"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id0a9a1917c8f47a5836ac770133b8421_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzItNy0xLTEtMTc4OTI1_621e4a71-3b90-4201-b555-3ed80df64038"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i92ee919d2f184cf7949d0916d4f1ccb1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzMtMS0xLTEtMTc4OTI1_b4a2e38d-1124-4c8c-86e2-9724cd303840"
      unitRef="usd">19093000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5f44fd8b7d7943429ac546aea13d21f6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzMtMy0xLTEtMTc4OTI1_7e7d054c-f14c-4774-b939-bb8362141d42"
      unitRef="usd">4839000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0f045e713b3f4183a844967854a098d2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzMtNS0xLTEtMTc4OTI1_62804cd8-61d8-4167-be5d-c89d760ae466"
      unitRef="usd">14153000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id0a9a1917c8f47a5836ac770133b8421_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjVhMGU3NDdlZmNiNTQyZTU5M2ZkZDBhMDMzYjI5NTNjL3RhYmxlcmFuZ2U6NWEwZTc0N2VmY2I1NDJlNTkzZmRkMGEwMzNiMjk1M2NfMzMtNy0xLTEtMTc4OTI1_61950ba9-91b3-4bfa-aa52-e6f118395f9e"
      unitRef="usd">101000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMjMw_0f530f52-95ca-4180-a8f6-fb1419cdf9f0"
      unitRef="usd">99000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib2516335975c48cf807e97640b5043bf_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMjQ0_f0a56f6f-580b-49e3-84f6-902d1fb69f7e"
      unitRef="number">0.003</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNDQ1Mw_2d9211a4-be47-4b43-ba37-7ed2a706fde5">During the year ended March&#160;31, 2023, the changes in the fair value of the assets measured using significant unobservable inputs (Level 3) were comprised of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Private Placements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance at January&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gains or losses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfMy0xLTEtMS0xNzg5MjU_98cb34ba-6a24-4ae4-aff9-fbed67402cf9"
      unitRef="usd">101000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="if66f7e3bde694a2fa6f2b9ad88e258ff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfMy0yLTEtMS0xODMzNDI_6862aa05-5166-4913-8dfd-b6f4662a4447"
      unitRef="usd">68000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfNi0xLTEtMS0xNzg5MjU_1852ca3e-6356-46a3-9c5a-3ece6c4a5f20"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfNi0yLTEtMS0xODMzNDI_dee33ec9-1336-457d-bb30-36bf2e38cdb0"
      unitRef="usd">-4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfNy0xLTEtMS0xNzg5MjU_ddc030d9-a586-4240-89ca-b3aebadd2a47"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfNy0yLTEtMS0xODMzNDI_d456f44d-cabd-433a-84a1-b6cd996a1c97"
      unitRef="usd">17000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfOC0xLTEtMS0xNzg5MjU_ccb94ea6-ade5-4881-b561-bea018ab4800"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfOC0yLTEtMS0xODMzNDI_da11d237-6e55-4579-a3c2-eab92a466830"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfMTAtMS0xLTEtMTkwMzk4_ecb35cf7-b7c6-4eda-8cff-2845b49f4226"
      unitRef="usd">4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfMTAtMi0xLTEtMTkwNTYy_8831a792-f437-4a1b-b888-0e73b3a1b257"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfMTAtMS0xLTEtMTc4OTI1_ad9ec439-9630-4eb2-87e3-39e1f51dbfe5"
      unitRef="usd">99000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i55a5772c9e08479ba75577876ccf8013_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYyZTEwZTViMjY3YjRhMWRiMWZlMjU0ODZiMDBkOTVhL3RhYmxlcmFuZ2U6NjJlMTBlNWIyNjdiNGExZGIxZmUyNTQ4NmIwMGQ5NWFfMTAtMi0xLTEtMTgzMzQy_b1f1ab49-db96-4094-bb5b-9c7410268d4f"
      unitRef="usd">80000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iba4807ab291b411ba709086ff2b0ca6b_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNjc4_0158e45f-7d3d-4a20-bfa7-cba6458ee0ed"
      unitRef="usd">11200000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic4b60d2223724b5b852a7861a92b748d_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNjkx_6e2dbd05-56e7-4ee5-8182-3a0e32d0bca2"
      unitRef="usd">10000000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i64b0b2cce9c4429eb7e08589df09657a_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNzQ1_f70f2478-6be4-470c-9951-7cf97f144c29"
      unitRef="usd">10900000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib2298c1aedcf4c389d4500f8dfca5cd7_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNzU4_5c4c6040-94e6-4721-8f8a-6978f70876da"
      unitRef="usd">9400000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ShortTermBorrowings
      contextRef="id7dfa681e84e4a328abd29adc43edeb8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMTIwNA_862ec798-6e95-4f4e-ab62-bac07addca10"
      unitRef="usd">426000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="iffacfea7d72c41969e8c61520fc3f3fe_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMTIxNw_e6259af5-d183-4835-ba04-fd14b7e3badd"
      unitRef="usd">1100000000</us-gaap:ShortTermBorrowings>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i8aecae41941c4949a148814d02c27b4c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMTc0MQ_e5f734ab-a29c-4d53-8345-35768aa891af"
      unitRef="usd">318000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <hum:FinancialAssetsFairValueDisclosure
      contextRef="i6c4cd7500ddd4042987e2f54456204e8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMTc0OA_ea6822df-9add-4ce0-bf71-290aa4421a24"
      unitRef="usd">8000000</hum:FinancialAssetsFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i9241eb7b1705466a9f42cbc6c027a7e3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMTg1Nw_769e9980-8247-4d32-9513-6ee26eabdd13"
      unitRef="usd">267000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <hum:FinancialAssetsFairValueDisclosure
      contextRef="ia9c5e672fb5646a5b6ef97e6cd7e5fe2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfMTg2NA_0fc2ffca-4525-4cfd-83b5-67fff74a3169"
      unitRef="usd">10000000</hum:FinancialAssetsFairValueDisclosure>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RleHRyZWdpb246NWI4NjVmMTdhMmY2NDNlYWJhOTVhMTAwNTM3Mzg3NjlfNDQ2MQ_2b3021f1-f2bc-4d08-9cef-6d94af9bd601">The table below presents the assumptions used for each reporting period.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7% - 19.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7% - 20.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2% - 1.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3% - 1.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue exit multiple&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5x - 2.5x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5x - 2.5x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average cost of capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0% - 13.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5% - 12.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term growth rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="ib841b2af88bc479392f83bdf0da74d8a_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMS0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjpiMGYwOGJkNjAyYTM0MjY5YWVhNjIzZDYxMTQ5MWYyZl80_ee11cd21-d78f-47f3-ab1f-eca7065591c4"
      unitRef="number">0.167</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i86e34249f19741d8bfc9dfb0d72a9a0a_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMS0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjpiMGYwOGJkNjAyYTM0MjY5YWVhNjIzZDYxMTQ5MWYyZl85_dd9b00c3-90a4-400d-89b6-1399fdce1c8b"
      unitRef="number">0.193</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i213d04e139894278bd43204227e8da44_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMS0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjplNjZmZDBhMjQ2MjA0MTQxYjMyOTg2YTA2OWYxYjA4ZF8xMDk5NTExNjI3Nzg4_1c77754a-f2bc-4a47-8d8c-3c2ab49a3448"
      unitRef="number">0.167</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i52c5649fd533485aa955d121bd05719e_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMS0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjplNjZmZDBhMjQ2MjA0MTQxYjMyOTg2YTA2OWYxYjA4ZF8xMDk5NTExNjI3Nzky_e05f58c7-52f5-465d-b41c-e5c5665a179e"
      unitRef="number">0.208</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i57134d84c2ac447a84c8200c372a35f8_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMi0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjoxYWU5YzRlMWRiZTk0ZTRlOTk5NzJlZjAxYzM3N2Q3Ml80_156f2ec4-e900-466c-81fa-9c2ac4a84a39"
      unitRef="number">0.012</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i8a0d174b8c8d4fe0ba5550e6b43544fa_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMi0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjoxYWU5YzRlMWRiZTk0ZTRlOTk5NzJlZjAxYzM3N2Q3Ml85_1d261057-b9f5-4ffe-8fcd-22a011fb90c0"
      unitRef="number">0.014</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="idee655553fa24a6bbe52a7b3d4ca04ad_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMi0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjo3M2UxZThhZjczZDE0N2IwYjhhY2Q3ZGU0YWM5ZWIwOF8xMDk5NTExNjI3Nzg4_3dec0312-52d4-498c-ac95-ec1755edca2f"
      unitRef="number">0.013</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i20d1e957c4434a06af24cf6ac0397e7f_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMi0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjo3M2UxZThhZjczZDE0N2IwYjhhY2Q3ZGU0YWM5ZWIwOF8xMDk5NTExNjI3Nzky_c375c258-0ab4-41a4-960a-277073d092a2"
      unitRef="number">0.015</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i2f0f9995f95947629017ed8fed503fa1_I20230331"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMy0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjpmZjI5NzdmNDJjZGQ0ZTlhYmYyMDk5NTlmMmFkNzg2MV80_2339571e-6526-4a9a-b40f-e196005bcc73"
      unitRef="number">1.5</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i61634fa707254b90a8db03c0fa13102a_I20230331"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMy0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjpmZjI5NzdmNDJjZGQ0ZTlhYmYyMDk5NTlmMmFkNzg2MV8xMA_dd212299-5f2a-4cd4-b420-2a9c5ff2a587"
      unitRef="number">2.5</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="ic46ba81be64948dfb5b93511ef5de0cb_I20221231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMy0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjphZDIxMzlmNmY2ZWY0OGYxYjA0NTkxNzRjYmQ2ZDY1MF80_9fdffc94-65c6-4d6c-96cd-1a311f756f93"
      unitRef="number">1.5</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i580fb323c37c4b618f287b4d6dfa7f5a_I20221231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfMy0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjphZDIxMzlmNmY2ZWY0OGYxYjA0NTkxNzRjYmQ2ZDY1MF8xMA_78497b69-a96e-4211-aee5-617af3a9a8ef"
      unitRef="number">2.5</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i000d5227848d42249813688992aac2b1_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfNC0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjoyNjZkMDViMzYzMDI0MmRmYTM0YjQxYTI5MjU0NmZkMF83MTQ2ODI1NTgwNTUy_36bdabd1-fa8a-4392-beb0-3fcc37a350a8"
      unitRef="number">0.120</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i377cc2a8446b4761b2676862a02afc19_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfNC0xLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjoyNjZkMDViMzYzMDI0MmRmYTM0YjQxYTI5MjU0NmZkMF83MTQ2ODI1NTgwNTU4_378cca39-3d15-4397-9122-58c949f1b53c"
      unitRef="number">0.130</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i93acdee7a8de48d2ad5e50b6216e5223_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfNC0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjplNDI5ODk4ZmFiNTk0MWVlYjczYzQxMTdjYjliYjkyYl8xMDk5NTExNjI3ODE2_0cd29704-c7ef-4adf-b9d8-f382ed30e53d"
      unitRef="number">0.115</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i6060040f6de2440d9e22ed16c9c48f07_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfNC0yLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjplNDI5ODk4ZmFiNTk0MWVlYjczYzQxMTdjYjliYjkyYl8xMDk5NTExNjI3ODA4_21eefee7-048c-4bef-b6d6-701f53b8ad3a"
      unitRef="number">0.125</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i32ddf5d36d5045038d50eaf21c6818b2_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfNS0xLTEtMS0xNzg5MjU_9091130c-898a-4bce-8b08-9982b8a7883f"
      unitRef="number">0.030</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i8f173f5f0d7a4516ad1a0ff666bedec2_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80Ni9mcmFnOjViODY1ZjE3YTJmNjQzZWFiYTk1YTEwMDUzNzM4NzY5L3RhYmxlOjYzOWFhZWY5ODYyZDRkNTc5N2ZlMzM1NzE1ZDg3NjA0L3RhYmxlcmFuZ2U6NjM5YWFlZjk4NjJkNGQ1Nzk3ZmUzMzU3MTVkODc2MDRfNS0yLTEtMS0xNzg5MjU_3705d7d2-9297-41d1-8be0-16e0eccfebdb"
      unitRef="number">0.030</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <hum:MedicarePartDDisclosureTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RleHRyZWdpb246ZjZmYWVhZmU4NzQ1NDU2NDllZjYyNTNjZDlhZGQ3MzlfODgz_95822979-a032-4f15-b6e6-0419fbb224f4">MEDICARE PART D&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with the Centers for Medicare and Medicaid Services, or CMS. The accompanying condensed consolidated balance sheets include the following amounts associated with Medicare Part D at March&#160;31, 2023 and December 31, 2022. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers. For additional information regarding our prescription drug benefits coverage in accordance with Medicare Part D, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Risk&lt;br/&gt;Corridor&lt;br/&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CMS&lt;br/&gt;Subsidies/&lt;br/&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Risk&lt;br/&gt;Corridor&lt;br/&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CMS&lt;br/&gt;Subsidies/&lt;br/&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current (liability) asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net long-term asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hum:MedicarePartDDisclosureTextBlock>
    <hum:BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RleHRyZWdpb246ZjZmYWVhZmU4NzQ1NDU2NDllZjYyNTNjZDlhZGQ3MzlfODc5_85a35a81-9810-42ff-a676-f34094d1a7e0">The accompanying condensed consolidated balance sheets include the following amounts associated with Medicare Part D at March&#160;31, 2023 and December 31, 2022. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers. For additional information regarding our prescription drug benefits coverage in accordance with Medicare Part D, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Risk&lt;br/&gt;Corridor&lt;br/&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CMS&lt;br/&gt;Subsidies/&lt;br/&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Risk&lt;br/&gt;Corridor&lt;br/&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CMS&lt;br/&gt;Subsidies/&lt;br/&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current (liability) asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net long-term asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</hum:BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock>
    <us-gaap:OtherAssetsCurrent
      contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfMy0xLTEtMS0xNzg5MjU_b7cc221c-dfe5-4a5b-b1b8-a18651a811f8"
      unitRef="usd">86000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfMy0zLTEtMS0xNzg5MjU_faae4a48-4bce-40a1-984d-5214a435a2f0"
      unitRef="usd">239000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i22ea645d881244feb48020446f2c6961_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfMy01LTEtMS0xNzg5MjU_16698487-7088-4684-b9af-b3c1eb5f5db5"
      unitRef="usd">240000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i1755902072d64e9cb2f6181073517a64_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfMy03LTEtMS0xNzg5MjU_5d57a408-d0dc-46f6-b6ae-86cc3226964c"
      unitRef="usd">696000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNC0xLTEtMS0xNzg5MjU_229dc0c8-4b57-4b10-87e4-69eea712b0c4"
      unitRef="usd">147000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNC0zLTEtMS0xNzg5MjU_98777acf-4f80-4554-a134-52c7daa747eb"
      unitRef="usd">3805000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i22ea645d881244feb48020446f2c6961_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNC01LTEtMS0xNzg5MjU_2ebb7e73-cffc-47ac-b319-5d6d40257bf9"
      unitRef="usd">166000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i1755902072d64e9cb2f6181073517a64_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNC03LTEtMS0xNzg5MjU_b8eda7bb-e0c2-4309-bcb0-af5e5177b7be"
      unitRef="usd">1236000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <hum:NetCurrentLiabilityAsset
      contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNS0xLTEtMS0xNzg5MjU_07bd10c3-b30a-44a4-b70a-c1fd30277fe0"
      unitRef="usd">-61000000</hum:NetCurrentLiabilityAsset>
    <hum:NetCurrentLiabilityAsset
      contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNS0zLTEtMS0xNzg5MjU_5b7823b6-3828-4611-a287-656216c36b69"
      unitRef="usd">-3566000000</hum:NetCurrentLiabilityAsset>
    <hum:NetCurrentLiabilityAsset
      contextRef="i22ea645d881244feb48020446f2c6961_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNS01LTEtMS0xNzg5MjU_6217c1a5-f53d-4839-8501-dfbef2ea0363"
      unitRef="usd">74000000</hum:NetCurrentLiabilityAsset>
    <hum:NetCurrentLiabilityAsset
      contextRef="i1755902072d64e9cb2f6181073517a64_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNS03LTEtMS0xNzg5MjU_ec31a05e-23d2-4bdf-baab-17865e52c43f"
      unitRef="usd">-540000000</hum:NetCurrentLiabilityAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNi0xLTEtMS0xNzg5MjU_702839ce-2e50-444f-a3a8-b036fea1f49a"
      unitRef="usd">307000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNi0zLTEtMS0xNzg5MjU_b37454ac-cc5c-42db-8ad7-599ad3038aaf"
      unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i22ea645d881244feb48020446f2c6961_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNi01LTEtMS0xNzg5MjU_ac18b658-6ac2-4fb9-a3a8-7133373cd8ad"
      unitRef="usd">19000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1755902072d64e9cb2f6181073517a64_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNi03LTEtMS0xNzg5MjU_51d39d8f-0bb3-41fb-b4c9-578cc672b1a3"
      unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNy0xLTEtMS0xNzg5MjU_e703dc66-ed9d-4ba6-ab87-f07df34f987c"
      unitRef="usd">93000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNy0zLTEtMS0xNzg5MjU_433d2a6a-aef1-4f18-86d3-81d345bef028"
      unitRef="usd">0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i22ea645d881244feb48020446f2c6961_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNy01LTEtMS0xNzg5MjU_3751817e-9ac5-4018-9841-ad1c53da5bd7"
      unitRef="usd">78000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1755902072d64e9cb2f6181073517a64_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfNy03LTEtMS0xNzg5MjU_cee6fd02-93b1-4348-8f7e-f1f5eda31505"
      unitRef="usd">0</us-gaap:OtherLiabilitiesNoncurrent>
    <hum:NetNoncurrentAssetLiability
      contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOC0xLTEtMS0xNzg5MjU_7991ea8e-d758-4877-97bc-13dff1038a55"
      unitRef="usd">214000000</hum:NetNoncurrentAssetLiability>
    <hum:NetNoncurrentAssetLiability
      contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOC0zLTEtMS0xNzg5MjU_61dc73bb-6837-4281-8af2-a87d312e50fe"
      unitRef="usd">0</hum:NetNoncurrentAssetLiability>
    <hum:NetNoncurrentAssetLiability
      contextRef="i22ea645d881244feb48020446f2c6961_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOC01LTEtMS0xNzg5MjU_58b567b3-ba2d-49c7-ab59-0368ca5bf99d"
      unitRef="usd">-59000000</hum:NetNoncurrentAssetLiability>
    <hum:NetNoncurrentAssetLiability
      contextRef="i1755902072d64e9cb2f6181073517a64_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOC03LTEtMS0xNzg5MjU_cf930033-01b1-473b-8bc6-7ed4f651c61e"
      unitRef="usd">0</hum:NetNoncurrentAssetLiability>
    <hum:NetAssetLiability
      contextRef="i17047b60198b4741bd5ebeea3412295e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOS0xLTEtMS0xNzg5MjU_d5f82f68-a2b5-4ad5-8d77-26426b290b80"
      unitRef="usd">153000000</hum:NetAssetLiability>
    <hum:NetAssetLiability
      contextRef="i62763ccb5eac4f28974a0b1010e8a360_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOS0zLTEtMS0xNzg5MjU_e2ea6727-7eb8-4e7d-8c7e-af78b3aefbe3"
      unitRef="usd">-3566000000</hum:NetAssetLiability>
    <hum:NetAssetLiability
      contextRef="i22ea645d881244feb48020446f2c6961_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOS01LTEtMS0xNzg5MjU_aa251e10-a046-46d0-af8e-2d41876074e0"
      unitRef="usd">15000000</hum:NetAssetLiability>
    <hum:NetAssetLiability
      contextRef="i1755902072d64e9cb2f6181073517a64_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV80OS9mcmFnOmY2ZmFlYWZlODc0NTQ1NjQ5ZWY2MjUzY2Q5YWRkNzM5L3RhYmxlOjBlMWRjZDllNDhmMjQ2YjNhYWEwZjBhZDZmODk3N2VhL3RhYmxlcmFuZ2U6MGUxZGNkOWU0OGYyNDZiM2FhYTBmMGFkNmY4OTc3ZWFfOS03LTEtMS0xNzg5MjU_32d2297e-278c-4973-9df7-0e5a049d1170"
      unitRef="usd">-540000000</hum:NetAssetLiability>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfOTI2_99086baf-905c-465b-b006-09ee7180cc06">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill for our reportable segments for the three months ended March 31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.557%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents details of our other intangible assets included in other long-term assets in the accompanying condensed consolidated balance sheets at March&#160;31, 2023 and December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.156%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of need&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/&lt;br/&gt;&#160;&#160;&#160;&#160;relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names and &lt;br/&gt;&#160;&#160;&#160;&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncompetes and &lt;br/&gt;&#160;&#160;&#160;&#160;other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other intangible &lt;br/&gt;&#160;&#160;&#160;&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March 31, 2023 and 2022, amortization expense for other intangible assets was approximately $18 million. The following table presents our estimate of amortization expense remaining for 2023 and each of the five next succeeding years at March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.351%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the years ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For additional information regarding our goodwill and intangible assets, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfOTE5_f0ac9160-1406-437e-a9de-f1cac3cbc78f">&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill for our reportable segments for the three months ended March 31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.557%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ib2ccf77cbd704aa9a50f730c09b643b5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfMi0xLTEtMS0xNzg5MjU_ceb36e4d-1b48-4b89-94c1-d248966f421c"
      unitRef="usd">2472000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i93e22a22917143fb9f847c7288ff5d00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfMi0zLTEtMS0xNzg5MjU_fe7c58a7-3180-4833-b0bd-e98d89336fbc"
      unitRef="usd">6670000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfMi05LTEtMS0xNzg5MjU_7da308d3-36dd-4782-8371-e3b3d8bbc9a9"
      unitRef="usd">9142000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic69f76c986f34f1b9ba9eb7a9c317d65_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfMy0xLTEtMS0xNzg5MjU_37ef68d2-dfa1-492d-b25a-e2ee53178379"
      unitRef="usd">106000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i83bf3dc5af6c4f2eb6caaad2ac9f84b8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfMy0zLTEtMS0xNzg5MjU_d6b24d9d-aa8a-47ec-829d-1b786224a3da"
      unitRef="usd">72000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfMy05LTEtMS0xNzg5MjU_dd38d2fa-d8e7-4cab-a75f-b74d85966fbd"
      unitRef="usd">178000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i602a0549ee5e4de58fd4f6d95c040179_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfNi0xLTEtMS0xNzg5MjU_ad72cd14-c40f-483a-a5e1-873259c56e8c"
      unitRef="usd">2578000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i54bd717275cd4a1ba7a908f4c92495ab_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfNi0zLTEtMS0xNzg5MjU_3d0c2aa4-b91b-49e3-8666-400612dcc957"
      unitRef="usd">6742000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmQwMDZhOGIxZjhlMTRjYTc4ZTg2ODYwOWMyOTdjNDcxL3RhYmxlcmFuZ2U6ZDAwNmE4YjFmOGUxNGNhNzhlODY4NjA5YzI5N2M0NzFfNi05LTEtMS0xNzg5MjU_2da94643-8d55-4ce0-8069-933f9f3e2b61"
      unitRef="usd">9320000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfOTIx_6f8a0bb3-f8eb-4875-8ecb-f5f76b739dad">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents details of our other intangible assets included in other long-term assets in the accompanying condensed consolidated balance sheets at March&#160;31, 2023 and December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.156%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of need&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/&lt;br/&gt;&#160;&#160;&#160;&#160;relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names and &lt;br/&gt;&#160;&#160;&#160;&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncompetes and &lt;br/&gt;&#160;&#160;&#160;&#160;other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other intangible &lt;br/&gt;&#160;&#160;&#160;&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfOTIx_d1f1ef04-f4ce-4d39-80f8-befbcf2be0e5">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents details of our other intangible assets included in other long-term assets in the accompanying condensed consolidated balance sheets at March&#160;31, 2023 and December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.156%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of need&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/&lt;br/&gt;&#160;&#160;&#160;&#160;relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names and &lt;br/&gt;&#160;&#160;&#160;&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncompetes and &lt;br/&gt;&#160;&#160;&#160;&#160;other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other intangible &lt;br/&gt;&#160;&#160;&#160;&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="idd572f2390164976be20fe3a140197cd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNC0zLTEtMS0xNzg5MjU_7f8a6bfc-13e5-4c79-9370-9b57bf89269d"
      unitRef="usd">1132000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="idd572f2390164976be20fe3a140197cd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNC03LTEtMS0xNzg5MjU_9b757b61-592a-4abf-9d5b-6e65123093fa"
      unitRef="usd">1132000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i7d23511b94f84defb1f54af0330dc9e3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNC05LTEtMS0xNzg5MjU_37b3565a-a7ce-4209-9581-6aecc09afc9e"
      unitRef="usd">1132000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i7d23511b94f84defb1f54af0330dc9e3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNC0xMy0xLTEtMTc4OTI1_6efa29d2-de57-4887-80b5-3fb24d598ee8"
      unitRef="usd">1132000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i3178f9117bab4d4788c41331f0e1dc09_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNS0zLTEtMS0xNzg5MjU_0a64ac50-5a79-48a2-9ba2-f9fe5f2ab5d8"
      unitRef="usd">286000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i3178f9117bab4d4788c41331f0e1dc09_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNS03LTEtMS0xNzg5MjU_13033999-7370-4813-83c1-1e5b890532ca"
      unitRef="usd">286000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic0802607a67b4c848b58734b6b762529_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNS05LTEtMS0xNzg5MjU_0f24d851-3efd-4fd5-a051-90a89140cdbb"
      unitRef="usd">286000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic0802607a67b4c848b58734b6b762529_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNS0xMy0xLTEtMTc4OTI1_bee00cb0-012a-49e2-a2bc-04fc5e9b06a9"
      unitRef="usd">286000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i150ea53c09e74fcb851b6053b9e40298_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi0xLTEtMS0xNzg5MjU_5307137c-4e41-4801-b57c-4b37be7660d6">P9Y3M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8054b45e04e441f6b73aeb7346969a3c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi0zLTEtMS0xNzg5MjU_842b4165-d045-4b98-99b3-09ceb288e061"
      unitRef="usd">932000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8054b45e04e441f6b73aeb7346969a3c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi01LTEtMS0xNzg5MjU_21d7221d-b677-4006-82b7-8aa102b57287"
      unitRef="usd">685000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8054b45e04e441f6b73aeb7346969a3c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi03LTEtMS0xNzg5MjU_931427ad-4781-48e6-bcee-1b296a59df03"
      unitRef="usd">247000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3f7aaf3b0b0d4b86bbe081d04e1b0c0e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi05LTEtMS0xNzg5MjU_2735b87a-107a-42a6-8038-da3e180b8c21"
      unitRef="usd">929000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3f7aaf3b0b0d4b86bbe081d04e1b0c0e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi0xMS0xLTEtMTc4OTI1_88cc70d4-9b28-4a86-8d33-038da43b44c4"
      unitRef="usd">673000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3f7aaf3b0b0d4b86bbe081d04e1b0c0e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNi0xMy0xLTEtMTc4OTI1_e381f428-7b82-417f-a669-85503cd82a87"
      unitRef="usd">256000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i2d0ef9aa2df04dada2b6de53639369a3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy0xLTEtMS0xNzg5MjU_d7279e1d-773d-4b66-bc16-92df2a5ef116">P6Y9M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i48b4610f5eff4676ae8a83d142ee62a3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy0zLTEtMS0xNzg5MjU_a98b9957-201c-4408-a743-c3745ff96c84"
      unitRef="usd">134000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i48b4610f5eff4676ae8a83d142ee62a3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy01LTEtMS0xNzg5MjU_0ddcf569-b24c-4b91-9154-5d1ecdedde78"
      unitRef="usd">101000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i48b4610f5eff4676ae8a83d142ee62a3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy03LTEtMS0xNzg5MjU_27ee7e3c-4f7d-480b-b63f-596b9a9a0268"
      unitRef="usd">33000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i58b795c8e2a749b195affd66d768c0f8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy05LTEtMS0xNzg5MjU_4970590e-8962-46f9-bec9-4db967a11c31"
      unitRef="usd">142000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i58b795c8e2a749b195affd66d768c0f8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy0xMS0xLTEtMTc4OTI1_e4258b7c-37ed-4d96-a8d0-4e774c2e1341"
      unitRef="usd">107000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i58b795c8e2a749b195affd66d768c0f8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfNy0xMy0xLTEtMTc4OTI1_2f6a893a-2ff2-4c14-9055-f91e00450914"
      unitRef="usd">35000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i209ef83489cc4686aca29a75e66a999e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC0xLTEtMS0xNzg5MjU_803b976c-e8a9-4637-9aca-db587b040c04">P11Y7M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i355b7a91cbe642259e6c7b0a6b9415a5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC0zLTEtMS0xNzg5MjU_fea6ef29-a4f9-460c-a7fa-5b76f01c4a87"
      unitRef="usd">73000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i355b7a91cbe642259e6c7b0a6b9415a5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC01LTEtMS0xNzg5MjU_c659c33f-ac8a-4c4f-8ebc-e1b3145dada7"
      unitRef="usd">63000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i355b7a91cbe642259e6c7b0a6b9415a5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC03LTEtMS0xNzg5MjU_c34dc1b9-6db3-4b40-9813-668d02d08836"
      unitRef="usd">10000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i586b2df071664278b33320a690171b5a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC05LTEtMS0xNzg5MjU_cfa351f3-f3bd-47d9-a4c7-4604948bc098"
      unitRef="usd">73000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i586b2df071664278b33320a690171b5a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC0xMS0xLTEtMTc4OTI1_c7e07e7d-7260-473c-aa3a-ead61feeaded"
      unitRef="usd">63000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i586b2df071664278b33320a690171b5a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOC0xMy0xLTEtMTc4OTI1_e7b55965-acea-4e75-846a-8162aa4daa92"
      unitRef="usd">10000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7208e156cf594c919494eb2550d73a05_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS0xLTEtMS0xNzg5MjU_882576a2-6dd2-4a4e-8856-490676681560">P8Y4M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1186c96f23294e26be46ab0face47239_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS0zLTEtMS0xNzg5MjU_3110fda5-f197-479e-be13-04806ceb73fe"
      unitRef="usd">84000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1186c96f23294e26be46ab0face47239_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS01LTEtMS0xNzg5MjU_5d408caf-f8cc-4f74-abca-b2342e7a78e6"
      unitRef="usd">38000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1186c96f23294e26be46ab0face47239_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS03LTEtMS0xNzg5MjU_4b3130e8-2b35-4cc4-9eca-9245f4c278d4"
      unitRef="usd">46000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i88f55df1f8fe486285179afd07008365_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS05LTEtMS0xNzg5MjU_51c8eb99-0e86-46ad-a753-dfda7962d004"
      unitRef="usd">86000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i88f55df1f8fe486285179afd07008365_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS0xMS0xLTEtMTc4OTI1_f7475324-d40e-4061-b1d5-f08ea12145d1"
      unitRef="usd">40000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i88f55df1f8fe486285179afd07008365_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfOS0xMy0xLTEtMTc4OTI1_6e48a372-e444-46cb-944e-085667dde2e5"
      unitRef="usd">46000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtMS0xLTEtMTc4OTI1_ef2e0dc0-fb02-4f61-9586-a7a17ec358c8">P9Y1M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtMy0xLTEtMTc4OTI1_787c07ab-4855-434a-b2d7-4c1914f1a914"
      unitRef="usd">2641000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtNS0xLTEtMTc4OTI1_721bc218-109c-4cb5-9a0f-ab351ee39791"
      unitRef="usd">887000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtNy0xLTEtMTc4OTI1_493c68c2-cdb3-4364-987f-bcc10b0ac52d"
      unitRef="usd">1754000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtOS0xLTEtMTc4OTI1_0d6778a9-f48e-45f4-a913-263b2ee42dae"
      unitRef="usd">2648000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtMTEtMS0xLTE3ODkyNQ_51694fad-471c-46be-b1a1-74cbc566f18b"
      unitRef="usd">883000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOmRmM2YwZmM0N2E3MjQ5ZmU4ZjQxZDMzNDBiNGUyMzZmL3RhYmxlcmFuZ2U6ZGYzZjBmYzQ3YTcyNDlmZThmNDFkMzM0MGI0ZTIzNmZfMTEtMTMtMS0xLTE3ODkyNQ_6bed6596-08aa-433c-aec8-dd126f11fac0"
      unitRef="usd">1765000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfNDEw_430bd533-e64d-480e-8702-6225add3c7cd"
      unitRef="usd">18000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfNDEw_d199871d-b1fe-4493-a566-e4874346973c"
      unitRef="usd">18000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RleHRyZWdpb246Zjc5ODA4ODM1ZjAyNDM2ZmEzOGZmN2M1ZDUyNWQxNGZfOTI0_fb636403-b0f0-437a-8b6c-30274326113b">The following table presents our estimate of amortization expense remaining for 2023 and each of the five next succeeding years at March&#160;31, 2023:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.351%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the years ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOjdlNmNmMGI1ODhkZTRlNjZiZjhjOWU3OWEzMzgyNjgxL3RhYmxlcmFuZ2U6N2U2Y2YwYjU4OGRlNGU2NmJmOGM5ZTc5YTMzODI2ODFfMi0xLTEtMS0xNzg5MjU_98460619-296e-422b-8d59-b638a8121c0f"
      unitRef="usd">47000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOjdlNmNmMGI1ODhkZTRlNjZiZjhjOWU3OWEzMzgyNjgxL3RhYmxlcmFuZ2U6N2U2Y2YwYjU4OGRlNGU2NmJmOGM5ZTc5YTMzODI2ODFfMy0xLTEtMS0xNzg5MjU_bdaa37a8-b56f-4005-ab17-20c081bc1339"
      unitRef="usd">56000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOjdlNmNmMGI1ODhkZTRlNjZiZjhjOWU3OWEzMzgyNjgxL3RhYmxlcmFuZ2U6N2U2Y2YwYjU4OGRlNGU2NmJmOGM5ZTc5YTMzODI2ODFfNC0xLTEtMS0xNzg5MjU_2a4620b7-46d3-4b2e-8b64-dae6fe1fc1dc"
      unitRef="usd">54000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOjdlNmNmMGI1ODhkZTRlNjZiZjhjOWU3OWEzMzgyNjgxL3RhYmxlcmFuZ2U6N2U2Y2YwYjU4OGRlNGU2NmJmOGM5ZTc5YTMzODI2ODFfNS0xLTEtMS0xNzg5MjU_ff49ea73-8e80-43e2-8dcb-2d0217feb413"
      unitRef="usd">41000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOjdlNmNmMGI1ODhkZTRlNjZiZjhjOWU3OWEzMzgyNjgxL3RhYmxlcmFuZ2U6N2U2Y2YwYjU4OGRlNGU2NmJmOGM5ZTc5YTMzODI2ODFfNi0xLTEtMS0xNzg5MjU_70de86de-186d-4f3c-8d85-657fd51c1d52"
      unitRef="usd">32000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81Mi9mcmFnOmY3OTgwODgzNWYwMjQzNmZhMzhmZjdjNWQ1MjVkMTRmL3RhYmxlOjdlNmNmMGI1ODhkZTRlNjZiZjhjOWU3OWEzMzgyNjgxL3RhYmxlcmFuZ2U6N2U2Y2YwYjU4OGRlNGU2NmJmOGM5ZTc5YTMzODI2ODFfNy0xLTEtMS0xNzg5MjU_bf10ca51-bfc3-4155-b1a6-20f5a4e8fb9d"
      unitRef="usd">27000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:InsuranceDisclosureTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RleHRyZWdpb246MDhjNzViNWU4ZjBjNDQ3YmExOTM2ZWFiNDBlMzJiZjhfMTQxMA_78ec0a91-5779-4fcf-a7d5-f5590d735905">BENEFITS PAYABLE&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a consolidated basis, which represents our Insurance segment net of eliminations, activity in benefits payable was as follows for the three months ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.435%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.103%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incurred related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paid related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total estimate of benefits payable for claims incurred but not reported, or IBNR, is included within the net incurred claims amounts. At March&#160;31, 2023, benefits payable included IBNR of approximately $6.3 billion, primarily associated with claims incurred in 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts incurred related to prior periods vary from previously estimated liabilities as the claims ultimately are settled. Negative amounts reported for incurred related to prior years result from claims being ultimately settled for amounts less than originally estimated (favorable development). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our reserving practice is to consistently recognize the actuarial best estimate of our ultimate liability for claims. Actuarial standards require the use of assumptions based on moderately adverse experience, which generally results in favorable reserve development, or reserves that are considered redundant. For additional information regarding our benefits payable and benefits expense recognition, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:InsuranceDisclosureTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RleHRyZWdpb246MDhjNzViNWU4ZjBjNDQ3YmExOTM2ZWFiNDBlMzJiZjhfMTQxNg_7db9a0c4-e151-4020-9aac-3c1511ca9e13">&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a consolidated basis, which represents our Insurance segment net of eliminations, activity in benefits payable was as follows for the three months ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.435%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.103%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incurred related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paid related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMy0yLTEtMS0xNzg5MjU_6f3f05e6-434e-4f28-a678-543ddf9c0343"
      unitRef="usd">9264000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="if66f7e3bde694a2fa6f2b9ad88e258ff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMy00LTEtMS0xNzg5MjU_db3276d5-bd45-4948-af77-697bd374dc50"
      unitRef="usd">8289000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfNi0yLTEtMS0xNzg5MjU_6155686b-cf0c-4aae-93e7-b1b9b5c52860"
      unitRef="usd">22380000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfNi00LTEtMS0xNzg5MjU_56654eaa-76d5-48e4-876e-9fcc463065b9"
      unitRef="usd">19985000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfNy0yLTEtMS0xNzg5MjU_f64284d7-afb2-48fb-b616-da973eb23e4c"
      unitRef="usd">-522000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfNy00LTEtMS0xNzg5MjU_4199f4ac-fe2e-4bd0-9103-6ec6cb21ee1c"
      unitRef="usd">-360000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfOC0yLTEtMS0xNzg5MjU_79db838a-ee3e-4011-8865-884c690030f6"
      unitRef="usd">21858000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfOC00LTEtMS0xNzg5MjU_9f52d2c2-7c20-4671-8585-64dde9b9630a"
      unitRef="usd">19625000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTAtMi0xLTEtMTc4OTI1_922fc5c9-52a5-4b4d-8687-3cbeff2492f7"
      unitRef="usd">14203000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTAtNC0xLTEtMTc4OTI1_428efc52-4877-4df7-a064-191835438f10"
      unitRef="usd">12284000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTEtMi0xLTEtMTc4OTI1_da7f58a8-c8b8-470a-b2fb-534d13fbcc6b"
      unitRef="usd">6901000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTEtNC0xLTEtMTc4OTI1_335e3d09-9b96-4547-8b84-0a0c2654e252"
      unitRef="usd">6252000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTItMi0xLTEtMTc4OTI1_16d521c2-85b2-4be1-95d8-b47f9c11e117"
      unitRef="usd">21104000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTItNC0xLTEtMTc4OTI1_cb79eede-a160-4bda-8160-b36d60678e4c"
      unitRef="usd">18536000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTMtMi0xLTEtMTc4OTI1_b8b96d3c-e26d-49cf-bb60-ab72df9ba9ed"
      unitRef="usd">10018000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i55a5772c9e08479ba75577876ccf8013_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RhYmxlOmQ3Y2VkYmVhZjUwZTRlZjU5N2U5NDk5YTE1NTEzOWJkL3RhYmxlcmFuZ2U6ZDdjZWRiZWFmNTBlNGVmNTk3ZTk0OTlhMTU1MTM5YmRfMTMtNC0xLTEtMTc4OTI1_7376ef24-1cf6-49b5-96c8-79c5771248e5"
      unitRef="usd">9378000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81NS9mcmFnOjA4Yzc1YjVlOGYwYzQ0N2JhMTkzNmVhYjQwZTMyYmY4L3RleHRyZWdpb246MDhjNzViNWU4ZjBjNDQ3YmExOTM2ZWFiNDBlMzJiZjhfMzQ1_11e618db-9b80-441f-84e0-2aaede14b4d0"
      unitRef="usd">6300000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RleHRyZWdpb246M2YzMTUyNTUyZjFkNDU2YjhmZmJlNTIyMWZjOTc1YjRfMzk3_24ea59ba-cd62-4c9e-88d6-f0a5ec68f47a">EARNINGS PER COMMON SHARE COMPUTATION&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Detail supporting the computation of basic and diluted earnings per common share was as follows for the three months ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.955%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(dollars in millions, except per common share results; number of shares in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income available for common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average outstanding shares of common stock &lt;br/&gt;&#160;&#160;&#160;&#160;used to compute basic earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of antidilutive stock options and restricted stock &lt;br/&gt;&#160;&#160;&#160;&#160;excluded from computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;For additional information regarding earnings per common share, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RleHRyZWdpb246M2YzMTUyNTUyZjFkNDU2YjhmZmJlNTIyMWZjOTc1YjRfNDAw_5419c6a1-e2d0-4f1c-8b62-2bc3cf06f34a">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Detail supporting the computation of basic and diluted earnings per common share was as follows for the three months ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.955%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(dollars in millions, except per common share results; number of shares in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income available for common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average outstanding shares of common stock &lt;br/&gt;&#160;&#160;&#160;&#160;used to compute basic earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of antidilutive stock options and restricted stock &lt;br/&gt;&#160;&#160;&#160;&#160;excluded from computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfMy0xLTEtMS0xNzg5MjU_06511023-bef2-44de-8b03-35077e669047"
      unitRef="usd">1239000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfMy0zLTEtMS0xNzg5MjU_04329df4-987f-4cb1-a2ba-43b2d1cd7af2"
      unitRef="usd">930000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfNC0xLTEtMS0xNzg5MjU_69a3864a-6651-445c-8d06-51d4ee190a4a"
      unitRef="shares">125005000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfNC0zLTEtMS0xNzg5MjU_bcda7a69-fd3d-4b86-a4cd-bf4ce8e99292"
      unitRef="shares">126938000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6a2c0126f2424bb8ab0ee87fe08cb666_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfNi0xLTEtMS0xNzg5MjU_d5d76f90-0ff7-4cc2-a988-2d4e403d52af"
      unitRef="shares">34000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i0e434f71448049a284869f73abeb0b98_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfNi0zLTEtMS0xNzg5MjU_98714e5c-b77f-4bea-b8cd-043e39f280ab"
      unitRef="shares">40000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i930b18f4afe34fec9820ff5a19092628_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfNy0xLTEtMS0xNzg5MjU_32fe3d73-a7e9-42b2-a74b-f626189ddbd4"
      unitRef="shares">525000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7542e08ec319422a9b4c757d3a9accd0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfNy0zLTEtMS0xNzg5MjU_5305de7d-c829-471a-abe6-f149300bdcde"
      unitRef="shares">496000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfOC0xLTEtMS0xNzg5MjU_60fc7ff8-946d-47aa-a8d5-e86965a1c586"
      unitRef="shares">125564000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfOC0zLTEtMS0xNzg5MjU_a8aae853-fe9f-4d3f-8db1-f154d54d00a1"
      unitRef="shares">127474000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfOS0xLTEtMS0xNzg5MjU_77bcccd5-0fa2-456e-b2da-793e6f79ff45"
      unitRef="usdPerShare">9.91</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfOS0zLTEtMS0xNzg5MjU_7c188305-f913-41e5-86e9-dd61f1b53652"
      unitRef="usdPerShare">7.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfMTAtMS0xLTEtMTc4OTI1_6e910401-6413-4288-9fbb-616e45c8da9a"
      unitRef="usdPerShare">9.87</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfMTAtMy0xLTEtMTc4OTI1_8546aeea-ba4d-42fa-b404-d0414adb5328"
      unitRef="usdPerShare">7.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfMTEtMS0xLTEtMTc4OTI1_a564dd1e-d8d3-481f-924e-785bb374af95"
      unitRef="shares">538000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV81OC9mcmFnOjNmMzE1MjU1MmYxZDQ1NmI4ZmZiZTUyMjFmYzk3NWI0L3RhYmxlOjFlYTlmOTJkMDQ4NTQ2OWQ4ZDBjNTZmMTM1NTA1MjYyL3RhYmxlcmFuZ2U6MWVhOWY5MmQwNDg1NDY5ZDhkMGM1NmYxMzU1MDUyNjJfMTEtMy0xLTEtMTc4OTI1_eb9a8e21-04c0-416e-9dbe-7c1069eb4f92"
      unitRef="shares">626000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMzEwMQ_389e6b2b-77cd-4ee4-8a09-5a2c06914457">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides details of dividend payments, excluding dividend equivalent rights for unvested stock awards, during 2023 under our Board approved quarterly cash dividend policy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Record&lt;br/&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment&lt;br/&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/27/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2023, the Board declared a cash dividend of $0.885 per share payable on April 28, 2023 to stockholders of record on March 31, 2023. In April 2023, the Board declared a cash dividend of $0.885 per share payable on July 28, 2023 to stockholders of record as of the close of business on June&#160;30, 2023. Declaration and payment of future quarterly dividends are at the discretion of our Board and may be adjusted as business needs or market conditions change.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our Board of Directors may authorize the purchase of our common stock shares. Under the share repurchase authorization, shares may be purchased from time to time at prevailing prices in the open market, by block purchases, through plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, or in privately-negotiated transactions, including pursuant to accelerated share repurchase agreements with investment banks, subject to certain regulatory restrictions on volume, pricing, and timing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On February 15, 2023, the Board of Directors replaced the previous share repurchase authorization of up to $3&#160;billion (of which approximately $1&#160;billion remained unused) with a new authorization for repurchases of up to $3&#160;billion of our common shares exclusive of shares repurchased in connection with employee stock plans, expiring as of February 15, 2026. During the three months ended March 31, 2023, we repurchased 0.1&#160;million shares in open market transactions for $67&#160;million at an average price of $495.68 under the current share repurchase authorization. During the three months ended March 31, 2022 we did not repurchase shares in open market transactions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our remaining repurchase authorization was $2.8&#160;billion as of April&#160;25, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with employee stock plans, we acquired 0.05 million common shares for $27 million and 0.06&#160;million common shares for $24 million during the three months ended March 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For additional information regarding our stockholders' equity, refer to Note 16 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:DividendsDeclaredTableTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMzEyNA_10620f4e-c971-4116-bf21-97f0eaa8ac6a">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides details of dividend payments, excluding dividend equivalent rights for unvested stock awards, during 2023 under our Board approved quarterly cash dividend policy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Record&lt;br/&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment&lt;br/&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/27/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DividendsDeclaredTableTextBlock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i0b9ac383e9ea4b719311556136d97415_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RhYmxlOjAyOTFkMDJkNmIwNDRmYmJiYWY0ODIxM2FlYjY3ZjViL3RhYmxlcmFuZ2U6MDI5MWQwMmQ2YjA0NGZiYmJhZjQ4MjEzYWViNjdmNWJfOC00LTEtMS0xNzg5MjU_ef889a05-4d41-4c65-9d6d-d906152c9344"
      unitRef="usdPerShare">0.7900</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:Dividends
      contextRef="i0b9ac383e9ea4b719311556136d97415_D20230127-20230127"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RhYmxlOjAyOTFkMDJkNmIwNDRmYmJiYWY0ODIxM2FlYjY3ZjViL3RhYmxlcmFuZ2U6MDI5MWQwMmQ2YjA0NGZiYmJhZjQ4MjEzYWViNjdmNWJfOC02LTEtMS0xNzg5MjU_d4e95af8-819d-4802-ae33-4e80f5e19325"
      unitRef="usd">98000000</us-gaap:Dividends>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i855926020dce4bea9a6964c5647f3657_D20230201-20230228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMTA5OTUxMTYzMjY4Mw_5f5c11f7-0bc8-470c-9416-0555cb8a1284"
      unitRef="usdPerShare">0.885</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i22b1e29a3e1c4bc98acae1e9ce50b759_D20230401-20230430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMjc3_614f76b1-5cd1-4b96-a799-22db2dd5a651"
      unitRef="usdPerShare">0.885</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="iab7b66d9b316428980dce49fe22290b3_I20230215"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMzg0ODI5MDcwNjQ0Ng_f910c654-e32b-4988-9270-02f4c7818d8f"
      unitRef="usd">3000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="iab7b66d9b316428980dce49fe22290b3_I20230215"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMzg0ODI5MDcwNjQ1OA_394da80e-3b38-472f-ac8a-771c84ac10b8"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="iab7b66d9b316428980dce49fe22290b3_I20230215"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMzg0ODI5MDcwNjQ3MA_4283ef96-ea95-4da2-b9fe-0f5ce6eda51e"
      unitRef="usd">3000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i1c95ac6806e14b6bbfa8a1f730d7bb0b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMTA5OTUxMTYzNjUxNA_77e4107b-b9e8-4b9e-9b06-16b4d1c71b17"
      unitRef="shares">100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1c95ac6806e14b6bbfa8a1f730d7bb0b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMTA5OTUxMTYzNjUzMA_f2993a50-f0ef-4a31-8ddc-1c0404433d67"
      unitRef="usd">67000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i1c95ac6806e14b6bbfa8a1f730d7bb0b_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMTA5OTUxMTYzNjU0OQ_bb198356-50af-468d-b709-774363fa52f0"
      unitRef="usdPerShare">495.68</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMzI5ODUzNDg5MjU5Mw_84b8b6ec-868e-4132-9ac3-d9ae2dbd513e"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i2b88da85e02742d1b115a353bcae6004_I20230425"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMjcxNw_98b34ea3-3f9a-4fce-b512-9056b985c9a0"
      unitRef="usd">2800000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMjc4Mw_3c251d50-73f7-457c-a327-e5a55ea76aaf"
      unitRef="shares">50000.00</hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares>
    <hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMjgwNA_3f27e753-f9c4-4529-af73-4efa03e50050"
      unitRef="usd">27000000</hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue>
    <hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMjgxMQ_8209086e-6a8d-4578-8cdd-3f33a4807b5e"
      unitRef="shares">60000.00</hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares>
    <hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82MS9mcmFnOjBiNjZiNzEwNjFjMDQ0OTE4N2RhYzk5OTE3MjExYjVkL3RleHRyZWdpb246MGI2NmI3MTA2MWMwNDQ5MTg3ZGFjOTk5MTcyMTFiNWRfMjgzMg_2d7e7465-ddcd-4700-957f-9a3663bcb917"
      unitRef="usd">24000000</hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82NC9mcmFnOmZiOGNjOTQ0ZGVkODRkN2M4YjM0MzM1NDFjZTVjNzRlL3RleHRyZWdpb246ZmI4Y2M5NDRkZWQ4NGQ3YzhiMzQzMzU0MWNlNWM3NGVfMTM5Nw_808f34b3-879c-40ea-8978-c42f3c873b75">INCOME TAXES&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective income tax rate was&#160;22.5% and 23.5% for the three months ended March 31, 2023 and 2022, respectively. The year-over-year decrease in the effective income tax rate is primarily due to the recognition of a non-taxable gain in the 2023 quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For additional information regarding income taxes, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82NC9mcmFnOmZiOGNjOTQ0ZGVkODRkN2M4YjM0MzM1NDFjZTVjNzRlL3RleHRyZWdpb246ZmI4Y2M5NDRkZWQ4NGQ3YzhiMzQzMzU0MWNlNWM3NGVfMTA5OTUxMTYzMDAxNg_c57ce828-d6a3-4ffb-be11-8fea6cd4578b"
      unitRef="number">0.225</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82NC9mcmFnOmZiOGNjOTQ0ZGVkODRkN2M4YjM0MzM1NDFjZTVjNzRlL3RleHRyZWdpb246ZmI4Y2M5NDRkZWQ4NGQ3YzhiMzQzMzU0MWNlNWM3NGVfMTA5OTUxMTYzMDAyMA_f50f9ee4-245b-4273-9338-30e3476e9b27"
      unitRef="number">0.235</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfNDA4OQ_4fd66e90-0c95-4295-8200-7e6d6d53d054">DEBT&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of debt outstanding, net of unamortized debt issuance costs, was as follows at March&#160;31, 2023 and December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.5&#160;billion, 0.650% due August 3, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 3.850% due October 1, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 4.500% due April 1, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500 million, 5.700% due March 13, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 1.350% due February 3, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 3.950% due March 15, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500 million, 5.750% due March 1, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million, 3.700% due March 23, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million, 3.125% due August 15, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million, 4.875% due April 1, 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 2.150% due February 3, 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million, 5.880% due March 1, 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$250&#160;million, 8.150% due June&#160;15, 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$400&#160;million, 4.625% due December&#160;1, 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 4.950% due October 1, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$400&#160;million, 4.800% due March 15, 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500 million, 3.950% due August 15, 2049&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million, 5.500% due March 15, 2053&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Delayed draw term loan, due May 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total term loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; In March 2023, we issued $500&#160;million of 5.700% unsecured senior notes due March 13, 2026 and $750&#160;million of 5.500% unsecured senior notes due March 15, 2053. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $1.2&#160;billion. We used the net proceeds to repay outstanding amounts under our $500&#160;million Delayed Draw Term Loan. The remaining net proceeds will be used for general corporate purposes, which include the repayment of existing indebtedness, including borrowings under our commercial paper program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2023, we entered into a Rule 10b5-1 Repurchase Plan, or the Plan, to repurchase a portion of our $1.5&#160;billion aggregate principal amount of 0.650% senior notes maturing in August 2023 and our $600&#160;million &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;aggregate principal amount of 3.850% senior notes maturing in October 2024 during the Plan period beginning on March 13, 2023 and ending on June 15, 2023. During the three months ended March 31, 2023, we repurchased $61&#160;million aggregate principal amount, for cash totaling approximately $60&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For additional information regarding our Senior Notes, refer to Note 13 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revolving Credit Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our credit agreements contain customary restrictive covenants and a financial covenant regarding maximum debt to capitalization of 60%, as well as customary events of default. We are in compliance with this financial covenant, with actual debt to capitalization of 41.1% as measured in accordance with the revolving credit agreements as of March&#160;31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023, we had no borrowings and approximately $39 million of letters of credit outstanding under the revolving credit agreements, including those of KAH. Accordingly, as of March&#160;31, 2023, we had $2.4 billion of remaining borrowing capacity under the 5-year revolving credit agreement and $1.5&#160;billion of remaining borrowing capacity under the 364-day revolving credit agreement (which excludes the uncommitted $750 million of incremental loan facilities), none of which would be restricted by our financial covenant compliance requirement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For additional information regarding our Revolving Credit Agreements, refer to Note 13 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Under our commercial paper program we may issue short-term, unsecured commercial paper notes privately placed on a discount basis through certain broker dealers at any time. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The net proceeds of issuances have been and are expected to be used for general corporate purposes. The maximum principal amount outstanding at any one time during the three months ended March 31, 2023 was $626 million, with $426 million outstanding at March&#160;31, 2023 compared to $595 million outstanding at December 31, 2022. The outstanding commercial paper at March&#160;31, 2023 had a weighted average annual interest rate of 5.45%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For additional information regarding our Commercial Paper refer to Note 13 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Short-term Borrowings&lt;/span&gt;&lt;/div&gt;We are a member, through one subsidiary, of the Federal Home Loan Bank of Cincinnati, or FHLB. As a member we have the ability to obtain short-term cash advances, subject to certain minimum collateral requirements. At March&#160;31, 2023 we had no outstanding short-term FHLB borrowings.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfNDA4Mg_bfac2291-7056-4ee6-8f76-b7c3cc49cb9c">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of debt outstanding, net of unamortized debt issuance costs, was as follows at March&#160;31, 2023 and December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.5&#160;billion, 0.650% due August 3, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 3.850% due October 1, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 4.500% due April 1, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500 million, 5.700% due March 13, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 1.350% due February 3, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 3.950% due March 15, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500 million, 5.750% due March 1, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million, 3.700% due March 23, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million, 3.125% due August 15, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million, 4.875% due April 1, 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 2.150% due February 3, 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million, 5.880% due March 1, 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$250&#160;million, 8.150% due June&#160;15, 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$400&#160;million, 4.625% due December&#160;1, 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 4.950% due October 1, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$400&#160;million, 4.800% due March 15, 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500 million, 3.950% due August 15, 2049&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million, 5.500% due March 15, 2053&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Delayed draw term loan, due May 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total term loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:ShortTermBorrowings
      contextRef="ie5378147acd6413d98ab4a87badd98a5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMy0xLTEtMS0xNzg5MjU_c4fd078d-4560-4611-af9a-54e5215a78e8"
      unitRef="usd">426000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i66bc861b6d684110a1c01760cf75a9d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMy0zLTEtMS0xNzg5MjU_04d38dca-5c97-40d3-b391-69409943e3da"
      unitRef="usd">595000000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia745190caecb4ad18029594fbd44dad9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfNi0wLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjpkODYxZTI5YzZhMzg0MDgwODllYTI4NzBiNTg4YTA2Zl80_ff5bcca1-a018-4d5b-8379-782e92bb951c"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia745190caecb4ad18029594fbd44dad9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfNi0wLTEtMS0xNzg5MjUvdGV4dHJlZ2lvbjpkODYxZTI5YzZhMzg0MDgwODllYTI4NzBiNTg4YTA2Zl84_5623ba52-ac5d-40c0-973c-b84cc2224d68"
      unitRef="number">0.00650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtCurrent
      contextRef="ia745190caecb4ad18029594fbd44dad9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfNi0xLTEtMS0xNzg5MjU_69471366-1921-470c-98f7-a52bb2424e9b"
      unitRef="usd">1441000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ia91bce3ad2614069b112478f13ea4bbd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfNi0zLTEtMS0xNzg5MjU_a25bb1bf-7d99-4e2d-b005-82812437c925"
      unitRef="usd">1497000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0baef8994ca946c49745a0878f83ccea_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfOS0xLTEtMS0xNzg5MjU_1a56b987-9c51-45e5-8d3e-d0b3ba7e5fd6"
      unitRef="usd">1441000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i86bac7559acf4a0a8e9e4af23f7cc8ec_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfOS0zLTEtMS0xNzg5MjU_a0a29e90-239d-481e-b132-16175a984190"
      unitRef="usd">1497000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTAtMS0xLTEtMTc4OTI1_2a772b74-26db-40ed-b6ef-ec729ca4f686"
      unitRef="usd">1867000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTAtMy0xLTEtMTc4OTI1_ac55a55f-5525-4665-8bb7-4cb7c166f904"
      unitRef="usd">2092000000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3a64f9f747cc4b969bd58c5a210d96b8_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTQtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246ZTU3MWVhZjdiNjFlNGVmMTk3OTIxNTIwOGMwMzg5NWVfNA_37bae04e-4051-4fc0-896b-648b02f7dfea"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3a64f9f747cc4b969bd58c5a210d96b8_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTQtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246ZTU3MWVhZjdiNjFlNGVmMTk3OTIxNTIwOGMwMzg5NWVfOA_4c316798-d986-4da2-8900-2c2127d8bcb3"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3a64f9f747cc4b969bd58c5a210d96b8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTQtMS0xLTEtMTc4OTI1_c71fbc36-6834-4dbb-80a6-85c75ca9e521"
      unitRef="usd">595000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie8ee81e69e7d4f708f12b170210cf50e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTQtMy0xLTEtMTc4OTI1_743b475a-4dca-4601-a003-60d9396d49a6"
      unitRef="usd">599000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia2dbfa0791a746e891144da65c98163c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MzE5NmRkMjcwYTY2NDRlYmJkNzRhYTY2ZGJmMDQxODBfNA_025d1709-f208-4e17-88d4-b4476ea495d2"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia2dbfa0791a746e891144da65c98163c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MzE5NmRkMjcwYTY2NDRlYmJkNzRhYTY2ZGJmMDQxODBfOA_2594439f-f1b5-4298-9860-50558a3fe000"
      unitRef="number">0.04500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia2dbfa0791a746e891144da65c98163c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMS0xLTEtMTc4OTI1_8e516d6b-326c-4c73-ad6d-dfd1b60a4fb5"
      unitRef="usd">597000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i601f7293934844dd8581d285010fe8a3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMy0xLTEtMTc4OTI1_7ea97d6e-9ae3-482d-9d24-4d52eec9e335"
      unitRef="usd">597000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2f93bb52470a423f83007bbe6311ef88_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMC0xLTEtMTg1NjkzL3RleHRyZWdpb246OGUwNzJmZTM4YTU0NDAyZjllZGNiYmJiMmFkNThhYjVfMTA5OTUxMTYyNzgwNQ_1f5854d7-ef11-4415-939a-b690eadc0467"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2f93bb52470a423f83007bbe6311ef88_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMC0xLTEtMTg1NjkzL3RleHRyZWdpb246OGUwNzJmZTM4YTU0NDAyZjllZGNiYmJiMmFkNThhYjVfMTA5OTUxMTYyNzgwOQ_7e71455d-a822-436e-b8a8-b934290a10b6"
      unitRef="number">0.05700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2f93bb52470a423f83007bbe6311ef88_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMS0xLTEtMTg1Njg2_3960ef32-746a-4406-848c-a922d664fb80"
      unitRef="usd">497000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i769a17d71bce4bc9ad29794468e1d407_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTUtMy0xLTEtMTg1Njg2_ab5a60d7-516a-4c1c-a445-807f9f54555d"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6f1e6a5d467542119ee41abdb08e8bfe_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MGU5Yjc2NmNjOGExNGMwYjhiNmJmZTE3ZmMyMjBjZTlfNA_040e5d74-d202-48f2-8d5e-3916b3387fc6"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6f1e6a5d467542119ee41abdb08e8bfe_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MGU5Yjc2NmNjOGExNGMwYjhiNmJmZTE3ZmMyMjBjZTlfOA_3386a8a9-d8bb-4983-9f7b-e4d0f54b078b"
      unitRef="number">0.01350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6f1e6a5d467542119ee41abdb08e8bfe_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMS0xLTEtMTc4OTI1_d5322749-feb6-42a5-ace3-6ee018b5cef7"
      unitRef="usd">745000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ice043f0edb0b45ebb9871681a935057d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMy0xLTEtMTc4OTI1_67b13b3a-6c8e-4c9f-961b-5de4006713df"
      unitRef="usd">745000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if56c1215e57f42b58ee613738b0f54df_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTctMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NDE4YzRjYTBkMDVlNDNjYTgwYTViMzBkNDRiOWU5YWNfNA_04fe4688-4fba-419a-bb00-c813c6f516d5"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if56c1215e57f42b58ee613738b0f54df_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTctMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NDE4YzRjYTBkMDVlNDNjYTgwYTViMzBkNDRiOWU5YWNfOA_3cc7a6fb-7572-41d8-a848-38b65907009f"
      unitRef="number">0.03950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if56c1215e57f42b58ee613738b0f54df_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTctMS0xLTEtMTc4OTI1_6369f3f2-7e10-4e4f-8425-b1357954b09e"
      unitRef="usd">597000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9826367b47364f6383b302d5941fb1b3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTctMy0xLTEtMTc4OTI1_e4762851-d221-49e6-ac68-212f37643834"
      unitRef="usd">597000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="idc6dc428ebc14290b36d57fb1719bf13_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMC0xLTEtMTkwMDY2L3RleHRyZWdpb246NTQwYjA2OTA2YTAzNDk1ZjgzNTk2NzA2OTVkNzJjMzRfODI0NjMzNzIwODM1MA_4d98a008-b77e-4e1e-96d1-4d31508feb33"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idc6dc428ebc14290b36d57fb1719bf13_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMC0xLTEtMTkwMDY2L3RleHRyZWdpb246NTQwYjA2OTA2YTAzNDk1ZjgzNTk2NzA2OTVkNzJjMzRfODI0NjMzNzIwODM1Ng_f27690e6-44d6-48ef-a933-b85822a03bdb"
      unitRef="number">0.05750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="idc6dc428ebc14290b36d57fb1719bf13_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMS0xLTEtMTkwMDg4_e7b516c1-d564-49b7-b438-7817e88280e6"
      unitRef="usd">494000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i352c829a0e07400faa05ac2176bc9839_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTYtMy0xLTEtMTkwMDg4_f3fee808-4350-47b1-b82b-a76771b0f697"
      unitRef="usd">494000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i26e5ceadc3fd4816b11932771a952db5_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTgtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246ODBlYzkxYWJiZDBkNDY2OWJjMDEzNjAyZTBiNDcwYmVfNA_bc91fbee-0291-483a-8f5d-8a5cfa0fc1a1"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i26e5ceadc3fd4816b11932771a952db5_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTgtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246ODBlYzkxYWJiZDBkNDY2OWJjMDEzNjAyZTBiNDcwYmVfOA_2b049883-55e8-4be2-ad0e-22e3f6e18908"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i26e5ceadc3fd4816b11932771a952db5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTgtMS0xLTEtMTc4OTI1_e9faa59f-0f58-4a26-86b5-1a88fb118e36"
      unitRef="usd">743000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia978a4df05104b8d9e0c86ae761b25a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTgtMy0xLTEtMTc4OTI1_06d61a0f-c9f7-4eb3-9b6c-3fed93d09f98"
      unitRef="usd">743000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icf8ec40657e04aa2b23060d00732bdef_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTktMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MjFjYzZmYzRiY2FhNDQ1YTg5MmQ5MjViMmE5ZjI4Y2JfNA_39ee0f25-23c9-4066-98c2-b122ca99ea54"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icf8ec40657e04aa2b23060d00732bdef_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTktMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MjFjYzZmYzRiY2FhNDQ1YTg5MmQ5MjViMmE5ZjI4Y2JfOA_d1e0343a-7570-4788-86a9-db0921a20e1a"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="icf8ec40657e04aa2b23060d00732bdef_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTktMS0xLTEtMTc4OTI1_3f9b5053-4044-4a23-bd78-28ebed03d1d0"
      unitRef="usd">496000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib78aa39252ea44aea1a09bb8f388149d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMTktMy0xLTEtMTc4OTI1_b6b6d216-00e5-4958-af6d-fdf740131ca4"
      unitRef="usd">496000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i14cc50d065954e1287d2acb52e3f4d75_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGM5NmVjMWY3ZDliNDIxZGEzMDYzZTRhYzgyZThlMmFfNA_e202fe44-787b-40ff-a935-d4f18be8c34e"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i14cc50d065954e1287d2acb52e3f4d75_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NGM5NmVjMWY3ZDliNDIxZGEzMDYzZTRhYzgyZThlMmFfOA_5cce96f3-dcb5-49fd-8a80-b1219bbd624d"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i14cc50d065954e1287d2acb52e3f4d75_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMS0xLTEtMTc4OTI1_22db682f-28c9-4c99-9f49-e6e516b40efe"
      unitRef="usd">496000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ifbbf8eeed67d47678e97ce557e665c35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMy0xLTEtMTc4OTI1_8f833a30-c728-4ea9-8ff4-07483e98408c"
      unitRef="usd">495000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iaf517366f109416a81eaf87157f208a6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjEtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246ZGE4NDA1NGVkNzIzNGY0ZDhmNjRmYmZmODMwNGFlM2RfNA_51a4c307-64f7-4714-9d37-a9f59ec685f4"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iaf517366f109416a81eaf87157f208a6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjEtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246ZGE4NDA1NGVkNzIzNGY0ZDhmNjRmYmZmODMwNGFlM2RfOA_d8447835-0a48-42c9-8109-85fe62c82ee6"
      unitRef="number">0.02150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iaf517366f109416a81eaf87157f208a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjEtMS0xLTEtMTc4OTI1_a1167d7f-26b9-4e33-86e8-f0c662d699c6"
      unitRef="usd">743000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i091bf184716543a691cccbef4e0a6911_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjEtMy0xLTEtMTc4OTI1_6df4d842-c188-4893-9eb2-fea9e1e5c563"
      unitRef="usd">743000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1987ecea13f144a6b016db1433b4edad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMC0xLTEtMTg1Nzc4L3RleHRyZWdpb246MzExNGRlN2E4ODRkNDkzYjg1NDcxZTJiODZiYjY2OTdfMTA5OTUxMTYyNzgyNw_788511fd-4a7e-4803-a0d8-e4a511dffc91"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1987ecea13f144a6b016db1433b4edad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMC0xLTEtMTg1Nzc4L3RleHRyZWdpb246MzExNGRlN2E4ODRkNDkzYjg1NDcxZTJiODZiYjY2OTdfMTA5OTUxMTYyNzgzMQ_f3e9ecbb-3685-4d65-98f6-48fc904234e3"
      unitRef="number">0.05880</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1987ecea13f144a6b016db1433b4edad_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMS0xLTEtMTg1NzY5_3416529b-68c2-443e-8106-9323f383f608"
      unitRef="usd">740000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4828bda4e27e4c81a26419b5e9fcf71d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjAtMy0xLTEtMTg1NzY5_508a4c1f-caf2-4934-a9b3-8dc8bb8525e9"
      unitRef="usd">739000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7c2bb3882bf541f0b41f0a999f57989e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246YTNhZTVmNmJkOTgwNGEzY2EyZDAzNDI1MzQ2YmZhMDBfNA_f324a8f4-3db4-431c-abb6-9ced36d280f6"
      unitRef="usd">250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7c2bb3882bf541f0b41f0a999f57989e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjItMC0xLTEtMTc4OTI1L3RleHRyZWdpb246YTNhZTVmNmJkOTgwNGEzY2EyZDAzNDI1MzQ2YmZhMDBfOA_eec145f9-f14f-4d4d-9d5f-0cd516f5991c"
      unitRef="number">0.08150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7c2bb3882bf541f0b41f0a999f57989e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjItMS0xLTEtMTc4OTI1_d05529e0-c1e9-449f-90f9-86a14c167411"
      unitRef="usd">261000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iecb222c03b6b4488b13789f1508b415c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjItMy0xLTEtMTc4OTI1_d60865b0-740f-4076-a5b7-8678055ab26e"
      unitRef="usd">261000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic9d6ead9d85d451e8b8a7651924f9bc1_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjMtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MmY5N2RiZDUyYjVkNDMwNjk0OTZlMmU0MTVlNTllZjdfNA_8ccd58cc-c568-4c8c-86ad-ba3011e8febd"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic9d6ead9d85d451e8b8a7651924f9bc1_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjMtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MmY5N2RiZDUyYjVkNDMwNjk0OTZlMmU0MTVlNTllZjdfOA_96d0e5a2-5fd2-40cc-8198-2a2757fced28"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic9d6ead9d85d451e8b8a7651924f9bc1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjMtMS0xLTEtMTc4OTI1_9521e5d8-31d3-44d1-b7c4-b61f85b36e78"
      unitRef="usd">396000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i11064c69b1ae4ba6a3588922076a07a4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjMtMy0xLTEtMTc4OTI1_96f7acaf-5d7a-4ab2-985d-3a2f4fda1fc9"
      unitRef="usd">396000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7717d896545c4a218cf32e09098785e2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjQtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NDVjNzgwNGJjOGFhNDI0Njk4ZThjM2ZlNDgwNzVhYWVfNA_8114f8ba-1e07-4536-a699-bd10478b0869"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7717d896545c4a218cf32e09098785e2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjQtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NDVjNzgwNGJjOGFhNDI0Njk4ZThjM2ZlNDgwNzVhYWVfOA_39824c11-cb89-4611-b02f-711199127c23"
      unitRef="number">0.04950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7717d896545c4a218cf32e09098785e2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjQtMS0xLTEtMTc4OTI1_8d46b383-d548-4c72-ab3e-36ff4948b251"
      unitRef="usd">740000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id7032ea7ab0740d38bc437206fc5d938_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjQtMy0xLTEtMTc4OTI1_1a704bb7-88d4-4a57-8773-b5bd8601adee"
      unitRef="usd">740000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ifd3cf22ac75d404380d62b35ce279abb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjUtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NDUwNWEyM2E3MGI2NDVhMjljZmZkYmRmZWM5NTYxOTZfNA_e65014b7-dac0-4e0b-bd5f-1a0950b8f4e5"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifd3cf22ac75d404380d62b35ce279abb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjUtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246NDUwNWEyM2E3MGI2NDVhMjljZmZkYmRmZWM5NTYxOTZfOA_21898189-da8f-447d-be6f-102e827cda43"
      unitRef="number">0.04800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ifd3cf22ac75d404380d62b35ce279abb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjUtMS0xLTEtMTc4OTI1_a5415041-b7d2-4748-b007-592791cdba5a"
      unitRef="usd">396000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i287c4ed0af71453dbafbd6c72bda52cd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjUtMy0xLTEtMTc4OTI1_b599a70d-4a92-4d80-8e16-e1f38c10ab02"
      unitRef="usd">396000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i15cd5b523c8b45408ca5a4cfbcaadc77_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjYtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MzQwMTQyNzcxMzcwNGE5ZmE2NGY5ZmM1ZTQ2ODFkMWVfNA_b96dbee0-f862-406b-b591-0e73a580683b"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i15cd5b523c8b45408ca5a4cfbcaadc77_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjYtMC0xLTEtMTc4OTI1L3RleHRyZWdpb246MzQwMTQyNzcxMzcwNGE5ZmE2NGY5ZmM1ZTQ2ODFkMWVfOA_2ae688c7-d774-4598-84f5-95c01802b046"
      unitRef="number">0.03950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i15cd5b523c8b45408ca5a4cfbcaadc77_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjYtMS0xLTEtMTc4OTI1_94758e20-0ffc-4475-9a0a-b5d0a1f54a33"
      unitRef="usd">493000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie58ccd3ad9cf4484869350e55c97daa9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjYtMy0xLTEtMTc4OTI1_e97d20f6-7496-4a96-8997-9f9f927402ba"
      unitRef="usd">493000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i81618d62a5464513a79e9149e2a960be_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjctMC0xLTEtMTg1NzI5L3RleHRyZWdpb246Njg2ZGMyZTU4MTk2NGFlOWE4NWQyMWM0MjIzY2ExNGRfMTA5OTUxMTYyNzgyOA_e666f93d-c6b5-4e4f-a8ee-788b7d879c81"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i81618d62a5464513a79e9149e2a960be_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjctMC0xLTEtMTg1NzI5L3RleHRyZWdpb246Njg2ZGMyZTU4MTk2NGFlOWE4NWQyMWM0MjIzY2ExNGRfMTA5OTUxMTYyNzgzMg_24bb6fa5-0fad-4182-a1d0-44ee6ecc2a74"
      unitRef="number">0.05500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i81618d62a5464513a79e9149e2a960be_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjctMS0xLTEtMTg1NzIw_3eba0079-4246-43a7-a484-69c3d231091f"
      unitRef="usd">714000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i44f39416bf6d42a18eb86f26dba70f57_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjctMy0xLTEtMTg1NzIw_044f9610-02e0-4683-b57e-e440ea25b193"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0baef8994ca946c49745a0878f83ccea_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjctMS0xLTEtMTc4OTI1_77cd897c-3d79-4e52-93d7-3b7f756970a0"
      unitRef="usd">9743000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i86bac7559acf4a0a8e9e4af23f7cc8ec_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMjctMy0xLTEtMTc4OTI1_b5058c28-ddf9-4f2c-9545-51d884338fe7"
      unitRef="usd">8534000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i14a912e506d74aabb1927dc325a1b647_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMzAtMS0xLTEtMTc4OTI1_7dac2080-831c-449b-8a4f-098080d578a6"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9d06da66baf1438495bd1819635d56fc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMzAtMy0xLTEtMTc4OTI1_214af7f2-6879-457b-993b-c9d12da373eb"
      unitRef="usd">500000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia699014a8a7c45b4877ccab91d786647_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMzEtMS0xLTEtMTc4OTI1_b9b2e031-9988-48e5-a974-4e8ecb0c95e2"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i80317ae1ece041a3be5e392acc5b7f32_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMzEtMy0xLTEtMTc4OTI1_d1c0ac12-f78e-4ea7-8c3e-32850d926e73"
      unitRef="usd">500000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMzItMS0xLTEtMTc4OTI1_d857a7b9-b8e1-4695-a70d-08e818b3570d"
      unitRef="usd">9743000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i192cbe1b72e34457bc41adff9b0e5179_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RhYmxlOjQxYjA2OTczMmMwNzQ2MDI5ZGNjMjU4OWFiZjQyYTk5L3RhYmxlcmFuZ2U6NDFiMDY5NzMyYzA3NDYwMjlkY2MyNTg5YWJmNDJhOTlfMzItMy0xLTEtMTc4OTI1_4c0af71e-2653-410d-9c92-d93f8604526c"
      unitRef="usd">9034000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9c6800fd78e7409d9fc9e4e3e89146b1_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMTY2_b09c807b-9039-4202-aa3f-48573bc810eb"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9c6800fd78e7409d9fc9e4e3e89146b1_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMTcy_a04b33f7-fb4d-407b-a7b7-5a6218c2691b"
      unitRef="number">0.05700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5e6bb461948f467880d14a15c5c56cc4_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMTY0OTI2NzQ1MzA0Nw_5bbd4ff3-52f4-46e3-838f-f19dfd8ca23e"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5e6bb461948f467880d14a15c5c56cc4_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMTY0OTI2NzQ1MzA2MQ_d7fd6195-8ed6-4004-b8b4-46f509e3d067"
      unitRef="number">0.05500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i6722660df9ae426fba8939630f33aba2_D20220301-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzAz_421a87ae-0755-4213-ac4f-0d9740ee5937"
      unitRef="usd">1200000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4600a55e099c4531bc7d43ae4f7b2b61_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5NDAyMA_01b90d9d-0adf-42fc-8fb4-eaa75f8acc0e"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia745190caecb4ad18029594fbd44dad9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5MTI3OA_9ece2bf2-1f55-4de1-9620-407336ab79fd"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia745190caecb4ad18029594fbd44dad9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5MTI5Mg_df1fb878-231e-44a6-9cce-026c1eb4c0b2"
      unitRef="number">0.00650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3a64f9f747cc4b969bd58c5a210d96b8_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5MTMwMA_96abe6bb-5c46-49aa-b080-284816a6b341"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3a64f9f747cc4b969bd58c5a210d96b8_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5MTMxNA_bc488a89-a609-4914-8547-a89f2b23b7d9"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5MTMyMQ_4eb666b1-b7fc-43ed-b050-a35b9c11464a"
      unitRef="usd">61000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="ib0b3e6cb82b043229c6de3f534953330_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzI5ODUzNDg5MTMyMg_9407bd54-9c0e-4b7b-b911-d5c2534aadbf"
      unitRef="usd">60000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <hum:DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum
      contextRef="if6ef86f63d5c4341b776612f407688ab_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjAwNA_e8f25886-7b97-4e34-bbc4-f9889475aa73"
      unitRef="number">0.60</hum:DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum>
    <hum:DebtInstrumentCovenantDebtToCapitalizationPercentageActual
      contextRef="ia699014a8a7c45b4877ccab91d786647_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjEzNw_8bbdae2a-230d-418c-9c84-0729fe055dd3"
      unitRef="number">0.411</hum:DebtInstrumentCovenantDebtToCapitalizationPercentageActual>
    <us-gaap:LinesOfCreditCurrent
      contextRef="if6ef86f63d5c4341b776612f407688ab_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjIyOQ_00a0e1bc-a1e1-457b-bd13-b50c751ba02e"
      unitRef="usd">0</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="if954b4dd458243c192b80a70934aab3b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjI2MQ_bc2ff647-af8b-41cf-86bd-8a2082c302a7"
      unitRef="usd">39000000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i277382cd831d44e68146d96819af483f_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjM5MA_e7fd02d2-465d-4888-92ca-6558d587105c"
      unitRef="usd">2400000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="idfe7731c31ef4c5d8ace727574933dbc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjQzNQ_86fb45ec-0d08-450b-806b-1a8c3ab3e0ad">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i16a8b22589364b0cabcaeebe88c025fd_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjQ3NA_8e8fdc05-11d7-46c7-90fc-f4bfa8df3a34"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="iac8c9ca5d8d047529559c7212dd98d0a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjUxOQ_41b1cff3-7a17-4176-9a32-4603d0cbaa2d">P364D</us-gaap:DebtInstrumentTerm>
    <hum:LineOfCreditFacilityUncommittedIncrementalCapacity
      contextRef="if6ef86f63d5c4341b776612f407688ab_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMjU4NQ_dcdc819d-f26e-495a-b862-ac0c52e27513"
      unitRef="usd">750000000</hum:LineOfCreditFacilityUncommittedIncrementalCapacity>
    <us-gaap:ShorttermDebtMaximumAmountOutstandingDuringPeriod
      contextRef="i1cfe16f46375489ab53b2a64c31248d4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzYyMw_71d186e3-faf5-4a91-bfb5-562f4f6fba3f"
      unitRef="usd">626000000</us-gaap:ShorttermDebtMaximumAmountOutstandingDuringPeriod>
    <us-gaap:ShortTermBorrowings
      contextRef="ie5378147acd6413d98ab4a87badd98a5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzYzMg_c4fd078d-4560-4611-af9a-54e5215a78e8"
      unitRef="usd">426000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i66bc861b6d684110a1c01760cf75a9d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzY2NQ_04d38dca-5c97-40d3-b391-69409943e3da"
      unitRef="usd">595000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate
      contextRef="ie5378147acd6413d98ab4a87badd98a5_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfMzc3Mw_fca96c62-f4cf-4dd9-bc13-03070f857f61"
      unitRef="number">0.0545</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:ShortTermBorrowings
      contextRef="ic709c99d9e6e4394aec61e0022ddc186_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV82Ny9mcmFnOmIxYjk4MWM0MTBhMjQ3MTA5ZTg3NmFmNTc5ZmY5YzJkL3RleHRyZWdpb246YjFiOTgxYzQxMGEyNDcxMDllODc2YWY1NzlmZjljMmRfNDAzMw_f6f82139-ccd7-4152-87ba-389fa718ea78"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfOTExOQ_c9cfbcd0-39f1-418c-af91-82524c9926f5">COMMITMENTS, GUARANTEES AND CONTINGENCIES&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Government Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Medicare products, which accounted for approximately 84% of our total premiums and services revenue for the three months ended March 31, 2023, primarily consisted of products covered under the Medicare Advantage and Medicare Part D Prescription Drug Plan contracts with the federal government. These contracts are renewed generally for a calendar year term unless CMS notifies us of its decision not to renew by May 1 of the calendar year in which the contract would end, or we notify CMS of our decision not to renew by the first Monday in June of the calendar year in which the contract would end. All material contracts between Humana and CMS relating to our Medicare products have been renewed for 2023, and all of our product offerings filed with CMS for 2023 have been approved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS uses a risk-adjustment model which adjusts premiums paid to Medicare Advantage, or MA, plans according to health status of covered members. The risk-adjustment model, which CMS implemented pursuant to the Balanced Budget Act of 1997, or BBA, and the Benefits Improvement and Protection Act of 2000, or BIPA, generally pays more where a plan's membership has higher expected costs. Under this model, rates paid to MA plans are based on actuarially determined bids, which include a process whereby our prospective payments are based on our estimated cost of providing standard Medicare-covered benefits to an enrollee with a "national average risk profile." That baseline payment amount is adjusted to account for certain demographic characteristics and health status of our enrolled members. Under the risk-adjustment methodology, all MA plans must collect from providers and submit the necessary diagnosis code information to CMS within prescribed deadlines. The CMS risk-adjustment model uses the diagnosis data, collected from providers, to calculate the health status-related risk-adjusted premium payment to MA plans, which CMS further adjusts for coding pattern differences between the health plans and the government fee-for-service, or FFS, program. We generally rely on providers, including certain providers in our network who are our employees, to code their claim submissions with appropriate diagnoses, which we send to CMS as the basis for our health status-adjusted payment received from CMS under the actuarial risk-adjustment model. We also rely on these providers to document appropriately all medical data, including the diagnosis data submitted with claims. In addition, we conduct medical record reviews as part of our data and payment accuracy compliance efforts, to more accurately reflect diagnosis conditions under the risk adjustment model.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS and the Office of the Inspector General of Health and Human Services, or HHS-OIG, perform audits of various companies&#x2019; risk adjustment diagnosis data submissions. We refer to these audits as Risk-Adjustment Data Validation Audits, or RADV audits. RADV audits review medical records in an attempt to validate provider medical record documentation and coding practices that influence the calculation of health status-related premium payments to MA plans. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2012, CMS released an MA contract-level RADV methodology that would extrapolate the results of each CMS RADV audit sample to the audited MA contract&#x2019;s entire health status-related risk adjusted premium amount for the year under audit.  In doing so, CMS recognized &#x201c;that the documentation standard used in RADV audits to determine a contract&#x2019;s payment error (medical records) is different from the documentation standard used to develop the Part C risk-adjustment model (FFS claims).&#x201d; To correct for this difference, CMS stated that it would apply a &#x201c;Fee-for-Service Adjuster (FFS Adjuster)&#x201d; as &#x201c;an offset to the preliminary recovery amount.&#x201d; This adjuster would be &#x201c;calculated by CMS based on a RADV-like review of records submitted to support FFS claims data.&#x201d;  CMS stated that this methodology would apply to audits beginning with PY 2011. Humana relied on CMS&#x2019;s 2012 guidance in submitting MA bids to CMS.  Humana also launched a &#x201c;Self-Audits&#x201d; program in 2013 that applied CMS&#x2019;s 2012 RADV audit methodology and included an estimated FFS Adjuster.  Humana completed Self-Audits for PYs 2011-2016 and reported results to CMS. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2018, however, CMS issued a proposed rule announcing possible changes to the RADV audit methodology, including elimination of the FFS Adjuster.  CMS proposed applying its revised methodology, including extrapolated recoveries without application of a FFS Adjuster, to RADV audits dating back to PY 2011.  On January 30, 2023, CMS published a final rule related to the RADV audit methodology (Final RADV Rule).  The Final RADV Rule confirmed CMS&#x2019;s decision to eliminate the FFS Adjuster. The Final RADV Rule states CMS&#x2019;s intention to extrapolate results from CMS and HHS-OIG RADV audits beginning with PY 2018, rather than PY 2011 as proposed.  However, CMS&#x2019;s Final RADV Rule does not adopt a specific sampling, extrapolation or audit methodology.  CMS instead stated its general plan to rely on &#x201c;any statistically valid method . . . that is determined to be well-suited to a particular audit.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Humana is considering its legal options with respect to CMS&#x2019;s changed position on the FFS Adjuster and seeking clarity regarding our compliance obligations in light of the Final RADV Rule. We believe that the Final RADV Rule fails to address adequately the statutory requirement of actuarial equivalence. Further, Humana&#x2019;s actuarially certified bids through PY 2023 preserved Humana&#x2019;s position that CMS should apply an FFS Adjuster in any RADV audit that CMS intends to extrapolate. We expect CMS to apply the Final RADV Rule, including the first application of extrapolated audit results to determine audit settlements without a FFS Adjuster, to CMS and HHS-OIG RADV audits conducted for PY 2018 and subsequent years.  The Final RADV Rule, including the lack of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a FFS Adjuster, and any related regulatory, industry or company reactions, could have a material adverse effect on our results of operations, financial position, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, as part of our internal compliance efforts, we routinely perform ordinary course reviews of our internal business processes related to, among other things, our risk coding and data submissions in connection with the risk adjustment model. These reviews may also result in the identification of errors and the submission of corrections to CMS that may, either individually or in the aggregate, be material. As such, the result of these reviews may have a material adverse effect on our results of operations, financial position, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As we explore our legal options and compliance obligations, we remain committed to working alongside CMS to promote the integrity of the MA program as well as affordability and cost certainty for our members.  It is critical that MA plans are paid accurately and that payment model principles, including the application of a FFS Adjuster, are in accordance with the requirements of the Social Security Act, which, if not implemented correctly could have a material adverse effect on our results of operations, financial position, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our state-based Medicaid business, which accounted for approximately 7% of our total premiums and services revenue for the three months ended March 31, 2023 primarily consisted of serving members enrolled in Medicaid, and in certain circumstances members who qualify for both Medicaid and Medicare, under contracts with various states. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; At March&#160;31, 2023, our Military business, which accounted for approximately 1% of our total premiums and services revenue for the three months ended March 31, 2023, primarily consisted of the TRICARE T2017 East Region contract. The T2017 East Region contract comprising 32 states and approximately 6 million TRICARE beneficiaries, under which delivery of health care services commenced on January 1, 2018. The T2017 East Region contract, which was originally set to expire on December 31, 2022, was subsequently extended by the DoD and is currently scheduled to expire on December 31, 2023, unless further extended. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, we were awarded the next generation of TRICARE Managed Care Support Contracts, or T-5, for the TRICARE East Region by the Defense Health Agency of the DoD. The contract is expected to go into effect in 2024. Until then the T2017 contract remains in place. Under the terms of the award, our service area covers approximately 4.6&#160;million beneficiaries in a region consisting of 24 states and Washington, D.C. The length of the contract is &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTA5OTUxMTY1MjExMw_2669b125-bc7d-4903-8a53-f6a32cfce9ee"&gt;one&lt;/span&gt; base year with eight annual option periods, which, if all options are exercised, would result in a total contract length of nine years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loss of any of the contracts above or significant changes in these programs as a result of legislative or regulatory action, including reductions in premium payments to us, regulatory restrictions on profitability, including reviews by regulatory bodies that may compare our Medicare Advantage profitability to our non-Medicare Advantage business profitability, or compare the profitability of various products within our Medicare Advantage business, and require that they remain within certain ranges of each other, or increases in member benefits or member eligibility criteria without corresponding increases in premium payments to us, may have a material adverse effect on our results of operations, financial position, and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Proceedings and Certain Regulatory Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously disclosed, the Civil Division of the United States Department of Justice provided us with an information request in December 2014, concerning our Medicare Part C risk adjustment practices. The request relates to our oversight and submission of risk adjustment data generated by providers in our Medicare Advantage network, as well as to our business and compliance practices related to risk adjustment data generated by our providers and by us, including medical record reviews conducted as part of our data and payment accuracy compliance efforts, the use of health and well-being assessments, and our fraud detection efforts. We believe that this request for information is in connection with a wider review of Medicare Risk Adjustment generally that includes a number of Medicare Advantage plans, providers and vendors. We cooperated with the Department of Justice, and we have not heard from the Department of Justice on this matter since 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously disclosed, on January 19, 2016, an individual filed a qui tam suit captioned United States of America ex rel. Steven Scott v. Humana, Inc., in United States District Court, Central District of California, Western Division. The complaint alleges certain civil violations by us in connection with the actuarial equivalence of the plan benefits under Humana&#x2019;s Basic PDP plan, a prescription drug plan offered by us under Medicare Part D. The action seeks damages and penalties on behalf of the United States under the False Claims Act. The court ordered the qui tam action unsealed on September 13, 2017, so that the relator could proceed, following notice from the U.S. Government that it was not intervening at that time. On January 29, 2018, the suit was transferred to the United States District Court, Western District of Kentucky, Louisville Division. We have substantially completed discovery with the relator who has pursued the matter on behalf of the United States following its unsealing. On March 31, 2022, the Court denied the parties' Motions for Summary Judgement. We take seriously our obligations to comply with applicable CMS requirements and actuarial standards of practice, and continue to vigorously defend against these allegations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Lawsuits and Regulatory Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our current and past business practices are subject to review or other investigations by various state insurance and health care regulatory authorities and other state and federal regulatory authorities. These authorities regularly scrutinize the business practices of health insurance, health care delivery and benefits companies. These reviews focus on numerous facets of our business, including claims payment practices, statutory capital requirements, provider contracting, risk adjustment, competitive practices, commission payments, privacy issues, utilization management practices, pharmacy benefits, access to care, sales practices, and provision of care by our healthcare services businesses, among others. Some of these reviews have historically resulted in fines imposed on us and some have required changes to some of our practices. We continue to be subject to these reviews, which could result in additional fines or other sanctions being imposed on us or additional changes in some of our practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also are involved in various other lawsuits that arise, for the most part, in the ordinary course of our business operations, certain of which may be styled as class-action lawsuits. Among other matters, this litigation may include employment matters, claims of medical malpractice, bad faith, nonacceptance or termination of providers, anticompetitive practices, improper rate setting, provider contract rate and payment disputes, including disputes over reimbursement rates required by statute, disputes arising from competitive procurement process, general contractual matters, intellectual property matters, and challenges to subrogation practices. Under state guaranty assessment laws, including those related to state cooperative failures in the industry, we may be assessed (up to prescribed limits) for certain obligations to the policyholders and claimants of insolvent insurance companies that write the same line or lines of business as we do.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a government contractor, we may also be subject to false claims litigation, such as qui tam lawsuits brought by individuals who seek to sue on behalf of the government, alleging that the government contractor submitted false claims to the government or related overpayments from the government, including, among other allegations, those resulting from coding and review practices under the Medicare risk adjustment model. Qui tam litigation is filed under seal to allow the government an opportunity to investigate and to decide if it wishes to intervene and assume control of the litigation. If the government does not intervene, the individual may continue to prosecute the action on his or her own, on behalf of the government. We also are subject to other allegations of nonperformance of contractual obligations to providers, members, and others, including failure to properly pay claims, improper policy terminations, challenges to our implementation of the Medicare Part D prescription drug program and other litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited number of the claims asserted against us are subject to insurance coverage. Personal injury claims, claims for extra contractual damages, care delivery malpractice, and claims arising from medical benefit denials are covered by insurance from our wholly owned captive insurance subsidiary and excess carriers, except to the extent that claimants seek punitive damages, which may not be covered by insurance in certain states in which insurance coverage for punitive damages is not permitted. In addition, insurance coverage for all or certain forms of liability has become increasingly costly and may become unavailable or prohibitively expensive in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record accruals for the contingencies discussed in the sections above to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described above because of the inherently unpredictable nature of legal proceedings, which also may be exacerbated by various factors, including: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties (including where it is uncertain how liability, if any, will be shared among multiple defendants); or (vii) there is a wide range of potential outcomes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The outcome of any current or future litigation or governmental or internal investigations, including the matters described above, cannot be accurately predicted, nor can we predict any resulting judgments, penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities or as a result of actions by third parties. Nevertheless, it is reasonably possible that any such outcome of litigation, judgments, penalties, fines or other sanctions could be substantial, and the outcome of these matters may have a material adverse effect on our results of operations, financial position, and cash flows, and may also affect our reputation.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock>
    <hum:PercentageOfTotalPremiumAndServicesRevenues
      contextRef="id20841ace72748718a4437b57f98c65a_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTI5_8aafa4f5-0bbf-4194-932c-900b2baaa53e"
      unitRef="number">0.84</hum:PercentageOfTotalPremiumAndServicesRevenues>
    <hum:PercentageOfTotalPremiumAndServicesRevenues
      contextRef="icb617ce6644248ea8db1728a74bbbf53_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfNzU4Nw_aa917ea5-06d6-4c77-8979-a166bce297ef"
      unitRef="number">0.07</hum:PercentageOfTotalPremiumAndServicesRevenues>
    <hum:PercentageOfTotalPremiumAndServicesRevenues
      contextRef="i4480f878da3046eca330bf17a448e268_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfNzg5OA_b51499c5-632b-4063-adee-6405e8c2351b"
      unitRef="number">0.01</hum:PercentageOfTotalPremiumAndServicesRevenues>
    <hum:NumberOfStatesComprisingTRICAREBeneficiaries
      contextRef="i2ff845a818d94f94ab5d91f1b9bd6c7e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfODA2MQ_c7cb7034-4c7a-4f20-a378-5a67032ec0fa"
      unitRef="state">32</hum:NumberOfStatesComprisingTRICAREBeneficiaries>
    <hum:NumberOfTRICAREBeneficiaries
      contextRef="i0bc5a60bb99048cbad4400d49e4dcfe7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfODA4OQ_85de43c0-6568-4304-92c7-a341aa84f98d"
      unitRef="beneficiary">6000000</hum:NumberOfTRICAREBeneficiaries>
    <hum:NumberOfTRICAREManagedCareSupportContractBeneficiaries
      contextRef="ie7875175150c464986253f694017f369_D20221201-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTA5OTUxMTY1MjA5Ng_6e1ffe2a-96c9-4f9e-a7ff-8c21d9b4508e"
      unitRef="beneficiary">4600000</hum:NumberOfTRICAREManagedCareSupportContractBeneficiaries>
    <hum:NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries
      contextRef="i78f2374ea9724509bf4c2fb579684e3f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTA5OTUxMTY1MjEwOQ_46e58455-5dc0-4f3a-b57c-3436369ae2b8"
      unitRef="state">24</hum:NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries>
    <hum:TRICAREManagedCareSupportContractNumberOfOptionPeriods
      contextRef="i78f2374ea9724509bf4c2fb579684e3f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTA5OTUxMTY1MjExNA_ee4f439f-7183-42f4-8164-570bd7481fa8"
      unitRef="option_period">8</hum:TRICAREManagedCareSupportContractNumberOfOptionPeriods>
    <hum:TRICAREManagedCareSupportContractTermWithOptionExercises
      contextRef="ie7875175150c464986253f694017f369_D20221201-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83MC9mcmFnOjE4MThmMGM0MzQyZDQ4NTFiZWJiZmUzODNhMzBiYWJiL3RleHRyZWdpb246MTgxOGYwYzQzNDJkNDg1MWJlYmJmZTM4M2EzMGJhYmJfMTA5OTUxMTY1MjExMg_de4c1308-c81d-4cd1-8656-60c4057a6397">P9Y</hum:TRICAREManagedCareSupportContractTermWithOptionExercises>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNjg0OA_f8412a44-2379-4643-a3cb-281b09d3f410">SEGMENT INFORMATION&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During December 2022, we realigned our businesses into two distinct segments: Insurance and CenterWell. The Insurance segment includes the businesses that were previously included in the Retail and Group and Specialty segments, as well as the Pharmacy Benefit Manager, or PBM, business which was previously included in the Healthcare Services segment. The CenterWell segment (formerly Healthcare Services) represents our payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. In addition to the new segment classifications being utilized to assess performance and allocate resources, we believe this simpler structure will create greater collaboration across the Insurance and CenterWell businesses and will accelerate work that is underway to centralize and integrate operations within the organization.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior period segment financial information has been recast to conform to the 2023 presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our two reportable segments, Insurance and CenterWell, are based on a combination of the type of health plan customer and adjacent businesses centered on well-being solutions for our health plans and other customers, as described below. These segment groupings are consistent with information used by our Chief Executive Officer, the Chief Operating Decision Maker, to assess performance and allocate resources. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as our contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which we refer to collectively as our state-based contracts. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only, or ASO. In addition, our Insurance segment includes our Military business, primarily our T-2017 East Region contract, as well as the operations of our PBM business. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The CenterWell segment includes our pharmacy, provider services, and home solutions operations. The segment also includes our strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as our minority ownership interest in hospice operations. Services offered by this segment are designed to enhance the overall healthcare experience. These services may lead to lower utilization associated with improved member health and/or lower drug costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our CenterWell intersegment revenues primarily relate to the operations of CenterWell Pharmacy (our mail- order pharmacy business), CenterWell Specialty Pharmacy, and retail pharmacies jointly located within CenterWell Senior Primary Care clinics. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, our CenterWell intersegment revenues include revenues earned by certain owned providers derived from certain value-based arrangements with our health plans. Under these value-based arrangements, our owned providers enter into agreements with our health plans to stand ready to deliver, integrate, direct and control the administration and management of certain health care services for our members. In exchange, the owned provider receives a premium that is typically paid on a per-member per-month basis. These value-based arrangements represent a single performance obligation where revenues are recognized in the period in which we are obligated to provide integrated health care services to our members. Fee-for-service revenue is recognized at agreed upon rates, net of contractual allowances, as the performance obligation is completed on the date of service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We present our condensed consolidated results of operations from the perspective of the health plans. As a result, the cost of providing benefits to our members, whether provided via a third party provider or internally through a stand-alone subsidiary, is classified as benefits expense and excludes the portion of the cost for which the health plans do not bear responsibility, including member co-share amounts and government subsidies of $4.0&#160;billion and $4.0 billion for the three months ended March 31, 2023 and 2022, respectively. In addition, depreciation and amortization expense associated with certain businesses delivering benefits to our members, primarily associated with our provider services and pharmacy operations, are included with benefits expense. The amount of this expense was $33 million and $30 million for the three months ended March 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than those described previously, the accounting policies of each segment are the same. For additional information regarding our accounting policies refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K. Transactions between reportable segments primarily consist of sales of services rendered by our CenterWell segment, primarily pharmacy, provider, and home services, to our Insurance segment customers. Intersegment sales and expenses are recorded at fair value and eliminated in consolidation. Members served by our segments often use the same provider networks, enabling us in some instances to obtain more favorable contract terms with providers. Our segments also share indirect costs and assets. As a result, the profitability of each segment is interdependent. We allocate most operating expenses to our segments. Assets and certain corporate income and expenses are not allocated to the segments, including the portion of investment income not supporting segment operations, interest expense on corporate debt, and certain other corporate expenses. These items are managed at a corporate level. These corporate amounts are reported separately from our reportable segments and are included with intersegment eliminations in the tables presenting segment results below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our segment results were as follows for the three months ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Eliminations/&lt;br/&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Group Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare stand-alone PDP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial fully-insured&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Supplement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Home solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial ASO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Military and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total services revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total external revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes and equity in net losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings (loss) attributable to Humana&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.975%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Eliminations/&lt;br/&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External Revenues  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Group Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare stand-alone PDP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial fully-insured&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Supplement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Home solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial ASO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Military and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total services revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total external revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes and equity in net losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss (income) attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings (loss) attributable to Humana&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i05af7d59e35843539a7b53e907c4cb75_D20221201-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNTQ5NzU1ODIwNzU3_edc5ec45-27db-41b8-8cce-e9e144e87d7a"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNTQ5NzU1ODIxNzM5_8a485072-83cb-4d31-be3e-af8642813c14"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <hum:GovernmentAndHealthPlanMemberSubsidiesAmount
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNDgyMQ_1443ae3e-41bd-469d-a825-ef1dd752f364"
      unitRef="usd">4000000000</hum:GovernmentAndHealthPlanMemberSubsidiesAmount>
    <hum:GovernmentAndHealthPlanMemberSubsidiesAmount
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNDgyOA_fbe55360-5ae9-49eb-971a-721cdf0b2187"
      unitRef="usd">4000000000</hum:GovernmentAndHealthPlanMemberSubsidiesAmount>
    <hum:DepreciationAndAmortizationClassifiedAsBenefitExpense
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNTIyMw_b9f6bb3f-7821-4f20-acb4-cf9192e7390c"
      unitRef="usd">33000000</hum:DepreciationAndAmortizationClassifiedAsBenefitExpense>
    <hum:DepreciationAndAmortizationClassifiedAsBenefitExpense
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNTIzMA_0afd1a99-33b9-494c-ad42-44bade9ef838"
      unitRef="usd">30000000</hum:DepreciationAndAmortizationClassifiedAsBenefitExpense>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RleHRyZWdpb246YWQ1NTUyNTY1Mjk3NDIxZGEzNWZhZjc3ZjM5NDk3MmRfNjg0MQ_8fae371d-f4c2-42ee-a64c-1a8800795070">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our segment results were as follows for the three months ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Eliminations/&lt;br/&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Group Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare stand-alone PDP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial fully-insured&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Supplement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Home solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial ASO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Military and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total services revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total external revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes and equity in net losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings (loss) attributable to Humana&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.975%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Eliminations/&lt;br/&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External Revenues  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Group Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare stand-alone PDP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial fully-insured&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Supplement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Home solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial ASO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Military and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total services revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total external revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes and equity in net losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss (income) attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings (loss) attributable to Humana&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:PremiumsEarnedNet
      contextRef="i7aa8e3070afb4b448db7275ed5cf09ca_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNS0xLTEtMS0xNzg5MjU_f98ad0a0-edf0-49ba-a5e1-74a3af6a3296"
      unitRef="usd">19809000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="if4319d9cb6494f90a71ae9662c3e17d5_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNS01LTEtMS0xNzg5MjU_060683a5-a2a0-4c22-8e10-e66828496ad4"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i470b8c2f91574be1a05a696adddc73d9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNS0xMy0xLTEtMTc4OTI1_e8202d4c-1008-4f50-b14c-f35cdafbc8b3"
      unitRef="usd">19809000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i941da18a02fd4a139b8237908e1baf76_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNi0xLTEtMS0xNzg5MjU_01e9a983-e58b-4617-a32b-25a44e2d4a49"
      unitRef="usd">1765000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i30d50dfae3c94d26a91ba9941b08ff7f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNi01LTEtMS0xNzg5MjU_49d27866-8d5c-483d-a6d6-73d5ef7ae3c1"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i81af849246674d489655377c62775fed_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNi0xMy0xLTEtMTc4OTI1_29e89448-9fba-470a-9ee7-7646c04f9df9"
      unitRef="usd">1765000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i66882a36b65243afb23812e2ec2c1d48_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNy0xLTEtMS0xNzg5MjU_27637d17-7670-4a3b-9211-c649104298d0"
      unitRef="usd">616000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i41ce6672cc904de4a0fa8074bf62a0c4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNy01LTEtMS0xNzg5MjU_3584a638-57a7-44a2-aeef-390f34a55ce5"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ia631787e98fd47d59231450f5a5d6e0c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNy0xMy0xLTEtMTc4OTI1_e875c873-22de-4b71-8893-3c97c2031750"
      unitRef="usd">616000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i993a679845f947fab947d46e0ae0bc4a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfOC0xLTEtMS0xNzg5MjU_6cf1c649-bd6c-465e-84f6-857e9cfbfa48"
      unitRef="usd">22190000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i0c8a4218c34d47a989b327c872bb0ba7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfOC01LTEtMS0xNzg5MjU_7e9cbef7-956a-4857-b559-4451de89182c"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i05c27701e7bf4a9eb3938c2a39eb4494_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfOC0xMy0xLTEtMTc4OTI1_62915f48-587f-4552-8340-da8b6ac4c20c"
      unitRef="usd">22190000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i85424f2642a04af48e0d21aa6e0a0e12_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfOS0xLTEtMS0xNzg5MjU_235dff6d-2a6a-4337-8c58-cea76e64b6a2"
      unitRef="usd">1018000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i06996810dd5b475591115e20ef9e8d24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfOS01LTEtMS0xNzg5MjU_fe342dcf-9ebc-428d-9f9b-e97f2369b1f1"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ia1aed85758234038bfaf99ea4aaa00a2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfOS0xMy0xLTEtMTc4OTI1_018cf8e8-d42e-4ccc-b8e0-af1fa30dfdbe"
      unitRef="usd">1018000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="icfaab4185db447efbc4d239013c8fa8a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTAtMS0xLTEtMTc4OTI1_6aa1c4c1-7b9b-4efb-a7e4-38fd1b484f2b"
      unitRef="usd">254000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i8a0dbdb752344a29bf7a8dc0c0719182_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTAtNS0xLTEtMTc4OTI1_b6cd9818-83fe-41e3-a07c-f89a9576d510"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ib49f1498622e4c778b5d7aa7fc4c3199_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTAtMTMtMS0xLTE3ODkyNQ_877c98dd-3722-4f16-b494-dfdb32aac451"
      unitRef="usd">254000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ib9ac0ab1a1dc41678e04eee0f1f1ad54_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTAtMS0xLTEtMTk0NTAy_cecbc917-b5f6-4e41-a20a-c4fe24b7be8c"
      unitRef="usd">179000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ib4b77a33b1934d86a91aee24b2970f4d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTAtMy0xLTEtMTk1MTIz_f35c1a9a-b8ad-459e-9424-f3d5e8b5f47b"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ie9c99fa97fdd46efa402ed8333894c1f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTAtMTEtMS0xLTE5NDUxMg_009405b0-cf8e-4630-9fad-c838d14cdbf9"
      unitRef="usd">179000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i96917ef2e24c4974a71ff8d5a0ea7000_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTEtMS0xLTEtMTc4OTI1_398d0399-b76e-4bf0-8e27-b605c18af110"
      unitRef="usd">1909000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i22a98e5c970f455fa835963d955ebff1_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTEtNS0xLTEtMTc4OTI1_eb67d6dd-40d0-481a-9454-3167c01a27a4"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i30b27af532384e309d0f76b56db9d08a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTEtMTMtMS0xLTE3ODkyNQ_74d37044-2ea7-40c8-b795-f66a110b0f1a"
      unitRef="usd">1909000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTItMS0xLTEtMTc4OTI1_38ff8800-aec4-4b2b-aaa5-338da5fc5c2d"
      unitRef="usd">25550000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTItNS0xLTEtMTc4OTI1_349c673a-6ee6-4d57-87ca-8b6a59256b55"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6382c523c2c14c259a92f891ff8641e2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTItMTMtMS0xLTE3ODkyNQ_d6e4768e-314a-45b5-87d4-3fbd3719079b"
      unitRef="usd">25550000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4bb29b1e903c42e8b12951e278dbb473_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTYtMS0xLTEtMTc4OTI1_65d4f50b-de7e-4b3d-8ae4-946995e92c7d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i047ea355a1614e12b9cde7bc63efd653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTYtNS0xLTEtMTc4OTI1_9d3fdcfc-300a-41e6-8a45-3dd3e2d868d7"
      unitRef="usd">314000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie6268a711de84001a5c09e366d9a3963_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTYtMTMtMS0xLTE3ODkyNQ_2be66b71-42bd-440c-ad36-68d970c7dfa1"
      unitRef="usd">314000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic03ae8d1abd346bfa0535b979b06277d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTctMS0xLTEtMTc4OTI1_80d8f75b-0f68-4e61-b48a-2501d1b67615"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7b40b350a7fb4e1d870155ce20f7d278_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTctNS0xLTEtMTc4OTI1_e7d42aec-7058-4a93-8d86-669599dd4ddd"
      unitRef="usd">201000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i43a33ad615e44970a83fb6e045c08ff2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTctMTMtMS0xLTE3ODkyNQ_d395d96f-514b-404c-a76c-5433af66c563"
      unitRef="usd">201000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3dcae53256ef467fa83afa413e3c23fc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTgtMS0xLTEtMTc4OTI1_9a215c3c-7b86-462c-865a-112ea67a07ee"
      unitRef="usd">71000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3bd5912c45d1492f813493782cbdbc80_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTgtNS0xLTEtMTc4OTI1_84be67a3-e374-4c9a-b030-8843de736a65"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4acc50637daf4886ae4c4f6c103cb12c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTgtMTMtMS0xLTE3ODkyNQ_20dda5c7-4252-4c72-9860-3dc549358033"
      unitRef="usd">71000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic7da82ae3b48451ab567fe66a54b3194_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTgtMS0xLTEtMTkzODE4_05c99404-0b5b-4552-9042-645d60f4b349"
      unitRef="usd">171000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i94f607e57a414dbd88161908a6184c14_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTktMy0xLTEtMTk1MTIz_89ffd539-14d0-4791-b0f1-1ee73df8d7e3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i36acb1a7c1d345b3943ed7a3681da4d7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTgtMTEtMS0xLTE5Mzg2MQ_be8fdf58-904b-422a-b325-4e6cc2c768e3"
      unitRef="usd">171000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6cc60e9c797f4763ae37557308571d2b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTktMS0xLTEtMTc4OTI1_0e6fdf07-d783-4fdd-9baa-26c073a6491c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4e3ed6555fe4401e81ef3b5e8e4a7609_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTktNS0xLTEtMTc4OTI1_bd14ea15-61ea-4812-8453-02f10cadd4a0"
      unitRef="usd">242000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idfea55c447bc431e88f5dd8ccd9676b6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMTktMTMtMS0xLTE3ODkyNQ_b33623ee-f724-4cfe-b133-2b814bed3b74"
      unitRef="usd">242000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjAtMS0xLTEtMTc4OTI1_55a82d03-e0aa-4a8f-a1d3-8687748bb96b"
      unitRef="usd">242000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjAtNS0xLTEtMTc4OTI1_9e7cd5c8-7ee4-4c55-a753-5b29bc5b9a56"
      unitRef="usd">757000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6382c523c2c14c259a92f891ff8641e2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjAtMTMtMS0xLTE3ODkyNQ_dc402f36-139b-4724-81c0-ec8ece56ed00"
      unitRef="usd">999000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:Revenues
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjEtMS0xLTEtMTc4OTI1_fde42edc-5146-4301-97cb-95a6f0ea2a88"
      unitRef="usd">25792000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjEtNS0xLTEtMTc4OTI1_3b8077a4-2f16-4646-94e0-a96851723a01"
      unitRef="usd">757000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6382c523c2c14c259a92f891ff8641e2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjEtMTMtMS0xLTE3ODkyNQ_ca4f6bbd-e415-43a2-b47a-0fd572a403ae"
      unitRef="usd">26549000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i809bb5ba4494400f9c6448d500364985_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjMtMS0xLTEtMTc4OTI1_4f10971f-9dd4-43fe-9015-2165f8275f68"
      unitRef="usd">14000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4e8cff38f04f46889b1ef765ac327305_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjMtNS0xLTEtMTc4OTI1_ecce749e-e3ab-4ee3-8f8c-8cb0356934b4"
      unitRef="usd">1133000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5f7364cde4984551936b23d0ec98a423_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjMtMTEtMS0xLTE3ODkyNQ_f53c237f-ce14-4a10-ab23-d00736dda763"
      unitRef="usd">-1147000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i83c34f3a227048a392485f67a2c322db_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjQtMS0xLTEtMTc4OTI1_655412ac-0970-4523-bab9-945440f2b28c"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i305512b6bb2e4e2e9206830a3cba8e75_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjQtNS0xLTEtMTc4OTI1_0c02182f-f134-4f97-901a-db8646b197b7"
      unitRef="usd">2615000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2682fa4c07b74a9c8032dd2cfde6c7b5_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjQtMTEtMS0xLTE3ODkyNQ_1b3d452e-714b-4277-9379-45400d723025"
      unitRef="usd">-2615000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i924faf8bcd494d4faa31ef8543a91f5d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjUtMS0xLTEtMTc4OTI1_63039c29-326e-47b6-8aed-0c5bdc9c04c0"
      unitRef="usd">14000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4e2db9b6b2644ba4bfd40bfe1aec493e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjUtNS0xLTEtMTc4OTI1_bdf9e588-91b8-4cbe-bc21-1855e4d6387a"
      unitRef="usd">3748000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i918c5fb606154cbba2f8731c331034bd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjUtMTEtMS0xLTE3ODkyNQ_7125c86f-df8b-49ec-8acb-810c2e293b72"
      unitRef="usd">-3762000000</us-gaap:Revenues>
    <us-gaap:NetInvestmentIncome
      contextRef="ic69f76c986f34f1b9ba9eb7a9c317d65_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjYtMS0xLTEtMTc4OTI1_0605a9c5-94db-42cf-9641-3e95e9dc5245"
      unitRef="usd">97000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i83bf3dc5af6c4f2eb6caaad2ac9f84b8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjYtNS0xLTEtMTc4OTI1_aa01bc75-889b-4ec0-b1da-077197d2c8e2"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjYtMTEtMS0xLTE3ODkyNQ_c290ddd7-7e25-4420-ad03-da0b7d7c0c0f"
      unitRef="usd">96000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjYtMTMtMS0xLTE3ODkyNQ_1593abe3-4063-4491-8398-0e5737ff872d"
      unitRef="usd">193000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="ic69f76c986f34f1b9ba9eb7a9c317d65_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjctMS0xLTEtMTc4OTI1_57056e9e-b644-4b43-be45-7b752ef37c9a"
      unitRef="usd">25903000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i83bf3dc5af6c4f2eb6caaad2ac9f84b8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjctNS0xLTEtMTc4OTI1_7faabcfa-8482-406e-bcc6-46669e93e5d3"
      unitRef="usd">4505000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjctMTEtMS0xLTE3ODkyNQ_b04b7fe3-1567-4f05-8b92-2686b299f948"
      unitRef="usd">-3666000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjctMTMtMS0xLTE3ODkyNQ_746b43be-f5c2-4962-a6aa-23981c7392c4"
      unitRef="usd">26742000000</us-gaap:Revenues>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjktMS0xLTEtMTc4OTI1_395d450d-adf6-4f98-8495-cc3b6a8f2126"
      unitRef="usd">21993000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjktNS0xLTEtMTc4OTI1_1bf51108-2e73-42dc-82ba-f29c9f007b7c"
      unitRef="usd">0</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjktMTEtMS0xLTE3ODkyNQ_8a2b1a64-fe0f-4488-91a7-1125c15f05fa"
      unitRef="usd">-135000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMjktMTMtMS0xLTE3ODkyNQ_3b66656d-0581-4c39-a25b-1e9d87c28bcd"
      unitRef="usd">21858000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzAtMS0xLTEtMTc4OTI1_37b700a2-4a66-4ee2-9af9-16a199ec360b"
      unitRef="usd">2418000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzAtNS0xLTEtMTc4OTI1_ba37c6d0-5b9e-416e-aeb4-6fcf6e368399"
      unitRef="usd">4126000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzAtMTEtMS0xLTE3ODkyNQ_075b52c8-243c-4f7f-89db-8685a73ff563"
      unitRef="usd">-3565000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzAtMTMtMS0xLTE3ODkyNQ_e5a00ec8-d832-4a38-9693-15e26641788c"
      unitRef="usd">2979000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzItMS0xLTEtMTc4OTI1_801fd0ef-4ec0-4cc9-886a-3e81e3e0f084"
      unitRef="usd">165000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzItNS0xLTEtMTc4OTI1_c6184cf2-080b-4ecf-8666-b189ada04bbd"
      unitRef="usd">49000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzItMTEtMS0xLTE3ODkyNQ_5f96eb38-9565-46dd-8aba-a0ce3930aae7"
      unitRef="usd">-28000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzItMTMtMS0xLTE3ODkyNQ_98267643-295c-41b8-bb65-10dc09868be7"
      unitRef="usd">186000000</hum:DepreciationAndAmortizationIncomeStatement>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="ic69f76c986f34f1b9ba9eb7a9c317d65_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzMtMS0xLTEtMTc4OTI1_afbca853-61bc-4962-986c-3628662e50cf"
      unitRef="usd">24576000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i83bf3dc5af6c4f2eb6caaad2ac9f84b8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzMtNS0xLTEtMTc4OTI1_66ff6657-3a82-42d2-957b-798c37bfbf14"
      unitRef="usd">4175000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzMtMTEtMS0xLTE3ODkyNQ_9cf30cef-cd66-4eb8-a7d5-97a1a2e5a55d"
      unitRef="usd">-3728000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzMtMTMtMS0xLTE3ODkyNQ_d614ea16-c8c8-4600-a37e-801397647761"
      unitRef="usd">25023000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzQtMS0xLTEtMTc4OTI1_c08329bf-6189-43a0-8713-22ba64b6beba"
      unitRef="usd">1327000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzQtNS0xLTEtMTc4OTI1_435fe939-b7e6-4ab2-b78d-fe80746927f5"
      unitRef="usd">330000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzQtMTEtMS0xLTE3ODkyNQ_06f29870-0fa9-4564-88b0-d143c03d779b"
      unitRef="usd">62000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzQtMTMtMS0xLTE3ODkyNQ_7b22056a-8ca7-4b0d-a3cd-a0e9510a2fea"
      unitRef="usd">1719000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzYtMS0xLTEtMTc4OTI1_16063c97-2abc-4be7-8065-547a8a829336"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzYtNS0xLTEtMTc4OTI1_384000a2-678c-41fc-a32d-d5668c1c2996"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzYtMTEtMS0xLTE3ODkyNQ_8c68ca5c-bebf-4061-a340-0d949dce408e"
      unitRef="usd">113000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzYtMTMtMS0xLTE3ODkyNQ_bd29d03b-f659-46c0-824b-b812eb843be4"
      unitRef="usd">113000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzctMS0xLTEtMTc4OTI1_2c871f76-fa41-4547-bf5d-8a251f9897e5"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzctNS0xLTEtMTc4OTI1_59300b0f-733d-4290-a58a-02ba9501210b"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzctMTEtMS0xLTE3ODkyNQ_b3eb41aa-e028-44f6-89d5-743e72652591"
      unitRef="usd">8000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzctMTMtMS0xLTE3ODkyNQ_812f48cb-e38b-4279-9664-873593ebb568"
      unitRef="usd">8000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzgtMS0xLTEtMTc4OTI1_391fa453-9333-4389-bcd3-728a660308a4"
      unitRef="usd">1327000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzgtNS0xLTEtMTc4OTI1_d2814356-16b1-4e82-aac2-c6eec7551a26"
      unitRef="usd">330000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzgtMTEtMS0xLTE3ODkyNQ_884a94ea-9253-454d-86d0-cec6058bbd04"
      unitRef="usd">-43000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzgtMTMtMS0xLTE3ODkyNQ_e975d651-64dc-403d-9817-7f04ceee9bd7"
      unitRef="usd">1614000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzktMS0xLTEtMTc4OTI1_7643f8f0-cea0-4a1e-980a-604fa0114c13"
      unitRef="usd">-3000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzktNS0xLTEtMTc4OTI1_9cd6c099-f10e-48ea-9168-267a8c94fd13"
      unitRef="usd">-14000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzktMTEtMS0xLTE3ODkyNQ_643b38a8-3b5e-4584-be79-c38baf4e349c"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfMzktMTMtMS0xLTE3ODkyNQ_c217a36a-444b-434e-aecc-49e2aefd956f"
      unitRef="usd">-17000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDAtMS0xLTEtMTc4OTI1_bab2f726-d56c-43d0-a985-3781bdc8ae20"
      unitRef="usd">1324000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDAtNS0xLTEtMTc4OTI1_8cc5feee-4708-473f-ac4c-a02f45c357a3"
      unitRef="usd">316000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDAtMTEtMS0xLTE3ODkyNQ_7ec9900b-b7b6-4237-8aff-eb6eb1738e4c"
      unitRef="usd">-43000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDAtMTMtMS0xLTE3ODkyNQ_53a3157f-c0c8-4d02-98c2-44198c79964e"
      unitRef="usd">1597000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDEtMS0xLTEtMTc4OTI1_96daad7c-7e54-4a20-8ce9-d5eba47b6d84"
      unitRef="usd">-1000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDEtNS0xLTEtMTc4OTI1_ed4ac962-cf0b-44e5-aa25-8cdbd9a93196"
      unitRef="usd">0</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDEtMTEtMS0xLTE3ODkyNQ_e23cdf92-440b-48fc-97d5-96a883dbe858"
      unitRef="usd">0</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDEtMTMtMS0xLTE3ODkyNQ_9c4ec1d8-733b-4f4d-8dd4-17c744ba8c0c"
      unitRef="usd">-1000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="iec6f8a1e38f84ef88c6186a1aa6c5653_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDItMS0xLTEtMTc4OTI1_a98e7f45-f10f-40ea-b2e0-cd39f5ac10b8"
      unitRef="usd">1325000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="i902976e0e687455ea7079d0816405649_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDItNS0xLTEtMTc4OTI1_f86dd8f2-49b9-47b1-a2ee-c0f0fa37cd15"
      unitRef="usd">316000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="i45e864ff071540b9b07efec659513ce6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDItMTEtMS0xLTE3ODkyNQ_a35ef26b-b2c8-4571-8ee4-9c6cf3c8317e"
      unitRef="usd">-43000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjdiNzBhYTJmOWI5OTRiYTRiZWNmMDRlYmRlZDI1YjQ0L3RhYmxlcmFuZ2U6N2I3MGFhMmY5Yjk5NGJhNGJlY2YwNGViZGVkMjViNDRfNDItMTMtMS0xLTE3ODkyNQ_334749c9-d18f-46b5-84e5-013c3b2c4cd3"
      unitRef="usd">1598000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <us-gaap:PremiumsEarnedNet
      contextRef="i3aa3a9ceced248e495a3ebf2f980dced_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNS0xLTEtMS0xNzg5MjU_68ff2d52-28a3-45bc-a9e2-7fc0b0996d46"
      unitRef="usd">17052000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="id2b6b9a177e640c9b1223decda0a16fb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNS01LTEtMS0xNzg5MjU_f5098c28-c5ad-4834-9c54-c628642187fe"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6e2b6793244a439ca56ce9a5219dc82d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNS05LTEtMS0xNzg5MjU_f02124bb-7c30-490d-8ba0-7994fd8f8044"
      unitRef="usd">17052000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ib02c4523f3fe4bc4867f91bdf4482fc4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNi0xLTEtMS0xNzg5MjU_523b1fc6-3c1d-42f6-b9db-b81e29f8c4f8"
      unitRef="usd">1875000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i0b8563afa71d4ffebd8b2d1bf8f9abc9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNi01LTEtMS0xNzg5MjU_1eef2324-bf3f-457c-958d-e5ef1dd9e42f"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ibf26032dd8144e439cadbdd99e543c72_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNi05LTEtMS0xNzg5MjU_1922a5d5-2da7-40a2-b892-bea9198606a5"
      unitRef="usd">1875000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i665f623ad1564c0f801b7a6398439b3f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNy0xLTEtMS0xNzg5MjU_c5f76661-7ed8-49a6-8780-d60f3a9d3051"
      unitRef="usd">639000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i9e6586aa7b7c4bfeb6055f8260cb2050_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNy01LTEtMS0xNzg5MjU_74149e21-4960-403c-867b-6b0d23de1648"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ibaeba68a15074c20a7a47147aa79fb77_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNy05LTEtMS0xNzg5MjU_9d9ddfa0-ba3d-4159-bac0-0b1c7943c3f2"
      unitRef="usd">639000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic0c10c27bb084521b8749197d596563b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfOC0xLTEtMS0xNzg5MjU_42786033-2610-4feb-8396-2a51430a45d6"
      unitRef="usd">19566000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i78789613dafe4a62a86c3ef058061f4c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfOC01LTEtMS0xNzg5MjU_31ed4e61-6023-4b81-8154-989e1dfce02f"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i05630ac13ae84efdb04206d248841934_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfOC05LTEtMS0xNzg5MjU_63e4523d-6380-4f62-a177-04b0c624c4ff"
      unitRef="usd">19566000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ifc8d8e3c20604d8987b4b3655c1d1355_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfOS0xLTEtMS0xNzg5MjU_db8644d5-5fa1-4412-aedd-34e6dbdbf818"
      unitRef="usd">1140000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic3d1b9e97d684afc9b309b5a8dc2e4d6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfOS01LTEtMS0xNzg5MjU_1a1f7c07-b968-4843-aa9b-4d16a2f0d96f"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="if043a642b7914944bf349068b08d7044_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfOS05LTEtMS0xNzg5MjU_330fc1db-fead-4226-b568-bb76a0a926a4"
      unitRef="usd">1140000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i7a01bf5c57d243ffb4876ff5019fcd4e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTAtMS0xLTEtMTc4OTI1_dd0bfd85-024e-44b2-9764-19e28de67024"
      unitRef="usd">261000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6079fbef93f6490d97c24453e1658164_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTAtNS0xLTEtMTc4OTI1_1c135835-2863-4c17-b29c-dc387ee4cad3"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ie50e4586d40f4d86b9ebbc2912804444_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTAtOS0xLTEtMTc4OTI1_5e14921e-3855-4091-b85c-55c6415bc68a"
      unitRef="usd">261000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i065f8703eb4643deb20037003c705c1b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTAtMS0xLTEtMTk0NDc0_07b9f72e-1ac9-4dfd-8a7a-e723906749e2"
      unitRef="usd">182000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i00a4268e2aca40b19aab2ba00cb0f314_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTAtMy0xLTEtMTk1MTM3_6624bb2c-9d34-4006-8fdb-2da0cadf354a"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ia0f2b22146644209b8afa3fee32230c6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTAtNy0xLTEtMTk0NDg3_9719cd78-3288-452f-b82a-b9ae04242cba"
      unitRef="usd">182000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ibb2fc93318814cb9b70dd7040ef479f3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTEtMS0xLTEtMTc4OTI1_0c634af0-cb28-4780-b33c-25df4e19cac8"
      unitRef="usd">1554000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i7cd9580b0c9c484ea82d73c64b502501_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTEtNS0xLTEtMTc4OTI1_030236b1-ce97-4e9f-8640-5a2caf15a8d8"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i8e3541bbcdc747cbbd38489ad83936dc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTEtOS0xLTEtMTc4OTI1_5bba8506-cbe3-4f4e-a984-54ace3853fba"
      unitRef="usd">1554000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTItMS0xLTEtMTc4OTI1_0486eecb-8c1f-4f74-865c-213a7b361c65"
      unitRef="usd">22703000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTItNS0xLTEtMTc4OTI1_fe05b170-b373-4c4d-b6b7-083a9174bdff"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i8dcfae0532054fd79308e5a557cced34_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTItOS0xLTEtMTc4OTI1_b27b6d52-0fe7-4f49-a72d-61bf7b967961"
      unitRef="usd">22703000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idb9f8bafe49f47b49a45569e1bcb1998_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTYtMS0xLTEtMTc4OTI1_f85ed13c-9abd-4831-a488-c1b06b2c1c26"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3d60c49195f64463b8e21dd65e9c6e65_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTYtNS0xLTEtMTc4OTI1_2abf5f52-6a7f-43c4-aca3-feeb9a6a94c6"
      unitRef="usd">726000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibd6bb8d1d674435d811376f081f0a3dd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTYtOS0xLTEtMTc4OTI1_8adeac68-1eca-48ae-9d19-e104d59bd7b7"
      unitRef="usd">726000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idc893a7474a44474861813dd6d84ae6e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTctMS0xLTEtMTc4OTI1_edb751d1-a02d-429d-af93-3c564eb0dcc8"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i949a7d5c28cd498e91c058a16f06bbe6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTctNS0xLTEtMTc4OTI1_d6b6d853-f991-42f7-8649-34fe8ba66137"
      unitRef="usd">113000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i851a87a7f05942cdbf990ae5cd30af78_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTctOS0xLTEtMTc4OTI1_91d4dbb0-1efa-4296-b3ec-fb7098eb6146"
      unitRef="usd">113000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic07c1d16537a42429449e7882849141c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTgtMS0xLTEtMTc4OTI1_e2f77128-13dd-441c-9735-85191e6a85eb"
      unitRef="usd">77000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i66f6101ae0774289b5b8751a4634d40e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTgtNS0xLTEtMTc4OTI1_0d747dbe-394b-46ff-af6e-0b3fc0eaedcf"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1b2d48e3ac324ec08b2ca88ab3f53e55_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTgtOS0xLTEtMTc4OTI1_ae922362-e79d-49c0-bcbe-455c4405c8f3"
      unitRef="usd">77000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i335400f88d18407a92f768050cebbf44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTgtMS0xLTEtMTkzODcw_a1b8d919-aff2-4d42-8ef3-63117bc42dd9"
      unitRef="usd">127000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7edb8e82518e4dc5b3fb898234ab15cb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTktMy0xLTEtMTk1MTM3_38c09ef5-bee9-4810-9397-a4d606d45ff0"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idf6ff2b013bb4cff8f0653d9c2b0488d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTgtNy0xLTEtMTkzODgw_1cac3d23-94a2-47b2-b553-2b52f7a1d529"
      unitRef="usd">127000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id7fbf5c1d49c42e5bed343c27eeb8965_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTktMS0xLTEtMTc4OTI1_cdeefec7-eea0-47c5-b309-85e3df81f858"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icd793a27f90f404091d71353a03a9ae4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTktNS0xLTEtMTc4OTI1_8a811563-f849-4a8f-add9-68217e9ad4f8"
      unitRef="usd">221000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if2e0f4edd2b64c2e85362a841a3aa4c4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMTktOS0xLTEtMTc4OTI1_118ed69b-ca25-40e4-9419-a8d9e77d4d3f"
      unitRef="usd">221000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjAtMS0xLTEtMTc4OTI1_944120b7-2071-4703-a033-4181e4f967ad"
      unitRef="usd">204000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjAtNS0xLTEtMTc4OTI1_9a9a19c9-b3dd-4b1a-9c8a-ee7301089587"
      unitRef="usd">1060000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8dcfae0532054fd79308e5a557cced34_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjAtOS0xLTEtMTc4OTI1_6b2ac94d-7fa7-41ed-9e01-6e8128fb083e"
      unitRef="usd">1264000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:Revenues
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjEtMS0xLTEtMTc4OTI1_0add8b8d-3c73-419e-9683-59c4d6b945d5"
      unitRef="usd">22907000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjEtNS0xLTEtMTc4OTI1_807c8f11-5888-4094-ab68-71df80efd6d7"
      unitRef="usd">1060000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8dcfae0532054fd79308e5a557cced34_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjEtOS0xLTEtMTc4OTI1_7789a5e1-5965-4e41-a648-4639e82ee4ca"
      unitRef="usd">23967000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i91de43b8e733413cacc845a70df17963_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjMtMS0xLTEtMTc4OTI1_ccd46083-9348-463f-935e-fb527f8b8f05"
      unitRef="usd">14000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i717dfb30995240bb96ad4c44b5acfbad_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjMtNS0xLTEtMTc4OTI1_a6bfd0ca-4f1d-4f52-9258-10e8f660b1fb"
      unitRef="usd">857000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i027d84a6dd0d47719c06eedaeaa90374_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjMtNy0xLTEtMTc4OTI1_fd9cf5ea-af22-4635-8e69-fd741fa31bb3"
      unitRef="usd">-871000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if2020e045c5147f5a45fe1de02a9f902_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjQtMS0xLTEtMTc4OTI1_85cd1c83-a9ae-46e9-985f-615ba03a7bad"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i746462efde464666b16b26676cbe2082_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjQtNS0xLTEtMTc4OTI1_db40aed5-d2e7-4bd4-bc32-f195bc14aa8b"
      unitRef="usd">2446000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibf76fe4fdae4409e884a7ac6c029af9b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjQtNy0xLTEtMTc4OTI1_c02eb3bf-f34a-4d29-92d7-3c58e539feb2"
      unitRef="usd">-2446000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i97353868e33140a2b65bce298de17656_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjUtMS0xLTEtMTc4OTI1_ab3417a1-413a-4440-9e48-4c62124eeb70"
      unitRef="usd">14000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i536c52251be647d6987d688d1febcad5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjUtNS0xLTEtMTc4OTI1_ea8c46e4-295b-48e3-a5e1-59603d91d519"
      unitRef="usd">3303000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8b05f4d2446843fa8e4a6429ac7a6e41_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjUtNy0xLTEtMTc4OTI1_6b0c9ea5-4be3-4833-b93b-becdebb901e4"
      unitRef="usd">-3317000000</us-gaap:Revenues>
    <us-gaap:NetInvestmentIncome
      contextRef="id04b5505b5b949b4b46f6df5221ff61b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjYtMS0xLTEtMTc4OTI1_741dda71-7742-42ae-8253-bb71a3930817"
      unitRef="usd">46000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia3ccf78d11e54281b041b1ad37820d52_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjYtNS0xLTEtMTc4OTI1_c1062616-9103-46dc-940c-a8ccb47545a3"
      unitRef="usd">2000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjYtNy0xLTEtMTc4OTI1_8649f234-6b2e-4308-a3e4-ecdd83276809"
      unitRef="usd">-45000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjYtOS0xLTEtMTc4OTI1_46fe60fe-61da-413e-96c6-3bfb040d45e8"
      unitRef="usd">3000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="id04b5505b5b949b4b46f6df5221ff61b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjctMS0xLTEtMTc4OTI1_e1a1d778-2fe1-4ce2-a35f-30e1663159b5"
      unitRef="usd">22967000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia3ccf78d11e54281b041b1ad37820d52_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjctNS0xLTEtMTc4OTI1_e916acbd-8aee-4bc3-8963-434839a5f43f"
      unitRef="usd">4365000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjctNy0xLTEtMTc4OTI1_2511af02-d934-40c3-93e1-d6282b06211c"
      unitRef="usd">-3362000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjctOS0xLTEtMTc4OTI1_66d35efa-ee7f-4911-9197-f006dadbdcc6"
      unitRef="usd">23970000000</us-gaap:Revenues>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjktMS0xLTEtMTc4OTI1_4d881025-4b4f-4058-9b50-7a4b6950f8c7"
      unitRef="usd">19734000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjktNS0xLTEtMTc4OTI1_f84ce179-2de6-4307-8cd2-6e0c92ff0687"
      unitRef="usd">0</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjktNy0xLTEtMTc4OTI1_8f0bf1c6-c517-4b8a-89e8-002e56744861"
      unitRef="usd">-109000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMjktOS0xLTEtMTc4OTI1_5917adb6-cc44-4253-87c7-e2f1c279dd58"
      unitRef="usd">19625000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzAtMS0xLTEtMTc4OTI1_d3cf2370-234e-40a3-91f9-d615a2d6496f"
      unitRef="usd">2087000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzAtNS0xLTEtMTc4OTI1_71241f5b-4359-497e-8478-1243dd346eff"
      unitRef="usd">3948000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzAtNy0xLTEtMTc4OTI1_b263f39a-d5a8-4dfd-aed6-cbbbbd86a1fa"
      unitRef="usd">-3149000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzAtOS0xLTEtMTc4OTI1_a225b9a5-c143-439e-83e6-bc51702d1eb3"
      unitRef="usd">2886000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzItMS0xLTEtMTc4OTI1_a32bdb4d-540f-4260-9537-ecd846fee3d0"
      unitRef="usd">150000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzItNS0xLTEtMTc4OTI1_9e4ea4fc-c8e3-4ecc-8057-dd4e8385a487"
      unitRef="usd">47000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzItNy0xLTEtMTc4OTI1_c084d4af-aa2d-43b0-9d3b-d32e83cbd9fc"
      unitRef="usd">-27000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzItOS0xLTEtMTc4OTI1_d91632ae-d684-48d9-8460-efa546a4a3b9"
      unitRef="usd">170000000</hum:DepreciationAndAmortizationIncomeStatement>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="id04b5505b5b949b4b46f6df5221ff61b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzMtMS0xLTEtMTc4OTI1_8be7b1e9-36fc-4ab6-997d-24cf549ac853"
      unitRef="usd">21971000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="ia3ccf78d11e54281b041b1ad37820d52_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzMtNS0xLTEtMTc4OTI1_2b0ee69f-7a49-4ef9-b806-709e760acbd5"
      unitRef="usd">3995000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzMtNy0xLTEtMTc4OTI1_559d0a7d-d143-40b2-bce3-946b5c5ff89d"
      unitRef="usd">-3285000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzMtOS0xLTEtMTc4OTI1_769661ce-15ac-4772-bde5-809c07866c6c"
      unitRef="usd">22681000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzQtMS0xLTEtMTc4OTI1_33a218c2-a046-4f61-add9-55426e5da964"
      unitRef="usd">996000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzQtNS0xLTEtMTc4OTI1_77f563b5-8484-4da5-bcfc-d292bf567247"
      unitRef="usd">370000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzQtNy0xLTEtMTc4OTI1_ed0bd06c-6b4a-409a-b941-d8a4ff32d6fc"
      unitRef="usd">-77000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzQtOS0xLTEtMTc4OTI1_5358aeba-bc0c-4bfd-8ecf-fdb0bdf4d574"
      unitRef="usd">1289000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzYtMS0xLTEtMTc4OTI1_8b7d55ee-1d3a-4ce4-a9a8-ec0d84a81ac5"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzYtNS0xLTEtMTc4OTI1_0a3f5e30-6b72-4085-a614-1727ed6c16c9"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzYtNy0xLTEtMTc4OTI1_49b7f93f-abba-4b2e-bd8a-5af649a3cb8d"
      unitRef="usd">90000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzYtOS0xLTEtMTc4OTI1_e2151b2e-8126-41fe-9cb5-4b8104846f2b"
      unitRef="usd">90000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzctMS0xLTEtMTc4OTI1_c782ab84-08cb-4ebc-94eb-447581f16374"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzctNS0xLTEtMTc4OTI1_ec329be1-6e30-44e0-9ac9-4e62548bb9c9"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzctNy0xLTEtMTc4OTI1_7bb8ef9d-1f0a-412d-82ac-b4b10d5d5d40"
      unitRef="usd">21000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzctOS0xLTEtMTc4OTI1_68d24a72-2bf9-4ba8-a7ae-93123a0c8611"
      unitRef="usd">21000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzgtMS0xLTEtMTc4OTI1_854bb3b7-9c72-4c9e-9fbb-c0616ff7f021"
      unitRef="usd">996000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzgtNS0xLTEtMTc4OTI1_2b3db9f3-6103-4a60-bf5b-72541a408e18"
      unitRef="usd">370000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzgtNy0xLTEtMTc4OTI1_86f5e2a2-e1f1-494d-a93f-8d4d92b19a84"
      unitRef="usd">-146000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzgtOS0xLTEtMTc4OTI1_d40a8fdc-b782-4997-a2ea-ba3a93f3a23c"
      unitRef="usd">1220000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzktMS0xLTEtMTc4OTI1_1d733dab-225e-48b7-9a0b-205061e220d9"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzktNS0xLTEtMTc4OTI1_2df9ac03-fade-4b7f-9ec1-f18d8eaaaf25"
      unitRef="usd">-4000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzktNy0xLTEtMTc4OTI1_f9b97f67-1ca6-4157-86ac-fdbf2ed50881"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfMzktOS0xLTEtMTc4OTI1_acddab66-dbfd-4677-8596-8f25bb8b7c92"
      unitRef="usd">-4000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDAtMS0xLTEtMTc4OTI1_22c9b012-5348-4653-a4d4-51ef6858694b"
      unitRef="usd">996000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDAtNS0xLTEtMTc4OTI1_2ac1b1e6-29ee-432c-9a8a-f1526c25e361"
      unitRef="usd">366000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDAtNy0xLTEtMTc4OTI1_4fe03da8-2bc4-4dd3-be94-222a27f49145"
      unitRef="usd">-146000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDAtOS0xLTEtMTc4OTI1_dd1c43dd-2d28-4e9c-a8c2-e73d4d726a61"
      unitRef="usd">1216000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDEtMS0xLTEtMTc4OTI1_89c8ca88-d71e-48ee-ad86-54f347f00b13"
      unitRef="usd">0</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDEtNS0xLTEtMTc4OTI1_3b489b1f-0dc0-4021-81fe-9cb646cc13b6"
      unitRef="usd">0</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDEtNy0xLTEtMTc4OTI1_9e3cebb8-4b92-4181-b751-363bd42fbb72"
      unitRef="usd">0</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDEtOS0xLTEtMTc4OTI1_f294bd09-e80f-4182-9ebf-eb8db22ba4b3"
      unitRef="usd">0</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="ic3915404f3b9471e9407e5b99fa021f6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDItMS0xLTEtMTc4OTI1_6c556de8-a20a-43b2-8d44-ce73970bf1d7"
      unitRef="usd">996000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="icb6d81e07b7b44c69f05f4168768673e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDItNS0xLTEtMTc4OTI1_9c5efd4d-def6-47eb-bb9f-6b37af54396e"
      unitRef="usd">366000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="ie379e7e0827b4a709048aee9055067ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDItNy0xLTEtMTc4OTI1_19a11b15-b5af-4ab1-bc8d-0787a760fac0"
      unitRef="usd">-146000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="i155caf7f46194391a86b1b1cfa3b3535_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxYzYwN2E4ZmFiYzQ4YWRiMTAyZDVlZWZjYWIxZWZhL3NlYzo5MWM2MDdhOGZhYmM0OGFkYjEwMmQ1ZWVmY2FiMWVmYV83Ni9mcmFnOmFkNTU1MjU2NTI5NzQyMWRhMzVmYWY3N2YzOTQ5NzJkL3RhYmxlOjA1OThhOWY5OGEyYzQyNzhhMTc5NmM3MjY3OTA0YWE3L3RhYmxlcmFuZ2U6MDU5OGE5Zjk4YTJjNDI3OGExNzk2YzcyNjc5MDRhYTdfNDItOS0xLTEtMTc4OTI1_37ee25d3-e836-44b1-94ba-508a079aea54"
      unitRef="usd">1216000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M%?7EBJJM'-<&ZOF2,?EVHS]NM!^SIO\#4$L#!!0    ( .=XFE;[/ V<-@,
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MF2(<%ICJG(>H(<L=2SG1(B\^^C.A<0M1#!/<Y8$T 7A](81^G)A]1+5OC/X
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MY D1L+GL7#D7$^IE"EKBSQ .\NB99*XL.?^1O=RN+SN]#!%$L%*9"88_>YA
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M.S_K,9YQ$;<75ME=;;(C![*[3UD0*]PF#=S0C*7AMT4:SVF6_XZFW]<1^Z'
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M>^K%3RGP(7Z*DAS%])$[&>^'_/\JV_PZP:;!TE7YU?6'E+%T65XN:#"G66'
M/W],4_:S47P;?OL;$1?_ 5!+ P04    " #G>)I6[D47=AT(   4)@  &
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MVS86_2L8M=,G6;9D-\VVB6=DQVD]G3A>*TUW9F<?(!*2L"$!!@"EJ+]^S[T
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M5VF+EAP\06@A32%&M-O9=@T7A.$B.BM)W:EQ%I6>M/[^$SCM_J/+6/G=8W)
M>O5;6TLC\XM:(>GB(W%MB@FOU"A]WRZ]+K5T\%],/0!!(UT'SA2JK\&21]"#
M,B>GDA<M5WHM/RBA?- U5Q"I(SU(3).P@((M5RO0#':^K*D\*2&I8 YU^(UX
M9\HA;*(&LOG 0DE6;&VUI5=T2FU]$%ZOC5ZAQA&X%F4-W_3T!X+2RO0D^6X)
M_%B1EQNYE\M*Q2K1.!9FX;W3_H.0Y;_!2#@?&F>WVK,#G*I8_U0L;U2)DW$(
MC..NZ*.LK:S: Z[F372"=BS2J<)"[ZP1[%+I,-_5S9@W?XNXRIKU4<60@^@I
MTBI""7EN;6VYTT 4SC5$![% J-)Z= F4J897TE9VOU?WG$KDL*2:_6#L#G6_
M9L=#<T?JJ.TAGD!OP'8,>AL 7^GMN MWURW@/T)?9"-HID<N[@4^\*F Z5*O
M" CHF],,W RG$<P[[2(4RK)D9]QK<DZM)9\V:"Q(RH)@BA)4 RAC&L=ZHP6I
MU)Y.WO$!IVZ0M6(6$4MU<'_9E_ HM4IHSZ??2O2?Z^NQN,9;\7PL1H]N(1<N
MV@9=D;X3=!(Q'I$$TGH(BK&0'F__&Q374JEL]N-T@QW!-)U.&O1F&CB*!!@D
MB[H7RTOF3P!OO-\VR+;<F/H:'(@.'$ESC.>V=RA#"$7W\9[.IM8DQ0KI?PA!
MK*/(<5(*@8U A&^+S4 .)3 6RT0!4E%1\C+H2,K2B;BJF\KN$=)?T28:[EO*
ML>-BU5<@S+9L2=&+UH,N>E#_3SJ0I5TGHRXV%CND@3'P5D%% R\TH D&GQ6M
M3VFLON;$93H1LC<:YJ7<B3Y;M50=('&PHQP#4:K5T:KE!DZFOE8ET:=\G!*_
M*5DAO!<1%M&4XF&D))6IA_X4"4^(8*$/!8D>L<G1>3O4E2>@7#M9P^\WP$<F
M(ZFY;>(1)!*N1Z' TS$0O7J.C862Y;6M,$%SH0H:-X)::[!TM<6@RNXL%79A
M1%3EMWJ..8NQC)78V%C/B!&QW2-7,.2C.8 >$I6C0XQ2)9/*XB"^9CJ$IUL5
MN0R)$Z0;D1N/TF0BB9 S)O.+@T'LX5B6_4P %Z'Q@UM5IRTA]A(T8!.1-Y]G
MU*<@IL])Z=D9.B)-H!/Q'@T#5 L]DVOKFEJ#I"L!+UZUG.61O!%.N#+"5D&K
MT<DDVJ .>WI$22/6F,,0NM@MNC:5$*9K@/-R"ZB7Z .=RK0C<U+U"3W=][A+
M3 C>2H,@@P<=O=15)(TXH"L><K@.J>^6Q*7["+]E8S-;)0QQ&!:\R@0/VXDG
M2.(-8\I12@2])1OUP3&Q'T59-%94*I$M#DI#N6=;WW,!H0N,3%B31AJOAC)W
MBGNSH]H# 7;K.)9\?_;3J:@14CZ@Q[.//L.S<Q?.,F @0%CSN$1L@!SS_>SL
M>2>4X)OZ=X\E#%B MZNP(^]S%U[B7VMH473#]]/ILTX4]/7HV8X;058 \M$3
M3;IOXO9 5U*P!8LLZ&*=;AIB>CM%EV;=%/*T(4AIY2BRU'6) 4#?E5+^OA-V
MZ-4']\I8I?B&FB-)%92.X$[=" ACB\S=:*%7ZQ3&/VD2C:NB-&S:]RT-W#<=
MLN@C4#U$*V(%L>6 D4/_Z.V+,\SEV_?7KXZF?XMU#N18T_S!BL7+Q>P38TEA
M*("TWFJ'48- )&_'; C0,(;.>$*G$^Z_D<RF;I,K<I*+OP'BVHAER ABUMSP
M"[ ?GHSP_' J97@9+P/H7&/-46<1N%>C [70,@UU\:Z!%B5+ QL:;R91M[FY
M<.5OY%:E^HF, Z!/AFQYO!]@Q-X3$6H#X"'GU3P&W,L:6:-KT/A.KT!85N?#
M [%#B@QPP/<L'D@;X.*. )F\I+AE#]7J;<N1>Z@I)B73)[_C/*\.G-DIW)>Y
MZII?Y$@/ C3HPWG>?EOK HD#!$,W)3;4!KIJ*P="'@1PX +*S_XX56KOVB;K
MVE>Q[)QU@L+R=IAO$<2Y@^!YY*:B0$OCR/?P,4Z<AKI&(@AIF/*)VQ9 <.SB
M*5+'$33UC]1XTQ31 -6!)&E0Z.;XC0)!Y&D.[^E^(J[G6! K'/?-[1&03)ZG
M1#F4:6F@+5/#?3 <RCW_7]L2Q4O)_TA/3(V>.'Q%DTZ\"_'WW8I,(>3+DW":
MN3&2FX0F4V9APY9S2"*TV%(A#?HXSQ72^D9UW;=0CKA-;Q @T$-N[SO^EOAU
MA D^!N45 6NC5R'+)9"G^0@R*PG6G5P1U>>AF9R&KJ[3I3((:5.UOELX'N9-
ME))NAD'Q@(:VZ:K8-MR1J8ZEWX@5:B0J2GZ)R=MYXD8F;G"5X!99H2 ^#3:<
MM\3_(HGD0H)Z<Z10A5$I7CYUT_=MN\2$F%GR02)H&C58;EB-IIG"B#>86:?3
M?'MUE[+GKC>>OX6A*:NZD8_H1:W;.GJNXT-IV40L[CWIT7W@KM',* E=TU;N
MENFRIM\BX]3>-E #D AVJ_T&#QJ5ZRE^)!(I7'<!Q*VIY=<(=6:\F;7$U9RP
MZ2A8^A??/!PLB3?9G!#E<"=@O&-R5!GWC3^8:A05&[@A7Y+<6_7%MBZ)U""'
MV+PQ.(+GF<GN)'<^TBW?Y;1R,'Z.O\;(+[R&L+UD^+^X0?@BJ] WY'I-WW./
MS&%:[C/MBIFU;]1]LZ=GV>[#)>)E=XGX+3Y(+IA^Q@6CAQ?CS"W>2(?!.O_^
M-L[W'91SA=);NCCL7P=V:<"L%%R\(]#1:PR8&Z=2WOMTHW[_E!VQ(N*BW6",
M3"Z/2K4,3$G@A5R4.(;/ZJ_-N=O=^W4/*GV8K:!.24YW\5HV+HA=MZL?:Q*=
M_H(?.N1];WV5R0^*N5=?<?A2CM.,#K0HY)A7@\M8(+=UF=>.TY6/!T_A@:+7
M;F&K\;&UTJ8"^;=+]U79B5 ^3JV/J$8A*-*9RX&F_ /2/M]Q\F\F/?WB_).X
M]Z/&/-#BL9]$CWL_?G,?HI_XZ>82B1E_!^^>=G]%,(\_GA^6QS]!0!0P37@@
MX I;3R8__3@"M^&?]>.78!O^*7UI0[ U?]SP#TFT .]7%N6:OM !W=]6G/\'
M4$L#!!0    ( .=XFE8J@853&04  .X+   8    >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&ULK59M;]LV$/XKA(H5+>#$MN*V65X,.([396C2($XV#,,^T-+9
M(B*1*DG%]7[]GJ->ZF2MNV'[D)BB>'?/\]P==2=K8Q]<1N3%YR+7[C3*O"^/
M^GV79%1(MV]*TGBS-+:0'H]VU7>E)9D&HR+OQX/!VWXAE8[&)V'OQHY/3.5S
MI>G&"E<5A;2;,\K-^C0:1NW&K5IEGC?ZXY-2KFA._KZ\L7CJ=UY259!VRFAA
M:7D:389'9R,^'P[\HFCMMM:"F2R,>>"'R_0T&C @RBGQ[$'BYY&FE.?L"# ^
M-3ZC+B0;;J];[Q>!.[@LI*.IR7]5J<].H\-(I+245>YOS?HG:OB\87^)R5WX
M+];UV7>C2"25\Z9HC(&@4+K^E9\;';8,#@??,(@;@SC@K@,%E.?2R_&)-6MA
M^32\\2)0#=8 IS0G9>XMWBK8^?'M;#J[OOOPF[B<S^]GYV(RG7Z\O[Z[O'XO
M;FX_7F,]G5WAQ/RD[Q&.C?I)X_JL=AU_P_6!N#+:9T[,=$KI4_L^8'98XQ;K
M6;S3X96T^^)@V!/Q(#[8X>^@XWX0_!U\P]\D24REO=(K,?=2I]*F3MR7J?0D
M\"BFF=0K$DJ+K9,W5NE$E3F)WR<+YRW*ZH^O:5.''GT]-+?:D2ME0J<1>LF1
M?:1H_/+%\.W@> >Q44=LM,O[?TOJ_^3Z4HMK\TC%@BSG:] 3/B-Q,9F?">5<
M1:G8)?^UV0]6>T.D^T)I"<UE+N802B7D7KXXC(?Q\:5VE<4K$J_N3*D2\>-H
M]/I(S)9+"LTNSMM4SJ3--V)2EKE*9+@.7K&/>' \F=^WD<+.\/CUOK@#5(FK
M)\6?=Z$"OAQ#^SV02$)Q..%-($9=S*Y\*,246S'-\A^0'A[N#>-_3_I.VA5Y
MR'I9E):%#\@;=%M1<8^+#T:O]L[A):":HDNYC-TS30*05I.>6&<JR<1:NC9_
MZDF&AX??DRV34(<^>^+K(, R5JU ,W^NWF(CC":Q@8*](*5&_?NGSJ4E?!0^
M5<K"&9,RE45$3U85P49J7<&UI=+8P+S$*P.U%X2@FG?D$L?%.24UB>&;<+7$
M-1&-+\JJ4FF0VE(.8$%/^53+G+5,6RV33DOD6G&FR+I&.DN/RL'' VT$ODHU
M#1QC8@5)/LM[HC IY2YP2)5+<L-O6JZUU:[ 37:@81N_AU625RE#KE5D1?[L
M:A(?,;(L8^L$'!',J<:S\S6:YT!AFBNY4#D.4@UJ67D&6QK4_ 9*:UHJ6%>.
M8R<5HFC?$\"<06^/%@*-Y('2/:61:2 O2@[J_IZ"'F(5B@L<.>!<7U&*OD*P
M>846JQ&A\M,*^%O!P]V*_9R<J\,-?V#8(.H D8LMA1$5JBIJCJYI-LX6Z0IA
M%Y2@[+9*E'E6VV7TLT2EV8UHODS!CPJULJ"Z_VO46SG2[ 5U!7U95<P5JJT%
M9=$DRH4" S^[X<6CS*N0N"K4OJ^M.@1-%?&-@TSXIM1%0Y_2IC534[8Y]XV\
MKKF$&%( GRIN-U]WJ\1=QQV%/E)%R97!UA#_B8"(@ADHX,>P6!<DBF[9W6"E
M:6H)RB7296*)6=#M Q/2QRG42&DH"8M>U![79E/%6\WFNNL2B?1!UPVKBE08
MV^Q9OF!*Y*D6?#>'[\(&R33@[CT#_K5/=']K!BL(=S%/FDX$^/4XUNUVP^RD
MGN&^'*\G8<PY2*Q#U2YA.MA_]R82MIXNZP=ORC#1+8S'?!B6&09RLGP [Y?&
M^/:! W0C_O@O4$L#!!0    ( .=XFE;8F91.U 0  .$*   9    >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;*56VW+;-A#]E1W6S9.B"^5;'4DSLN3&FDX2
MU[+3ATX?(')%8@("# !*5KZ^NR!%*XWE3J<O$BZ[9\]>B='6V"\N1_3P5"CM
MQE'N?7G5Z[DDQT*XKBE1T\W:V$)XVMJLYTJ+(@U*A>K%_?YYKQ!21Y-1.+NS
MDY&IO)(:[RRXJBB$W5VC,MMQ-(CV!_<RRST?]":C4F2X1/]8WEG:]5J45!:H
MG30:+*['T71P=7W*\D'@L\2M.U@#>[(RY@MO%NDXZC,A5)AX1A#TM\$9*L5
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M.DT]!((X/PV!#(Y("#(A02"*@V^ 0,H"-HH) M'T#T!@,H  O) $X3,(I,D
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M.-%$@/=SI6Q_0QML/[1>_P]02P,$%     @ YWB:5E*F#9)("P  VQ\  !D
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M@O.8LXIS5])4[9+:W8K<.+<^H[$[""ST+TT+3"F&B*%:&\\R0#QZJ 4V#L!
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MA$_)X<;IQG^^G6CG]-)?HERC>Z8!>#_3B%R\H0GZ[_EG_P-02P,$%     @
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M1M7L%2/#19=HA(SKQ[BN*PJ;=7M(6%%4T;MG;XH"MRD%$MMP<J)!!:7!"/N
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MY?9?A59PNO;/<Z8=/O9^6.+OBAO:@.LKC8F_%<A ]U^;_P-02P,$%     @
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;)56;6_C-@S^*X1W&%K
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M!;VJJ)T"G>^5LN>-<]"^T[-_ %!+ P04    " #G>)I6.V4R,A4&  !.#@
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M*3X5S&LM4,P5'C'9503 A%T871>R&W()(-W +.0:SSTZV^CZX;C[3;/=H@E
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M?)8\4VHT;I8G!WC"8')<05&X0[2W(PGF\^<"1[1TS&81C!SVE\]W#'ZN2]'
MC^8LG$[<<Q+OPY^V\G9!Y1C$(8L@ 3W[>.*=P?9<+XX](CR'+.;C(Q:.9SL&
MR0L>L6>"F$P0N>=00\DQ!@E4-(D[1ST2HV=#4O=\F$0Q^TB!ERM>(M9N1<ZW
ME,(TWS#;3@P;#EL6SIM8:VD3?D^_6VV.3.9[$8X8]0#H=PP(3<#_UV&[*UN'
M'9/+;H3+I0#55Q;EW"9,Z]*(%'4HVQ?Q2/12BNTKT!-)OHQ(H]F O:^UR_J5
M5JD0&7([MM4IMJ*-8Q9UHT;AUALM(;#Y#\M0*55=6N/XI\C'D(>R-1*RS$A
MU%#DWK#-O0'[$S0,"!*Q/BMF%9A5,$2O!C%4'D?>L<6,WM=4:]-;LJDS]J^P
M4N JG!;46Q*1/38;;&6+!@1)M1*ET+!CJG2E-+>"537>C*#*MI;0CRS3O,Z$
M@^P@HKETE5$\26.)@RS)]B(KA<$NOY[&%TJCK..M+T%Z6+: ;:5Y$1QQ#S 2
M9#E90CV<?:AS!/]XD9Q.V <!G.D:G26[S\F1&POY#Z_-=@%G%55P[Q9.B[UZ
MR/AJI<7*2:Z!759 YA5/RYMBN><[Z&IK[05OP[DK](Y\KQI\AGQ3]%XDWZ8C
M%YJ9'V[%9-">5!G,N9*E,[4J]P/#0Q+>F3#9RYXA_/UV1\^NM1"L\.VIH/;T
MH#]Q]MCI%.&&O/MY&8?.R5)NUK )\H7SZ@HF?Y(04^1;4E9+)V X,C">99*,
M!1JR].<G?Y19<>T%@8K[>87"= D=P>CT#>'IE:3B\$/X)5JETJA<9IP^WLD2
M[1OYWX/% 'FS:9V<7(W=<VW9W=V0W6$6J90-CFXAU3[4596[;RIZ=)08$ 5"
MZ%HX.@+!8T]_">"PCRI_)/QOX=+2LFOHK"%%B2?UHWPWFL(:B.'F/$,,T$=;
M+=V)#+./ J@:()PM.XSM3$]E./K(HFYR-)23\DJ2-?[A;5A,QV^&U,9N<-*C
MWQU3\>C0N![9'=M<%N-(;81-%54N73N\D19&7DMS!,K0S^(D46/T913Q))B\
M(?:%X*;VH8]=2$Y9GP=Y8JO-YWKC#NR^^P;L^K O=QZ]YAFBKI^IG#;W/10-
M2:^NY,)2^J?7AG<_9?M$]QF(_21IUTBV1.R7ZY^ TLF*\7P[/"I(A_HD#.(N
MAV'9+N%WPI"">2KMMH<J.=T*KE\!YVMI/T%^.?%H&I]F?/L:]>]\41%/+MY,
M4U5=[;04G8=5'(K2/L!RUX.P)9CF2!#"?(\SFBJ=[CS1C:IS2H==G(#>8NNB
M\4AT]%Q7B[]KZ=E\10YZ):+_'2FI=X*\=Z7X]\]6:?*^ A9VC5OO^#?L]5G/
M]OJRAM+PZ .JRCDU550XNAZ*+HDDN8-6]6K-4J%=[EMH]0D4,L%SBCE.[KEE
M5A8"L=)T1_R1RYPO<M'SQ!8N885#>*\5V=!U,#)SFM+BM!UG2ZT*1];9R9'_
M>-BBD3<V9W^#$$0.7@A1^H2!;"B>*N%<#A2^K,/R/-K<_+P]Z'>"7G!R=X<R
M^XK2[6XH3J9HD[OCA<NC)_%NZ)#9 06*%:Z];"=T%G]AV[-+#"]B?]4S[WC.
MC=(;AZ?1U2!X0M.:KQ Z95F[@*2F$#V7TZ5K]./DS5?$[3.W_S?$ZGL TOU+
MH)NN9!V[3AOU[C8A[,K=X%)+ <?RUYS=:'=)?.WO1G?+_0TSC(/^TJ#N+;%U
M',R2 =/^UM9_6%6YF]*%LF@9W.M:<$0B+<#\4D&MS0<QZ*[.K_X/4$L#!!0
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M7O_6RZE:=H_/!S_#XC$76)MZQ-VYJ=BW[5<SIO8TX4VOO0E]P2.[WI%=GF7
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MK@U?5PPU7A9VLGN*8T&D2_=!P]N/D;*HLG!D)M2?%:U7-O1\AP8( U_K14V
M*T*<MN>4O<6N2+H90!@.5,E^1O;:SF.9/28*"XG>.7A^5WSE'LC2T88[91'A
M;#=Y]Z6E;8WE(@GJ<M/)1DBU3S$?)AQK1\$E8EE)O@\KCG.'4CA9C-4"  O5
M'1^^?C!1IMR&),44+0Q-O/CCY&E]N+6*G%GS<R%]4;YLJ;2:S[K\85B@:=GZ
M2-@<"DT0(04:?6-6#3@MS;OJH_F.5G+CZEHX'=)L'K<0FC59"U^7T8H00>O!
M4RH1XB1Y^$:$- %&Z]QXN03-*#GT=/+0(@H_Q4YPK UA0G7KG,O@PS%PFUJ/
M+MS5FU:$MB\X1>5O&:]X0D#4[/Y4,%MZ3".7AQKZ?_@T7)2,[.W7H5K& D:L
M"L_N3Z93WQ<KQI0ZOMP#BVMM#-BQ^.1CFG)/X8KH.^U^FS(5Q>#8;17M '#"
MN^!8JM8RD%A!!CP)6A31>"^;3#T[H9S%_Y,;+^.+,5FQ=GPO/%M#ZQ;QP/Z$
M-NTL11^E@6%6F1*>IN1GUR_J>)C]SI6UA>_Q-\O(3IM>?_U*^C3]\II3_9TM
MX^/ZFV\NX+J\VU';!88>'CS^>@\<7WZ;C/[0^XW\!I>Y[WN_EG^N+."[Y0/X
M?N'A7^$'+I!^I<_S_P%02P,$%     @ YWB:5NT!(7WU#@  &2L  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&ULK5IK<]LV%OTK&#>SH\S0MDB]TR0S
MCN,TGJUC3^S=?MC9#Q )26A)0N7#BO?7[[D7 $D]FW9WIJDH$+BX[W, Z^W&
M%+^5*Z4J\2U+\_+=V:JJUF\N+\MXI3)97IBURO%F88I,5OA:+"_+=:%DPHNR
M]#+J]\>7F=3YV?NW//90O']KZBK5N7HH1%EGF2Q>/JC4;-Z=A6=^X*M>KBH:
MN'S_=BV7ZE%5_U@_%/AVV4A)=*;R4IM<%&KQ[NPJ?/-A2/-YPC^UVI2=9T&6
MS(WYC;[<)N_.^J202E5<D02)CV=UK=*4!$&-WYW,LV9+6MA]]M(_L>VP92Y+
M=6W27W12K=Z=3<]$HA:R3JNO9O-9.7M&)"\V:<G_%QL[-YJ=B;@N*Y.YQ= @
MT[G]E-^<'SH+IOTC"R*W(&*][4:LY4=9R?=O"[,1!<V&-'I@4WDUE-,Y!>6Q
M*O!68UWU_O'FI[N;+T_B]LNG^Z]W5T^W]U_>7E803*\O8R?D@Q42'1$R$'<F
MKU:EN,D3E6ROOX1"C5:1U^I#=%+@G2PNQ" ,1-2/!B?D#1HK!RQO<,Q*M40B
M5>*K6INBTOE2_.MJ7E8%<N+?A\RUTH:'I5&=O"G7,E;OSE (I2J>U=G[O_T0
MCOL_GM!UV.@Z/"7]>R-R4LAA%0](%A_K@MSQ4<4JFZN"'!X%8J-0<#+5RUPE
MPM1(_+K$#F6I2J'SRHAJ8T2B2[@RKD1IO5N^$;=Y61<RCY60>2*N,:B*7U!Q
M%^)II3IOW0K(BM,Z@= *KSM[5"M908E""6C_K$U=IB]^<H('GO]555*GO--/
MA:G7_/2X5K&6:?72:!4(64)6FM(GK7M8291S_"(^J%PM="7N9([^4P3"%.+A
MPUW0:"(V*QVOQ 8+3^CQ&9ZJ5K&$MH]PM(YA@-O<VMWZH3&\1^U4%9!V8/5K
M.)^C!NW9^VOY8HISN<P-/!Z+5;ND]!N:Q4)1)&&NU8^BNO:6(E1K:J08\RL"
MF&2>=8*8MT/DP97)6KD7")J02:*YA5+@84^.7NL-B5-9EGJA8TDS2C%7M$E=
MZ53_!R[""DD1A0-5P1#BDT.FJ<$B2K02-O+V2+NY2K5Z5MA'PXLZ6Z>D8%74
M<57#WHV&$V/D)A8N^:,0:(&IG)M"NC9?F-(&^E@V=C.-WK!0&<> BH($$X[8
M%(0.-5I:L9$O9$H,$84DRW@=*D$M>04PLG .V&BH;A,#4"ES_1]^<2$>"HW\
MPD1MDL9]"YU#020LA%F$)1M6DARI"/5B65:\M>'W/@34%X7+$2?_'HE"95EP
MCY/S5'5*X)@K$')XE6 -=0[G89]L#IU8#;/@O:J7M:)GFW9BG<K<(1.<SZ%,
M?I7DFJY?8]["2J7B.[>)49JTMGZ"-9S;':DV&@9[%LT&MGS1(N)"SR%N3C2"
MRZILV\B2RI^2GZV!JTJT)GI!P=CR;$V&SE]XY^N55@MQ\TW%-3$#<;] &E,;
M(*/MRWL;5]L@-1.1._D;S_D3B7VL^SE%J7C%G4HT5_3<-B78#9+TFZIL$>D\
MT2C66J8E=:E$(S,J=(]G+:WUK0 DLJEW^Q[9B^T8\:Q7KN\>V8@$I(*\5;#9
M/^M,TY:W>4QMX(O:8),; (&F?'J"_B6W NZ5/]^>?[EY"C@/$9XU>S@IZJ7-
M$?075$?&3O%[V_H0S[*@9HK"AJ-*TL,U(V>&3@)!Q@KEMTY4!F]5MLILH_K9
MY,OS)X6B>*S7E/-M^VV=Z#HX16-!-AIN%XJY($QSKF$]SFT9-*I2V'33RA'7
MTK2 !7V3FNQQ0:0<01@5&I9YP48V*' B<ICK>U&GZ<NYIB3 )AF;:<&K;"#+
MU8)N,L7;<307:/WVGEL D%![0)$_<^X&G?HJX;)49?S>[]MZK9,Y/D'(\\]=
MP,G3%\Z"J\?[+90(V*,GL)Y>WP$?*AP"FI9!6:1AI4YM<3Z=1_UP(FZH_7U5
M2\HL'Y@]0.]T7X2 5@/%&\E',7A+(0^5?P"+3?MJ][3R#V>)S2V"B"5P>RV+
M*D=+6^FUJX-?KJ^X"A- 7FHL@[&226(.P#A?F)B:5K!# KR_7@07O6VW^S6/
MV)E"([7,QNW,J(6")?MA5+F&B5O6/&Y1"MLNJZU"**@<2TL.H;S*5QQH#L4S
M!*5IEZ*H;X1Y"C/:MNUVR "K*4Z2) 5M'3ZWQ,$A>5D:% 9EO>WC&86&BX>I
MJLM:^.P2:6C7<_>)X:'2 F(G[&RWMP%L3N4UU['/ND*EY'8'L-LYU1'3L,<>
M^Q<,]!Q50/G2L"V?>:^#[L*6F3XTN4;Q+BR-=:LU=/K50%=H9'$D\92B*XMS
M@R@%I\ UIP#. #HN#]3B'SK!Y6L[H&21V\@#$*%>SOF3-+5!B%QHBL6B,%DS
MZ5FFM6^CLD#Y+[G#N&3?1?L+\0_B5N1N),6QM=:$W>W9(GL4D>"!I[:AB**_
MLZ=E\F+++87R1= RN,!!:@M6.(E3'G3;'^4D7F=\7& /(C6\[6[+;5;N28[-
M6!L;]2U>D7669VP;1H1/036T74+53-=90T1!PP@RD!=KX*-E:TC2<U<-_$BG
M<&)SNO2U=C0DS1$#8NA@ (SM,ADS!_):FS<K.H@UN2'Y2VR6.3-\QW4=K]5Y
MB[@TT8FQC<)C?./UY+#7,'7+:9^40ALLSMT$KPHYI:,(O,2ID(AZ31=&Q"P"
MG%5LE!QV$*<@@K8A(VV[=-H?LEP3O-,1I+)$EJ8FS/<77ML+\8OR1-RS+*"N
M(Q+ "YVPH9A1IY;J=5H+5X]3@&@ 0ZRCW=NE<D4I8878Q*$F1U.M4PGL&[*P
M[3_B0(HQW_D_8=8HJ:D7"8/22YN IK ](N=,JU:@%,L5I0A5T+E,38Y U?,2
M6Z+S!.PB=P2D&+34B_L^_& IRK?..9^O8-KC!1M"A6(39]=TD1B1&YPMT)/(
M 6OB6W.B#R]=IN.J(#;GY8I9<,8DF'=?$BKE7+!.=48W\6IXT1<0E?K*WAH@
ME?CXLT)2B<Q><"FZX,(9H("F_GZ*E]I[$]+/<\N=1IQ0O1&<^<V@(?S@L*YQ
MU@[F^>[2.5FYYG4RXBVJ[0IDKK/+<%B?!K[:_+2GP^:^@P7LQM?2'^MN&U+=
MQIYN3EX-!J A'2</^LWW_]W']YS9Z)%4G:94G:-B>V5C*\8=C/AB!'49NRQ0
M$OMTN0W-+64&RSY!/1_!G2-ZH9:RX,PCCQX2W1PXOAATC,@3"XE\I6A<=[O#
MI^8:X)%.(K9#=^^9'E"EXO86!WF\%=- G!U<PC=@+;,'-:!+X3.20&J2 \FH
M3(3]\[]?V/.<C/W-3;6Q=PY[]P>=?'+''>Z ,K4>;-*HH- 5G1/V'NGNIN8^
MY3YP 17XW#YP?/97!%1I'5IC];)MA].PQ:PBL4"QD+JPT&CGI3CVYAP)G7?Z
M-M^KW-FB8HU:TQK7F$6E^%ZAR9NVO@ ^_->5 #D-A_+-&,45YXB,ZHJ:J@>\
M.=<Y>H*"=L^FX  T1W:8ESE^TY @RW ;1?CD89L?G1"9S3 3MMT&O:,ZA",0
MAW*6MJ/NU8,N+1R@>U%LZ483>-=<<60,0LTE2>-O%S.O&VU+VUMVY5H:HK$V
M?-+1]K)A+V+4]OU6B:^?]DZK;?X[J*)S,*C*G_%(-$DJ[26!O0.UUG4[77,L
M\KW+=%5,U+P*MM1WUU3-#*^Y)UXH\LR:8?FB)2B=!2F=^?SL=K@!+DY9TEC1
M=2%@&F]1-4P9R+F'ZI0CO=>RMTB_SW6N>4?>6$KI:4S70YZVN&NW3L(UK_B:
M7A+7)5Y5_H6>WOV[0:=EW'0TO=SNET]_*+M'Q611IGPM;KY92M.RV ?+KOEO
M%OXZI;U#NTJ>)?KG4HE7(IP%T_X,#W_[81J%T8];3^[E3]M7<.WR,)B,1\U\
M_VE'F^E=;O7P\4&,P_'>$AI[,E5728!A..OOS73#U\>NGL*@'TX/J$2C[1FU
M@?EH--S? F.-&BW>B' RVQ>,,7^IU[E_"H-9_\!D'K5VNO,/:1",1@?LM,./
M+?AP:-^(S]LW-7[^(!QN/3_LL:!&<C_<>NZX\NKQ7DS"/5TPU-QH=6P\,)/&
MFBN$?26C8;3U;%U1[MC(KR:C23-U-O->4WN9#C]-9MO3HW$P&LZV4;.9WS@4
M/@J#$.RMAX_AY'6S_,'??3;R@G$X$CW^:*=9A0[?.$#V()@,IZ*'CW'4+KK=
MZ]VSCIEC%-S ">X:..L/Q# 8]4<D;SP>OR83)W#2_1XVO?%_]L-"I!O$>>F]
M< #M,3@=33L++89&P1#U,0S":$Q[C,8T-9@AN3^>)/8A"AVN[D73UR*<^AH^
M )D1])^,:8<)6S&A%3"-FIF[C;>MOST]AL$@FH@!^/0XHIX2NI!V46PO_\(!
M_[.\V;K8GI)W9_:P/_USF_=24Z*3SM7"% UD5_*;IUJ_U\0?T'5)%LU5705[
MPP'L1WX,Q<VAF3V\[H7#UYU@(.'\G^WI.HK_O..4>,62A_@<H"V^LM)I<(1D
M^>*D F\K' 1J"Y$5G2)S=[/#3,P#/M3<]]+1K7>%?JX)WIU&HT,:3?_OZ!8=
M0[>O?P'=)D%_%!U#-_OR!+I-)X?0C4:/H]M@O^_3V ZZ 5E'XWT<=,,GT"T<
M[F.%'3V$;N/]X-/8072;1ON",780W48'8-..[J);%$SZ@WTE[/!WH]LD&F\]
M'T<WJO[N\RZZ3?9TP= A=(OV9]+8*72+PJWG8^C6)^3IC_L=ST7CX7&$0R/N
M3W:61(-@-IY\!\9- 8R]Z20\B6_#X9CP#1]_ M\&"" Z^2"<G,(WUUBP >IZ
M"%C9![B(31D&@S%#PX  D^R;]$\#'(IE,FCSL!?V9Z]I<(Q.M0]P_2EZ=3"S
MH!P.9P1P4T#6'P <.-@0'HQ@9 B%C@,<T!;D!SO,V(IH2A *SC -=S!F%^=F
MP/T!1/<FM <6?@?.@0'CO^] N0B!Y__]#SC7*!A2?D##J'\8YII=NT@W/ 5T
M)!J@,F908?&$*A% IL&YGE5R'YN. MZN$W8__S3X'=?RT _B+CL_5T3K6?*/
M,NFJ'0=?^\O%9K3YW>>5_;EC.]W^:!2XN$3KQV%Z@:7]B\GH3!3VAYCV2V76
M_./'N:DJD_'C2DDT1IJ ]PMC*O^%-FA^#?O^OU!+ P04    " #G>)I6R.S#
MLP8+  !5'0  &0   'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6S565M3&SD6
M_BLJ3^U4ILH8; C+)D"5(9!X9T-83#);M;4/<K=L:^F6>J1NC//K]SM'ZHN)
MXUS>]@7<:NG<+]]1GZZL>_!+I4KQE&?&G_6695F\VM_WR5+ET@]LH0S>S*W+
M98E'M]CWA5,RY4-YMC\Z.#C>SZ4VO?-37KMUYZ>V*C-MU*T3OLISZ=87*K.K
ML]ZP5R_<Z<6RI(7]\]-"+M14E1^+6X>G_89*JG-EO+9&.#4_ZXV'KRZ.:3]O
M^*35RG=^"])D9NT#/4S2L]X!":0RE91$0>+?H[I464:$(,:?D6:O84D'N[]K
MZM>L.W292:\N;?:'3LOE6>^D)U(UEU56WMG5.Q7U>4GT$IMY_BM6<>]!3R25
M+VT>#T."7)OP7SY%.WS/@5$\,&*Y R.6\HTLY?FILROA:#>HT0]6E4]#.&W(
M*=/2X:W&N?+\8CR=3,6':W%[=S6]NKD?WT\^W(CQS1LQG;R]F5Q/+L<W]^+J
M$UY-Q8M;F^E$*__;Z7X)YD1B/XF,+@*CT5<8'8KWUI1++ZY,JM+-\_L0NI%\
M5$M^,=I)\+UT W$X[(O1P>AP![W#QA*'3._P*_0^N(4T^K.D8.F+2VL\E$UE
MB!V3BENGO#)E6+!S<:V--(F6F9AB42%02R_^/9[YTB'4_K/-0D& H^T"4/J]
M\H5,U%FO(%[N4?7.?_UE>'SP>H=Z1XUZ1[NHGU](KSW)W=5CFY [R6P7\GZI
MD%Z)S0MIUMHL1&5DE>I2I2*Q<+?QX5>T*![FC?%\:SSIE"B"=-BB#=-T*38J
M9$6Y% MEE)-9MJ8WJJ!=M*4R)3$MG ;)(E->H%CA?*F<SCNLM E%K/8HTRPA
MNS9P6L5EPHO2"LIW,3S8^R=O&[M2)YG" IGO3BVJ+-"8[OUK(,8L(_AGZSX1
M6XO4"F-+$$VR*H5ALHS.$9]4^R2SOH*.V )12!6G_JRT@RJS]5>TV:(VC$,$
M/QHV,@<@.W><0^=$]@4,\'8\ON4?Y=)ZU3+,9:K8ND:,C:E@F#M56%<*J%1K
M_OM D%/72KH]9;[JQIG,V#NA?V!-BI7TJ(H.I19>=C87=21L<WE?S"J<LVR/
M39-U;=4U$6DU(#G%O'*P@>NZE3T@J#EAG8V.F&^]Z9>VRE+J)7@-/]O*M1IS
MT)11::&H2HDW*E'Y#)MCG1D1 UFRDG.=J4X,3552.5VB.'+07#TE2VD6"H4D
MS[7W+%QD,+VZ[+.QU<Q5Z(1B>!RJV$#\H5KI-H3_78 E'?[UEY/1Z. U"=.^
MY,7AZQ 6.)7:I"(##^!:4%/P$9UVMEK !.7F)N(5J:Y4OR855RK_? 5&>[YT
M&3*_628#Q%?OJEP:6;_(%8(N+(F)20:\4R/U?37S.M72P7XA]% ("NF::DNN
M^I%:LJ5Z4.34H>1%Q9F>RP<EE"]USAE$XD@/@%+$6D#.EO,Y( 0;7^:4GA20
ME#!M'OYDO3/I9ME$#M3JHQ9*TN+19H_TBKCDUI?"ZX71<^0X'%<AK6&;CORH
MH+0SKD3;S5 _YF3E0J[E+%,A2S380BV\=]H_")G^%VB#XZ%P]E%[-H!3&<L?
MD^6]2L$93* <MSD?:#W*K&KK:GV(.&C'))U*+.2N)8)>*C+S3=[T^?#/D,NL
M6>QE7'+@/452A5)"EEM8FZXT*@K'&KP#7\!5<3^Z!-)4PRKQ*)O?JV=&)>"7
M4LX^&+M"WB_8\)#<D3CJL?4GJC?*=G!Z5:)\Q;?]QMU-MX#]J/HB&@$A/6)Q
M+?"#N:),IWI.A8">G.;"S>4T%/-&NE *99JR,9XU.:<6DKEM-):(X3A -0IE
M"..0;[0AIMKNX.VW=>H&42M&H6*IIMQ?=BELQ4JQVC/W6XG^,YGTQ01OQ4E?
M]+8>(1-.JP)=D9ZI=!+H[1$%DGJS*(9$VM[^ETBNF5*UVMOA!AN"(3AQVNC-
M-$PDL6 0+>I>3"^J/T!YX_.V0+35C:DK00MT8$B:43RWO38-013=QWOB3:U)
MBCG"OW5!R*. <6(( 8V A*^2Y08="F!LEA$"Q*2BX.6B(RE*!^(J+S*[ADO?
MHDT4W+>48\.%K,^ '&U:D: 7E0<L],#R3[HD39M.1EVL+U8( V-@K822!E8H
M !,,?BO:'\-8_0C'6>0(VDL-]6+L!)O-*\H.@#CHD?914;+YWKSB!DZJ7JN4
MX%/-3HEW2F9P[T4HBVA*@1D)26GJ(3]YPE-%L)"'G$1+K'(PW@IYY:E0+IS,
M8?<;U$<&([&Y+0,+(@G3(U%@Z>"(3CZ'QD+!<FTS3,><J(+FAU(M--"X>L00
MRN9,%4YA_%/ISUJ.,8NQ7"MQL+">*T:H[1ZQ@@$>S0'PD* <,3%*I0PJDY9\
MSG (JX\J8!DB)T@V C<>J<E $B[GFLPO6H78PB$MNY$ +$)C!K>J1EJJV#/
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M;/J^7Q5,J7R9\XPP>*NE1 &<YR=1K=[/N2P/36K0[.%)]>RKG?WTF?VT9[]
M^QKLDRV7'+\N10'$H C3!$*=KKM8&_F//.7E@LNVUYL"$Z@--WNY>#HEEZ60
M.O\_6/I#"J6:W]]9+LDXKV#'% 5L?C5YJ?S^Y.Z$S('&5"V?C"FAUV#']*_$
M Y>5F=6^'%!5E3X1L2CR%4-F4>0=<:<T\>&9P-_8CR:V*PAA-TB]@B'O%RS]
M#E[V5HE.$S<A$<A[= )O@4/)G#V^YX^\W&A2UE6>YAM6],=$H4=<,O; 0D2'
MM)^26Z[R#*:0@P8_<LBOO\2>Z_U&QA%:2R)R)<J2RQ2_N], %'<2KI],H,]W
M*;E4BNL#SKO@?$ \,@Y]%(T#"OKD1DBF.;#BXAD>PFGD!<0-03H))_#J^ &9
M"PV67XK"NH&T'T&#!KB8X$:$W@13ZE#C,W YT&+ZO?/7:LH/0O%=.W(/23\?
M DY"\8E>!X&%@$.380B$$ @?(>,B!#SJO $" 7'(F"($O/@?0"#J00"BX#ON
M"P@$?@\". -$=3( @=A)$(TF/M.(NH,0" *74#*.O7A" @!$>!P!P33QPW8W
M@68'%L?UIQXX^ P T6NAAS&A2P8X-^@X-W@SYUJ*N:\ $85AGD_P#O80&89X
MOK&B-I([2CY$M\,6K95Z9Z7865FBE0>T N^KE>2 0I!8//57(H6^E6@06_!J
MI=?HDX:2"I]YE>4/>58?B(!> QFOV0,G"\XKD"2,I)#5\ZH6]9Y/9"-4;BHL
M*!')=IT#S5:",*1U5J5<F?Y4\BS7=L ::-]HECP5$LJ$GY4,/G%EO*^(ZY'2
MUB&[%G@!R8(WF#&1ZF6+O>9/21]ILR$,1W3483;G&VG%2QS<!1[R"4U"DU\,
MN81QV":; 8:)0T@P+LAX4Q?\'OM.B.T$M-J\\QK=4!]&@4'J DUYX$881#8!
MO95Y@/K1?1HF0!5(<Y I31+JLP]DPK'))%X48 )JV,=ODM$Q#@IB\,X#I4D$
M1.332<-C)BT=9R-(*@&U:P<43(U\@K3DQ%&3I(Z1$\C')B))C%%(8(AG:8K&
MKB%];XI9>I>Z?CSS_'OT!*[Q)+#HB4S;,7X[29NG!M #X0!6'[N."4V(BTU#
M Z;$;;/6:P *?1/^$,H%& R-"$)-X[?CQ_40!0C;" /E(()BF\-Z"/(0IZX!
M@(L(=7W/U#".TR2S8Q */<RF1MAQ$42AF2O..XJ'010BM!$'=!IC,Z(.@L@/
MG";/'0.1#[6567\O,M&(ITD'&6I11!%/N_PWD,/"+H>%;\YAMRV#_P'G=N Z
MF\(FT%^85*+%D:/%3946-5+VG[E> T/VI."3*/FA3#?LUWR-:ZM97J!GXZ)Q
M964\DSN'#F=YA'[>.K6U3O4D<^,4V4)RZ>47S$BPX^!/<M[F!XXGUD-Y!_?L
M*9F_*FOV]O.T85.)G8JHCA8J;=D%FY0V8YIT?W30. 2<C-T]$]R>9/LX[=2_
MU+PONZO_'(#O%ZY-CEY5_0ID8!YF=[XS>W, L%$'V.CM11?,S\)T@@[LG=</
MP6Y8.\+.KIH]F)JY]>"VOSC_'#4O</>#(,(P6$^[S=&+RL$X9M"H5L;;#9>Y
MR-J#B8DKUDFG/Z)6B2([H!NH,H!$=[]7K+ZJ3\,DR9J#5BCY4"/'9+A\[OAN
M=XPA2P\ *^Z %;\96%<0"[SFP4+X,]/HV1/VFZNA'O%=/@!!X:V8@<$=*PXR
MW:#=PU<HB,.TYT1IG4";X,;+W,&>N:' C?UB&<OB%9-9@>6P7<P<[RX++,>)
MO>MMKVA24RI,"9/X16PKJ,P!JB?D^A$+:PA<SY^2/9$L7RZA5%E*41YS>\%3
M5BLX/0@)@>'2#C0'"HRKQ(M2W&$IG!&P*H>UV+#GE0L2.7["IZCU"U%#/!M>
ML0+MG?0N@0Y<_'R$LUB3%T3%R1-G$@LC!XLX/PG,=[;4,*?N,VQP4:_69 GG
M"M.C(&.[;HA7-K[;&]$3:,=H.-?8'@KUA ^E4@CEP&[([CL45W DAJH#?MM:
MR%9R1RJ5:!J'(?RZX<#9N;T]::X]#NV66>^Z&,JGE;D45Q#-NM+VYKCK[>[=
M+^UU\T[<7MH#\%;(( 5?PE#G)()#K;07X?9%BXVY?%X(K45IFFO.,BY1 +XO
MA=#M"QKH_AMQ\3=02P,$%     @ YWB:5O)#R$[L!0  R \  !D   !X;"]W
M;W)K<VAE971S+W-H965T,C0N>&ULO5?;4N,X$/T550:FH,HDON3*0*H2F*EE
M:ZAEN<P\;.V#XG02%;;DD>0$]NNW6PY&@23+T[[8NK2Z3TNGNZ6SE=*/9@%@
MV5.>27/>6%A;G+9:)EU SDU3%2!Q9J9TSBUV];QE"@U\ZA;E62L.PVXKYT(V
MAF=N[$8/SU1I,R'A1C-3YCG7SV/(U.J\$35>!F[%?&%IH#4\*_@<[L ^%#<:
M>ZU:RU3D((U0DFF8G3=&T>FX2_).X(> E?':C#R9*/5(G:OI>2,D0)!!:DD#
MQ]\2+B#+2!'"^+76V:A-TD*__:+]F_,=?9EP Q<J^RFF=G'>Z#?8%&:\S.RM
M6OT&:W\ZI"]5F7%?MEK+A@V6EL:J?+T8$>1"5G_^M-Z'CRR(UPMBA[LRY%!>
M<LN'9UJMF"9IU$8-YZI;C>"$I$.YLQIG!:ZSPV^CJUOV8_3]X2L[NN>3#,SQ
M6<NB8IINI6LEXTI)O$-)PJZ5M O#OLHI3#?7MQ!0C2I^036.]RJ\YKK)DBA@
M<1@G>_0EM9>)TY?L\I(+S7[PK 1V*4R:*5-J,.ROT<18C<3X>YO/E<KV=I44
M+*>FX"F<-S :#.@E-(:?/T7=\,L>P.T:<'N?]N$=!M^TS("I&?LF))>IX!D;
M&0/6L&O@A'_*N&6>9\CQ6TA+K86<LS$WPFSS:J_=[5[=+X#-5(;Q2YHML60=
MQ.(?W$55:C8C&$L'(Z_08> B5$2(9YDNZL-D7$[9):203T"_C,8!QK<IP$5H
M]AR@-519N\TKMW//;<\>A38N?W%\0HZ?^OMR[0-Z,"3D9O\LE45M-UJDZ,4?
M=H& 'J2:D-?.QR,A,>2R#+.'.7[KQP4W"P:_2H$HG.8#%B5!-TK\QN=/_3B*
MOWBM2YA89@BML (0Z$/SKLGNM</X['9'54AH?*Z6H"4AWR*'.5.FSTQ-,C'G
ME.(,BX*DTZUM;?:NE;9S7',RX>DC^OT*@B5!)TQJP<W>/7\Z@2?("\OR4HI4
M%'@BWMI>\FK";^\V=XHT-6**3M'A)H/>JV6O?:'R'+0[_RAH1XGGE=]S(;'%
MI2CH=_PU?N]"Z4)I;@'3]\9IL&X0MCNU7"<8M+ML,&#WRB*,M\)1)TB\C<)N
M'+9)G* C*S%WIX_U]*Y_I5O()1ABXYKK!RSN!X.HN\&JRL !F7@70=OXV [Z
M2>S]_W\VALG .P._MY>-<1)Z;/1[_\G&N/_*1J_]43:VPZA>X[<WV)@,?*_\
MWFXV]I+(6^/W=K.Q$_3BKL?&;MQA$8+:0<=V$'?:KT;:082<)_D-/O98[\,<
MC 9!.$C6#!K00*7TP*G=4^8Z=9GK?+S,U1D[>%?HWI>V8#-57\FBM"2CL&1D
MPA%P6_7;"V=[];LLG54, _8,7#.@.\Z;:A"XZ73!Y1Q/ LL&=?T:-7,C;PM9
MZ8J1$7,I9B+E&%>E[Y0@IPP[^@Y8%5ERS%:@T8K*"RT,[4JEM2[-6/6P;M*0
M76C 2EQ=RK8!_K!D3/5Q2>R\R7!CJB*Z61C',!=25K4WPY(-5*!_Y[+$2SZ+
MUF0Y8-W^FF=S?"K@K4$SO(89EW0D)I(,[Q)3VKHJX3@O84&W_R7M!/8!E1VU
MC]E-B?CP(HZ49U&/W6&^,S65CZ)CS$M<FADJP4>(6_$R.7[%]^)DE4X/6#_<
MQ^=NS>?NA_F,'"XQ3[E,^$#'15M^51WIE=QQ0=G&V?TFZ7)67<DF],)BCKAT
M2&O"U1A*PD 7*^#HN09,.I8.K0 MU+3YEB#O*\Q(XI%6Q[14&898)BP><+?9
M.V0GF"N:R6'=B\-F_Y!=(,D%)BGW7&11,W:"S3;*D3"U.X<8M4N0N WP)"BK
M9U84Z U./9$B^OGMG^Z=15D*BQ%F=&2*L;3?*2\$T2N*FZ'3G= _<B9.:!3_
MWQ5%,NB<S?%D+6X#,1L%V6'UW<:!EO>ZPB(P=V](@W9+::N'5CU:/U-'U>OL
M5;QZX^(>SXG\&<QP:=CL83[2U;NQZEA5N+?:1%E\^;GF O<.- G@_$SAG77=
M(0/UXWWX+U!+ P04    " #G>)I6UDSU#T<$  !)"0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q]5FUOXC@0_BNC[&I%)0HDO)1V 8F^K Z=NE>5
MWNV'TWUPD@&L.G;.=DK[[V_&@=#V:+\X'MOSS#.>%V>R-?;1;1 ]/!=*NVFT
M\;Z\Z'9=ML%"N(XI4=/.RMA">!+MNNM*BR(/2H7J)KW>J%L(J:/9)*S=V=G$
M5%Y)C7<67%44PKY<HC+;:11'^X5[N=YX7NC.)J58XQ+]G^6=):G;H.2R0.VD
MT6!Q-8WF\<7E@,^' W])W+I7<V!/4F,>65CDTZC'A%!AYAE!T.<)KU I!B(:
M_^XPH\8D*[Z>[]%_!-_)EU0XO#+JE\S]9AJ-(\AQ)2KE[\WV-]SY,V2\S"@7
M1MC69T>C"++*>5/LE(E!(77]%<^[>WBE,.Y]H)#L%)+ NS846%X++V83:[9@
M^32A\22X&K2)G-0<E*6WM"M)S\]N;ZX75_/[&[B;WS_ -;0>1*K0G4RZGM#Y
M3#?;(5W62,D'2'VX-=IO'-SH'/.W^EUBU5!+]M0NDT\!;X7M0#]N0])+^I_@
M]1M7^P&O_P'>0KO*"ITA_#U/G;>4$/\<<[-&&1Q'X2*Y<*7(<!I1%3BT3QC-
MOGV)1[WOGW <-!P'GZ'/EE1T>:40S HNA0ILEZ$XYX6IM'<P=\YD4GC,X9?T
M&[C%7&;"(MP)Z^'ZF$.?FWS8(-5&9HI2Z!>IUY 9"J!V9(!FSBB9!VOICD[(
M-0=29ZK*$3RIKXRBXF9=L6,I#BRW1UB"\$#AS39-?$'H'*XQPR)%NU]-.G!U
MNZ2&D3J92W3=7+JL-B!UL.PY6R'EWO*&D4791)N1:?^4]DV!Y)3S!TA859RN
MD+X$4]3E8+N11&R+[$1%"MJ E>Z11%I4BK^I95 M:)>3(+.R##TFM]4:#B09
M;>=P29<')<UE)NFB#QYDY@DMM3]8B_(=&;91;@3UG@PK4A2**E]7*TK<RJ)U
M':#&!"+/)1NG7:GK+ETWS+6P.<?$5/8(RQ0UKB3Q: A('?+ YN'6CH6MS6V8
MPN,-_#0>(>$9.R$JXD#$KUXGS ^I"4D2KZ6G!>KDA[3)V5H 72S:L*!=&+<A
M.JK"U["LRE(%F5X.X$X7,0*[QGG"%U% W#O]O?,^K_Z74W#/P>3[;28M@BJD
M4G0Y[@3^((\L]5YKR1PG :?[5QB/:$CZYSP.>C2.SD?P8$5>ET\(>"E>0D(R
M95JT%3F*SR57DX-6/#@[@5:_/>X-Z1N/1CRVDSY]?U*%[RVVE!2I5-*_G-36
MH36*@^*05<X&T!H.>GN>RNCUJ4=R?\>TWSN#;U_&29Q\A_B\F;X_O3?"-= Z
M[Y\T!UMGXX/ O-Y9>,,OB0<'Q>'Y0?'!>(JB1G]$Z2O$PSZ->X]89I&].M9#
MNZ^>MP+M.CSBG+ATY_5+UZPV_PGS^GD\'*]_,B@YUM090.&*5'N=LV%$Q1T>
M[EKPI@R/96H\/;UANJ%_';1\@/97AA)_)["!YN]I]A]02P,$%     @ YWB:
M5J#FG&CT!   )0\  !D   !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL[5?;
M;MLX$/V5@5L4+9#:NEE2W,2 [:1MBC0)8N_F8;$/M#2VB4JD2U)ULE^_0TI6
MW,0QBMW7OI@7S>4,9P[-.=E(]4VO$ W<EX70IYV5,>M!KZ>S%99,=^4:!7U9
M2%4R0TNU[.FU0I8[I;+H!9X7]TK&16=XXO9NU/!$5J;@ F\4Z*HLF7H88R$W
MIQV_L]VXY<N5L1N]X<F:+7&*YH_UC:)5K[62\Q*%YE* PL5I9^0/QHF5=P)_
M<MSHG3G82.92?K.+B_RTXUE 6&!FK 5&PP^<8%%80P3C>V.ST[JTBKOSK?6/
M+G:*9<XT3F1QQW.S.NVD'<AQP:K"W,K-9VSBZ5M[F2RT^X5-+9M$'<@J;639
M*!."DHMZ9/?-.>PHI-X+"D&C$#C<M2.'\HP9-CQ1<@/*2I,U.W&A.FT"QX5-
MRM0H^LI)SPP_75^?W5U<7L+HZ@RN9Y_/;^'B:C:Z^G0QOCR'T71Z/IO"VQF;
M%ZC?G?0,N;2*O:PQ/Z[-!R^8#^&K%&:EX5SDF/^LWR.H+=Y@BW<<'#3XE:DN
MA/X1!%X0'K 7MO&'SE[X4OQ2YAM>%,!$#A?",+'D%"N,M$:CX8SKK)"Z4@A_
MC>;:**JBO_<=0^TEVN_%,FN@URS#TPY11Z/Z@9WAFU=^['TX$$/4QA =LCZ<
M$E/SBD#+!4Q6% %JX (F3*D'+I8P*F4EC/W:1CM^@%M<2V5L8F&*2^*9T?L"
M.^AZ?V [&,P*(=OB8"V.Y18'W2H@*T7T;L'H!HS[9O7-2B%"6=<1VCH"JH)L
MU98!;)#RPZQ&09>,'E B*65,9 @3,H7JCE@/,VE8 6\)54FNZ4K0[V#,"B?&
M#'QAHJ)K";9&7T-P%"4!C?%1G'@T'A_Y40"C['O%-;=WB@;?BX%D_"3=-?4$
MGK74)PEK*8D"9RD,/#B0^GZ;^OXOI_Z:#DL]K^$CVJ)KB@MN\/TE78'YOC0?
M=+,_S3/*37WB-KEU\MQ7F[P<#>.%MKAL?J7#QA^QL9I?7&1%93-*6:EE"BF6
M[REEY:.(JP*69;)<,^$J*9,4DM"D1S,M"YXS0XMYDP)W'>H]F; D/\,,RSEY
M:G:#P5.I9Q)PYRYW\C"1VE %9%59%<[E%?UO[MU\^QI^JK3K_2<PH I5AB]X
M1IKNN 1BOI,RJA;_R ]MU;QYE09^\&%GYZ4O7S$G@T2*@F?VG/2NP2"-6P4[
M?[J>N'\= DMGZRX\W8/C;@@/R)2&8S(?IWT(H@2.@V.(DQ""?@PSQ7($P4IR
M9H\Y[J:-AA]&Q!,?PA L?WPO@; /-TK^X/FN%_#];MSHD-&8Q+W'R944M@#0
M-/;3;M3(IA&$*40Q$/;(LY.:Z<]J[KCK-RJ6D7'DTYBFB3NUI!\UNZG;#>O=
MN'^(I7'+TOC_LY1N:2J$?RR-]A'TH(??!/U-T-\$?4[0I"5H\LL$/=>&EZY*
MMHQT[</Y_=HF:A\U#]K^#]2T?,0&A47$=G%@C8->3+;ELMKVG=22!QD1A70L
M(Q?T9T_5>F^HY<HRJEHK79_O,^8-GCR,/C:/KUJ<7EU6]RGO; ZHRF@6 548
MC7V@--%(B?;M2)44V#$%FNY+5&^G=:&27KH&35/-T4NQ[F+:W;8''-6MSZ-X
MW4!20$M.;[("%Z3J=1-ZTZBZ*:L71JY=(S27AOCCIBOJ8U%9 ?J^D-)L%]9!
MVQD/_P502P,$%     @ YWB:5C4EZX<I P  SP8  !D   !X;"]W;W)K<VAE
M971S+W-H965T,C<N>&ULC55_C]HX$/TJH_1T BG:)$Z@@0,DV-M55VKO4'?O
M3J>J?YAD(%8=.[6=I?OM;YP 9246G03XU[PW;^R98;;7YINM$!W\J*6R\Z!R
MKIE&D2TJK+F]T0TJ.MEJ4W-'2[.+;&.0EQVHEA&+XW%4<Z&"Q:S;6YO%3+=.
M"H5K [:M:VY>5BCU?AXDP7'CL]A5SF]$BUG#=_B([J]F;6@5G5A*4:.R0BLP
MN)T'RV2ZRKQ]9_"WP+T]FX./9*/U-[]X*.=![ 6AQ,)Y!D[#,]ZBE)Z(9'P_
M< 8GEQYX/C^RWW>Q4RP;;O%6RW]$Z:IYD =0XI:WTGW6^P]XB&?D^0HM;?<+
M^]XV(X]%:YVN#V!:UT+U(_]QN(<S0!Z_ 6 ' .MT]XXZE;]SQQ<SH_=@O#6Q
M^4D7:H<F<4+Y1WETADX%X=QB=??'W?W#TR.LE_\N5Q_O8/#$-Q+M<!8YHO=&
M47&@6O54[ VJ%#YIY2H+=ZK$\C4^(EDG;>RH;<6N$G[BY@;2) 06L_0*7WJ*
M->WXTC?X'I1M#5<%PI?EQCI#&?'U4I@]2W:9Q5?)U#:\P'E 96#1/&.P^/5=
M,HY_NZ(Q.VG,KK$O'JGJRE8BZ"TL?<8*]P)"P0H5;H6SL.8O_H$NZ;[*?%GW
MGU074&AEM10E=UCZ%!<VA'TEBHJJKC-5Y%>W!GY>H,4=5:8#16V#E*(4E)O<
MUQEA^9GNS5%WT^N&/;= GZV6U _\:,!52%^#"'6?0.@3".CY2<+Q_8&KTD_8
M%.[_-\;;PX!DU$)*+VX(*RY]!"1S@SNAE% ['T&#1N@2?H%)R,89C7G(\@E%
M7+3&$+%!V5V/TU.X]5L4_ MR XR%:1Y#,@DG^0C6Q&*Z PN#$6-#&*3C> A/
MVG%)]W%@8TF8CW(/&C,"<7'%P2#)0A:GQ)0PTI0-7SL9AY,X&?J1C=C14>,9
M!^0EB3,/S,-1.CZ/G6[K5=1)',9)WH6?OL_A4B)'9TVF1K/K6JFEY&F5Z_O-
M:??4K9=]D_IIWK=Z>B6Z>@L2MP2-;]Z/ C!]^^P73C==R]IH1PVPFU;TCX/&
M&]#Y5FMW7'@'I_^PQ7]02P,$%     @ YWB:5M7R7&1R P  L0<  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C@N>&ULC551;^(X$/XKH]SJM"LA$I( A04D
M:+G=/I1%T+U].-V#22;$JA/G;*=T__V-'<A1E;(G(6S',]]\W]@SGARD>M(Y
MHH&70I1ZZN7&5&/?UTF.!=-=66%).YE4!3.T5'M?5PI9ZIP*X8=!,/ +QDMO
M-G'?UFHVD;41O,2U ET7!5,_%RCD8>KUO-.'#=_GQG[P9Y.*[7&+YGNU5K3R
M6Y24%UAJ+DM0F$V]>6^\B*V],_B3XT&?S<$JV4GY9!?WZ=0++"$4F!B+P&AX
MQEL4P@(1C7^.F%X;TCJ>ST_H?SCMI&7'--Y*\8.G)I]Z-QZDF+%:F(T\?,6C
MGK[%2Z30[A\.C>V@[T%2:R.+HS,Q*'C9C.SEF(<SAYO@'8?PZ! ZWDT@Q_*.
M&3:;*'D 9:T)S4Z<5.=-Y'AI#V5K%.UR\C.SY7RSNE]]V<)ZN8';;P\/WU:P
M_3K?+.UB_?UQ_GA/7SX^LIU _6GB&XII/?WDB+]H\,-W\"-XD*7)-2S+%-/7
M_CYQ;0F')\*+\"K@ U-=B'H="(,PNH(7M0F('%[T7@*8*GFYU[!&!=N<*82_
MYCMM%-V7OR_I;>#BRW"VAL:Z8@E./2H2C>H9O=GOO_4&P><K9..6;'P-?;:E
MFDQK@2 SN$/#N-"PK:M**D,:X%8656V8N^YD\5;:)3U7(U[6TX2F0FXCFQPA
M>1V=:H4GP,H44BYJ@RG@B4]%?,BZ($/M,GY@&NB724%-PH[*(9I<(4+17""T
M%PCH^).\/7\'3Y-P#(^_M+5V\#&E&$QIX"65DQ!$5G< 7Q*LS%M>I)BJ6W^&
MLBYVM$FRW(9S-[FL-1'0GV!%W9.7Y(K GBDUMEJ<BA.:D<E3+D6*%/D#]#IA
M-*)Q% 7PP_4-8LN>45$;!.J<VA"L3>LQ&(4]!X)>V.\$09_&06<4W<"=33 U
M-\ LHVY']F-8%I60/RDEC8NL[+EHB&*( ]@@77">V+#-=C_L0SP:-+=$0ZUI
MQ\CCD>+_.$%+J3^(:1QVXF$,"W?Z[]N3^.ZH1\.P&X6-@*OXUOYFZ.S#$:S:
MXV"EX>E)_FNI]FZH-T(I78-P )>*T3]KHP6JO7LL-/&H2]-TU/9K^Q[-FS;\
MGWGSF-'5VW/B(# CUZ [I/:OF@>B61A9N::\DX9:O)OF]*:BL@:TGTEI3@L;
MH'VE9_\"4$L#!!0    ( .=XFE:@](:VMP(  ,8%   9    >&PO=V]R:W-H
M965T<R]S:&5E=#(Y+GAM;'U4;6_:,!#^*Z=LVE:I:D*@;PPB0<O4:JO*@&Z:
MIGTP\4&L.G%J.U#^_<X.9$RB?$G\<L]SS]E^KK=6^MEDB!9><UF8?I!96W;#
MT*09YLR<J1(+VEDHG3-+4[T,3:F1<0_*91A'T468,U$$2<^OC7724Y65HL"Q
M!E/E.=.;(4JU[@>M8+<P$<O,NH4PZ95LB5.T3^58TRQL6+C(L3!"%:!QT0\&
MK>ZPX^)]P ^!:[,W!E?)7*EG-[GG_2!R@E!B:AT#H]\*;U!*1T0R7K:<09/2
M ??'._8OOG:J9<X,WBCY4W";]8.K #@N6"7M1*WO<%O/N>-+E33^"^LZMD,9
MT\I8E6_!-,]%4?_9Z_8<]@!7T1N > N(O>XZD5=YRRQ+>EJM0;MH8G,#7ZI'
MDSA1N$N96DV[@G VF<X>;[[>/7Z['4VF'V'T_>E^]@L^S=A<HCGIA992N, P
MW=(-:[KX#;HV/*C"9@9&!4?^/SXD:8V^>*=O&!\E?&#Z#-JM4XBCN'V$K]W4
MV_9\[3?X1B^5L!OX/9@;J^E)_#E48TW1.4SA;-(U)4NQ'Y /#.H5!LF'=ZV+
MZ/,1@9U&8.<8>S(EV_%*(J@%W*)E0AH_%"O!L> P9AORA#6'=!]E/JQ[EB$L
ME"1OBF()UMT[E%JY9(9>=Y.?[_*7V_RG@*^IK+B#-9M(I[MBDO9!.SL8XM90
M%2LT%CG0:TZ?@:V9YH3GE79@=[$4PE&#JC0,%>T"*YT(@KQ43%O4<@,I,]F>
M#"5%NNG"!%.EFU.!0:XJ^LV491(^B8(L(R6YWYQ *P[;$36K.(96&%^&/N][
MB,XNKZ.(!M=7<.CZPCUOY:B7OH,82%V>VF;-:M.D!K4W_X77'8[>\E(4!B0N
M"$J)SX/ZF'83JTKOU+FRY'L_S*C1HG8!M+]0RNXF+D'3NI._4$L#!!0    (
M .=XFE;FGETV$00  "4*   9    >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM
M;'U6VX[;-A#]E8'B!@F@ZD))MNS8!O:2H"T:9)'=I@]%'VB)MH50HD-2ZVR_
MOD/J8LNK74"4>)DY<\Y0(W%Y%/*[VC.FX6?)*[5R]EH?%KZOLCTKJ?+$@56X
MLA6RI!J'<N>K@V0TMTXE]TD03/V2%I6S7MJY.[E>BEKSHF)W$E1=EE0^73,N
MCBLG=+J)K\5NK\V$OUX>Z([=,_W7X4[BR.]1\J)DE2I$!9)M5\Y5N+B.C;TU
M^%:PHSKK@U&R$>*[&?R>KYS $&*<9=H@4'P\LAO&N0%"&C]:3*</:1S/^QWZ
M)ZL=M6RH8C>"_UWD>K]R4@=RMJ4UUU_%\3?6ZDD,7B:XLG<X-K;QS(&L5EJ4
MK3,R*(NJ>=*?;1[.'-+@!0?2.A#+NPED6=Y23==+*8X@C36BF8Z5:KV17%&9
M3;G7$E<+]-/KVX_7#_#N@6XX4^^7OD9(L^!GK?MUXTY><(_@LZCT7L''*F?Y
MT-]'*CT?TO&Y)J\"?J;2@RAT@00D>@4OZO5%%B]Z21_;:+@M5,:%JB6#?ZXV
M2DM\%_X=$]M@Q>-8ICX6ZD SMG*P !23C\Q9OWT33H,/KS"->Z;Q:^CK>ZRW
MO.8,Q!9NJ)1/1;6#;Y37=L;J^%)KI6F5X\H8^U?QQ]D_[!ED7;#'+EAN@HE3
M,!<J_#S@0EW14DA=_,?RQJA0JJ95AB!":>7"D2K :RLX5CMV->"&9OM^1P$!
M44O&R@V3W2Q97%H]LX!W186O/^=8R>H]W.^1Q:^:R=+26,"-*$LFLX)R.- #
M.DX@)E.\)_,$[EE5" F5T$PM8!)Z"6P:*!<";YH$OT".PJ_J'=8;1"V'T(WC
MT-SG,W@0&I'5&<[8\I 4!@_==#K#)W&#.8$_1;4[YWQ!:QH$G4(7(B_M:'W)
MM#"I:#(1MYK,?7[A%'M)T&DYR(*W+@F:SFR;).?FB3?KS)OTAXWT*1A-;]^D
M)"0?8#)+SGQ"+^IX?6(;6>-WO$W8#&9Q8MNEDGDRC)*T]B^RNK"WYBF2BFT;
M$HHN19"&SARI1+8-X2,O),E@OUL^<P2?VC9TB+UTECQ+:A2TYLD%'^*%XPF*
MR(G1P"/QTO2YX,B8!C"+<)/)N7EZ"O!'7;&6?I0"F8:V3>(A_6FGMR\J&R F
M$*$"TX9\XM.&#5Z].&X88;L,D08C.QS/3@&2%]Z(P1;$9@LBVRXSE(P%2#!%
M8=R_J",U.G=-NE,WB6)X,(7'!:VPUFX9IT_F$R;I$72WX+81GH"D;:UUV(9_
M@]];JY%%/JAPK-&&@'D&2&'L)^&?_;KQ"[:S!Q2%G].ZTLU?O)_MST!7S:__
M9-X<H# WNP)Y<;9%UP#KR '9'$J:@18'>Q#8"(W'"MO=XSF.26. ZUN!66L'
M)D!_,ES_#U!+ P04    " #G>)I6%$(EUG<&  #H$@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970S,2YX;6RM6%MOVS84_BN$5Q0.H-8B=4\3 TF:MGE(8L39
M^C#L@;;H6*@DNA25RW[]/DJR8ENRVVX#8I,^.N?CN9&?PI,GJ;X52R$T><[2
MO#@=++5>'8]&Q7PI,EZ\ERN1X\E"JHQK_%0/HV*E!(\KHRP=,=OV1QE/\L'X
MI))-U/A$ECI-<C%1I"BSC*N7<Y'*I],!':P%=\G#4AO!:'RRX@]B*O3OJXG"
MKU&+$B>9R(M$YD2)Q>G@C!Z?NT:_4O@C$4_%QIR82&92?C,_KN+3@6T<$JF8
M:X/ ,3R*"Y&F!@AN?&\P!^V2QG!SOD;_5,6.6&:\$!<R_9K$>GDZ" <D%@M>
MIOI./GT133R>P9O+M*B^R5.MRZ(!F9>%EEEC# ^R)*]'_MSD8<,@M/<8L,:
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M/L(/,]<I'$J+'R%[SO<^@V(JRS1]+"ZNUN<#IT#$(K;B10@J_CVQ&8NB(I+
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M7'Y\8'3-LL) _'Z7IOS71?%"6_T"X_1_4$L#!!0    ( .=XFE9W@M[P#@0
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M<::$?DNUGQJ,[[^,9H^3T?TCS$;#IX?QXW@T@P]P3X0@:8;A[!85H:$\AW=
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M;4U4Y$-GOE \SN:V.5=Z"LQNEWI01Y$:Z/<+SM5FD08H1__!?U!+ P04
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MTC#&X4O*(:_(]66M&ZI&+G9R;NC,W5OI%!2\GX> "&';ZQINU:9N5 Z:O!@
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M=#L:3DB-7&(!2'+\DTL)\H0\,!6SC(RR%4B%+U'A,.0ID.,!*,H2-*F1N\F
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M3(PS>]_:GU<3;12^]E^'/,S/J!X^PU: AI[3&%H>?N(:U!*\Z..'<CWX<LB
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M/V4S40=4X/H&=7W)F'SLZ"-0?>2-_@)02P,$%     @ YWB:5L"=$;X@#
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MRX F><5@UB^O^(+ ?"("\W6VZNH7H(D:GV O?_@S59"LXNM%*BTLW:1O*X4
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M9=NQ81N?#2_1<B5U@^F-4KPD4R)?TV>NGLR"$D8Q243$$L3)8FS<VC>!X^B
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M?^#!H8[CBY4PQ2_L#[91 '%NK,H.8%*0<5G^LU^'0!P!B,</:!X S5- ^PU
MZP!H%8Z6R@JW[IAEXZ%6>]#.FMC<HHA-@29ON'1I7%A-3SGA[/CSY'X.3Y,O
MRT]P#0N^D7S-8R8M+*5:&=0[MA((]W*;6P,77W"' EJ7<'&'EG%A+@FU7-S!
MQ<=+^ A<P@,7@M)CAJ$E=>Z.,#XHF99*FF\H:<&#DC8U\$DFF+S&A^15Y5KS
MV;5ILY;P@>D;:#6NH!DU6QX]L_\/;];(:561;A5\K;<BS;B&)R9RO(*),4CQ
M?$!F<HT)T/L\QSC7FLL-3)GAYLJ3 &>C9,P%9^X3N((9$W$NB@U\FRLA@%[M
M/=/)=U_X2WEMOSQ7+F[-EL4X"J@>N(LQ&/_VH=&-?O?%[IW(7D6R746R7<<^
MGN*&2^E"M6*"R1B!6?B3R9SJ4'E)P^=_2=HM2%UUVXT;$1GNCMTZM^GV*Y-7
M8CN5V$YMVK\JRP1LJ* :4!J$HM2;6Y^^SGOFYYW(7KG<K5SNUN9G*:FA"/X/
MO=A4$91-44.L,KHI=?5_AW1,>_0%H63N'"?I)$7G%M=M?XIZE=Y>K=['7,<I
MM0)OT>K]IR"/1<\OJ%\)ZM<*6C#A%],_NRHZ$7-N<=WPBQE48@:U8KYJ)LV:
M4DA#@$_3H"X?I:ASD\BOJ1&]M*VHO@:\?/E4J..4*K6WY41G'_1@<*+.8],_
MU1<>==@,]:88/ R]U;FT94>J3JOA9E*T])/SJ1MZBL[]0E-.3.3&QA4)@6NB
MC&YZ%"]=#B'EQJIMT<=7RM)44"Q3&MQ0.P-ZOE;*/F_<!=4H./X74$L#!!0
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M886G8\$W0)AHC68.2F[*;-T-S<PR/BJAKU*=IZ;7ES</X.GR]M-OX .X+Q3
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M ]< =7W-F#P.]*>F_-/B^%]02P,$%     @ YWB:5JVJ5J,. P  %@L  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#8N>&ULM59M;]HP$/XK5E9-G=0U<8
M'42"TK5(?5-IU\\F.<!J8E/;0/OO9R<AI()D$Z5?$K\]SSUGG\_767'Q(F<
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M!LH3)5R\-XFW(X[33 !!& \7,  >>3(-M[D5YT#=_5QWW\KREDD2 &;N\@_
M94*:I*>@@P0T+M /4S3HP8GS4-1E#!KE026^@YSOP,IW_W#') U\B>ONPEU
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MC@NR9OI.5%?8^/ED^3+!E'M"U>0&'F1KI479@(V"DO+Z39Z;.NP #,]^0-@
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MVN!BN#9_*B"M@/F^%$+O)G:#^M]G]!]02P,$%     @ YWB:5K3#/Z=/!
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MHPT(9DZ_'#0^@<YG6KM7QZ]!\Q-+_P)02P,$%     @ YWB:5HB^U.Z9!0
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M0603 @XY6@(UCSW,@7,+,FG\;IE!]TDK/%T?Z1^==^-E0S7,)?_."JPFP?N
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MP$)PB(68R!*1]I2F5M2;60)@EL#-+$]RM\ER;Y>5LOAHG3RCH@F6-5TMH$F
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M'-:AYFX-C[G]7IFHPV/G4@0%TJ$#2<<,.@S6)SZI[I?6(8=;5:&"#I8UO6T
M="@NZ%!4T,&RIHL'T*$HH$--T.D,.5-P#@7.H=B<0^V<PXR(,P7F4, <V@=S
M>D0<$W1XQXX*-3G'+*I7%S"'#L2<\=NU;D^#!]P4@,, <!@NX#!4P,&RIHL'
MP&$H@,-,P.F:5;D=CA4$@,.P 8?9 <?8NW4['BL,^(9=V41J#]^(MX&!S.EY
MEO*#?,X/2?ZM7AR)K,*1]H[JYIEB)XHU#LHPW%&,"DQ8UG3Q $S,O:_5=Q3S
MWEL:;H=C!0$$,3<$C1C%H744$]J&!K?GL<J AIB;AGJ?Z+)L/S'[-*4NRIU%
M]>H"X[ K>TM]UD9B;ME&[8@Y2#M*M?(I]J<8$!6+<6,.*C9A6=//^@$V<?>N
M5\^84UOI,T]Q.QPK"%"(NU%H>,RI#1I+(W$[YK@]CU4&3,3[[%I=CSG</%'3
M-5'AYK;5E8D*!]+A TFG/5'AYIFP0%@%H1(.EC6]68!P."[A<%3"P;*FBV\<
M+48A'&X23M<\Q>UPK" @'(Y-.-Q..#PRHLT4A,.!<#@.X7"3<%AL/[7!3<(Q
MB^K5!<+A PE'.R-&V\LBP6E"%5L5H<(-EC6]70!N."[<<%2XP;*F'^('N E1
MX"8TX:9K0N5V.%80P$V(#3=A!]RTET7<CL<* [8)<=@FM)P6[CCA$IIL8Q;5
MJPML$PYG&V,^10*N'7"I)U36F./V-_@-DBD0)P3$"7$1)T1%'"QKNGA G! %
M<<+^B.-V.%90XU4H;,2I#1+6BCDD:#..V_58:< X(0[CA#;&">TWR\8X[:)Z
M=8%QPH&,8T8=-A<1-S:;J6]5A<HY6-;TM@'."7$Y)T3E'"QK^CM[P#D1"N=$
M)N=TOK8W!>=$P#D1-N?4!MLQAPEC7N5V/58:D$Z$0SJ123I=,2<R28<99V'T
MZ@+I1/_W?E4P)_;]*AI8A:&B#I8UO7D =2)<U(E040?+FBX>4"="09VH_WZ5
MV^%808 Z$3;J1/;5G( 846>2M[H;KW7CD$YDVZ^RSZ\BVWZ5<WX5 >E$ TDG
M,**.@*CSM\-.GCX]3;&H=179[7+PT)L"=R+ G0@7=R)4W,&RIK_5#[@C4'!'
MF+@3=,0=M\.Q@@!W!#;N"/NRCC#BCMOS6&5 .P*'=H1).T%H?XE F+1C%M6K
M"[0C!M(.L\RPPO.ZSJ-<RNVSS.O84X4>9D4>M]>AHP_+FMY&@#P"%WD$*O)@
M6=/% _((%.01)O*<WY,WNO,4R", >00V\@C[Z@X+C=4=M^NQTH!Y! [S")-Y
M:,=,2YC,8Q;5J]M(5C-\!\N(/;'U_25F?7_)[6_PP)L"> 0 C\ %'H$*/%C6
M](P_ #PQ"O#$_?>QW ['"@+@B;&!)[8##S,.Z;@]CU4&P!/C $]LV\CJN%>V
MC:QV4;VZ #PQ O (6WX59CT8Z'8W=-AA6=,;!T@GQB6=&)5TL*SIXH%T8A32
MB?N3CMOA6$% .C$VZ<3VQ1W6SM[D=CQ6&'!.C,,Y<7_.B0=S3@R<$P_?Q?)L
MQY"U;7-FW39WNQH\XB;)Z]=([(>+.#$JXF!9:V4,;*8,1(&<LYD^NUA77(X6
MU4@ Z&.#SMGB]>/(5WR/5A<TU.' SMF.OIEE7U8^E^7.LJTJ-W+X^</WL\;F
MDG.[&IZK<I(D@'XC"Z"/RSMG>V@-, 7Q$+^15]!'89ZSF5Y)Y=PN1XMJ) GT
ML;GG;/%Z8CFWZ]'B&DD _2OL4X6='[-D9]>!]&;Y6>TD"0+]1H9 7R /4%0^
M0C/7:H!&)D$?*96@;^82-$>FF430!(E6YM\&SEQ)@7SIF>HA\RC3Y)L:@ZL\
M>?..%4_5!Q_JY\PW+Q#=68BN^!F>%'B:E,C-G,C829&1LR)/0DW-O,A7$B/W
M[L3$)"&C$UO*7.W$#5JZDO+X(=MNU8-BH^J[3]0CPUY-7 R:)A=R,QDR0<8@
M=W;EX0TP"08UTRM?R:_\=/UK-<XF-*(/[(L)MK)FKJ93;1>-[WVIOG5'4?AZ
MLRN\5+ZH:_UY=4 H/WV/S>F7,ML?OPKF.2O+;'O\\54F*YE7!=3G+YDB_?J7
MZMME+E\G=/<_4$L#!!0    ( .=XFE8S'.Y0[ 4  - N   9    >&PO=V]R
M:W-H965T<R]S:&5E=#4V+GAM;+6:[V^C-AS&_Q4KZZ8[J4O !-)V::2VOFF5
MKEMUO=M>3'OA@).@ YP9I[F3]L?/_ B.4^I"],V]N +A^S%^" ]^8D^W7'S-
M5XQ)]"U-LOQZL))R?34:Y>&*I30?\C7+U"<++E(JU:Y8CO*U8#0JB])DA!TG
M&*4TS@:S:7GL4<RF?".3.&./ N6;-*7B^RU+^/9ZX YV!S[%RY4L#HQFTS5=
MLB<FOZP?A=H;-90H3EF6QSQ#@BVN!S?N%?&"HJ \X\^8;?.];51T9<[YUV+G
M/KH>.,45L82%LD!0]>>9W;$D*4CJ.OZMH8.FS:)P?WM'_[7LO.K,G.;LCB=_
MQ9%<70\N!BAB"[I)Y">^_8W5'?(+7LB3O/P?;>MSG0$*-[GD:5VLKB"-L^HO
M_58+L5>@..T%N"[ 70N\NL [+!B_4C"N"\:E,E572AT(E70V%7R+1'&VHA4;
MI9AEM>I^G!7W_4D*]6FLZN2,?+C]C'Y&3RR+N4"_<\ER](XP2>,D?Z\^^/)$
MT+NS]].15(T5):.P!M]68/P*V$4//).K''W((A:UU-_9ZSU+_4AULNDIWO7T
M%EN!#U0,D>>>(^Q@W'8]W<N]EG)R=.M&;[SFOGDESWOMOK&Y1/=9+L5&/842
M_?U1G8#N)4OS?]IN5D4;M],*<[G*US1DUP/E'CD3SVPP^^D'-W!^:5,*$D:
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M1E4E8M4Q<NW*LKDT6.2YY@K+:E!V +Y?2&EV'9N@*=0G_P)02P,$%     @
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M.B"_XP\*!W%TC#3*(V.?]<D\&CN>'A'$$$HM0=37$P00QUI)C>/?4M2I<NK
MX^,7]=]R> 7S2 0$+/Z31G(W=@8.BF!#]K%<L</O4 +UM%[(8I'_18?R7L]!
MX5Y(EI3!:@0)38MO\EP6XBB@VS\1@,L _"J@@T\$=,J 3@Y:C"S'NB.23$:<
M'1#7=RLU?9#7)H]6-#35T_@@N?J5JC@Y"3XN%O/U8K9</[Q#[S]-5]/E>C9[
M0-/E'0H^+M?SY?O9,IBK*S_=@20T%C^/7*D2ZW W+)/<%DGPB20^6K!4[@2:
MI1%$+?&!.;YCB'<5<$6-7ZAOL5'P#L(KU/'?(>QAC(0D$A#+=%_]DP&G+$*/
MD,*&AE2U=MMXS?(+PBOYSK%4D<H T*FFK9-GZ)[(L,:>?XUF1$BT@JT:=]ND
M&"7T^G C,A+"V%$+@ #^!,[DQQ_\OO=K&[$EL09MMZ+MYNJ=$[0?F! H4"U
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M JYO4+]O&),O)SI!M8<^^0]02P,$%     @ YWB:5JE#5L@$ P  - D  !D
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MZUQ,I'1%TTG=E?.I:7JZH;/6%Q#VD1MSN1&,8S$W AB6!W. <2P+R_,_S6>
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M_RGKH[6K/XX?GT5GFOXSGXW_[;EZ!U!+ 0(4 Q0    ( .=XFE8'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ YWB:5D7'KL/O    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ YWB:5IE<G",0!@  G"<  !,
M         ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #G
M>)I6$",MTB0%   F%0  &               @($."   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ YWB:5K:&N)6$!@  V!H  !@
M         ("!: T  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0
M   ( .=XFE;[/ V<-@,  $,*   8              " @2(4  !X;"]W;W)K
M<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #G>)I6V^8L4ST%  "2%
M&               @(&.%P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!
M A0#%     @ YWB:5HNF='7, P  H P  !@              ("! 1T  'AL
M+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( .=XFE;)N+WK)@@
M "]"   8              " @0,A  !X;"]W;W)K<VAE971S+W-H965T-BYX
M;6Q02P$"% ,4    " #G>)I6[D47=AT(   4)@  &               @(%?
M*0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ YWB:5J8%
M[LJL#   9R$  !@              ("!LC$  'AL+W=O<FMS:&5E=',O<VAE
M970X+GAM;%!+ 0(4 Q0    ( .=XFE8J@853&04  .X+   8
M  " @90^  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #G
M>)I6V)F43M0$  #A"@  &0              @('C0P  >&PO=V]R:W-H965T
M<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( .=XFE8ECF2_F H  '0=   9
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M970Q-2YX;6Q02P$"% ,4    " #G>)I60!LU.5P#  "S!P  &0
M    @($[;@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    (
M .=XFE8[93(R%08  $X.   9              " @<YQ  !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&UL4$L! A0#%     @ YWB:5D0D(V3P @  : 8  !D
M             ("!&G@  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"
M% ,4    " #G>)I6SB7/E5@(  !&%P  &0              @(%!>P  >&PO
M=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( .=XFE9'KR2[AQD
M -Y'   9              " @="#  !X;"]W;W)K<VAE971S+W-H965T,C N
M>&UL4$L! A0#%     @ YWB:5NT!(7WU#@  &2L  !D              ("!
MCIT  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #G>)I6
MR.S#LP8+  !5'0  &0              @(&ZK   >&PO=V]R:W-H965T<R]S
M:&5E=#(R+GAM;%!+ 0(4 Q0    ( .=XFE9\)[X#6 @  )D8   9
M      " @?>W  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%
M  @ YWB:5O)#R$[L!0  R \  !D              ("!AL   'AL+W=O<FMS
M:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #G>)I6UDSU#T<$  !)"0
M&0              @(&IQ@  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+
M 0(4 Q0    ( .=XFE:@YIQH] 0  "4/   9              " @2?+  !X
M;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ YWB:5C4EZX<I
M P  SP8  !D              ("!4M   'AL+W=O<FMS:&5E=',O<VAE970R
M-RYX;6Q02P$"% ,4    " #G>)I6U?)<9'(#  "Q!P  &0
M@(&RTP  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( .=X
MFE:@](:VMP(  ,8%   9              " @5O7  !X;"]W;W)K<VAE971S
M+W-H965T,CDN>&UL4$L! A0#%     @ YWB:5N:>7381!   )0H  !D
M         ("!2=H  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
M    " #G>)I6%$(EUG<&  #H$@  &0              @(&1W@  >&PO=V]R
M:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( .=XFE8M 67$ P0  +$5
M   9              " @3_E  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL
M4$L! A0#%     @ YWB:5IKDO/5P @  C@4  !D              ("!>>D
M 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #G>)I6;G>=
M6HP#   1#   &0              @($@[   >&PO=V]R:W-H965T<R]S:&5E
M=#,T+GAM;%!+ 0(4 Q0    ( .=XFE9;72XO< 8  ,PH   9
M  " @>/O  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @
MYWB:5G>"WO .!   !A   !D              ("!BO8  'AL+W=O<FMS:&5E
M=',O<VAE970S-BYX;6Q02P$"% ,4    " #G>)I6G%.NUL$'  #F-@  &0
M            @('/^@  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4
M Q0    ( .=XFE:E6Y:(]@(  *<(   9              " @<<" 0!X;"]W
M;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ YWB:5H!'O47O @
MRP<  !D              ("!] 4! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6Q02P$"% ,4    " #G>)I6$8N'JHL#  #^#@  &0              @($:
M"0$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( .=XFE;
MG1&^( P  %Z"   9              " @=P, 0!X;"]W;W)K<VAE971S+W-H
M965T-#$N>&UL4$L! A0#%     @ YWB:5A43>$3\!   0",  !D
M     ("!,QD! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .=XFE93--\<W04  /LA   9              "
M@80N 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ YWB:
M5O6CU+-] @  R04  !D              ("!F#0! 'AL+W=O<FMS:&5E=',O
M<VAE970T."YX;6Q02P$"% ,4    " #G>)I6A)%CGXL"  "(!@  &0
M        @(%,-P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0
M   ( .=XFE9T@B&0SP,   <-   9              " @0XZ 0!X;"]W;W)K
M<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ YWB:5K3#/Z=/!   ?Q
M !D              ("!%#X! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q0
M2P$"% ,4    " #G>)I6(;M#B$L"  #0!   &0              @(&:0@$
M>&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( .=XFE:(OM3N
MF04  &4N   9              " @1Q% 0!X;"]W;W)K<VAE971S+W-H965T
M-3,N>&UL4$L! A0#%     @ YWB:5E'24 A1 @  F 4  !D
M ("![$H! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " #G
M>)I6AP.WSA,+  !::   &0              @(%T30$ >&PO=V]R:W-H965T
M<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( .=XFE8S'.Y0[ 4  - N   9
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M970V,"YX;6Q02P$"% ,4    " #G>)I6MS!'6"84  #7P   &0
M    @($<;@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    (
M .=XFE9QW0!,6@,  /(5   -              "  7F" 0!X;"]S='EL97,N
M>&UL4$L! A0#%     @ YWB:5I>*NQS     $P(   L              ( !
M_H4! %]R96QS+RYR96QS4$L! A0#%     @ YWB:5AVE2'4F!0  ;R@   \
M             ( !YX8! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( .=X
MFE;U29+, 0(  %XD   :              "  3J, 0!X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( .=XFE;63,"2X $  .,C   3
M          "  7.. 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !% $4
*VA(  (20 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>370</ContextCount>
  <ElementCount>298</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>107</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTS</Role>
      <ShortName>BASIS OF PRESENTATION AND SIGNIFICANT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTS</Role>
      <ShortName>RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - ACQUISITIONS AND DIVESTITURES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - INVESTMENT SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIES</Role>
      <ShortName>INVESTMENT SECURITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - FAIR VALUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/FAIRVALUE</Role>
      <ShortName>FAIR VALUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - MEDICARE PART D</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/MEDICAREPARTD</Role>
      <ShortName>MEDICARE PART D</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - BENEFITS PAYABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/BENEFITSPAYABLE</Role>
      <ShortName>BENEFITS PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION</Role>
      <ShortName>EARNINGS PER COMMON SHARE COMPUTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - COMMITMENTS, GUARANTEES AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS, GUARANTEES AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT EVENTS (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSPolicies</Role>
      <ShortName>BASIS OF PRESENTATION AND SIGNIFICANT EVENTS (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - INVESTMENT SECURITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESTables</Role>
      <ShortName>INVESTMENT SECURITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/INVESTMENTSECURITIES</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - FAIR VALUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/FAIRVALUETables</Role>
      <ShortName>FAIR VALUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/FAIRVALUE</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - MEDICARE PART D (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/MEDICAREPARTDTables</Role>
      <ShortName>MEDICARE PART D (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/MEDICAREPARTD</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - BENEFITS PAYABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/BENEFITSPAYABLETables</Role>
      <ShortName>BENEFITS PAYABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/BENEFITSPAYABLE</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables</Role>
      <ShortName>EARNINGS PER COMMON SHARE COMPUTATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/DEBT</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails</Role>
      <ShortName>BASIS OF PRESENTATION AND SIGNIFICANT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails</Role>
      <ShortName>RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTS</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - ACQUISITIONS AND DIVESTITURES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - INVESTMENT SECURITIES - Securities Classified as Current and Long-Term (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails</Role>
      <ShortName>INVESTMENT SECURITIES - Securities Classified as Current and Long-Term (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - INVESTMENT SECURITIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails</Role>
      <ShortName>INVESTMENT SECURITIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - INVESTMENT SECURITIES - Gross Unrealized Losses and Fair Values of Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails</Role>
      <ShortName>INVESTMENT SECURITIES - Gross Unrealized Losses and Fair Values of Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - INVESTMENT SECURITIES - Gains (Losses) Within Investment Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails</Role>
      <ShortName>INVESTMENT SECURITIES - Gains (Losses) Within Investment Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - INVESTMENT SECURITIES - Gains and Losses Related to Equity Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails</Role>
      <ShortName>INVESTMENT SECURITIES - Gains and Losses Related to Equity Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - INVESTMENT SECURITIES - Contractual Maturities of Debt Securities Available for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails</Role>
      <ShortName>INVESTMENT SECURITIES - Contractual Maturities of Debt Securities Available for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - FAIR VALUE - Financial Assets Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE - Financial Assets Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - FAIR VALUE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/FAIRVALUENarrativeDetails</Role>
      <ShortName>FAIR VALUE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - FAIR VALUE - Significant Unobservable Inputs (Level 3) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details</Role>
      <ShortName>FAIR VALUE - Significant Unobservable Inputs (Level 3) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - FAIR VALUE - Put and Call Options Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails</Role>
      <ShortName>FAIR VALUE - Put and Call Options Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - MEDICARE PART D (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/MEDICAREPARTDDetails</Role>
      <ShortName>MEDICARE PART D (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/MEDICAREPARTDTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Goodwill by Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Goodwill by Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Other Intangible Assets Subject to Amortization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Other Intangible Assets Subject to Amortization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Amortization and Estimated Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Amortization and Estimated Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - BENEFITS PAYABLE - Activity in Benefits Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails</Role>
      <ShortName>BENEFITS PAYABLE - Activity in Benefits Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails</Role>
      <ShortName>EARNINGS PER COMMON SHARE COMPUTATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - STOCKHOLDERS' EQUITY - Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/STOCKHOLDERSEQUITYDividendsDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/INCOMETAXES</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - DEBT - Debt Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DEBTDebtOutstandingDetails</Role>
      <ShortName>DEBT - Debt Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - DEBT - Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.humana.com/role/DEBTSeniorNotesDetails</Role>
      <ShortName>DEBT - Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - DEBT - Revolving Credit Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails</Role>
      <ShortName>DEBT - Revolving Credit Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - DEBT - Commercial Paper and Other Short-term Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails</Role>
      <ShortName>DEBT - Commercial Paper and Other Short-term Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - COMMITMENTS, GUARANTEES AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS, GUARANTEES AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - SEGMENT INFORMATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails</Role>
      <ShortName>SEGMENT INFORMATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="hum-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - SEGMENT INFORMATION - Segment Results (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails</Role>
      <ShortName>SEGMENT INFORMATION - Segment Results (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: hum:TRICAREManagedCareSupportContractBaseTerm, us-gaap:CommonStockParOrStatedValuePerShare -  hum-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="hum-20230331.htm">hum-20230331.htm</File>
    <File>hum-20230331.xsd</File>
    <File>hum-20230331_cal.xml</File>
    <File>hum-20230331_def.xml</File>
    <File>hum-20230331_lab.xml</File>
    <File>hum-20230331_pre.xml</File>
    <File>hum-20230331xex31x1.htm</File>
    <File>hum-20230331xex31x2.htm</File>
    <File>hum-20230331xex32.htm</File>
    <File>humanaseverancepolicyfinal.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1086">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>79
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hum-20230331.htm": {
   "axisCustom": 1,
   "axisStandard": 27,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1086,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 370,
   "dts": {
    "calculationLink": {
     "local": [
      "hum-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "hum-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "hum-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hum-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hum-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hum-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 550,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 4,
    "http://www.humana.com/20230331": 1,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 10
   },
   "keyCustom": 35,
   "keyStandard": 263,
   "memberCustom": 55,
   "memberStandard": 51,
   "nsprefix": "hum",
   "nsuri": "http://www.humana.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.humana.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - ACQUISITIONS AND DIVESTITURES",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES",
     "shortName": "ACQUISITIONS AND DIVESTITURES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - INVESTMENT SECURITIES",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIES",
     "shortName": "INVESTMENT SECURITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - FAIR VALUE",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.humana.com/role/FAIRVALUE",
     "shortName": "FAIR VALUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:MedicarePartDDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - MEDICARE PART D",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.humana.com/role/MEDICAREPARTD",
     "shortName": "MEDICARE PART D",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:MedicarePartDDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - BENEFITS PAYABLE",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.humana.com/role/BENEFITSPAYABLE",
     "shortName": "BENEFITS PAYABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION",
     "shortName": "EARNINGS PER COMMON SHARE COMPUTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - STOCKHOLDERS' EQUITY",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.humana.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.humana.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - DEBT",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.humana.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - COMMITMENTS, GUARANTEES AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES",
     "shortName": "COMMITMENTS, GUARANTEES AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - SEGMENT INFORMATION",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.humana.com/role/SEGMENTINFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT EVENTS (Policies)",
     "menuCat": "Policies",
     "order": "22",
     "role": "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSPolicies",
     "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT EVENTS (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - INVESTMENT SECURITIES (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESTables",
     "shortName": "INVESTMENT SECURITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - FAIR VALUE (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.humana.com/role/FAIRVALUETables",
     "shortName": "FAIR VALUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - MEDICARE PART D (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.humana.com/role/MEDICAREPARTDTables",
     "shortName": "MEDICARE PART D (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - BENEFITS PAYABLE (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.humana.com/role/BENEFITSPAYABLETables",
     "shortName": "BENEFITS PAYABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables",
     "shortName": "EARNINGS PER COMMON SHARE COMPUTATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsDeclaredTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.humana.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsDeclaredTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - DEBT (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.humana.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - SEGMENT INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.humana.com/role/SEGMENTINFORMATIONTables",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i2449d3dd94054171a333473a8b30e8d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:DiscontinuedOperationsSegmentPhaseOutPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT EVENTS (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails",
     "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i2449d3dd94054171a333473a8b30e8d9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:DiscontinuedOperationsSegmentPhaseOutPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i6dfc221ac14a4241a352cd2c7e2133be_D20230101-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails",
     "shortName": "RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i6dfc221ac14a4241a352cd2c7e2133be_D20230101-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "iec2ff4cf5f8a4840a5cfda8104745276_I20220811",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - ACQUISITIONS AND DIVESTITURES (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "iec2ff4cf5f8a4840a5cfda8104745276_I20220811",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - INVESTMENT SECURITIES - Securities Classified as Current and Long-Term (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails",
     "shortName": "INVESTMENT SECURITIES - Securities Classified as Current and Long-Term (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - INVESTMENT SECURITIES - Narrative (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails",
     "shortName": "INVESTMENT SECURITIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "2",
      "lang": "en-US",
      "name": "hum:MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - INVESTMENT SECURITIES - Gross Unrealized Losses and Fair Values of Securities (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails",
     "shortName": "INVESTMENT SECURITIES - Gross Unrealized Losses and Fair Values of Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRealizedGainLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "hum:DebtSecuritiesRealizedGainGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - INVESTMENT SECURITIES - Gains (Losses) Within Investment Income (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails",
     "shortName": "INVESTMENT SECURITIES - Gains (Losses) Within Investment Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRealizedGainLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "hum:DebtSecuritiesRealizedGainGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - INVESTMENT SECURITIES - Gains and Losses Related to Equity Securities (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails",
     "shortName": "INVESTMENT SECURITIES - Gains and Losses Related to Equity Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - INVESTMENT SECURITIES - Contractual Maturities of Debt Securities Available for Sale (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails",
     "shortName": "INVESTMENT SECURITIES - Contractual Maturities of Debt Securities Available for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - FAIR VALUE - Financial Assets Measured on Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
     "shortName": "FAIR VALUE - Financial Assets Measured on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i96e6af2307314f46be9d1d0b03502013_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - FAIR VALUE - Narrative (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.humana.com/role/FAIRVALUENarrativeDetails",
     "shortName": "FAIR VALUE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i8aecae41941c4949a148814d02c27b4c_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i192cbe1b72e34457bc41adff9b0e5179_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - FAIR VALUE - Significant Unobservable Inputs (Level 3) (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details",
     "shortName": "FAIR VALUE - Significant Unobservable Inputs (Level 3) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib841b2af88bc479392f83bdf0da74d8a_I20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetLiabilityNetMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - FAIR VALUE - Put and Call Options Measured at Fair Value (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails",
     "shortName": "FAIR VALUE - Put and Call Options Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib841b2af88bc479392f83bdf0da74d8a_I20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetLiabilityNetMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - MEDICARE PART D (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.humana.com/role/MEDICAREPARTDDetails",
     "shortName": "MEDICARE PART D (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i17047b60198b4741bd5ebeea3412295e_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i192cbe1b72e34457bc41adff9b0e5179_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Goodwill by Segments (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Goodwill by Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Other Intangible Assets Subject to Amortization (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Other Intangible Assets Subject to Amortization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AmortizationOfIntangibleAssets",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AmortizationOfIntangibleAssets",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Amortization and Estimated Future Amortization Expense (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Amortization and Estimated Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i192cbe1b72e34457bc41adff9b0e5179_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - BENEFITS PAYABLE - Activity in Benefits Payable (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails",
     "shortName": "BENEFITS PAYABLE - Activity in Benefits Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "if66f7e3bde694a2fa6f2b9ad88e258ff_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails",
     "shortName": "EARNINGS PER COMMON SHARE COMPUTATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i0b9ac383e9ea4b719311556136d97415_D20230127-20230127",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - STOCKHOLDERS' EQUITY - Dividends (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.humana.com/role/STOCKHOLDERSEQUITYDividendsDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i0b9ac383e9ea4b719311556136d97415_D20230127-20230127",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i855926020dce4bea9a6964c5647f3657_D20230201-20230228",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i855926020dce4bea9a6964c5647f3657_D20230201-20230228",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - INCOME TAXES (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.humana.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - DEBT - Debt Outstanding (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.humana.com/role/DEBTDebtOutstandingDetails",
     "shortName": "DEBT - Debt Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i2f93bb52470a423f83007bbe6311ef88_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - DEBT - Senior Notes (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.humana.com/role/DEBTSeniorNotesDetails",
     "shortName": "DEBT - Senior Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ib0b3e6cb82b043229c6de3f534953330_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRepurchasedFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ia699014a8a7c45b4877ccab91d786647_I20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "hum:DebtInstrumentCovenantDebtToCapitalizationPercentageActual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - DEBT - Revolving Credit Agreements (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
     "shortName": "DEBT - Revolving Credit Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "ia699014a8a7c45b4877ccab91d786647_I20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "hum:DebtInstrumentCovenantDebtToCapitalizationPercentageActual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i1cfe16f46375489ab53b2a64c31248d4_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShorttermDebtMaximumAmountOutstandingDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - DEBT - Commercial Paper and Other Short-term Borrowings (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails",
     "shortName": "DEBT - Commercial Paper and Other Short-term Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i1cfe16f46375489ab53b2a64c31248d4_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShorttermDebtMaximumAmountOutstandingDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i2ff845a818d94f94ab5d91f1b9bd6c7e_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hum:NumberOfStatesComprisingTRICAREBeneficiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - COMMITMENTS, GUARANTEES AND CONTINGENCIES (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS, GUARANTEES AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i2ff845a818d94f94ab5d91f1b9bd6c7e_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hum:NumberOfStatesComprisingTRICAREBeneficiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "id52b99f262dd4f5fbc64485fdc490c62_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "id52b99f262dd4f5fbc64485fdc490c62_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i05af7d59e35843539a7b53e907c4cb75_D20221201-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - SEGMENT INFORMATION - Narrative (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails",
     "shortName": "SEGMENT INFORMATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i05af7d59e35843539a7b53e907c4cb75_D20221201-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - SEGMENT INFORMATION - Segment Results (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails",
     "shortName": "SEGMENT INFORMATION - Segment Results (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetInvestmentIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT EVENTS",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTS",
     "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTS",
     "shortName": "RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20230331.htm",
      "contextRef": "i4cda7d03bcb749d582cb1599def4ec24_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 107,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "hum_A065PercentSeniorNotesDueAugust2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.65 Percent Senior Notes Due August 2023",
        "label": "0.65 Percent Senior Notes Due August 2023 [Member]",
        "terseLabel": "$1.5\u00a0billion, 0.650% due August 3, 2023"
       }
      }
     },
     "localname": "A065PercentSeniorNotesDueAugust2023Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A135PercentSeniorNotesDueFebruary2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.35 Percent Senior Notes Due February 2027",
        "label": "1.35 Percent Senior Notes Due February 2027 [Member]",
        "terseLabel": "$750\u00a0million, 1.350% due February 3, 2027"
       }
      }
     },
     "localname": "A135PercentSeniorNotesDueFebruary2027Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A2021ShareRepurchaseAuthorizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Share Repurchase Authorization",
        "label": "2021 Share Repurchase Authorization [Member]",
        "terseLabel": "2021 Share Repurchase Authorization"
       }
      }
     },
     "localname": "A2021ShareRepurchaseAuthorizationMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A2023ShareRepurchaseAuthorizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2023 Share Repurchase Authorization",
        "label": "2023 Share Repurchase Authorization [Member]",
        "terseLabel": "2023 Share Repurchase Authorization"
       }
      }
     },
     "localname": "A2023ShareRepurchaseAuthorizationMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A215PercentSeniorNotesDueFebruary2032Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.15 Percent Senior Notes Due February 2032",
        "label": "2.15 Percent Senior Notes Due February 2032 [Member]",
        "terseLabel": "$750\u00a0million, 2.150% due February 3, 2032"
       }
      }
     },
     "localname": "A215PercentSeniorNotesDueFebruary2032Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A3.85PercentSeniorNotesDueOctober2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.85 Percent Senior Notes Due October 2024 [Member]",
        "label": "3.85 Percent Senior Notes Due October 2024 [Member]",
        "terseLabel": "$600\u00a0million, 3.850% due October 1, 2024"
       }
      }
     },
     "localname": "A3.85PercentSeniorNotesDueOctober2024Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A3.95PercentSeniorNotesDueMarch2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.95 Percent Senior Notes Due March 2027 [Member]",
        "label": "3.95 Percent Senior Notes Due March 2027 [Member]",
        "terseLabel": "$600\u00a0million, 3.950% due March 15, 2027"
       }
      }
     },
     "localname": "A3.95PercentSeniorNotesDueMarch2027Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A3125PercentSeniorNotesDueAugust2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A 3.125 Percent Senior Notes Due August 2029 [Member]",
        "label": "3.125 Percent Senior Notes Due August 2029 [Member]",
        "terseLabel": "$500\u00a0million, 3.125% due August 15, 2029"
       }
      }
     },
     "localname": "A3125PercentSeniorNotesDueAugust2029Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A3700PercentSeniorNotesDueMarch2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.700 Percent Senior Notes Due March 2029",
        "label": "3.700 Percent Senior Notes Due March 2029 [Member]",
        "terseLabel": "$750 million, 3.700% due March 23, 2029"
       }
      }
     },
     "localname": "A3700PercentSeniorNotesDueMarch2029Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A395PercentSeniorNotesDueAugust2049Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.95 Percent Senior Notes Due August 2049 [Member]",
        "label": "3.95 Percent Senior Notes Due August 2049 [Member]",
        "terseLabel": "$500 million, 3.950% due August 15, 2049"
       }
      }
     },
     "localname": "A395PercentSeniorNotesDueAugust2049Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A4.625PercentSeniorNotesDueDecember2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.625 Percent Senior Notes Due December 2042 [Member]",
        "label": "4.625 Percent Senior Notes Due December 2042 [Member]",
        "terseLabel": "$400\u00a0million, 4.625% due December\u00a01, 2042"
       }
      }
     },
     "localname": "A4.625PercentSeniorNotesDueDecember2042Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A4.80PercentSeniorNotesDueMarch2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.80 Percent Senior Notes Due March 2047 [Member]",
        "label": "4.80 Percent Senior Notes Due March 2047 [Member]",
        "terseLabel": "$400\u00a0million, 4.800% due March 15, 2047"
       }
      }
     },
     "localname": "A4.80PercentSeniorNotesDueMarch2047Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A4.95PercentSeniorNotesDueOctober2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.95 Percent Senior Notes Due October 2044 [Member]",
        "label": "4.95 Percent Senior Notes Due October 2044 [Member]",
        "terseLabel": "$750\u00a0million, 4.950% due October 1, 2044"
       }
      }
     },
     "localname": "A4.95PercentSeniorNotesDueOctober2044Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A450PercentSeniorNotesDueApril2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A 4.50 Percent Senior Notes Due April 2025 [Member]",
        "label": "4.50 Percent Senior Notes Due April 2025 [Member]",
        "terseLabel": "$600\u00a0million, 4.500% due April 1, 2025"
       }
      }
     },
     "localname": "A450PercentSeniorNotesDueApril2025Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A4875PercentSeniorNotesDueApril2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A 4.875 Percent Senior Notes Due April 2030 [Member]",
        "label": "4.875 Percent Senior Notes Due April 2030 [Member]",
        "terseLabel": "$500\u00a0million, 4.875% due April 1, 2030"
       }
      }
     },
     "localname": "A4875PercentSeniorNotesDueApril2030Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A550PercentSeniorNotesDueMarch2053Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.50 Percent Senior Notes Due March 2053",
        "label": "5.50 Percent Senior Notes Due March 2053 [Member]",
        "terseLabel": "$750 million, 5.500% due March 15, 2053"
       }
      }
     },
     "localname": "A550PercentSeniorNotesDueMarch2053Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.70 Percent Senior Notes Due March 2026 And 5.50 Percent Senior Notes Due March 2053",
        "label": "5.70 Percent Senior Notes Due March 2026 And 5.50 Percent Senior Notes Due March 2053 [Member]",
        "terseLabel": "5.70 Percent Senior Notes Due March 2026 and 5.50 Percent Senior Notes Due March 2053"
       }
      }
     },
     "localname": "A570PercentSeniorNotesDueMarch2026And550PercentSeniorNotesDueMarch2053Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A570PercentSeniorNotesDueMarch2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.70 Percent Senior Notes Due March 2026",
        "label": "5.70 Percent Senior Notes Due March 2026 [Member]",
        "terseLabel": "$500 million, 5.700% due March 13, 2026"
       }
      }
     },
     "localname": "A570PercentSeniorNotesDueMarch2026Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A5750PercentSeniorNotesDueMarch2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.750 Percent Senior Notes Due March 2028",
        "label": "5.750 Percent Senior Notes Due March 2028 [Member]",
        "terseLabel": "$500 million, 5.750% due March 1, 2028"
       }
      }
     },
     "localname": "A5750PercentSeniorNotesDueMarch2028Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A588PercentSeniorNotesDueMarch2033Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.88 Percent Senior Notes Due March 2033",
        "label": "5.88 Percent Senior Notes Due March 2033 [Member]",
        "terseLabel": "$750 million, 5.880% due March 1, 2033"
       }
      }
     },
     "localname": "A588PercentSeniorNotesDueMarch2033Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A8.15PercentSeniorNotesDueJune2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "8.15 Percent Senior Notes Due June 2038 [Member]",
        "label": "8.15 Percent Senior Notes Due June 2038 [Member]",
        "terseLabel": "$250\u00a0million, 8.150% due June\u00a015, 2038"
       }
      }
     },
     "localname": "A8.15PercentSeniorNotesDueJune2038Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance Sheet Account Associated With Medicare Part D",
        "label": "Balance Sheet Account Associated With Medicare Part D Table [Table Text Block]",
        "terseLabel": "Schedule of Balance Sheet Amounts Associated With Medicare Part D"
       }
      }
     },
     "localname": "BalanceSheetAccountAssociatedWithMedicarePartDTableTableTextBlock",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_BookOverdraftLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Book Overdraft Liability",
        "label": "Book Overdraft Liability",
        "terseLabel": "Book overdraft"
       }
      }
     },
     "localname": "BookOverdraftLiability",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_CenterWellSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CenterWell Segment",
        "label": "CenterWell Segment [Member]",
        "terseLabel": "CenterWell"
       }
      }
     },
     "localname": "CenterWellSegmentMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_CertificateOfNeedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certificate Of Need",
        "label": "Certificate Of Need [Member]",
        "terseLabel": "Certificates of need"
       }
      }
     },
     "localname": "CertificateOfNeedMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_CmsSubsidiesOrDiscountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CMS Subsidies Or Discounts [Member]",
        "label": "Cms Subsidies Or Discounts [Member]",
        "terseLabel": "CMS Subsidies/ Discounts"
       }
      }
     },
     "localname": "CmsSubsidiesOrDiscountsMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_CommercialASOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial ASO",
        "label": "Commercial ASO [Member]",
        "terseLabel": "Commercial ASO"
       }
      }
     },
     "localname": "CommercialASOMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_CommercialFullyInsuredMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Fully-Insured",
        "label": "Commercial Fully-Insured [Member]",
        "terseLabel": "Commercial fully-insured"
       }
      }
     },
     "localname": "CommercialFullyInsuredMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_CorporateAndEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate And Eliminations [Member]",
        "label": "Corporate And Eliminations [Member]",
        "terseLabel": "Eliminations/ Corporate"
       }
      }
     },
     "localname": "CorporateAndEliminationsMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Debt To Capitalization Percentage, Actual",
        "label": "Debt Instrument, Covenant, Debt To Capitalization Percentage, Actual",
        "terseLabel": "Actual debt to capitalization percentage"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDebtToCapitalizationPercentageActual",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Debt To Capitalization Percentage, Maximum",
        "label": "Debt Instrument, Covenant, Debt To Capitalization Percentage, Maximum",
        "terseLabel": "Debt to capitalization percentage, maximum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Securities, Number Of Positions",
        "label": "Debt, Securities, Available-For-Sale, Securities, Number Of Positions",
        "terseLabel": "Securities, number of positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_DebtSecuritiesRealizedGainGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndEquitySecuritiesGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Realized Gain, Gross",
        "label": "Debt Securities, Realized Gain, Gross",
        "terseLabel": "Gross gains on investment securities"
       }
      }
     },
     "localname": "DebtSecuritiesRealizedGainGross",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_DebtSecuritiesRealizedLossGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndEquitySecuritiesGainLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Realized Loss, Gross",
        "label": "Debt Securities, Realized Loss, Gross",
        "negatedTerseLabel": "Gross losses on investment securities"
       }
      }
     },
     "localname": "DebtSecuritiesRealizedLossGross",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_DelayedDrawTermLoanMay2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Delayed Draw Term Loan May 2024",
        "label": "Delayed Draw Term Loan May 2024 [Member]",
        "terseLabel": "Delayed draw term loan, due May 28, 2024"
       }
      }
     },
     "localname": "DelayedDrawTermLoanMay2024Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_DelayedDrawTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Delayed Draw Term Loan",
        "label": "Delayed Draw Term Loan [Member]",
        "terseLabel": "Delayed Draw Term Loan"
       }
      }
     },
     "localname": "DelayedDrawTermLoanMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_DepreciationAndAmortizationClassifiedAsBenefitExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation and amortization expense that has been reclassified to be included with benefit expenses. The reclassification is the result of depreciation and amortization expense associated primarily from the delivery of pharmacy services by our wholly-owned pharmacy business included in our Healthcare Services segment.",
        "label": "Depreciation And Amortization Classified As Benefit Expense",
        "terseLabel": "Depreciation and amortization classified as benefit expense"
       }
      }
     },
     "localname": "DepreciationAndAmortizationClassifiedAsBenefitExpense",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_DepreciationAndAmortizationIncomeStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation and amortization expense excluding depreciation and amortization primarily from the delivery of pharmacy services by our wholly-owned pharmacy business (included in our Healthcare Services segment) which has been reclassified to benefit expenses.",
        "label": "Depreciation And Amortization Income Statement",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortizationIncomeStatement",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_DiscontinuedOperationsSegmentPhaseOutPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discontinued Operations, Segment Phase Out Period",
        "label": "Discontinued Operations, Segment Phase Out Period",
        "terseLabel": "Business segment phase out period"
       }
      }
     },
     "localname": "DiscontinuedOperationsSegmentPhaseOutPeriod",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Equity Interest Sold",
        "label": "Disposal Group, Including Discontinued Operation, Equity Interest Sold",
        "terseLabel": "Equity interest to be sold"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationEquityInterestSold",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss)",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) [Abstract]",
        "terseLabel": "Total gains or losses:"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "hum_FairValueRiskMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Risk",
        "label": "Fair Value Risk [Member]",
        "terseLabel": "Fair Value Risk"
       }
      }
     },
     "localname": "FairValueRiskMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_FinancialAssetsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Assets, Fair Value Disclosure",
        "label": "Financial Assets, Fair Value Disclosure",
        "terseLabel": "Fair value of financial asset"
       }
      }
     },
     "localname": "FinancialAssetsFairValueDisclosure",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_GentivaHospiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gentiva Hospice",
        "label": "Gentiva Hospice [Member]",
        "terseLabel": "Gentiva Hospice"
       }
      }
     },
     "localname": "GentivaHospiceMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_GovernmentAndHealthPlanMemberSubsidiesAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of member co-share amounts and government subsidies that are excluded from benefits expense because the health plans do not bear responsibility.",
        "label": "Government And Health Plan Member Subsidies Amount",
        "terseLabel": "Member co-share amounts and government subsidies"
       }
      }
     },
     "localname": "GovernmentAndHealthPlanMemberSubsidiesAmount",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_GroupMedicareAdvantageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Group Medicare Advantage",
        "label": "Group Medicare Advantage [Member]",
        "terseLabel": "Group Medicare Advantage"
       }
      }
     },
     "localname": "GroupMedicareAdvantageMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_HomeSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Home Solutions",
        "label": "Home Solutions [Member]",
        "terseLabel": "Home solutions"
       }
      }
     },
     "localname": "HomeSolutionsMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails": {
       "order": 2.0,
       "parentTag": "hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) From Continuing Operations Before Income Taxes, Attributable To Noncontrolling Interest",
        "label": "Income (Loss) From Continuing Operations Before Income Taxes, Attributable To Noncontrolling Interest",
        "negatedTerseLabel": "Net loss (income) attributable to noncontrolling interests"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) From Continuing Operations Before Income Taxes, Attributable To Parent",
        "label": "Income (Loss) From Continuing Operations Before Income Taxes, Attributable To Parent",
        "totalLabel": "Segment earnings (loss) attributable to Humana"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_InsuranceSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance Segment",
        "label": "Insurance Segment [Member]",
        "terseLabel": "Insurance"
       }
      }
     },
     "localname": "InsuranceSegmentMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_LineOfCreditFacilityUncommittedIncrementalCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Uncommitted Incremental Capacity",
        "label": "Line Of Credit Facility, Uncommitted Incremental Capacity",
        "terseLabel": "Uncommitted incremental loan facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityUncommittedIncrementalCapacity",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Individual State General Bond Obligation, As Percentage Of Total Debt Securities",
        "label": "Maximum Individual State General Bond Obligation, As Percentage Of Total Debt Securities",
        "terseLabel": "Maximum individual state general bond obligation as a percentage of total debt securities (percent)"
       }
      }
     },
     "localname": "MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_MedicaidAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and Other [Member]",
        "label": "Medicaid And Other [Member]",
        "terseLabel": "Medicaid and other"
       }
      }
     },
     "localname": "MedicaidAndOtherMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid [Member]",
        "label": "Medicaid [Member]",
        "terseLabel": "Medicaid"
       }
      }
     },
     "localname": "MedicaidMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MedicareAdvantageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Advantage [Member]",
        "label": "Medicare Advantage [Member]",
        "verboseLabel": "Individual Medicare Advantage"
       }
      }
     },
     "localname": "MedicareAdvantageMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MedicareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare [Member]",
        "label": "Medicare [Member]",
        "terseLabel": "Total Medicare",
        "verboseLabel": "Medicare"
       }
      }
     },
     "localname": "MedicareMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MedicarePartDDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance sheet amounts associated with Medicare Part D.",
        "label": "Medicare Part D Disclosure [Text Block]",
        "terseLabel": "MEDICARE PART D"
       }
      }
     },
     "localname": "MedicarePartDDisclosureTextBlock",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTD"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_MedicareStandAlonePrescriptionDrugPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Stand Alone Prescription Drug Plan [Member]",
        "label": "Medicare Stand Alone Prescription Drug Plan [Member]",
        "terseLabel": "Medicare stand-alone PDP"
       }
      }
     },
     "localname": "MedicareStandAlonePrescriptionDrugPlanMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MedicareSupplementProductMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Supplement Product",
        "label": "Medicare Supplement Product [Member]",
        "terseLabel": "Medicare Supplement"
       }
      }
     },
     "localname": "MedicareSupplementProductMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MilitaryAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Military And Other",
        "label": "Military And Other [Member]",
        "terseLabel": "Military and other"
       }
      }
     },
     "localname": "MilitaryAndOtherMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MilitaryServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Military Service [Member]",
        "label": "Military Service [Member]",
        "terseLabel": "Military services"
       }
      }
     },
     "localname": "MilitaryServiceMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_NetAssetLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Asset (Liability)",
        "label": "Net Asset (Liability)",
        "totalLabel": "Total net asset (liability)"
       }
      }
     },
     "localname": "NetAssetLiability",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_NetCurrentLiabilityAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": 1.0,
       "parentTag": "hum_NetAssetLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net current (liability) asset",
        "label": "Net Current (Liability) Asset",
        "totalLabel": "Net current (liability) asset"
       }
      }
     },
     "localname": "NetCurrentLiabilityAsset",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_NetNoncurrentAssetLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": 2.0,
       "parentTag": "hum_NetAssetLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Noncurrent Asset (Liability)",
        "label": "Net Noncurrent Asset (Liability)",
        "totalLabel": "Net long-term asset (liability)"
       }
      }
     },
     "localname": "NetNoncurrentAssetLiability",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash or Part Noncash Acquisition, Noncontrolling Interest Acquired",
        "label": "Noncash or Part Noncash Acquisition, Noncontrolling Interest Acquired",
        "negatedTerseLabel": "Less: Noncontrolling interests acquired"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_NoncompetesAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncompetes and Other [Member]",
        "label": "Noncompetes And Other [Member]",
        "terseLabel": "Noncompetes and other"
       }
      }
     },
     "localname": "NoncompetesAndOtherMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase (Decrease) From Contributions Or Distributions To Noncontrolling Interest Holders",
        "label": "Noncontrolling Interest, Increase (Decrease) From Contributions Or Distributions To Noncontrolling Interest Holders",
        "terseLabel": "Distribution from (to) noncontrolling interest holders, net"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of States Comprising Of TRICARE Managed Care Support Contract Beneficiaries",
        "label": "Number Of States Comprising Of TRICARE Managed Care Support Contract Beneficiaries",
        "terseLabel": "Number of states comprising of TRICARE managed care support contract beneficiaries"
       }
      }
     },
     "localname": "NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_NumberOfStatesComprisingTRICAREBeneficiaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of States Comprising TRICARE Beneficiaries",
        "label": "Number Of States Comprising TRICARE Beneficiaries",
        "terseLabel": "Number of states comprising TRICARE beneficiaries"
       }
      }
     },
     "localname": "NumberOfStatesComprisingTRICAREBeneficiaries",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_NumberOfTRICAREBeneficiaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of TRICARE Beneficiaries",
        "label": "Number Of TRICARE Beneficiaries",
        "terseLabel": "Number of TRICARE beneficiaries"
       }
      }
     },
     "localname": "NumberOfTRICAREBeneficiaries",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of TRICARE Managed Care Support Contract Beneficiaries",
        "label": "Number Of TRICARE Managed Care Support Contract Beneficiaries",
        "terseLabel": "Number of TRICARE managed care support contract beneficiaries"
       }
      }
     },
     "localname": "NumberOfTRICAREManagedCareSupportContractBeneficiaries",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_PaymentsForProceedsFromContractDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Proceeds From Contract Deposits",
        "label": "Payments For Proceeds From Contract Deposits",
        "negatedTerseLabel": "Receipts from contract deposits, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromContractDeposits",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Total Debt Securities, Investment Grade Quality",
        "label": "Percentage Of Total Debt Securities, Investment Grade Quality",
        "terseLabel": "Percentage of debt securities considered to be of investment-grade (percent)"
       }
      }
     },
     "localname": "PercentageOfTotalDebtSecuritiesInvestmentGradeQuality",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_PercentageOfTotalPremiumAndServicesRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Total Premium And Services Revenues",
        "label": "Percentage Of Total Premium And Services Revenues",
        "terseLabel": "Percentage of premiums and services revenue"
       }
      }
     },
     "localname": "PercentageOfTotalPremiumAndServicesRevenues",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_PharmacySolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Solutions",
        "label": "Pharmacy Solutions [Member]",
        "terseLabel": "Pharmacy solutions"
       }
      }
     },
     "localname": "PharmacySolutionsMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_ProviderServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provider Services",
        "label": "Provider Services [Member]",
        "terseLabel": "Provider services"
       }
      }
     },
     "localname": "ProviderServicesMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_RevenueExitMultipleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Exit Multiple",
        "label": "Revenue Exit Multiple [Member]",
        "terseLabel": "Revenue exit multiple"
       }
      }
     },
     "localname": "RevenueExitMultipleMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_RevolvingCreditAgreementJune2021FiveYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Agreement June 2021 Five Year",
        "label": "Revolving Credit Agreement June 2021 Five Year [Member]",
        "terseLabel": "5-year unsecured revolving credit agreement"
       }
      }
     },
     "localname": "RevolvingCreditAgreementJune2021FiveYearMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_RevolvingCreditAgreementJune2021OneYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Agreement June 2021 One Year",
        "label": "Revolving Credit Agreement June 2021 One Year [Member]",
        "terseLabel": "364-day unsecured revolving credit agreement"
       }
      }
     },
     "localname": "RevolvingCreditAgreementJune2021OneYearMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_RiskCorridorSettlementsMedicarePartDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk Corridor Settlements - Medicare Part D [Member]",
        "label": "Risk Corridor Settlements Medicare Part D [Member]",
        "terseLabel": "Risk Corridor Settlement"
       }
      }
     },
     "localname": "RiskCorridorSettlementsMedicarePartDMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock that were repurchased in the administration of our employee share-based compensation plans. Under the terms of these plans, we accept shares of common stock from option holders if they elect to surrender previously-owned shares upon exercise of the option to cover the exercise price of the options or, in the case of restricted shares of common stock, the withholding of shares to satisfy tax withholding obligations associated with the vesting of such shares.",
        "label": "Share Repurchases Related To Employee Stock Based Compensation Awards Shares",
        "terseLabel": "Common shares acquired in connection with employee stock plans (in shares)"
       }
      }
     },
     "localname": "ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of common stock that were repurchased in the administration of our employee share-based compensation plans. Under the terms of these plans, we accept shares of common stock from option holders if they elect to surrender previously-owned shares upon exercise of the option to cover the exercise price of the options or, in the case of restricted shares of common stock, the withholding of shares to satisfy tax withholding obligations associated with the vesting of such shares.",
        "label": "Share Repurchases Related To Employee Stock Based Compensation Awards Value",
        "terseLabel": "Common shares acquired in connection with employee stock plans, amount"
       }
      }
     },
     "localname": "ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_SpecialtyBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specialty [Member]",
        "label": "Specialty Benefits [Member]",
        "terseLabel": "Specialty benefits"
       }
      }
     },
     "localname": "SpecialtyBenefitsMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_TRICARE2017EastRegionContractMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TRICARE 2017 East Region Contract",
        "label": "TRICARE 2017 East Region Contract [Member]",
        "terseLabel": "T2017 East Region"
       }
      }
     },
     "localname": "TRICARE2017EastRegionContractMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_TRICAREContractAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TRICARE Contract",
        "label": "TRICARE Contract [Axis]",
        "terseLabel": "TRICARE Contract [Axis]"
       }
      }
     },
     "localname": "TRICAREContractAxis",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hum_TRICAREContractDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TRICARE Contract [Domain]",
        "label": "TRICARE Contract [Domain]",
        "terseLabel": "TRICARE Contract [Domain]"
       }
      }
     },
     "localname": "TRICAREContractDomain",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_TRICAREManagedCareSupportContractBaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TRICARE Managed Care Support Contract, Base Term",
        "label": "TRICARE Managed Care Support Contract, Base Term",
        "terseLabel": "Contract base term"
       }
      }
     },
     "localname": "TRICAREManagedCareSupportContractBaseTerm",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_TRICAREManagedCareSupportContractEffective2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TRICARE Managed Care Support Contract, Effective 2024",
        "label": "TRICARE Managed Care Support Contract, Effective 2024 [Member]",
        "terseLabel": "T-5, Effective 2024"
       }
      }
     },
     "localname": "TRICAREManagedCareSupportContractEffective2024Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TRICARE Managed Care Support Contract, Number Of Option Periods",
        "label": "TRICARE Managed Care Support Contract, Number Of Option Periods",
        "terseLabel": "Annual option periods"
       }
      }
     },
     "localname": "TRICAREManagedCareSupportContractNumberOfOptionPeriods",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_TRICAREManagedCareSupportContractTermWithOptionExercises": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TRICARE Managed Care Support Contract, Term With Option Exercises",
        "label": "TRICARE Managed Care Support Contract, Term With Option Exercises",
        "terseLabel": "Contract term with exercises"
       }
      }
     },
     "localname": "TRICAREManagedCareSupportContractTermWithOptionExercises",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_TermLoanAndCommercialPaperMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan And Commercial Paper",
        "label": "Term Loan And Commercial Paper [Member]",
        "terseLabel": "Term Loan And Commercial Paper"
       }
      }
     },
     "localname": "TermLoanAndCommercialPaperMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_TermLoanDueOctober2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Due October 2023",
        "label": "Term Loan Due October 2023 [Member]",
        "terseLabel": "Term Loan Due October 2023"
       }
      }
     },
     "localname": "TermLoanDueOctober2023Member",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_ValueCreationInitiativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value Creation Initiatives",
        "label": "Value Creation Initiatives [Member]",
        "terseLabel": "Value Creation Initiatives"
       }
      }
     },
     "localname": "ValueCreationInitiativesMember",
     "nsuri": "http://www.humana.com/20230331",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r265",
      "r307",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r329",
      "r401",
      "r402",
      "r403",
      "r404",
      "r406",
      "r407",
      "r409",
      "r411",
      "r412",
      "r732",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r265",
      "r307",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r329",
      "r401",
      "r402",
      "r403",
      "r404",
      "r406",
      "r407",
      "r409",
      "r411",
      "r412",
      "r732",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CreditRatingStandardPoorsAxis": {
     "auth_ref": [
      "r657",
      "r705",
      "r713",
      "r731",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Rating, Standard &amp; Poor's [Axis]",
        "terseLabel": "Credit Rating, Standard &amp; Poor's [Axis]"
       }
      }
     },
     "localname": "CreditRatingStandardPoorsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ExternalCreditRatingStandardPoorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "External Credit Rating, Standard &amp; Poor's [Domain]",
        "terseLabel": "External Credit Rating, Standard &amp; Poor's [Domain]"
       }
      }
     },
     "localname": "ExternalCreditRatingStandardPoorsMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r334",
      "r668",
      "r735",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r397",
      "r398",
      "r399",
      "r400",
      "r468",
      "r597",
      "r629",
      "r647",
      "r648",
      "r666",
      "r674",
      "r679",
      "r734",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r397",
      "r398",
      "r399",
      "r400",
      "r468",
      "r597",
      "r629",
      "r647",
      "r648",
      "r666",
      "r674",
      "r679",
      "r734",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r334",
      "r668",
      "r735",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r331",
      "r599",
      "r667",
      "r678",
      "r728",
      "r729",
      "r735",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails",
      "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r331",
      "r599",
      "r667",
      "r678",
      "r728",
      "r729",
      "r735",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails",
      "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r397",
      "r398",
      "r399",
      "r400",
      "r461",
      "r468",
      "r493",
      "r494",
      "r495",
      "r573",
      "r597",
      "r629",
      "r647",
      "r648",
      "r666",
      "r674",
      "r679",
      "r725",
      "r734",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r397",
      "r398",
      "r399",
      "r400",
      "r461",
      "r468",
      "r493",
      "r494",
      "r495",
      "r573",
      "r597",
      "r629",
      "r647",
      "r648",
      "r666",
      "r674",
      "r679",
      "r725",
      "r734",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StandardPoorsAARatingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Standard &amp; Poor's, AA Rating [Member]",
        "terseLabel": "Standard &amp; Poor's, AA Rating"
       }
      }
     },
     "localname": "StandardPoorsAARatingMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Receivables and Other [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": 2.0,
       "parentTag": "hum_NetCurrentLiabilityAsset",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "negatedLabel": "Trade accounts payable and accrued expenses",
        "terseLabel": "Trade accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r336",
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r32",
      "r34",
      "r35",
      "r232",
      "r619",
      "r634",
      "r637"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r31",
      "r35",
      "r150",
      "r564",
      "r630",
      "r631",
      "r688",
      "r689",
      "r690",
      "r699",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r497",
      "r498",
      "r499",
      "r699",
      "r700",
      "r701",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital\u00a0In Excess\u00a0of Par Value"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r59",
      "r103"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r133",
      "r134",
      "r469"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r233",
      "r338",
      "r360"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Receivables, net of allowances"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r59",
      "r97",
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Number of antidilutive stock options and restricted stock excluded from computation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r669",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "terseLabel": "Asset-backed securities",
        "verboseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r176",
      "r193",
      "r228",
      "r262",
      "r315",
      "r321",
      "r327",
      "r356",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r408",
      "r410",
      "r412",
      "r413",
      "r519",
      "r523",
      "r547",
      "r677",
      "r732",
      "r733",
      "r741"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r221",
      "r235",
      "r262",
      "r356",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r408",
      "r410",
      "r412",
      "r413",
      "r519",
      "r523",
      "r547",
      "r677",
      "r732",
      "r733",
      "r741"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total invested assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r342",
      "r366"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Book value",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r85",
      "r345",
      "r615"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r85",
      "r344",
      "r614"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Due after ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r85",
      "r346",
      "r616"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Due after ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost, Rolling Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r85",
      "r343",
      "r613"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [
      "r347"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Mortgage and asset-backed securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r90",
      "r617"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Mortgage and asset-backed securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r82",
      "r341",
      "r366",
      "r606"
     ],
     "calculation": {
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "netLabel": "Total debt securities",
        "terseLabel": "Fair value",
        "totalLabel": "Fair Value",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r81",
      "r224",
      "r366"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "terseLabel": "Long-term investment securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Investment Securities, Available-for-sale Amortized Cost to Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Gain (Loss) [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BenefitsLossesAndExpenses": {
     "auth_ref": [
      "r205"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.",
        "label": "Benefits, Losses and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "BenefitsLossesAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CallOptionMember": {
     "auth_ref": [
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial contract between two parties, the buyer and the seller of the option, where the buyer has the right but not the obligation to buy an agreed quantity of a particular commodity or financial instrument (the underlying instrument) from the seller of the option for a certain price (the strike price). Seller is obligated to sell the asset to the buyer, if the buyer exercises the option.",
        "label": "Call Option [Member]",
        "terseLabel": "Call option"
       }
      }
     },
     "localname": "CallOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r164",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r61",
      "r223",
      "r650"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r55",
      "r61",
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r55",
      "r169"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r90",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage-Backed Securities [Member]",
        "terseLabel": "Commercial"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock": {
     "auth_ref": [
      "r114",
      "r117",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments, contingencies, and guarantees.",
        "label": "Commitments Contingencies and Guarantees [Text Block]",
        "terseLabel": "COMMITMENTS, GUARANTEES AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsContingenciesAndGuaranteesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Amount per Share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r699",
      "r700",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r11",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balances (in shares)",
        "periodStartLabel": "Balances (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r11",
      "r677"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at March\u00a031, 2023 and December 31, 2022"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r37",
      "r242",
      "r244",
      "r251",
      "r609",
      "r623"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Humana"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r72",
      "r73",
      "r166",
      "r167",
      "r334",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/MEDICAREPARTDDetails",
      "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r72",
      "r73",
      "r166",
      "r167",
      "r334",
      "r639",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/MEDICAREPARTDDetails",
      "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r72",
      "r73",
      "r166",
      "r167",
      "r334",
      "r646",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r72",
      "r73",
      "r166",
      "r167",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk (percent)",
        "verboseLabel": "Concentration risk, less than (percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r70",
      "r72",
      "r73",
      "r74",
      "r166",
      "r168",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r72",
      "r73",
      "r166",
      "r167",
      "r334",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r456",
      "r457",
      "r460"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Unearned revenues"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Provider contracts"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r669",
      "r671",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities",
        "verboseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditSpreadOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An option on the yield spread on a bond.",
        "label": "Credit Spread Option [Member]",
        "terseLabel": "Credit spread"
       }
      }
     },
     "localname": "CreditSpreadOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerContractsMember": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts.",
        "label": "Customer Contracts [Member]",
        "terseLabel": "Customer contracts/ relationships"
       }
      }
     },
     "localname": "CustomerContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesGainLoss": {
     "auth_ref": [
      "r42",
      "r43"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in debt and equity securities.",
        "label": "Debt and Equity Securities, Gain (Loss)",
        "negatedLabel": "Loss on investment securities, net",
        "totalLabel": "Net recognized losses on investment securities"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r230"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.humana.com/role/DEBTDebtOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Short-term debt",
        "totalLabel": "Total short-term debt"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r120",
      "r260",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r430",
      "r437",
      "r438",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r177",
      "r178",
      "r191",
      "r265",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420",
      "r426",
      "r427",
      "r428",
      "r429",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r560",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r171",
      "r173",
      "r414",
      "r560",
      "r662",
      "r663"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r428",
      "r546",
      "r662",
      "r663"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt outstanding"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r24",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r25",
      "r265",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420",
      "r426",
      "r427",
      "r428",
      "r429",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r560",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Debt instrument, repurchase amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt instrument, repurchased face amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r25",
      "r123",
      "r124",
      "r125",
      "r126",
      "r170",
      "r171",
      "r173",
      "r190",
      "r265",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420",
      "r426",
      "r427",
      "r428",
      "r429",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r439",
      "r560",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument term (in years)"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r353",
      "r372",
      "r659"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "12 months or more"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r353",
      "r372"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedTerseLabel": "12 months or more"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r353",
      "r372",
      "r659"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r353",
      "r372"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedTerseLabel": "Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r350",
      "r368",
      "r659"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r351",
      "r369"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "negatedTotalLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable": {
     "auth_ref": [
      "r367",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r352",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Securities in unrealized loss positions, number of positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r59",
      "r110"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetLiabilityNetMeasurementInput": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure net derivative asset (liability).",
        "label": "Derivative Asset (Liability) Net, Measurement Input",
        "terseLabel": "Significant unobservable inputs"
       }
      }
     },
     "localname": "DerivativeAssetLiabilityNetMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r0",
      "r1",
      "r2"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax",
        "terseLabel": "Pre-tax gain, net of transaction costs"
       }
      }
     },
     "localname": "DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r109",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Dispositions",
        "verboseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Consideration to be received"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r3",
      "r220"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r127",
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "terseLabel": "Total Amount"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Dividends and dividend equivalents"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsDeclaredTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.",
        "label": "Dividends Declared [Table Text Block]",
        "terseLabel": "Schedule of Details of Dividend Payments"
       }
      }
     },
     "localname": "DividendsDeclaredTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r252",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r286",
      "r288",
      "r294",
      "r295",
      "r296",
      "r300",
      "r529",
      "r530",
      "r610",
      "r624",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r252",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r288",
      "r294",
      "r295",
      "r296",
      "r300",
      "r529",
      "r530",
      "r610",
      "r624",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted earnings per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER COMMON SHARE COMPUTATION"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r122",
      "r215",
      "r245",
      "r246",
      "r247",
      "r266",
      "r267",
      "r268",
      "r272",
      "r280",
      "r282",
      "r302",
      "r357",
      "r455",
      "r497",
      "r498",
      "r499",
      "r505",
      "r506",
      "r528",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r557",
      "r564",
      "r630",
      "r631",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r94",
      "r316",
      "r686"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "verboseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r229",
      "r544",
      "r651"
     ],
     "calculation": {
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r711"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "totalLabel": "Net gains (losses) recognized on equity securities during the period"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGain": {
     "auth_ref": [
      "r711"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtAndEquitySecuritiesGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain",
        "terseLabel": "Gross gains on equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r625",
      "r711"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EquitySecuritiesFvNiGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "terseLabel": "Less: Net gains (losses) recognized on equity securities sold during the period"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedLoss": {
     "auth_ref": [
      "r711"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtAndEquitySecuritiesGainLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Loss",
        "negatedTerseLabel": "Gross losses on equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesWithinInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r625",
      "r711"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EquitySecuritiesFvNiGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized losses recognized on equity securities still held at the end of the period"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsandLossesRelatedtoEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r428",
      "r546",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r534",
      "r535",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used For Inputs In Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r157",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Financial Assets Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r160",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r157",
      "r164",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r428",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r535",
      "r570",
      "r571",
      "r572",
      "r662",
      "r663",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r157",
      "r163",
      "r428",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r534",
      "r535",
      "r537",
      "r538",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r428",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r428",
      "r462",
      "r467",
      "r535",
      "r570",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted\u00a0Prices in Active Markets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r428",
      "r462",
      "r467",
      "r535",
      "r571",
      "r662",
      "r663",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Other Observable Inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r428",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r535",
      "r572",
      "r662",
      "r663",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Unobservable Inputs (Level 3)",
        "verboseLabel": "Level 3 fair value measurement"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Unrealized in other comprehensive income"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "auth_ref": [
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": {
     "auth_ref": [
      "r161"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales",
        "negatedTerseLabel": "Sales"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "negatedTerseLabel": "Transfer out"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r160"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Balance at March 31",
        "periodStartLabel": "Beginning balance at January\u00a01",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r428",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r570",
      "r571",
      "r572",
      "r662",
      "r663",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r541",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring Basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r63",
      "r64",
      "r65"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair value of assets acquired, net of cash and cash equivalents acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FederalHomeLoanBankAdvancesMember": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowings from the Federal Home Loan Bank, which are primarily used to cover shortages in the required reserve balance and also in times of liquidity shortages. The member institution executes a promissory note, which is generally collateralized by government securities to the Federal Reserve or loans.",
        "label": "Federal Home Loan Bank Advances [Member]",
        "terseLabel": "FHLB borrowings"
       }
      }
     },
     "localname": "FederalHomeLoanBankAdvancesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r348",
      "r349",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r371",
      "r373",
      "r374",
      "r439",
      "r453",
      "r525",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r659",
      "r708",
      "r709",
      "r710",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Fair value of financial liability"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableRecordedInvestmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Financing Receivable, Credit Quality Indicator [Line Items]",
        "terseLabel": "Financing Receivable, Credit Quality Indicator [Line Items]"
       }
      }
     },
     "localname": "FinancingReceivableRecordedInvestmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Weighted average life (in years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r226",
      "r390"
     ],
     "calculation": {
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      },
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Amortizable intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2028"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r387",
      "r389",
      "r390",
      "r392",
      "r600",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]",
        "terseLabel": "Estimated amortization remaining for the years ending December 31,"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAmortizationandEstimatedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r102",
      "r604"
     ],
     "calculation": {
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Amortizable intangible assets, cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r98",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r102",
      "r600"
     ],
     "calculation": {
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Amortizable intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security.",
        "label": "Gain (Loss) on Securities [Table Text Block]",
        "terseLabel": "Schedule of Gain (Loss) on Equity Securities"
       }
      }
     },
     "localname": "GainLossOnInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r225",
      "r375",
      "r605",
      "r660",
      "r677",
      "r714",
      "r721"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r377",
      "r660"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r59",
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Assets held for abandonment"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r39",
      "r174",
      "r185",
      "r203",
      "r315",
      "r320",
      "r326",
      "r329",
      "r611",
      "r656"
     ],
     "calculation": {
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails": {
       "order": 1.0,
       "parentTag": "hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Segment earnings (loss)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r315",
      "r320",
      "r326",
      "r329",
      "r656"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes and equity in net losses"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r40",
      "r59",
      "r94",
      "r184",
      "r201",
      "r312"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity in net losses",
        "terseLabel": "Equity in net losses"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from an individually significant component disposed of or held-for-sale including the portion attributable to the noncontrolling interest. Excludes discontinued operations.",
        "label": "Income (Loss) from Individually Significant Component Disposed of or Held-for-sale, Excluding Discontinued Operations, before Income Tax",
        "terseLabel": "Pretax earnings"
       }
      }
     },
     "localname": "IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r263",
      "r502",
      "r503",
      "r504",
      "r510",
      "r512",
      "r514",
      "r515",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r264",
      "r281",
      "r282",
      "r313",
      "r500",
      "r511",
      "r513",
      "r626"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income tax payments (refund), net"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInBookOverdrafts": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in cash during the period due to the net increase or decrease in book overdrafts.",
        "label": "Increase (Decrease) in Book Overdrafts",
        "terseLabel": "Change in book overdraft"
       }
      }
     },
     "localname": "IncreaseDecreaseInBookOverdrafts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r598",
      "r695"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Unearned revenues"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in health care insurance liability balances during the period.",
        "label": "Increase (Decrease) in Health Care Insurance Liabilities",
        "terseLabel": "Benefits payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of effect of businesses acquired and disposed:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r296",
      "r470"
     ],
     "calculation": {
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of employee stock options and restricted stock (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r388",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r99",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InsuranceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]",
        "terseLabel": "Insurance [Abstract]"
       }
      }
     },
     "localname": "InsuranceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InsuranceDisclosureTextBlock": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.",
        "label": "Insurance Disclosure [Text Block]",
        "terseLabel": "BENEFITS PAYABLE"
       }
      }
     },
     "localname": "InsuranceDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Total other intangible assets, cost"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r96",
      "r100"
     ],
     "calculation": {
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "totalLabel": "Total other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
        "terseLabel": "Other intangible assets:"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r172",
      "r187",
      "r248",
      "r309",
      "r559"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r255",
      "r258",
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest payments"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r307",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r200"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Total investment securities"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of Contractual Maturity of Debt Securities Available for Sale"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r93",
      "r175",
      "r188",
      "r214",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "INVESTMENT SECURITIES"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets held for their financial return, rather than for the entity's operations.",
        "label": "Investments [Member]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r22",
      "r262",
      "r356",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r408",
      "r410",
      "r412",
      "r413",
      "r520",
      "r523",
      "r524",
      "r547",
      "r655",
      "r732",
      "r741",
      "r742"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r16",
      "r180",
      "r197",
      "r677",
      "r698",
      "r712",
      "r740"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r63",
      "r64",
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "negatedTerseLabel": "Less: Fair value of liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r23",
      "r222",
      "r262",
      "r356",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r408",
      "r410",
      "r412",
      "r413",
      "r520",
      "r523",
      "r524",
      "r547",
      "r677",
      "r732",
      "r741",
      "r742"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r206",
      "r209"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Balances, end of period",
        "periodStartLabel": "Balances, beginning of period",
        "terseLabel": "Benefits payable"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails",
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Paid related to:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "negatedLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "negatedLabel": "Prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount": {
     "auth_ref": [
      "r211"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount",
        "terseLabel": "Total IBNR included in benefits payable"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r207"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total incurred"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Incurred related to:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Medicare licenses"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r19"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Remaining borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r19",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r7",
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Outstanding borrowings"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.humana.com/role/DEBTDebtOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Total senior notes"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r25",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r115",
      "r116",
      "r396",
      "r397",
      "r398",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Weighted average cost of capital"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputLongTermRevenueGrowthRateMember": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using compounded annualized rate of long-term growth in revenue.",
        "label": "Measurement Input, Long-Term Revenue Growth Rate [Member]",
        "terseLabel": "Long term growth rate"
       }
      }
     },
     "localname": "MeasurementInputLongTermRevenueGrowthRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputOptionVolatilityMember": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns.",
        "label": "Measurement Input, Option Volatility [Member]",
        "terseLabel": "Annualized volatility"
       }
      }
     },
     "localname": "MeasurementInputOptionVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r4",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "ACQUISITIONS AND DIVESTITURES"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r30",
      "r179",
      "r196",
      "r262",
      "r356",
      "r401",
      "r404",
      "r405",
      "r406",
      "r412",
      "r413",
      "r547"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r127",
      "r146",
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedTerseLabel": "Acquisition"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities collateralized by real estate mortgage loans (mortgages), issued by US Government Sponsored Enterprises, such as Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac).",
        "label": "Mortgage-Backed Securities, Issued by US Government Sponsored Enterprises [Member]",
        "verboseLabel": "Mortgage-backed securities"
       }
      }
     },
     "localname": "MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r257"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r257"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r55",
      "r57",
      "r60"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r41",
      "r60",
      "r186",
      "r202",
      "r220",
      "r240",
      "r243",
      "r247",
      "r262",
      "r271",
      "r275",
      "r276",
      "r277",
      "r278",
      "r281",
      "r282",
      "r293",
      "r315",
      "r320",
      "r326",
      "r329",
      "r356",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r408",
      "r410",
      "r412",
      "r413",
      "r530",
      "r547",
      "r656",
      "r732"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to Humana",
        "totalLabel": "Net income attributable to Humana",
        "verboseLabel": "Net income available for common stockholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r148",
      "r152",
      "r240",
      "r243",
      "r281",
      "r282",
      "r690"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentIncome": {
     "auth_ref": [
      "r622"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.",
        "label": "Net Investment Income",
        "verboseLabel": "Investment income (loss)"
       }
      }
     },
     "localname": "NetInvestmentIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r217",
      "r269",
      "r270",
      "r273",
      "r274",
      "r283",
      "r284",
      "r285",
      "r339",
      "r340",
      "r358",
      "r359",
      "r507",
      "r508",
      "r509",
      "r527",
      "r531",
      "r532",
      "r533",
      "r548",
      "r549",
      "r550",
      "r561",
      "r562",
      "r563",
      "r565",
      "r601",
      "r602",
      "r603",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Details of businesses acquired in purchase transactions:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r142",
      "r455",
      "r699",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NontaxableMunicipalNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments that are not taxable.",
        "label": "Nontaxable Municipal Notes [Member]",
        "terseLabel": "Tax-exempt municipal securities"
       }
      }
     },
     "localname": "NontaxableMunicipalNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r315",
      "r320",
      "r326",
      "r329",
      "r656"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityEquityAxis": {
     "auth_ref": [
      "r121",
      "r154",
      "r155",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of options indexed to an issuer's equity.",
        "label": "Option Indexed to Issuer's Equity [Axis]",
        "terseLabel": "Option Indexed to Issuer's Equity [Axis]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityEquityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OptionOnSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of a security at a specified price during a specified period or at a specified date.",
        "label": "Option on Securities [Member]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "OptionOnSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r5",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "BASIS OF PRESENTATION AND SIGNIFICANT EVENTS"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r234",
      "r677"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": 1.0,
       "parentTag": "hum_NetCurrentLiabilityAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": 1.0,
       "parentTag": "hum_NetNoncurrentAssetLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r38",
      "r122",
      "r241",
      "r244",
      "r250",
      "r551",
      "r556",
      "r557",
      "r608",
      "r621",
      "r688",
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r144",
      "r145",
      "r149",
      "r241",
      "r244"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax": {
     "auth_ref": [
      "r32",
      "r36",
      "r92",
      "r239"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax",
        "negatedLabel": "Reclassification adjustment for net realized losses (gains)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r32",
      "r36",
      "r92",
      "r239"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedTotalLabel": "Total reclassification adjustment, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax": {
     "auth_ref": [
      "r33",
      "r92"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax",
        "terseLabel": "Effect of income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r236",
      "r238",
      "r354"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax",
        "terseLabel": "Change in gross unrealized investment gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r236",
      "r238"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "totalLabel": "Total change in unrealized investment gains (losses), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r33",
      "r237"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "negatedLabel": "Effect of income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": 2.0,
       "parentTag": "hum_NetNoncurrentAssetLiability",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "negatedTerseLabel": "Other long-term liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other income, net",
        "negatedTerseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Stockholders' Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r56",
      "r208"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "negatedTotalLabel": "Total paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Common stock repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Debt issue costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r48",
      "r80",
      "r253"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedLabel": "Purchases of investment securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash and cash equivalents acquired",
        "verboseLabel": "Cash paid for acquired businesses, net of cash and cash equivalents acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment, net"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r204"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "terseLabel": "Benefits"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r10",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r10",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r10",
      "r677"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $1 par; 10,000,000 shares authorized; none issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r607",
      "r620",
      "r627",
      "r638"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-Term Debt",
        "terseLabel": "Proceeds from issuance of senior notes, net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r80",
      "r253",
      "r254"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from maturities of investment securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r692",
      "r694"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r691",
      "r693",
      "r696"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.",
        "label": "Proceeds from (Repayments of) Commercial Paper",
        "terseLabel": "Repayments from issuance of commercial paper, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r47",
      "r80",
      "r253"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from sales of investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r220",
      "r240",
      "r243",
      "r256",
      "r262",
      "r271",
      "r281",
      "r282",
      "r315",
      "r320",
      "r326",
      "r329",
      "r356",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r408",
      "r410",
      "r412",
      "r413",
      "r518",
      "r521",
      "r522",
      "r530",
      "r547",
      "r611",
      "r656",
      "r675",
      "r676",
      "r690",
      "r732"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r111",
      "r199",
      "r618",
      "r677"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PutOptionMember": {
     "auth_ref": [
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A financial contract between two parties, the buyer and the seller (writer) of the option, where the buyer has the right but not the obligation to sell a commodity or financial instrument (the underlying instrument) to the seller (writer) at a certain time for a certain price (the strike price). The seller (writer) has the obligation to purchase the underlying asset at that strike price, if the buyer exercises the option.",
        "label": "Put Option [Member]",
        "terseLabel": "Put option"
       }
      }
     },
     "localname": "PutOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r198",
      "r213",
      "r677"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables, net of allowances of $69 in 2023 and $70 in 2022"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r693"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayment of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedTerseLabel": "Repayment of term loan"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedTerseLabel": "Repayments of senior notes"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResidentialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r706",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by residential real estate mortgage loans.",
        "label": "Residential Mortgage-Backed Securities [Member]",
        "terseLabel": "Residential"
       }
      }
     },
     "localname": "ResidentialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCostsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs and Asset Impairment Charges",
        "terseLabel": "Restructuring and impairment charge"
       }
      }
     },
     "localname": "RestructuringCostsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r13",
      "r127",
      "r195",
      "r633",
      "r637",
      "r677"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r215",
      "r266",
      "r267",
      "r268",
      "r272",
      "r280",
      "r282",
      "r357",
      "r497",
      "r498",
      "r499",
      "r505",
      "r506",
      "r528",
      "r630",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r306",
      "r307",
      "r319",
      "r324",
      "r325",
      "r331",
      "r332",
      "r334",
      "r458",
      "r459",
      "r599"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Services",
        "verboseLabel": "Services revenue:"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": {
     "auth_ref": [
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.",
        "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
        "terseLabel": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r249",
      "r262",
      "r306",
      "r307",
      "r319",
      "r324",
      "r325",
      "r331",
      "r332",
      "r334",
      "r356",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r408",
      "r410",
      "r412",
      "r413",
      "r547",
      "r611",
      "r732"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r334",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/RECENTLYISSUEDACCOUNTINGPRONOUNCEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Investment Securities Classified as Current and Long-Term"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r135",
      "r136",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Carrying Value of Debt Outstanding"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Details Supporting Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r67",
      "r69",
      "r288",
      "r292",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable": {
     "auth_ref": [
      "r658",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about credit quality indicator for financing receivable.",
        "label": "Financing Receivable, Credit Quality Indicator [Table]",
        "terseLabel": "Financing Receivable, Credit Quality Indicator [Table]"
       }
      }
     },
     "localname": "ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r98",
      "r101",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r98",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Intangible Assets, Amortizable"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r660",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill By Reportable Segments"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r105",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r105",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Intangible Assets, Indefinite-Lived"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of Activity in Benefits Payable"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRealizedGainLossTableTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the proceeds from sales of available-for-sale securities and the gross realized gains and gross realized losses that have been included in earnings as a result of those sales.",
        "label": "Schedule of Realized Gain (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Realized Gains (Losses) Related to Investment Securities Included Within Investment Income"
       }
      }
     },
     "localname": "ScheduleOfRealizedGainLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Results"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r303",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r334",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r394",
      "r395",
      "r660",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r303",
      "r304",
      "r305",
      "r315",
      "r318",
      "r323",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r334",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Operating costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior notes:"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BASISOFPRESENTATIONANDSIGNIFICANTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r6",
      "r177",
      "r194",
      "r677"
     ],
     "calculation": {
      "http://www.humana.com/role/DEBTDebtOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term debt",
        "verboseLabel": "Short-term debt outstanding"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermDebtWeightedAverageInterestRate": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.",
        "label": "Short-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Weighted average annual interest rate (percent)"
       }
      }
     },
     "localname": "ShortTermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r181",
      "r182",
      "r192",
      "r687"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Investment securities"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the form of debt having an initial term of less than one year or less than the normal operating cycle, if longer, the maximum amount borrowed at any time during the period.",
        "label": "Short-Term Debt, Maximum Amount Outstanding During Period",
        "terseLabel": "Maximum amount outstanding during period"
       }
      }
     },
     "localname": "ShorttermDebtMaximumAmountOutstandingDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r218",
      "r303",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r334",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r393",
      "r394",
      "r395",
      "r660",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillbySegmentsDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r27",
      "r122",
      "r215",
      "r245",
      "r246",
      "r247",
      "r266",
      "r267",
      "r268",
      "r272",
      "r280",
      "r282",
      "r302",
      "r357",
      "r455",
      "r497",
      "r498",
      "r499",
      "r505",
      "r506",
      "r528",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r557",
      "r564",
      "r630",
      "r631",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r302",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r10",
      "r11",
      "r122",
      "r127"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross",
        "terseLabel": "Restricted stock unit vesting"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r27",
      "r122",
      "r127"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock option exercises"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "verboseLabel": "Share repurchase authorization"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r11",
      "r14",
      "r15",
      "r79",
      "r677",
      "r698",
      "r712",
      "r740"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r142",
      "r143",
      "r151",
      "r215",
      "r216",
      "r246",
      "r266",
      "r267",
      "r268",
      "r272",
      "r280",
      "r357",
      "r455",
      "r497",
      "r498",
      "r499",
      "r505",
      "r506",
      "r528",
      "r551",
      "r552",
      "r557",
      "r564",
      "r631",
      "r632",
      "r698",
      "r712",
      "r740"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balances",
        "periodStartLabel": "Balances",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r132",
      "r261",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r455",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r558",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r558",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r558",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow disclosures:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names and technology"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSOtherIntangibleAssetsSubjecttoAmortizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r348",
      "r349",
      "r439",
      "r453",
      "r525",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r708",
      "r709",
      "r710",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Stock repurchase average price (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r29",
      "r128",
      "r131"
     ],
     "calculation": {
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "negatedLabel": "Treasury stock, at cost, 73,721,604 shares at March\u00a031, 2023 and 73,691,955 shares at December 31, 2022"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r11",
      "r122",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Stock repurchases (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r122",
      "r127",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Common stock repurchases",
        "terseLabel": "Stock repurchases"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r612",
      "r669",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "U.S. Treasury and agency obligations"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESSecuritiesClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrealized gains and losses on investments.",
        "label": "Unrealized Gain (Loss) on Investments [Table Text Block]",
        "terseLabel": "Schedule of Gross Unrealized Losses and Fair Value of Securities"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r287",
      "r296"
     ],
     "calculation": {
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Shares used to compute diluted earnings per common share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r286",
      "r296"
     ],
     "calculation": {
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average outstanding shares of common stock used to compute basic earnings per common share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "https://asc.fasb.org/topic&trid=2155896",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=126970277&loc=d3e23176-110880",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4616395-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90198-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13(3)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5,6,7)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "40",
   "Subparagraph": "(SAB TOPIC 5.W)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "https://asc.fasb.org/topic&trid=2303980",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column E)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column F)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921842-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r681": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r682": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r683": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r684": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r685": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>80
<FILENAME>0000049071-23-000025-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000049071-23-000025-xbrl.zip
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M'= S5#;)XD#HV48N.GG+Z93S(J@E .N&5?K\L K!2B^R#W6G'<,6994N"DL
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MOQ?[--L59O+HI(MO1^/'?9Q<@&M<KYMF'2$WB7(C<+FL:NEG#,"1BK]WE,4
M%L9'Y!1::+S5 %QSG)Z1SI<@I8L8(8/S/H%D6RJ"9.;4:PFMZ_R#SWNIGFNX
M_W!_3.>#&TW86!)>*"L<VMH/TH./QCL-T49GE5%A"6WLID";XR!4G?<TFFV*
M')04O9'1"J-C(! JM*3IG_P=Y!X?3::C 8T?C^HX5KH*W&Y>Y7M1MUDU)(
M9&&#U,BIN 8;;$#=0._61<7V:NHVBT,L.HHH,J?5=;VZ\'+6V2J*)-KHW+/H
M<,UQ?6D65 *BRD5 QHPJ6DZEM=5!5_-:=A>Z,\9,FSBXBJTC;]YWLHP!*T4Q
M5 I89Y$\>ITE*"*K4"^I[[Q*4*]FM,1'%TSRI-!!B#(8+"5;FYWU29QU>%H^
MIWE-.,VS&46@XC7XD!)8;S&A"N@,U7;8(="R>\OSZ':$_>W>_L%R"DYM3)WI
MD:DNOE7*!++)18$V!I &S9(ZS6O ]HI\IXU5O3AI[:QOJM9:,5JU4X:,C:P6
M772XYN="G1*>I+&IF  IR  !*"IC1.;$3K0TL_J7<*LCFINC81H-#FE*DX?#
MO#4]N(H-5&[>@4KI;0JV**T86V4C@<4H"B8"IW0# Z"+B>S5%&3[8DPNLOA"
MX*WR1KJ )0LGA->V@1*AA0=KCDN@4"4A%9L6*(C1LU41>5=(^!2MM0TYSX<?
M<)S_6#.^,3CLCTZ(7DU'Z=U5=>JZ>1<I"#04)P$\/UI4GDTO% Z D:*(9R/7
MZAQ(M0+R$D"JRP.IY@9DT")*7P +,:"4@E>B%%.W! ^*O6G[%KE-D^FXEZ:4
M9U NHS4Z XI=*"7-<E0I#!&2,RYK#)A2%NU;X_6">".6R&X3D_:: B%$)X.6
MTA@KM<UU=YE/B85RG?-?KAK$OT5^Y2Y)_M\?^B/S:\:PIQ)*9);GD9CR-EBH
MVR^XPOK/G3TW=>[!E/(+^-S4Y9V&ZB@_A^>F5)2D FJ2"2([?DQ(DD*JW1F<
M"6?/#<Z?&VBQJ$ZCKG"@_QSQAS;>\X\_NH\O#KCZ& "7AQ,Z6LP!3HR.%70.
M44L+R@<_LX=02"D51#R?*E'2+"R*!SBF;3H\&J<#G-"+\6A_C(//:<]#_@+R
MBX,>'DT/1N/>1[R.ANB<!YDY)$$R!8/)>F%)U@*=6-"CK.M:LHNLGAN27)>!
M3%\O9#>OQE3T/J,W))0#E67D.([:Z,C^M78 .;-$4(MKB3?N3R\:'G34/ R/
MC'9>@L.4+4B=.>1%0.\BYOI[ Q,CW]CC^O.8>HM;CUL;D[<RVFP]2"E0)B&=
M%:DX@R$W4+JX0+#,<3->!T8&P4XKL95DZ86J/=Q+S% +;1H8!:_]&J;?1.45
M#7NC\>9H.K_^%O5"7W;5F(5!8<T+9@#_\7=773_B6+A_-)G6Y]B(K6*0,9'&
MK*P$80/'-@7.%ZEKTAH;V,QE18KY]WR-2,6'  D#V 2!/0<*S[3P.B5JH,_]
MO$BQ*&;J;<14.QQ@*H "/04"+$H7EY*G='O,=%%L1*.%$HH#!@!B8,^9C4\&
ME10YV-C 'HC?]&/ZKO^Z(]M*TQ&?C+\8S,N9+@8MYF>HY(F\)!O(92A.<"15
M43K!M$C%M%!MOJ+%56AOE6-!X8)D%6[)!RFKZ+8F!2]M"VM&ODD+,.+KJN=P
MW.OSMS++Q8DYILE"%J>"#AH\DR%[XV56W@@I2FT&UK"KN&6<F.?N:D'':#@%
M$PBL[KP6PL5(5M>==GS+JL*XKW.B6YM%\K>RC9BMLP&ERZ[FS76:C5/GX *
M]20SM-#U>4$AFF-56F$%AB:#K8444@8BD!AS%)Y\+ WTQ5R<00VIOR[ZGE <
M'^'XA)^D:\1R$PG011#SH*[?C3%X)ZV7&+01QJW&NEJBQ?R\13$V224-&5=
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M:-*^HL55U#-FG8I2=;UH!@':BVQ5U"9Q[A@P-K#3X2+1PO_IO#:T4L^HO$M
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M4!:X<CY-<F4!?$\J)&T!JYT!'S :'15:X#"GP&=HB%@WO4W2S8.9.(E((>1
MED '0$I6DA"*W422OH%UUM_!\ EE&F/_WZ,!U63\$0[?/<SO<9B:J6?*2GB0
MI](1O),> ;2+QI7@DS4M./+)>'J_BV]'X\='DRDC,9Y\]J1=]I\)QU<PA;,
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M(:-#JX-G)D5=&F=/NYMVKP+X7QR\)6N\1731)8@<P*TPIGCVC2DJ8<2*R*N
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MO+?XS2SW9>GHLDG*UQ:RGH),POC:44NP Z06QBB6+5ZN./N]1-9(] Y=$2:
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MT HN9=!7;KG;M-^;U. \W>1W;I_UFM\PNV+K.!]D&3I@D^]@ -FAE-!C1AV
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M.*M??/[6N/@,&_']HX__G!X=?FCM?WQWTKAXUSQ.?H=6'..DPXU+IP2S&K!
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M)^"-_NRG^49O/ARO=OGF:8_VLR/[C>X-:GLO:B^O[.Y[G1%ICA?>8S.,(:=
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MS11T9J-K9CHE[3]U3_Z9@EU[_B1>E\I993;ZQ&NT+&Q4W62CB_TDRV*C4\O
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M89/X,OYH->#I3,>7V1AQL/[G$O]45Y891DE$E5G/87>@6V6PGO$,W!D<O^2
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MQB-W0,JFSF8*2$TA,U;PP&U$IW7,JU1/-/O+*DH?LCP_L3S?9AO..T<I3AJ
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M_K6JF_\SKK>9"Y@_GY_]>A74W6(U,D25!U&?K[&,S[A^:MDGQ:BFSCE .;2
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M60;G/2;L3E(\A1=7>^<D,UM9#WRG5$W<Y\<A<NM62S6Q>.ZB5RUQ?LY%>)!
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M,@4D81PHRB1S# F>BN/%-Y<J8+MR]UAY'"G!'Y)QY.EP9)K+Q'/)J2' 8.(
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M_V2D2VI]BP%]C[UNN1(6OA)FE%HN1*:U)LAC0Q%/(1=K40XECXDQ05*IV 7
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M_"WOP*N)#2BHLP#JP%PKQ*F0Y]#S_<-=\DD+Y[46%!F..>)8)V0"[(H+V(-
MAC$/ #M/T3!:B/7>+(F%6)=#K.=3Q)HRCV"T0M0EAGCR0+9$,Q1E4((JEY3!
MP".P%2+6YZ-RV(FG/:")GV<,GH68LG3&8'+9"\(LA#"O9]F!$)DW'@<4H@2$
ML<DC:[E!+!HA"4Z4&9Z=M>]L1"FJA-6ET:7S X5&[T*CTUP 8SQ28P7BF@?$
M97+(2DZ084:D2*EV(FUL$4U6B$:?CZY@^Z0+(_E>] ,/RP9<^G2]Z?8F]Z#@
MS4)XLSO+$RC%6!!&(FQP0ISJA'0 [H P[HQTTF"&,]ZLD-115 2KSA(4>ET:
MO4[S!UPX;)A+2%FJ$!=:(*TI10%'PC*#[S30*[VS*:%X4CR= 3\A/<RK8]LY
M@NY:G<G8RWX_#OH-VPF-=LNZ5OO2%;;130V8:?35;S]T\';#/KPN^Y(TK/_O
ML-6+H>HR+WBW'\.S=?9>"!PD>:'$*I^@=]''UM><&N7G?(;6ER/XQV.R\+L=
MWXNV'W=B_>]N9V(C2H3D\GB&#[,\OC$F.4HDHHP!SQ"U058KCJC!+F0F3U"6
M0R0YFS4N_+-P^$^!GI?.XA=Z?CAZGI8!@A)8&X:1$4: S.X(<DY+Y#UG7(I@
M&-69GMF<<(A'H>=E\J<KSV#L#XYC;\23/C-3X8IQ&-5.[(_%A.UJ1PKZ+(0^
M?I:;P"+0(+%%.%J/>- 4.<4\"E+##>,5"=9N;!D\ZY!\>^PI!L05IMP'X"4*
MY2Z#<F=TA])Q:4E FO)L__<<61(=4M$'3Y1+6/F-+4EGE?V/0KG/2BWQ6^S$
MU!KT&Z?V///0STPWL5J,P[^C;0^.7]D>_-X?]FS'QS\N%8L%B!8"HJ-9%L(;
MR;&7%NE ->)<)V2I,LA'DJPEUA@#+(02JV3%*#J)5;<Z+D['14NQ1"*?YC:(
M(M0DQ1%LID/<8(.TPA$11C'/#LW4FJREP-JL$)D_0U7%A,VLZ"L>)XSZA^)/
M83U^%I6^S+(>*1CKO*8H*HD15](#$X(38I&2A(,+5+*-K7G)(HOVXDG0\;V&
M4A<ZOB\ZGN8N= Q:TFB0X(DC+K5#FJ2 I/# :BBJE K 7>"[6#2++N/GR/%]
M)]I>)X9&+WZ-G>&S<[18+67&*WA?'LG?+1"%AGU8EM@;0]%YD8&6AE*?YP1@
MV\"8\H$@&6W.^T E<K"'*&(<HB"V3A4K-PTKJHXG3.4/H.JX@<H+(2]&R#/*
M#"<,U4XB!1("XMPX9*)7(#8 (^*-$S0'9Z\4%3\?I^"*S7YFJHO'Y#&FK+,7
MZ;!S=9PW[>[9P< .8H[^*+BS$.[,"=G6G##J/$76"8NX)UG,"1HQ:Z(45G(:
M254V=66"08O&8M69AT*^]T:^,YZ:CEDFDD2P=P[E.C7(4JR1=AP+@SVV.6LU
MH2M$O\]*4]&<4P5BL:)NMY!M;EWY[^EAU])9#]BP#%-_CK;KM_/W_1AV.W/0
MK&@VEH=L<^+&L8U6>BR1=[D(#B8<F6 L,H!LBA%J#0M9LR'UG1/3+DI&:Z3V
M>,;0L'2V9A%H*-2_&/7/6%\T[).T!.DD$N+6.62(XT@SZR5C6/$ 8@G#=V9L
M'HKVGUWEVKIZT"V9G%LLQ-**8M]G]//B@WSZJ0!^P+ZO>*&W'*3?;V54N8SU
MKYCY'+5?_1*AQ5= ^EP+;AS3_\QLD8\:DO6G/:_RQQ]VM^O5_^TBQP+<UOLI
M@]+HFU NY84NY?>S++D@PANJ%5S*#EAR1B6RQ%I$8/<"UMQ[J3>V5(GQ?J+D
MN_R:L85\[Y%\IWEJHXD5P0ADLY<TYRDAIZ5&4AGE>#*>9E\!-6MB7/N0[M7F
M,_X<]ORQS6F!@+\X[67MX."\XC$R>W&:*>3GJVZNKP5CM1B+/T?[\F?;=L:5
M_$Z+#6-A7)J3/0:D^4BQQ8B1J!'W2B+ (H:HTLGK0!75.6LT71%/RV)_7#^^
MHE#OTJAWFJN@(2E.O$6"Q92KQV%D318*HN!:,:\Q-4"]1JP&]3X?]<45MF)N
M+>^BJ7A$AF+[JVVU<R#^FV[O "#HLBAPKA5<C(O+ ZUY*6: I5 F$!2"HH@[
MJ9"E'B-))-4JQ! <KQ)<D:+,>*(4?O],1Z'P!Z3P664'DY@%BYCV!''L!#**
M8H0E%]XEFG"BP)9L$CE;Z*+H.^Z7,>EU8>AA9"<$$AA1Q7+YE/45G1Z531GM
M3:[5NW>Q,W_VXND(W4!X>F7;[?Y^NA[>"GHMA%YS\M<P'KD@,B(;J4.YDB:R
M,C'D58J!$B<]%X!>LM3D?L+$O7P.I1#W8Q#W-&L2K0O<:PFLB0R(:^R1<9@A
M@.\8#'PF6=S8$OK.)7&*VN3.W$D?CGI1H*P88Y(!Z4<058M7!:86@*DYB6P(
M," V$0V<AXF(LZS833PA29RE'$>B@P68NG,MSZ(E65TROE<6Y'9D7+0D2Z3Q
M&58$\^@DM4BY:!!7R2#-.$'!AT2-YD%E5H1L4O-4 \_7)X)LV(\AEZ5:R+'Z
M%D+44PL168V<>]<$B^R.-Z_$D=T#Q'V?DR&'9*:%"(]2,ASQ*!.RQ'@D2, R
M6N^Q)S7$S<:2+&RA7ID0LB4J69XS/MQ?+K]%\*% P&(0,,WE8"$EMRHB24&<
MX8(K9 ,.2#)-+1/2&<LWMB1?0DK.U8LCF\]WK0*_<[LXLM3JV(Y?0AS9(I%^
M/Q4#=ENI\EX&^7S,AU49N-/!Z'CX45HR0-W3;K\UZ#]'5^E'Y7B/AR<7O@\@
MPT]*^..<<3NCO2FL[O+NN3DI$R(E'$>3LTY[G;V:##)48$2T@KV,Q+.@LL^#
M,<5N^(1)?/E,:R'QQR+QF;P(R@C*(P%!UEO$.95(4T'A!Q56**(Q\YG$N9KU
MMR[6PX>V'K;Z_6&N"9,-B/W8:75[C4YW$._ HSP+J\.]&@]W1WNRGPZJ'?FC
MVSDZC+V38FU8+GCMS5'%>2^TI@JE1"@P*0SD<$4MBE(2V.7$),65*H[<&;R*
M47%UR?M>C8H_)N]"P8M1\$R!3Y)\#(XBD6N"<^4\LM%Q9+4"MD1BRC'+(>1/
MU5JXVLS'NPM'OFF&XYGI0QXUTNMR%\885+!G8>QY.\$]?#EO[GP![(DJ2$,X
M I;! _8$$'TD9R@ (V&8YTD1NK$E9_V12I3XRA+J8W(-U]'II B06M]B0-]C
MKUOH=U'Z/9^F7]@Y3:E$)*>0XI)CI$DDR D::62$&2PW@$_0E-!?B_+B<?F'
M&?6%[YZ<Q)YOV7;CU)[&WG-48:R&9]&DM#.)8:\N=NC/O$$%L'Z:X1A7\G0X
M1NTUTI@EQ(4-2&NAD#/ ?"3X2LFTL474K#&EA(@_"1J^/^^?0L/WS72,ZV,P
MHD/4$6&;$SU(&;*I)"*%510),%HHG ,I[Y*=YN%T%4\@&_#Z*U<R-S2(O9-&
MNVL[1;'R.(J59M9J_6G/<^!(0<F%4').!KY(#."@8H@$$'>Y9 89'BB2-GG)
M@V 8AQSJ570K:T2KJZ);N4JJ1;NR'!*>9G04LY0+ ^R-"1+Q( FRG&<5J90@
MJ>#L+U*T*X_)0&3M8J52B3#1_N"Y!8^O1/:]_91W86PC?I6WH4#/0M S)YF>
M,"Q*0 2DM,.(NZ21)5(CIK2,-C'E<X35BJ05+UJ2%=22%&*]-V*=YA-\))&1
M9!&-3 &?P# RT4GDN/*8QL"$RP5#5X-8GX]VX=6Q[1S%'-[MNMTOC2X,+/1L
M*H$L#\<C['9\+]I^W(GUO[N=WV K]L<[4;!G,>R9D]4N"JRD\@;!OP%Q!3**
M=HPB9QT.SFG+I #LP:N4^*KH&E:07[C&JE(H>-D4/)/LWU/-D[(H"*H13R8A
M1X)'+'$M:&)!1[NQ959#3?A\5 O9;-C-;^WZ+XU>/!UG_B\JAH=7,;SI]MY=
M[$!MT>UV#O+.%/A9"'[FI*3S6BFL?4"&^X@X)1SI$("+8 PNDL!A0P/ 3U$U
M/%&BO3=5PX^(MH2$+9&B9\P6*C&=$@<.0F-@*() QBN-0O8'#1YC8DT."<-T
M18CZ^:@D=EHY,U$G]!NGMO5S58V?AT!SG]:*\1X4I%D :9H[<_+  9(P ?^A
M!/N%@'_(Q8NQA]^(\80$H[3/RH?BX_!$R?0^[12%3'^63*<9 H>3D<HS)(26
MB"OLD U<H"!DQE/+E'# XM_%0%%4##]!:?N#X]@K^H1'CO>8D%>J#7DS3HY7
MTD7^) 2]GN//$*UE1%(4L1>(,\>1T38BG 15P3#C8LB<@EP-B:2H&5:04RBT
M_#BT/,U.2"*D=DX!\4:'N$@1:64P4D1Y39TE-.3LSRM2Y?-Y)K8_'>5 ;KCS
MQ;*]/L/DU8^IEK@F9?5<W"I*TV6!VKP\GX9S$ZU#GF<&!4N5W;<(4LQZAH-0
M(>J-+;9)U:PE]N<\*4I>^R<%#4M7A11H>"1HF.9WF*-,$((124DB;HQ%6GL0
M8' ,2@A,X/-L3]%D5GI946AX0AGOYQ/NV&TI>W]6#)'MA/J7^-]AZRL01.=N
MT2+/&.F6S@1EF,O_O;[<FG>Q/^BU_""&_,5V)US]8*+EGS#?;IAU4_/M8=Z#
MU]]\Y0;\S@[BZY2B+PE)EXB6<Q*2!F*I%MX@*Z5!G :)3. !1$2IX3MG##$;
M6WI3JF4E-%P91FJ)VJ!G#"]+9Z0*O*PQO,S8L@+C)&&+;& $F#%-D4N)(F4,
M34)SKF,V.6]RM:PBJJO'C,W74*TN,_;J.@:L80<-%X]:G4[63G53X[2BMF?F
M%[,(-AK@M2)QBD;&N5#.<V)#2L;A*(@RGW8S)!)ZKY!8$&YY"#<G11JWG&(3
M$XJ19*<:Y9%F7F;W&F>%L)G!VM@2FUC.&NQ+3,^3(?4D95*1N1"EX98F*Q-U
MQ@:M(Q4ZI8K422'U=2+UF2**S@ALC$1>Y\HS0/C(2/B1I-&,2V^9YEGIS.Y>
M*GKU''36E%^)\/FUG,HM><EZ/5\RV(#0';IVK/C)ZSG-FZ%NW@(^*M+]SZ,L
MS9-!?X==3@#B-'68,TJ-ER&R)!@W@C&&*_2_;]5:0?_EH?_[.9HR 3MLD\C5
MQCSBV!%DB8H(.RP"2=%$[[(?Q:9BRZK=LPPB>V0M6H'8 K%+@5B1B_LIZDW$
MFBOCK!+PMU;2^Z0Q8;4L72!VG2!V1ELH 5H)<-0"NYR9)SED% W(),6,35Q:
M PPVW]1RR<:(1T'8BC'_99"30L*_H?5UZU_P8SSD$]L[:G6J=ZNKR.;A),;>
MB&*W_N5ZOVQ=3/OI]S+"#Z%?9->^JN(J;/_+7FS;0>MK_/6L%0;'8WB9>&ZT
MQ?CR$>M@0X>#ZQ^Y;H0/B)(TCTE=78S)G\>]\6!.[5%$KA?M%V03C/6E;9_9
M\_[&+U?W #9@U+>B\/+IJ5^_!8][*.YOR=7<)?_W$+JPC=V.?W'MT%=EK*_V
MFSNOFP>O=QKPV\'^'[L[VX?PQ\$A_+/WNGEXT-A_TWBU??#OQIL_]O\^&"5
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MG 2Z6H^K2S:Y5I-+E&?U(H^SD88]6(/>Y+96.P#-88:]>M%;_8G=[!]WA^T
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MQS:WFNPKSO^X%T? W1_%K%5'JG%YFLZR>)^-7!?.L0#% 7;$#2K9&LAX?*O
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MNI0B4]JCB&WV%F J!\LS1!EUDD1#&&9/,G_I$Z?H1=0"CTW212UP%Y*>40O
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M%_'EN1M KAY0K !.%'W>@T#!C"<N#DPJ&Y"@6"%. T>6ZX"888$K:N&/"%#
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M]O2TU_T&C-<@ML\;_[, 8Y@T-HD[*U@RG AI;9)2$6L8$]))6S&&#+/B2[8
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M9Q%<<A^GM>W<MG-7<UK;SAW4SKT_^LLZ*C!_&Q^/SGW;L[\O<5V7D+3I;S#
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MRQI\29JA%(H$.!KFI2R,IP 8@_=!N8TM*YH$7QV4#P[D+8:W".SV8G@8L+B
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M_M'PZL /-WJP%_YD^"<>T?P<$0K3^'4XO&L(X::1V^$1TRUX*>D81=1&0.*
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M#9D9*1CTI[?2JZ(4-VYC2T*K\+%JX+Y===$AHKNI('<$>Z^*5Q"FQ)18RH;
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M1A?/?WX!#?-AG9;9Y'"<W[_Y62:[:L:^*9']]S><H&%3_"T87GB9(HIH)2H
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MVV"W[_"Q2A1+B 6=>#UTH)C3,3 99#U[:)3JS!E^E[YAS>7SI2Z?.4/X(6M
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M1#^=,K$(.T1)?'\.KSR>'!WA-'VI07\O$N;0>)E5#D7F0,9A<1 @RQ@#D1.
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M 6K+7 %.N$^"[! ;O%]X?D.#_)I ?E$.B0;Y)4*^YW?06CH+J)A7"1G0LI&
M5XZ!!)D,2NG3X@X\-<BO%^07Y7AHD%\FY"]+>>>5RS8 *SSFFCF1F3<*F5)2
M**65-[#P=MT#\T#\54Z%>2!7(*=B?/P&9R>81Z&68.CE5'RQ1^A&I'75A'Q3
MSOKOY8U_?<AZ42DDW8;[/HRGOX3#4]P>S]+A9'8ZQ18A6AQMIRO\,5R"M;8Z
M8*0A_2R1788Z,RUXUD)F7P1I:M)M>K&H;FTW1LDW#A(UMFMLMZPLF<9V7X7M
M>H4X<O2%EHR)Q$E)+9PL5(R%B1*4X,K0@I:-+:$VS=VK^36V:VRWVFRWL&2@
MQG9?@^UZ7CC0)6&"P(PVU23GA3DN @.-KEB3A)#PM;)_&MLUMALVVRTLW^EZ
MMFN$=CM"NZR^)4$"2 O/C.2:@3.)!:<U4UJJ8H016<2OD>"T8 _CQ8-<[%S9
M4=753'>;_K$?'E_1 ^;):3S$WO/?X$;M.Q?QG9]Q)W_[O#5_B5'M%8PZ?RRB
MOUJ#AY#UD%"#TWK5QM8V)CR*.!TIL3DBKI0WZ#V]G-59^4O7/_DQS Y&^+^G
MXS<D$8]O$6FXZ9'Q%5;!KAKB^FA9$M$+GV41#E*Q'GSF7I@,U=*,\QH74LC/
M:5EU STZSO6?)Q^V4;,QEZF2O7IT534J(Y( ))4LD4IF2V9!2F!U87U04@69
M-[9@TRDYH./R"\KF:"RUIBRE"YE\9 ':3/M8@?0A:3 !@U!9BF(:2PV;I7HM
M0)U+(B1D*EO)P&C!G/>%)8M.\9R4Q=)8JK'4 ,9V"Y;BA8-&*U14!813P0%X
M8YV&P+W+<LDLU;+GOIB@^@FS/$>,B Q35:.XM<SS%)@.I!-KSC'PA2?,-HIJ
M%+7TVL,\^""\L,D5L$$[94*RE@NEHKOH6MPH:H@4=5F'\MX+D95C(:3"0,_K
M#B?F@\Y1@LM!P1 I:D%IO,/UI6U_6@CMX0W<KE]>,*'=8SCWN#]5_U\\>/Y@
MM#?%0!1_-@K'>30Y.<#IJ'M]?T+/>7Q$ N%?<?J/<Z;I_TSGG0.(C6;=+<(^
M'J<O!LQ-#_JT>PSG'HL\T:'L:@&FV^UGHTFD)YN#H/73O+:?)C>UA*(3.40
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MSA7]*"!(5"XS(20P2"XQ9U R;R6DK(CPNPJ5?I/[!<>*[HJA;QQ):CS:>'2
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M/;$Q^,0]@]GG N.D0_)6^*!*P'B41?"-[PG/O<0<(\,CD'U%"=))6R2-TK!
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M/VQ?3/W;K-WZH%G?WMB+8']0&A("LR.@7*<)N:0(H@9;RSDEEO*5]9OG?!5
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M/;C>AFL^:GCV9[I=W2+UQH_C>N/;R1Z3+E@7""Q&#3R6&8I<=!BQY$$36B;
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M9NKP A))O9Z!W?!^V!ZV[/F";'>A;:>%6Z4<\$<8\'J<92&70U>"0 D"KW;
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M# *!!9-2VH"L$@P%X,K*2!IPCEE<JC(/I;"^/&$M:?%B?$,3NTI A$%<*4?
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MKHFB!=T$]V3=E6#B*QV8RDI_F&/',RD8A>%5[&"DQD;*[DR7O9O4\6/&4A"
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MATCHM:RECKK]8GS>]6(+KOT9Q^$A8]R\=-]XRO'%+=9!MX>#FV^9B%)XIH5
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M,):YW$*SG\LN0?][T7=_=.#1HUII?C $60!%X&!@KFB#7'_A;(#/I_SDDDX
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ML\JNFFMY'?]YZ/E=NO0R!FI3R:02<.C)A0*,81>LXGY=!O2=F?1*;VQE#-A
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M$;( 7JEO;F3>PN6WO_$=4WJ0=[PNQ%"!)& P!'IX-AF5X;=@379EUM(Z'J(
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M#.;6&9#=(+1<! +/CH]!?S'.4\'@6+G2X(^O)_U8.WJYV&QMS^XW!@T46Z=
M4<<CO #,]^I.@FW,+/N9=7Z_Z-%#I2DNTN;,F1#6$/M>!'O1?G,HHRN*PN'
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M=#$ON*;794%1 8$Y,9%WK'*-YF_AKE20Y.K&+?L5JJ#SDJA>D.S5$N;4\AP
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MO-<S5"[YP)+1+'L 2>&1 -*GR_[J=67"4F5"N:Y,6(FUK"L3UI4)OV]EPJU
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M84NG4.S]YKO-UEQ#^&E3$UN5L.>:#""H>IY7]: \R'*NTP"O:%EOU!4/]?5
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M>T[S!,K>V6Y=GDT*VO.4CK>3V;E(\KL<2MXX6V[]F,A:@4I; S)9T E=_C-
MYB",U'FHT=@]HJG7S]L*4_G$BIHD+BA/0,E(#"1%C,R[BT\N(9CM7<YWF*4=
M^;56R2T=BO-Z@QF >H/ F?$"LBV"UE@GN,X['W>..M15GO8%_"UY6B#N8M+$
M2H4$,N:)D])FH2I9B,8RPWW7AYV#0_\Z:-<U9:D['9,.;B%NX 2OL@U)S[6F
M+&J7 &UTP@KC.8K\)8#MW$M:#=&[&:(MO:RX93*!(=+H1$!*3HP 2@(:I]!#
MULQ^:);HYAR_/I\<'<6I'V5%G4X.#[^04:D1=JG"SHH^O UF,R.!0^(*.%+
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M87EFK8U>*.I*S3)@=V:H6KBLO^#NW,=1P?WPX&X7G4&AO0J42&<C :8BP>B
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MEDF>V*9YO4)C1'#12+,)A%6)H// N:I4^H3\EF?&^CRO+)A2R#(C/Y4TXQ"
M,.TU@$/CJ>^75GF@4+M'1>PUT78M5\R_3O)'X2U]8_,W?"KR/(3)2;ECXQ^K
M7OJ[#LW:[ :=!?!UL@G\A-.,B>JK[VY'>-7V7:$U42>0)7FK-#>)2!R/E/@@
M;)+H&75F'J@GN_74WPERPSCXK(1;"7=(;L,EX59.78E36^[ 9%0()F5U;9TE
MH!TCR&,DGB::4&@?F+R'4+\A,VI/'(-=!0)6YM](YG_<(,*Z!SRB7=WVL:*0
M,7'ELCU=8F"D9L3$",1ZY9/P1C =.PT6'#+_5UZMO-H7AW9U8?2<:EM.;2$@
M3[:W)#"3""@GB2F'\#3OI"+3;UX48AYNV&[%,#R3NW&(?]>LL/QW&'W>7;[4
M_LE1!IB?_[>?+]=FG>[^,U^V?*DCG'X8C9?/;B_RX>\GQ[-1^K( ^NX_W?2[
MW=/!:3[KW)T6()7FB<QW^30Y'I4/>SJ-A_E3/\=__#$*LX,EAL_]WN*CZ=FO
MH,N#=#*[_E?./:*/Y3SHX:F(EV<2[.)HG/_S8+I\FD_X(1(WC?B18,H/^Q0/
M_\ OQ]O?79R(/ N+FUMHAO#RVU_[CBEU\H[ZBG><KX;,3I,YQSW-JS].RU7Y
MF; WS[)U,"V$_W]&EGE%-9J$SH/!X!CE0<:8/#H6$[[7V[MOFP.42=HJ'%XJ
M=OSS.VPOZQNM^>L6XBU_[?[6[U7CN;T[/T':RCO6D]X_Z_[KMR_?;+U]O?7\
M]?Z+E_MO7KXH7[UY_>.K%\_>YO_X_M7^L_WGKY[]N/7F;?[&WLO]MV\6,0M_
M6VS6,?R]]Z_YMW^/\22,9JUG;3WQ1>:&B\Q]^@Z7N']N520:M:$T2,$5%%A@
M2MS3K$%UWATYN_;WM!=(DV72<<B_;B++%E7 J'PTGF+^O?GIY"FU-UM?'KM#
M_'0<GRZ_^,?2H3(:-R/0_-(_+KY08<#+!5#*^\U_O"!':Y\880L_+LZ$%Q^\
MH,XG#75>VL;G/Y/P1$MS[8_I$W;MS[YV6_-$Z.M_^K6[?OUGBO+.G]4^H>QV
M=WV,9[5:#NA9[8WN^HUHAA7\HU^);YA3P<-(./,MCENTYCH^F>+8QVN31FXU
M!A?-\&_6F^[W&#UOGNC7>'A8!^G:07IY.,IF\UQ\?]>87,\GTT_%/*Q+ZRM+
M*X]6>?H\2N'", VWF+J]T8N_S2HA;AWEZPZ.MV(6#V%K#Z?^8$NPG2U..;\^
MB8U]>Q16J77?[P7RM]%X*]_UL,#J[]]>(6J-*MV]_#//Q1@/MWZ)GV-6#,=;
MUW>#[/:$L][C+O?HB+KFAP+\"9=]7J0_3>/1Z.3H^.FMEN;J^3OU'H]]CX["
MGN?+V_9Y;;\:A]'G43C)%+P70WZD:=QZ%C[C>(8?6D;=*J^_I@=^ZWEP)Q %
M6A]]#!Q,!"M11)=XLH:&_,WFX(XO#^[XM^N'+"GS)4[',>S'C3B&>\9>OSTX
M>/WK._GZAY=?\K-]V?_KX&#OK9?[1WMB[_=WXO7;9_3=KR_%Y6.XO1?_+K\C
M?_O]([Q[^[^_[[]X)?)__[G_U\?\2?[+_N]>[KW(O_,VI-.(M_SW_E\?9'[&
M]\JDQ(/DA!LL_>N<)V@C)SIYZJBU*H J]9MWJ.0='<(-*'ZATE*?WFT%6@K<
M*6>1:1T54&\=XUQDS@A(D:GDNJ:EM<MS?3!&8I<9*4E:B@X9XB4& D:4V"L)
MQ"MN%'!F=(J=);E62JJ4=)=W6RS#NNKJJNOG1JABW@FU%1P 05B/4OEH47)F
M@S>\VN?]V@UE:S>DF5_ .:*]H 0L#<0XI$3;TJ'-)$,!>FB?=^KEZ[4;Y(?\
M&I]NX &IQ2N6E.0H]R"Y2")%*,%?2B?+7$@ AB</E9)Z1$FCMLL@3YUCR2LB
M/,L&.D^*.!L<<89%;I/QD)K<8Z/OG'M<:]#T%\;4&:D$)M0L0$K1!>-X8"Z9
M9-%Y6R5V7Q#<DM@L+T^>34+B,@>7'"=/K#2!1!D3"\'&#.I:1VJH&+Z=)JW3
MU%^J=8DK*G@(A@'$1L8%EW%JHP3A-:\64Z_XMB7BF.4<99"$!]0$*/)L+-G\
M1T3+K%%4H>R?Q;0Y1]FGZNUXAOEU\' RCEL_O?CI5AKNIAZS03.24C(I+C P
MJ<#39"AS&I6P)K.3$ZD+1JJD<W/2^=*6:5XFK91B1,=@"%A4Q&A#25 T";1!
M4,FV=_.4]<AMU'60VL;CU$8EC4+43GMP6:0I*F4RV9SPCE-)JTCK"WY;(DT#
M*TVT68:NHMEH$)X8I1U1CH9RELT4=%?LMV)X$"*M3E-_J=9A=*@,,DDU>$Y1
M(V@&.I.O34[K:A(]-*6V=)@--H2$E#@4@0"3-G_E*:&.>6VSE!:)]\TDZO(D
M3>@^J["WD]FY6.*[G)_=.,%G_5C(4\^HY]HY:D!RYHP&RTJ7 *ND$IT'OE57
MT>TIZO7SMFH#KHW*LT*X8MGJRQ8[,<(JPE$R$!1!AA*/:W>DNG,=RENDPPW%
M'[S!#*"SRK>*B8 I BJ.1GD1$Y6&*I; 5\G7%_"W))]@,4!4C"C*!0%G&#%,
M K'&1A:2C[3[<[F*_OZC_TXG>G6"^S_!JX1=9"N.HF<"8VGV$!P%3E5)OC+
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M79(IZU.%.A$0'@AZ%"3%Z"PJM. SG#6_<]W2"N4AN1'K-/60<5U0SIG @M(
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M&HMH+H$A4!.9Z23AHY+'8,BC'PD?E49Z3".M?J<JR<B1D\@2(V A$"S!#R9
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M&)C! HQ.&^ :!PR79W7?W@B#_F:^U;\DT?HO01*N_Z3VF/Z,,ZE'$D[ZP4(
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M5W!D" 6L I^D,DB4U W8 VK:XTH91 >5P+$ [PV]"]='(G1 ^PAO=C9+*%Z
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M!^:6K>?H0%2W&=$H_QM&4*^Y02DK(@2F_P=@GX2GIC7@KPN/KV*T&]XE:+<
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MC.PI,],S(U5ZZ6G#O<\L*5->3*U]$)2XWC6'B1"-%'6#N67H1-AQ2EIO0)&
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MY!Y2%O@!I8ZJ)V</\L7V D2-"@HW"[.'.#RUQ&R5!>U)4^ !7D4M"?#4$'N
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MRB''=U7L=)FZ0/>,KZ&AS1P=Q[T1J!)*P@"X(5+U9T%")L_%YW]_?'=F3@#
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MN<%NYJX]9QZL%KY6>F>IZ];H/1GZ24ZQ1('M\AB^NW'CN1I.KW&I[W5/DP@
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M1$$G9P0Q#&^O<<A*9_6I !, AZZ,PX,<Z%RU%61&RD<,I'..!P=QYI,2*$C
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MC5.@#O+P'WA#:OZ+Z9AHY%@<;L)UZJI3U_&V&JV6;/'+HM:8IFEJCB[05 8
M$Z>LJ =%[IK/E6_UGLJS"I!J=/\^\E+6U^MA?:+ !+PG)5?0^/79Z;FF/T'O
M&#W:DYGM_6>#IC55<<PI.8*+8YQ%:<^=%TDI"I+0\4DE"KEF^_L<B+<8,G66
M)(_!M>DB*XK)@KH+'QFUXV$_OAI= O=O2>UO^K6SBS3M-^99@%5=SA58A*TZ
M43SI&_7PKIP29.&:?D2KS^3^"U!+ P04    " #G>)I6RU4M:3P3  "ES0
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MKFS,.^6%SK??H42CF;%<Q#=LME2GSHM _*G<R>?S>M836L(O/_P_4$L#!!0
M   ( .=XFE:I'<NTXR<  +*0 0 4    :'5M+3(P,C,P,S,Q7V-A;"YX;6SE
M?5ES6T>2]7O_"HV_U\E6[4M'=T]0%&4S0B(9(MV>>4+4*J(-XFHN %F:7_]E
M 5PA4,)2%[R4(VP)!"'<4Y6G<JG*S/K[?WV^&KWXE-K)L!G_XR?Z5_+3BS0.
M31R./_SCIU\OWH#YZ;_^^9>__/T_ /[[U?NW+UXW87:5QM,7AVURTQ1?_#&<
M7K[X+:;)[R]RVUR]^*UI?Q]^<@#_G/^CP^;CEW;XX7+Z@A'&EW_;_LUI*4PP
M%H(/ 01A!*P4%HAGCEH>F"/L/S_\34LEG"42F$@,A/,"K/,<HI>21)JDXF;^
MI:/A^/>_E3^\FZ07.+CQ9/[C/WZZG$X__NWERS_^^..OGWT[^FO3?GC)".$O
M;S[]T_7'/W_U^3_X_-/46OMR_MO;CTZ&JSZ(7TM?_O>[M^?A,ETY&(XG4S<.
MY0&3X=\F\S??-L%-YW/^75PO'OU$^0EN/@;E+: ,./WKYTG\Z9]_>?%B,1UM
M,TKO4WY1_O[U_?&#1U[.KMS8_34T5R_+KU\>GIZ\/CHY/WJ-+\Y/WQZ_/K@X
M>OWJX.W!R>'1^2]'1Q?G.(KYMTZ_?$S_^&DRO/HX2C?O7;8IX]?/KJ!(F_ %
ME/^WQI>^O(,;W"C,1O/9>8L_7W]U05<5>?H\3>.8%A-U\^Q1$QY\:%3$U+0W
M_W+D?!K-WQW,)O#!N8^#\VD3?K]L1A'7T-'_SH;3+\?C,)J5!736M&40!]-I
M._2SJ?.C=-&<-+B\QE.$C-_XX7@\36V:3 ?&YY!%]J"#X2!REN"5%. C<4$2
MJ4(P2[.,4S'!N9A3(KN)G_/B&A;R@[&7:32=W+Q3),+FTJB+?"&Y[>?O(,9A
M>98;G;EA/!X?NH_#J1L=-E=7S7@.<9"C8D11"<X% X(+ \8X!L1ZIWTF3%)6
M>6Z^C^KAN.]Q]J -+YH6)Q75Z4\O_DA%^5UKU@5$UX:OR/QP75]_XN5D=G4U
M_TX83M/5S;\O:O;).3AM.A7C@CTX#[O2ZP+-U&36?IE#6*#YEQO-T@"?J;.1
M%D1($@3+!IRQ 93F@7OI=?*Z,JD>P[(.E=@=E>!'YU(5F55CT$% CZ<(),73
MZ65J$=#'-EVF\63X*>'<-%?I;3.9G*3I:;YPGP<RJQ0TNB/">'15 B<(4@20
MR1#N"NU%;4V^(<1U^,;_1*JK0P%78^$]1;I8"]3PD"AJ4R\C+HB$OI\EV0(/
ME'-KE*2)5*;9,H9U>"3^/#S:2435B'*&LDYMF^(]($J(E)6+P#SR5 3! %\D
M\$02HWWT^('*7%D!8QVZR#\/77855#7&O!N.FW8^ ]>C8DXK+CAZ9BY'$(H2
M0*.K(&03E'1.,5I;M2QC6(<KZL_#E9U$5(TH[]/4#<<I'KEVC".;W#.<KU,>
MAN%TH!2G/F@/+%A3!NG ,BLA(B+/=1"9Q,K4^3ZJ=<BD_SQDJBS&>H[V9)*F
MDX'S5L9,'7!)$@@7T+U",,"Y0PA"\:B7]YMV]I_G3]X9_R<W'!6IO6G:<S=*
MYRG,<-$.T^1U\M.[GXI(9ZCXQ],!5<1'QW#=$JU 2*8Q),X!8K(F>1/*!FCM
ML6Z,LD\['5MPY"MWOULQ55L./S=-_&,X&@VDQJA",E>B7G0*=-+@G!.@E V,
MDZ"%LI5)<O/L#7<F^B[ZK::THF?>?$SM],O9R(VG!^-8U/_'<I:"D>5 H W/
MU&KP- H00A*P":,&CDB<-UPY5WL[ZEMX^K1%4$'PU::^&AD6MO]=FEXV\7C\
M"6UZ@3,9&":$+SX=4A'IJ0(:=D$#8%"@9:19:E<[5'L$2I^B^PH4J#'AU:0_
MWV=:#.J>F4E<:Z(C 4Z8Q>'QHI4DAX3JRGN5M):JLNQ7 NE3H%Y!\KM/=F47
M]_#&K8C2"AT]^A&>HA42'CRG##"0H\YP$VFH'2P] -"G(+N&8[?UY%:3[]NA
M\\/1W'V\P:&T\0@C0+8!?<>L*?B @5O649GRGZ:TLI"_1E'A#*29H;8\<U^*
MYXP6%-]I9RFN&+ A)'NNT#NFHASS^00N<0Y!<&)E\%Q$5__\8UUX?0IF=F3+
MBG.,3H14;764^.IN>5K.#/K=/+&2T",XV) )"'P[&)$,C;5UW[W']RFNJ<R"
M;2=Y9RE?SJX&KYKF]]-/J8VMR].;@7T9<"<)<TJC\I6(0Z4,%K&!B]$I@B%T
M9,M'HLLI1(]_>Y]"E4JRK#25U<W:ES=->SARPZL)*I?K%_'?LX4K??3Y8QI/
MTB!)P;1PZ% ;8PI" B:C=R5-HM*A66:R*X.W#KX^A365EWYG8JIXBCV>MBY,
M?QM.+P\14'.5VEO4M[9):R4,0:<MQ S"8#!F'/[H?9:"4I*EJ1T&K8.K3U%1
M9>)4%TL7#O4@*8L>O/>@C4  J C!^9))EEEDFN4@<FW'\M[C=QY),_YPD=JK
M8I_OA:'9F1B)EV"9PZ$PBJ]\9E!&DU&?4YI#[4&M1-)3QW@CJ7^E$'>?\RY#
MP^"9\$ECG.L-+BO/-'B;'#KA3/)H32*RM@^\74#T!*[P;G+?;:[K;O/= W-_
M^TFB@46U"30Q')[G ;Q MTXSQ?"%HMS5SK%X'$U/7>B=.%!I[CO:^G,R$^N4
MA;*_#$([M*,R<1R>10@Y<F'X_K;^=MK OAE2M,GF; E$=$1 $*[0-5 4<&Q.
M2N>%3+7/LK]&T2<KMKW$O[&#O<UL5^/P^6733HM!O7^ XJ/T9:L5,LF(A*4$
MQ@</4@K!'"[3$&M3>16./MFQ>I+?><;KA6YN<EG"2?RK'*5]<J."Y6!ZZ-KV
MRW#\89' R#436254K;9DZ!M9$H<B <^5"-F)R%1MEV8M8'VR</7845\F%7,%
M0T) ?I1*XOSM8(DTCD8.+$I9JCW1"\L6@]3L&4F9*<YJVXB50/JT"52/#KO/
M>1?1#A+TZZ3'@6'$YU!RXS'BPG$&"U8H#NBG1Q:(B3[5WN3Y'J::>Q5,>THI
M.JV*9PN"6PXVD00QZV2$94*+O>U5]":6WYT)WPCT-IKR>AY1G71>5-'<T,QP
MK0<!PD9<HYX+(()**G0,VLK:/E0'U;^]V3VHS[0G$'2')!V(8*V2@@ N&C0S
MW@JP$1T#KP134C.<CMKZJ;["7:/F6$89HU?EB)M[$#$I,"P38#PRSIG*AM?>
M7GWNI>,;<6.+,O!-1-)]&7A$YYC84I2>&7I'%-UD9R0#1TA(AC'+?6V/])F6
M@>_$BRKS_V0EW2X'8:)&7T)XI"Q):#B\0<H:3K-6Y<2@^F[=CU32O9M*Z5!8
MW95G.TZRM +#+,8(",8=&&DL1$Y=XEIR6CT+[GF59^_$B9VFN]M2:YTLL825
M1E7E&%YP, HIZ$FD6D1M**GM<#R[4NN=1+_KI.^S&C8E8GEF'A0"*!NU\WV<
M!"$*(@A-,NK:Q1QUJF&?KK1Z)VY4%LD25?[^<GG&WN+/%=NLG5_@G^^.3B[.
M3]\<GQR>OCMZB&3[7FLKOKFCAFO?&T.EKFMG;9.'TV+W!QK#:1*\ 6M#*>10
M'GR8A_:YA/16!U9[[^3NZ;LJD3O_Y0TNCI*'-1S/D+JG'U,[%\CD5<I->^WG
MH'N3)LN]  [&\>&W/%;IA%:0""<L!,[11F8TCY83#0P](X\NDN:FMFG:X_#Z
M%%1OR<YE==97<E0SH;? KY-27Z4QJNGI@'CCO*("(DD9@T+NP1I)084LLW?1
M,E'[%/$1*+V*R:O2:K=9KTR![[%31A>"MA2R<VBUN:%@?&1 ,="+0CNK4NV>
M$-64SK["[DZ43@V!=,25;O4A4UI9HQUD02(.,$BPU!)0-E-OO*'4UW;=G\Q8
M;I'^M8!4#C9NGC;(S$;O& >/X3>(DIKBF:#@E(I99V&8J;U&5\#HDQO05[Y^
ME5ZVHS0K+O#%J&]J5%3TFFCA(&A-T2*5'@W*4> (QV2)@:+*U1?A PB]LO_/
MA4^[B+%N[O5),VX>DOL&$X]<:N4S)%W.@J5Q8"-ZOI%&8HRFQE>O4OLVHCZY
M$L^%:!5E7'%;\%,:S])D@/K32!\2J)Q*QV(BP!**+I(CE@;TM.N?+-X\N\+&
M]M5P=C4I^V@ISGOD$*>=QH5+-=,H)<W!D10@.H+SF(R*MGY[HB40?3+M6TEY
MQ5;V#M-<T>K>K,;%\KFWA%\//PUC&L=!,MXC" 4ZD0+,V/F&+$3E)&,\V%"]
M3&T-6'W*/JK"B-JBJ*W5;LS!<K'H;2Y426;%_V(YB&76!1=B B90J0O!)9B<
M$I!$O<(8%"/(VIS9 F:?[&X5#G4MJGH>VHJP0P5)J0T$DBQ[4*6WNHE,@'3)
M>B>RPFG==Q"Y@P^ L VUZ,T(D= #"=*!L?B*Q5)DQE@FMG8 L]H'>%IKN:ND
M'Z'X9O-;C;?7^Z63,HQYJNFUOSD94$UUXH0!"<67]2RA:B[;<$D+0I0SFM3>
M-'H43*\BU]H$J"."/3 BDAR"9 J?7_IT6X5(M.<0I!=1<&%9]1V,-1FQ11IQ
MFN<R_XS?W[I1:2\5KX;CX61:1/OI-NHR/B?#N =G=:FN5Q$,X1:(B=D$H:6K
MWJYV/61]THAU&/-5DGI]"=5+EFI&P_!ED>MQ,_K;]C3'B]KL^$MR(W157)L&
M-A-B7,(I,$*!B":C>A 1<I229:D,][4W:#:$V*?HHQL^=2FS*OW&7J>/;0K#
MQ:PCW:]**<;_S7]<6)KSJ<-YFY?!"<ZM-1+"//$G9 9&9P'<F,1SH$K*Y6AD
M50^R]9_8I\"B+CTZG/EJZN8D3>_Y&CH'(TOOHE#NS! AZI)@K@&U'C?1NDA\
M[6S<!P JM Z_.=L5)B;\0+GO(].2Z4IP* R]*!.-E%99%FH/Y;%TIZ<UH=M+
M>$5W\&UFMQNNKE5&IB1Q/D=>NE1[$!BDHRWGQ8Q[7,]1L?J]-C8&V:L I!Y9
MNA764Z:<'IZ^.WM_] M^YOA?1]WEGZYZS!Z24;\[NDJ9J2O*4VY+4U#8#B<K
M TT"F6#M_$(X"F@&'5$L"UF]CN@;<*J<L'ZG&F=E;>R9FS<F8%)KRZD&[F5&
M76LM>"H5<!%E9BX$Q3LY@MT><I_,7RV>K3Q3W9-4._+VF!)"YN"!$T) :!(!
MIZ!TO! Q6N:-R[5[2WS#VWO:P+ KFFP_XW4S/%:,[]=QBR'I\/\P-,7(M>R'
MN.&XP#P=W]WN=- .)_BKU_CC^,-9:H=-O)T7E4W,Y0#6."M!N)+<* 6#H*F6
M*CHN=.WTXZ[&TK<Y7N2-E$DF(GN71 9&%0:>F0OPGEC@+D2>HP]25S_IZ6HP
M?;(+O5@5ZQJ5_=*HMYJG#(12M)<F!7!4E![+N716]@E81.VI14 5W??UL.9*
MV-^ITY]A*6S*G<X70<'\/H61FTR&>1@6TK]M/U_2$@Y.#X^O+U\\S?<N7+R9
M7F.4E3D&P,F<]X3 6)F6:RN0!%%SR:FO?6C6V6!Z-\MWJM-*$[2-#J01#J<9
M]:?37I9]6:\-"88GW_=I?E8F>+\K8Y/ ;H],ZJ_^*2,1*8>4-.ISFW$D I6Z
M+7E140F6G5,ZVMHY:UV,XUF8X1]L.6Q*G[TLA'5V;+2T60M/T(5F'H2/!JQ4
M#G2BSA$?K!>=7#M9:Q_NZ?WW6T+&H!W2+J(GZ#3*7Q%P0F TPG2RWA(:Z//<
M.>BO0:W-\*[]]:VXTE^C>==VBVL:'3- 5+E2VWD&+@8)SBC# LE4RMKGTGMR
MVGML/I^*_/NERY,>BAZ<__+F[>EOYYT<A=Y^^3X.0%>/I-*Q9VDX[B:79VU3
MRE3BJR^_3E(\'B\*6DJU09@./RT:-7N3O+!60HP)%5](%*R@!J,%9:EUE/KJ
MM63KH]LY4\=]F=<U7C0'X7]GPS:]FJ$%*(46"^[/6_8O?A,'Q/G(I&* ZS.B
M_^HL.'P+D@B.1YET$LOW8NZ<R[,!O@U=@,XS.+H@V%>Y0%W)KV+7P09CC#@O
MJGWGIM>*]:Q-'Z^ASV^$&(TFI_G@DQN.BC&XUL1W>GB04DXN) _91@%"8_!N
MLE*0LDY2*:(YK>WT5P'>I[/5?5%R[P+OA*L+5^!QA.62OH'2DG C#"22$J(L
MQ8W:XMI* J?0^1!T_?:9FV'L4U[O$S"PNACKD6U9=7\'I+/.$LL#!!-+YP&9
MP"K4WMXJ)9T3-*3:)VX;0MRP@^^/:8 K2K$[JN&L?$SM],O9R(U+M7;I=O%Q
MGOUNHI-9H;9UE*'>E:SX"!K_H"I*S3U3N?9AUOKH-NP3_&,2K([L:N:RK9J&
MVQ+*>],@F(LY>QP\*?4VQD4PDFOT/UDN;?5=4!TDNJV)KD*WMW)I0'J=%G_C
M0\INQ-V3YO=FH5]C/8W%KR%4+BYV-8X+8$%:[B0U6M?O$;4.LN<0/>U*JA7-
M VO+;,^=)GGFP@9'047C0$1)P22M0++2&IIKQE3MRHIJG2;W64VQ)S95EEA-
M,BT1?56OC9L;J;X,K/!.IRQ!V1! $.'1B*#5(CEXH5B*HHMVDIM ? 9A3??:
MJIX0Z]U5<[>MWK3WRRQ1BWIK@M.@'2^W8[L )=4:6**,6Y^HU+7S=QX%TZ>[
M1O;$GCJ"J7NRMV*,92K>C)H_[NIQ5>F*8G0)SM&A%1XC=%LN7Z*F]&.D)5F_
M=H.&M<'UZ>*2/?&H&\'5W,*[*8Y-$1]2C*P,FH-0'MTV$A&.BCSXR%*H7A>Q
M6>GQOJXMV1,SMISZ#IV<AUR]?_LJ6L3@"1I#Y;,J+<<%V$#10,:$PS>EL4!M
M8[0!O'7(HW\L\G0EO'JWDEZZ-KU"9+$D&*3Q9&$\T8OWS.4 097VA@(!6:LE
M:&&"Y-D*''5E(JU&L@YGS(_%F0HBZ5#YW+O>?""%2H:+",0D5H*^ ,8%"MQE
M)VGD3(;NU<T]0.N0Q?YXX7DE"75(FKON1,?CR:QUXY#N:SXGG13!&>!)"Q"<
MEM1=(2 'IF,4J 5Y[:RU33&NM8](?BQ%U*D<J['M?@^D@0S""6,EF"1MN3"!
M0]&.4$[=HPT\D5"[F\']YZ_%DCVVYMD'2[:>_XH,\#<G1M,O=P>3-ZG @RAC
MUCQFB%'ZTA4MEG[> M!ECTG[1+VHK5Z^ VDMGOQH&\DUQ53ORF <>/F_H/KD
M1F4O^WV:3-MAF*+_5=+,QO'A&_<^N<@E_UI-7O=V/OH<+MWX0WKOINDHYQ2F
M YFXBL&B2N2E1M00 UYC+.E3R%S9B$%D[1WH_8YPC^>N/DCB?=#@C908C:.A
M,3(&D.CA)!D8K;\1LNVYZQ,WJ>DOQU<T-.E"_%VG!:S*CD@"!\VM!L)T!B'+
M_G.F)7+S)&3E969]2;!^XN8XSYZ>NXJ_:WJ^&8[157^(+^8@,D=47HF2L94S
M&,T5:)T"#\)K6KU(;GUT?3H&??[TW%7\3T'/Q'.DR5O(F1H0.#>X?"+#R)(+
M96U(7NY)>WZ7GNO/0VG9>Y/X]J9I[R?TWIQY8S353(;3R<!(+:4D%#(-I:6.
M\AA+&P;.H^K@P422R-($K.J4O.;CGD.:U*XTN=\XN0LI=)*O?P_H_.1@U20H
MX[US"4%J6JX,+FN9Z0C),6NU8L*'VME2&T+LD[O1,;OV(<3J&=2GN03GQY/)
MK&SI'383I'[FF>CD"(;C OUKG318ER58HW3*66E2W7_]!IP-/8)GK:!J2Z<Z
M79#'[]/'68O.RR2=YL/FZJH9GT^;\/N 2,DU41JT)0($CA(<BQQ<<HZJ$ U)
MU1NC?Q?5<ZC@Z(H\E635B7&[H72I31\/F_9M,_YPD=JK>4F)ULHS93,$5IK
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M?@D25NB4B;(J5L^HVZA[QV;E?P^7T/M[!YWS39.!4Y%0'QQX7^HZ!"'@E..
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MK\A:6?#[*NW]NK"/<*F(-PY<%NA?T\1+$K(%QTO%$?>.ZSU7\79>H;]6!/(
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MF'_\89#_\N. "Z&BML5RHQ2//":>O!?::B:R=>E\DP?61<Z7>3%*7SW_HN[
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MS:LKMN^89[VHKX>;H)/)!*<KH!65BT&E@&..M=N@ 9\* \.(_8C&1M::68_
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M7O75!>P?E84M-;Y5^=<FZMH[QPB.3Z5X<BF5 I4U U>$!"-UBL)H&9IG,QP
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M*P"[WY,:ZGOQM-E<M#T8GW_'>N!A/OF,X_ !WUQ5L9R6V9HGIU?3">W'^6:
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MX(Z^S%)K5CJ=!%T?> P,Z$6X#7N@78/DX@G/=8Y2&RVUE03+JSI TQ?R7*4
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ML)A#X"IZ-+A=Y6JG+=T]_%L79 O6'J_C\TB'FO5?UQ\1YOB?__'_4$L#!!0
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M_D+C$"<\(9 SSB'V? ^2$!/H,9\B$G"?>O[%[5_B,,*4>"'TL?0AI@Q#0ED
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M3M'@8T ]Q;I: _TX(M A5RSBGH0\8@1B&H9ZV^1A*$.,,(Z('YOJ+ X!5V,
M/4'\U>C?:!XDDOF>@B'W3<DX;2L2%4?0YYH_&&4!1DSO3ZL7@'FS5ZW&WJ?6
M06ZFF#0H-R*.A+?=!G.,K^O(AJ%%(MRI,M8^QV>2A+0[W<XHW^QS,-S2R1YX
MO\^V%?DGTL*L37M"(Q43)6"L[1>(61";J#H$PS"FGB](R./$?M]JV^W<%M@#
MI]O!*ZW,@=VK[[1[M1X'F^WK&.B.OG_50MODBNJW@;6&UV4'.P;,DQUR#PFX
MXR[6%;?.;:QU8Q/N8UT5W-_(.K_=]Q[^P\.RODQ'EU>TO'NWS+^]S[1-<-\D
MA5S?@HHC' :<1-H2I1)BY >0^CZ'DK)8)<*CL:!NM_*M^IT;\^^*#;B6&R@M
M.!";6/;R+ZX7]>WPM[-,1T!U9,;? ]2(#(S,8$=H\-M:[$'O]#L!-=@-?[M>
M)[[O[P3%\]O_;J]/=2?W?:8MXT**UZM*4^<7^9 7E13O7W_ZTK[0E+ABF"<Q
M,4G%(J8-6N$+2#%#$''?9P0'0F^_Q[VN:R?HW(BPV94;*4U0>5,7*\T DYE4
M:56"!_K#;%K&OJAK.<IV[#F'L1N9;GM?[S7![XVN@*TJ8R*"M;K@)Z/PG]MW
MAR][-O:PO-C=8$LQ9WYMV WL\V\4._;7;[WY)<_%-[VW_Y!F\GTE[\N%1P.!
M]/]@0#DW=;01I @'4$B,41 )+)!R62B>]3 WAE\+"'XS(H):1L=[A,]1M"/B
ML[ 9F4'=8'$FNZ.J#\12S]N?E%Z.JO>4%XX_V'.?6]&JME(_J[656FXV5R06
MF,>)@(%,&,0*19 212'A>FXS+)6?Q$Z;VX[.YC;--[*:I%&;#5AIL^MR!]IR
M%SL0?&-O7?LCY[Y?M8!DJ$UJ5U?3[DPME'ZV';5YQXU"A$P7;[-*VRB70N@O
M4%GW\=D$+#_JO8]<),HCBIE@OB2@$'L,0QK$"$:>+X7^-61V<0>G.IH;=32R
M@E;8"U"+"YJ ^EI@.^8XB6\W:PR)VLB,T1\P:\*P1>, 6922O[K-'W_6330\
MH7_8TL/)AB>A!EOUUK1@_7P_JV*3S&0G*=W?TNKNURQGI2P>C0ND3E)GJBUI
MS?1.I_:*?3''MB83PFM:IF6=&.6FH%FI]*S]O-+<]4$^RF6P"",4(L(3B*BY
MG\!C!A.?>9#&82"H]$).L,,=LXG$=HL?F>Q^VEI4D*\L[Z%--<QV9M$<1FT:
MGMRKR+R3G/.;UA;LJMNDZRS!OL)UI;U&95#K? %JK2_ 1F_S'3!F6ZTZ&*#R
MT,2#-)"M-[:TDYJ+$T'_U.*<JMLS5ZA&A+I-M+Z$0@B5H;96 T[UMC=2#%(6
M"DB(X"R((R]6R&7;V]'7W$S7_WN5ZU6GB>&Y+E(N2W-Z<<DK4[;S(RU^EYI5
M?FK8 3F66NF"W)'ISP-R0I9N!+UH^12-D#'9 I.A2?% 3R]#:,=5/DI&':_T
M+>F6%Y4VT^Y-V.$ZZ_AEDW1\G6K'I&!>1#)@29*$,.180:S\"#+!C?6JXI#Z
M'%,:NI5WL^MX;A3S+#,[S;)5G:ZS32)5F,W?3P]-D(\CQUB/AJ7';02,Q_:^
M&9&AD1D8H2_ !N]6[FVV+B-Y?;_Y.D_K)&C@)AVR2)0K>H,5C[/L=N)"<FY@
M/"\JY_A^GWCG5\GAX+K/O,HU56JH<;M@)X*)6/@)3$*IV4QX"B822XA$$ B"
M8Q2:JRZV <_6_<Z-S/X8'8AX3M;W=5OQFXQ>/G8)R;4?B6XF&Q'?D8G,"'T\
M G<-K1&]5\RS/< N0<^C #W9Q=WA '>,>7:&K3/HV;ZU":.>G57<#WMV?_W%
M/;?F5H[)-QW&,:$$^L3#INX'AHDO?<B(+VFH?,)]_K*NVEK.F?IF:]E>S"G;
MC.#D7EC[ ?EO[G;M'MV7]+'N#<'\G*J->/]=O:A[X([H-MWOI]]Z\+FZDX4I
M<5G(.YF5Z:-LL@A_R,ORDZP^JQOZ72],:2[TWTWF(/E&-O_=!+<P0I. 1P)R
MC .(8XX@260(!6$")8B' 7.*$#Q?I+GM(FJ- -]5:;^FM>/EF0$&S8[TIQV*
MD6F^&84];=H,Y^ GH]"?+X"IJITKH+4:)9II.#@'HNP!!)J4I(<#\"DM#]AR
MGR3KKZ(CUQ[7*05]#_OKXZN(1IA+!I47"Q-VY4,2J!#Z<>PIS;=,?VB?:-VA
MY[G1ZA_Q@63KT?HZ^EK^YHG:18,M$S*ZCXF%DV8LI$=FS5KLXVZ#3<I+(WRO
M_.LN,+OD8!\)[HF<-</"[IB(O0=TG<G87=J;,"%[#S7WD[+W:<!]==C/=_)%
MTF7Z7U*8A>F70O^S(")*D*D9'\E FF1)"C+&,/0B3H(X9HH*X9B0_427,W6F
MU+(!8U#K69)G;8' >BOOFD')!O?3G#\$C"^4)VDM+##27H!:WN&@L^?Q 2&<
MB+G/@]*)J2W!Z>#F4RU,QL:6JNSRK^TK[HS[T=S,I,6/K[)X3/FZ GSB89E$
MTH=U/A"<^!2R6&&HL$!<H$0@1&SM[H,]S,V^7@L)RD9*!P(XC.!IQCP;EY%Y
M<@-)*V /B_<P-/:,>#9$$_&@.U1.W-<)0P?C'7YO,I[K%'N7W;H?[)F^UY0H
MO]'OUG5- T%%&#("0Z),P3:F(-5_@8*1* DCA +DE )DK_6Y<5DM'##2]:H,
MNX^<G?.T-QXC<Y@]%.X9, ^I/%2:R[VVI\UE>4BM9PDK#S[4;Z)^DI6YQ5G?
MUA)2O/[Q:RG%^^SS@RPT:V>W=<!VD[K5EW$081I!90[A]2Q&D'*$8$A5%&)!
M4"RP2TYB^ZZ=IO@$68F-\[Y.3?;0R@[8#Y"OY09T([C;U'<8"SM>& ?AD4G#
M@%O?];[> ?<G([G>9O\9;(0'EZ=A=J85=\0&XAR'CB<E)'= GK)5CQ;Z4=G'
MO*ANZ:U\3?GO4FSW:^_+<E7W^_67_%$6F;%(OS[D69D74KPU :\/15K*<EU=
M-J"^4!)!2;F". @"R!"CD"0(J3C$RB.>6T&!801SF:+3E!M8ZP59K5COY.$#
M#9P=)TX_&&-O%->CT&BTYQ!JE#($^NM7L-4+;!0#.YJ-<*5H6+ 'HMJ!A)J4
MAH<%\BE%#]QZSRTCYR:M6%F?;%QFXD-.L[*N>%I'*GW89+@BH=!;1E]"))6I
MC4$1)"@*(8NCV/-)HEC(G':3EAW/;:.Y%;')+-A$G?3/)68] ):;TA%@'7N_
MVHI\T9Q_7H!:YAK<=VE&,V[,SJT*(R4H<P5NJ%VO;;?3;H@=P7BV5W9]OV?V
MW#R[75^I^I0W^1.S:N'%(E(QBJ' GH28Q9YF*<$@IRPB/&2^4FZY;P]V,S=B
M,E+"RMP;-#5E'!/4'@:2L4A&YC DDE(#R2,*$Q9CB+!"H1]&"8Y"-Z/\?"BG
M,;*;-,#+X2&U8_'S81J9L^LOV\XEU;??3:YD0]17C:S@(ZU.;4O<,^9VPC)4
MOMO#G4R;K;93T6>Y9KN?/B\SN?%[B< +>!(0*+BO-^=10F""$8.)Y,P70L2(
M)"X^R)VVY^9D;"?^5L!^F;[MO84]L1A[?EL T#OA]?!^O-V67R2M=(<G[M C
M@YX:O*_#H/9\>IMK ))$BE#EZ77;BTQV9PR9'TL8,$\E-" R($ZFD+L(<S.3
MKM;%34I@AK,-(AOA *%K6,XZ2!@([)<]4-@HL7.@,,J=C/X@CGO&T"7 ',X:
M+ "R/'.P:6FJZBG-GZ_UD]=%FA?_*6E1HH7$"B,4Q3#Q?:+M&_T/(XC 6/)0
MAC0,PR!81]BZ63AG2F8UG_<#<4>FSUHX\,-(-W8-E,-CY69538'_["N<M!\9
MW2Y ,X#_V3F $Y0RZ83[Q2J7')9JYH5*.J$\ORY)=_-]4XY?Y??W>?:UROGO
M7^^HGBB?5U59Z2^R7B<6<10K'"0!%*'O0^SK32=)8@QCH@$-N/!X:%6WP*Z[
MN5FH;3;M1F10RWP!&JG!CMBN2<@[$>]FU>%Q')DLSX6P1UIR&V3.2$[>V?S$
M*<IM5'V>J-SJK>&2WI2;/_XUE85N\N['F_R>IMF",H6HSP*(/<X@EI)!%B@?
M,L6Y%"*(*+4J:]"K][F1S38W"MA(6ML3GR[_ _S6R.QXHNDV&G;VW&@8CTQ$
MY\$[2 :9DS"-F![F>-\OGOOE)"PVB5U.-^)^.<GPI"QX2I>77S^W058R$B'W
MN0_])/%--<\ THA'T!<148H& ;-+P7*D_;F1TE9$H&6TOWIS"+IN?AD D)$9
M9!^+'O>1#H%B?QOI3' FNHMD^85QNH#4H7G']:-#;TUV^:A#Y-VK1UV/]3/
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M$H&-VL]HP>HE]TL\ U:!_D7;&.;$?G/8*?Q(!800DY!/08P5A43Y'$9AC&3
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M%N8:7:L'N&\4 5QK LI&%<!;70#;5<;>6=-SO$X[X<8?A9$9IAV S]L!:'4
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MW5..N;%&?4BG%U>^)S9XV,A] >X;R=T.2OL.D]W)]03@3W!VO1,_<P'6BER
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MZ<CACJ8_$.E4^. 92/<;/?FCL87:RB;:>%2(RA@J%FC*B$-N;AIX,% 1"7'
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M5OD^@50@"7F@) HC+K'TW6ZMG".."\M,<ZUEK0VHU;D :X6,\X3]  W9:*W
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MVB2DR;/+JBI2MJKJI!GY?@VJ=:FB!9>,$"(D3"2)(/:QA#2)(Y@D2A$:8C]
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MK5. )61>R"(6Z<U3;'6_R:73N1'N1N:V5D$C]::\7^\+[%8#8.NY'A;6T2W
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MB%0DU])7ZJ#.9B 4+]W/T->[GDBM-DNW[HXEUZ040\Q3ZWUFF%NJ@I:J%!%
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M=O[5K:+E=/[-/F#U638_ON&KZ<J]7X;]W6OY?3[]QT:OR@N<72R @1Q37N2
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MUD;UG+AA]ZN>QA]L6WW?N_ D[,W3]H]_G5K_;BF_/WW4/RPF984$RR9$B11
MB3' KK\EQ=1Z70C:'6RNH.%!E8O]Q(Z-<O9.<K;*EJ=AGZ__UJEJ@B?Z@6=A
MT3 =[F L&,[NQV->Z,0^*VL7^CH'9UY G#Q%\WN[8]"'GLU<9SD]MP//RA+P
M#Y8&74#)VA+A^Y^/>K[2$^ORR#RG&FB4*H"E=8.HX070.>$%S0RU/P4%@GB)
M'1LI[<*LG,L3&-CFB;1GI$AT_/J.'JD4MHY.I7))/L^53FJM(X:4!*$4*\S$
M3^BPH2=!0!R$HX2]W34<]\^Z:J<5]66YF-L_RJKX@Y7X]KO]9=*KF_G^,].Y
MG#[.].I>_UR_L>;^?:((YQ0: IC1F?6=M %,$6:Y*J76G3+0*!(6H'NY4F,C
ML:_OW[[_?/_QOY*;N[O?W[]+KM^^O?W]\_W-Y]^2+U]O/]L_OWW_R3YQ%QJW
M&V'^_,AOZ%GIF1IW>KJRY7/%EVJ5_/ZH^%J7+%D99#?>R=Z36Y.2/YQ-26E4
MU$#?>!A'"_V-H-+ P<#Q0#P,#XXX=C?*=IE952JOJXDY;4+!4J8+*6@.B.(&
M8(HL_RHE@4R%3B7GF2J"+EN/BQD;K9;)\<_4[!:E=P)4/V:\'*J>N:X#2L'4
MU0Y")#(Z(610>FDW]"5AG'FZ&P58XE$;V52O)52SC%$%4J,1P 4J ).( B4-
MALS^/P\+LW@V^M@6?*U<X"[P.6!^J[HS##TOYEJO'HKH';4XTLI]/O:@"_:H
M62_7Z?&'XC32>U&68]<ZMCS??EZ,XXTVBZ5VU1$XRQ3-, *,( @P@PR(5&M0
MY R3C.<P9]EDKK^Y@>Z[M]3KI)S7<F#5<CA0L;^E4:K\LG9.:"IDG-GSXYCA
M)F-$98[VFUP?G;&K1)2VQ2U=$17KGGKI==/I5=OI703CN8YZEPW>N7-5(^54
M<8S:CZ <48%4"B1W=X8LMULNGEGO*Y/,[L9@AJ%748I@R6-SRO97=%L]FYFK
M9Q/<[<IS-CP9MP^,^SZJ<N5]KM?KY51LUF4XR'J1?.'+?CHZ!",4K_>5I]RA
M&V&%P7&D*U;@ .'EE;<WE5^GJ[_7Z\%D18%1!H&0E *<NSC2PC" .,0,YX@A
MZ-7SX<3X8^.@O;MVIZ1_]=YCV+5S201$>F:,%V"<9PDO5/QK%U^(SD UBGU_
M98(J$+>8WE)I^-A;@U44;E%YOW)PVV/AE/7V876W$:NILH[=[;(,Q7>] ^M?
M-:0ETP9QRUNY_9\44\ UU" U1(I"8\93KYH_9R6-C<;>?KI+MMK^:[+5UG_E
MM@-[GMFBP=4SQUD]=T@EM\L=5AWHKATT?^*+!MY %/CLURT0Q"!:] *FA2#;
MWQ^,*KW,V"=-OQ=&4F%W[_"12V*R5(',B+*)J@*4ZA04.4+<SHV$:'OXZ+>Y
M[4_9#H>1/9/X0<%6OE>P=;$L<\VW)UZS\HPR^>4;G\Y#=\<]_@;X;:=?>5;_
M#RG1V\=Q9_\S,]9ZO:]T,-H_X+W7[KWT"'6_;.C]DL^KNO)?]>-BN9X0@UD!
M,0,HHQG SIL7J>MM"RG12DI"( LMX?M2R-B\^6V-VIVB2:5I> W? T#;&3H6
M3'W?&(4CU*F*[RD(+BKC>S#HX'5\3YEUK)#OR6?#%_E'B_GLR_?%7'_>E#ND
M#,H,$KN:32XTP-QHP"G, *$RDX88U[O:=W&_''QLB[K4+RD53"H-_1?S 7#G
M%_$E</2\> .0"%JTITSNM%@/!AMLD9XR8W]QGGRFXY:PR979>0(3S:&ARC7.
M*FO*2H8 0X8#GJ6%XAKGF<DGZ\6:SSQW<H<R@I;H5E)_OYBU=[Y?'#NX9?PQ
M*#TW19<!U/=N9IM.]6P/$W'G<=K\6%N&(Q*&]?5/FWC@I+<\&CUGY\MB-I5/
MU?_N\CMR7$!:N*9Y,I< IQEV!%  1@4K"I45)@LJ%1NJP-@^X'9O9'6=/24W
MJY4K_O0LP6/?FFBY.,?GQ8]-^D2[9ZJQJI\&]RJI%$_^J/\[=$9-*WK]9\\<
M%S^63)E6< *R8MK'Z4: ;Q</#XOYW=J.=/>=VU_8V\UZY7*XK/2)R% .!1*
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M.H/DBUZZ<_@[/9\NEI\7:[UZM]$?M%AN^/(I2U%6^QZ%X(5,<PX,SER:98H
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M2P?C1^-@F$;_A#L#_.^%/7!N7^#QT>MYR6^532IMK_9]M9W&42'TOU2/"^5
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M5D6>EJ6N,PEP7D# 4M=^ 1=%@5D!L0IB@U."QL8&E9Z!N\N3*/HQ0 QL>F:
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MK>JF.:N[:2ZU7'R;E^%Z+H&D-"99[9IIJBKU8?U=)X]E5'Q@S8VVJ?#CIE@
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M\=W[KW?_DKS_C]]O[O^K0UUB+]#]J*<7*'LFH'V=_R6I@\R<VL')"-W*#X?
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MRE-53K?WUU]2+U5RN4HB592LP6*V[5@2SWDH/3R'/"\6QM$%:!2Y*"N[:/U
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MW:KOY;F,Z6AB;.^JP=+/@+5D-^%O?WEZ8 6S/WCP-87]9SMO,#$CD_Z+#NK
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MH?!*,LA-+80LXBQ,$"<AMTZ]&@[6)"VK304+<#9@_2O6<!A&7I5V7.B^Z!R
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MV=#V1.@/?_ZDD?=GPW 847_^ X?W&M>&;]6 <9\1_ O+B[*+=! GDL51!E6
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M,(',5%,R-3H@(ZG)% F9HBJ-N%VE1E\"S6U9:'=MK%4"I4Z@4>H"[-0".[U
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MT5IOWCU_7:_DD]B:WHZW:OTC%VI3'3Y&3!(14P*3.(T@#E,$*9;:(HB5P%%
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MG'K#]2(QJ#G<Z:=.UAVN5[%V>[C^BX>M^TVKR4_E5L%E(3_4$7^+3(F AY3
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M=?;D,1P\?%(_X;ABA][!B:L&]A]?%=^W3;TN_8CW*U->8<$%)R34*R)#VC/
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M;'/+,&8IU 5H!\?]IM4#;?VJ<+D->*FA*;!8ZPA*)2_J9G7_V4G"P_,]/<^
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M='+QR]\FTW\,OSF _UC\T?[DZX_I\/S+_!=&&'_XV^F_.BV%"<9"\"& ((R
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M);'V#(YB]?:FR2WHYM0*:74$EHLG+70&YZ@ (4FT2?N<]</[J37O:^Z\;34
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MX4:)K >:.F4P9 *9T$$64J-,C(B0> [,.\_IK7JV"4!>H&$UD#1\.EE9S&V
M!B4W=:/#<4S?_S/]&%"MI#)4 DO!@*!!@5,B84BEDU-662VK!*KW7[L:-!H^
MN=Q>F'W?5RU#I7?#67"COR<WO4XMSXQ$K[+'S<_A7AB$ :]"@N1T(C((_,]V
M=]W/O7DU3#1\J%E%I(UDZ]\R\0Y_,AOHE*W+,@"7(J 'S0PX+2E80GRB21KG
MM@M%GGGQ:J!H^)2SAD";PL2R$&7)A$D)Q6(44.(H AM#:Q]S0)Q3S:F+!CWG
MBJBX\^K5<-'P$6<=H?:,C#WD("ZX&+ES-',^."H(<*_0S'$$MY%&0U T!IY(
M%&J[K,I[KUL- 0V?8&XNO&I:_[=?'PGO _Y@PTKLXZ.W!T>G!V_QB]/C#X=O
M]\X.WK[9^[!WM']P^MO!P=GI??I7*]-^_:$U:KC7)'W+ N_+&9P[]W6PR(4K
M"#C.[X9C-PY#M 2394G7#;PD.@]*1@,&O<B2<(W X$X"<4EQ+JUE\25_++N9
M7Z#@ZJ7+I95&\]GU3V[7V#IT;6HVKM^Q-YNE^>R&2QYD]"YF) ;]),$8Q3A*
M>T@B9A*E3XJ\E#&U"9?W*>BG?+PS)%P;F@KB[G&/N4_]E7]]PX2CDBC&&,98
M)*/)].A"*>K0MXY4VJ@\<R\=AVZ.F0>$] N=;33[)$BV$7,#6-EWLR][XUC^
M<_#?E\-O;H3,S/;F^VXZ_3$<G__5C2[30%&F#$L9=)86!*$>K/(>> @TB4!]
M9B\=>VR"G94(:P%+6P%@TK4V&H#8Z9?)='Z6IA>'XV]I-B]V>S9(TL7@-07T
MU= -9#:!44*"S42RJ-"/R[6MT5-T]-/^HCL ;2WK!O!RDD)"Z/M1FAVE^762
M A?*$>D=D"21"1W04DOB@,8H3:0L45;;L7N2D'XZ9'2'F.VEW0!DCN=?,,2\
M*YL!NGI"Q^Q *%8*[) 7+S4!$F*TFDF9PDO7?)O@Y3$5_?3.Z XL6\JY :3<
M)]Y$B0Z>H*!CN8_2R(8A-N#&:G&317E(9;OTB?OIJM$=/C:7[N;0F,S=J HT
M/DTG7]-T_N/3R*$XQK%X8%_+#HIV<8#A@$D9/2U/%<)<.P%&*P/,J("_P1#3
MDLI(>8F>%OR6*D%4-:&W8%N^N>&H[*3O)M-3=-VO4K:':?8V^?GM=T>3<;A:
M(HEP2C(S:#,S!V%#!$>$!B852RYG;U^L@=K( *U-90LN3YV(O5L%-0#!LGSF
M/SZF^9=)O!L"2.>YB\06#DJ'1%)ZH2G\RHK$;-0RO5B2O0G.GB&E!9>H"IAJ
MB'ICQ'Q+4S^IA)GWDTG\?3@:#0*5D5&K0#E:BDF5 FMS 7PBS%..SO]+A3F;
M@.3ZW2TX0E50L9$P&S <=SS[N]8OFL X6K\4<RX(YF X)Q!TC)K:Y&5\*2UN
MRR!JS1VH>JY+!_#87LP-8&5)_X!'6^J,$UBI2O_$<JSD7(*8%,_$*TWT2WVC
M-@^>^NDNUMD-PEJ";"!.^C!T?CA:.$KHL"\R/;],1BCTV7)+O!$-P6 O&NX
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M.?SK07?%6$^]9A>56:^R5[_SU1*@)??E<5?DVTQ (8S*"H-^Q\HM8R2E 64
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M2BB/3,C*B+G[_GZ!4D&=#\N#-I5M [C8OQW*<<5 0$YC=!02$R683;A47 R
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MHH>8#"WM0$R)A3.PH()"943!8W6__UERJI7A/QF0>T<6G0)%+$VA,XU@K*7
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M'DQ2!E)*5K*48ZH^/J<"V=N/LL<WED[X1>DGP]D_EG%[-%*@!;<@9<951H3
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M.OC^XI7NPS5K&;=&"(,KU:&(5#;@9*20I*6.&/1BJC=N[X'-E9:$^NF61.N
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MPTJJ@@P.O&,9E)=!^Y 5>N,K6.&-">@W&7U')G<WZOEYY@@\4="69FX<;RH
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M8"]9H<D*0[(![6-)<L#@W67.(3E-K1%6"OTP)6IUQ-R\IE]WLS?$;";F=KS
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M><G8-JIUA85H$(0QZO+IPF6Z$A(&$9@2F0*7UEFQ7TGH%TC':OEF[NL$D7>
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MT/SI8J,D\C(^7RY/??;CY[^SB=+6'/]D>YK>7^#TVNC^K)C5SB00)M;WD:P
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MD01EBL8:91W#O:*O/;^W'WR>4-YY"#F/C1WW'W><B?^UFF;B:1L2\)B$UDJ
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M^>S/R?3SXES&6G@B$61.OK8#./!:<W N:*>E9$ZTWZEVBXR>JJ';H.A467<
ME]HNN9WS\'PUKY(\%T$D&9P&DV($9019610%C(J699%,44.,,[A!1D_^4!NX
MG"KK#N!RG70OM?')(?A8BP4<<L"D!=BZSLGP*'BXF0IL<64= H]'2BRWNY..
MD>WQL)@M\:*Y%7D[F\8-%UDX%5V=X.#K;L'@B(ML&-0'%)^X,-RT1LAN2GHJ
M9FYO2XZ4>,.U+<TG15[/3YTT)7+'#S6:$/D0B<-.AW08A;)20-$$()4- L;
M(2:K,'@5"Q\B;_$XTR%=ILO0"P'2AT#6SQ-SGD4P:+B,3B7KAYU-T.]TR$/T
MOL]TR$-$W8G_<:/]GB%3(K,"5O(ZM85",U^;?VSF,; 2/?/#1LY]SH4\2+$/
M#[(X1,K=X>1:/IPAYDAW!'C&<EUW; $Y&DA!!^6B<<6V'KWU9 99'*3C?0=9
M'"+PT=\A'VI2/9NF?=_0@G<IY6PAVFJH/=JZX=9!IO_A):C(S%XOW0UIZ@EP
MQR+DH)[B@=35/4RW)0!)6D]1))UB+^@\4R3I8_&06!#.QN2YWZM6IV7+>G-X
MC8N$8UK<#U'+Z%#;4VCDC 823P;!E8&Z81F"4AZ\R\$(<D0DWZM%IZ4E:_X@
MT1'4!E#+V%#;>[@1,X+D)FT=TU@+X^JB3^%K L7K0( 2P>S53MATBM3C]V(<
M?6T.(NBQT7/ 8"/415A#]M?F9$$E9<$+BI%LG0YA3'3>[&6K&D^1>OR.C*,1
M-)"P.RPEVXQ3JZ-GA'10F.-U,V<&-,*"31Z%X,DJM\_"P#L_T--35P-\M!%D
M!UF$G0.J3?!(8;( )ID&99D'5ZMKLTC6,,T=4S?;N?YG#'L_)>-TLJ0[1,MV
M90+/*<@BH!2^KEG2=;<! X[2J,R%M,U'ISZ98>\':7B_8>^'B+L#T-R>0NY\
M270UICHRK_:>:07!I@2&&6ELBMFZUO;E:0Q[/TBS#PY[/T3,'>!DQPQRE57@
M@EPK9\UZS)D#5$I!#H4\<\N8CS>[^?Z'#'L_!2DG"KH#J-Q5;A!*DBRF# [U
M.KT?Z.^$ 3H$BFN&BLY#1Z7NCSKVO=UKV7'R[@XVUXJN?3+DF"<-62D&BCD*
MX9!30)!]#,Z%(%AK._.T2MT/4O2^I>Z'2+T[]-Q;4"U\M"B]AZA5'?%::H6L
MU<!M*;$8+TIJO<OQJ9>ZMT-8,\UT@+GW\UG,.2U^(SF^6BQ6.(WY7;ET]:[7
MQYV'[(5"5)#J+#2EK:*S9 MPI4NR-CMM6X=@^]+6TU78!F^#:*4#M/TJJP_Y
MVVH>O^ BIVM&6T;I=10()"='!TB3!"V)46;O5=T(;FXMN&AKVG:2U5-Z<0B;
M=KHN.H;7AIL2$Z=;/X/VEH/".I68VP12BY2SDB6%UEF!^RGJL_Y^"% =H8%F
M>&I>6/TA?Y]=?)],/S\GDB;+L\_SG"N[)Y99/_BSC8JN#R-_V!)L$R(2W@0$
MQBT!0B3P,2HP-GHID\@^#]'_TKX$NQZ?=^52HF1 )Q>3Y8_+L-A+X;P7$KC@
M%(1(KL&;:"%1/.*<3_IV6<?)*::[B!D_]CL1 [<R34W$WL'5]2L+EXE]IX(J
MKH SWM5IUA)"R0@2B0.O5-2\=0OA;2I&SF*W4>_-)=JGR;H[M&PRMBBR*5E[
M*)'1O9UK&V1T&6(L5B>7Z>YMOG5]!QWC(N94W=X+E2,$W0%8;MSW6V:N*BD#
M!8N&!)/J%E:F H0H%?$FA U)AQ);#^&XEZ">X'.,OF=#";\#)+W.2_JQK4'>
M#KI*!A5C!I36M3JI)'#*DCG.R)1G7"?9.A6YBXYQDX[-<7.RJ'N RZYR!6XQ
M^^0-9 K_ZEIP\O:XM(#)2"4S1IN:N\/=E?X,X]><+.\.,;,]2C86YGUMQZ[6
M4A>*%HQ.( +SBF-B7C0W,D^E .@@#>]7 '2(N+L S:UZ Z&=MW6E/+)<;U:*
M+'W)#(3T47%64FK>HWAD8<=CEP =I-N'"SL.$70'4-FU>]RHH N78%4=$FS1
M@_,\ U%NDE?!&ARVIF/O^VBP-ZQA[J,39=T=6JZ5=1M1LI>%@7:"#A$:"6@L
M@V2C\G5+%.>MIX$]F1;H@W2\;POT(0(?N0?BKOSZY:H-P7^;?,__E7&^W97)
MF2XV>++"C(-2@9-3SP)XI+"!:66=OCF%9%=CQ&%?[0DTQVIY]B@B[QQ,[Z;7
M&=,\8D2I(%23K521=/1TH&O9D_B,R_K6L*ACL/3+1WNJ]GD$*!TO\ [NLUWW
M_.NKAU]A4C*UVI?X)!:0&2 F- CCN3(\%1U;7VKW$C1NS<5 ,7HS#8S>Z7?]
MX#V??<]3G"[7L<;L.7Z;+/%B\G_6ROI9'/<&_YI\I?^N8\B#9 Z,\10S*)]K
MI; ')HKST0N=W3[+F$X@H;]GK2-!,'M\C3Q!X)W%Y0HOSKG,T67#@65$LM&U
MI\&0CUK'L+M44"NWS_5X/ 7]91W'@=T1^NCD]EQL!;B=,LJ5\"9[!<EKBG:,
MY1 H\*&3DR@0*E)P:P>X-&_2T5_^X#1D-9-Y)[BY*9T/N7JIY&9>C;VFLT+_
M;/GC7 N>H^$.BJM;S%UBX)AB$ ,/G!N9>&S]CG\8A?WY9>VP-I">.D#AC9:M
M/*=;7R.Z6*>1!*1S)#0#7$^Z25+JDB5C?-B"V$K%N$6PPZ'I1'F/[&7MDLL?
MTSC[^G6R7.;T:AKGZ[ 8+Z[.@PP4\!9,X(2MPD(#2.XC")N4+L4[5V[:K5W>
MU>%?'G<R]3!>U<#R[[>X^CFQ2'[B!"_>X[<\QVEZM_R2Y^LU$<M?UD2<5FU]
M^'<:E5^?R."P]=C!Q!(S.K"L6%!1:$ L% <65UN-C,)!!@&WK\?^&+_DM+JH
M75/;!2/KD&2=P#$>B4F*.YSTA?Q'EB!X'XAI"CFRMSGJUC4H]]$S?C+^1"3<
MFA312O@=N$V_<K"MN9#)>,<5V7%DQ$2)D9@HJBX?<8(K+DUHW<^]DY!QH=-.
MSW<M!3I:Z#TB9_,R$5)T2G%;EQ(G\@(=L6&Y!YNBSIJ< [RUO[<Y=GIX.FZ@
MY(=@<X3$.P#.#0]A.P6P4)#@.)VG@F20!7((7.6ZA90%+KP+NG69RDY".@/-
M,2J^6>1_LKP[ ,UOF02/%_^8?<VU2NL93O]UEK[7QO'MM"81N+.R)O63-*!\
MD11]$D,YNI0EEN1-Z[S2@T2-FQ ? DQM]= !L'X1TL_ 5KK"L!;Z9<?K?FMD
MY!]* 2QDQC-3.3;/>^^F9&0(/8H+=)S8>P'/M@AU\]AXV0O^;K5<+"GXI4#W
MQ6I.?WV?YY-9.D<5BTR2@T'TH')*X+,U9'NY-L8J)LH@>S8/(;*C*_!(9.P"
MVV!JZ@6'-[:,AFQ5",%"EK4*K!@#+D<)/'O4F2<R]8/YX0=N='V<&[ AEDX0
M=<.5>HTNO7_FR><ORYS.Z OX.5\?_U3GNZ=4Z AXH=8%8 B!_$;(QK'B2_ 8
M6C=I[TO;N$_"0R*KI5+ZS(0_?_?FS:M/;UZ^_?3Q]S_./IR]_?3RY<>SMR^>
MOWO[Z=7;WU^^??[JY<?C$^ '_7R#O/?Q[#1*=S]?/YRLIYR<3=/SV71)=BE/
MXR0O=BT(M-Y%P118H=9+10FDC/X.(_VG13"G7>O%D <1>'J_U&+QRR<NW56F
M7?;1)CJ,L@[^P5*?DNB/,92Z5B>IT/I"W$W)R#W@@V'E=CO5R7H8T;=:S)?G
M;_"_9_/GJ\62PMWY8IW \^@,TXI<0;/>QNT02$ <)"8?**[V6N]55$ _?PU!
M]*>?Z-G]Y;&[[4[7Y:R98$>&1:W#?U=^X6&36HF)IZ!1 F/>@+(D%,14('IG
MBR)#SW"O1MX'T'$G >. I(5&9ZW%.W*%R9N<)I&DMLF*<<VEBI:!84Y4QS "
M4AA9:_HD2PJS9S?-QJ[JD5]_=3QM-U+1K(F\1@VI?M(^21O:<PHL!UG :Z%
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M\SJU <OXT_75W&$$ \$0VO<,(YF;ARW8A ?I7)K;ABC\<N=(1F6KY6#/_4K
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M[=?^1F[=2_=G\^GE C7 9C@F[5W_PN:.9^L3I?<MB;+[ST#_-::G!EO9_Z?
MWR!:;[:Z:$K<[\J[_W4)\0S<7Y1]^&R; N*>II+2T]<(AK^^PYNF]GV C-3Q
MI_GG(>_G+>REWQROXJ?A6KDUO>*]SY\RZ;__ZOOG\A.^\D'48FU=.]A<#*$C
M+'!N'A[RT!=%#WY=5?SZ;[W<5V?'_P-02P,$%     @ YWB:5A]4S E;!0
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MMXH)JEM*J9%<U.6HIA0O."1(0P*\[F'\?.NK&S;9,DGC,*\?=!#Z_E#SS&?
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M 3VG!*O&[XVOK-)RRJRB-H='YYIN3RR<5.<F<WJ"<R:0$?(V!',:Z>*KS<^
M8TH_8.P$[]<HM(_[T!>FJ'0B[<V*%*W +8,#6,RDFS2ZW\\.(UOCG)R NE*E
M=_I132_8V(HOG%'Y.*OH]AEB%JZ$0&L.Z#!*R,L=./GNJNK42[A&0'U7:71W
MA,Q=$)BW?FUO=.Z-SA]M=#Y[D$;G\:A(5_#7M)QEK_X?4$L! A0#%     @
MYWB:5A%HF$8?AP( 92XA !               ( !     &AU;2TR,#(S,#,S
M,2YH=&U02P$"% ,4    " #G>)I6RU4M:3P3  "ES0  $
M@ %-AP( :'5M+3(P,C,P,S,Q+GAS9%!+ 0(4 Q0    ( .=XFE:I'<NTXR<
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$!     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
